PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Izaddoost, S; Nam, SC; Bhat, MA; Bellen, HJ; Choi, KW				Izaddoost, S; Nam, SC; Bhat, MA; Bellen, HJ; Choi, KW			Drosophila Crumbs is a positional cue in photoreceptor adherens junctions and rhabdomeres	NATURE			English	Article							LEBER CONGENITAL AMAUROSIS; RETINITIS-PIGMENTOSA; EXPRESSION; EPITHELIA; MUTATIONS; MEMBRANE; PROTEIN; DOMAIN	Drosophila Crumbs (Crb) is required for apical-basal polarity and is an apical determinant in embryonic epithelia(1,2). Here, we describe properties of Crb that control the position and integrity of the photoreceptor adherens junction and photosensitive organ, or rhabdomere(3). In contrast to normal photoreceptor adherens junctions and rhabdomeres, which span the depth of the retina, adherens junctions and rhabdomeres of Crb-deficient photoreceptors initially accumulate at the top of the retina and fail to maintain their integrity as they stretch to the retinal floor. We show that Crb controls localization of the adherens junction through its intracellular domain containing a putative binding site for a protein 4.1 superfamily protein (FERM)(4,5). Although loss of Crb or overexpression of the FERM binding domain causes mislocalization of adherens junctions, they do not result in a significant loss of photoreceptor polarity. Mutations in CRB1, a human homologue of crb, are associated with photoreceptor degeneration in retinitis pigmentosa 12 (RP12) and Leber congenital amaurosis (LCA)(6-10). The intracellular domain of CRB1 behaves similarly to its Drosophila counterpart when overexpressed in the fly eye. Our studies may provide clues for mechanisms of photoreceptor degeneration in RP12 and LCA.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Mt Sinai Sch Med, Inst Cardiovasc Res, Dept Med, Dept Mol Cell & Dev Biol, New York, NY 10029 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Icahn School of Medicine at Mount Sinai	Choi, KW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	kchoi@bcm.tmc.edu	Choi, Kwang-Wook/C-1707-2011; Nam, Sang-Chul/J-5518-2014; BHAT, MANZOOR/S-9273-2018	Choi, Kwang-Wook/0000-0002-8997-3065; Nam, Sang-Chul/0000-0001-7176-601X; Bellen, Hugo/0000-0001-5992-5989; BHAT, MANZOOR/0000-0003-0989-1498				Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; CAGAN RL, 1989, DEV BIOL, V136, P346, DOI 10.1016/0012-1606(89)90261-3; Chang HY, 2000, SCIENCE, V290, P1978, DOI 10.1126/science.290.5498.1978; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; den Hollander AI, 2001, AM J HUM GENET, V69, P198; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; Kumar JP, 1995, DEVELOPMENT, V121, P4359; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Littleton JT, 1997, J CELL BIOL, V137, P793, DOI 10.1083/jcb.137.4.793; LONGLEY RL, 1995, DEV BIOL, V171, P415, DOI 10.1006/dbio.1995.1292; Lotery AJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P415, DOI 10.1001/archopht.119.3.415; MIZUNO K, 1977, AM J OPHTHALMOL, V83, P32, DOI 10.1016/0002-9394(77)90188-X; NOBLE KG, 1978, ARCH OPHTHALMOL-CHIC, V96, P818, DOI 10.1001/archopht.1978.03910050424004; Rapraeger AC, 1998, CURR OPIN CELL BIOL, V10, P620, DOI 10.1016/S0955-0674(98)80038-0; Tanentzapf G, 2000, J CELL BIOL, V151, P891, DOI 10.1083/jcb.151.4.891; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Wolff Tanya, 1993, P1277; XU T, 1993, DEVELOPMENT, V117, P1223	23	208	209	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2002	416	6877					178	182		10.1038/nature720	http://dx.doi.org/10.1038/nature720			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11850624				2022-12-24	WOS:000174348100038
J	Stowers, L; Holy, TE; Meister, M; Dulac, C; Koentges, G				Stowers, L; Holy, TE; Meister, M; Dulac, C; Koentges, G			Loss of sex discrimination and male-male aggression in mice deficient for TRP2	SCIENCE			English	Article							PUTATIVE PHEROMONE RECEPTORS; MUS-MUSCULUS; OLFACTORY CONTROL; MULTIGENE FAMILY; BEHAVIOR; CHANNEL; TESTOSTERONE; ORGANIZATION; NEURONS; VISION	The mouse vomeronasal organ (VNO) is thought to mediate social behaviors and neuroendocrine changes elicited by pheromonal cues. The molecular mechanisms underlying the sensory response to pheromones and the behavioral repertoire induced through the VNO are not fully characterized. Using the tools of mouse genetics and multielectrode recording, we demonstrate that the sensory activation of VNO neurons requires TRP2, a putative ion channel of the transient receptor potential family that is expressed exclusively in these neurons. Moreover, we show that mate mice deficient in TRP2 expression fail to display mate-mate aggression, and they initiate sexual and courtship behaviors toward both males and females. Our study suggests that, in the mouse, sensory activation of the VNO is essential for sex discrimination of conspecifics and thus ensures gender-specific behavior.	Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute	Dulac, C (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	dulac@fas.harvard.edu	Stowers, Lisa/K-6137-2015; Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051; Dulac, Catherine/0000-0001-5024-5418; Meister, Markus/0000-0003-2136-6506; Stowers, Lisa/0000-0002-4403-1269	NIDCD NIH HHS [DC03903] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003903] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALBERTS JR, 1971, PHYSIOL BEHAV, V6, P619, DOI 10.1016/0031-9384(71)90218-6; BARKLEY MS, 1977, HORM BEHAV, V9, P32, DOI 10.1016/0018-506X(77)90048-4; BEAN NJ, 1982, PHYSIOL BEHAV, V29, P433, DOI 10.1016/0031-9384(82)90262-1; Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; CLANCY AN, 1984, J NEUROSCI, V4, P2222; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; CONNOR J, 1972, PSYCHON SCI, V27, P1; Del Punta K, 2000, GENOME RES, V10, P1958, DOI 10.1101/gr.10.12.1958; DRIVER PM, 1970, NATURE, V226, P968, DOI 10.1038/226968a0; Dulac C, 2000, CURR OPIN NEUROBIOL, V10, P511, DOI 10.1016/S0959-4388(00)00121-5; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; EDWARDS DA, 1973, PHYSIOL BEHAV, V11, P867, DOI 10.1016/0031-9384(73)90282-5; FARBMAN AI, 1992, CELL BIOL OLFACTION; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Hofmann T, 2000, BIOCHEM J, V351, P115, DOI 10.1042/0264-6021:3510115; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Keverne EB, 1999, SCIENCE, V286, P716, DOI 10.1126/science.286.5440.716; LEE CT, 1972, PSYCHON SCI, V27, P287; Li HS, 2000, J CELL BIOL, V150, P1411, DOI 10.1083/jcb.150.6.1411; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; Liman ER, 1996, J NEUROSCI, V16, P4625; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; MARUNIAK JA, 1986, PHYSIOL BEHAV, V37, P655, DOI 10.1016/0031-9384(86)90300-8; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; MEREDITH M, 1986, PHYSIOL BEHAV, V36, P737, DOI 10.1016/0031-9384(86)90362-8; Meredith M, 2001, CHEM SENSES, V26, P433, DOI 10.1093/chemse/26.4.433; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; NYBY J, 1979, J COMP PHYSIOL PSYCH, V93, P957, DOI 10.1037/h0077623; Pantages E, 2000, NEURON, V28, P835, DOI 10.1016/S0896-6273(00)00157-4; POWERS JB, 1973, PHYSIOL BEHAV, V10, P361; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; SIPOS ML, 1995, PHYSIOL BEHAV, V58, P529, DOI 10.1016/0031-9384(95)00089-2; VANNIER B, 1996, P NATL ACAD SCI USA, V93, P571; VANOORTMERSSEN GA, 1971, BEHAVIOUR, V38, P1, DOI 10.1163/156853971X00014; WYSOCKI CJ, 1991, J STEROID BIOCHEM, V39, P661, DOI 10.1016/0960-0760(91)90265-7; WYSOCKI CJ, 1979, NEUROSCI BIOBEHAV R, V3, P301, DOI 10.1016/0149-7634(79)90015-0; Xu XZS, 2000, NEURON, V26, P647, DOI 10.1016/S0896-6273(00)81201-5; Zann RA., 1996, ZEBRA FINCH SYNTHESI; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X; Zuker CS, 1996, P NATL ACAD SCI USA, V93, P571, DOI 10.1073/pnas.93.2.571	45	618	635	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2002	295	5559					1493	1500		10.1126/science.1069259	http://dx.doi.org/10.1126/science.1069259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11823606				2022-12-24	WOS:000173981300044
J	Whitchurch, CB; Tolker-Nielsen, T; Ragas, PC; Mattick, JS				Whitchurch, CB; Tolker-Nielsen, T; Ragas, PC; Mattick, JS			Extracellular DNA required for bacterial biofilm formation	SCIENCE			English	Article							PSEUDOMONAS-AERUGINOSA		Univ Queensland, Inst Mol Biosci, ARC Special Res Ctr Funct & Appl Genom, Brisbane, Qld 4072, Australia; Tech Univ Denmark, Bioctr DTU, Mol Microbial Ecol Grp, DK-2800 Lyngby, Denmark	University of Queensland; Technical University of Denmark	Mattick, JS (corresponding author), Univ Queensland, Inst Mol Biosci, ARC Special Res Ctr Funct & Appl Genom, Brisbane, Qld 4072, Australia.		Mattick, John/ABH-6130-2020; Whitchurch, Cynthia B/A-5954-2008; Mattick, John S/I-7789-2012	Mattick, John/0000-0002-7680-7527; Whitchurch, Cynthia B/0000-0003-2296-3791; Mattick, John S/0000-0002-7680-7527; Tolker-Nielsen, Tim/0000-0002-9751-474X				Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; KADURUGAMUWA JL, 1995, J BACTERIOL, V177, P3998, DOI 10.1128/jb.177.14.3998-4008.1995; Lipford GB, 1998, TRENDS MICROBIOL, V6, P496, DOI 10.1016/S0966-842X(98)01408-5; MUTO Y, 1986, MICROBIOL IMMUNOL, V30, P621, DOI 10.1111/j.1348-0421.1986.tb02989.x; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; Tolker-Nielsen T, 2000, J BACTERIOL, V182, P6482, DOI 10.1128/JB.182.22.6482-6489.2000	8	1428	1535	11	376	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2002	295	5559					1487	1487		10.1126/science.295.5559.1487	http://dx.doi.org/10.1126/science.295.5559.1487			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859186				2022-12-24	WOS:000173981300042
J	Fox, BA; Bzik, DJ				Fox, BA; Bzik, DJ			De novo pyrimidine biosynthesis is required for virulence of Toxoplasma gondii	NATURE			English	Article							CARBAMOYL-PHOSPHATE SYNTHETASE; PLASMODIUM-FALCIPARUM; PROTOZOAN PARASITE; GENE; TRANSFORMATION; RESISTANCE; CLONING	Toxoplasma gondii is a ubiquitous protozoan parasite that is responsible for severe congenital birth defects and fatal toxoplasmic encephalitis in immunocompromized people(1). Fundamental aspects of obligate intracellular replication and pathogenesis are only now beginning to emerge for protozoan parasites. T. gondii has a fragmented pathway for salvaging pyrimidine nucleobases derived from the parasite or host cell, and this limited pyrimidine salvage capacity is funnelled exclusively through uracil phosphoribosyltransferase(2,3). Disrupting the function of this enzyme does not affect the growth of T. gondii tachyzoites(4), which suggests that the de novo pyrimidine biosynthesis pathway may be necessary for growth. We have examined the virulence of T. gondii mutants that lack carbamoyl phosphate synthetase II (uracil auxotrophs) to determine whether de novo pyrimidine biosynthesis is required in vivo. Here we show that T. gondii uracil auxotrophs are completely avirulent not only in immune-competent BALB/c mice but also in mice that lack interferon-gamma. A single injection of the uracil auxotroph into BALB/c mice induces long-term protective immunity to toxoplasmosis. Our findings indicate the significance of the de novo pyrimidine biosynthesis pathway for the virulence of parasitic protozoa, and suggest routes for developing vaccines and chemotherapy.	Dartmouth Coll Sch Med, Dept Microbiol & Immunol, Lebanon, NH 03756 USA	Dartmouth College	Bzik, DJ (corresponding author), Dartmouth Coll Sch Med, Dept Microbiol & Immunol, Lebanon, NH 03756 USA.	David.J.Bzik@Dartmouth.edu			NIAID NIH HHS [R01 AI041930] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041930] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASAI T, 1983, MOL BIOCHEM PARASIT, V7, P89, DOI 10.1016/0166-6851(83)90037-3; BZIK DJ, 1987, P NATL ACAD SCI USA, V84, P8360, DOI 10.1073/pnas.84.23.8360; Chansiri K, 1995, MOL BIOCHEM PARASIT, V74, P239, DOI 10.1016/0166-6851(95)02499-9; Charest H, 2000, J IMMUNOL, V165, P2084, DOI 10.4049/jimmunol.165.4.2084; DONALD RGK, 1995, P NATL ACAD SCI USA, V92, P5749, DOI 10.1073/pnas.92.12.5749; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; FLORES MVC, 1994, MOL BIOCHEM PARASIT, V68, P315, DOI 10.1016/0166-6851(94)90176-7; Fox BA, 2001, MOL BIOCHEM PARASIT, V116, P85, DOI 10.1016/S0166-6851(01)00302-4; ILTZSCH MH, 1993, J EUKARYOT MICROBIOL, V40, P24, DOI 10.1111/j.1550-7408.1993.tb04877.x; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; MAHAN MJ, 1993, SCIENCE, V259, P686, DOI 10.1126/science.8430319; MAHMOUD AAF, 1976, NATURE, V263, P56, DOI 10.1038/263056a0; PFEFFERKORN ER, 1976, EXP PARASITOL, V36, P365, DOI 10.1016/0014-4894(76)90040-0; PFEFFERKORN ER, 1978, EXP PARASITOL, V44, P26, DOI 10.1016/0014-4894(78)90077-2; Schardl J, 1996, J PLAST FILM SHEET, V12, P157, DOI 10.1177/875608799601200208; SIBLEY LD, 1994, P NATL ACAD SCI USA, V91, P5508, DOI 10.1073/pnas.91.12.5508; SOLDATI D, 1993, SCIENCE, V260, P349, DOI 10.1126/science.8469986; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869	19	168	189	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2002	415	6874					926	929		10.1038/415926a	http://dx.doi.org/10.1038/415926a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859373	Bronze			2022-12-24	WOS:000173941000049
J	Chou, KM; Cheng, YC				Chou, KM; Cheng, YC			An exonucleolytic activity of human apurinic/apyrimidinic endonuclease on 3 ' mispaired DNA	NATURE			English	Article							BASE EXCISION-REPAIR; HUMAN APURINIC ENDONUCLEASE; POLYMERASE-BETA; L-CONFIGURATION; CELLS; MUTAGENESIS; EXPRESSION; MUTATIONS; HOMOLOGY; ANALOGS	Human apurinic/apyrimidinic endonuclease (APE1) is an essential enzyme in DNA base excision repair that cuts the DNA backbone immediately adjacent to the 5' side of abasic sites to facilitate repair synthesis by DNA polymerase beta (ref. 1). Mice lacking the murine homologue of APE1 die at an early embryonic stage(2). Here we report that APE1 has a DNA exonuclease activity on mismatched deoxyribonucleotides at the 3' termini of nicked or gapped DNA molecules. The efficiency of this activity is inversely proportional to the gap size in DNA. In a base excision repair system reconstituted in vitro, the rejoining of nicked mismatched DNA depended on the presence of APE1, indicating that APE1 may increase the fidelity of base excision repair and may represent a new 3' mispaired DNA repair mechanism. The exonuclease activity of APE1 can remove the anti-HIV nucleoside analogues 3'-azido-3'-deoxythymidine and 2',3'-didehydro-2', 3'-dideoxythymidine from DNA, suggesting that APE1 might have an impact on the therapeutic index of antiviral compounds in this category.	Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Cheng, YC (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St,Sterling Hall Med B-315, New Haven, CT 06520 USA.							Bennett RAO, 1997, P NATL ACAD SCI USA, V94, P7166, DOI 10.1073/pnas.94.14.7166; Bhagwat AS, 1999, NUCLEIC ACIDS RES, V27, P4028, DOI 10.1093/nar/27.20.4028; Bouayadi K, 1997, CANCER RES, V57, P110; CHEN DS, 1991, NUCLEIC ACIDS RES, V19, P5907, DOI 10.1093/nar/19.21.5907; CHENG YC, 1990, ANN NY ACAD SCI, V616, P217; Chou KM, 2000, J BIOL CHEM, V275, P31009, DOI 10.1074/jbc.M004082200; DEMPLE B, 1991, P NATL ACAD SCI USA, V88, P11450, DOI 10.1073/pnas.88.24.11450; GROVE KL, 1995, CANCER RES, V55, P3008; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; HUSAIN I, 1995, J BIOL CHEM, V270, P9683, DOI 10.1074/jbc.270.16.9683; KUNKEL TA, 1985, J BIOL CHEM, V260, P5787; Lindahl T, 2000, MUTAT RES-REV MUTAT, V462, P129, DOI 10.1016/S1383-5742(00)00024-7; Loeb KR, 2000, CARCINOGENESIS, V21, P379, DOI 10.1093/carcin/21.3.379; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; McCullough AK, 1999, ANNU REV BIOCHEM, V68, P255, DOI 10.1146/annurev.biochem.68.1.255; ROBSON CN, 1991, NUCLEIC ACIDS RES, V19, P1087, DOI 10.1093/nar/19.5.1087; SKALSKI V, 1995, BIOCHEM PHARMACOL, V50, P815, DOI 10.1016/0006-2952(95)00205-E; Strauss PR, 1997, J BIOL CHEM, V272, P1302, DOI 10.1074/jbc.272.2.1302; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; Zhu QY, 1996, AIDS RES HUM RETROV, V12, P507, DOI 10.1089/aid.1996.12.507	25	182	195	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					655	659		10.1038/415655a	http://dx.doi.org/10.1038/415655a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832948				2022-12-24	WOS:000173709100050
J	Golz, J; MacLeod, DIA				Golz, J; MacLeod, DIA			Influence of scene statistics on colour constancy	NATURE			English	Article							MUTUAL ILLUMINATION; NATURAL IMAGES; APPEARANCE; CHROMATICITY; PERCEPTION; MECHANISMS; MODEL	The light reflected from an object depends not only on the surface properties of this object but also on the illuminant. The same is true for the excitations of the photoreceptors, which serve as the basis for the perceived colour. However, our visual system has the ability to perceive constant surface colours despite changes in illumination(1). The average chromaticity of the retinal image of a scene depends on the illumination, and thus might be used by the visual system to estimate the illumination and to modulate the correction that subserves colour constancy(2-4). But this measure is not sufficient: a reddish scene under white light can produce the same mean stimulation as a neutral scene in red light. Higher order scene statistics-for example, the correlation between redness and luminance within the image-allow these cases to be distinguished. Here we report that the human visual system does exploit such a statistic when estimating the illuminant, and gives it a weight that is statistically appropriate for the natural environment.	Univ Kiel, Dept Psychol, D-24098 Kiel, Germany; Univ Calif San Diego, Dept Psychol, La Jolla, CA 93093 USA	University of Kiel; University of California System; University of California San Diego	Golz, J (corresponding author), Univ Kiel, Dept Psychol, Olshaussenstr 40, D-24098 Kiel, Germany.							BAUML KH, 1994, J OPT SOC AM A, V11, P531, DOI 10.1364/JOSAA.11.000531; Bloj MG, 1999, NATURE, V402, P877, DOI 10.1038/47245; Brainard DH, 1997, J OPT SOC AM A, V14, P1393, DOI 10.1364/JOSAA.14.001393; Brown RO, 1997, CURR BIOL, V7, P844, DOI 10.1016/S0960-9822(06)00372-1; BUCHSBAUM G, 1980, J FRANKLIN I, V310, P1, DOI 10.1016/0016-0032(80)90058-7; DZMURA M, 1986, J OPT SOC AM A, V3, P1662, DOI 10.1364/JOSAA.3.001662; DZMURA M, 1995, GEOMETRIC REPRESENTATIONS OF PERCEPTUAL PHENOMENA, P187; Eskew R. T., 1999, COLOR VISION GENES P, P345, DOI DOI 10.1016/B978-012370880-9.00302-9; FORSYTH DA, 1990, INT J COMPUT VISION, V5, P5, DOI 10.1007/BF00056770; FORSYTH DA, 1990, AI AND THE EYE, P201; FUNT BV, 1993, IEEE T PATTERN ANAL, V15, P1319, DOI 10.1109/34.250838; FUNT BV, 1991, INT J COMPUT VISION, V6, P5, DOI 10.1007/BF00127123; GERSHON R, 1989, COLOR RES APPL, V14, P325, DOI 10.1002/col.5080140610; GILCHRIST AL, 1992, INVEST OPHTH VIS SCI, V33, P756; Golz J, 1999, INVEST OPHTH VIS SCI, V40, pS749; JENNESS JW, 1995, VISION RES, V35, P797, DOI 10.1016/0042-6989(94)00169-M; Kraft JM, 1999, P NATL ACAD SCI USA, V96, P307, DOI 10.1073/pnas.96.1.307; LAND EH, 1986, VISION RES, V26, P7, DOI 10.1016/0042-6989(86)90067-2; LEE HC, 1986, J OPT SOC AM A, V3, P1694, DOI 10.1364/JOSAA.3.001694; MACLEOD DI, IN PRESS COLOUR PERC; MACLEOD DIA, 1979, J OPT SOC AM, V69, P1183, DOI 10.1364/JOSA.69.001183; MALONEY TM, IN PRESS COLOUR PERC; Mausfeld R, 1998, PERCEPTION, V27, P42; MAUSFELD R, IN PRESS PERCEPTION; Mausfeld R., 1998, COLOR VISION PERSPEC, P219; Ruderman DL, 1998, J OPT SOC AM A, V15, P2036, DOI 10.1364/JOSAA.15.002036; STOCKMAN A, 1993, J OPT SOC AM A, V10, P2491, DOI 10.1364/JOSAA.10.002491; TOMINAGA S, 1989, J OPT SOC AM A, V6, P576, DOI 10.1364/JOSAA.6.000576; Webster MA, 1997, VISION RES, V37, P3283, DOI 10.1016/S0042-6989(97)00125-9; WYSZECKI G, 1982, COLOR SCI CONCEPTS M, P145	30	93	95	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					637	640		10.1038/415637a	http://dx.doi.org/10.1038/415637a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832945				2022-12-24	WOS:000173709100045
J	Zhang, YX; Perry, K; Vinci, VA; Powell, K; Stemmer, WPC; del Cardayre, SB				Zhang, YX; Perry, K; Vinci, VA; Powell, K; Stemmer, WPC; del Cardayre, SB			Genome shuffling leads to rapid phenotypic improvement in bacteria	NATURE			English	Article							STREPTOMYCES-FRADIAE; PROTOPLAST FUSION; GENETIC-RECOMBINATION; REGENERATION; BIOSYNTHESIS; EVOLUTION; TYLOSIN	For millennia, selective breeding, on the basis of biparental mating, has led to the successful improvement of plants and animals to meet societal needs(1). At a molecular level, DNA shuffling mimics, yet accelerates, evolutionary processes, and allows the breeding and improvement of individual genes and subgenomic DNA fragments. We describe here whole-genome shuffling; a process that combines the advantage of multi-parental crossing allowed by DNA shuffling with the recombination of entire genomes normally associated with conventional breeding. We show that recursive genomic recombination within a population of bacteria can efficiently generate combinatorial libraries of new strains. When applied to a population of phenotypically selected bacteria, many of these new strains show marked improvements in the selected phenotype. We demonstrate the use of this approach through the rapid improvement of tylosin production from Streptomyces fradiae. This approach has the potential to facilitate cell and metabolic engineering and provide a non-recombinant alternative to the rapid production of improved organisms.	Maxygen, Redwood City, CA 94063 USA; Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA	Eli Lilly	del Cardayre, SB (corresponding author), Maxygen, 515 Galveston Dr, Redwood City, CA 94063 USA.							AHARONOWITZ Y, 1981, SCI AM, V245, P141, DOI 10.1038/scientificamerican0981-140; BALTZ RH, 1981, ANTIMICROB AGENTS CH, V20, P214, DOI 10.1128/AAC.20.2.214; BALTZ RH, 1988, ANNU REV MICROBIOL, V42, P547; BALTZ RH, 1978, J GEN MICROBIOL, V107, P93, DOI 10.1099/00221287-107-1-93; Christians FC, 1999, NAT BIOTECHNOL, V17, P259, DOI 10.1038/7003; Hamlyn P.F., 1979, GENETICS IND MICROOR, P185; HOPWOOD DA, 1980, PHILOS T R SOC B, V290, P313, DOI 10.1098/rstb.1980.0097; HOPWOOD DA, 1979, J GEN MICROBIOL, V111, P137, DOI 10.1099/00221287-111-1-137; HOPWOOD DA, 1978, MOL GEN GENET, V162, P307, DOI 10.1007/BF00268856; HOPWOOD DA, 1977, NATURE, V268, P171, DOI 10.1038/268171a0; IKEDA H, 1983, J ANTIBIOT, V36, P283, DOI 10.7164/antibiotics.36.283; Ness JE, 1999, NAT BIOTECHNOL, V17, P893, DOI 10.1038/12884; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Vinci V, 1999, MANUAL IND MICROBIOL, V2, P103; [No title captured]; [No title captured]; [No title captured]	17	409	518	7	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					644	646		10.1038/415644a	http://dx.doi.org/10.1038/415644a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832946				2022-12-24	WOS:000173709100047
J	Schwetz, BA				Schwetz, BA			Congenital heart defect devices	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2002	287	5					578	578		10.1001/jama.287.5.578-a	http://dx.doi.org/10.1001/jama.287.5.578-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UR	11829678				2022-12-24	WOS:000173686700006
J	Nicolas, JM; Fernandez-Sola, J; Estruch, R; Pare, JC; Sacanella, E; Urbano-Marquez, A; Rubin, E				Nicolas, JM; Fernandez-Sola, J; Estruch, R; Pare, JC; Sacanella, E; Urbano-Marquez, A; Rubin, E			The effect of controlled drinking in alcoholic cardiomyopathy	ANNALS OF INTERNAL MEDICINE			English	Article							IDIOPATHIC DILATED CARDIOMYOPATHY; LEFT-VENTRICULAR MASS; NATURAL-HISTORY; NUTRITIONAL-STATUS; HEART-FAILURE; LIVER-DISEASE; MYOPATHY; ETHANOL; CONSUMPTION; MEN	Background: Cardiomyopathy is a potentially fatal complication of alcohol abuse. In alcoholic persons who develop cardiac dysfunction, abstinence is thought to be essential to halt further deterioration of cardiac contractility. Some evidence indicates that reducing alcohol intake may also be beneficial. Objective: To evaluate the effect of moderate "controlled" drinking on cardiac function in patients with alcoholic cardiomyopathy. Design: 4-year prospective cohort study. Setting: A university hospital in Barcelona, Spain. Patients: 55 alcoholic men with cardiomyopathy who had been drinking a minimum of 100 g of ethanol per day for at least 10 years. Measurements: Evaluation of ethanol intake and nutrition, clinical assessment of cardiac status, and sequential echocardiography and radionuclide cardiac angiography. Results: After the first year of evaluation, all patients with cardiomyopathy who abstained from alcoholic beverages demonstrated significant improvement in left ventricular function (average increase in left ventricular ejection fraction, 0.131 [95% Cl, 0.069 to 0.193]). Patients who drank 20 to 60 g of ethanol per day showed a comparable mean improvement of 0.125 (CI, 0.082 to 0.168). In contrast, left ventricular election fraction deteriorated further in most patients who continued to abuse alcohol (>80 g/d). After 4 years, left ventricular ejection fraction had continued to improve in both abstinent patients and those who controlled their drinking. Ten patients who had continued to consume more than 80 g of ethanol per day died during the study. Conclusion: In patients with alcoholic cardiomyopathy, both abstinence and controlled drinking of up to 60 g of ethanol per day (four standard drinks) were comparably effective in promoting improvement in cardiac function.	Thomas Jefferson Univ, Jefferson Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; Univ Barcelona, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain	Jefferson University; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Rubin, E (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Pathol Anat & Cell Biol, 1020 Locust St,Suite 279, Philadelphia, PA 19107 USA.		SOLA, JOAQUIM FERNANDEZ/K-3991-2019	SOLA, JOAQUIM FERNANDEZ/0000-0002-3218-0582				ASKANAS A, 1980, AM HEART J, V99, P9, DOI 10.1016/0002-8703(80)90309-9; BORY M, 1977, NOUV PRESSE MED, V6, P3295; Christakis GT, 1996, ANN THORAC SURG, V62, P1084, DOI 10.1016/0003-4975(96)00533-4; Cohn JN, 1996, NEW ENGL J MED, V335, P490, DOI 10.1056/NEJM199608153350707; De Vries JHM, 1999, HLTH ISSUES RELATED, P27; DEMAKIS JG, 1974, ANN INTERN MED, V80, P293, DOI 10.7326/0003-4819-80-3-293; ESTRUCH R, 1993, ALCOHOL ALCOHOLISM, V28, P543; ESTRUCH R, 1989, MED CLIN-BARCELONA, V92, P69; ESTRUCH R, 1995, HEPATOLOGY, V22, P532, DOI 10.1016/0270-9139(95)90576-6; Estruch R, 1998, ALCOHOL CLIN EXP RES, V22, P2023, DOI 10.1111/j.1530-0277.1998.tb05911.x; Fernandez-Sola J, 2000, QJM-MON J ASSOC PHYS, V93, P35, DOI 10.1093/qjmed/93.1.35; FERNANDEZSOLA J, 1994, ANN INTERN MED, V120, P529, DOI 10.7326/0003-4819-120-7-199404010-00001; FernandezSola J, 1997, ADDICT BIOL, V2, P9, DOI 10.1080/13556219772822; FILLMORE KM, 1991, BRIT J ADDICT, V86, P1203, DOI 10.1111/j.1360-0443.1991.tb01700.x; FOY A, 1988, ALCOHOL CLIN EXP RES, V12, P360, DOI 10.1111/j.1530-0277.1988.tb00208.x; FUSTER V, 1981, AM J CARDIOL, V47, P525, DOI 10.1016/0002-9149(81)90534-8; GOLDMAN L, 1981, CIRCULATION, V64, P1227, DOI 10.1161/01.CIR.64.6.1227; GOULD L, 1971, J AMER MED ASSOC, V218, P1799, DOI 10.1001/jama.218.12.1799; Guillo P, 1997, AM J CARDIOL, V79, P1276, DOI 10.1016/S0002-9149(97)00101-X; JOHNSON RA, 1982, NEW ENGL J MED, V307, P1119, DOI 10.1056/NEJM198210283071804; KALANT H, 1999, HLTH ISSUES RELATED, P1; KASPER EK, 1994, J AM COLL CARDIOL, V23, P586, DOI 10.1016/0735-1097(94)90740-4; KUPARI M, 1991, AM J CARDIOL, V67, P274, DOI 10.1016/0002-9149(91)90559-4; KUPARI M, 1984, POSTGRAD MED J, V60, P151, DOI 10.1136/pgmj.60.700.151; LANGER RD, 1992, CIRCULATION, V85, P910, DOI 10.1161/01.CIR.85.3.910; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; MOUSHMOUSH B, 1991, ARCH INTERN MED, V151, P36, DOI 10.1001/archinte.151.1.36; NICOLAS JM, 1993, ALCOHOL ALCOHOLISM, V28, P551; Nie N.H., 1975, STAT PACKAGE SOCIAL; Oren S, 1996, AM J CARDIOL, V77, P93, DOI 10.1016/S0002-9149(97)89144-8; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; REDFIELD MM, 1993, J AM COLL CARDIOL, V22, P1921, DOI 10.1016/0735-1097(93)90780-5; SAVOLAINEN VT, 1993, ALCOHOL CLIN EXP RES, V17, P1112, DOI 10.1111/j.1530-0277.1993.tb05673.x; Sobell LC, 1996, AM J PUBLIC HEALTH, V86, P966, DOI 10.2105/AJPH.86.7.966; SOBELL LC, 1979, BEHAV RES THER, V17, P157, DOI 10.1016/0005-7967(79)90025-1; URBANOMARQUEZ A, 1995, JAMA-J AM MED ASSOC, V274, P149, DOI 10.1001/jama.274.2.149; URBANOMARQUEZ A, 1989, NEW ENGL J MED, V320, P409, DOI 10.1056/NEJM198902163200701; VANDENBERG BF, 1989, CURR OPIN CARDIOL, V4, P815, DOI 10.1097/00001573-198912000-00011; WYNNE J, 1998, HARRISONS PRINCIPLES, P1328	39	79	81	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2002	136	3					192	200		10.7326/0003-4819-136-3-200202050-00007	http://dx.doi.org/10.7326/0003-4819-136-3-200202050-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517YD	11827495				2022-12-24	WOS:000173637400002
J	Shahbazi, M; Pravica, V; Nasreen, N; Fakhoury, H; Fryer, AA; Strange, RC; Hutchinson, PE; Osborne, JE; Lear, JT; Smith, AG; Hutchinson, IV				Shahbazi, M; Pravica, V; Nasreen, N; Fakhoury, H; Fryer, AA; Strange, RC; Hutchinson, PE; Osborne, JE; Lear, JT; Smith, AG; Hutchinson, IV			Association between functional polymorphism in EGF gene and malignant melanoma	LANCET			English	Article							EPIDERMAL GROWTH-FACTOR; RECEPTOR; SUSCEPTIBILITY	Background Malignant melanoma, the most serious cutaneous malignancy, has attracted substantial attention because of its rapidly increasing incidence and the poor prognosis of some tumours. Little is known of the genetic factors that mediate susceptibility to, and outcome of, sporadic malignant melanoma. Because of its role in mitogenesis, which is especially relevant to wound healing, tumorigenesis, and proliferation of epidermal tissues, epidermal growth factor (EGF) is an attractive candidate in which to look for genetic polymorphisms. Methods We enrolled 135 white European patients with malignant melanoma and 99 healthy white European controls, and screened a selection of DNA samples for polymorphisms in the promoter and 5' untranslated region of the EGF gene by single-stranded conformational polymorphism (SSCP) analysis. We then screened DNA samples from all participants for the identified polymorphism by restriction-fragment-length polymorphism (RFLP) analysis. In-vitro EGF production was measured in peripheral-blood mononuclear cells from 34 controls, and the results were compared with the individuals' EGF genotypes. Findings We identified a single nucleotide substitution (G to A) at position 61 of the EGF gene. Allele frequencies in the controls were 56% EGF 61*A and 44% EGF 61*G. Cells from individuals homozygous for the 61*A allele produced significantly less EGF than cells from 61*G homozygotes (p=0.0004) or heterozygous A/G individuals (p=0.001). Compared with the A/A genotype, G/G was significantly associated with Breslow thickness (p=0.045) and with risk of malignant melanoma (odds ratio 4.9 [95% Cl 2.3-10.2], P<0.0001). Interpretation This study suggests that high EGF production might be important in the development of malignant melanoma.	Univ Manchester, Sch Biol Sci, Immunol Res Grp, Manchester M13 9PT, Lancs, England; Keele Univ, N Staffordshire Hosp, Postgrad Med Sch, Ctr Cell & Mol Med, Stoke On Trent, Staffs, England; Leicester Royal Infirm, Dept Dermatol, Leicester, Leics, England; N Staffordshire Hosp, Dept Dermatol, Stoke On Trent, Staffs, England	University of Manchester; Keele University; University Hospital of North Staffordshire NHS Trust; University of Leicester; Keele University; University Hospital of North Staffordshire NHS Trust	Pravica, V (corresponding author), Univ Manchester, Sch Biol Sci, Immunol Res Grp, Stopford Bldg, Manchester M13 9PT, Lancs, England.		Shahbazi, Majid/E-1452-2012; Fakhoury, Hana/F-6457-2017; lear, john/I-5465-2015	Fakhoury, Hana/0000-0001-9974-2108; Shahbazi, Majid/0000-0002-4143-8282; Fryer, Anthony/0000-0001-8678-0404; lear, john/0000-0002-2969-9922				BOYLE P, 1995, BRIT MED BULL, V51, P523, DOI 10.1093/oxfordjournals.bmb.a072978; FISHER DA, 1990, ENDOCR REV, V11, P418, DOI 10.1210/edrv-11-3-418; GROENEN LC, 1994, GROWTH FACTORS, V11, P235, DOI 10.3109/08977199409010997; Hutchinson PE, 2000, CLIN CANCER RES, V6, P498; Ichii-Jones F, 1998, J INVEST DERMATOL, V111, P218, DOI 10.1046/j.1523-1747.1998.00287.x; LAFUENTE A, 1995, BRIT J CANCER, V72, P324, DOI 10.1038/bjc.1995.332; LAURENCE DJR, 1990, TUMOR BIOL, V11, P229, DOI 10.1159/000217659; Lazar-Molnar E, 2000, CYTOKINE, V12, P547, DOI 10.1006/cyto.1999.0614; Lear JT, 1998, INT J CLIN PRACT, V52, P145; Ma D, 1998, INVEST OPHTH VIS SCI, V39, P1067; MACKIE RM, 1995, BRIT J CANCER, V71, P173, DOI 10.1038/bjc.1995.35; MORTON CC, 1986, CYTOGENET CELL GENET, V41, P245, DOI 10.1159/000132237; Rivers JK, 1996, LANCET, V347, P803, DOI 10.1016/S0140-6736(96)90873-9; Rodeck U, 1988, Cancer Treat Res, V43, P3; RODECK U, 1993, CANCER METAST REV, V12, P219, DOI 10.1007/BF00665954; Strange RC, 1999, PHARMACOGENETICS, V9, P269, DOI 10.1097/00008571-199906000-00001; Valverde P, 1996, HUM MOL GENET, V5, P1663, DOI 10.1093/hmg/5.10.1663; Wagner SN, 1998, BRIT J DERMATOL, V138, P13; WOLF CR, 1992, TOHOKU J EXP MED, V168, P73, DOI 10.1620/tjem.168.73; WORM M, 1995, EXP DERMATOL, V4, P305	20	226	242	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 2	2002	359	9304					397	401		10.1016/S0140-6736(02)07600-6	http://dx.doi.org/10.1016/S0140-6736(02)07600-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UP	11844511				2022-12-24	WOS:000173686500011
J	Sisodia, SS				Sisodia, SS			Biomedicine - A cargo receptor mystery APParently solved?	SCIENCE			English	Editorial Material							AMYLOID PRECURSOR PROTEIN; AXONAL-TRANSPORT; GAMMA-SECRETASE; KINESIN; APP; PHOSPHORYLATION; LOCALIZATION; PRESENILIN-1; MICE		Ctr Mol Neurobiol, Chicago, IL 60637 USA		Sisodia, SS (corresponding author), Ctr Mol Neurobiol, Chicago, IL 60637 USA.	ssisodia@drugs.bsd.uchicago.edu						Ando K, 1999, J NEUROSCI, V19, P4421; Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cook DG, 1996, P NATL ACAD SCI USA, V93, P9223, DOI 10.1073/pnas.93.17.9223; Cupers P, 2001, J CELL BIOL, V154, P731, DOI 10.1083/jcb.200104045; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; FERREIRA A, 1993, J NEUROSCI, V13, P3112; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Heber S, 2000, J NEUROSCI, V20, P7951; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Iijima K, 2000, J NEUROCHEM, V75, P1085, DOI 10.1046/j.1471-4159.2000.0751085.x; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Matsuda S, 2001, J NEUROSCI, V21, P6597; Mattson M P, 2001, Trends Neurosci, V24, P441, DOI 10.1016/S0166-2236(00)01936-6; Muresan V, 2001, MOL BIOL CELL, V12, p311A; SCHEINFELD MH, 2001, J BIOL CHEM     1127; SISODIA SS, 1993, J NEUROSCI, V13, P3136; Sisodia SS, 2001, TRENDS NEUROSCI, V24, pS2, DOI 10.1016/S0166-2236(00)01987-1; Torroja L, 1999, CURR BIOL, V9, P489, DOI 10.1016/S0960-9822(99)80215-2; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6	27	25	27	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2002	295	5556					805	807		10.1126/science.1069661	http://dx.doi.org/10.1126/science.1069661			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823626				2022-12-24	WOS:000173733000028
J	Ruitenberg, A; van Swieten, JC; Witteman, JCM; Mehta, KM; van Duijn, CM; Hofman, A; Breteler, MMB				Ruitenberg, A; van Swieten, JC; Witteman, JCM; Mehta, KM; van Duijn, CM; Hofman, A; Breteler, MMB			Alcohol consumption and risk of dementia: the Rotterdam Study	LANCET			English	Article							APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; VASCULAR DEMENTIA; ACETYLCHOLINE; VALIDATION; DIAGNOSIS; DRINKING; ETHANOL; HEALTH; WINE	Background Light-to-moderate alcohol consumption reduces the risk of coronary heart disease and stroke. Because vascular disease is associated with cognitive impairment and dementia, we hypothesised that alcohol consumption might also affect the risk of dementia. Methods We examined the relation between alcohol consumption and risk of dementia in individuals taking part in the Rotterdam Study-a prospective population-based study of 7983 individuals aged 55 years and older. We studied all participants who did not have dementia at baseline (1990-93) and who had complete data on alcohol consumption (n=5395). Through follow-up examinations in 1993-94 and 1997-99 and an extensive monitoring system, we obtained nearly complete follow-up (99.7%) until the end of 1999. We used proportional hazards regression analysis, adjusted for age, sex, systolic blood pressure, education, smoking, and body-mass index, to compare the risk of developing dementia between individuals who regularly consumed alcohol and individuals who did not consume alcohol. Findings The average follow-up was 6.0 years. During this period, 197 individuals developed dementia (146 Alzheimer's disease, 29 vascular dementia, 22 other dementia). The median alcohol consumption was 0.29 drinks per day. Light-to-moderate drinking (one to three drinks per day) was significantly associated with a lower risk of any dementia (hazard ratio 0.58 [95% CI 0.38-0.90]) and vascular dementia (hazard ratio 0.29 [0.09-0.93]). We found no evidence that the relation between alcohol and dementia varied by type of alcoholic beverage. Interpretation These findings suggest that light-to-moderate alcohol consumption is associated with a reduced risk of dementia in individuals aged 55 years or older. The effect seems to be unchanged by the source of alcohol.	Eramus Med Ctr, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Eramus Med Ctr, Dept Neurol, NL-3000 DR Rotterdam, Netherlands; Eramus Med Ctr, Netherlands Inst Hlth Sci, NL-3000 DR Rotterdam, Netherlands		Breteler, MMB (corresponding author), Eramus Med Ctr, Dept Epidemiol & Biostat, POB 1738, NL-3000 DR Rotterdam, Netherlands.	breteler@epib.fgg.eur.nl	Breteler, Monique M.B./J-5058-2014	Breteler, Monique M.B./0000-0002-0626-9305; Van Duijn, Cornelia/0000-0002-2374-9204; van Swieten, John/0000-0001-6278-6844				American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Berger K, 1999, NEW ENGL J MED, V341, P1557, DOI 10.1056/NEJM199911183412101; BRETELER MMB, 1994, BRIT MED J, V308, P1604, DOI 10.1136/bmj.308.6944.1604; BYERS T, 1987, AM J EPIDEMIOL, V125, P999, DOI 10.1093/oxfordjournals.aje.a114638; Carmelli D, 1999, NEUROEPIDEMIOLOGY, V18, P125, DOI 10.1159/000026204; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; DOLL R, 1994, BRIT MED J, V309, P911, DOI 10.1136/bmj.309.6959.911; Dufouil C, 2000, EPIDEMIOLOGY, V11, P280, DOI 10.1097/00001648-200005000-00009; FENN CG, 1982, THROMB HAEMOSTASIS, V48, P49; Feunekes GIJ, 1999, AM J EPIDEMIOL, V150, P105; FRATIGLIONI L, 1993, ANN NEUROL, V33, P258, DOI 10.1002/ana.410330306; GOLDBERG DM, 1995, CLIN CHIM ACTA, V237, P155, DOI 10.1016/0009-8981(95)06069-P; GOLDBOHM RA, 1994, EUR J CLIN NUTR, V48, P253; Hebert R, 2000, STROKE, V31, P1487, DOI 10.1161/01.STR.31.7.1487; Henn C, 1998, N-S ARCH PHARMACOL, V357, P640, DOI 10.1007/PL00005219; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; JOYCE EM, 1994, BRIT MED BULL, V50, P99, DOI 10.1093/oxfordjournals.bmb.a072888; KLATSKY AL, 1986, CIRCULATION, V73, P628, DOI 10.1161/01.CIR.73.4.628; Klipstein-Grobusch K, 1998, EUR J CLIN NUTR, V52, P588, DOI 10.1038/sj.ejcn.1600611; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MILLER NE, 1988, J EPIDEMIOL COMMUN H, V42, P220, DOI 10.1136/jech.42.3.220; Orgogozo JM, 1997, REV NEUROL-FRANCE, V153, P185; Ott A, 1998, AM J EPIDEMIOL, V147, P574; Perry E, 1999, TRENDS NEUROSCI, V22, P273, DOI 10.1016/S0166-2236(98)01361-7; Rimm EB, 1996, BRIT MED J, V312, P731, DOI 10.1136/bmj.312.7033.731; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; RUITENBERG A, IN PRESS NEUROBIOL A; SAUNDERS PA, 1991, BRIT J PSYCHIAT, V159, P213, DOI 10.1192/bjp.159.2.213; Skoog I, 1998, NEUROEPIDEMIOLOGY, V17, P2, DOI 10.1159/000026147; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; 1993, NEVO TABLE DUTCH FOO	34	359	367	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 26	2002	359	9303					281	286		10.1016/S0140-6736(02)07493-7	http://dx.doi.org/10.1016/S0140-6736(02)07493-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517AC	11830193				2022-12-24	WOS:000173588100007
J	Mellor, J; Nicoll, RA; Schmitz, D				Mellor, J; Nicoll, RA; Schmitz, D			Mediation of hippocampal mossy fiber long-term potentiation by presynaptic I-h channels	SCIENCE			English	Article							INWARD RECTIFYING CURRENT; GYRUS GRANULE CELLS; SYNAPTIC TRANSMISSION; ADENYLATE-CYCLASE; CATION CURRENT; CYCLIC-AMP; 2 FORMS; NEURONS; EXPRESSION; PACEMAKER	Hippocampal mossy fiber long-term potentiation (LTP) is expressed presynaptically, but the exact mechanisms remain unknown. Here, we demonstrate the involvement of the hyperpolarization-activated cation channel (I-h) in the expression of mossy fiber LTP. Established LTP was blocked and reversed by I-h. channel antagonists. Whole-cell recording from granule cells revealed that repetitive stimulation causes a calcium- and I-h-dependent long-lasting depolarization mediated by protein kinase A. Depolarization at the terminals would be expected to enhance transmitter release, whereas somatic depolarization would enhance the responsiveness of granule cells to afferent input. Thus, I-h channels play an important rote in the long-lasting control of transmitter release and neuronal excitability.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.		MELLOR, Jack/B-4548-2019	MELLOR, Jack/0000-0002-7706-8105; Schmitz, Dietmar/0000-0003-2741-5241				Abi-Gerges N, 2000, J PHYSIOL-LONDON, V523, P377, DOI 10.1111/j.1469-7793.2000.t01-2-00377.x; Accili EA, 1997, J PHYSIOL-LONDON, V500, P643, DOI 10.1113/jphysiol.1997.sp022049; Beaumont V, 2000, NAT NEUROSCI, V3, P133, DOI 10.1038/72072; Biel M, 1999, REV PHYSIOL BIOCH P, V136, P165, DOI 10.1007/BFb0032324; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; CASTILLO PE, 2000, SOC NEUR ABSTR, V27; CHANG F, 1991, J PHYSIOL-LONDON, V440, P367, DOI 10.1113/jphysiol.1991.sp018713; Chen CF, 1997, J NEUROSCI, V17, P8687; FROEMKE RC, 2000, SOC NEUR ABSTR, V27; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; GLATT CE, 1993, NATURE, V361, P536, DOI 10.1038/361536a0; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; Harris NC, 1995, J NEUROPHYSIOL, V74, P2366, DOI 10.1152/jn.1995.74.6.2366; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; Huang YY, 1995, CELL, V83, P1211, DOI 10.1016/0092-8674(95)90146-9; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Janigro D, 1997, J MEMBRANE BIOL, V160, P101, DOI 10.1007/s002329900299; KOCSIS JD, 1983, J PHYSIOL-LONDON, V334, P225, DOI 10.1113/jphysiol.1983.sp014491; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mellor J, 2001, NAT NEUROSCI, V4, P125, DOI 10.1038/83941; Moosmang S, 1999, BIOL CHEM, V380, P975, DOI 10.1515/BC.1999.121; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Sakaba T, 2001, P NATL ACAD SCI USA, V98, P331, DOI 10.1073/pnas.021541098; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Southan AP, 2000, J PHYSIOL-LONDON, V526, P91, DOI 10.1111/j.1469-7793.2000.t01-1-00091.x; STABEL J, 1992, NEUROSCI LETT, V135, P231, DOI 10.1016/0304-3940(92)90443-B; STALEY KJ, 1992, J NEUROPHYSIOL, V67, P1346, DOI 10.1152/jn.1992.67.5.1346; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; Trudeau LE, 1996, NEURON, V17, P789, DOI 10.1016/S0896-6273(00)80210-X; Turecek R, 2001, NATURE, V411, P587, DOI 10.1038/35079084; Villacres EC, 1998, J NEUROSCI, V18, P3186; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WORLEY PF, 1986, P NATL ACAD SCI USA, V83, P4053, DOI 10.1073/pnas.83.11.4053; XIA ZG, 1991, NEURON, V6, P431, DOI 10.1016/0896-6273(91)90251-T; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	41	128	134	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2002	295	5552					143	147		10.1126/science.1064285	http://dx.doi.org/10.1126/science.1064285			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778053				2022-12-24	WOS:000173143100054
J	Haas, W; Shepard, BD; Gilmore, MS				Haas, W; Shepard, BD; Gilmore, MS			Two-component regulator of Enterococcus faecalis cytolysin responds to quorum-sensing autoinduction	NATURE			English	Article							MEMBRANE-PROTEINS; TOXIN; IDENTIFICATION; ACTIVATION; PREDICTION	Bacteria of the genus Enterococcus are the main causes of highly antibiotic-resistant infections that are acquired in hospitals(1,2). Many clinical isolates of Enterococcus faecalis produce an exotoxin called cytolysin that contributes to bacterial virulence(3). In addition to its toxin activity, the cytolysin is bactericidal for nearly all Gram-positive organisms(4). An understanding of conditions that regulate cytolysin expression has advanced little since its initial description(5). Here we show that the products of two genes, cylR1 and cylR2, which lack homologues of known function, work together to repress transcription of cytolysin genes. Derepression occurs at a specific cell density when one of the cytolysin subunits reaches an extracellular threshold concentration. These observations form the basis of a model for the autoinduction of the cytolysin by a quorum-sensing mechanism involving a two-component regulatory system.	Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Gilmore, MS (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, 975 NE 10th St, Oklahoma City, OK 73104 USA.							Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Booth MC, 1996, MOL MICROBIOL, V21, P1175, DOI 10.1046/j.1365-2958.1996.831449.x; BRENNAN RG, 1989, J BIOL CHEM, V264, P1903; BROCK TD, 1963, J BACTERIOL, V86, P702, DOI 10.1128/JB.86.4.702-707.1963; Coburn PS, 1999, INFECT IMMUN, V67, P3339, DOI 10.1128/IAI.67.7.3339-3347.1999; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; DUNNY GM, 1999, CELL CELL SIGNALING; Francia MV, 2001, PLASMID, V46, P117, DOI 10.1006/plas.2001.1533; Gerberding J, 2000, AM J INFECT CONTROL, V28, P429, DOI 10.1067/mic.2000.110544; GILMORE MS, 1994, J BACTERIOL, V176, P7335, DOI 10.1128/JB.176.23.7335-7344.1994; GILMORE MS, 1990, INFECT IMMUN, V58, P3914, DOI 10.1128/IAI.58.12.3914-3923.1990; Haas W, 1999, MED MICROBIOL IMMUN, V187, P183, DOI 10.1007/s004300050091; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; IKE Y, 1984, J BACTERIOL, V158, P777, DOI 10.1128/JB.158.3.777-783.1984; Mundy LM, 2000, CLIN MICROBIOL REV, V13, P513, DOI 10.1128/CMR.13.4.513-522.2000; Poyart C, 1997, FEMS MICROBIOL LETT, V156, P193, DOI 10.1016/S0378-1097(97)00423-0; Sambrook J., 2001, MOL CLONING; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shepard BD, 1999, APPL ENVIRON MICROB, V65, P1470; Todd EW, 1934, J PATHOL BACTERIOL, V39, P299, DOI 10.1002/path.1700390207; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Zhang HZ, 2001, SCIENCE, V291, P1962, DOI 10.1126/science.1055144; [No title captured]	24	159	168	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					84	87		10.1038/415084a	http://dx.doi.org/10.1038/415084a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780122				2022-12-24	WOS:000173028800045
J	Glorieux, FH				Glorieux, FH			A disease of the osteoblast	LANCET			English	Article									Shriners Hosp Children, Genet Unit, Montreal, PQ H3G 1A6, Canada; McGill Univ, Montreal, PQ H3A 2T5, Canada	McGill University; McGill University	Glorieux, FH (corresponding author), Shriners Hosp Children, Genet Unit, 1529 Cedar Ave, Montreal, PQ H3G 1A6, Canada.								0	14	14	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2001				S			S45	S45						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505HK	11784594				2022-12-24	WOS:000172907200045
J	Winston, WM; Molodowitch, C; Hunter, CP				Winston, WM; Molodowitch, C; Hunter, CP			Systemic RNAi in C-elegans requires the putative transmembrane protein SID-1	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; GENETIC INTERFERENCE	Double-stranded RNA-mediated gene interference (RNAi) in Caenorhabditis elegans systemically inhibits gene expression throughout the organism. To investigate how gene-specific silencing information is transmitted between cells, we constructed a strain that permits visualization of systemic RNAi. We used this strain to identify systemic RNA interference-deficient (sid) loci required to spread gene-silencing information between tissues but not to initiate or maintain an RNAi response. One of these loci, sid-1, encodes a conserved protein with predicted transmembrane domains. SID-1 is expressed in cells sensitive to RNAi, is localized to the cell periphery, and is required cell-autonomously for systemic RNAi.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Hunter, CP (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.							BUCH JP, 1985, UROL CLIN N AM, V12, P3; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fagard M, 2000, PLANT MOL BIOL, V43, P285, DOI 10.1023/A:1006404016494; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fortier E, 2000, GENESIS, V26, P240, DOI 10.1002/(SICI)1526-968X(200004)26:4<240::AID-GENE40>3.0.CO;2-P; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Marathe R, 2000, PLANT MOL BIOL, V43, P295, DOI 10.1023/A:1006456000564; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Parrish S, 2001, RNA, V7, P1397; Piccin A, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e55; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 1998, SCIENCE, V282, P430, DOI 10.1126/science.282.5388.430; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7; WINSTON WM, UNPUB	21	592	656	2	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 29	2002	295	5564					2456	2459		10.1126/science.1068836	http://dx.doi.org/10.1126/science.1068836			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	536QD	11834782				2022-12-24	WOS:000174712600057
J	Vasan, RS; Beiser, A; Seshadri, S; Larson, MG; Kannel, WB; D'Agostino, RB; Levy, D				Vasan, RS; Beiser, A; Seshadri, S; Larson, MG; Kannel, WB; D'Agostino, RB; Levy, D			Residual lifetime risk for developing hypertension in middle-aged women and men - The Framingham Heart Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BLOOD-PRESSURE; ALZHEIMERS-DISEASE; UNITED-STATES; TRENDS; MORTALITY; PREVALENCE; POPULATION	Context The long-term risk for developing hypertension is best described by the lifetime risk statistic. The lifetime risk for hypertension and trends in this risk over time are unknown. Objectives To estimate the residual lifetime risk for hypertension in older US adults and to evaluate temporal trends in this risk. Design, Setting, and Participants Community-based prospective cohort study of 1298 participants from the Framingham Heart Study who were aged 55 to 65 years and free of hypertension at baseline 1976-1998). Main Outcome Measures Residual lifetime risk (lifetime cumulative incidence not adjusted for competing causes of mortality) for hypertension, defined as blood pressure of 140/90 mm Hg or greater or use of anti hypertensive medications. Results The residual lifetime risks for developing hypertension and stage 1 high blood pressure or higher (greater than or equal to140/90 mm Hg regardless of treatment) were 90% in both 55- and 65-year-old participants. The lifetime probability of receiving anti hypertensive medication was 60%. The risk for hypertension remained unchanged for women, but it was approximately 60% higher for men in the contemporary 1976-1998 period compared with an earlier 1952-1975 period. In contrast, the residual lifetime risk for stage 2 high blood pressure or higher greater than or equal to160/100 mm Hg regardless of treatment) was considerably lower in both sexes in the recent period (35%-57% in 1952-1975 vs 35%-44% in 1976-1998), likely due to a marked increase in treatment of individuals with substantially elevated blood pressure. Conclusion The residual lifetime risk for hypertension for middle-aged and elderly individuals is 90%, indicating a huge public health burden. Although the decline in lifetime risk for stage 2 high blood pressure or higher represents a major achievement, efforts should be directed at the primary prevention of hypertension.	NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; Boston Univ, Sch Med, Cardiol Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Boston, MA USA; Boston Univ, Dept Math, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Clin Epidemiol, Boston, MA 02215 USA; NHLBI, Bethesda, MD 20892 USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Boston University; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Vasan, RS (corresponding author), NHLBI, Framingham Heart Study, 5 Thurber St, Framingham, MA 01702 USA.	vasan@fram.nhlbi.nih.gov	Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABB-2752-2021; Levy, Daniel/ABF-6873-2021	Ramachandran, Vasan/0000-0001-7357-5970; Levy, Daniel/0000-0003-1843-8724; Beiser, Alexa/0000-0001-8551-7778; Larson, Martin/0000-0002-9631-1254; Seshadri, Sudha/0000-0001-6135-2622	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC038038] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-38038, K24 HL 04334-01A1] Funding Source: Medline; NINDS NIH HHS [NS17950, R01 NS017950] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON RN, 1999, NATL CTR HLTH STAT S, V47, P12; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; Barker WH, 1998, HYPERTENSION, V31, P552, DOI 10.1161/01.HYP.31.1.552; Beiser A, 2000, STAT MED, V19, P1495, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1495::AID-SIM441>3.0.CO;2-E; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Chalmers J, 1999, J HYPERTENS, V17, P151; Cox D. R., 1984, ANAL SURVIVAL DATA; CUMMINGS SR, 1989, ARCH INTERN MED, V149, P2445, DOI 10.1001/archinte.149.11.2445; DANNENBERG AL, 1988, AM J PUBLIC HEALTH, V78, P676, DOI 10.2105/AJPH.78.6.676; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Fortin J M, 2001, BMC Med Inform Decis Mak, V1, P2, DOI 10.1186/1472-6947-1-2; GARRAWAY WM, 1987, JAMA-J AM MED ASSOC, V258, P214, DOI 10.1001/jama.258.2.214; GLYNN RJ, 1993, AM J EPIDEMIOL, V138, P365, DOI 10.1093/oxfordjournals.aje.a116869; GLYNN RJ, 1995, ARCH INTERN MED, V155, P1855; Hyman DJ, 2000, ARCH INTERN MED, V160, P2281, DOI 10.1001/archinte.160.15.2281; KINSELLA K, 2001, US GUREAU CENSUS SER, P1; Lloyd-Jones DM, 2000, HYPERTENSION, V36, P594, DOI 10.1161/01.HYP.36.4.594; Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9; MCGOVERN PG, 1992, JAMA-J AM MED ASSOC, V268, P753; Meissner I, 1999, HYPERTENSION, V34, P466, DOI 10.1161/01.HYP.34.3.466; Miura K, 2001, ARCH INTERN MED, V161, P1501, DOI 10.1001/archinte.161.12.1501; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Mosterd A, 1999, NEW ENGL J MED, V340, P1221, DOI 10.1056/NEJM199904223401601; Phillips KA, 1999, NEW ENGL J MED, V340, P141, DOI 10.1056/NEJM199901143400211; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; SAS Institute, 1996, SAS STAT SOFTW CHANG; Sasieni PD, 1999, AM J EPIDEMIOL, V149, P869; Seshadri S, 1997, NEUROLOGY, V49, P1498, DOI 10.1212/WNL.49.6.1498; STAMLER J, 1993, ARCH INTERN MED, V153, P598, DOI 10.1001/archinte.153.5.598; Stamler J, 1998, JAMA-J AM MED ASSOC, V279, P878, DOI 10.1001/jama.279.11.878; Sytkowski PA, 1996, CIRCULATION, V93, P697, DOI 10.1161/01.CIR.93.4.697; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101; WHELTON PK, 1993, ARCH INTERN MED, V153, P186, DOI 10.1001/archinte.153.2.186; Wun LM, 1998, LIFETIME DATA ANAL, V4, P169, DOI 10.1023/A:1009685507602	34	892	969	0	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2002	287	8					1003	1010		10.1001/jama.287.8.1003	http://dx.doi.org/10.1001/jama.287.8.1003			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525CX	11866648				2022-12-24	WOS:000174052100028
J	Eisenmesser, EZ; Bosco, DA; Akke, M; Kern, D				Eisenmesser, EZ; Bosco, DA; Akke, M; Kern, D			Enzyme dynamics during catalysis	SCIENCE			English	Article							HUMAN CYCLOPHILIN-A; PROTEIN DYNAMICS; BACKBONE DYNAMICS; CRYSTAL-STRUCTURE; NMR RELAXATION; TRANS; ISOMERIZATION; ISOMERASE; FLEXIBILITY; DOMAIN	Internal protein dynamics are intimately connected to enzymatic catalysis. However, enzyme motions linked to substrate turnover remain largely unknown. We have studied dynamics of an enzyme during catalysis at atomic resolution using nuclear magnetic resonance relaxation methods. During catalytic action of the enzyme cyclophilin A, we detect conformational fluctuations of the active site that occur on a time scale of hundreds of microseconds. The rates of conformational dynamics of the enzyme strongly correlate with the microscopic rates of substrate turnover. The present results, together with available structural data, allow a prediction of the reaction trajectory.	Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; Lund Univ, Dept Biophys Chem, SE-22100 Lund, Sweden	Brandeis University; Lund University	Kern, D (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA.			Akke, Mikael/0000-0002-2395-825X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062117] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62117] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bruice TC, 2000, BIOCHEMISTRY-US, V39, P6267, DOI 10.1021/bi0003689; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FERSHT A, 1999, STRUCTURE MECH PROTE, P44; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; Fischer MWF, 1998, PROG NUCL MAG RES SP, V33, P207, DOI 10.1016/S0079-6565(98)00023-5; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Gothel SF, 1996, BIOCHEMISTRY-US, V35, P3636, DOI 10.1021/bi9520803; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Ishima R, 1999, STRUCTURE, V7, P1047, DOI 10.1016/S0969-2126(99)80172-5; Ishima R, 2000, NAT STRUCT BIOL, V7, P740, DOI 10.1038/78963; Jardetzky O, 1996, PROG BIOPHYS MOL BIO, V65, P171, DOI 10.1016/S0079-6107(96)00010-7; Kay LE, 1998, NAT STRUCT BIOL, V5, P513, DOI 10.1038/755; KERN D, 1995, BIOCHEMISTRY-US, V34, P13594, DOI 10.1021/bi00041a039; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LUZ Z, 1963, J CHEM PHYS, V39, P366, DOI 10.1063/1.1734254; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; NICHOLSON LK, 1995, NAT STRUCT BIOL, V2, P274, DOI 10.1038/nsb0495-274; Osborne MJ, 2001, BIOCHEMISTRY-US, V40, P9846, DOI 10.1021/bi010621k; Ottiger M, 1997, J MOL BIOL, V272, P64, DOI 10.1006/jmbi.1997.1220; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Palmer AG, 1997, CURR OPIN STRUC BIOL, V7, P732, DOI 10.1016/S0959-440X(97)80085-1; PLOTTO M, 1992, J BIOMOL NMR, V2, P661; Rovira P, 2000, CURR MED CHEM, V7, P673, DOI 10.2174/0929867003374778; Rozovsky S, 2001, J MOL BIOL, V310, P271, DOI 10.1006/jmbi.2001.4673; Schiene C, 2000, CURR OPIN STRUC BIOL, V10, P40, DOI 10.1016/S0959-440X(99)00046-9; Stevens SY, 2001, NAT STRUCT BIOL, V8, P947, DOI 10.1038/nsb1101-947; Tjandra N, 1996, J AM CHEM SOC, V118, P6986, DOI 10.1021/ja960510m; Wang LC, 2001, P NATL ACAD SCI USA, V98, P7684, DOI 10.1073/pnas.121069998; WILLIAMS JC, 1995, BIOCHEMISTRY-US, V34, P8309, DOI 10.1021/bi00026a012; Zhao YD, 1996, BIOCHEMISTRY-US, V35, P7356, DOI 10.1021/bi9602775; Zhao YD, 1997, STRUCTURE, V5, P139, DOI 10.1016/S0969-2126(97)00172-X; Zhao YD, 1996, BIOCHEMISTRY-US, V35, P7362, DOI 10.1021/bi960278x; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P1092, DOI 10.1002/pro.5560010903	33	579	589	6	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2002	295	5559					1520	1523		10.1126/science.1066176	http://dx.doi.org/10.1126/science.1066176			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859194	Green Submitted			2022-12-24	WOS:000173981300052
J	Ronshaugen, M; McGinnis, N; McGinnis, W				Ronshaugen, M; McGinnis, N; McGinnis, W			Hox protein mutation and macroevolution of the insect body plan	NATURE			English	Article							CASEIN KINASE-II; GENE-EXPRESSION; EVOLUTION; DROSOPHILA; ULTRABITHORAX; PHYLOGENY; PHOSPHORYLATION; ARTHROPODS; ORIGIN; CLADE	A fascinating question in biology is how molecular changes in developmental pathways lead to macroevolutionary changes in morphology. Mutations in homeotic (Hox) genes have long been suggested as potential causes of morphological evolution(1,2), and there is abundant evidence that some changes in Hox expression patterns correlate with transitions in animal axial pattern(3). A major morphological transition in metazoans occurred about 400 million years ago, when six-legged insects diverged from crustacean-like arthropod ancestors with multiple limbs(4-7). In Drosophila melanogaster and other insects, the Ultrabithorax (Ubx) and abdominal A (AbdA, also abd-A) Hox proteins are expressed largely in the abdominal segments, where they can suppress thoracic leg development during embryogenesis(3). In a branchiopod crustacean, Ubx/AbdA proteins are expressed in both thorax and abdomen, including the limb primordia, but do not repress limbs(8-11). Previous studies led us to propose that gain and loss of transcriptional activation and repression functions in Hox proteins was a plausible mechanism to diversify morphology during animal evolution(12). Here we show that naturally selected alteration of the Ubx protein is linked to the evolutionary transition to hexapod limb pattern.	Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	McGinnis, W (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.			Ronshaugen, Matthew/0000-0001-5326-5924				Abzhanov A, 2000, DEVELOPMENT, V127, P2239; Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Averof M, 1997, NATURE, V388, P682, DOI 10.1038/41786; AVEROF M, 1995, NATURE, V376, P420, DOI 10.1038/376420a0; BOORE JL, 1995, NATURE, V376, P163, DOI 10.1038/376163a0; Carroll S.B., 2001, DNA DIVERSITY; CHAN SK, 1993, GENE DEV, V7, P796, DOI 10.1101/gad.7.5.796; Fienberg AA, 1999, J EXP ZOOL, V285, P76, DOI 10.1002/(SICI)1097-010X(19990415)285:1<76::AID-JEZ9>3.0.CO;2-K; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; FRIEDRICH M, 1995, NATURE, V376, P165, DOI 10.1038/376165a0; GALANT R, 2002, NATURE          0202; Goldschmidt R., 1940, MAT BASIS EVOLUTION; GONZALEZREYES A, 1990, CELL, V61, P515, DOI 10.1016/0092-8674(90)90533-K; Grenier JK, 2000, P NATL ACAD SCI USA, V97, P704, DOI 10.1073/pnas.97.2.704; Grenier JK, 1997, CURR BIOL, V7, P547, DOI 10.1016/S0960-9822(06)00253-3; Jaffe L, 1997, GENE DEV, V11, P1327, DOI 10.1101/gad.11.10.1327; KELSH R, 1994, DEV GENET, V15, P19, DOI 10.1002/dvg.1020150104; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li C, 1999, MOL CELL, V3, P77, DOI 10.1016/S1097-2765(00)80176-8; Li XL, 1999, P NATL ACAD SCI USA, V96, P6802, DOI 10.1073/pnas.96.12.6802; MANN RS, 1990, CELL, V60, P597, DOI 10.1016/0092-8674(90)90663-Y; PANGANIBAN G, 1995, SCIENCE, V270, P1363, DOI 10.1126/science.270.5240.1363; Regier JC, 1997, MOL BIOL EVOL, V14, P902, DOI 10.1093/oxfordjournals.molbev.a025833; VACHON G, 1992, CELL, V71, P437, DOI 10.1016/0092-8674(92)90513-C	24	281	290	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2002	415	6874					914	917		10.1038/nature716	http://dx.doi.org/10.1038/nature716			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859370				2022-12-24	WOS:000173941000046
J	Weimerskirch, H; Bonadonna, F; Bailleul, F; Mabille, G; Dell'Omo, G; Lipp, HP				Weimerskirch, H; Bonadonna, F; Bailleul, F; Mabille, G; Dell'Omo, G; Lipp, HP			GPS tracking of foraging albatrosses	SCIENCE			English	Editorial Material							SEABIRDS; FLIGHT		Ctr Etud Biol Chize, CNRS, F-79360 Villiers En Bois, France; Inst Francais Rech & Technol Polaire, F-29280 Plouzane, France; Univ Zurich, Inst Anat, Div Neuroanat & Behav, CH-8057 Zurich, Switzerland	Centre National de la Recherche Scientifique (CNRS); University of Zurich	Weimerskirch, H (corresponding author), Ctr Etud Biol Chize, CNRS, F-79360 Villiers En Bois, France.		Weimerskirch, Henri/K-7306-2019; Bonadonna, Francesco/A-7456-2008; Weimerskirch, Henri/F-5562-2013	Weimerskirch, Henri/0000-0002-0457-586X; Bonadonna, Francesco/0000-0002-2702-5801; Dell'Omo, Giacomo/0000-0002-9601-9675				ALERSTAM T, 1993, PHILOS T ROY SOC B, V340, P55, DOI 10.1098/rstb.1993.0048; Batschelet E, 1981, CIRCULAR STAT BIOL; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Hays GC, 2001, ANIM BEHAV, V61, P1035, DOI 10.1006/anbe.2001.1685; PENNYCUICK CJ, 1982, PHILOS T ROY SOC B, V300, P75, DOI 10.1098/rstb.1982.0158; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; WEIMERSKIRCH H, 1994, P ROY SOC B-BIOL SCI, V255, P91, DOI 10.1098/rspb.1994.0013	8	174	182	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1259	1259		10.1126/science.1068034	http://dx.doi.org/10.1126/science.1068034			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847332				2022-12-24	WOS:000173926000032
J	Xu, X; Norell, MA; Wang, XL; Makovicky, PJ; Wu, XC				Xu, X; Norell, MA; Wang, XL; Makovicky, PJ; Wu, XC			A basal troodontid from the Early Cretaceous of China	NATURE			English	Article							REPUBLIC-OF-CHINA; INNER-MONGOLIA; THEROPOD; DINOSAUR; BIRDS; SKULL	Troodontid dinosaurs form one of the most avian-like dinosaur groups(1-5). Their phylogenetic position is hotly debated, and they have been allied with almost all principal coelurosaurian lineages(6-13). Here we report a basal troodontid dinosaur, Sinovenator changii gen. et sp. nov., from the lower Yixian Formation of China. This taxon has several features that are not found in more derived troodontids, but that occur in dromaeosaurids and avialans. The discovery of Sinovenator and the examination of character distributions along the maniraptoran lineage indicate that principal structural modifications toward avians were acquired in the early stages of maniraptoran evolution.	Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Amer Museum Nat Hist, New York, NY 10024 USA; Field Museum Nat Hist, Chicago, IL 60605 USA; Canadian Museum Nat, Ottawa, ON K1P 6P4, Canada	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; American Museum of Natural History (AMNH); Field Museum of Natural History (Chicago)	Xu, X (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China.	xxu@midwest.com.cn						BARSBOLD R, 1987, Acta Palaeontologica Polonica, V32, P121; Barsbold R, 1999, ACTA PALAEONTOL POL, V44, P189; Chatterjee S., 1997, THE RISE OF BIRDS; Chiappe LM, 1998, NATURE, V392, P275, DOI 10.1038/32642; Currie P.J., 1987, Journal of Vertebrate Paleontology, V7, P72; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2224, DOI 10.1139/e93-193; CURRIE PJ, 1985, CAN J EARTH SCI, V22, P1643, DOI 10.1139/e85-173; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; HOLTZ TR, 1994, J PALEONTOL, V68, P1100, DOI 10.1017/S0022336000026706; HOLTZ TR, J PALEONTOL, V70, P536; KURZANOV S M, 1976, Paleontologicheskii Zhurnal, P127; Li JL, 2001, CHINESE SCI BULL, V46, P782, DOI 10.1007/BF03187223; MAKIVICKY P, 1998, AM MUS NOVIT, P1; Norell MA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P49; Norell MA, 2000, J VERTEBR PALEONTOL, V20, P7, DOI 10.1671/0272-4634(2000)020[0007:ANTTFU]2.0.CO;2; Norell Mark A., 1999, American Museum Novitates, V3282, P1; Osmolska H., 1990, P259; Perle A., 1999, NEW MANIRAPTORAN THE; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2107, DOI 10.1139/e93-183; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2163, DOI 10.1139/e93-187; Saurornithoididae BarsboldR., 1974, PALAENTOL POL, V30, P5; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Walker A., 1985, P123; Wang Xiaolin, 1998, Vertebrata Palasiatica, V36, P81; WITMER LM, 1990, ZOOL J LINN SOC-LOND, V100, P327, DOI 10.1111/j.1096-3642.1990.tb01865.x; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; XU X, 2000, SPECIAL PUBLICATION, P179; Xu Xing, 2000, Vertebrata Palasiatica, V38, P318	30	160	176	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2002	415	6873					780	784		10.1038/415780a	http://dx.doi.org/10.1038/415780a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845206				2022-12-24	WOS:000173833900043
J	Gallivan, S; Utley, M; Treasure, T; Valencia, S				Gallivan, S; Utley, M; Treasure, T; Valencia, S			Booked inpatient admissions and hospital capacity: mathematical modelling study	BRITISH MEDICAL JOURNAL			English	Article							SYSTEM; DESIGN	Objectives To investigate the variability of patients' length of stay in intensive care after cardiac surgery. To investigate potential interactions between such variability, booked admissions, and capacity requirements. Design Mathematical modelling study using routinely collected data. Setting A cardiac surgery department. Source of data Hospital records of 7014 people entering intensive care after cardiac surgery. Main outcome measures Length of stay in intensive care; capacity requirements of an intensive care unit for a hypothetical booked admission system. Results Although the vast majority of patients (89.5%) had a length of stay in intensive care of less than or equal to48 hours, there was considerable overall variability and the distribution of stays has a lengthy tail. A mathematical model of the operation of a hypothetical booking system indicates that such variability has a considerable impact on intensive care capacity requirements, indicating that a high degree of reserve capacity is required to avoid high rates of operation cancellation because of unavailability of suitable postoperative care. Conclusion Despite the considerable enthusiasm for booked admissions systems, queuing theory suggests that caution is required when considering such systems for inpatient admissions. Such systems may Well result in frequent operational difficulties if there is a high degree of variability in length of stay and where reserve capacity is limited. Both of these are common in the NHS.	UCL, Clin Operat Res Unit, London WC1E 6BT, England; Guys Hosp, Cardiothorac Unit, London SE1 9RT, England; Univ London St Georges Hosp, Sch Med, Dept Cardiol Sci, London SW17 0RE, England	University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; St Georges University London	Gallivan, S (corresponding author), UCL, Clin Operat Res Unit, Mortimer St, London WC1E 6BT, England.	s.gallivan@ucl.ac.uk		Utley, Martin/0000-0001-9928-1516				BAILEY NTJ, 1952, J ROY STAT SOC B, V14, P185; Goodyear OM., 1998, CURRENT PERSPECTIVES, P345; GOODYEAR OM, 1997, CURRENT PERSPECTIVES, P316; HARRIS RA, 1986, EUR J OPER RES, V25, P121, DOI 10.1016/0377-2217(86)90121-9; JACKSON RRP, 1964, OPER RES QUART, V15, P219, DOI 10.2307/3007209; KIPPING R, 2000, BOOKING PATIENTS HOS; Mackay M, 1999, Aust Health Rev, V22, P118; Millard PH, 2000, ANN ROY COLL SURG, V82, P75; VISSERS J, 1979, EUR J OPER RES, V3, P459, DOI 10.1016/0377-2217(79)90245-5; WORTHINGTON D, 1991, J OPER RES SOC, V42, P833, DOI 10.1057/jors.1991.164; WORTHINGTON DJ, 1987, J OPER RES SOC, V38, P413, DOI 10.1057/jors.1987.69	11	64	64	0	13	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 2	2002	324	7332					280	282		10.1136/bmj.324.7332.280	http://dx.doi.org/10.1136/bmj.324.7332.280			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	519LT	11823362	Green Published, Bronze			2022-12-24	WOS:000173728300021
J	Reef, SE; Frey, TK; Theall, K; Abernathy, E; Burnett, CL; Icenogle, J; McCauley, MM; Wharton, M				Reef, SE; Frey, TK; Theall, K; Abernathy, E; Burnett, CL; Icenogle, J; McCauley, MM; Wharton, M			The changing epidemiology of rubella in the 1990s - On the verge of elimination and new challenges for control and prevention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WORKPLACE	Context In 1989, the United States established a goal to eliminate indigenous rubella and congenital rubella syndrome (CRS) by 2000. Reported rubella cases are at record low levels; however, cases and outbreaks have occurred, primarily among unvaccinated foreign-born adults. Objective To evaluate the current epidemiology of rubella and CRS and assess progress toward elimination. Design, Setting, and Subjects Analysis of rubella cases reported to the National Notifiable Diseases Surveillance System from 1990 through 1999 and CRS cases reported to the National Congenital Rubella Syndrome Registry from 1990 through 1999. Since 1996, US and international viral isolates have been sequenced. Main Outcome Measures incidence and characteristics of rubella and CRS cases; molecular typing of virus isolates. Results Annually from 1990 through 1999, the median number of reported rubella cases was 232 (range, 128-1412), and between 1992 and 1999, fewer than 300 rubella cases were reported annually, except in 1998. During the 1990s, the incidence of rubella in children younger than 15 years decreased (0.63 vs 0.06 per 100000 in 1990 vs 1999), whereas the incidence in adults aged 15 to 44 years increased (0.13 vs 0.24 per 100000). In 1992, incidence among Hispanics was 0.06 per 100000 and increased to a high in 1998 of 0.97 per 100000. From 1997 through 1999, 20 (83%) of 24 CRS infants were born to Hispanic mothers, and 21 (91%) of 23 CRS infants were born to foreign-born mothers. Molecular typing identified 3 statistically distinct genotypic groups. In group 1, the close relatedness of viruses suggests that a single imported source seeded an outbreak that did not spread beyond the Northeast. Similarly, within groups 2 and 3, relatedness of viruses obtained from clusters of cases suggests that single imported sources seeded each one. Diversity of viruses found in 1 state is consistent with the conclusion that several viruses were imported. Moreover, the similarity of viruses found across the country, combined with a lack of epidemiologic evidence of endemic transmission, support the conclusion that some viruses that are common abroad, particularly in Latin America and the Carribean, were introduced into the United States on several separate occasions. Conclusions The epidemiology of rubella and CRS has changed significantly in the last decade. These changes and molecular typing suggest that the United States is on the verge of elimination of the disease. To prevent future rubella outbreaks and CRS, current strategies must be enhanced and new strategies developed.	Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Atlanta, GA USA; Georgia State Univ, Atlanta, GA 30303 USA; Emory Univ, Sch Publ Hlth, Atlanta, GA USA; Utah Dept Hlth, Salt Lake City, UT 84116 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University System of Georgia; Georgia State University; Emory University	Reef, SE (corresponding author), Ctr Dis Control & Prevent, Natl Immunizat Program, 1600 Clifton Rd NE,MS E-61, Atlanta, GA 30333 USA.	sreef@cdc.gov						*CDCP, 1997, MMWR-MORBID MORTAL W, V46, P30; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P560; *CDCP, 1985, MMWR-MORBID MORTAL W, V34, P228; *CDCP, 2000, MMWR-MORBID MORTAL W, V49, P225; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P1137; *CDCP, 1986, MMWR-MORBID MORTAL W, V35, P770; Centers for Disease Control and Prevention, 1980, MMWR-MORBID MORTAL W, V29, P517; Centers for Disease Control and Prevention (CDC), 1994, MMWR Morb Mortal Wkly Rep, V43, P57; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V46, P1247; Centers for Disease Control and Prevention (CDC), 1985, MMWR-MORBID MORTAL W, V34, P615; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P173; Centers for Disease Control (CDC), 1983, MMWR Morb Mortal Wkly Rep, V32, P349; Centers for Disease Control & Prevention, 1991, MMWR-MORBID MORTAL W, V40, P93; Danovaro-Holliday MC, 2000, JAMA-J AM MED ASSOC, V284, P2733, DOI 10.1001/jama.284.21.2733; DOUGHERTY N, 1995, IMMUNICATION ACTION, V1, P2; Frey TK, 1998, J INFECT DIS, V178, P642, DOI 10.1086/515370; GOODMAN AK, 1987, AM J PUBLIC HEALTH, V77, P725, DOI 10.2105/AJPH.77.6.725; LEE SH, 1992, JAMA-J AM MED ASSOC, V267, P2616, DOI 10.1001/jama.267.19.2616; LINDEGREN ML, 1991, EPIDEMIOL REV, V13, P341, DOI 10.1093/oxfordjournals.epirev.a036077; MELLINGER AK, 1995, PEDIATR INFECT DIS J, V14, P573, DOI 10.1097/00006454-199507000-00004; *NAT CTR HLTH STAT, 1997, HLTH PEOPL 1996 97 I; *PAN AM HLTH ORG, 2001, EPI NEWSLETTER, V23, P3; *PHS, 1991, US DEP HHS PHS PUBLI; Preblud S R, 1980, Epidemiol Rev, V2, P171; Rangel Maria C., 1999, Ethnicity and Disease, V9, P230; REEF S, 1999, MANUAL SURVEILLIANCE; Reef SE, 2000, CLIN INFECT DIS, V31, P85, DOI 10.1086/313928	27	94	99	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2002	287	4					464	472		10.1001/jama.287.4.464	http://dx.doi.org/10.1001/jama.287.4.464			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	513VX	11798368	Bronze			2022-12-24	WOS:000173401900023
J	Cheng, HYM; Pitcher, GM; Laviolette, SR; Whishaw, IQ; Tong, KI; Kockeritz, LK; Wada, T; Joza, NA; Crackower, M; Goncalves, J; Sarosi, I; Woodgett, JR; Oliveira-dos-Santos, AJ; Ikura, M; van der Kooy, D; Salter, MW; Penninger, JM				Cheng, HYM; Pitcher, GM; Laviolette, SR; Whishaw, IQ; Tong, KI; Kockeritz, LK; Wada, T; Joza, NA; Crackower, M; Goncalves, J; Sarosi, I; Woodgett, JR; Oliveira-dos-Santos, AJ; Ikura, M; van der Kooy, D; Salter, MW; Penninger, JM			DREAM is a critical transcriptional repressor for pain modulation	CELL			English	Article							KAPPA-OPIOID RECEPTOR; LONG-LASTING ALLODYNIA; SPINAL-CORD NEURONS; DYNORPHIN-A; NEUROPATHIC PAIN; ADMINISTERED DYNORPHIN; PRODYNORPHIN GENE; RAT; NMDA; MECHANISMS	Control and treatment of chronic pain remain major clinical challenges. Progress may be facilitated by a greater understanding of the mechanisms underlying pain processing. Here we show that the calcium-sensing protein DREAM is a transcriptional repressor involved in modulating pain. dream(-/-) mice displayed markedly reduced responses in models of acute thermal, mechanical, and visceral pain. dream(-/-) mice also exhibited reduced pain behaviors in models of chronic neuropathic and inflammatory pain. However, dream(-/-) mice showed no major defects in motor function or learning and memory. Mice lacking DREAM had elevated levels of prodynorphin mRNA and dynorphin A peptides in the spinal cord, and the reduction of pain behaviors in dream(-/-) mice was mediated through dynorphin-selective kappa (kappa)-opiate receptors. Thus, DREAM appears to be a critical transcriptional repressor in pain processing.	Amgen Inst, Toronto, ON M5G 2C1, Canada; Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria; Univ Hlth Network, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2M9, Canada; Hosp Sick Children, Programme Brain & Behav, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Cell Biol Programme, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Physiol, Ctr Study Pain, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Anat & Cell Biol, Neurobiol Res Grp, Toronto, ON M5S 1A8, Canada; NeuroDetect Inc, Lethbridge, AB T1K 3M4, Canada; Amgen Inc, Dept Pharmacol & Pathol, Thousand Oaks, CA 91320 USA	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Amgen	Penninger, JM (corresponding author), Amgen Inst, 620 Univ Ave, Toronto, ON M5G 2C1, Canada.	jpenning@amgen.com	Penninger, Josef M/I-6860-2013; Woodgett, Jim/F-1087-2010	Penninger, Josef M/0000-0002-8194-3777; Woodgett, Jim/0000-0003-3731-5797				AKIL H, 1976, SCIENCE, V191, P961, DOI 10.1126/science.1251210; Akil H, 1996, NIDA Res Monogr, V161, P127; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Appleyard SM, 1997, J NEUROCHEM, V69, P2405; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Cao YQ, 1998, NATURE, V392, P390, DOI 10.1038/32897; Carrion AM, 1998, MOL CELL BIOL, V18, P6921, DOI 10.1128/MCB.18.12.6921; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; CAUDLE RM, 1994, J NEUROSCI, V14, P5580; Chen L, 1998, J PHARMACOL EXP THER, V284, P826; CHEN L, 1995, J NEUROSCI, V15, P4602; Choi EK, 2001, J BIOL CHEM, V276, P19197, DOI 10.1074/jbc.M008597200; DawsonBasoa ME, 1996, PAIN, V64, P607, DOI 10.1016/0304-3959(96)87175-2; DICKENSON AH, 1991, BRIT MED BULL, V47, P690, DOI 10.1093/oxfordjournals.bmb.a072501; Dockstader CL, 2001, EUR J NEUROSCI, V13, P995, DOI 10.1046/j.1460-9568.2001.01455.x; DORES RM, 1990, BRAIN BEHAV EVOLUT, V36, P80, DOI 10.1159/000115300; GOLDSTEIN A, 1989, MOL PHARMACOL, V36, P265; GRUDT TJ, 1993, P NATL ACAD SCI USA, V90, P11429, DOI 10.1073/pnas.90.23.11429; Hauser KF, 1999, EXP NEUROL, V160, P361, DOI 10.1006/exnr.1999.7235; Ho J, 1997, J PHARMACOL EXP THER, V281, P136; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; IADAROLA MJ, 1988, PAIN, V35, P313, DOI 10.1016/0304-3959(88)90141-8; Jevtovic-Todorovic V, 1998, BRAIN RES, V781, P202, DOI 10.1016/S0006-8993(97)01247-X; Jo DG, 2001, FASEB J, V15, P589; KAJANDER KC, 1990, PEPTIDES, V11, P719, DOI 10.1016/0196-9781(90)90187-A; Lai SL, 1998, NEUROSCI LETT, V247, P115, DOI 10.1016/S0304-3940(98)00293-6; Laughlin TM, 1997, PAIN, V72, P253, DOI 10.1016/S0304-3959(97)00046-8; Laughlin TM, 2001, J PHARMACOL EXP THER, V299, P6; LUCAS JJ, 1993, NEURON, V10, P599, DOI 10.1016/0896-6273(93)90163-L; Lutfy K, 1997, PAIN, V70, P31, DOI 10.1016/S0304-3959(96)03290-3; Malan TP, 2000, PAIN, V86, P185, DOI 10.1016/S0304-3959(00)00243-8; MANSOUR A, 1988, TRENDS NEUROSCI, V11, P308, DOI 10.1016/0166-2236(88)90093-8; Mason DJ, 1999, EUR J PHARMACOL, V378, P237, DOI 10.1016/S0014-2999(99)00479-3; MESSERSMITH DJ, 1994, MOL CELL NEUROSCI, V5, P238, DOI 10.1006/mcne.1994.1028; Mosconi T, 1996, PAIN, V64, P37, DOI 10.1016/0304-3959(95)00077-1; Nakamura TY, 2001, P NATL ACAD SCI USA, V98, P12808, DOI 10.1073/pnas.221168498; Ogura M, 2000, J NEUROPHYSIOL, V83, P3366, DOI 10.1152/jn.2000.83.6.3366; Pitcher GM, 1999, PAIN, V83, P37, DOI 10.1016/S0304-3959(99)00085-8; RANDIC M, 1995, J NEUROSCI, V15, P6809; Rusin KI, 1997, J NEUROSCI, V17, P6565; SCHAFER M, 1994, P NATL ACAD SCI USA, V91, P4219, DOI 10.1073/pnas.91.10.4219; Sharifi N, 2001, MOL BRAIN RES, V86, P70, DOI 10.1016/S0169-328X(00)00264-3; Spreafico F, 2001, MOL CELL NEUROSCI, V17, P1, DOI 10.1006/mcne.2000.0913; Suzuki R, 1999, PAIN, V80, P215, DOI 10.1016/S0304-3959(98)00208-5; Tang QB, 1999, J PHARMACOL EXP THER, V291, P760; TanNo K, 1996, EUR J PHARMACOL, V314, P61, DOI 10.1016/S0014-2999(96)00518-3; Vaccarino AL, 2000, PEPTIDES, V21, P1975, DOI 10.1016/S0196-9781(00)00345-4; Vanderah TW, 1996, PAIN, V68, P275, DOI 10.1016/S0304-3959(96)03225-3; Wagner L, 2000, J BIOL CHEM, V275, P24740, DOI 10.1074/jbc.M001974200; Wang ZJ, 2001, J NEUROSCI, V21, P1779, DOI 10.1523/JNEUROSCI.21-05-01779.2001; Whishaw IQ, 1999, MODERN TECHNIQUES NE, P1243, DOI 10.1007/978-3-642-58552-4_44; Wickenden AD, 1999, CIRC RES, V85, P1067; Wiley JW, 1997, J NEUROPHYSIOL, V77, P1338, DOI 10.1152/jn.1997.77.3.1338; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Zachariou V, 1997, EUR J PHARMACOL, V323, P159, DOI 10.1016/S0014-2999(97)00038-1	58	225	242	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2002	108	1					31	43		10.1016/S0092-8674(01)00629-8	http://dx.doi.org/10.1016/S0092-8674(01)00629-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792319	Bronze			2022-12-24	WOS:000173280700006
J	Peichel, CL; Nereng, KS; Ohgi, KA; Cole, BLE; Colosimo, PF; Buerkle, CA; Schluter, D; Kingsley, DM				Peichel, CL; Nereng, KS; Ohgi, KA; Cole, BLE; Colosimo, PF; Buerkle, CA; Schluter, D; Kingsley, DM			The genetic architecture of divergence between threespine stickleback species	NATURE			English	Article							GASTEROSTEUS-ACULEATUS; NATURAL-SELECTION; SPECIATION; ADAPTATION; EVOLUTION; PREDATION; ECOLOGY; PAIR; SIZE	The genetic and molecular basis of morphological evolution is poorly understood, particularly in vertebrates. Genetic studies of the differences between naturally occurring vertebrate species have been limited by the expense and difficulty of raising large numbers of animals and the absence of molecular linkage maps for all but a handful of laboratory and domesticated animals. We have developed a genome-wide linkage map for the three-spined stickleback (Gasterosteus aculeatus), an extensively studied teleost fish that has undergone rapid divergence and speciation since the melting of glaciers 15,000 years ago(1). Here we use this map to analyse the genetic basis of recently evolved changes in skeletal armour and feeding morphologies seen in the benthic and limnetic stickleback species from Priest Lake, British Columbia. Substantial alterations in spine length, armour plate number, and gill raker number are controlled by genetic factors that map to independent chromosome regions. Further study of these regions will help to define the number and type of genetic changes that underlie morphological diversification during vertebrate evolution.	Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Univ Wisconsin, Dept Biol, Eau Claire, WI 54702 USA; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1ZT, Canada; Univ British Columbia, Ctr Biodivers, Vancouver, BC V6T 1ZT, Canada	Stanford University; Howard Hughes Medical Institute; Stanford University; University of Wisconsin System; University of British Columbia; University of British Columbia	Kingsley, DM (corresponding author), Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA.			Buerkle, Alex/0000-0003-4222-8858; Schluter, Dolph/0000-0003-1683-7836; Peichel, Catherine/0000-0002-7731-8944				Ahn DG, 1999, EVOL DEV, V1, P100, DOI 10.1046/j.1525-142x.1999.99009.x; Beavis William D., 1998, P145; Bell M.A., 1984, P431; Bell M.A., 1994, EVOLUTIONARY BIOL TH; BENTZEN P, 1984, CAN J ZOOL, V62, P2280, DOI 10.1139/z84-331; CHEN TR, 1970, CYTOGENETICS, V9, P321, DOI 10.1159/000130102; HAGEN DW, 1972, EVOLUTION, V26, P32, DOI 10.1111/j.1558-5646.1972.tb00172.x; Hatfield T, 1997, AM NAT, V149, P1009, DOI 10.1086/286036; Hatfield T, 1999, EVOLUTION, V53, P866, DOI 10.1111/j.1558-5646.1999.tb05380.x; Hawthorne DJ, 2001, NATURE, V412, P904, DOI 10.1038/35091062; HINEGARD.R, 1968, AM NAT, V102, P517, DOI 10.1086/282564; Largiader CR, 1999, MOL ECOL, V8, P342; Lynch M., 1998, AM J HUM GENET; McPhail J.D., 1994, P399; MOODIE GEE, 1972, HEREDITY, V28, P155, DOI 10.1038/hdy.1972.21; Nagel L, 1998, EVOLUTION, V52, P209, DOI 10.1111/j.1558-5646.1998.tb05154.x; Orr HA, 2001, TRENDS ECOL EVOL, V16, P343; REIMCHEN TE, 1983, EVOLUTION, V37, P931, DOI 10.1111/j.1558-5646.1983.tb05622.x; REIMCHEN TE, 1980, CAN J ZOOL, V58, P1232, DOI 10.1139/z80-173; Reimchen TE, 1995, BEHAVIOUR, V132, P1079, DOI 10.1163/156853995X00469; RICO C, 1993, MOL ECOL, V2, P271, DOI 10.1111/j.1365-294X.1993.tb00017.x; RIDGWAY MS, 1984, CAN J ZOOL, V62, P1813, DOI 10.1139/z84-264; ROZEN S, 1997, PRIMER3; SCHLUTER D, 1993, ECOLOGY, V74, P699, DOI 10.2307/1940797; Stam P., 1995, JOINMAP VERSION 2 0; SWAIN DP, 1992, EVOLUTION, V46, P998, DOI 10.1111/j.1558-5646.1992.tb00615.x; Taylor AC, 1998, MOL ECOL, V7, P925; Vamosi SM, 1999, EVOLUTION, V53, P874, DOI 10.1111/j.1558-5646.1999.tb05381.x; Van Ooijen JW, 1999, HEREDITY, V83, P613, DOI 10.1038/sj.hdy.6886230; [No title captured]	30	401	414	1	189	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					901	905		10.1038/414901a	http://dx.doi.org/10.1038/414901a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780061	Green Accepted			2022-12-24	WOS:000172813300044
J	Kurz, T; Pintard, L; Willis, JH; Hamill, DR; Gonczy, P; Peter, M; Bowerman, B				Kurz, T; Pintard, L; Willis, JH; Hamill, DR; Gonczy, P; Peter, M; Bowerman, B			Cytoskeletal regulation by the Nedd8 ubiquitin-like protein modification pathway	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; CELL-CYCLE; CENTROSOME DUPLICATION; SPINDLE COMPONENT; C-ELEGANS; GENE; FAMILY; LIGASE; SCF; TRANSITION	The Nedd8 ubiquitin-like protein modification pathway regulates cell-cycle progression. Our analysis of Nedd8 requirements during Caenorhabditis elegans embryogenesis indicates that the cytoskeleton is another target. Nedd8 conjugation negatively regulated contractility of the microfilament-rich cell cortex during pronuclear migration and again during cytokinesis. The Nedd8 pathway also was required after meiosis to negatively regulate katanin, a microtubule-severing complex, permitting the assembly of a large mitotic spindle. We propose that Nedd8-modified cullin, as part of an E3 ubiquitin ligase complex, targets katanin for degradation during the transition from meiosis to mitosis.	Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Ohio Wesleyan Univ, Dept Zool, Delaware, OH 43015 USA	University of Oregon; Ohio Wesleyan University	Bowerman, B (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.		PINTARD, Lionel/AAP-7361-2020; pintard, lionel/AAD-8356-2020; PINTARD, Lionel/H-3756-2018; Kurz, Thimo/E-4116-2012	PINTARD, Lionel/0000-0003-0286-4630; PINTARD, Lionel/0000-0003-0286-4630; Gonczy, Pierre/0000-0002-6305-6883; Kurz, Thimo/0000-0003-0700-6993; Peter, Matthias/0000-0002-2160-6824	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058017] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM58017] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Chen YZ, 2000, J BIOL CHEM, V275, P8929, DOI 10.1074/jbc.275.12.8929; CLARKMAGUIRE S, 1994, GENETICS, V136, P533; CLARKMAGUIRE S, 1994, J CELL BIOL, V126, P199, DOI 10.1083/jcb.126.1.199; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dow MR, 1998, GENETICS, V150, P119; EDGAR LG, 1988, CELL, V53, P589, DOI 10.1016/0092-8674(88)90575-2; Feng H, 1999, NAT CELL BIOL, V1, P486, DOI 10.1038/70272; Freed E, 1999, GENE DEV, V13, P2242, DOI 10.1101/gad.13.17.2242; Gonczy P, 2001, DEV CELL, V1, P363, DOI 10.1016/S1534-5807(01)00046-6; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Guo S, 1996, NATURE, V382, P455, DOI 10.1038/382455a0; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hochstrasser M, 2000, SCIENCE, V289, P563, DOI 10.1126/science.289.5479.563; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Jones D, 2000, DEV BIOL, V226, P152, DOI 10.1006/dbio.2000.9847; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; MAINS PE, 1990, GENETICS, V126, P593; Mathias N, 1996, MOL CELL BIOL, V16, P6634; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; SEVERSON A, COMMUNICATION; Sharp DJ, 2000, MOL BIOL CELL, V11, P241, DOI 10.1091/mbc.11.1.241; Shelton CA, 1999, J CELL BIOL, V146, P439, DOI 10.1083/jcb.146.2.439; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Skop AR, 1998, CURR BIOL, V8, P1110, DOI 10.1016/S0960-9822(98)70465-8; Srayko M, 2000, GENE DEV, V14, P1072; Wojcik EJ, 2000, CURR BIOL, V10, P1131, DOI 10.1016/S0960-9822(00)00703-X; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	34	160	167	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1294	1298		10.1126/science.1067765	http://dx.doi.org/10.1126/science.1067765			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847342				2022-12-24	WOS:000173926000044
J	Chatterton, JE; Awobuluyi, M; Premkumar, LS; Takahashi, H; Talantova, M; Shin, Y; Cui, JK; Tu, SC; Kevin, ASK; Nakanishi, N; Tong, G; Lipton, SA; Zhang, DX				Chatterton, JE; Awobuluyi, M; Premkumar, LS; Takahashi, H; Talantova, M; Shin, Y; Cui, JK; Tu, SC; Kevin, ASK; Nakanishi, N; Tong, G; Lipton, SA; Zhang, DX			Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits	NATURE			English	Article							RAT SPINAL-CORD; BINDING-SITE; XENOPUS OOCYTES; AMINO-ACIDS; ANTAGONIST; POTENT; IDENTIFICATION; MEMANTINE; RESPONSES; CLONING	The N-methyl-D-aspartate subtype of glutamate receptor (NMDAR) serves critical functions in physiological and pathological processes in the central nervous system, including neuronal development, plasticity and neurodegeneration(1,2). Conventional heteromeric NMDARs composed of NR1 and NR2A-D subunits(3,4) require dual agonists, glutamate and glycine, for activation. They are also highly permeable to Ca2+, and exhibit voltage-dependent inhibition by Mg2+. Coexpression of NR3A with NR1 and NR2 subunits modulates NMDAR activity(5-7). Here we report the cloning and characterization of the final member of the NMDAR family, NR3B, which shares high sequence homology with NR3A. From in situ and immunocytochemical analyses, NR3B is expressed predominantly in motor neurons, whereas NR3A is more widely distributed(5,6). Remarkably, when co-expressed in Xenopus oocytes, NR3A or NR3B co-assembles with NR1 to form excitatory glycine receptors that are unaffected by glutamate or NMDA, and inhibited by D-serine, a co-activator of conventional NMDARs. Moreover, NR1/NR3A or -3B receptors form relatively Ca2+-impermeable cation channels that are resistant to Mg2+, MK-801, memantine and competitive antagonists. In cerebrocortical neurons containing NR3 family members, glycine triggers a burst of firing, and membrane patches manifest glycine-responsive single channels that are suppressible by D-serine. By itself, glycine is normally thought of as an inhibitory neurotransmitter. In contrast, these NR1/NR3A or -3B 'NMDARs' constitute a type of excitatory glycine receptor.	Burnham Inst, Ctr Neurosci & Aging, La Jolla, CA 92037 USA; So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA; Kanazawa Univ, Grad Sch Med, Dept Mol Pharmacol, Kanazawa, Ishikawa 9208640, Japan; Univ Connecticut, Ctr Hlth, Dept Psychiat, Farmington, CT 06030 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; Southern Illinois University System; Southern Illinois University; Kanazawa University; University of Connecticut; University of California System; University of California San Diego	Lipton, SA (corresponding author), Burnham Inst, Ctr Neurosci & Aging, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Tong, Gary/AAC-9426-2022	Lipton, Stuart/0000-0002-3490-1259				Anson LC, 1998, J NEUROSCI, V18, P581; BARON BM, 1990, MOL PHARMACOL, V38, P554; BORMANN J, 1989, EUR J PHARMACOL, V166, P591, DOI 10.1016/0014-2999(89)90385-3; CHEN HSV, 1992, J NEUROSCI, V12, P4427; CIABARRA AM, 1995, J NEUROSCI, V15, P6498; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; CURTIS DR, 1967, NATURE, V215, P1502, DOI 10.1038/2151502a0; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; DAVIES J, 1981, NEUROSCI LETT, V21, P77, DOI 10.1016/0304-3940(81)90061-6; Hirai H, 1996, P NATL ACAD SCI USA, V93, P6031, DOI 10.1073/pnas.93.12.6031; Ishimaru H, 1996, RECEPTOR CHANNEL, V4, P31; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; LEONARD JP, 1990, NEURON, V4, P53, DOI 10.1016/0896-6273(90)90443-J; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCBAIN CJ, 1989, MOL PHARMACOL, V36, P556; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Nishi M, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-23-j0003.2001; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Palecek J, 1999, EUR J NEUROSCI, V11, P827, DOI 10.1046/j.1460-9568.1999.00489.x; Perez-Otano I, 2001, J NEUROSCI, V21, P1228; Soloviev MM, 1997, J MOL BIOL, V273, P14, DOI 10.1006/jmbi.1997.1272; Souverbie F, 1996, EUR J PHARMACOL, V307, P347, DOI 10.1016/0014-2999(96)00273-7; SUCHER NJ, 1995, J NEUROSCI, V15, P6509; vonEuler M, 1997, J NEUROTRAUM, V14, P53, DOI 10.1089/neu.1997.14.53; WAFFORD KA, 1995, MOL PHARMACOL, V47, P374; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104	30	484	529	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					793	798		10.1038/nature715	http://dx.doi.org/10.1038/nature715			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11823786				2022-12-24	WOS:000173833900047
J	Rubenstein, DR; Chamberlain, CP; Holmes, RT; Ayres, MP; Waldbauer, JR; Graves, GR; Tuross, NC				Rubenstein, DR; Chamberlain, CP; Holmes, RT; Ayres, MP; Waldbauer, JR; Graves, GR; Tuross, NC			Linking breeding and wintering ranges of a migratory songbird using stable isotopes	SCIENCE			English	Article							CARBON; GROUNDS; POPULATIONS; BEHAVIOR; RATIOS; TRENDS	We used the natural abundance of stable isotopes (carbon and hydrogen) in the feathers of a neotropical migrant songbird to determine where birds from particular breeding areas spend the winter and the extent to which breeding populations mix in winter quarters. We show that most birds wintering on western Caribbean islands come from the northern portion of the species' North American breeding range, whereas those on more easterly islands are primarily from southern breeding areas. Although segregated by breeding latitude, birds within local wintering areas derive from a wide range of breeding longitudes, indicating considerable population mixing with respect to breeding Longitude. These results are useful for assessing the effects of wintering habitat Loss on breeding population abundances and for predicting whether the demographic consequences will be concentrated or diffuse.	Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; Dartmouth Coll, Dept Earth Sci, Hanover, NH 03755 USA; Smithsonian Inst, Dept Systemat Biol, Washington, DC 20560 USA; Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA	Dartmouth College; Dartmouth College; Smithsonian Institution; Smithsonian Institution; Smithsonian National Museum of Natural History	Rubenstein, DR (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	drr24@cornell.edu	Graves, Gary R/P-1003-2017; Ayres, Matthew/AAI-6873-2020; Rubenstein, Dustin R/A-3451-2015; Rubenstein, Dustin R./N-9302-2019	Graves, Gary R/0000-0003-1406-5246; Ayres, Matthew/0000-0001-6120-9068; Rubenstein, Dustin R/0000-0002-4999-3723; Rubenstein, Dustin R./0000-0002-4999-3723				Chamberlain CP, 1997, OECOLOGIA, V109, P132, DOI 10.1007/s004420050067; Chamberlain CP, 2000, P ROY SOC B-BIOL SCI, V267, P43, DOI 10.1098/rspb.2000.0964; CORMIE AB, 1994, GEOCHIM COSMOCHIM AC, V58, P365, DOI 10.1016/0016-7037(94)90470-7; DANSGAARD W, 1964, TELLUS, V16, P436; DEWOLFE BB, 1995, CONDOR, V97, P376, DOI 10.2307/1369024; GREENBERG R, 1980, MIGRANT BIRDS NEOTRO, P593; Hobson KA, 1997, OECOLOGIA, V109, P142, DOI 10.1007/s004420050068; Hobson KA, 2001, AUK, V118, P16, DOI 10.1642/0004-8038(2001)118[0016:LBAWGO]2.0.CO;2; Hobson KA, 2001, ECOL APPL, V11, P1545, DOI 10.2307/3060938; HOLMES RT, 1994, BIRDS N AM, V87; Hultine KR, 2000, OECOLOGIA, V123, P32, DOI 10.1007/s004420050986; James FC, 1996, ECOLOGY, V77, P13, DOI 10.2307/2265650; KORNER C, 1991, OECOLOGIA, V88, P30, DOI 10.1007/BF00328400; Lajtha K, 1994, STABLE ISOTOPES ECOL, P1; MIZUTANI H, 1990, AUK, V107, P400, DOI 10.2307/4087626; PELLEK R, 1990, J FOREST, V88, P15; Ramos M.A., 1980, P173; SAUER JR, 2001, N AM BREEDING BIRD S; Sharp ZD, 2001, CHEM GEOL, V178, P197, DOI 10.1016/S0009-2541(01)00262-5; Sherry Thomas W., 1995, P85; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; Wassenaar LI, 2000, ECOL APPL, V10, P911, DOI 10.1890/1051-0761(2000)010[0911:SCAHIR]2.0.CO;2; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wilcove D.S., 1984, American Birds, V38, P10; ZIEGLER H, 1988, STABLE ISOTOPES ECOL, P105	25	208	216	2	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2002	295	5557					1062	1065		10.1126/science.1067124	http://dx.doi.org/10.1126/science.1067124			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834833				2022-12-24	WOS:000173793000063
J	Brugha, R; Starling, M; Walt, G				Brugha, R; Starling, M; Walt, G			GAVI, the first steps: lessons for the Global Fund	LANCET			English	Article								The Global Alliance for Vaccines and Immunization (GAVI) Is seen as a model for the new Global Fund to Fight AIDS, Tuberculosis and Malaria, to be launched early in 2002. We did an assessment in four African countries to report the experiences of ministries of health and their partners in applying to GAVI for funds to strengthen health systems and for new vaccines. Countries welcomed the introduction of hepatitis B vaccine, safe Injection equipment, and the financial support to strengthen Immunisation programmes. All reported that the pace of the application process was too rapid. District visits revealed low staffing levels, insufficient transport and fuel, poorly functioning cold chains, and infrequent supervision. Information systems were unreliable, which will be an obstacle to GAVI when monitoring and rewarding improvements in Immunisation coverage. Also, the high cost of expensive new vaccines will be difficult to sustain if GAVI funding stops at the end of its 5 year commitment. Our study suggests that applications for support and planning for AIDS, tuberculosis, and malaria control under the new Global Fund, will be more complex and demanding on already overstretched ministries of health. Further, the rapid onset of activities, coupled with uncertainty about the time-scale of donor commitment, could be problematic. A limited and carefully assessed set of initial activities, focusing on where and how to strengthen existing country systems, is more likely to be successful and could provide useful models for scaling-up to larger programmes in different contexts.	Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Policy Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Brugha, R (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Policy Unit, London WC1E 7HT, England.		Ayres, Jose Ricardo C. M./G-2618-2012; Brugha, Ruairi/C-8420-2012	Ayres, Jose Ricardo C. M./0000-0002-5225-6492; Brugha, Ruairi/0000-0003-0729-0197				Cutts FT, 2000, TROP MED INT HEALTH, V5, P157, DOI 10.1046/j.1365-3156.2000.00536.x; *GAVI, 2002, UPD COUNTR LEV GAV V; *GAVI, 2002, PROP CALC GAVI REW S; *LATH CONS, 2001, IMM DAT QUAL AUD EV; LEVIN A, 2001, CASE STUDY COSTS FIN; Starling M., 2002, NEW PRODUCTS OLD SYS; *TRANS WORK GROUP, 2002, IN PRESS FRAM DOC GL; Walt G, 2000, TROP MED INT HEALTH, V5, P467, DOI 10.1046/j.1365-3156.2000.00596.x; WHO, 2002, MACR HLTH INV HLTH E	9	76	78	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 2	2002	359	9304					435	438		10.1016/S0140-6736(02)07607-9	http://dx.doi.org/10.1016/S0140-6736(02)07607-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UP	11844535				2022-12-24	WOS:000173686500035
J	McConnell, R; Berhane, K; Gilliland, F; London, SJ; Islam, T; Gauderman, WJ; Avol, E; Margolis, HG; Peters, JM				McConnell, R; Berhane, K; Gilliland, F; London, SJ; Islam, T; Gauderman, WJ; Avol, E; Margolis, HG; Peters, JM			Asthma in exercising children exposed to ozone: a cohort study	LANCET			English	Article							AIR-POLLUTION; BRONCHIAL RESPONSIVENESS; SCHOOL CHILDREN; PREVALENCE; POLLUTANTS; CHILDHOOD; ASSOCIATION; SYMPTOMS	Background Little is known about the effect of exposure to air pollution during exercise or time spent outdoors on the development of asthma. We investigated the relation between newly-diagnosed asthma and team sports in a cohort of children exposed to different concentrations and mixtures of air pollutants. Methods 3535 children with no history of asthma were recruited from schools in 12 communities in southern California and were followed up for up to 5 years. 265 children reported a new diagnosis of asthma during follow-up. We assessed risk of asthma in children playing team sports at study entry in six communities with high daytime ozone concentrations, six with lower concentrations, and in communities with high or low concentrations of nitrogen dioxide, particulate matter, and inorganic-acid vapour. Findings In communities with high ozone concentrations, the relative risk of developing asthma in children playing three or more sports was 3.3 (95% CI 1.9-5.8), compared with children playing no sports. Sports had no effect in areas of low ozone concentration (0.8, 0.4-1.6). Time spent outside was associated with a higher incidence of asthma in areas of high ozone (1.4, 1.0-2.1), but not in areas of low ozone. Exposure to pollutants other than ozone did not alter the effect of team sports. Interpretation Incidence of new diagnoses of asthma is associated with heavy exercise in communities with high concentrations of ozone, thus, air pollution and outdoor exercise could contribute to the development of asthma in children.	Univ So Calif, Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; NIEHS, Res Triangle Pk, NC 27709 USA; Calif Air Resources Board, Sacramento, CA USA	University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	McConnell, R (corresponding author), Univ So Calif, Sch Med, Dept Prevent Med, 1540 Alcazar St,CHP 236, Los Angeles, CA 90089 USA.	rmcconne@hsc.usc.edu	London, Stephanie/C-3734-2019; , Talat/AAV-6834-2020	London, Stephanie/0000-0003-4911-5290; , Talat/0000-0002-2837-865X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007048, Z01ES049019] Funding Source: NIH RePORTER; NHLBI NIH HHS [1R01HL61768] Funding Source: Medline; NIEHS NIH HHS [5P30ES07048-05, 1PO1ES0939581-02] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Asher MI, 1998, EUR RESPIR J, V12, P315; Avol EL, 1998, ENVIRON SCI TECHNOL, V32, P463, DOI 10.1021/es970351m; Baldi I, 1999, EUR RESPIR J, V14, P132, DOI 10.1034/j.1399-3003.1999.14a22.x; Becklake MR, 1997, LANCET, V350, P10; BRUNEKREEF B, 1994, AM J RESP CRIT CARE, V150, P962, DOI 10.1164/ajrccm.150.4.7921470; BURR ML, 1992, CLIN EXP ALLERGY, V22, P509, DOI 10.1111/j.1365-2222.1992.tb00158.x; Clark NM, 1999, ENVIRON HEALTH PERSP, V107, P421, DOI 10.1289/ehp.99107s3421; Corrao W, 1996, CHEST, V109, P298, DOI 10.1378/chest.109.2.298; Ehrlich RI, 1995, INT J EPIDEMIOL, V24, P1138, DOI 10.1093/ije/24.6.1138; Gauderman WJ, 2000, AM J RESP CRIT CARE, V162, P1383; Guo YLL, 1999, ENVIRON HEALTH PERSP, V107, P1001, DOI 10.1289/ehp.991071001; Heir T., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P94; Helenius IJ, 1998, J ALLERGY CLIN IMMUN, V101, P646, DOI 10.1016/S0091-6749(98)70173-3; HORSTMAN DH, 1990, AM REV RESPIR DIS, V142, P1158, DOI 10.1164/ajrccm/142.5.1158; Jenkins HS, 1999, AM J RESP CRIT CARE, V160, P33, DOI 10.1164/ajrccm.160.1.9808119; Kehrl HR, 1999, J ALLERGY CLIN IMMUN, V104, P1198, DOI 10.1016/S0091-6749(99)70013-8; KOREN HS, 1995, ENVIRON HEALTH PERSP, V103, P235, DOI 10.2307/3432379; MCARDLE WD, 1996, EXERCISE PHYSL ENERG, P228; McConnell R, 1999, ENVIRON HEALTH PERSP, V107, P757, DOI 10.2307/3434662; McDonnell WF, 1999, ENVIRON RES, V80, P110, DOI 10.1006/enrs.1998.3894; Miller FJ, 1995, TOXICOL LETT, V82-3, P277, DOI 10.1016/0378-4274(95)03562-1; OSEBOLD JW, 1988, P SOC EXP BIOL MED, V188, P259; Peters JM, 1999, AM J RESP CRIT CARE, V159, P760, DOI 10.1164/ajrccm.159.3.9804143; Rasmussen F, 2000, EUR RESPIR J, V16, P866, DOI 10.1183/09031936.00.16586600; RUPP NT, 1992, AM J DIS CHILD, V146, P941, DOI 10.1001/archpedi.1992.02160200063028; SAMET JM, 1987, CHEST, V91, pS74, DOI 10.1378/chest.91.6.74S; Sears MR, 1997, LANCET, V350, P1015, DOI 10.1016/S0140-6736(97)01468-2; SueChu M, 1996, RESP MED, V90, P99, DOI 10.1016/S0954-6111(96)90206-1; TAGER IB, 1998, RES REP HLTH EFF I, V81, P27; Wang TN, 1999, ENVIRON RES, V81, P239, DOI 10.1006/enrs.1999.3985; WICHMANN HE, 1995, ENVIRON HEALTH PERSP, V103, P29, DOI 10.2307/3432446	32	531	542	6	89	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2002	359	9304					386	391		10.1016/S0140-6736(02)07597-9	http://dx.doi.org/10.1016/S0140-6736(02)07597-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UP	11844508				2022-12-24	WOS:000173686500008
J	Doran, PT; Priscu, JC; Lyons, WB; Walsh, JE; Fountain, AG; McKnight, DM; Moorhead, DL; Virginia, RA; Wall, DH; Clow, GD; Fritsen, CH; McKay, CP; Parsons, AN				Doran, PT; Priscu, JC; Lyons, WB; Walsh, JE; Fountain, AG; McKnight, DM; Moorhead, DL; Virginia, RA; Wall, DH; Clow, GD; Fritsen, CH; McKay, CP; Parsons, AN			Antarctic climate cooling and terrestrial ecosystem response	NATURE			English	Article							TAYLOR-VALLEY; DRY VALLEYS; COMMUNITIES; TEMPERATURE	The average air temperature at the Earth's surface has increased by 0.06degreesC per decade during the 20th century(1), and by 0.19degreesC per decade from 1979 to 1998(2). Climate models generally predict amplified warming in polar regions(3,4), as observed in Antarctica's peninsula region over the second half of the 20th century(5-9). Although previous reports suggest slight recent continental warming(9,10), our spatial analysis of Antarctic meteorological data demonstrates a net cooling on the Antarctic continent between 1966 and 2000, particularly during summer and autumn. The McMurdo Dry Valleys have cooled by 0.7degreesC per decade between 1986 and 2000, with similar pronounced seasonal trends. Summer cooling is particularly important to Antarctic terrestrial ecosystems that are poised at the interface of ice and water. Here we present data from the dry valleys representing evidence of rapid terrestrial ecosystem response to climate cooling in Antarctica, including decreased primary productivity of lakes (6-9% per year) and declining numbers of soil invertebrates (more than 10% per year). Continental Antarctic cooling, especially the seasonality of cooling, poses challenges to models of climate and ecosystem change.	Univ Illinois, Dept Earth & Environm Sci, Chicago, IL 60607 USA; Montana State Univ, Bozeman, MT 59717 USA; Ohio State Univ, Byrd Polar Res Ctr, Columbus, OH 43210 USA; Univ Illinois, Dept Atmospher Sci, Urbana, IL 61801 USA; Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; Portland State Univ, Dept Geol, Portland, OR 97207 USA; Univ Toledo, Dept Earth Ecol & Environm Sci, Toledo, OH 43606 USA; Dartmouth Coll, Environm Studies Program, Hanover, NH 03755 USA; Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; US Geol Survey, Climate Program, Denver, CO 80225 USA; Desert Res Inst, Div Earth & Ecosyst Sci, Reno, NV 89512 USA; NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Montana State University System; Montana State University Bozeman; University System of Ohio; Ohio State University; University of Illinois System; University of Illinois Urbana-Champaign; University of Colorado System; University of Colorado Boulder; Portland State University; University System of Ohio; University of Toledo; Dartmouth College; Colorado State University; United States Department of the Interior; United States Geological Survey; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Doran, PT (corresponding author), Univ Illinois, Dept Earth & Environm Sci, 845 W Taylor St, Chicago, IL 60607 USA.		Wall, Diana H/F-5491-2011	Walsh, John/0000-0001-9541-5927; MCKNIGHT, DIANE/0000-0002-4171-1533				Bromley A. M., 1985, INFORMATION PUBLICAT, V11; BROMWICH DH, 1998, ANTARCTICA BAROMETER; CATTLE H, 1995, PHILOS T R SOC A, V352, P201, DOI 10.1098/rsta.1995.0064; CHEN CTA, 1986, ANNU REV EARTH PL SC, V14, P201, DOI 10.1146/annurev.ea.14.050186.001221; Chinn T.J., 1993, ANTARCT RES SER, V59, P1, DOI DOI 10.1029/AR059P0001; Clow GD, 1988, J CLIMATE, V1, P715, DOI 10.1175/1520-0442(1988)001<0715:COAPSR>2.0.CO;2; Comiso JC, 2000, J CLIMATE, V13, P1674, DOI 10.1175/1520-0442(2000)013<1674:VATIAS>2.0.CO;2; DORAN P. T., 1995, ANTARCT J US, V30, P276; DORAN PT, UNPUB J CLIM; Fountain AG, 1999, BIOSCIENCE, V49, P961, DOI 10.2307/1313730; Freckman DW, 1997, ECOLOGY, V78, P363, DOI 10.1890/0012-9658(1997)078[0363:LDASNC]2.0.CO;2; Houghton J. T., 2001, CLIMATE CHANGE 2001; Jacka TH, 1998, ANN GLACIOL, V27, P553; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; MCKAY CP, 1993, ANTARCT RES SER, V61, P201; McKnight DM, 1999, BIOSCIENCE, V49, P985, DOI 10.2307/1313732; National Research Council, 2000, REC OBS GLOB TEMP CH; Parish TR, 2001, J APPL METEOROL, V40, P810, DOI 10.1175/1520-0450(2001)040<0810:FOTWAB>2.0.CO;2; PORAZINSKA DL, IN PRESS ARCTIC ANTA; Powers LE, 1998, ARCTIC ALPINE RES, V30, P133, DOI 10.2307/1552128; PRISCU JC, 1995, FRESHWATER BIOL, V34, P215, DOI 10.1111/j.1365-2427.1995.tb00882.x; Priscu JC, 1999, BIOSCIENCE, V49, P997, DOI 10.2307/1313733; RIORDAN A. J, 1973, CLIMATE ARCTIC, P268; Smith RC, 1999, BIOSCIENCE, V49, P393, DOI 10.2307/1313632; Vaughan DG, 1996, NATURE, V379, P328, DOI 10.1038/379328a0; Vaughan DG, 2001, SCIENCE, V293, P1777, DOI 10.1126/science.1065116; Virginia RA, 1999, BIOSCIENCE, V49, P973, DOI 10.2307/1313731; Weller G, 1998, ANN GLACIOL, V27, P543; WHARTON RA, 1992, J GEOPHYS RES-OCEANS, V97, P3503, DOI 10.1029/91JC03106	29	335	346	2	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					517	520		10.1038/nature710	http://dx.doi.org/10.1038/nature710			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11793010				2022-12-24	WOS:000173564300044
J	Lobachev, KS; Gordenin, DA; Resnick, MA				Lobachev, KS; Gordenin, DA; Resnick, MA			The Mre11 complex is required for repair of hairpin-capped double-strand breaks and prevention of chromosome rearrangements	CELL			English	Article							DNA DOUBLE-STRAND; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; GENE AMPLIFICATION; MEIOTIC RECOMBINATION; PROTEIN COMPLEX; INVERTED REPEAT; HUMAN GENOME; YEAST-CELLS; MEIOSIS	Inverted repeats (IRs) that can form a hairpin or cruciform structure are common in the human genome and may be sources of instability. An IR involving the human Alu sequence (Alu-IR) has been studied as a model of such structures in yeast. We found that an Alu-IR is a mitotic recombination hotspot requiring MRE11/RAD50/XRS2 and SAE2. Using a newly developed approach for mapping rare double-strand breaks (DSBs), we established that induction of recombination results from breaks that are terminated by hairpins. Failure of the mre11, rad50, xrs2, and sae2 mutants to process the hairpins blocks recombinational repair of the DSBs and leads to generation of chromosome inverted duplications. Our results suggest an additional role for the Mre11 complex in maintaining genome stability.	NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Resnick, MA (corresponding author), NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA.		Dmitry, Gordenin/C-3907-2018; resnick, Michael/F-1668-2019	Dmitry, Gordenin/0000-0002-8399-1836; resnick, Michael/0000-0002-8473-7506	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES065073, Z01ES065073, Z01ES021122] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Akgun E, 1997, MOL CELL BIOL, V17, P5559, DOI 10.1128/MCB.17.9.5559; ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; Berger JM, 1998, BBA-GENE STRUCT EXPR, V1400, P3, DOI 10.1016/S0167-4781(98)00124-9; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Bressan DA, 1999, MOL CELL BIOL, V19, P7681; BRISON O, 1993, BIOCHIM BIOPHYS ACTA, V1155, P25, DOI 10.1016/0304-419X(93)90020-D; Butler DK, 1996, CELL, V87, P1115, DOI 10.1016/S0092-8674(00)81805-X; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; Catasti P, 1999, GENETICA, V106, P15, DOI 10.1023/A:1003716509180; CHALKER AF, 1988, GENE, V71, P201, DOI 10.1016/0378-1119(88)90092-3; Connelly JC, 1999, NUCLEIC ACIDS RES, V27, P1039, DOI 10.1093/nar/27.4.1039; D'Amours D, 2001, GENE DEV, V15, P2238, DOI 10.1101/gad.208701; DASGUPTA U, 1987, GENETICS, V115, P41; Delidakis C, 1989, CURR OPIN CELL BIOL, V1, P488, DOI 10.1016/0955-0674(89)90010-0; Deneke J, 2000, P NATL ACAD SCI USA, V97, P7721, DOI 10.1073/pnas.97.14.7721; ERLICH DS, 1989, MOBILE DNA, P799; Freudenreich CH, 1998, SCIENCE, V279, P853, DOI 10.1126/science.279.5352.853; Galli A, 1998, GENETICS, V149, P1235; GIBSON FP, 1992, J BACTERIOL, V174, P1222, DOI 10.1128/jb.174.4.1222-1228.1992; Gordenin DA, 1998, MUTAT RES-FUND MOL M, V400, P45, DOI 10.1016/S0027-5107(98)00047-5; GORDENIN DA, 1993, MOL CELL BIOL, V13, P5315, DOI 10.1128/MCB.13.9.5315; Grenon M, 2001, NAT CELL BIOL, V3, P844, DOI 10.1038/ncb0901-844; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; HABER JE, 1995, BIOESSAYS, V17, P609, DOI 10.1002/bies.950170707; HUANG T, 1995, J BIOL CHEM, V270, P9607, DOI 10.1074/jbc.270.16.9607; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; Jankowski C, 2000, P NATL ACAD SCI USA, V97, P2134, DOI 10.1073/pnas.040460297; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; KEENEY S, 1995, P NATL ACAD SCI USA, V92, P11274, DOI 10.1073/pnas.92.24.11274; KRAMER KM, 1994, MOL CELL BIOL, V14, P1293, DOI 10.1128/MCB.14.2.1293; Leach DRF, 1997, MOL MICROBIOL, V26, P597, DOI 10.1046/j.1365-2958.1997.6071957.x; LEACH DRF, 1994, BIOESSAYS, V16, P893, DOI 10.1002/bies.950161207; Lewis LK, 2000, MUTAT RES-FUND MOL M, V451, P71, DOI 10.1016/S0027-5107(00)00041-5; Lin CT, 2001, NUCLEIC ACIDS RES, V29, P3529, DOI 10.1093/nar/29.17.3529; Lobachev KS, 2000, EMBO J, V19, P3822, DOI 10.1093/emboj/19.14.3822; Lobachev KS, 1998, GENETICS, V148, P1507; Malagon F, 1998, MOL GEN GENET, V259, P639, DOI 10.1007/s004380050858; Malkova A, 1996, GENETICS, V143, P741; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; McKee AHZ, 1997, GENETICS, V146, P797; MEUTH M, 1989, MOBILE DNA, P833; Moreau S, 1999, MOL CELL BIOL, V19, P556; Nasar F, 2000, MOL CELL BIOL, V20, P3449, DOI 10.1128/MCB.20.10.3449-3458.2000; OUELLETTE M, 1991, RES MICROBIOL, V142, P737, DOI 10.1016/0923-2508(91)90089-S; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Prinz S, 1997, GENETICS, V146, P781; Qin ZJ, 2000, GENE DEV, V14, P1789; Rattray AJ, 2001, GENETICS, V158, P109; Schar P, 2001, CELL, V104, P329, DOI 10.1016/S0092-8674(01)00220-3; Sharples GJ, 1999, J BACTERIOL, V181, P5543, DOI 10.1128/JB.181.18.5543-5550.1999; SHARPLES GJ, 1995, MOL MICROBIOL, V17, P1215, DOI 10.1111/j.1365-2958.1995.mmi_17061215_1.x; STARK GR, 1989, CELL, V57, P901, DOI 10.1016/0092-8674(89)90328-0; Stenger JE, 2001, GENOME RES, V11, P12, DOI 10.1101/gr.158801; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; TIMME TL, 1988, AM J MED SCI, V295, P40, DOI 10.1097/00000441-198801000-00009; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Tsukamoto Y, 2001, CURR BIOL, V11, P1328, DOI 10.1016/S0960-9822(01)00372-4; Usui T, 2001, MOL CELL, V7, P1255, DOI 10.1016/S1097-2765(01)00270-2; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WINDLE BE, 1992, MUTAT RES, V276, P199, DOI 10.1016/0165-1110(92)90009-X; YASUDA LF, 1991, CELL, V67, P505, DOI 10.1016/0092-8674(91)90525-4	64	319	324	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 25	2002	108	2					183	193		10.1016/S0092-8674(02)00614-1	http://dx.doi.org/10.1016/S0092-8674(02)00614-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832209	Bronze			2022-12-24	WOS:000173521300006
J	Castillo, PE; Schoch, S; Schmitz, F; Sudhof, TC; Malenka, RC				Castillo, PE; Schoch, S; Schmitz, F; Sudhof, TC; Malenka, RC			RIM1 alpha is required for presynaptic long-term potentiation	NATURE			English	Article							MOSSY FIBER SYNAPSES; CYCLIC-AMP; SYNAPTIC TRANSMISSION; CAMP; LTP; HIPPOCAMPUS; MICE; RAB3; ENHANCEMENT; ACTIVATION	Two main forms of long-term potentiation (LTP)-a prominent model for the cellular mechanism of learning and memory-have been distinguished in the mammalian brain(1). One requires activation of postsynaptic NMDA (N-methyl D-aspartate) receptors, whereas the other, called mossy fibre LTP, has a principal presynaptic component. Mossy fibre LTP is expressed in hippocampal mossy fibre synapses(1,2), cerebellar parallel fibre synapses(3,4) and corticothalamic synapses(5), where it apparently operates by a mechanism that requires activation of protein kinase A. Thus, presynaptic substrates of protein kinase A are probably essential in mediating this form of long-term synaptic plasticity. Studies of knockout mice have shown that the synaptic vesicle protein Rab3A is required for mossy fibre LTP6, but the protein kinase A substrates rabphilin, synapsin I and synapsin II are dispensable(7,8). Here we report that mossy fibre LTP in the hippocampus and the cerebellum is abolished in mice lacking RIM1alpha, an active zone protein that binds to Rab3A and that is also a protein kinase A substrate(9,10). Our results indicate that the long-term increase in neurotransmitter release during mossy fibre LTP may be mediated by a unitary mechanism that involves the GTP-dependent interaction of Rab3A with RIM1alpha at the interface of synaptic vesicles and the active zone.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Friend Pritzker Lab, Stanford, CA 94304 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dept Mol Genet, Dallas, TX 75390 USA	Stanford University; Yeshiva University; Albert Einstein College of Medicine; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Friend Pritzker Lab, Stanford, CA 94304 USA.		Schoch, Susanne/F-7741-2012	Castillo, Pablo/0000-0002-9834-1801				Beaumont V, 2000, NAT NEUROSCI, V3, P133, DOI 10.1038/72072; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; Castro-Alamancos MA, 1999, J NEUROSCI, V19, P9090, DOI 10.1523/JNEUROSCI.19-20-09090.1999; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; Huang YY, 1995, CELL, V83, P1211, DOI 10.1016/0092-8674(95)90146-9; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Linden DJ, 1999, J NEUROSCI, V19, P10221; Lonart G, 1998, NEURON, V21, P1141, DOI 10.1016/S0896-6273(00)80631-5; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; REGEHR WG, 1994, J NEUROSCI, V14, P523; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Schluter OM, 1999, J NEUROSCI, V19, P5834, DOI 10.1523/JNEUROSCI.19-14-05834.1999; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; SPILLANE DM, 1995, NEUROPHARMACOLOGY, V34, P1573, DOI 10.1016/0028-3908(95)00107-H; Tzounopoulos T, 1998, NEURON, V21, P837, DOI 10.1016/S0896-6273(00)80599-1; Villacres EC, 1998, J NEUROSCI, V18, P3186; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	29	287	301	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2002	415	6869					327	330		10.1038/415327a	http://dx.doi.org/10.1038/415327a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797010				2022-12-24	WOS:000173293500045
J	Zhang, S; Xu, L; Lee, J; Xu, T				Zhang, S; Xu, L; Lee, J; Xu, T			Drosophila atrophin homolog functions as a transcriptional corepressor in multiple developmental processes	CELL			English	Article							DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; EVEN-SKIPPED PROTEIN; REPRESSES TRANSCRIPTION; GENE-PRODUCT; EMBRYO; PATTERN; SEGMENTATION; EXPRESSION; REPEAT; HAIRY	Dentatorubral-pallidoluysian atrophy is a progressive neurodegenerative disease caused by the expansion of a polyglutamine repeats within the Atrophin-1 protein. The In vivo function of Atrophin-1 is unknown. We have characterized a Drosophila gene encoding an Atrophin family protein. Analysis of mutant phenotypes indicates that Drosophila Atrophin is required in diverse developmental processes including early embryonic patterning. Drosophila Atrophin genetically interacts with the transcription repressor even-skipped and is required for its repressive function in vivo. Drosophila Atrophin directly binds to Even-skipped in vitro. Furthermore, both human Atrophin-1 and Drosophila Atrophin repress transcription in vivo when tethered to DNA, and poly-Q expansion in Atrophin-1 reduces this repressive activity. We propose that Atrophin proteins function as versatile transcriptional corepressors and discuss a model that deregulation of transcription may contribute to the pathogenesis of neurodegeneration.	Yale Univ, Sch Med, Dept Genet, Howard Hughes Med Inst, New Haven, CT 06536 USA	Howard Hughes Medical Institute; Yale University	Xu, T (corresponding author), Yale Univ, Sch Med, Dept Genet, Howard Hughes Med Inst, 295 Congress Ave, New Haven, CT 06536 USA.				NATIONAL CANCER INSTITUTE [R01CA069408] Funding Source: NIH RePORTER; NCI NIH HHS [CA69408] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BASTIAN H, 1990, EMBO J, V9, P1839, DOI 10.1002/j.1460-2075.1990.tb08309.x; Boutell JM, 1999, HUM MOL GENET, V8, P1647, DOI 10.1093/hmg/8.9.1647; CHOU TB, 1992, GENETICS, V131, P643; DINARDO S, 1987, GENE DEV, V1, P1212, DOI 10.1101/gad.1.10.1212; FRASCH M, 1988, GENE DEV, V2, P1824, DOI 10.1101/gad.2.12b.1824; Fujioka M, 1999, DEVELOPMENT, V126, P2527; HAN KY, 1993, GENE DEV, V7, P491, DOI 10.1101/gad.7.3.491; Jimenez G, 1997, GENE DEV, V11, P3072, DOI 10.1101/gad.11.22.3072; Kobayashi M, 2001, DEVELOPMENT, V128, P1805; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; LA SA, 1991, NATURE, V352, P77; Li C, 1998, MOL CELL BIOL, V18, P3771, DOI 10.1128/MCB.18.7.3771; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Mannervik M, 1999, P NATL ACAD SCI USA, V96, P6797, DOI 10.1073/pnas.96.12.6797; Mannervik M, 1999, SCIENCE, V284, P606, DOI 10.1126/science.284.5414.606; MANOUKIAN AS, 1992, GENE DEV, V6, P1740, DOI 10.1101/gad.6.9.1740; NAGAFUCHI S, 1994, NAT GENET, V8, P177, DOI 10.1038/ng1094-177; NAITO H, 1982, NEUROLOGY, V32, P798, DOI 10.1212/WNL.32.8.798; Nibu Y, 1998, SCIENCE, V280, P101, DOI 10.1126/science.280.5360.101; Nibu Y, 1998, EMBO J, V17, P7009, DOI 10.1093/emboj/17.23.7009; NUSSLEINVOLHARD C, 1985, COLD SPRING HARB SYM, V50, P145, DOI 10.1101/SQB.1985.050.01.020; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Poortinga G, 1998, EMBO J, V17, P2067, DOI 10.1093/emboj/17.7.2067; ROSS CA, 1995, NEURON, V15, P493, DOI 10.1016/0896-6273(95)90138-8; Seki N, 1997, DNA Res, V4, P345, DOI 10.1093/dnares/4.5.345; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; STJOHNSTON D, 1992, CELL, V68, P201; WEIGEL D, 1990, SCIENCE, V248, P495, DOI 10.1126/science.2158673; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; Wood JD, 2000, J CELL BIOL, V150, P939, DOI 10.1083/jcb.150.5.939; XU TA, 1995, DEVELOPMENT, V121, P1053; Zeitlinger J, 1999, DEVELOPMENT, V126, P3947; ZHENG L, 1995, DEVELOPMENT, V121, P3045; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	35	119	119	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 11	2002	108	1					45	56		10.1016/S0092-8674(01)00630-4	http://dx.doi.org/10.1016/S0092-8674(01)00630-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792320	Bronze			2022-12-24	WOS:000173280700007
J	Ischenko, AA; Saparbaev, MK				Ischenko, AA; Saparbaev, MK			Alternative nucleotide incision repair pathway for oxidative DNA damage	NATURE			English	Article							COLI ENDONUCLEASE-IV; BASE-EXCISION-REPAIR; ESCHERICHIA-COLI; STRUCTURAL GENE; GLYCOSYLASE; ENZYMES; RECONSTITUTION; SUBSTRATE; ADDUCT; SITE	The DNA glycosylase pathway(1), which requires the sequential action of two enzymes for the incision of DNA(2), presents a serious problem for the efficient repair of oxidative DNA damage, because it generates genotoxic intermediates such as abasic sites and/or blocking 3'-end groups that must be eliminated by additional steps before DNA repair synthesis can be initiated. Besides the logistical problems, biological evidence hints at the existence of an alternative repair pathway. Mutants of Escherichia coli(3) and mice (ref. 4 and M. Takao et al., personal communication) that are deficient in DNA glycosylases that remove oxidized bases are not sensitive to reactive oxygen species, and the E. coli triple mutant nei, nth, fpg is more radioresistant than the wild-type strain(5). Here we show that Nfo-like endonucleases nick DNA on the 5' side of various oxidatively damaged bases, generating 3'-hydroxyl and 5'-phosphate termini. Nfo-like endonucleases function next to each of the modified bases that we tested, including 5,6-dihydrothymine, 5,6-dihydrouracil, 5-hydroxyuracil and 2,6-diamino-4-hydroxy-5-N-methylformamidopyrimidine residues. The 3'-hydroxyl terminus provides the proper end for DNA repair synthesis; the dangling damaged nucleotide on the 5' side is then a good substrate for human flap-structure endonuclease(6) and for DNA polymerase I of E. coli.	Inst Gustave Roussy, LBPA ENS Cachan, Grp Reparat ADN, CNRS,UMR 8532, F-94805 Villejuif, France; Russian Acad Sci, Novosibirsk Bioorgan Chem Inst, Siberian Div, Novosibirsk 630090, Russia	Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Saparbaev, MK (corresponding author), Inst Gustave Roussy, LBPA ENS Cachan, Grp Reparat ADN, CNRS,UMR 8532, Rue Camille Desmoulins, F-94805 Villejuif, France.		Saparbaev, Murat K/N-3225-2015; Ishchenko, Alexander/D-4133-2013; Saparbaev, Murat/AAC-5478-2020	Saparbaev, Murat K/0000-0002-4630-1074; Ishchenko, Alexander/0000-0002-0488-8858; Saparbaev, Murat/0000-0002-4630-1074				Alleva JL, 2000, BIOCHEMISTRY-US, V39, P2659, DOI 10.1021/bi992751n; BAILLY V, 1989, BIOCHEM J, V259, P761, DOI 10.1042/bj2590761; BARZILAY G, 1995, NAT STRUCT BIOL, V2, P561, DOI 10.1038/nsb0795-561; Blaisdell JO, 2001, P NATL ACAD SCI USA, V98, P7426, DOI 10.1073/pnas.131077798; BOITEUX S, 1987, EMBO J, V6, P3177, DOI 10.1002/j.1460-2075.1987.tb02629.x; CHAN E, 1987, P NATL ACAD SCI USA, V84, P3189, DOI 10.1073/pnas.84.10.3189; CUNNINGHAM RP, 1986, J BACTERIOL, V168, P1120, DOI 10.1128/jb.168.3.1120-1127.1986; DEMPLE B, 1991, P NATL ACAD SCI USA, V88, P10450; FURLONG EA, 1986, BIOCHEMISTRY-US, V25, P4344, DOI 10.1021/bi00363a025; Gonzalez-Flecha B, 2000, ANN NY ACAD SCI, V899, P69; Hang B, 1996, P NATL ACAD SCI USA, V93, P13737, DOI 10.1073/pnas.93.24.13737; Hosfield DJ, 1999, CELL, V98, P397, DOI 10.1016/S0092-8674(00)81968-6; IDE H, 1994, BIOCHEMISTRY-US, V33, P7842, DOI 10.1021/bi00191a011; Kim K, 1998, J BIOL CHEM, V273, P8842, DOI 10.1074/jbc.273.15.8842; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; Laval J, 1998, MUTAT RES-FUND MOL M, V402, P93, DOI 10.1016/S0027-5107(97)00286-8; LAVAL J, 1977, NATURE, V269, P829, DOI 10.1038/269829a0; LINDAHL T, 1976, NATURE, V259, P64, DOI 10.1038/259064a0; Maksimenko AV, 1999, NUCLEOS NUCLEOT, V18, P2071, DOI 10.1080/07328319908044865; McCullough AK, 1999, ANNU REV BIOCHEM, V68, P255, DOI 10.1146/annurev.biochem.68.1.255; Petit C, 1999, BIOCHIMIE, V81, P15, DOI 10.1016/S0300-9084(99)80034-0; POPOFF SC, 1990, P NATL ACAD SCI USA, V87, P4193, DOI 10.1073/pnas.87.11.4193; RAMOTAR D, 1991, MOL MICROBIOL, V5, P149, DOI 10.1111/j.1365-2958.1991.tb01835.x; Reardon JT, 1997, P NATL ACAD SCI USA, V94, P9463, DOI 10.1073/pnas.94.17.9463; ROGERS SG, 1980, GENE, V11, P187, DOI 10.1016/0378-1119(80)90059-1; Saparbaev M, 1998, P NATL ACAD SCI USA, V95, P8508, DOI 10.1073/pnas.95.15.8508; Wilson DM, 1997, P NATL ACAD SCI USA, V94, P12754, DOI 10.1073/pnas.94.24.12754; Yasui A, 1998, BIOESSAYS, V20, P291, DOI 10.1002/(SICI)1521-1878(199804)20:4<291::AID-BIES5>3.0.CO;2-T	29	206	223	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					183	187		10.1038/415183a	http://dx.doi.org/10.1038/415183a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805838				2022-12-24	WOS:000173159300045
J	Shiu, PKT; Raju, NB; Zickler, D; Metzenberg, RL				Shiu, PKT; Raju, NB; Zickler, D; Metzenberg, RL			Meiotic silencing by unpaired DNA	CELL			English	Article							DIRECTED RNA-POLYMERASE; INDUCED POINT MUTATION; DOUBLE-STRANDED-RNA; NEUROSPORA-CRASSA; MATING-TYPE; GENETIC INTERFERENCE; EXPRESSION; TRANSVECTION; RECOGNITION; INSTABILITY	The silencing of gene expression by segments of DNA present in excess of the normal number is called cosuppression in plants and quelling in fungi. We describe a related process, meiotic silencing by unpaired DNA (MSUD). DNA unpaired in meiosis causes silencing of all DNA homologous to it, including genes that are themselves paired. A semidominant Neurospora mutant, Sad-1, fails to perform MSUD. Sad-1 suppresses the sexual phenotypes of many ascus-dominant mutants. MSUD may provide insights into the function of genes necessary for meiosis, including genes for which ablation in vegetative life would be lethal. It may also contribute to reproductive isolation of species within the genus Neurospora. The wild-type allele, sad-1(+), encodes a putative RNA-directed RNA polymerase.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Univ Paris 11, Inst Genet & Microbiol, F-91405 Orsay, France	Stanford University; UDICE-French Research Universities; Universite Paris Saclay	Shiu, PKT (corresponding author), Stanford Univ, Dept Biol Sci, 385 Serra Mall, Stanford, CA 94305 USA.	ktshiu@stanford.edu			NIGMS NIH HHS [GM 08995] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM008995, R01GM008995] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], 1990, FUNGAL GENET NEWSL, DOI [10.4148/1941-4765.1472, DOI 10.4148/1941-4765.1472]; Aramayo R, 1996, GENETICS, V144, P991; Aramayo R, 1996, CELL, V86, P103, DOI 10.1016/S0092-8674(00)80081-1; BUTLER DK, 1993, CHROMOSOMA, V102, P519, DOI 10.1007/BF00368345; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; CARROLL AM, 1994, FUNGAL GENET NEWSLET, V41, P22, DOI DOI 10.4148/1941-4765.1367; Carthew RW, 2001, CURR OPIN CELL BIOL, V13, P244, DOI 10.1016/S0955-0674(00)00204-0; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Cogoni C, 2000, CURR OPIN GENET DEV, V10, P638, DOI 10.1016/S0959-437X(00)00134-9; Coppin E, 2000, GENETICS, V155, P657; CRISP TM, 1992, MUTAT RES, V296, P89, DOI 10.1016/0165-1110(92)90034-7; Crow JF, 1997, P NATL ACAD SCI USA, V94, P8380, DOI 10.1073/pnas.94.16.8380; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; HAGER KM, 1986, P NATL ACAD SCI USA, V83, P7693, DOI 10.1073/pnas.83.20.7693; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; Margolin BS, 1997, FUNGAL GENET NEWSLET, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; Mitchell M. B, 1966, NEUROSPORA NEWSL, V10, P6; Noubissi FK, 2000, FUNGAL GENET BIOL, V31, P91, DOI 10.1006/fgbi.2000.1235; Pal-Bhadra M, 1999, CELL, V99, P35, DOI 10.1016/S0092-8674(00)80060-4; PERKINS DD, 1988, EXP MYCOL, V12, P91, DOI 10.1016/0147-5975(88)90001-1; Perkins DD, 1997, GENETICS, V147, P125; Perkins DD, 1997, ADV GENET, V36, P239, DOI 10.1016/S0065-2660(08)60311-9; PERKINS DD, 2001, NEUROSPORA COMPENDIU, P92; RAJU NB, 1977, EXP MYCOL, V1, P152, DOI 10.1016/S0147-5975(77)80040-6; RAJU NB, 1980, EUR J CELL BIOL, V23, P208; RAJU NB, 1978, CAN J GENET CYTOL, V20, P41, DOI 10.1139/g78-007; RANDALL TA, 1995, GENETICS, V141, P119; Sambrook JFE, 1989, MOL CLONING LAB MANU; Schiebel W, 1998, PLANT CELL, V10, P2087, DOI 10.1105/tpc.10.12.2087; SCHROEDER AL, 1986, CURR GENET, V10, P381, DOI 10.1007/BF00418410; SCHROEDER AL, 1975, MOL MECHANISMS REP B, P567; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; Selker EU, 1997, TRENDS GENET, V13, P296, DOI 10.1016/S0168-9525(97)01201-8; Shiu PKT, 2000, CURR OPIN MICROBIOL, V3, P183, DOI 10.1016/S1369-5274(00)00073-4; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Svoboda P, 2000, DEVELOPMENT, V127, P4147; THOMPSONCOFFE C, 1994, DEV BIOL, V165, P257, DOI 10.1006/dbio.1994.1251; Tinsley JH, 1998, MOL GEN GENET, V259, P601, DOI 10.1007/s004380050853; TOPPER VM, 1972, THESIS CORNELL U; TRELOGAN SA, 1995, P NATL ACAD SCI USA, V92, P1520, DOI 10.1073/pnas.92.5.1520; VOLLMER SJ, 1986, P NATL ACAD SCI USA, V83, P4869, DOI 10.1073/pnas.83.13.4869; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; WOUDT LP, 1983, NUCLEIC ACIDS RES, V11, P5347, DOI 10.1093/nar/11.16.5347; Wu CT, 1999, CURR OPIN GENET DEV, V9, P237, DOI 10.1016/S0959-437X(99)80035-5; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	54	339	360	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2001	107	7					905	916		10.1016/S0092-8674(01)00609-2	http://dx.doi.org/10.1016/S0092-8674(01)00609-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779466	Bronze			2022-12-24	WOS:000173024200011
J	Rycroft, B				Rycroft, B			My adventure with breast cancer	LANCET			English	Article											Rycroft, B (corresponding author), POB 24002, ZA-7735 Claremont, South Africa.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2001				S			S6	S6		10.1016/S0140-6736(01)07019-2	http://dx.doi.org/10.1016/S0140-6736(01)07019-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505HK	11784555				2022-12-24	WOS:000172907200006
J	Sawamura, H; Shima, K; Tanji, J				Sawamura, H; Shima, K; Tanji, J			Numerical representation for action in the parietal cortex of the monkey	NATURE			English	Article							NEURONAL-ACTIVITY; MACAQUE MONKEYS; AREA-5; ARM; ORGANIZATION; MOVEMENTS; NUMBERS; MOTOR	The anterior part of the parietal association area in the cerebral cortex of primates has been implicated in the integration of somatosensory signals(1,2), which generate neural images of body parts and apposed objects and provide signals for sensorial guidance of movements(3-6). Here we show that this area is active in primates performing numerically based behavioural tasks. We required monkeys to select and perform movement A five times, switch to movement B for five repetitions, and return to movement A, in a cyclical fashion. Cellular activity in the superior parietal lobule reflected the number of self-movement executions. For the most part, the number-selective activity was also specific for the type of movement. This type of numerical representation of self-action was seen less often in the inferior parietal lobule, and rarely in the primary somatosensory cortex. Such activity in the superior parietal lobule is useful for processing numerical information, which is necessary to provide a foundation for the forthcoming motor selection.	Tohoku Univ, Sch Med, Dept Physiol, Sendai, Miyagi 980, Japan; Core Res Evolut Sci & Technol Program, Kawaguchi 3320012, Japan	Tohoku University; Japan Science & Technology Agency (JST)	Tanji, J (corresponding author), Tohoku Univ, Sch Med, Dept Physiol, Sendai, Miyagi 980, Japan.							Balint R, 1909, MON PSYCHIATR NEUROL, V25, P51; Boysen S. T., 1993, DEV NUMERICAL COMPET; Brannon EM, 1998, SCIENCE, V282, P746, DOI 10.1126/science.282.5389.746; BURBAUD P, 1991, J NEUROPHYSIOL, V66, P429, DOI 10.1152/jn.1991.66.2.429; Chochon F, 1999, J COGNITIVE NEUROSCI, V11, P617, DOI 10.1162/089892999563689; CRAMMOND DJ, 1989, EXP BRAIN RES, V76, P458; Darian-Smith, 1984, HDB PHYSL 2 1, V3, P789; DEHAENE S, 1993, J COGNITIVE NEUROSCI, V5, P390, DOI 10.1162/jocn.1993.5.4.390; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Hauser MD, 1996, P NATL ACAD SCI USA, V93, P1514, DOI 10.1073/pnas.93.4.1514; Iriki A, 1996, NEUROREPORT, V7, P2325; JONES EG, 1978, J COMP NEUROL, V181, P291, DOI 10.1002/cne.901810206; Lewis JW, 1999, SOMATOSENS MOT RES, V16, P382; MATSUZAWA T, 1985, NATURE, V315, P57, DOI 10.1038/315057a0; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Orlov T, 2000, NATURE, V404, P77, DOI 10.1038/35003571; PONS TP, 1985, J COMP NEUROL, V241, P445, DOI 10.1002/cne.902410405; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; SAKATA H, 1973, BRAIN RES, V64, P85, DOI 10.1016/0006-8993(73)90172-8; SEAL J, 1982, BRAIN RES, V250, P229, DOI 10.1016/0006-8993(82)90417-6; Shima K, 2000, J NEUROPHYSIOL, V84, P2148, DOI 10.1152/jn.2000.84.4.2148; WASHBURN DA, 1991, PSYCHOL SCI, V2, P190, DOI 10.1111/j.1467-9280.1991.tb00130.x	23	196	208	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2002	415	6874					918	922		10.1038/415918a	http://dx.doi.org/10.1038/415918a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859371				2022-12-24	WOS:000173941000047
J	Vassallo, R; Ryu, JH; Schroeder, DR; Decker, PA; Limper, AH				Vassallo, R; Ryu, JH; Schroeder, DR; Decker, PA; Limper, AH			Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LARGE INDUSTRIAL-STATE; HIGH-RESOLUTION CT; EOSINOPHILIC GRANULOMA; MULTIPLE-MYELOMA; ACUTE-LEUKEMIA; LUNG; ASSOCIATION; MALIGNANCY; LYMPHOMAS; MICHIGAN	Background: Pulmonary Langerhans'-cell histiocytosis is an uncommon interstitial lung disease in adults. It has an unpredictable course and may be associated with an increased susceptibility to the development of malignant neoplasms. Methods: We reviewed the records of 102 adults with histopathologically confirmed pulmonary Langerhans'-cell histiocytosis to ascertain their vital status and whether cancer had been diagnosed. The health status of surviving patients was quantified with the use of the 36-Item Short-Form General Health Survey. Factors potentially associated with survival after the diagnosis of pulmonary Langerhans'-cell histiocytosis were analyzed with the Cox proportional-hazards model. Results: The median follow-up period was 4 years (range, 0 to 23). There were 33 deaths, 15 of which were attributable to respiratory failure. Six hematologic cancers were diagnosed. The overall median survival was 12.5 years, which was significantly shorter than that expected for persons of the same sex and calendar year of birth (P<0.001). In a univariate analysis, variables predictive of shorter survival included an older age (P=0.003), a lower forced expiratory volume in one second (FEV1 (P=0.004), a higher residual volume (P=0.007), a lower ratio of FEV1 to forced vital capacity (P=0.03), and a reduced carbon monoxide diffusing capacity (P=0.001). Conclusions: The survival of adults with pulmonary Langerhans'-cell histiocytosis is shorter than that in the general population, and respiratory failure accounts for a substantial proportion of deaths among such patients. (N Engl J Med 2002;346:484-90.) Copyright (C) 2002 Massachusetts Medical Society.	Mayo Clin & Mayo Fdn, Thorac Dis Res Unit, Div Pulm Crit Care & Internal Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Vassallo, R (corresponding author), Mayo Clin & Mayo Fdn, Thorac Dis Res Unit, Div Pulm Crit Care & Internal Med, Stable Bldg 8-54,200 1st St SW, Rochester, MN 55905 USA.		Vassallo, Robert/R-7752-2019	Vassallo, Robert/0000-0003-2328-0255; Ryu, Jay/0000-0002-9576-2272				American Thoracic Society, 1991, AM REV RESP DIS, V144, P1202; BASSET F, 1978, AM REV RESPIR DIS, V118, P811; BENEZRA JM, 1993, AM J CLIN PATHOL, V99, P464, DOI 10.1093/ajcp/99.4.464; Bernstrand C, 2000, ACTA PAEDIATR, V89, P1389, DOI 10.1080/080352500300002642; Bonelli FS, 1998, AM J ROENTGENOL, V170, P1507, DOI 10.2214/ajr.170.6.9609163; BRAUNER MW, 1989, RADIOLOGY, V172, P255, DOI 10.1148/radiology.172.1.2787036; Brauner MW, 1997, RADIOLOGY, V204, P497, DOI 10.1148/radiology.204.2.9240543; BURNS BF, 1983, AM J SURG PATHOL, V7, P529, DOI 10.1097/00000478-198309000-00003; Chang JA, 1999, CHEST, V116, P1175, DOI 10.1378/chest.116.5.1175; COLBY TV, 1983, HUM PATHOL, V14, P847, DOI 10.1016/S0046-8177(83)80160-9; Collins J, 2001, RADIOL CLIN N AM, V39, P1115, DOI 10.1016/S0033-8389(05)70334-1; de Andres CI, 1999, VIRCHOWS ARCH, V434, P259, DOI 10.1007/s004280050338; DECAMARGO B, 1993, MED PEDIATR ONCOL, V21, P451, DOI 10.1002/mpo.2950210612; Delobbe K, 1996, EUR RESPIR J, V9, P2002; EGELER RM, 1993, CANCER, V71, P865, DOI 10.1002/1097-0142(19930201)71:3<865::AID-CNCR2820710334>3.0.CO;2-0; Egeler RM, 1998, HEMATOL ONCOL CLIN N, V12, P369, DOI 10.1016/S0889-8588(05)70516-5; EGELER RM, 1994, MED PEDIATR ONCOL, V23, P81, DOI 10.1002/mpo.2950230204; EMILE JF, 1995, AM J SURG PATHOL, V19, P636, DOI 10.1097/00000478-199506000-00003; FRIEDMAN PJ, 1981, MEDICINE, V60, P385, DOI 10.1097/00005792-198111000-00001; HOUSINI I, 1994, ARCH PATHOL LAB MED, V118, P523; KRENACS L, 1993, J PATHOL, V171, P99, DOI 10.1002/path.1711710206; LOMBARD CM, 1987, ARCH PATHOL LAB MED, V111, P339; Malpas JS, 1996, MED PEDIATR ONCOL, V27, P540; Michetti G, 1996, Minerva Med, V87, P243; MILLER A, 1986, B EUR PHYSIOPATH RES, V22, P589; MILLER A, 1983, AM REV RESPIR DIS, V127, P270; Nagai S, 2000, Curr Opin Pulm Med, V6, P415, DOI 10.1097/00063198-200009000-00005; Ryu JH, 2001, EUR RESPIR J, V17, P122, DOI 10.1183/09031936.01.17101220; *SURV EP END RES, 2000, SEER PROGR PUBL US D; Therneau TMSJ, 1994, TECHNICAL REPORT SER, V52; TRAVIS WD, 1993, AM J SURG PATHOL, V17, P971, DOI 10.1097/00000478-199310000-00002; Vassallo R, 2000, NEW ENGL J MED, V342, P1969, DOI 10.1056/NEJM200006293422607; Ware J.E, 1994, PHYS MENTAL HLTH SUM; YAMASHITA H, 1992, CLIN EXP DERMATOL, V17, P275, DOI 10.1111/j.1365-2230.1992.tb02167.x; Yousem SA, 2001, AM J SURG PATHOL, V25, P630, DOI 10.1097/00000478-200105000-00010	35	272	295	0	5	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2002	346	7					484	490		10.1056/NEJMoa012087	http://dx.doi.org/10.1056/NEJMoa012087			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521AE	11844849				2022-12-24	WOS:000173815300004
J	Kelly, J; Hunt, BJ				Kelly, J; Hunt, BJ			Role of D-dimers in diagnosis of venous thromboembolism	LANCET			English	Editorial Material							SUSPECTED PULMONARY-EMBOLISM; SIMPLE CLINICAL-MODEL; DEEP-VEIN THROMBOSIS; OUTPATIENTS; MANAGEMENT; VALIDITY		St Thomas Hosp, Guys & St Thomas Trust, Dept Haematol, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust	Hunt, BJ (corresponding author), St Thomas Hosp, Guys & St Thomas Trust, Dept Haematol, London SE1 7EH, England.							Anderson DR, 2001, BLOOD, V98, p447A; Bernardi E, 1998, BRIT MED J, V317, P1037; de Groot MR, 1999, THROMB HAEMOSTASIS, V82, P1588; HULL R, 1981, CIRCULATION, V64, P622, DOI 10.1161/01.CIR.64.3.622; HULL RD, 1990, CHEST, V97, P23, DOI 10.1378/chest.97.1.23; Kearon C, 2001, ANN INTERN MED, V135, P108, DOI 10.7326/0003-4819-135-2-200107170-00011; Kraaijenhagen RA, 1998, BAILLIERE CLIN HAEM, V11, P541, DOI 10.1016/S0950-3536(98)80083-8; KRAAIJENHAGEN RA, 1997, THROMB HAEMOST S JUN, P159; Perrier A, 1997, AM J RESP CRIT CARE, V156, P492, DOI 10.1164/ajrccm.156.2.9702032; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; Schutgens REG, 2001, BLOOD, V98, p448A; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; Wells PS, 1998, J INTERN MED, V243, P15; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416	15	34	36	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 9	2002	359	9305					456	458		10.1016/S0140-6736(02)07669-9	http://dx.doi.org/10.1016/S0140-6736(02)07669-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520ML	11853785				2022-12-24	WOS:000173785600002
J	Lowenstein, E; Wanzer, SH				Lowenstein, E; Wanzer, SH			Sounding board - The US Attorney General's intrusion into medical practice	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Lowenstein, E (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.							*ACOG, 1999, ACOG PRACT B, V10; *ACOG, 1999, 228 ACOG; ASHCROFT J, 2001, COMMUNICATION   1106; Goldberg AB, 2001, NEW ENGL J MED, V344, P38, DOI 10.1056/NEJM200101043440107; *MED EC, 2002, PHYS DESK REF, P3202; Quill TE, 1997, NEW ENGL J MED, V337, P1768, DOI 10.1056/NEJM199712113372413; Steinbrook R, 2002, NEW ENGL J MED, V346, P460, DOI 10.1056/NEJM200202073460624	7	6	6	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2002	346	6					447	448		10.1056/NEJM200202073460613	http://dx.doi.org/10.1056/NEJM200202073460613			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UN	11832536				2022-12-24	WOS:000173686400011
J	Schwetz, BA				Schwetz, BA			New contraceptive patch	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2002	287	5					578	578		10.1001/jama.287.5.578-a	http://dx.doi.org/10.1001/jama.287.5.578-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UR	11829678				2022-12-24	WOS:000173686700005
J	Makeig, S; Westerfield, M; Jung, TP; Enghoff, S; Townsend, J; Courchesne, E; Sejnowski, TJ				Makeig, S; Westerfield, M; Jung, TP; Enghoff, S; Townsend, J; Courchesne, E; Sejnowski, TJ			Dynamic brain sources of visual evoked responses	SCIENCE			English	Article							ALPHA-BAND; SPATIAL ATTENTION; RHYTHMS; EEG; POTENTIALS	It has been long debated whether averaged electrical responses recorded from the scalp result from stimulus-evoked brain events or stimulus-induced changes in ongoing brain dynamics. In a human visual selective attention task, we show that nontarget event-related potentials were mainly generated by partial stimulus-Induced phase resetting of multiple electroencephalographic processes. Independent component analysis applied to the single-trial data identified at least eight classes of contributing components, including those producing central and lateral posterior alpha, left and right mu, and frontal midline theta rhythms. Scalp topographies of these components were consistent with their generation in compact cortical domains.	Salk Inst Biol Studies, Computat Neurobiol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Univ Calif San Diego, Sch Med, Inst Neural Computat, San Diego, CA 92093 USA; Univ Calif San Diego, Dept Biol, San Diego, CA 92093 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Makeig, S (corresponding author), Salk Inst Biol Studies, Computat Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Sejnowski, Terrence/AAV-5558-2021		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH036840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034155] Funding Source: NIH RePORTER; NIMH NIH HHS [2RO1-MH36840] Funding Source: Medline; NINDS NIH HHS [1RO1-NS34155] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andrew C, 1997, NEUROSCI LETT, V222, P103, DOI 10.1016/S0304-3940(97)13358-4; Barry RJ, 2000, INT J PSYCHOPHYSIOL, V39, P39, DOI 10.1016/S0167-8760(00)00114-8; Basar E., 1980, EEG BRAIN DYNAMICS R; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BELL AJ, INPRESS HDB NEURAL N; Brandt ME, 1997, INT J PSYCHOPHYSIOL, V26, P285, DOI 10.1016/S0167-8760(97)00771-X; BRANDT ME, 1991, ELECTROEN CLIN NEURO, V80, P16, DOI 10.1016/0168-5597(91)90037-X; BRANDT ME, 1991, ELECTROENCEPHALOGR C, V80, P241; Brown GD, 2001, TRENDS NEUROSCI, V24, P54, DOI 10.1016/S0166-2236(00)01683-0; CHAPMAN R, 2001, 7 ANN M ORG HUM BRAI; Destexhe A., 2001, THALAMOCORTICAL ASSE, DOI [10.7554/elife.47314, DOI 10.7554/eLife.47314]; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fellous JM, 2001, NEUROCOMPUTING, V38, P587, DOI 10.1016/S0925-2312(01)00422-2; Hari R, 1997, INT J PSYCHOPHYSIOL, V26, P51, DOI 10.1016/S0167-8760(97)00755-1; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Jung TP, 2001, P IEEE, V89, P1107, DOI 10.1109/5.939827; Klopp J, 2000, HUM BRAIN MAPP, V11, P286, DOI 10.1002/1097-0193(200012)11:4<286::AID-HBM80>3.3.CO;2-I; Kolev V, 2001, INT J PSYCHOPHYSIOL, V39, P159, DOI 10.1016/S0167-8760(00)00139-2; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lutzenberger W, 1997, INT J PSYCHOPHYSIOL, V26, P273, DOI 10.1016/S0167-8760(97)00770-8; Makeig S, 1999, PHILOS T ROY SOC B, V354, P1135, DOI 10.1098/rstb.1999.0469; Makeig S, 2000, IEEE T REHABIL ENG, V8, P208, DOI 10.1109/86.847818; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Makeig S, 1996, ADV NEUR IN, V8, P145; MANGUN R, 1992, INDUCED RHYTHMS BRAI, P219; Mima T, 2001, J NEUROSCI, V21, P3942, DOI 10.1523/JNEUROSCI.21-11-03942.2001; Pfurtscheller G, 2000, CLIN NEUROPHYSIOL, V111, P1873, DOI 10.1016/S1388-2457(00)00428-4; RougeulBuser A, 1997, INT J PSYCHOPHYSIOL, V26, P191, DOI 10.1016/S0167-8760(97)00764-2; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; SAYERS BMA, 1974, NATURE, V247, P481, DOI 10.1038/247481a0; SCHERG M, 1985, ELECTROEN CLIN NEURO, V62, P32, DOI 10.1016/0168-5597(85)90033-4; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; TOWNSEND J, 1994, J COGNITIVE NEUROSCI, V6, P220, DOI 10.1162/jocn.1994.6.3.220; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Worden MS, 2000, J NEUROSCI, V20	35	1178	1237	4	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					690	694		10.1126/science.1066168	http://dx.doi.org/10.1126/science.1066168			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809976				2022-12-24	WOS:000173560900049
J	Germain, P; Iyer, J; Zechel, C; Gronemeyer, H				Germain, P; Iyer, J; Zechel, C; Gronemeyer, H			Co-regulator recruitment and the mechanism of retinoic acid receptor synergy	NATURE			English	Article							NUCLEAR HORMONE RECEPTORS; LIGAND-BINDING DOMAINS; HETERODIMERIC COMPLEX; RESPONSE PATHWAYS; X-RECEPTOR; RAR; RXR; ACTIVATION; TIF2; TRANSACTIVATION	Crystal structure and co-regulator interaction studies have led to a general mechanistic view of the initial steps of nuclear receptor (NR) action. Agonist-induced transconformation of the ligand-binding domain (holo-LBD) leads to the formation of co-activator complexes, and destabilizes the co-repressor complexes bound to the ligand-free (apo) LBD1-3. However, the molecular basis of retinoid-X receptor (RXR) 'subordination' in heterodimers, an essential mechanism to avoid signalling pathway promiscuity, has remained elusive. RXR, in contrast to its heterodimer partner, cannot autonomously induce transcription on binding of cognate agonists(4-7). Here we show that RXR can bind ligand and recruit co-activators as a heterodimer with apo-retinoic-acid receptor (apo-RAR). However, in the usual cellular environment co-repressors do not dissociate and they prohibit co-activator access because co-regulator binding is mutually exclusive. Accordingly, RXR subordination can be overcome in heterodimers that bind co-repressor weakly or in cells with a high co-activator content. We identify two types of RAR antagonists that differentially modulate co-regulator interaction, and we demonstrate that synergy between RAR ligands and RXR agonists(6,8) results from increased interaction efficiency of a single p160 with the heterodimer, requiring two intact receptor-binding surfaces on the co-activator.	Univ Strasbourg 1, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, F-67404 Illkirch Graffenstaden, CU Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Gronemeyer, H (corresponding author), Univ Strasbourg 1, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, BP 163, F-67404 Illkirch Graffenstaden, CU Strasbourg, France.	hg@igbmc.u-strasbg.fr	Gronemeyer, Hinrich/G-6240-2011; Gronemeyer, Hinrich/H-7002-2016; Gronemeyer, Hinrich/AAH-5575-2019	Gronemeyer, Hinrich/0000-0001-9454-2449; Gronemeyer, Hinrich/0000-0001-9454-2449; Gronemeyer, Hinrich/0000-0001-9454-2449; Germain, Pierre/0000-0003-2962-9593				Alen P, 1999, MOL CELL BIOL, V19, P6085; Benecke A, 2000, EMBO REP, V1, P151, DOI 10.1093/embo-reports/kvd028; Bourguet W, 2000, TRENDS PHARMACOL SCI, V21, P381, DOI 10.1016/S0165-6147(00)01548-0; Bourguet W, 2000, PROTEIN EXPRES PURIF, V19, P284, DOI 10.1006/prep.2000.1248; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; CHEN JY, 1995, EMBO J, V14, P1187, DOI 10.1002/j.1460-2075.1995.tb07102.x; Chen JY, 1996, NATURE, V382, P819, DOI 10.1038/382819a0; Cohen RN, 2001, MOL ENDOCRINOL, V15, P1049, DOI 10.1210/me.15.7.1049; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; Freedman LP, 1999, CELL, V97, P5, DOI 10.1016/S0092-8674(00)80708-4; Glass CK, 2000, GENE DEV, V14, P121; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; Hu X, 2001, MOL CELL BIOL, V21, P1747, DOI 10.1128/MCB.21.5.1747-1758.2001; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Iyer J, 1999, PROTEIN EXPRES PURIF, V16, P308, DOI 10.1006/prep.1999.1053; Klein ES, 1996, J BIOL CHEM, V271, P22692, DOI 10.1074/jbc.271.37.22692; KUROKAWA R, 1994, NATURE, V371, P528, DOI 10.1038/371528a0; LEHMANN JM, 1992, SCIENCE, V258, P1944, DOI 10.1126/science.1335166; NAGPAL S, 1993, EMBO J, V12, P2349, DOI 10.1002/j.1460-2075.1993.tb05889.x; Nagy L, 1999, GENE DEV, V13, P3209, DOI 10.1101/gad.13.24.3209; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; ROY DY, 1995, MOL CELL BIOL, V15, P6481; Vivat V, 1997, EMBO J, V16, P5697, DOI 10.1093/emboj/16.18.5697; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Westin S, 1998, NATURE, V395, P199, DOI 10.1038/26040; Wong CW, 1998, MOL CELL BIOL, V18, P5724, DOI 10.1128/MCB.18.10.5724; Yang W, 2000, MOL CELL BIOL, V20, P8008, DOI 10.1128/MCB.20.21.8008-8017.2000; Yang W, 1999, J BIOL CHEM, V274, P16838, DOI 10.1074/jbc.274.24.16838	30	248	256	2	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2002	415	6868					187	192		10.1038/415187a	http://dx.doi.org/10.1038/415187a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805839				2022-12-24	WOS:000173159300046
J	Lee, C; Etchegaray, JP; Cagampang, FRA; Loudon, ASI; Reppert, SM				Lee, C; Etchegaray, JP; Cagampang, FRA; Loudon, ASI; Reppert, SM			Posttranslational mechanisms regulate the mammalian circadian clock	CELL			English	Article							DNA-BINDING ACTIVITY; TRANSCRIPTION FACTOR; GENE-EXPRESSION; NUCLEAR ENTRY; DOUBLE-TIME; PHOSPHORYLATION; PROTEIN; PERIOD; RHYTHMS; MUTATION	We have examined posttranslational regulation of clock proteins in mouse liver in vivo. The mouse PERIOD proteins (mPER1 and mPER2), CLOCK, and BMAL1 undergo robust circadian changes in phosphorylation. These proteins, the cryptochromes (mCRY1 and mCRY2), and casein kinase I epsilon (CKI epsilon) form multimeric complexes that are bound to DNA during negative transcriptional feedback. CLOCK:BMAL1 heterodimers remain bound to DNA over the circadian cycle. The temporal increase in mPER abundance controls the negative feedback interactions. Analysis of clock proteins in mCRY-deficient mice shows that the mCRYs are necessary for stabilizing phosphorylated mPER2 and for the nuclear accumulation of mPER1, mPER2, and CKI epsilon. We also provide in vivo evidence that casein kinase I delta is a second clock relevant kinase.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01655 USA; Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	University of Massachusetts System; University of Massachusetts Worcester; University of Manchester	Reppert, SM (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 55 Lake Ave N, Worcester, MA 01655 USA.	steven.reppert@umassmed.edu	Cagampang, Felino/AAG-5141-2019	Cagampang, Felino/0000-0003-4404-9853; Loudon, Andrew/0000-0003-3648-445X	NICHD NIH HHS [R37 HD 14427] Funding Source: Medline; NINDS NIH HHS [R01 NS 39303] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD014427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039303] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bae K, 2000, J NEUROSCI, V20, P1746; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Camacho F, 2001, FEBS LETT, V489, P159, DOI 10.1016/S0014-5793(00)02434-0; Cermakian N, 2001, EMBO J, V20, P3967, DOI 10.1093/emboj/20.15.3967; Denault DL, 2001, EMBO J, V20, P109, DOI 10.1093/emboj/20.1.109; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Ishida Y, 2001, J NEUROSCI RES, V64, P612, DOI 10.1002/jnr.1114; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kloss B, 2001, NEURON, V30, P699, DOI 10.1016/S0896-6273(01)00320-8; Kuhlman SJ, 2000, NEUROREPORT, V11, P1479, DOI 10.1097/00001756-200005150-00023; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 1999, MOL CELL BIOL, V19, P5316; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Lee E, 2001, J CELL BIOL, V154, P983, DOI 10.1083/jcb.200102074; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Lucas RJ, 1999, ENDOCRINOLOGY, V140, P758, DOI 10.1210/en.140.2.758; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Miyamoto Y, 1999, MOL BRAIN RES, V71, P238, DOI 10.1016/S0169-328X(99)00192-8; Neufeld B, 2000, J BIOL CHEM, V275, P20239, DOI 10.1074/jbc.C901040199; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Park SK, 2000, ARCH BIOCHEM BIOPHYS, V381, P302, DOI 10.1006/abbi.2000.1999; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Ueyama T, 1999, NAT NEUROSCI, V2, P1051, DOI 10.1038/15973; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vielhaber E, 2000, MOL CELL BIOL, V20, P4888, DOI 10.1128/MCB.20.13.4888-4899.2000; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Yagita K, 2000, GENE DEV, V14, P1353; Young MW, 2000, TRENDS BIOCHEM SCI, V25, P601, DOI 10.1016/S0968-0004(00)01695-9; Zhang JH, 2000, J BIOL CHEM, V275, P8895, DOI 10.1074/jbc.275.12.8895; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	45	864	889	3	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2001	107	7					855	867		10.1016/S0092-8674(01)00610-9	http://dx.doi.org/10.1016/S0092-8674(01)00610-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779462	Bronze			2022-12-24	WOS:000173024200007
J	Roberts, R				Roberts, R			Muscular dystrophy through an evolutionary lens	LANCET			English	Article									Kings Coll London, London WC2R 2LS, England	University of London; King's College London	Roberts, R (corresponding author), Guys Hosp, GKT Med Sch, Div Med & Mol Genet, 8th Floor,Guys Tower, London SE1 9RT, England.	roland.roberts@kcl.ac.uk	Roberts, Roland G/C-3596-2009	Roberts, Roland/0000-0001-6636-1579					0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2001				S			S25	S25		10.1016/S0140-6736(01)07038-6	http://dx.doi.org/10.1016/S0140-6736(01)07038-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505HK	11784574				2022-12-24	WOS:000172907200025
J	Pellikka, M; Tanentzapf, G; Pinto, M; Smith, C; McGlade, CJ; Ready, DF; Tepass, U				Pellikka, M; Tanentzapf, G; Pinto, M; Smith, C; McGlade, CJ; Ready, DF; Tepass, U			Crumbs, the Drosophila homologue of human CRB1/RP12, is essential for photoreceptor morphogenesis	NATURE			English	Article							ZONULA ADHERENS FORMATION; RETINITIS-PIGMENTOSA; CELL FATES; MEMBRANE; SPECTRIN; EPITHELIA; MUTATIONS; STARDUST; POLARITY; CRB1	The apical transmembrane protein Crumbs is a central regulator of epithelial apical-basal polarity in Drosophila. Loss-of-function mutations in the human homologue of Crumbs, CRB1 (RP12), cause recessive retinal dystrophies, including retinitis pigmentosa. Here we show that Crumbs and CRB1 localize to corresponding subdomains of the photoreceptor apical plasma membrane: the stalk of the Drosophila photoreceptor and the inner segment of mammalian photoreceptors. These subdomains support the morphogenesis and orientation of the photosensitive membrane organelles: rhabdomeres and outer segments, respectively. Drosophila Crumbs is required to maintain zonula adherens integrity during the rapid apical membrane expansion that builds the rhabdomere. Crumbs also regulates stalk development by stabilizing the membrane-associated spectrin cytoskeleton, a function mechanistically distinct from its role in epithelial apical-basal polarity. We propose that Crumbs is a central component of a molecular scaffold that controls zonula adherens assembly and defines the stalk as an apical membrane subdomain. Defects in such scaffolds may contribute to human CRB1-related retinal dystrophies.	Univ Toronto, Dept Zool, Toronto, ON M5S 3G5, Canada; Univ Toronto, Hosp Sick Children, Arthur & Sonia Labatt Brain Tumor Res Ctr, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1X8, Canada; Purdue Univ, Dept Biol Sci, W Lafayette, IN 47906 USA	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Tepass, U (corresponding author), Univ Toronto, Dept Zool, Toronto, ON M5S 3G5, Canada.	utepass@zoo.utoronto.ca	Pellikka, Milena/L-8930-2015; Tanentzapf, Guy/C-8864-2012	Tanentzapf, Guy/0000-0002-2443-233X				ARIKAWA K, 1992, J CELL BIOL, V116, P659, DOI 10.1083/jcb.116.3.659; Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; BASCOM RA, 1992, NEURON, V8, P1171, DOI 10.1016/0896-6273(92)90137-3; BENNETT V, 1993, ANNU REV CELL BIOL, V9, P27, DOI 10.1146/annurev.cellbio.9.1.27; Bessant DAR, 2001, CURR OPIN GENET DEV, V11, P307, DOI 10.1016/S0959-437X(00)00195-7; Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; BYERS TJ, 1987, J CELL BIOL, V105, P2103, DOI 10.1083/jcb.105.5.2103; De Matteis MA, 2000, J CELL SCI, V113, P2331; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; den Hollander AI, 2001, HUM MOL GENET, V10, P2767, DOI 10.1093/hmg/10.24.2767; den Hollander AI, 2001, AM J HUM GENET, V69, P198; DUNN RF, 1973, ULTRASTRUCTURE SENSO, P153; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; Grawe F, 1996, DEVELOPMENT, V122, P951; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; Kamal A, 1998, J CELL BIOL, V142, P937, DOI 10.1083/jcb.142.4.937; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; Kumar JP, 1995, DEVELOPMENT, V121, P4359; LONGLEY RL, 1995, DEV BIOL, V171, P415, DOI 10.1006/dbio.1995.1292; Lotery AJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P415, DOI 10.1001/archopht.119.3.415; Michaely P, 1999, J BIOL CHEM, V274, P35908, DOI 10.1074/jbc.274.50.35908; Milam AH, 1998, PROG RETIN EYE RES, V17, P175; MORROW JS, 1997, HDB PHYSIOL 14, P485; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Nelson WJ, 2000, FR MOLEC B, V28, P106; Newsome TP, 2000, DEVELOPMENT, V127, P851; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Tabuchi K, 2000, J NEUROSCI RES, V59, P94, DOI 10.1002/(SICI)1097-4547(20000101)59:1<94::AID-JNR11>3.3.CO;2-H; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; Tanentzapf G, 2000, J CELL BIOL, V151, P891, DOI 10.1083/jcb.151.4.891; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; TEPASS U, 1990, ROUX ARCH DEV BIOL, V199, P189, DOI 10.1007/BF01682078; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; THOMAS GH, 1994, DEVELOPMENT, V120, P2039; Thomas GH, 1998, DEVELOPMENT, V125, P2125; Thomas GH, 2001, BIOESSAYS, V23, P152, DOI 10.1002/1521-1878(200102)23:2<152::AID-BIES1022>3.0.CO;2-1; Van Soest S, 1999, SURV OPHTHALMOL, V43, P321, DOI 10.1016/S0039-6257(98)00046-0; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Wolff Tanya, 1993, P1277	43	332	335	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2002	416	6877					143	149		10.1038/nature721	http://dx.doi.org/10.1038/nature721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11850625				2022-12-24	WOS:000174348100028
J	Enquist, BJ; Niklas, KJ				Enquist, BJ; Niklas, KJ			Global allocation rules for patterns of biomass partitioning in seed plants	SCIENCE			English	Article							SYSTEM; HISTORY; GROWTH	A general allometric model has been derived to predict intraspecific and interspecific scaling relationships among seed plant leaf, stem, and root biomass. Analysis of a large compendium of standing organ biomass sampled across a broad sampling of taxa inhabiting diverse ecological habitats supports the relations predicted by the model and defines the boundary conditions for above- and below-ground biomass partitioning. These canonical biomass relations are insensitive to phyletic affiliation (conifers versus angiosperms) and variation in averaged local environmental conditions. The model thus identifies and defines the limits that have guided the diversification of seed plant biomass allocation strategies.	Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; Conservat Int, Ctr Appl Biodivers Sci, Washington, DC 20036 USA; Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA	University of Arizona; Conservation International; Cornell University	Enquist, BJ (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA.	benquist@u.arizona.edu	Niklas, Karl/AAV-4760-2021; Enquist, Brian J/B-6436-2008	Enquist, Brian J/0000-0002-6124-7096				Bazzaz FA., 1997, PLANT RESOURCE ALLOC; Bazzaz Fakhri A., 1997, P1, DOI 10.1016/B978-012083490-7/50002-5; BROWN S, 1997, FOOD AGR ORG UN PAP, V134, P5; CALLAWAY RM, 1994, ECOLOGY, V75, P1474, DOI 10.2307/1937470; CANNELL MGR, 1994, ADV ECOL RES, V25, P59, DOI 10.1016/S0065-2504(08)60213-5; Cannell MGR, 1982, WORLD FOREST BIOMASS; Caspersen JP, 2000, SCIENCE, V290, P1148, DOI 10.1126/science.290.5494.1148; Charnov EL, 1997, NATURE, V387, P393, DOI 10.1038/387393a0; DETWILER RP, 1988, SCIENCE, V239, P42, DOI 10.1126/science.239.4835.42; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Enquist BJ, 1999, NATURE, V401, P907, DOI 10.1038/44819; IWASA Y, 1984, THEOR POPUL BIOL, V25, P78, DOI 10.1016/0040-5809(84)90007-8; Levis S, 2000, J CLIMATE, V13, P1313, DOI [10.1175/1520-0442(2000)013<1313:LSVFOA>2.0.CO;2, 10.1175/1520-0442(2000)013&lt;1313:LSVFOA&gt;2.0.CO;2]; MONK C, 1966, B TORREY BOT CLUB, V93, P402, DOI 10.2307/2483412; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Niklas K.., 1994, PLANT ALLOMETRY; Niklas KJ, 2001, P NATL ACAD SCI USA, V98, P2922, DOI 10.1073/pnas.041590298; Pearsall WH, 1927, ANN BOT-LONDON, V41, P549, DOI 10.1093/oxfordjournals.aob.a090091; Smith B.W., 1983, NC299 US DEP AGR FOR, DOI DOI 10.2737/NC-RN-299; TAYLOR CR, 1981, RESP PHYSIOL, V44, P1, DOI 10.1016/0034-5687(81)90073-6; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; WARDLAW IF, 1990, NEW PHYTOL, V116, P341, DOI 10.1111/j.1469-8137.1990.tb00524.x; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251	24	509	636	19	296	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2002	295	5559					1517	1520		10.1126/science.1066360	http://dx.doi.org/10.1126/science.1066360			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859193				2022-12-24	WOS:000173981300051
J	Florig, HK				Florig, HK			Public health - Is safe mail worth the price?	SCIENCE			English	Article									Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Florig, HK (corresponding author), Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA.	florig@cmu.edu						DAY TG, 2001, COMMUNICATION    NOV; Reichmanis Elsa, 1993, IRRADIATION POLYM MA; SULLIVAN DJ, 1987, ANN EMERG MED, V16, P662, DOI 10.1016/S0196-0644(87)80066-5; TENGS TO, 1995, RISK ANAL, V15, P369, DOI 10.1111/j.1539-6924.1995.tb00330.x; 2002, US POST REASSURES FE	6	8	8	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2002	295	5559					1467	1468		10.1126/science.1068835	http://dx.doi.org/10.1126/science.1068835			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859178				2022-12-24	WOS:000173981300032
J	McEvilly, RJ; de Diaz, MO; Schonemann, MD; Hooshmand, F; Rosenfeld, MG				McEvilly, RJ; de Diaz, MO; Schonemann, MD; Hooshmand, F; Rosenfeld, MG			Transcriptional regulation of cortical neuron migration by POU domain factors	SCIENCE			English	Article							EXPRESSION; FOREBRAIN; BRAIN; PATTERNS; REELIN; ORIGIN; GENES; BRN-2	The identification of pathways mediated by the kinase Cdk5 and the ligand reelin has provided a conceptual framework for exploring the molecular mechanisms underlying proper lamination of the developing mammalian cerebral cortex. In this report, we identify a component of the regulation of Cdk5-mediated cortical lamination by genetic analysis of the roles of the class III POU domain transcription factors, Brn-1 and Brn-2, expressed during the development of the forebrain and coexpressed in most layer II-V cortical neurons. Brn-1 and Brn-2 appear to critically control the initiation of radial migration, redundantly regulating the cell-autonomous expression of the p35 and p39 regulatory subunits of Cdk5 in migrating cortical neurons, with Brn-1((-)/-)/Brn-2((-)/-) mice exhibiting cortical inversion.	Univ Calif San Diego, Howard Hughes Med Inst, Dept Med, La Jolla, CA 92037 USA; Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	McEvilly, RJ (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept Med, 9500 Gilman Dr, La Jolla, CA 92037 USA.	rmcevilly@ucsd.edu; mrosenfeld@ucsd.edu						Acampora D, 1999, CEREB CORTEX, V9, P533, DOI 10.1093/cercor/9.6.533; Alcantara S, 1998, J NEUROSCI, V18, P7779; Allen T, 1999, CELL MOL BIOL, V45, P687; ALVAREZBOLADO G, 1995, J COMP NEUROL, V355, P237, DOI 10.1002/cne.903550207; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Cooper JA, 1999, CELL, V97, P671, DOI 10.1016/S0092-8674(00)80778-3; FUJII H, 1993, NEURON, V11, P1197, DOI 10.1016/0896-6273(93)90231-F; Herz J, 2001, NEURON, V29, P571, DOI 10.1016/S0896-6273(01)00234-3; Ko J, 2001, J NEUROSCI, V21, P6758; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; LI P, 1993, GENE DEV, V7, P2483, DOI 10.1101/gad.7.12b.2483; MCEVILLY RJ, UNPUB; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Rice DS, 1998, DEVELOPMENT, V125, P3719; Schonemann MD, 1995, GENE DEV, V9, P3122, DOI 10.1101/gad.9.24.3122; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Smith DS, 2001, CELL GROWTH DIFFER, V12, P277; Takahashi T, 1999, J NEUROSCI, V19, P10357; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0; Zhou C, 1999, NEURON, V24, P847, DOI 10.1016/S0896-6273(00)81032-6	21	201	202	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2002	295	5559					1528	1532		10.1126/science.1067132	http://dx.doi.org/10.1126/science.1067132			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859196				2022-12-24	WOS:000173981300055
J	Hattar, S; Liao, HW; Takao, M; Berson, DM; Yau, KW				Hattar, S; Liao, HW; Takao, M; Berson, DM; Yau, KW			Melanopsin-containing retinal. ganglion cells: Architecture, projections, and intrinsic photosensitivity	SCIENCE			English	Article							RETINOHYPOTHALAMIC TRACT; SUPRACHIASMATIC NUCLEUS; INTERGENICULATE LEAFLET; BODY-TEMPERATURE; LIGHT REFLEX; RAT; OLIVARY; PACAP; EEG	The primary circadian pacemaker, in the suprachiasmatic nucleus (SCN) of the mammalian brain, is photoentrained by light signals from the eyes through the retinohypothalamic tract. Retinal rod and cone cells are not required for photoentrainment. Recent evidence suggests that the entraining photoreceptors are retinal ganglion cells (RGCs) that project to the SCN. The visual pigment for this photoreceptor may be melanopsin, an opsin-like protein whose coding messenger RNA is found in a subset of mammalian RGCs. By cloning rat melanopsin and generating specific antibodies, we show that melanopsin is present in cell bodies, dendrites, and proximal axonal segments of a subset of rat RGCs. In mice heterozygous for tau-lacZ targeted to the melanopsin gene locus, P-galactosidase-positive RGC axons projected to the SCN and other brain nuclei involved in circadian photoentrainment or the pupillary light reflex. Rat RGCs that exhibited intrinsic photosensitivity invariably expressed melanopsin. Hence, melanopsin is most likely the visual pigment of phototransducing RGCs that set the circadian clock and initiate other non-image-forming visual functions.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Brown University	Yau, KW (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, 725 N Wolfe St, Baltimore, MD 21205 USA.	kwyau@mail.jhmi.edu	Hattar, Samer/W-6927-2019; Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X	NATIONAL EYE INSTITUTE [R37EY006837] Funding Source: NIH RePORTER; NEI NIH HHS [R37 EY006837-13, R37 EY006837, R37 EY006837-15S1, R37 EY006837-15, R37 EY006837-14] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aggelopoulos NC, 2000, J PHYSIOL-LONDON, V523, P211, DOI 10.1111/j.1469-7793.2000.t01-1-00211.x; BADIA P, 1991, PHYSIOL BEHAV, V50, P583, DOI 10.1016/0031-9384(91)90549-4; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; CAJOCHEN C, 1992, SLEEP, V15, P337; Cajochen C, 2000, BEHAV BRAIN RES, V115, P75, DOI 10.1016/S0166-4328(00)00236-9; CLARKE RJ, 1985, EXP BRAIN RES, V57, P224; CRESPO D, 1985, DEV BRAIN RES, V19, P129, DOI 10.1016/0165-3806(85)90238-X; DRAGER UC, 1980, J COMP NEUROL, V191, P383, DOI 10.1002/cne.901910306; DUNN FA, COMMUNICATION; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Green DG, 1999, VISUAL NEUROSCI, V16, P727, DOI 10.1017/S0952523899164125; Hannibal J, 2000, J COMP NEUROL, V418, P147; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hannibal J, 1997, J NEUROSCI, V17, P2637, DOI 10.1523/jneurosci.17-07-02637.1997; Harrington ME, 1997, NEUROSCI BIOBEHAV R, V21, P705, DOI 10.1016/S0149-7634(96)00019-X; JOHNSON RF, 1988, BRAIN RES, V460, P297, DOI 10.1016/0006-8993(88)90374-5; KLEIN DC, 1972, SCIENCE, V177, P532, DOI 10.1126/science.177.4048.532; KLEIND C, 1991, SUPRACHIASMATIC NUCL; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MOORE RY, 1972, J COMP NEUROL, V146, P1, DOI 10.1002/cne.901460102; MOORE RY, 1995, J COMP NEUROL, V352, P351, DOI 10.1002/cne.903520304; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; PERRY VH, 1979, PROC R SOC SER B-BIO, V204, P363, DOI 10.1098/rspb.1979.0033; PICKARD GE, 1985, NEUROSCI LETT, V55, P211, DOI 10.1016/0304-3940(85)90022-9; Provencio I, 1998, J COMP NEUROL, V395, P417, DOI 10.1002/(SICI)1096-9861(19980615)395:4<417::AID-CNE1>3.0.CO;2-4; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; TREJO LJ, 1984, BRAIN RES, V300, P49, DOI 10.1016/0006-8993(84)91340-4	29	1729	1783	7	223	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2002	295	5557					1065	1070		10.1126/science.1069609	http://dx.doi.org/10.1126/science.1069609			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834834	Green Accepted			2022-12-24	WOS:000173793000064
J	Tanaka, TU; Rachidi, N; Janke, C; Pereira, G; Galova, M; Schiebel, E; Stark, MJR; Nasmyth, K				Tanaka, TU; Rachidi, N; Janke, C; Pereira, G; Galova, M; Schiebel, E; Stark, MJR; Nasmyth, K			Evidence that the Ipl1-Sli15 (Aurora knase-INCENP) complex by altering promotes chromosome bi-orientation kinetochore-spindle pole connections	CELL			English	Article							CENTROMERE PROTEIN INCENP; HISTONE H3 PHOSPHORYLATION; INNER CENTROMERE; BUDDING YEAST; CHROMATID COHESION; KINASE; SEGREGATION; PHOSPHATASE; MITOSIS; CLEAVAGE	How sister kinetochores attach to microtubules from opposite spindle poles during mitosis (bi-orientation) remains poorly understood. In yeast, the ortholog of the Aurora B-INCENP protein kinase complex (Ipl1-Sli15) may have a role in this crucial process, because it is necessary to prevent attachment of sister kinetochores to microtubules from the same spindle pole. We investigated IPL1 function in cells that cannot replicate their chromosomes but nevertheless duplicate their spindle pole bodies (SPBs). Kinetochores detach from old SPBs and reattach to old and new SPBs with equal frequency in IPL1+ cells, but remain attached to old SPBs in ipl1 mutants. This raises the possibility that Ipl1-Sli15 facilitates bi-orientation by promoting turnover of kinetochore-SPB connections until traction of sister kinetochores toward opposite spindle poles creates tension in the surrounding chromatin.	Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland; Res Inst Mol Pathol, A-1030 Vienna, Austria; Beatson Inst Canc Res, CRC, Beatson Labs, Glasgow G61 1BD, Lanark, Scotland	University of Dundee; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Beatson Institute	Tanaka, TU (corresponding author), Univ Dundee, Sch Life Sci, MSI WTB Complex, Dundee DD1 5EH, Scotland.	t.tanaka@dundee.ac.uk	Pereira, Gislene/D-4024-2014; Tanaka, Tomoyuki U/A-4775-2008; Stark, Michael J. R./B-2815-2014; Janke, Carsten/A-7279-2011	Stark, Michael J. R./0000-0001-9086-191X; Janke, Carsten/0000-0001-7053-2000; Rachidi, Najma/0000-0002-1247-7768; Tanaka, Tomoyuki/0000-0002-9886-5947; Nasmyth, Kim/0000-0001-7030-4403				Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Adams RR, 2001, J CELL BIOL, V153, P865, DOI 10.1083/jcb.153.4.865; Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8; Amon A, 1999, CURR OPIN GENET DEV, V9, P69, DOI 10.1016/S0959-437X(99)80010-0; ARAKI H, 1992, J MOL BIOL, V225, P25, DOI 10.1016/0022-2836(92)91023-I; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Bloecher A, 1999, GENE DEV, V13, P517, DOI 10.1101/gad.13.5.517; CHAN CSM, 1993, GENETICS, V135, P677; COOKE CA, 1987, J CELL BIOL, V105, P2053, DOI 10.1083/jcb.105.5.2053; FRANCISCO L, 1994, MOL CELL BIOL, V14, P4731, DOI 10.1128/MCB.14.7.4731; Friedman KL, 1996, GENE DEV, V10, P1595, DOI 10.1101/gad.10.13.1595; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Kaitna S, 2000, CURR BIOL, V10, P1172, DOI 10.1016/S0960-9822(00)00721-1; Kim JH, 1999, J CELL BIOL, V145, P1381, DOI 10.1083/jcb.145.7.1381; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Mackay AM, 1998, J CELL BIOL, V140, P991, DOI 10.1083/jcb.140.5.991; MCCARROLL RM, 1988, CELL, V54, P505, DOI 10.1016/0092-8674(88)90072-4; Murnion ME, 2001, J BIOL CHEM, V276, P26656, DOI 10.1074/jbc.M102288200; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; NICKLAS RB, 1994, J CELL BIOL, V126, P1241, DOI 10.1083/jcb.126.5.1241; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; OSTERGREN G, 1951, HEREDITAS, V37, P85; Pearson CG, 2001, J CELL BIOL, V152, P1255, DOI 10.1083/jcb.152.6.1255; Pereira G, 2001, EMBO J, V20, P6359, DOI 10.1093/emboj/20.22.6359; PLATTI S, 1995, EMBO J, V14, P3788; Rieder CL, 1999, J CELL SCI, V112, P2607; Rudner AD, 1996, CURR OPIN CELL BIOL, V8, P773, DOI 10.1016/S0955-0674(96)80077-9; Sassoon I, 1999, GENE DEV, V13, P545, DOI 10.1101/gad.13.5.545; Segal M, 2001, TRENDS CELL BIOL, V11, P160, DOI 10.1016/S0962-8924(01)01954-7; Sonoda E, 2001, DEV CELL, V1, P759, DOI 10.1016/S1534-5807(01)00088-0; Stern BM, 2001, CURR BIOL, V11, P1462, DOI 10.1016/S0960-9822(01)00451-1; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Winey M, 2001, NAT CELL BIOL, V3, pE23, DOI 10.1038/35050663; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669	45	564	604	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2002	108	3					317	329		10.1016/S0092-8674(02)00633-5	http://dx.doi.org/10.1016/S0092-8674(02)00633-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	520VB	11853667	Bronze			2022-12-24	WOS:000173801600005
J	Seward, JF; Watson, BM; Peterson, CL; Mascola, L; Peloso, JW; Zhang, JX; Maupin, TJ; Goldman, GS; Tabony, LJ; Brodovicz, KG; Jumaan, AO; Wharton, M				Seward, JF; Watson, BM; Peterson, CL; Mascola, L; Peloso, JW; Zhang, JX; Maupin, TJ; Goldman, GS; Tabony, LJ; Brodovicz, KG; Jumaan, AO; Wharton, M			Varicella disease after introduction of varicella vaccine in the United States, 1995-2000	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTLICENSURE; IMMUNIZATION; SAFETY; SURVEILLANCE; EPIDEMIOLOGY; CHICKENPOX; LICENSURE	Context Before licensure of varicella vaccine in 1995, varicella was a universal childhood disease in the United States, causing 4 million cases, 11000 hospitalizations, and 100 deaths every year. Objective To examine population-based disease surveillance data in 3 communities to document the impact of the varicella vaccination program. Design, Setting, and Subjects Active surveillance for varicella conducted among the populations of Antelope Valley, Calif; Travis County, Tex; and West Philadelphia, Pa; from January 1, 1995, to December 31, 2000. Reporting sites included child care centers, schools, universities, physicians, public health clinics, hospitals, emergency departments, and households. Main Outcome Measures Trends in number and rate of varicella cases and hospitalizations; varicella vaccine coverage. Results From 1995 through 1998, in each surveillance area, the number of verified varicella cases varied from year to year with marked springtime seasonality. In 1999, the number and rates of varicella cases and hospitalizations declined markedly. From 1995 through 2000, in Antelope Valley, Travis County, and West Philadelphia, varicella cases declined 71%, 84%, and 79%, respectively. Cases declined to the greatest extent among children aged 1 to 4 years, but cases declined in all age groups, including infants and adults. In the combined 3 surveillance areas, hospitalizations due to varicella declined from a range of 2.7 to 4.2 per 100000 population in 1995 through 1998 to 0.6 and 1.5 per 100000 population in 1999 and 2000, respectively (P=.15). By 2000, vaccine coverage among children aged 19 to 35 months was 82.1%, 73.6%, and 83.8% in Los Angeles County, Texas, and Philadelphia County, respectively. Conclusions Varicella disease has declined dramatically in surveillance areas with moderate vaccine coverage. Continued implementation of existing vaccine policies should lead to further reductions of varicella disease in these communities and throughout the United States.	Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Philadelphia Dept Publ Hlth, Philadelphia, PA USA; Los Angeles Cty Dept Hlth Serv, Los Angeles, CA USA; Texas Dept Hlth, Austin, TX 78756 USA	Centers for Disease Control & Prevention - USA; Texas Department of State Health Services	Seward, JF (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop E-62, Atlanta, GA 30333 USA.	jseward@cdc.gov	Goldman, Gary/D-1131-2016; Goldman, Gary/AAD-6289-2021	Goldman, Gary/0000-0002-6039-3921				[Anonymous], 1999, MMWR Recomm Rep, V48, P1; Black S, 1999, PEDIATR INFECT DIS J, V18, P1041, DOI 10.1097/00006454-199912000-00003; Buchholz U, 1999, PEDIATRICS, V104, P561, DOI 10.1542/peds.104.3.561; *CDCP, 1997, MMWR-MORBID MORTAL W, V47, P944; *CDCP, 1998, MMWR-MORBID MORTAL W, V47, P365; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P55; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P637; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P657; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P409; Chen RT, 1996, EPIDEMIOL REV, V18, P99, DOI 10.1093/oxfordjournals.epirev.a017931; Clements DA, 1999, PEDIATR INFECT DIS J, V18, P1047, DOI 10.1097/00006454-199912000-00004; Clements DA, 2001, ARCH PEDIAT ADOL MED, V155, P455, DOI 10.1001/archpedi.155.4.455; Comm Infect Dis, 2000, PEDIATRICS, V105, P136; Deguen S, 1998, J EPIDEMIOL COMMUN H, V52, p46S; FREED GL, 1994, PEDIATRICS, V93, P747; GALIL K, 2000, JOINT M PED AC SOC A; Gershon A, 1998, ARCH DIS CHILD, V79, P470, DOI 10.1136/adc.79.6.470; GORDON JE, 1962, AM J MED SCI, V244, P362, DOI 10.1097/00000441-196209000-00013; GUESS HA, 1986, PEDIATRICS, V78, P723; HALL CB, 1995, PEDIATRICS, V95, P791; Izurieta HS, 1997, JAMA-J AM MED ASSOC, V278, P1495, DOI 10.1001/jama.278.18.1495; JOSEPH CA, 1988, BMJ-BRIT MED J, V296, P673, DOI 10.1136/bmj.296.6623.673; Kann Laura, 1996, Morbidity and Mortality Weekly Report, V45, P1; Meyer PA, 2000, J INFECT DIS, V182, P383, DOI 10.1086/315714; PETERSON CL, 1997, 37 INT C ANT AG CHEM, P233; Plotkin SA, 1996, PEDIATRICS, V97, P251; Schaffer SJ, 1999, ARCH PEDIAT ADOL MED, V153, P357; Shapiro ED, 1997, JAMA-J AM MED ASSOC, V278, P1529, DOI 10.1001/jama.278.18.1529; Sharrar RG, 2000, VACCINE, V19, P916, DOI 10.1016/S0264-410X(00)00297-8; SMITH PJ, 2001, AM J PREV MED, V20, P61; THACKER SB, 1988, EPIDEMIOL REV, V10, P164, DOI 10.1093/oxfordjournals.epirev.a036021; Vazquez M, 2001, NEW ENGL J MED, V344, P955, DOI 10.1056/NEJM200103293441302; WATSON BM, 1993, PEDIATRICS, V91, P17; Wharton M, 1996, INFECT DIS CLIN N AM, V10, P571, DOI 10.1016/S0891-5520(05)70313-5; Wise RP, 2000, JAMA-J AM MED ASSOC, V284, P1271, DOI 10.1001/jama.284.10.1271; 1968, N ENGL J MED, V278, P275	37	379	405	1	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2002	287	5					606	611		10.1001/jama.287.5.606	http://dx.doi.org/10.1001/jama.287.5.606			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UR	11829699	Bronze			2022-12-24	WOS:000173686700029
J	Jefferson, JA; Escudero, E; Hurtado, ME; Pando, J; Tapia, R; Swenson, ER; Prchal, J; Schreiner, GF; Schoene, RB; Hurtado, A; Johnson, RJ				Jefferson, JA; Escudero, E; Hurtado, ME; Pando, J; Tapia, R; Swenson, ER; Prchal, J; Schreiner, GF; Schoene, RB; Hurtado, A; Johnson, RJ			Excessive erythrocytosis, chronic mountain sickness, and serum cobalt levels	LANCET			English	Article								In a subset of high-altitude dwellers, the appropriate erythrocytotic response becomes excessive and can result in chronic mountain sickness. We studied men with (study group) and without excessive erythrocytosis (packed-cell volume >65%) living in Cerro de Pasco, Peru (altitude 4300 m), and compared them with controls living in Lima, Peru (at sea-level). Toxic serum cobalt concentrations were detected in 11 of 21 (52%) study participants with excessive erythrocytosis, but were undetectable in high altitude or sea-level controls. In the mining community of Cerro de Pasco, cobalt toxicity might be an important contributor to excessive erythrocytosis.	Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA; Univ Washington, Med Ctr, Div Nephrol, Seattle, WA 98195 USA; Univ Peruana Cayetano Heredia, Div Nephrol, Hosp Loayza, Carlos Monge Cassinelli Nephrol Ctr, Lima, Peru; Scios, Sunnyvale, CA USA	Baylor College of Medicine; University of Washington; University of Washington Seattle; Universidad Peruana Cayetano Heredia; Scios	Johnson, RJ (corresponding author), Baylor Coll Med, Dept Med, Div Nephrol, Smith 1273,6550 Fannin St, Houston, TX 77030 USA.		Jefferson, Jonathan/AAA-9679-2019	Hurtado, Abdias/0000-0001-8850-7903	BLRD VA [I01 BX002586] Funding Source: Medline	BLRD VA		ALIPPI RM, 1992, HAEMATOLOGICA, V77, P446; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; MONGE CARLOS, 1942, SCIENCE, V95, P79, DOI 10.1126/science.95.2456.79; NORDBERG G, 1994, SCI TOTAL ENVIRON, V150, P201, DOI 10.1016/0048-9697(94)90151-1; Winslow RM, 1987, HYPOXIA POLYCYTHEMIA	5	58	61	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 2	2002	359	9304					407	408		10.1016/S0140-6736(02)07594-3	http://dx.doi.org/10.1016/S0140-6736(02)07594-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UP	11844517				2022-12-24	WOS:000173686500017
J	Spiegelhalter, DJ				Spiegelhalter, DJ			Mortality and volume of cases in paediatric cardiac surgery: retrospective study based on routinely collected data	BRITISH MEDICAL JOURNAL			English	Article							IN-HOSPITAL MORTALITY; TRANSPLANTATION CENTERS; LIVER-TRANSPLANTATION	Objectives To determine whether mortality between 1991 and 1995 in hospitals in England carrying out surgery for congenital heart disease in children was associated with the annual volume of cases and to estimate the extent to which an association could explain the apparent divergent mortality at Bristol Royal Infirmary. Design Retrospective analysis of data from two sources, a register of returns by surgeons to their professional society and an administrative database. Setting 12 hospitals in England carrying out surgery for congenital heart disease over the period April 1991 to March 1995. Main outcome measure 30 day mortality. Results For open heart operations in children under 1 year old, and in particular for arterial switches and repair of atrioventricular septal defect, there is strong and consistent evidence of an inverse association between mortality and volume of cases (not taking into account any data from Bristol). A hospital carrying out 120 open operations per year in 1991-5 on children aged under 1 year would be expected to have a mortality 25% lower than that in a hospital carrying out 40 operations. If the children in the hospitals had the same mix of operations, this reduction is 34%. Stratifying for types of operation or including the results from Bristol strengthens this association. It was also estimated that less than a fifth of the excess mortality at Bristol Royal Infirmary in open operations in children less than 1 year old was due to the hospital's lower volume of surgery. Conclusions Using appropriate methods, this study showed that mortality in paediatric cardiac surgery was inversely related to the Volume of surgery. Considerable caution is needed in interpreting these results, and it does not necessarily follow that concentrating resources in fewer centres would reduce mortality.	Inst Publ Hlth, MRC, Biostat Unit, Cambridge CB2 2SR, England	MRC Biostatistics Unit; University of Cambridge	Spiegelhalter, DJ (corresponding author), Inst Publ Hlth, MRC, Biostat Unit, Cambridge CB2 2SR, England.							Aylin P, 2001, LANCET, V358, P181, DOI 10.1016/S0140-6736(01)05404-6; *BRIST ROYAL INF I, 2001, INQ ISS LIST 1; Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159; Edwards EB, 1999, NEW ENGL J MED, V341, P2049, DOI 10.1056/NEJM199912303412703; Hannan EL, 1998, PEDIATRICS, V101, P963, DOI 10.1542/peds.101.6.963; JENKINS KJ, 1995, PEDIATRICS, V95, P323; Kennedy I, 2001, INQUIRY MANAGEMENT C; Laks MP, 2000, NEW ENGL J MED, V342, P1527; Posnett J, 1999, BRIT MED J, V319, P1063, DOI 10.1136/bmj.319.7216.1063; Sollano JA, 1999, J THORAC CARDIOV SUR, V117, P419, DOI 10.1016/S0022-5223(99)70320-X	10	62	65	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 2	2002	324	7332					261	264		10.1136/bmj.324.7332.261	http://dx.doi.org/10.1136/bmj.324.7332.261			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	519LT	11823355	Green Published, Bronze			2022-12-24	WOS:000173728300013
J	Lois, C; Hong, EJ; Pease, S; Brown, EJ; Baltimore, D				Lois, C; Hong, EJ; Pease, S; Brown, EJ; Baltimore, D			Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors	SCIENCE			English	Article							RETROVIRAL VECTORS; HIGH-TITER; MICE; MOUSE; METHYLATION; ELEMENT; VIRUS; CELLS; LINE; DNA	Single-cell mouse embryos were infected in vitro with recombinant lentiviral vectors to generate transgenic mice carrying the green fluorescent protein (GFP) gene driven by a ubiquitously expressing promoter. Eighty percent of founder mice carried at least one copy of the transgene, and 90% of these expressed GFP at high levels. Progeny inherited the transgene(s) and displayed green fluorescence. Mice generated using lentiviral vectors with muscle-specific and T lymphocyte-specific promoters expressed high levels of GFP only in the appropriate cell types. We have also generated transgenic rats that express GFP at high levels, suggesting that this technique can be used to produce other transgenic animal species.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Baltimore, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.							Charreau B, 1996, TRANSGENIC RES, V5, P223, DOI 10.1007/BF01972876; Coffin J.M., 1997, RETROVIRUSES; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; Hogan B, 1994, MANIPULATING MOUSE E; JAENISCH R, 1976, P NATL ACAD SCI USA, V73, P1260, DOI 10.1073/pnas.73.4.1260; JAENISCH R, 1988, SCIENCE, V240, P1468, DOI 10.1126/science.3287623; JAHNER D, 1982, NATURE, V298, P623, DOI 10.1038/298623a0; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; MCBURNEY MW, 1994, DEV DYNAM, V200, P278, DOI 10.1002/aja.1002000403; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; NAITO K, 1992, HUM REPROD, V7, P281, DOI 10.1093/oxfordjournals.humrep.a137633; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Petitte JN, 1997, POULTRY SCI, V76, P1084, DOI 10.1093/ps/76.8.1084; SCHMIDT EV, 1990, MOL CELL BIOL, V10, P4406, DOI 10.1128/MCB.10.8.4406; Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787; YEE JK, 1994, METHOD CELL BIOL, V43, P99; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	22	1526	1689	2	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					868	872		10.1126/science.1067081	http://dx.doi.org/10.1126/science.1067081			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11786607				2022-12-24	WOS:000173733000049
J	McDaniel, L; Houchin, LA; Williamson, SJ; Paul, JH				McDaniel, L; Houchin, LA; Williamson, SJ; Paul, JH			Plankton blooms - Lysogeny in marine Synechococcus	NATURE			English	Article							VIRUSES; ABUNDANCE; MORTALITY; SEAWATER		Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA	State University System of Florida; University of South Florida	McDaniel, L (corresponding author), Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA.							Ackermann H., 1987, VIRUSES PROKARYOTES, V1; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; BRATBAK G, 1993, MAR ECOL PROG SER, V93, P39, DOI 10.3354/meps093039; COTTRELL MT, 1995, LIMNOL OCEANOGR, V40, P730, DOI 10.4319/lo.1995.40.4.0730; Noble RT, 1998, AQUAT MICROB ECOL, V14, P113, DOI 10.3354/ame014113; SUTTLE CA, 1992, MAR ECOL PROG SER, V87, P105, DOI 10.3354/meps087105; SUTTLE CA, 1993, MAR ECOL PROG SER, V92, P99, DOI 10.3354/meps092099; WATERBURY JB, 1993, APPL ENVIRON MICROB, V59, P3393, DOI 10.1128/AEM.59.10.3393-3399.1993; Weinbauer MG, 1996, APPL ENVIRON MICROB, V62, P4374, DOI 10.1128/AEM.62.12.4374-4380.1996; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000	10	97	105	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					496	496		10.1038/415496a	http://dx.doi.org/10.1038/415496a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823851	Bronze			2022-12-24	WOS:000173564300037
J	van't Veer, LJ; Dai, HY; van de Vijver, MJ; He, YDD; Hart, AAM; Mao, M; Peterse, HL; van der Kooy, K; Marton, MJ; Witteveen, AT; Schreiber, GJ; Kerkhoven, RM; Roberts, C; Linsley, PS; Bernards, R; Friend, SH				van't Veer, LJ; Dai, HY; van de Vijver, MJ; He, YDD; Hart, AAM; Mao, M; Peterse, HL; van der Kooy, K; Marton, MJ; Witteveen, AT; Schreiber, GJ; Kerkhoven, RM; Roberts, C; Linsley, PS; Bernards, R; Friend, SH			Gene expression profiling predicts clinical outcome of breast cancer	NATURE			English	Article							SPORADIC BREAST; BRCA1; PATTERNS; TUMORS	Breast cancer patients with the same stage of disease can have markedly different treatment responses and overall outcome. The strongest predictors for metastases (for example, lymph node status and histological grade) fail to classify accurately breast tumours according to their clinical behaviour(1-3). Chemotherapy or hormonal therapy reduces the risk of distant metastases by approximately one-third; however 70-80% of patients receiving this treatment would have survived without it(4,5). None of the signatures of breast cancer gene expression reported to date(6-12) allow for patient-tailored therapy strategies. Here we used DNA microarray analysis supervised classification to identify a gene expression signature strongly predictive of a short interval to distant metastases ('poor prognosis' signature) in patients without tumour cells in local lymph nodes at diagnosis (lymph node negative). In addition, we established a signature that identifies tumours of BRCA1 carriers. The poor prognosis signature consists of genes regulating cell cycle, invasion, metastasis and angiogenesis. This gene expression profile will outperform all currently used clinical parameters in predicting disease outcome. Our findings provide a strategy to select patients who would benefit from adjuvant therapy.	Rosetta Inpharmat, Kirkland, WA 98034 USA; Netherlands Canc Inst, Div Diagnost Oncol, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands	Merck & Company; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute	Friend, SH (corresponding author), Rosetta Inpharmat, 12040 115th Ave NE, Kirkland, WA 98034 USA.			van de Vijver, Marc/0000-0002-0385-4787; Bernards, Rene/0000-0001-8677-3423				Abe O, 1998, LANCET, V352, P930; BIECHE I, 1995, GENE CHROMOSOME CANC, V14, P227, DOI 10.1002/gcc.2870140402; Brenton JD, 2001, BREAST CANCER RES, V3, P77, DOI 10.1186/bcr274; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Clarke M, 1998, LANCET, V351, P1451; Eifel P, 2001, JNCI-J NATL CANCER I, V93, P979; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; Goldhirsch A, 1998, J NATL CANCER I, V90, P1601, DOI 10.1093/jnci/90.21.1601; Gruvberger S, 2001, CANCER RES, V61, P5979; He YDD, 2001, NAT MED, V7, P658, DOI 10.1038/89022; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Janicke F, 2001, J NATL CANCER I, V93, P913, DOI 10.1093/jnci/93.12.913; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Lakhani SR, 1998, JNCI-J NATL CANCER I, V90, P1138, DOI 10.1093/jnci/90.15.1138; Martin K, 2000, CANCER RES, V60, P2232; MCGUIRE WL, 1991, J NATL CANCER I, V83, P154, DOI 10.1093/jnci/83.3.154; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Steeg PS, 1998, BREAST CANCER RES TR, V52, P17, DOI 10.1023/A:1006102916060; vanDiest PJ, 1997, AM J PATHOL, V150, P705; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Zajchowski DA, 2001, CANCER RES, V61, P5168; Zheng L, 2001, P NATL ACAD SCI USA, V98, P9587, DOI 10.1073/pnas.171174298	26	6997	7395	17	798	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					530	536		10.1038/415530a	http://dx.doi.org/10.1038/415530a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823860	Green Published			2022-12-24	WOS:000173564300048
J	Cardinale, BJ; Palmer, MA; Collins, SL				Cardinale, BJ; Palmer, MA; Collins, SL			Species diversity enhances ecosystem functioning through interspecific facilitation	NATURE			English	Article							CHANGING BIODIVERSITY; PARTICLE CAPTURE; PLANT DIVERSITY; FLOW; CONSEQUENCES; PRODUCTIVITY; SEDIMENTS	Facilitation between species is thought to be a key mechanism by which biodiversity affects the rates of resource use that govern the efficiency and productivity of ecosystems(1-4); however, there is no direct empirical evidence to support this hypothesis. Here we show that increasing the species diversity of a functional group of aquatic organisms induces facilitative interactions, leading to non-additive changes in resource consumption. We increased the richness and evenness of suspension-feeding caddisfly larvae (Insecta, Trichoptera) in stream mesocosms and found that the increased topographical complexity of the benthic habitat alters patterns of near-bed flow such that the feeding success of individuals is enhanced. Species diversity reduces 'current shading' (that is, the deceleration of flow from upstream to downstream neighbours), allowing diverse assemblages to capture a greater fraction of suspended resources than is caught by any species monoculture. The fundamental nature of this form of hydrodynamic facilitation suggests that it is broadly applicable to freshwater and marine habitats; in addition, it has several analogues in terrestrial ecosystems where fluxes of energy and matter can be influenced by biophysical complexity(3,5,6). Thus, changes in species diversity may alter the probability of positive species interactions, resulting in disproportionately large changes in the functioning of ecosystems.	Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Cardinale, BJ (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.		Collins, Scott L/P-7742-2014; Palmer, Margaret A/F-9648-2013; Cardinale, Bradley J/I-7076-2013	Collins, Scott L/0000-0002-0193-2892; Palmer, Margaret A/0000-0003-1468-7993; 				[Anonymous], 1997, PHYSL ECOLOGY TROPIC; BUTMAN CA, 1994, LIMNOL OCEANOGR, V39, P1755, DOI 10.4319/lo.1994.39.7.1755; Cardinale BJ, 2000, OIKOS, V91, P175, DOI 10.1034/j.1600-0706.2000.910117.x; CARDINALE BJ, IN PRESS ECOLOGY; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chapin FS, 1998, BIOSCIENCE, V48, P45, DOI 10.2307/1313227; ECKMAN JE, 1981, J MAR RES, V39, P361; ENGLUND G, 1991, FRESHWATER BIOL, V26, P425, DOI 10.1111/j.1365-2427.1991.tb01409.x; Finnigan J, 2000, ANNU REV FLUID MECH, V32, P519, DOI 10.1146/annurev.fluid.32.1.519; Fridley JD, 2001, OIKOS, V93, P514, DOI 10.1034/j.1600-0706.2001.930318.x; HART DD, 1986, OIKOS, V46, P88, DOI 10.2307/3565384; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; HUETTEL M, 1992, MAR ECOL PROG SER, V89, P253, DOI 10.3354/meps089253; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; JOHNSON AS, 1990, LIMNOL OCEANOGR, V35, P1395, DOI 10.4319/lo.1990.35.6.1395; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; LOUDON C, 1990, AM NAT, V135, P360, DOI 10.1086/285051; Mulder CPH, 2001, P NATL ACAD SCI USA, V98, P6704, DOI 10.1073/pnas.111055298; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; NOWELL ARM, 1984, ANNU REV ECOL SYST, V15, P303, DOI 10.1146/annurev.es.15.110184.001511; OKAMURA B, 1992, ECOLOGY, V73, P1502, DOI 10.2307/1940693; Palmer M, 1997, AMBIO, V26, P571; Sebens KP, 1997, J EXP MAR BIOL ECOL, V211, P1, DOI 10.1016/S0022-0981(96)02636-6; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Vogel S, 1994, LIFE MOVING FLUIDS; Wardle DA, 1999, OIKOS, V87, P403, DOI 10.2307/3546757	30	570	626	7	511	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					426	429		10.1038/415426a	http://dx.doi.org/10.1038/415426a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807553				2022-12-24	WOS:000173433600049
J	Pomeroy, SL; Tamayo, P; Gaasenbeek, M; Sturla, LM; Angelo, M; McLaughlin, ME; Kim, JYH; Goumnerova, LC; Black, PM; Lau, C; Allen, JC; Zagzag, D; Olson, JM; Curran, T; Wetmore, C; Biegel, JA; Poggio, T; Mukherjee, S; Rifkin, R; Califano, A; Stolovitzky, G; Louis, DN; Mesirov, JP; Lander, ES; Golub, TR				Pomeroy, SL; Tamayo, P; Gaasenbeek, M; Sturla, LM; Angelo, M; McLaughlin, ME; Kim, JYH; Goumnerova, LC; Black, PM; Lau, C; Allen, JC; Zagzag, D; Olson, JM; Curran, T; Wetmore, C; Biegel, JA; Poggio, T; Mukherjee, S; Rifkin, R; Califano, A; Stolovitzky, G; Louis, DN; Mesirov, JP; Lander, ES; Golub, TR			Prediction of central nervous system embryonal tumour outcome based on gene expression	NATURE			English	Article							HUMAN HOMOLOG; CEREBELLAR MEDULLOBLASTOMA; SONIC HEDGEHOG; RECEPTOR TRKC; CELL LINEAGE; GERM-LINE; MUTATIONS; CANCER; PATTERNS	Embryonal tumours of the central nervous system (CNS) represent a heterogeneous group of tumours about which little is known biologically, and whose diagnosis, on the basis of morphologic appearance alone, is controversial. Medulloblastomas, for example, are the most common malignant brain tumour of childhood, but their pathogenesis is unknown, their relationship to other embryonal CNS tumours is debated(1,2), and patients' response to therapy is difficult to predict(3). We approached these problems by developing a classification system based on DNA microarray gene expression data derived from 99 patient samples. Here we demonstrate that medulloblastomas are molecularly distinct from other brain tumours including primitive neuroectodermal tumours (PNETs), atypical teratoid/rhabdoid tumours (AT/RTs) and malignant gliomas. Previously unrecognized evidence supporting the derivation of medulloblastomas from cerebellar granule cells through activation of the Sonic Hedgehog (SHH) pathway was also revealed. We show further that the clinical outcome of children with medulloblastomas is highly predictable on the basis of the gene expression profiles of their tumours at diagnosis.	Harvard Univ, Sch Med, Dept Neurol, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurosurg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol & Neurosurg Serv, Boston, MA 02115 USA; MIT, Whitehead Inst MIT Ctr Genome Res, Cambridge, MA 02139 USA; MIT, McGovern Inst, Ctr Biol & Computat Learning, AI Lab, Cambridge, MA 02139 USA; Baylor Coll Med, Div Pediat Oncol, Houston, TX 77030 USA; Beth Israel Deaconess Med Ctr, New York, NY 10128 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; Univ Penn, Childrens Hosp Philadelphia, Sch Med, Dept Pediat,Div Human Genet, Philadelphia, PA 19104 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Baylor College of Medicine; Harvard University; Beth Israel Deaconess Medical Center; New York University; Fred Hutchinson Cancer Center; St Jude Children's Research Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Massachusetts Institute of Technology (MIT); International Business Machines (IBM)	Pomeroy, SL (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Div Neurosci, Boston, MA 02115 USA.	scott.pomeroy@tch.harvard.edu; golub@genome.wi.mit.edu	Curran, Thomas/AAE-7631-2019; Mesirov, Jill/AGF-7626-2022; Curran, Tom/F-5234-2018; Califano, Andrea/F-7239-2012; Curran, Tom/C-1164-2008; Curran, Tom/D-7515-2011	Curran, Thomas/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551; Allen, Jeffrey/0000-0001-9957-6664; Mukherjee, Sayan/0000-0002-6715-3920; Califano, Andrea/0000-0003-4742-3679				ARUGA J, 1994, J NEUROCHEM, V63, P1880; Biegel JA, 1999, CANCER RES, V59, P74; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; CALIFANO, 2000, P 8 INT C INT SYST M, P75; DASARATHY VB, 1991, NEAREST NEIGHBOOR NN; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; GIANGASPERO F, 2000, WHO CLASSIFICATION T, P129; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hahn H, 2000, J BIOL CHEM, V275, P28341, DOI 10.1074/jbc.C000352200; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; KADIN ME, 1970, J NEUROPATH EXP NEUR, V29, P583, DOI 10.1097/00005072-197010000-00005; Kim JYH, 1999, CANCER RES, V59, P711; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; Mardia K. V., 1979, MULTIVARIATE ANAL; MUKHERJEE S, 1999, 182AI CBCL MIT; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Packer RJ, 1999, J CLIN ONCOL, V17, P2127, DOI 10.1200/JCO.1999.17.7.2127; Pietsch T, 1997, CANCER RES, V57, P2085; Raffel C, 1997, CANCER RES, V57, P842; Rorke LB, 1996, J NEUROSURG, V85, P56, DOI 10.3171/jns.1996.85.1.0056; RORKE LB, 1983, J NEUROPATH EXP NEUR, V42, P1, DOI 10.1097/00005072-198301000-00001; SEGAL RA, 1994, P NATL ACAD SCI USA, V91, P12867, DOI 10.1073/pnas.91.26.12867; SLONIM DK, 2000, P 4 ANN INT C COMP M, P263; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Wetmore C, 2000, CANCER RES, V60, P2239; XIE J, 1997, CANCER RES, V57, P2397; Yokota N, 1996, CANCER RES, V56, P377	30	1711	1781	0	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2002	415	6870					436	442		10.1038/415436a	http://dx.doi.org/10.1038/415436a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807556				2022-12-24	WOS:000173433600052
J	Wang, X; Chen, HF; Yin, H; Kim, SS; Tan, SL; Gosden, RG				Wang, X; Chen, HF; Yin, H; Kim, SS; Tan, SL; Gosden, RG			Fertility after intact ovary transplantation	NATURE			English	Article							KIDNEYS		Ctr Hosp Univ Montreal, Notre Dame Hosp, Expt Surg Lab, Montreal, PQ H2L 4M1, Canada; McGill Univ, Royal Victoria Hosp, Dept Obstet & Gynecol, Montreal, PQ H3A 1A1, Canada; Univ Washington, Sch Med, Dept Obstet & Gynecol, Seattle, WA 98105 USA	Universite de Montreal; McGill University; Royal Victoria Hospital; University of Washington; University of Washington Seattle	Wang, X (corresponding author), Ctr Hosp Univ Montreal, Notre Dame Hosp, Expt Surg Lab, Montreal, PQ H2L 4M1, Canada.							CORNIER E, 1985, Journal de Gynecologie Obstetrique et biologie de la Reproduction, V14, P567; GOSDEN RG, 1994, HUM REPROD, V9, P597, DOI 10.1093/oxfordjournals.humrep.a138556; GUTTMAN FM, 1977, CRYOBIOLOGY, V14, P559, DOI 10.1016/0011-2240(77)90166-3; JACOBSEN IA, 1984, CRYOBIOLOGY, V21, P637, DOI 10.1016/0011-2240(84)90223-2; LEE S, 1974, J RES I MED SCI KORE, V6, P112; Picton HM, 2000, BRIT MED BULL, V56, P603, DOI 10.1258/0007142001903418; Radford JA, 2001, LANCET, V357, P1172, DOI 10.1016/S0140-6736(00)04335-X; Song YC, 2000, NAT BIOTECHNOL, V18, P296, DOI 10.1038/73737	8	163	180	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					385	385		10.1038/415385a	http://dx.doi.org/10.1038/415385a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807540				2022-12-24	WOS:000173433600035
J	Arantes-Oliveira, N; Apfeld, J; Dillin, A; Kenyon, C				Arantes-Oliveira, N; Apfeld, J; Dillin, A; Kenyon, C			Regulation of life-span by germ-line stem cells in Caenorhabditis elegans	SCIENCE			English	Article							C-ELEGANS; GENE; GLP-1; SPERMATOGENESIS; DROSOPHILA; RECEPTORS; EMBRYOS; MUTANT; STRESS; LAG-2	The germ line of the nematode Caenorhabditis elegans influences life-span; when the germ-line precursor cells are removed, life-span is increased dramatically. We find that neither sperm, nor oocytes, nor meiotic precursor cells are responsible for this effect. Rather life-span is influenced by the proliferating germ-line stem cells. These cells, as well as a downstream transcriptional regulator, act in the adult to influence aging, indicating that the aging process remains plastic during adulthood. We propose that the germ-line stem cells affect life-span by influencing the production of, or the response to, a steroid hormone that promotes longevity.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kenyon, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.			Kenyon, Cynthia/0000-0003-3446-2636; Apfeld, Javier/0000-0001-9897-5671				Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; BARTON MK, 1990, GENETICS, V125, P29; Berry LW, 1997, DEVELOPMENT, V124, P925; ELLIS RE, 1995, GENETICS, V139, P561; FRANCIS R, 1995, GENETICS, V139, P579; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; HENDERSON ST, 1994, DEVELOPMENT, V120, P2913; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Karashima T, 2000, DEVELOPMENT, V127, P1069; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; PRIESS JR, 1987, CELL, V51, P601, DOI 10.1016/0092-8674(87)90129-2; SCHEDL T, 1988, GENETICS, V119, P43; SCHEDL T, 1997, C ELEGANS, V2, P241; Sgro CM, 1999, SCIENCE, V286, P2521, DOI 10.1126/science.286.5449.2521; STROME S, 1995, DEVELOPMENT, V121, P2961; TAX FE, 1994, NATURE, V368, P150, DOI 10.1038/368150a0; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605	24	335	351	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					502	505		10.1126/science.1065768	http://dx.doi.org/10.1126/science.1065768			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799246				2022-12-24	WOS:000173350700052
J	Lazaris, A; Arcidiacono, S; Huang, Y; Zhou, JF; Duguay, F; Chretien, N; Welsh, EA; Soares, JW; Karatzas, CN				Lazaris, A; Arcidiacono, S; Huang, Y; Zhou, JF; Duguay, F; Chretien, N; Welsh, EA; Soares, JW; Karatzas, CN			Spider silk fibers spun from soluble recombinant silk produced in mammalian cells	SCIENCE			English	Article							FORCE-ELONGATION BEHAVIOR; DRAGLINE SILK; FIBROIN; PROTEIN; EXPRESSION; PURIFICATION; SEQUENCE; DESIGN	Spider silks are protein-based "biopolymer" filaments or threads secreted by specialized epithelia[ cells as concentrated soluble precursors of highly repetitive primary sequences. Spider dragline silk is a flexible, lightweight fiber of extraordinary strength and toughness comparable to that of synthetic high-performance fibers. We sought to "biomimic" the process of spider silk production by expressing in mammalian cells the dragline silk genes (ADF-3/MaSpll and MaSpl) of two spider species. We produced soluble recombinant (rc)-dragline silk proteins with molecular masses of 60 to 140 kilodaltons. We demonstrated the wet spinning of silk monofilaments spun from a concentrated aqueous solution of soluble rc-spider silk protein (ADF-3; 60 kilodaltons) under modest shear and coagulation conditions. The spun fibers were water insoluble with a fine diameter (10 to 40 micrometers) and exhibited toughness and modulus values comparable to those of native dragline silks but with tower tenacity. Dope solutions with rc-silk protein concentrations >20% and postspinning draw were necessary to achieve improved mechanical properties of the spun fibers. Fiber properties correlated with finer fiber diameter and increased birefringence.	Nexia Biotechnol, Quebec City, PQ J7V 8P5, Canada; USA, Soldier Biol Chem Command, Mat Sci Team, Natick, MA 01760 USA		Lazaris, A (corresponding author), Nexia Biotechnol, Quebec City, PQ J7V 8P5, Canada.	alazaris@nexiabiotech.com						Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133; CANDELAS GC, 1990, DEV BIOL, V140, P215, DOI 10.1016/0012-1606(90)90069-U; DENNY M, 1976, J EXP BIOL, V65, P483; Fahnestock S R, 2000, J Biotechnol, V74, P105, DOI 10.1016/S1389-0352(00)00008-8; Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883; Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884; FAHNESTOCK SR, 1994, Patent No. 9429450; Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561; GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9; Gosline JM, 1999, J EXP BIOL, V202, P3295; Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112; Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0; Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477; HINMAN M, 1992, BIOPOLYMERS, P227; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5; KAPLAN D, 1994, ACS SYM SER, V544, P2; KOOVER J, 1987, ECOPHYSIOLOGY SPIDER, P160; Lewis RV, 1996, PROTEIN EXPRES PURIF, V7, P400, DOI 10.1006/prep.1996.0060; LILVAK O, 1998, MACROMOLECULES, V31, P2947; LIZARDI PM, 1979, P NATL ACAD SCI USA, V76, P6211, DOI 10.1073/pnas.76.12.6211; Lock, 1993, Process for Making Silk Fibroin Fibers, Patent No. [US5252285A, 5252285]; LUCAS FRED, 1964, DISCOVERY, V25, P20; O'Brien JP, 1998, ADV MATER, V10, P1185, DOI 10.1002/(SICI)1521-4095(199810)10:15<1185::AID-ADMA1185>3.0.CO;2-T; PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022; Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335; Seidel A, 1998, MACROMOLECULES, V31, P6733, DOI 10.1021/ma9808880; Seidel A, 2000, MACROMOLECULES, V33, P775, DOI 10.1021/ma990893j; TERMONIA Y, 2000, PERG MAT SER, V4, P271; TERMONIA Y, 2000, PERG MAT SER, V4, P337; Trabbic KA, 1998, MACROMOLECULES, V31, P462, DOI 10.1021/ma9708860; Viney C., 1994, SILK POLYM MAT SCI B, P120; VINEY C, 2000, PERG MAT SER, V4, P295; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; WORK RW, 1976, TEXT RES J, V46, P485, DOI 10.1177/004051757604600704; WORK RW, 1977, TEXT RES J, V47, P650, DOI 10.1177/004051757704701003; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; ZEMLIN JC, 1968, 6929CM US ARM NAT LA	38	497	602	12	308	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2002	295	5554					472	476		10.1126/science.1065780	http://dx.doi.org/10.1126/science.1065780			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799236				2022-12-24	WOS:000173350700042
J	Meshorer, E; Erb, C; Gazit, R; Pavlovsky, L; Kaufer, D; Friedman, A; Glick, D; Ben-Arie, N; Soreq, H				Meshorer, E; Erb, C; Gazit, R; Pavlovsky, L; Kaufer, D; Friedman, A; Glick, D; Ben-Arie, N; Soreq, H			Alternative splicing and neuritic mRNA translocation under long-term neuronal hypersensitivity	SCIENCE			English	Article							ACETYLCHOLINE-RELEASE; DENDRITIC TRANSPORT; PROTEIN-SYNTHESIS; STRESS; RESPONSES; TRANSCRIPTS; EXPRESSION; STABILITY; MEMORY; SITES	To explore neuronal mechanisms underlying long-term consequences of stress, we studied stress-induced changes in the neuritic translocation of acetylcholinesterase (AChE) splice variants. Under normal conditions, we found the synaptic AChE-S mRNA and protein in neurites, Corticosterone, anticholinesterases, and forced swim, each facilitated a rapid (minutes), yet long-lasting (weeks), shift from AChE-S to the normally rare AChE-R mRNA, promoted AChE-R mRNA translocation into neurites, and induced enzyme secretion, Weeks after stress, electrophysiological measurements in hippocampus slices displayed apparently normal evoked synaptic responses but extreme hypersensitivity to both anticholinesterases and atropine. Our findings suggest that neuronal hypersensitivity under stress involves neuritic replacement of AChE-S with AChE-R.	Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Inst Life Sci, Dept Cell & Anim Biol, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Eric Roland Ctr Neurodegenerat Dis, IL-91904 Jerusalem, Israel; Ben Gurion Univ Negev, Zlotowsky Ctr Neurosci, Dept Physiol, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Zlotowsky Ctr Neurosci, Dept Neurosurg, IL-84105 Beer Sheva, Israel; Soroka Med Ctr, IL-84105 Beer Sheva, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center	Soreq, H (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	soreq@shum.huji.ac.il	Gazit, Roi/J-3352-2017; Pavlovsky, Lev/AAD-1348-2021; Ben-Arie, Nissim/K-4997-2012	Soreq, Hermona/0000-0002-0955-526X; Gazit, Roi/0000-0002-0548-2147; Pavlovsky, Lev/0000-0001-8400-9587; Meshorer, Eran/0000-0003-4777-986X				Aigner Thomas G., 1995, Current Opinion in Neurobiology, V5, P155, DOI 10.1016/0959-4388(95)80021-2; ANTELMAN SM, 1980, SCIENCE, V207, P329, DOI 10.1126/science.7188649; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Chan RYY, 1998, J BIOL CHEM, V273, P9727, DOI 10.1074/jbc.273.16.9727; Daoud R, 1999, EUR J NEUROSCI, V11, P788, DOI 10.1046/j.1460-9568.1999.00486.x; DAVIS L, 1987, NATURE, V330, P477, DOI 10.1038/330477a0; DAVIS L, 1990, J NEUROSCI, V10, P3056; Erb C, 2001, J NEUROCHEM, V77, P638, DOI 10.1046/j.1471-4159.2001.00287.x; Foster JA, 1996, J NEUROSCI RES, V46, P652; Friedman A, 1998, J PHYSIOLOGY-PARIS, V92, P329, DOI 10.1016/S0928-4257(98)80042-9; Galyam N, 2001, ANTISENSE NUCLEIC A, V11, P51, DOI 10.1089/108729001750072128; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; IMPERATO A, 1991, BRAIN RES, V538, P111, DOI 10.1016/0006-8993(91)90384-8; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Luo ZD, 1999, MOL PHARMACOL, V56, P886, DOI 10.1124/mol.56.5.886; McCormick JA, 2000, MOL ENDOCRINOL, V14, P506, DOI 10.1210/me.14.4.506; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Mezey G, 2001, BRIT MED J, V323, P561, DOI 10.1136/bmj.323.7312.561; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; SCHRAMM M, 1990, P NATL ACAD SCI USA, V87, P1193, DOI 10.1073/pnas.87.3.1193; Shapira M, 2000, HUM MOL GENET, V9, P1273, DOI 10.1093/hmg/9.9.1273; SOREQ H, 1984, EMBO J, V3, P1371, DOI 10.1002/j.1460-2075.1984.tb01979.x; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Wallace CS, 1998, J NEUROSCI, V18, P26; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443	30	196	206	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2002	295	5554					508	512		10.1126/science.1066752	http://dx.doi.org/10.1126/science.1066752			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799248				2022-12-24	WOS:000173350700054
J	Zhu, Y; Bian, Z; Lu, P; Karas, RH; Bao, L; Cox, D; Hodgin, J; Shaul, PW; Thoren, P; Smithies, O; Gustafsson, JA; Mendelsohn, ME				Zhu, Y; Bian, Z; Lu, P; Karas, RH; Bao, L; Cox, D; Hodgin, J; Shaul, PW; Thoren, P; Smithies, O; Gustafsson, JA; Mendelsohn, ME			Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta	SCIENCE			English	Article							NITRIC-OXIDE SYNTHASES; SMOOTH-MUSCLE; RESPONSES; ARTERIES; CLONING	Blood vessels express estrogen receptors, but their rote in cardiovascular physiology is not wet[ understood. We show that vascular smooth muscle cells and blood vessels from estrogen receptor beta (ERbeta)-deficient mice exhibit multiple functional abnormalities. In wild-type mouse blood vessels, estrogen attenuates vasoconstriction by an ERbeta-mediated increase in inducible nitric oxide synthase expression. In contrast, estrogen augments vasoconstriction in blood vessels from ERbeta-deficient mice. Vascular smooth muscle cells isolated from ERbeta-deficient mice show multiple abnormalities of ion channel function. Furthermore, ERbeta-deficient mice develop sustained systolic and diastolic hypertension as they age. These data support an essential role for ERbeta in the regulation of vascular function and blood pressure.	Tufts Univ, Sch Med, New England Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA; Huddinge Univ Hosp, Novum, Dept Med Nutr, S-14186 Huddinge, Sweden; Huddinge Univ Hosp, Novum, Ctr Biotechnol, S-14186 Huddinge, Sweden; Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; Univ N Carolina, Dept Pathol, Chapel Hill, NC 27599 USA; Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX 75390 USA	Tufts Medical Center; Tufts University; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Mendelsohn, ME (corresponding author), Tufts Univ, Sch Med, New England Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD030276] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056069, R01HL061298, P50HL063494, R01HL053546, R01HL055309, R29HL056235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020069, R37GM020069] Funding Source: NIH RePORTER; NHLBI NIH HHS [P50 HL63494, R01 HL55309, HL53546, HL56235, R01 HL61298, R01 HL56069] Funding Source: Medline; NICHD NIH HHS [HD30276] Funding Source: Medline; NIGMS NIH HHS [GM20069] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bakir S, 2000, CIRCULATION, V101, P2342, DOI 10.1161/01.CIR.101.20.2342; Binko J, 1998, AM J PHYSIOL-HEART C, V274, pH853, DOI 10.1152/ajpheart.1998.274.3.H853; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Farhat MY, 1996, FASEB J, V10, P615, DOI 10.1096/fasebj.10.5.8621060; Guetta V, 1997, CIRCULATION, V96, P2795, DOI 10.1161/01.CIR.96.9.2795; Kauser K, 1997, J VASC RES, V34, P229, DOI 10.1159/000159227; Kolyada AY, 1996, BIOCHEM BIOPH RES CO, V220, P600, DOI 10.1006/bbrc.1996.0449; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; LANTINHERMOSO RL, 1997, AM J PHYSIOL, V273, P119; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lindner V, 1998, CIRC RES, V83, P224, DOI 10.1161/01.RES.83.2.224; McDonnell DP, 1999, TRENDS ENDOCRIN MET, V10, P301, DOI 10.1016/S1043-2760(99)00177-0; Mendelsohn ME, 2000, CIRC RES, V87, P956, DOI 10.1161/01.RES.87.11.956; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; MENDELSON ME, 1994, CURR OPIN CARDIOL, V9, P619, DOI 10.1097/00001573-199409000-00018; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; Mugge A, 1997, PHARMACOLOGY, V54, P162, DOI 10.1159/000139483; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; WALTER P, 1985, P NATL ACAD SCI USA, V82, P7889, DOI 10.1073/pnas.82.23.7889; WEINER CP, 1994, P NATL ACAD SCI USA, V91, P5212, DOI 10.1073/pnas.91.11.5212; WILLIAMS JK, 1992, J AM COLL CARDIOL, V20, P452, DOI 10.1016/0735-1097(92)90116-5; [No title captured]	24	389	403	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					505	508		10.1126/science.1065250	http://dx.doi.org/10.1126/science.1065250			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799247				2022-12-24	WOS:000173350700053
J	Brex, PA; Ciccarelli, O; O'Riordan, JI; Sailer, M; Thompson, AJ; Miller, DH				Brex, PA; Ciccarelli, O; O'Riordan, JI; Sailer, M; Thompson, AJ; Miller, DH			A longitudinal study of abnormalities on MRI and disability from multiple sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OPTIC NEURITIS; FOLLOW-UP; SPINAL-CORD; NATURAL-HISTORY; CLINICAL COURSE; AXONAL DAMAGE; BRAIN-STEM; EARLY RISK; LESIONS; PROGRESSION	Background: In patients with isolated syndromes that are clinically suggestive of multiple sclerosis, such as optic neuritis or brain-stem or spinal cord syndromes, the presence of lesions as determined by T(2)-weighted magnetic resonance imaging (MRI) of the brain increases the likelihood that multiple sclerosis will develop. We sought to determine the relation between early lesion volume, changes in volume, and long-term disability. Methods: Seventy-one patients in a serial MRI study of patients with isolated syndromes were reassessed after a mean of 14.1 years. Disability was measured with the use of Kurtzke's Expanded Disability Status Scale (EDSS; possible range, 0 to 10, with a higher score indicating a greater degree of disability). Results: Clinically definite multiple sclerosis developed in 44 of the 50 patients (88 percent) with abnormal results on MRI at presentation and in 4 of 21 patients (19 percent) with normal results on MRI. The median EDSS score at follow-up for those with multiple sclerosis was 3.25 (range, 0 to 10); 31 percent had an EDSS score of 6 or more (including three patients whose deaths were due to multiple sclerosis). The EDSS score at 14 years correlated moderately with lesion volume on MRI at 5 years (r=0.60) and with the increase in lesion volume over the first 5 years (r=0.61). Conclusions: In patients who first present with isolated syndromes suggestive of multiple sclerosis, the increases in the volume of the lesions seen on magnetic resonance imaging of the brain in the first five years correlate with the degree of long-term disability from multiple sclerosis. This relation is only moderate, so the volume of the lesions alone may not be an adequate basis for decisions about the use of disease-modifying treatment. (N Engl J Med 2002;346:158-64.) Copyright (C) 2002 Massachusetts Medical Society.	UCL Inst Neurol, NMR Res Unit, London WC1N 3BG, England; Ninewells Hosp, Tayside Multiple Sclerosis Res Unit, Dundee DD1 9SY, Scotland; Otto Von Guericke Univ, Magdeburg, Germany	University of London; University College London; University of Dundee; Otto von Guericke University	Miller, DH (corresponding author), UCL Inst Neurol, NMR Res Unit, Queen Sq, London WC1N 3BG, England.		Calabrese, Massimiliano/I-6195-2012; Thompson, Alan J/C-2654-2008	Thompson, Alan J/0000-0002-4333-8496; O'Riordan, Jonathan/0000-0001-6774-2488	Multiple Sclerosis Society [491] Funding Source: Medline	Multiple Sclerosis Society(National Multiple Sclerosis Society)		ALTMAN DG, 1991, PRACTICAL STAT MED R, P293; Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059; Brodsky M, 1997, NEUROLOGY, V49, P1404; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Confavreux C, 2000, NEW ENGL J MED, V343, P1430, DOI 10.1056/NEJM200011163432001; CONFAVREUX C, 1980, BRAIN, V103, P281, DOI 10.1093/brain/103.2.281; Efron Bradley., 1994, INTRO BOOTSTRAP; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Filippi M, 1997, NEUROLOGY, V49, P371, DOI 10.1212/WNL.49.2.371; FRANCIS DA, 1987, J NEUROL NEUROSUR PS, V50, P758, DOI 10.1136/jnnp.50.6.758; Fu L, 1998, BRAIN, V121, P103, DOI 10.1093/brain/121.1.103; Ghezzi A, 1999, J NEUROL, V246, P770, DOI 10.1007/s004150050453; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; KATZ D, 1993, ANN NEUROL, V34, P661, DOI 10.1002/ana.410340507; Katz-Levy Y, 2000, J IMMUNOL, V165, P5304, DOI 10.4049/jimmunol.165.9.5304; KURTZKE JF, 1977, J CHRON DIS, V30, P819, DOI 10.1016/0021-9681(77)90010-8; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LASSMANN H, 1994, ANN NEUROL, V36, pS42, DOI 10.1002/ana.410360713; LECHNERSCOTT J, IN PRESS CAN EXPANDE; Losseff NA, 1996, BRAIN, V119, P701, DOI 10.1093/brain/119.3.701; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; MILLER DH, 1988, J NEUROL NEUROSUR PS, V51, P1569, DOI 10.1136/jnnp.51.12.1569; MILLER DH, 1989, ANN NEUROL, V26, P635, DOI 10.1002/ana.410260508; MILLER DH, 1988, BRAIN, V111, P927, DOI 10.1093/brain/111.4.927; MILLER DH, 1987, ANN NEUROL, V22, P714, DOI 10.1002/ana.410220607; Molyneux PD, 1998, AM J NEURORADIOL, V19, P1715; MORRISSEY SP, 1993, BRAIN, V116, P135, DOI 10.1093/brain/116.1.135; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; ORMEROD IEC, 1986, J NEUROL NEUROSUR PS, V49, P124, DOI 10.1136/jnnp.49.2.124; ORMEROD IEC, 1986, J NEUROL NEUROSUR PS, V49, P737, DOI 10.1136/jnnp.49.7.737; PATY DW, 1993, NEUROLOGY, V43, P6627; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Riordan T, 1998, EPIDEMIOL INFECT, V121, P495, DOI 10.1017/S0950268898001496; RIZZO JF, 1988, NEUROLOGY, V38, P185, DOI 10.1212/WNL.38.2.185; RUNMARKER B, 1993, BRAIN, V116, P117, DOI 10.1093/brain/116.1.117; Sailer M, 1999, NEUROLOGY, V52, P599, DOI 10.1212/WNL.52.3.599; SANDBERG-WOLLHEIM M, 1990, Annals of Neurology, V27, P386, DOI 10.1002/ana.410270406; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; STEWART WA, 1984, LANCET, V2, P412; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; WEINSHENKER BG, 1989, BRAIN, V112, P1419, DOI 10.1093/brain/112.6.1419	42	630	653	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2002	346	3					158	164		10.1056/NEJMoa011341	http://dx.doi.org/10.1056/NEJMoa011341			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511NZ	11796849	Green Published, Bronze			2022-12-24	WOS:000173273600003
J	Hack, M; Flannery, DJ; Schluchter, M; Cartar, L; Borawski, E; Klein, N				Hack, M; Flannery, DJ; Schluchter, M; Cartar, L; Borawski, E; Klein, N			Outcomes in young adulthood for very-low-birth-weight infants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHILDREN BORN; FOLLOW-UP; HEALTH; RISK; AGE; INTELLIGENCE; ABILITIES; COHORT; BOYS; SEX	Background: Very-low-birth-weight infants (those weighing less than 1500 g) born during the initial years of neonatal intensive care have now reached young adulthood. Methods: We compared a cohort of 242 survivors among very-low-birth-weight infants born between 1977 and 1979 (mean birth weight, 1179 g; mean gestational age at birth, 29.7 weeks) with 233 controls from the same population in Cleveland who had normal birth weights. We assessed the level of education, cognitive and academic achievement, and rates of chronic illness and risk-taking behavior at 20 years of age. Outcomes were adjusted for sex and sociodemographic status. Results: Fewer very-low-birth-weight young adults than normal-birth-weight young adults had graduated from high school (74 percent vs. 83 percent, P=0.04). Very-low-birth-weight men, but not women, were significantly less likely than normal-birth-weight controls to be enrolled in postsecondary study (30 percent vs. 53 percent, P=0.002). Very-low-birth-weight participants had a lower mean IQ (87 vs. 92) and lower academic achievement scores (P<0.001 for both comparisons). They had higher rates of neurosensory impairments (10 percent vs. <1 percent, P<0.001) and subnormal height (10 percent vs. 5 percent, P=0.04). The very-low-birth-weight group reported less alcohol and drug use and had lower rates of pregnancy than normal-birth-weight controls; these differences persisted when comparisons were restricted to the participants without neurosensory impairment. Conclusions: Educational disadvantage associated with very low birth weight persists into early adulthood. (N Engl J Med 2002;346:149-57.) Copyright (C) 2002 Massachusetts Medical Society.	Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; Cleveland State Univ, Dept Special Educ, Cleveland, OH 44115 USA; Kent State Univ, Inst Study & Prevent Violence, Kent, OH 44242 USA	Case Western Reserve University; Case Western Reserve University; University System of Ohio; Cleveland State University; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Hack, M (corresponding author), Univ Hosp Cleveland, Rainbow Babies & Childrens Hosp, 11100 Euclid Ave, Cleveland, OH 44106 USA.	mxh7@po.cwru.edu	Borawski, Elaine/R-9959-2019; Fahimifar, Sepideh/M-5303-2019	Borawski, Elaine/0000-0001-7629-6889; 	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034177] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000080] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00080] Funding Source: Medline; NICHD NIH HHS [R01 HD34177] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADAMS PF, 1994, VITAL HLTH STAT, V10; [Anonymous], J ADOLESCENT RES, DOI DOI 10.1177/074355489381003; ARAM DM, 1991, J SPEECH HEAR RES, V34, P1169, DOI 10.1044/jshr.3405.1169; AYLWARD GP, 1985, J DEV BEHAV PEDIATR, V6, P3; Bacharach VR, 1998, J PEDIATR PSYCHOL, V23, P197, DOI 10.1093/jpepsy/23.3.197; Belcher HME, 1998, ARCH PEDIAT ADOL MED, V152, P952; Bjerager M, 1995, ACTA PAEDIATR, V84, P1339, DOI 10.1111/j.1651-2227.1995.tb13565.x; Botting N, 1997, J CHILD PSYCHOL PSYC, V38, P931, DOI 10.1111/j.1469-7610.1997.tb01612.x; CHILCOAT HD, 1995, AM J EPIDEMIOL, V141, P25, DOI 10.1093/oxfordjournals.aje.a117340; Chilcoat HD, 1999, J AM ACAD CHILD PSY, V38, P1347, DOI 10.1097/00004583-199911000-00008; Dessens AB, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.6.e77; Ericson A, 1998, ARCH DIS CHILD-FETAL, V78, pF171, DOI 10.1136/fn.78.3.F171; *FED INT FOR CHILD, 2000, AM CHILDR KEY NAT IN; Flannery DJ, 1999, AM J ORTHOPSYCHIAT, V69, P247, DOI 10.1037/h0080426; FLANNERY DJ, 1994, J YOUTH ADOLESCENCE, V23, P195, DOI 10.1007/BF01537445; Hack M, 2000, ARCH PEDIAT ADOL MED, V154, P725, DOI 10.1001/archpedi.154.7.725; HACK M, 1992, J DEV BEHAV PEDIATR, V13, P412; Hack M, 1996, ARCH PEDIAT ADOL MED, V150, P1122, DOI 10.1001/archpedi.1996.02170360012002; HACK M, 1993, J PEDIATR-US, V122, P887, DOI 10.1016/S0022-3476(09)90012-9; HACK M, 1995, FUTURE CHILD, V5, P176, DOI 10.2307/1602514; HACK M, 1991, NEW ENGL J MED, V325, P231, DOI 10.1056/NEJM199107253250403; Halpern CT, 2000, J ADOLESCENT HEALTH, V26, P213, DOI 10.1016/S1054-139X(99)00061-0; Hardy JB, 1997, PEDIATRICS, V99, P80, DOI 10.1542/peds.99.1.80; HESS JH, 1953, PEDIATRICS, V11, P425; Johnson EO, 2000, BIOL PSYCHIAT, V47, P490, DOI 10.1016/S0006-3223(99)00223-1; KANN L, 2000, CDC SURVEILLANCE SUM, V49, P1; KUCZMARSKI RJ, 2000, DHHS PUBLICATION; MACKAY AP, 2000, DHHS PUBLICATION; Mazurier E, 1999, PEDIATR RES, V45, p250A, DOI 10.1203/00006450-199904020-01487; MCCORMICK MC, 1992, JAMA-J AM MED ASSOC, V267, P2204, DOI 10.1001/jama.267.16.2204; Moss N, 1997, AM J PUBLIC HEALTH, V87, P1411, DOI 10.2105/AJPH.87.9.1411; Piecuch RE, 1998, CLIN PEDIATR, V37, P537, DOI 10.1177/000992289803700903; Saigal S, 2000, PEDIATRICS, V105, P325, DOI 10.1542/peds.105.2.325; Saigal S, 2000, Semin Neonatol, V5, P107, DOI 10.1053/siny.1999.0003; Sattler J., 1992, ASSESSMENT CHILDREN; Simantov E, 2000, ARCH PEDIAT ADOL MED, V154, P1025, DOI 10.1001/archpedi.154.10.1025; STARFIELD B, 1995, MED CARE, V33, P553, DOI 10.1097/00005650-199505000-00008; *US C, 1987, OTA PUBL; VERLOOVEVANHORICK SP, 1994, PEDIATRICS, V93, P576; Vohr BR, 2000, PEDIATRICS, V105, P1216, DOI 10.1542/peds.105.6.1216; Wechsler D., 1981, WAIS R MANUAL WECHSL; WOLKE D, 1995, LANCET, V345, P447, DOI 10.1016/S0140-6736(95)90425-5; Woodcock R. W., 1989, WJ R TESTS ACHIEVEME; Xu BZ, 1998, EPIDEMIOLOGY, V9, P662, DOI 10.1097/00001648-199811000-00017; 1994, MMWR MORB MORTAL WKL, V43, P231	45	776	793	1	60	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2002	346	3					149	157		10.1056/NEJMoa010856	http://dx.doi.org/10.1056/NEJMoa010856			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	511NZ	11796848				2022-12-24	WOS:000173273600002
J	Jaswal, SS; Sohl, JL; Davis, JH; Agard, DA				Jaswal, SS; Sohl, JL; Davis, JH; Agard, DA			Energetic landscape of alpha-lytic protease optimizes longevity through kinetic stability	NATURE			English	Article							ENGINEERING SUBSTRATE-SPECIFICITY; LINEAR EXTRAPOLATION METHOD; HYDROGEN-EXCHANGE; INFLUENZA HEMAGGLUTININ; CONFORMATIONS; CORE	During the evolution of proteins the pressure to optimize biological activity is moderated by a need for efficient folding. For most proteins, this is accomplished through spontaneous folding to a thermodynamically stable and active native state. However, in the extracellular bacterial alpha-lytic protease (alphaLP) these two processes have become decoupled. The native state of alphaLP is thermodynamically unstable, and when denatured, requires millennia (t(1/2), similar to 1,800 years)(1) to refold. Folding is made possible by an attached folding catalyst, the pro-region, which is degraded on completion of folding, leaving alphaLP trapped in its native state by a large kinetic unfolding barrier (t(1/2) similar to1.2 years)(1). alphaLP faces two very different folding landscapes: one in the presence of the pro-region controlling folding, and one in its absence restricting unfolding. Here we demonstrate that this separation of folding and unfolding pathways has removed constraints placed on the folding of thermodynamically stable proteins, and allowed the evolution of a native state having markedly reduced dynamic fluctuations. This, in turn, has led to a significant extension of the functional lifetime of alphaLP by the optimal suppression of proteolytic sensitivity.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Agard, DA (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.							BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Baker D, 1993, CURR OPIN CELL BIOL, V5, P966, DOI 10.1016/0955-0674(93)90078-5; BOLEN DW, 1988, BIOCHEMISTRY-US, V27, P8069, DOI 10.1021/bi00421a015; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Chamberlain AK, 1997, STRUCTURE, V5, P859, DOI 10.1016/S0969-2126(97)00240-2; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Englander SW, 1996, CURR OPIN STRUC BIOL, V6, P18, DOI 10.1016/S0959-440X(96)80090-X; Halfon S, 1996, J AM CHEM SOC, V118, P1227, DOI 10.1021/ja9533813; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; Huyghues-Despointes BMP, 1999, NAT STRUCT BIOL, V6, P910; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; Lee C, 2000, P NATL ACAD SCI USA, V97, P7727, DOI 10.1073/pnas.97.14.7727; Li RH, 1999, PROTEIN SCI, V8, P1571, DOI 10.1110/ps.8.8.1571; MACE JE, 1995, J MOL BIOL, V254, P720, DOI 10.1006/jmbi.1995.0650; Orosz A, 1996, MOL CELL BIOL, V16, P7018; PERONA JJ, 1995, PROTEIN SCI, V4, P337; RUPLEY JA, 1967, METHOD ENZYMOL, V11, P905; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sohl JL, 1998, NATURE, V395, P817, DOI 10.1038/27470; Wang ECW, 1997, PROTEIN ENG, V10, P405, DOI 10.1093/protein/10.4.405; Wang L, 1998, PROTEIN SCI, V7, P2460, DOI 10.1002/pro.5560071124; 1988, J MOL GRAPH, V6, P13; [No title captured]	24	144	146	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2002	415	6869					343	346		10.1038/415343a	http://dx.doi.org/10.1038/415343a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797014				2022-12-24	WOS:000173293500049
J	Motani, R				Motani, R			Scaling effects in caudal fin propulsion and the speed of ichthyosaurs	NATURE			English	Article							DOLPHINS TURSIOPS-TRUNCATUS; LARGE WATER TUNNEL; TUNA SWIMMING PERFORMANCE; POWER OUTPUT; ENERGY-EXPENDITURE; OSCILLATING FOILS; FISH PROPULSION; KINEMATICS; MACKEREL; SIZE	Four unrelated groups of large cruising vertebrates (tunas, whales, lamnid sharks and parvipelvian ichthyosaurs) evolved tuna-shaped (thunniform) body plans(1,2). Stringent physical constraints, imposed by the surrounding fluids, are probably responsible for this example of evolutionary convergence(1,2). Here I present a mathematical model of swimming kinematics and fluid mechanics that specifies and quantifies such constraints, and test the model with empirical data. The test shows quantitatively that morphology, kinematics, and physiology indeed covary tightly in large cruisers. The model enables calculations of optimal cruising speed from external measurements, and also predicts that wide caudal fin spans, typical of thunniform swimmers, are necessary for large cruisers. This finding is contrary to a popular yet rather teleological view that thunniform tails were selected for their high aspect ratios that increased propulsive efrciency(1,2). I also show by calculation that Stenopterygius, a Jurassic ichthyosaur, probably had optimal cruising speeds and basal metabolic rates similar to living tunas.	Royal Ontario Museum, Dept Paleobiol, Toronto, ON M5S 2C6, Canada	Royal Ontario Museum	Motani, R (corresponding author), Royal Ontario Museum, Dept Paleobiol, 100 Queens Pk, Toronto, ON M5S 2C6, Canada.		Motani, Ryosuke/K-2607-2015	Motani, Ryosuke/0000-0001-5022-1053				ALTRINGHAM JD, 1990, J EXP BIOL, V151, P453; ALTRINGHAM JD, 1991, J EXP BIOL, V157, P381; Anderson JM, 1998, J FLUID MECH, V360, P41, DOI 10.1017/S0022112097008392; Arata Jr G. F, 1954, B MAR SCI GULF CARIB, V4, P183; Barrett DS, 1999, J FLUID MECH, V392, P183, DOI 10.1017/S0022112099005455; BLIX AS, 1995, ACTA PHYSIOL SCAND, V153, P61, DOI 10.1111/j.1748-1716.1995.tb09834.x; BLOCK BA, 1992, J EXP BIOL, V166, P267; BOSE N, 1990, P ROY SOC B-BIOL SCI, V242, P163, DOI 10.1098/rspb.1990.0120; BOSE N, 1989, PROC R SOC SER B-BIO, V237, P175, DOI 10.1098/rspb.1989.0043; DEWAR H, 1994, J EXP BIOL, V192, P13; DEWAR H, 1994, J EXP BIOL, V192, P45; Drucker EG, 1996, AM ZOOL, V36, P555; Fish FE, 1998, J EXP BIOL, V201, P2867; FISH FE, 1993, J EXP BIOL, V185, P179; Gibb AC, 1999, J EXP BIOL, V202, P2433; GRAHAM JB, 1990, J EXP BIOL, V151, P175; Hind AT, 1997, J EXP BIOL, V200, P531; HUNTER JR, 1971, FISH BULL NATL OC AT, V69, P253; Martill D.M., 1987, Modern Geology, V11, P265; MASSARE JA, 1988, PALEOBIOLOGY, V14, P187, DOI 10.1017/S009483730001191X; MCGOWAN C, 1991, DINOAURS SPITFIRES S; MOTANI R, UNPUB PALEOBIOLOGY; Nakamura I., 1985, FAO FISH SYNOPSIS, V125, P1; TRIANTAFYLLOU GS, 1993, J FLUID STRUCT, V7, P205, DOI 10.1006/jfls.1993.1012; VIDELER JJ, 1984, J EXP BIOL, V109, P209; Vogel S, 1994, LIFE MOVING FLUIDS; WEBB PW, 1984, J EXP BIOL, V109, P77; WILLIAMS TM, 1993, J EXP BIOL, V179, P31; Wolfgang MJ, 1999, J EXP BIOL, V202, P2303; Yazdi P, 1999, MAR BIOL, V134, P601, DOI 10.1007/s002270050575	30	54	55	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2002	415	6869					309	312		10.1038/415309a	http://dx.doi.org/10.1038/415309a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797005				2022-12-24	WOS:000173293500040
J	Beaudouin, J; Gerlich, D; Daigle, N; Eils, R; Ellenberg, J				Beaudouin, J; Gerlich, D; Daigle, N; Eils, R; Ellenberg, J			Nuclear envelope breakdown proceeds by microtubule-induced tearing of the lamina	CELL			English	Article							CYTOPLASMIC DYNEIN; FUNCTIONAL-ORGANIZATION; ENDOPLASMIC-RETICULUM; PHOSPHORYLATION SITES; MEMBRANE-PROTEIN; SEA-URCHIN; MITOSIS; CELL; INTERPHASE; DYNAMICS	The mechanism of nuclear envelope breakdown (NEBD) was investigated in live cells. Early spindle microtubules caused folds and invaginations in the NE up to one hour prior to NEBD, creating mechanical tension in the nuclear lamina. The first gap in the NE appeared before lamin B depolymerization, at the site of maximal tension, by a tearing mechanism. Gap formation relaxed this tension and dramatically accelerated the rate of chromosome condensation. The hole produced in the NE then rapidly expanded over the nuclear surface. NE fragments remaining on chromosomes were removed toward the centrosomes in a microtubule-dependent manner, suggesting a mechanism mediated by a minus-end-directed motor.	European Mol Biol Lab, Gene Express Programme, D-69117 Heidelberg, Germany; European Mol Biol Lab, Cell Biol Biophys Programme, D-69117 Heidelberg, Germany; German Canc Res Ctr, D-69120 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ)	Ellenberg, J (corresponding author), European Mol Biol Lab, Gene Express Programme, D-69117 Heidelberg, Germany.	jan.ellenberg@embl-heidelberg.de	Ellenberg, Jan/I-4688-2014; Eils, Roland/B-6121-2009; Gerlich, Daniel Wolfram W/A-6991-2016	Ellenberg, Jan/0000-0001-5909-701X; Eils, Roland/0000-0002-0034-4036; Gerlich, Daniel Wolfram W/0000-0003-1637-3365				Alberts B., 1994, MOL BIOL CELL; BAJER A, 1969, CHROMOSOMA, V27, P448, DOI 10.1007/BF00325682; Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081; Buendia B, 1997, EXP CELL RES, V230, P133, DOI 10.1006/excr.1996.3395; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; COURVALIN JC, 1992, J BIOL CHEM, V267, P19035; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; Drummond S, 1999, J CELL BIOL, V144, P225, DOI 10.1083/jcb.144.2.225; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; Ellenberg J, 1999, METHODS, V19, P362, DOI 10.1006/meth.1999.0872; ELLENBERG J, 1997, CELLS LAB MANUAL; Favreau C, 1996, BIOCHEMISTRY-US, V35, P8035, DOI 10.1021/bi9600660; FEY EG, 1984, J CELL BIOL, V98, P1973, DOI 10.1083/jcb.98.6.1973; FOLSNER R, 1993, CELL, V73, P1267; FURUKAWA K, 1995, EMBO J, V14, P1626, DOI 10.1002/j.1460-2075.1995.tb07151.x; Georgatos SD, 1997, J CELL SCI, V110, P2129; GERACE L, 1980, CELL, V19, P277, DOI 10.1016/0092-8674(80)90409-2; GERACE L, 1988, ANNU REV CELL BIOL, V4, P335, DOI 10.1146/annurev.cb.04.110188.002003; Gerlich D, 2001, NAT CELL BIOL, V3, P852, DOI 10.1038/ncb0901-852; GOLDBERG MW, 1995, CURR OPIN CELL BIOL, V7, P301, DOI 10.1016/0955-0674(95)80083-2; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Gruenbaum Y, 2000, J STRUCT BIOL, V129, P313, DOI 10.1006/jsbi.2000.4216; HAMAGUCHI Y, 1993, BIOIMAGES, V1, P129; HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y; Kiseleva E, 2001, J CELL SCI, V114, P3607; Lee KK, 2000, MOL BIOL CELL, V11, P3089, DOI 10.1091/mbc.11.9.3089; LONGO FJ, 1972, J MORPHOL, V138, P207, DOI 10.1002/jmor.1051380206; Ma S, 1999, J CELL BIOL, V147, P1261, DOI 10.1083/jcb.147.6.1261; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Marshall ICB, 1997, TRENDS CELL BIOL, V7, P69, DOI 10.1016/S0962-8924(96)10047-7; NEWPORT J, 1987, CELL, V48, P219, DOI 10.1016/0092-8674(87)90425-9; PAWELETZ N, 1988, EUR J CELL BIOL, V47, P334; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; PETER M, 1991, EMBO J, V10, P1535, DOI 10.1002/j.1460-2075.1991.tb07673.x; PFALLER R, 1991, CELL, V65, P209, DOI 10.1016/0092-8674(91)90155-R; PLAMANN M, 1994, J CELL BIOL, V127, P139, DOI 10.1083/jcb.127.1.139; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Reinsch S, 1998, J CELL SCI, V111, P2283; ROBBINS E, 1964, J CELL BIOL, V21, P429, DOI 10.1083/jcb.21.3.429; Robinson JT, 1999, J CELL BIOL, V146, P597, DOI 10.1083/jcb.146.3.597; Rolls MM, 1999, J CELL BIOL, V146, P29, DOI 10.1083/jcb.146.1.29; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; Sasagawa S, 1999, EUR J CELL BIOL, V78, P593, DOI 10.1016/S0171-9335(99)80025-9; STICK R, 1988, J CELL BIOL, V107, P397, DOI 10.1083/jcb.107.2.397; Terasaki M, 2000, MOL BIOL CELL, V11, P897, DOI 10.1091/mbc.11.3.897; Terasaki M, 2001, MOL BIOL CELL, V12, P503, DOI 10.1091/mbc.12.2.503; WARD GE, 1990, CELL, V61, P561, DOI 10.1016/0092-8674(90)90469-U; Wilson KL, 2000, TRENDS CELL BIOL, V10, P125, DOI 10.1016/S0962-8924(99)01708-0; Yamamoto A, 1999, J CELL BIOL, V145, P1233, DOI 10.1083/jcb.145.6.1233; Yang L, 1997, J CELL BIOL, V137, P1199, DOI 10.1083/jcb.137.6.1199; YE Q, 1994, J BIOL CHEM, V269, P11306; Zaal KJM, 1999, CELL, V99, P589, DOI 10.1016/S0092-8674(00)81548-2; ZATSEPINA OV, 1977, CYTOBIOLOGIE, V16, P130	54	337	348	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2002	108	1					83	96		10.1016/S0092-8674(01)00627-4	http://dx.doi.org/10.1016/S0092-8674(01)00627-4			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792323	Bronze			2022-12-24	WOS:000173280700010
J	Tahirov, TH; Sato, K; Ichikawa-Iwata, E; Sasaki, M; Inoue-Bungo, T; Shiina, M; Kimura, K; Takata, S; Fujikawa, A; Morii, H; Kumasaka, T; Yamamoto, M; Ishii, S; Ogata, K				Tahirov, TH; Sato, K; Ichikawa-Iwata, E; Sasaki, M; Inoue-Bungo, T; Shiina, M; Kimura, K; Takata, S; Fujikawa, A; Morii, H; Kumasaka, T; Yamamoto, M; Ishii, S; Ogata, K			Mechanism of c-Myb-C/EBP beta cooperation from separated sites on a promoter	CELL			English	Article							DNA-BINDING DOMAIN; V-MYB; TRANSCRIPTIONAL ACTIVATION; MIM-1 GENE; IN-VITRO; SYNERGISTIC ACTIVATION; PROTOONCOGENE PRODUCT; MYELOMONOCYTIC CELLS; ONCOGENE PRODUCT; HYDROPHOBIC CORE	c-Myb, but not avian myeloblastosis virus (AMV) v-Myb, cooperates with C/EBPbeta to regulate transcription of myeloid-specific genes. To assess the structural basis for that difference, we determined the crystal structures of complexes comprised of the c-Myb or AMV v-Myb DNA-binding domain (DBD), the C/EBPbeta DBD, and a promoter DNA fragment. Within the c-Myb complex, a DNA-bound C/EBPbeta interacts with R2 of c-Myb bound to a different DNA fragment; point mutations in v-Myb R2 eliminate such interaction within the v-Myb complex. GST pull-down assays, luciferase trans-activation assays, and atomic force microscopy confirmed that the interaction of c-Myb and C/EBPbeta observed in crystal mimics their long range interaction on the promoter, which is accompanied by intervening DNA looping.	Kanagawa Acad Sci & Technol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; Yokohama City Univ, Sch Med, Dept Biol Struct, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; Yokohama City Univ, Sch Med, Dept Biochem, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; Yokohama City Univ, Sch Med, Dept Pathol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; Yokohama City Univ, Sch Med, Dept Urol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; RIKEN, Tsukuba Inst, Mol Genet Lab, Tsukuba, Ibaraki 3050074, Japan; Japan Sci & Technol Corp, CREST Res Project, Tsukuba, Ibaraki 3050074, Japan; Natl Inst Adv Ind Sci & Technol, Prot Dynam Grp, Cent 6, Tsukuba, Ibaraki 3058566, Japan; RIKEN, Harima Inst, SPring 8, Biocrystallog Technol Div, Sayo, Hyogo 6795148, Japan; RIKEN, Harima Inst, SPring 8, Struct Biophys Lab, Sayo, Hyogo 6795148, Japan	Kanagawa Academy Science & Technology; Yokohama City University; Yokohama City University; Yokohama City University; Yokohama City University; RIKEN; Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST); Japan Synchrotron Radiation Research Institute; RIKEN; Japan Synchrotron Radiation Research Institute; RIKEN	Tahirov, TH (corresponding author), Kanagawa Acad Sci & Technol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.		Kumasaka, Takashi/D-7428-2018; Yamamoto, Masaki/B-7844-2015; Ishii, Shunsuke/A-5271-2016	Kumasaka, Takashi/0000-0001-9289-1557; Yamamoto, Masaki/0000-0002-1311-1768; Ishii, Shunsuke/0000-0002-6530-2478; Tahirov, Tahir/0000-0002-1238-0069; Watanabe, Shioka/0000-0003-2411-1891				BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; Brendeford EM, 1998, FEBS LETT, V425, P52, DOI 10.1016/S0014-5793(98)00196-3; Brendeford EM, 1997, J BIOL CHEM, V272, P4436, DOI 10.1074/jbc.272.7.4436; BRISTOSBRAY M, 1997, MOL CELL BIOL, V17, P5127; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURK O, 1993, EMBO J, V12, P2027, DOI 10.1002/j.1460-2075.1993.tb05852.x; Burk O, 1997, EMBO J, V16, P1371, DOI 10.1093/emboj/16.6.1371; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Dai P, 1996, GENE DEV, V10, P528, DOI 10.1101/gad.10.5.528; DINI PW, 1993, MOL CELL BIOL, V13, P7334, DOI 10.1128/MCB.13.12.7334; DUDEK H, 1992, P NATL ACAD SCI USA, V89, P1291, DOI 10.1073/pnas.89.4.1291; Fong IC, 2000, MOL IMMUNOL, V37, P391, DOI 10.1016/S0161-5890(00)00056-0; FRIEDMAN AM, 1995, SCIENCE, V268, P1721, DOI 10.1126/science.7792597; Ganter B, 1999, FEBS LETT, V460, P401, DOI 10.1016/S0014-5793(99)01373-3; Ganter B, 1998, EMBO J, V17, P255, DOI 10.1093/emboj/17.1.255; HERNANDEZMUNAIN C, 1994, MOL CELL BIOL, V14, P473, DOI 10.1128/MCB.14.1.473; HOWE KM, 1991, NUCLEIC ACIDS RES, V19, P3913, DOI 10.1093/nar/19.14.3913; INTRONA M, 1990, CELL, V63, P1287, DOI 10.1016/0092-8674(90)90424-D; Janin J, 1997, NAT STRUCT BIOL, V4, P973, DOI 10.1038/nsb1297-973; KaneiIshii C, 1997, SCIENCE, V277, P246, DOI 10.1126/science.277.5323.246; KANEIISHII C, 1990, J BIOL CHEM, V265, P19990; KLEMPNAUER KH, 1993, ONCOGENE, V8, P111; KowenzLeutz E, 1997, CELL, V91, P185, DOI 10.1016/S0092-8674(00)80401-8; Lipsick JS, 1999, ONCOGENE, V18, P3047, DOI 10.1038/sj.onc.1202745; Lutz PG, 2001, BLOOD, V97, P2449, DOI 10.1182/blood.V97.8.2449; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; Mink S, 1996, MOL CELL BIOL, V16, P1316; Morii H, 1999, J MOL BIOL, V292, P909, DOI 10.1006/jmbi.1999.3099; NAKAGOSHI H, 1990, J BIOL CHEM, V265, P3479; NESS SA, 1993, GENE DEV, V7, P749, DOI 10.1101/gad.7.5.749; NESS SA, 1989, CELL, V59, P1115, DOI 10.1016/0092-8674(89)90767-8; Ness SA, 1999, ONCOGENE, V18, P3039, DOI 10.1038/sj.onc.1202726; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Oda M, 1997, PROTEIN ENG, V10, P1407, DOI 10.1093/protein/10.12.1407; OELGESCHLAGER M, 1996, EMBO J, V15, P277; OGATA K, 1995, NAT STRUCT BIOL, V2, P309, DOI 10.1038/nsb0495-309; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Ogata K, 1996, NAT STRUCT BIOL, V3, P178, DOI 10.1038/nsb0296-178; OGATA K, 1992, P NATL ACAD SCI USA, V89, P6428, DOI 10.1073/pnas.89.14.6428; Ording E, 1996, ONCOGENE, V13, P1043; ORDING E, 1994, EUR J BIOCHEM, V222, P113, DOI 10.1111/j.1432-1033.1994.tb18848.x; SAKURA H, 1989, P NATL ACAD SCI USA, V86, P5758, DOI 10.1073/pnas.86.15.5758; Sasaki M, 2000, J BIOCHEM-TOKYO, V127, P945, DOI 10.1093/oxfordjournals.jbchem.a022710; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(01)00271-9; Tahirov TH, 2001, ACTA CRYSTALLOGR D, V57, P1655, DOI 10.1107/S0907444901011982; TANIKAWA J, 1993, P NATL ACAD SCI USA, V90, P9320, DOI 10.1073/pnas.90.20.9320; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; Verbeek W, 1999, BLOOD, V93, P3327, DOI 10.1182/blood.V93.10.3327; WESTON K, 1992, NUCLEIC ACIDS RES, V20, P3043, DOI 10.1093/nar/20.12.3043; WESTON K, 1989, CELL, V58, P85, DOI 10.1016/0092-8674(89)90405-4; Wolberger C, 1998, CURR OPIN GENET DEV, V8, P552, DOI 10.1016/S0959-437X(98)80010-5; Yamamoto M, 1998, J SYNCHROTRON RADIAT, V5, P222, DOI 10.1107/S0909049597014738; Zhang XH, 1997, J BIOL CHEM, V272, P29272, DOI 10.1074/jbc.272.46.29272	54	132	138	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 11	2002	108	1					57	70		10.1016/S0092-8674(01)00636-5	http://dx.doi.org/10.1016/S0092-8674(01)00636-5			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792321	Bronze			2022-12-24	WOS:000173280700008
J	Martin, SJ; Beekman, M; Wossler, TC; Ratnieks, FLW				Martin, SJ; Beekman, M; Wossler, TC; Ratnieks, FLW			Parasitic Cape honeybee workers, Apis mellifera capensis, evade policing	NATURE			English	Article							BEE; REMOVAL	Relocation of the Cape honeybee, Apis mellifera capensis, by bee-keepers from southern to northern South Africa in 1990 has caused widespread death of managed African honeybee, A. m. scutellata, colonies(1). Apis mellifera capensis worker bees are able to lay diploid, female eggs without mating by means of automictic thelytoky(2) (meiosis followed by fusion of two meiotic products to restore egg diploidy), whereas workers of other honeybee subspecies are able to lay only haploid, male eggs. The A. m. capensis workers, which are parasitizing and killing A. m. scutellata colonies in northern South Africa, are the asexual offspring of a single, original worker in which the small amount of genetic variation observed is due to crossing over during meiosis(3) (P. Kryger, personal communication). Here we elucidate two principal mechanisms underlying this parasitism. Parasitic A. m. capensis workers activate their ovaries in host colonies that have a queen present (queenright colonies), and they lay eggs that evade being killed by other workers (worker policing)-the normal fate of worker-laid eggs in colonies with a queen(4-8). This unique parasitism by workers is an instance in which a society is unable to control the selfish actions of its members.	Univ Sheffield, Dept Anim & Plant Sci, Lab Apiculture & Social Insects, Sheffield S10 2TN, S Yorkshire, England; Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa	University of Sheffield; University of Pretoria	Ratnieks, FLW (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Lab Apiculture & Social Insects, Sheffield S10 2TN, S Yorkshire, England.	F.Ratnieks@Shefreld.ac.uk	Beekman, Madeleine/A-3983-2011; Beekman, Madeleine/AAF-8574-2019; martin, stephen/B-5254-2009	Beekman, Madeleine/0000-0002-9040-3756; Beekman, Madeleine/0000-0002-9040-3756; Wossler, Theresa/0000-0003-3725-6133				ALLSOPP MH, 1993, AM BEE J, V133, P121; Barron AB, 2001, BEHAV ECOL SOCIOBIOL, V50, P199, DOI 10.1007/s002650100362; BEEKMAN M, UNPUB INSECTES SOCIA; Downs SG, 2001, BEHAV ECOL, V12, P47, DOI 10.1093/oxfordjournals.beheco.a000377; Downs SG, 2000, BEHAV ECOL, V11, P326, DOI 10.1093/beheco/11.3.326; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; KRYGER P, 2001, P 13 ENT C S AFR, P38; MARTIN S, IN PRESS APIDOLOGIE; Neumann P, 2000, APIDOLOGIE, V31, P67, DOI 10.1051/apido:2000107; Nunney L, 1999, MG BEH ECOL, P238; Oldroyd BP, 2000, BEHAV ECOL SOCIOBIOL, V47, P268, DOI 10.1007/s002650050665; OLDROYD BP, 1994, NATURE, V371, P749, DOI 10.1038/371749a0; RATNIEKS FLW, 1988, AM NAT, V132, P217, DOI 10.1086/284846; RATNIEKS FLW, 1993, BEHAV ECOL SOCIOBIOL, V32, P191, DOI 10.1007/BF00173777; RATNIEKS FLW, 1995, J APICULT RES, V34, P31, DOI 10.1080/00218839.1995.11100883; RATNIEKS FLW, 1989, NATURE, V342, P796, DOI 10.1038/342796a0; VERMA S, 1983, APIDOLOGIE, V14, P41, DOI 10.1051/apido:19830104; Visscher PK, 1996, BEHAV ECOL SOCIOBIOL, V39, P237, DOI 10.1007/s002650050286	18	101	107	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2002	415	6868					163	165		10.1038/415163a	http://dx.doi.org/10.1038/415163a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805832	Green Accepted			2022-12-24	WOS:000173159300039
J	Crutzen, PJ				Crutzen, PJ			Geology of mankind	NATURE			English	Editorial Material									Max Planck Inst Chem, D-55020 Mainz, Germany; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	Max Planck Society; University of California System; University of California San Diego; Scripps Institution of Oceanography	Crutzen, PJ (corresponding author), Max Planck Inst Chem, POB 3060, D-55020 Mainz, Germany.		Quinn, Patrick/B-5489-2010; Crutzen, Paul J/F-6044-2012					Berger A, 1996, CR ACAD SCI II A, V323, P1; CLARK WC, 1986, SUSTAINABLE DEV BIOS, pCH1; Crutzen P. J, 2000, IGBP NEWSLETTER, V41; Houghton J. T., 2001, CLIMATE CHANGE 2001; Marsh G.P., 1864, MAN NATURE; McNeill John R, 2000, FACE NATURAL HIST; Schellnhuber HJ, 1999, NATURE, V402, pC19, DOI 10.1038/35011515; Turner B., 1990, EARTH TRANSFORMED HU; VERNADSKI VI, 1998, BIOSPHERE	9	2198	2290	34	624	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					23	23		10.1038/415023a	http://dx.doi.org/10.1038/415023a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780095	Bronze			2022-12-24	WOS:000173028800020
J	Hoang, C; Ferre-D'Amare, AR				Hoang, C; Ferre-D'Amare, AR			Cocrystal structure of a tRNA Psi 55 pseudouridine synthase: Nucleotide flipping by an RNA-modifying enzyme	CELL			English	Article							CRYSTAL-STRUCTURE; DYSKERATOSIS-CONGENITA; ESCHERICHIA-COLI; RESOLUTION; PROTEINS; BASE; RECOGNITION; SYNTHETASE; TRNA(PHE); MUTATIONS	Pseudouridine (Psi) synthases catalyze the isomerization of specific uridines in cellular RNAs to pseudouridines and may function as RNA chaperones. TruB is responsible for the Psi residue present in the T loops of virtually all tRNAs. The close homolog Cbf5/dyskerin is the catalytic subunit of box H/ACA snoRNPs. These carry out the pseudouridylation of eukaryotic rRNA and snRNAs. The 1.85 Angstrom resolution structure of TruB bound to RNA reveals that this enzyme recognizes the preformed three-dimensional structure of the T loop, primarily through shape complementarity. It accesses its substrate uridyl residue by flipping out the nucleotide and disrupts the tertiary structure of tRNA. Structural comparisons with TruB demonstrate that all Psi synthases are descended from a common molecular ancestor.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Ferre-D'Amare, AR (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	aferre@fhcrc.org			NCRR NIH HHS [RR 15943] Funding Source: Medline; NIGMS NIH HHS [GM 63576] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063576] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Becker HF, 1997, J MOL BIOL, V274, P505, DOI 10.1006/jmbi.1997.1417; Becker HF, 1997, NUCLEIC ACIDS RES, V25, P4493, DOI 10.1093/nar/25.22.4493; BENESCH RE, 1953, SCIENCE, V118, P447, DOI 10.1126/science.118.3068.447; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; CUSACK S, 1998, MANY FACES RNA, P55; Dinner AR, 2001, NATURE, V413, P752, DOI 10.1038/35099587; Dirheimer G., 1995, P93; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Foster PG, 2000, NAT STRUCT BIOL, V7, P23; Freeland SJ, 1999, SCIENCE, V286, P690, DOI 10.1126/science.286.5440.690; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Goldgur Y, 1997, STRUCTURE, V5, P59, DOI 10.1016/S0969-2126(97)00166-4; Grosjean H, 1996, J MOL BIOL, V255, P67, DOI 10.1006/jmbi.1996.0007; Gu XR, 1999, P NATL ACAD SCI USA, V96, P14270, DOI 10.1073/pnas.96.25.14270; Gu XR, 1998, BIOCHEMISTRY-US, V37, P339, DOI 10.1021/bi971590p; Gustafsson C, 1996, NUCLEIC ACIDS RES, V24, P3756, DOI 10.1093/nar/24.19.3756; Gutgsell N, 2000, RNA, V6, P1870, DOI 10.1017/S1355838200001588; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huang LX, 1998, BIOCHEMISTRY-US, V37, P344, DOI 10.1021/bi971874+; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIM JL, 1994, NAT STRUCT BIOL, V1, P638, DOI 10.1038/nsb0994-638; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Koonin EV, 1996, NUCLEIC ACIDS RES, V24, P2411, DOI 10.1093/nar/24.12.2411; Koshlap KM, 1999, BIOCHEMISTRY-US, V38, P8647, DOI 10.1021/bi990118w; MAIZELS N, 1993, RNA WORLD, P577; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; NISHIKURA K, 1981, J MOL BIOL, V145, P405, DOI 10.1016/0022-2836(81)90212-6; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; NURSE K, 1995, RNA, V1, P102; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Roberts RJ, 1998, ANNU REV BIOCHEM, V67, P181, DOI 10.1146/annurev.biochem.67.1.181; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; Rupert PB, 2001, NATURE, V410, P780, DOI 10.1038/35071009; SAMUELSSON T, 1991, NUCLEIC ACIDS RES, V19, P6139, DOI 10.1093/nar/19.22.6139; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; VIDHYASHANKAR R, 1999, J BIOL CHEM, V274, P22225; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Watanabe Y, 2000, NUCLEIC ACIDS RES, V28, P2342, DOI 10.1093/nar/28.12.2342; Yang XJ, 2001, NAT STRUCT BIOL, V8, P968, DOI 10.1038/nsb1101-968; Yu YT, 1998, EMBO J, V17, P5783, DOI 10.1093/emboj/17.19.5783; Zebarjadian Y, 1999, MOL CELL BIOL, V19, P7461	48	228	233	3	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2001	107	7					929	939		10.1016/S0092-8674(01)00618-3	http://dx.doi.org/10.1016/S0092-8674(01)00618-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779468	Bronze			2022-12-24	WOS:000173024200013
J	Deloukas, P; Matthews, LH; Ashurst, J; Burton, J; Gilbert, JGR; Jones, M; Stavrides, G; Almeida, JP; Babbage, AK; Bagguley, CL; Bailey, J; Barlow, KF; Bates, KN; Beard, LM; Beare, DM; Beasley, OP; Bird, CP; Blakey, SE; Bridgeman, AM; Brown, AJ; Buck, D; Burrill, W; Butler, AP; Carder, C; Carter, NP; Chapman, JC; Clamp, M; Clark, G; Clark, LN; Clark, SY; Clee, CM; Clegg, S; Cobley, VE; Collier, RE; Connor, R; Corby, NR; Coulson, A; Coville, GJ; Deadman, R; Dhami, P; Dunn, M; Ellington, AG; Frankland, JA; Fraser, A; French, L; Garner, P; Grafham, DV; Griffiths, C; Griffiths, ND; Gwilliam, R; Hall, RE; Hammond, S; Harley, JL; Heath, PD; Ho, S; Holden, JL; Howden, PJ; Huckle, E; Hunt, AR; Hunt, SE; Jekosch, K; Johnson, CM; Johnson, D; Kay, MP; Kimberley, AM; King, A; Knights, A; Laird, GK; Lawlor, S; Lehvaslaiho, MH; Leversha, M; Lloyd, C; Lloyd, DM; Lovell, JD; Marsh, VL; Martin, SL; McConnachie, LJ; McLay, K; McMurray, AA; Milne, S; Mistry, D; Moore, MJF; Mullikin, JC; Nickerson, T; Oliver, K; Parker, A; Patel, R; Pearce, TAV; Peck, AI; Phillimore, BJCT; Prathalingam, SR; Plumb, RW; Ramsay, H; Rice, CM; Ross, MT; Scott, CE; Sehra, HK; Shownkeen, R; Sims, S; Skuce, CD; Smith, ML; Soderlund, C; Steward, CA; Sulston, JE; Swann, M; Sycamore, N; Taylor, R; Tee, L; Thomas, DW; Thorpe, A; Tracey, A; Tromans, AC; Vaudin, M; Wall, M; Wallis, JM; Whitehead, SL; Whittaker, P; Willey, DL; Williams, L; Williams, SA; Wilming, L; Wray, PW; Hubbard, T; Durbin, RM; Bentley, DR; Beck, S; Rogers, J				Deloukas, P; Matthews, LH; Ashurst, J; Burton, J; Gilbert, JGR; Jones, M; Stavrides, G; Almeida, JP; Babbage, AK; Bagguley, CL; Bailey, J; Barlow, KF; Bates, KN; Beard, LM; Beare, DM; Beasley, OP; Bird, CP; Blakey, SE; Bridgeman, AM; Brown, AJ; Buck, D; Burrill, W; Butler, AP; Carder, C; Carter, NP; Chapman, JC; Clamp, M; Clark, G; Clark, LN; Clark, SY; Clee, CM; Clegg, S; Cobley, VE; Collier, RE; Connor, R; Corby, NR; Coulson, A; Coville, GJ; Deadman, R; Dhami, P; Dunn, M; Ellington, AG; Frankland, JA; Fraser, A; French, L; Garner, P; Grafham, DV; Griffiths, C; Griffiths, ND; Gwilliam, R; Hall, RE; Hammond, S; Harley, JL; Heath, PD; Ho, S; Holden, JL; Howden, PJ; Huckle, E; Hunt, AR; Hunt, SE; Jekosch, K; Johnson, CM; Johnson, D; Kay, MP; Kimberley, AM; King, A; Knights, A; Laird, GK; Lawlor, S; Lehvaslaiho, MH; Leversha, M; Lloyd, C; Lloyd, DM; Lovell, JD; Marsh, VL; Martin, SL; McConnachie, LJ; McLay, K; McMurray, AA; Milne, S; Mistry, D; Moore, MJF; Mullikin, JC; Nickerson, T; Oliver, K; Parker, A; Patel, R; Pearce, TAV; Peck, AI; Phillimore, BJCT; Prathalingam, SR; Plumb, RW; Ramsay, H; Rice, CM; Ross, MT; Scott, CE; Sehra, HK; Shownkeen, R; Sims, S; Skuce, CD; Smith, ML; Soderlund, C; Steward, CA; Sulston, JE; Swann, M; Sycamore, N; Taylor, R; Tee, L; Thomas, DW; Thorpe, A; Tracey, A; Tromans, AC; Vaudin, M; Wall, M; Wallis, JM; Whitehead, SL; Whittaker, P; Willey, DL; Williams, L; Williams, SA; Wilming, L; Wray, PW; Hubbard, T; Durbin, RM; Bentley, DR; Beck, S; Rogers, J			The DNA sequence and comparative analysis of human chromosome 20	NATURE			English	Article							COMMON DELETED REGION; HUMAN-GENOME; PHYSICAL MAPS; GENE; CHROMOSOME-20; IDENTIFICATION; PROGRAM; NUMBER; LOCUS; MOUSE	The finished sequence of human chromosome 20 comprises 59,187,298 base pairs (bp) and represents 99.4% of the euchromatic DNA. A single contig of 26 megabases (Mb) spans the entire short arm, and five contigs separated by gaps totalling 320 kb span the long arm of this metacentric chromosome. An additional 234,339 bp of sequence has been determined within the pericentromeric region of the long arm. We annotated 727 genes and 168 pseudogenes in the sequence. About 64% of these genes have a 59 and a 39 untranslated region and a complete open reading frame. Comparative analysis of the sequence of chromosome 20 to whole-genome shotgun-sequence data of two other vertebrates, the mouse Mus musculus and the puffer fish Tetraodon nigroviridis, provides an independent measure of the efficiency of gene annotation, and indicates that this analysis may account for more than 95% of all coding exons and almost all genes.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Wellcome Trust Sanger Institute	Deloukas, P (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	panos@sanger.ac.uk	Durbin, Richard/AAE-7178-2019; Deloukas, Panos/B-2922-2013; Hubbard, Tim J/C-2567-2008; Hubbard, Tim J.P./AAT-4571-2020; Johnson, David/A-3907-2011	Durbin, Richard/0000-0002-9130-1006; Deloukas, Panos/0000-0001-9251-070X; Hubbard, Tim J/0000-0002-1767-9318; Hubbard, Tim J.P./0000-0002-1767-9318; Johnson, David/0000-0003-0887-3343; Howe, Kerstin/0000-0003-2237-513X; Fosker, Christine/0000-0002-3799-9474; Kay, Mike/0000-0002-3282-0834; Davidson, Claire/0000-0002-4910-8202; Hunt, Adrienne/0000-0002-1227-0310; Steward, Charles/0000-0001-8829-5349; Gilbert, James/0000-0001-8079-3159; Wilming, Laurens/0000-0002-4154-7358; Martin, Sancha/0000-0001-6213-5259; Hunt, Sarah/0000-0002-8350-1235				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Bench AJ, 2000, ONCOGENE, V19, P3902, DOI 10.1038/sj.onc.1203728; Bench AJ, 1998, GENOMICS, V49, P351, DOI 10.1006/geno.1998.5231; Bentley DR, 2001, NATURE, V409, P942, DOI 10.1038/35057165; Berry R, 2000, AM J HUM GENET, V67, P82, DOI 10.1086/302994; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Brett D, 2000, FEBS LETT, V474, P83, DOI 10.1016/S0014-5793(00)01581-7; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; CHUTE I, 1997, GENOMICS, V41, P51; Collins C, 2001, GENOME RES, V11, P1034, DOI 10.1101/gr.GR1743R; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Felsenfeld A, 1999, GENOME RES, V9, P1; Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Hayward BE, 2000, HUM MOL GENET, V9, P835, DOI 10.1093/hmg/9.5.835; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; McMurray AA, 1998, GENOME RES, V8, P562, DOI 10.1101/gr.8.5.562; MORTON NE, 1991, P NATL ACAD SCI USA, V88, P7474, DOI 10.1073/pnas.88.17.7474; Mott R, 1997, COMPUT APPL BIOSCI, V13, P477; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Riethman HC, 2001, NATURE, V409, P948, DOI 10.1038/35057180; Rigaud G, 2001, CANCER RES, V61, P285; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; Rosenblum BB, 1997, NUCLEIC ACIDS RES, V25, P4500, DOI 10.1093/nar/25.22.4500; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Stone DL, 2000, NAT GENET, V25, P79, DOI 10.1038/75637; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185; Zheng SL, 2001, HUM GENET, V108, P430, DOI 10.1007/s004390100513; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	38	166	736	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2001	414	6866					865	U3		10.1038/414865a	http://dx.doi.org/10.1038/414865a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780052	Bronze			2022-12-24	WOS:000172813300035
J	Lee, SH; Fu, KK; Hui, JN; Richman, JM				Lee, SH; Fu, KK; Hui, JN; Richman, JM			Noggin and retinoic acid transform the identity of avian facial prominences	NATURE			English	Article							EPITHELIAL-MESENCHYMAL INTERACTIONS; BONE MORPHOGENETIC PROTEIN-4; NEURAL CREST; CHICK-EMBRYOS; LIMB BUDS; SONIC HEDGEHOG; EXPRESSION; PRIMORDIA; OUTGROWTH; BMP-4	The signals that determine body part identity in vertebrate embryos are largely unknown, with some exceptions such as those for teeth and digits(1,2). The vertebrate face is derived from small buds of tissue, facial prominences, that surround the embryonic oral cavity(3). In chicken embryos, the skeleton of the upper beak is derived from the frontonasal mass and maxillary prominences(4). Here we show that bone morphogenetic proteins (Bmps) and the vitamin A derivative, retinoic acid (RA), are used to specify the identity of the frontonasal mass and maxillary prominences. Implanting two beads adjacent to the stage-15 presumptive maxillary field, one soaked in the Bmp antagonist Noggin(5) and one soaked in RA, induces a duplicate set of frontonasal mass skeletal elements in place of maxillary bones. We also show that the duplicated beak is due to transformation of the maxillary prominence into a second frontonasal mass and not due to ectopic migration of cells or splitting of the normal frontonasal mass. Thus the levels of Bmp and RA determine whether specific regions of the face form maxillary or frontonasal mass derivatives.	Univ British Columbia, Fac Dent, Dept Oral Hlth Sci, Vancouver, BC V6T 1Z3, Canada; Gyeongsang Natl Univ, Coll Med, Dept Dent, Chinju, South Korea	University of British Columbia; Gyeongsang National University	Richman, JM (corresponding author), Univ British Columbia, Fac Dent, Dept Oral Hlth Sci, Vancouver, BC V6T 1Z3, Canada.		Richman, Joy M./C-3111-2018; Richman, Joy/AAD-9445-2020	Richman, Joy M./0000-0002-1409-8163; Richman, Joy/0000-0002-1409-8163; /0000-0002-9438-2489				Barlow AJ, 1999, DEV DYNAM, V214, P291, DOI 10.1002/(SICI)1097-0177(199904)214:4<291::AID-AJA2>3.0.CO;2-E; Barlow AJ, 1997, DEVELOPMENT, V124, P391; BROWN JM, 1993, DEVELOPMENT, V119, P41; Couly G, 1998, DEVELOPMENT, V125, P3445; Drossopoulou G, 2000, DEVELOPMENT, V127, P1337; EICHELE G, 1984, ANAL BIOCHEM, V142, P542, DOI 10.1016/0003-2697(84)90504-9; FALLON JF, 1994, SCIENCE, V264, P104, DOI 10.1126/science.7908145; FRANCISWEST PH, 1994, DEV DYNAM, V201, P168, DOI 10.1002/aja.1002010207; Haeckel E., 1886, EVOLUTION MAN POPULA; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hu D, 1999, DEVELOPMENT, V126, P4873; LELIEVRE CS, 1978, J EMBRYOL EXP MORPH, V47, P17; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; MINA M, 1987, ARCH ORAL BIOL, V32, P123, DOI 10.1016/0003-9969(87)90055-0; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; RICHMAN JM, 1992, DEV BIOL, V154, P299, DOI 10.1016/0012-1606(92)90069-S; RICHMAN JM, 1989, DEV BIOL, V136, P201, DOI 10.1016/0012-1606(89)90142-5; Rodriguez-Esteban C, 1999, NATURE, V398, P814, DOI 10.1038/19769; Schneider RA, 2001, DEVELOPMENT, V128, P2755; Shen H, 1997, DEV BIOL, V188, P248, DOI 10.1006/dbio.1997.8617; Shigetani Y, 2000, DEV BIOL, V228, P73, DOI 10.1006/dbio.2000.9932; Takeuchi JK, 1999, NATURE, V398, P810, DOI 10.1038/19762; Tucker AS, 1998, SCIENCE, V282, P1136, DOI 10.1126/science.282.5391.1136; WALL NA, 1995, MECH DEVELOP, V53, P383, DOI 10.1016/0925-4773(95)00453-X; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	26	98	101	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					909	912		10.1038/414909a	http://dx.doi.org/10.1038/414909a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780063				2022-12-24	WOS:000172813300046
J	Ohta, A; Sitkovsky, M				Ohta, A; Sitkovsky, M			Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage	NATURE			English	Article							T-CELL-ACTIVATION; RELEASE; MECHANISMS; INHIBITOR; ARTHRITIS	Inappropriate or prolonged inflammation is the main cause of many diseases(1); for this reason it is important to understand the physiological mechanisms that terminate inflammation in vivo(2). Agonists for several G(s)-protein-coupled receptors(3), including cell-surface adenosine purinergic receptors(4-7), can increase levels of immunosuppressive cyclic AMP in immune cells(8-15); however, it was unknown whether any of these receptors regulates inflammation in vivo. Here we show that A2a adenosine receptors have a non-redundant role in the attenuation of inflammation and tissue damage in vivo. Sub-threshold doses of an inflammatory stimulus(16,17) that caused minimal tissue damage in wild-type mice were sufficient to induce extensive tissue damage, more prolonged and higher levels of pro-inflammatory cytokines, and death of male animals deficient in the A2a adenosine receptor. Similar observations were made in studies of three different models of inflammation and liver damage as well as during bacterial endotoxin-induced septic shock. We suggest that A2a adenosine receptors are a critical part of the physiological negative feedback mechanism for limitation and termination of both tissue-specific and systemic inflammatory responses.	NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sitkovsky, M (corresponding author), NIAID, Immunol Lab, NIH, 10 Ctr Dr,Room 10-11N311, Bethesda, MD 20892 USA.	mvsitkov@helix.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000626] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Apasov SG, 2000, BRIT J PHARMACOL, V131, P43, DOI 10.1038/sj.bjp.0703532; Armstrong JM, 2001, BIOCHEM J, V354, P123, DOI 10.1042/0264-6021:3540123; Burnstock G, 2001, TRENDS PHARMACOL SCI, V22, P182, DOI 10.1016/S0165-6147(00)01643-6; Cheng P, 1999, J POROUS MEDIA, V2, P19, DOI 10.1615/JPorMedia.v2.i1.20; CRONSTEIN BN, 1995, J INVEST MED, V43, P50; CRONSTEIN BN, 1994, J APPL PHYSIOL, V76, P5, DOI 10.1152/jappl.1994.76.1.5; Eigler A, 1997, SCAND J IMMUNOL, V45, P132, DOI 10.1046/j.1365-3083.1997.d01-377.x; FILIPPINI A, 1990, P NATL ACAD SCI USA, V87, P8267, DOI 10.1073/pnas.87.21.8267; FIRESTEIN GS, 1994, J IMMUNOL, V152, P5853; Fredholm BB, 2000, N-S ARCH PHARMACOL, V362, P364, DOI 10.1007/s002100000313; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HOSKIN DW, 1994, INT J CANCER, V59, P854, DOI 10.1002/ijc.2910590625; Huang S, 1997, BLOOD, V90, P1600, DOI 10.1182/blood.V90.4.1600.1600_1600_1610; Ji X D, 1999, Drug Des Discov, V16, P217; Kaneko Y, 2000, J EXP MED, V191, P105, DOI 10.1084/jem.191.1.105; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; Luster MI, 2001, TOXICOL LETT, V120, P317, DOI 10.1016/S0378-4274(01)00284-3; Malfait AM, 1999, J IMMUNOL, V162, P6278; MARQUARDT DL, 1984, P NATL ACAD SCI-BIOL, V81, P6192, DOI 10.1073/pnas.81.19.6192; OLAH ME, 1995, ANNU REV PHARMACOL, V35, P581, DOI 10.1146/annurev.pa.35.040195.003053; RUDOLPHI KA, 1992, TRENDS PHARMACOL SCI, V13, P439, DOI 10.1016/0165-6147(92)90141-R; Schumann J, 1998, J IMMUNOL, V161, P5745; Sullivan GW, 2000, J LEUKOCYTE BIOL, V67, P591, DOI 10.1002/jlb.67.5.591; Tarkowski A, 1998, MOL MED TODAY, V4, P15, DOI 10.1016/S1357-4310(97)80540-0; Tiegs G, 1997, ACTA GASTRO-ENT BELG, V60, P176; van der Pouw Kraan TCTM, 1998, J CLIN INVEST, V102, P1866, DOI 10.1172/JCI3692; VANBELLE H, 1987, AM J PHYSIOL, V252, pH886, DOI 10.1152/ajpheart.1987.252.5.H886; WINN HR, 1981, AM J PHYSIOL, V241, pH235, DOI 10.1152/ajpheart.1981.241.2.H235	30	977	1019	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2001	414	6866					916	920		10.1038/414916a	http://dx.doi.org/10.1038/414916a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780065	Green Published			2022-12-24	WOS:000172813300048
J	Sui, HX; Han, BG; Lee, JK; Walian, P; Jap, BK				Sui, HX; Han, BG; Lee, JK; Walian, P; Jap, BK			Structural basis of water-specific transport through the AQP1 water channel	NATURE			English	Article							ELECTRON CRYSTALLOGRAPHY; PROTEIN; GLYCEROL; CONDUCTION; CHAIN; CHIP; PORE	Water channels facilitate the rapid transport of water across cell membranes in response to osmotic gradients. These channels are believed to be involved in many physiological processes that include renal water conservation, neuro-homeostasis, digestion, regulation of body temperature and reproduction. Members of the water channel superfamily have been found in a range of cell types from bacteria to human. In mammals, there are currently 10 families of water channels, referred to as aquaporins (AQP): AQP0-AQP9. Here we report the structure of the aquaporin 1 (AQP1) water channel to 2.2 Angstrom resolution. The channel consists of three topological elements, an extracellular and a cytoplasmic vestibule connected by an extended narrow pore or selectivity filter. Within the selectivity filter, four bound waters are localized along three hydrophilic nodes, which punctuate an otherwise extremely hydrophobic pore segment. This unusual combination of a long hydrophobic pore and a minimal number of solute binding sites facilitates rapid water transport. Residues of the constriction region, in particular histidine 182, which is conserved among all known water-specific channels, are critical in establishing water specificity. Our analysis of the AQP1 pore also indicates that the transport of protons through this channel is highly energetically unfavourable.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Grad Grp Comparat Biochem, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Walian, P (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA.	PJWalian@lbl.gov; BKJap@lbl.gov	Sui, Haixin/L-4265-2017; Han, Bong-Gyoon/J-9120-2012	Sui, Haixin/0000-0002-5560-4325; 				AGMON N, 1995, CHEM PHYS LETT, V244, P456, DOI 10.1016/0009-2614(95)00905-J; AGRE P, 1993, AM J PHYSIOL, V265, pF463; BACIOU L, 1995, BIOCHEMISTRY-US, V34, P7967, DOI 10.1021/bi00025a001; Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425; Borgnia MJ, 2001, P NATL ACAD SCI USA, V98, P2888, DOI 10.1073/pnas.051628098; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Cheng AC, 1997, NATURE, V387, P627, DOI 10.1038/42517; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DENKER BM, 1988, J BIOL CHEM, V263, P15634; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Groll M, 1999, P NATL ACAD SCI USA, V96, P10976, DOI 10.1073/pnas.96.20.10976; Ishibashi K, 1998, BIOCHEM BIOPH RES CO, V244, P268, DOI 10.1006/bbrc.1998.8252; JAP BK, 1995, J MOL BIOL, V251, P413, DOI 10.1006/jmbi.1995.0444; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li HL, 1997, NAT STRUCT BIOL, V4, P263, DOI 10.1038/nsb0497-263; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P7275, DOI 10.1073/pnas.90.15.7275; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JH, 1996, J MEMBRANE BIOL, V153, P171, DOI 10.1007/s002329900120; Pomes R, 1998, BIOPHYS J, V75, P33, DOI 10.1016/S0006-3495(98)77492-2; Ponamarev MV, 1998, BIOCHEMISTRY-US, V37, P17199, DOI 10.1021/bi981814j; Ren G, 2000, J MOL BIOL, V301, P369, DOI 10.1006/jmbi.2000.3949; Ren G, 2001, P NATL ACAD SCI USA, V98, P1398, DOI 10.1073/pnas.041489198; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; SMITH BL, 1991, J BIOL CHEM, V266, P6407; Sui HX, 2000, ACTA CRYSTALLOGR D, V56, P1198, DOI 10.1107/S0907444900008143; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VERKMAN AS, 1992, ANNU REV PHYSIOL, V54, P97, DOI 10.1146/annurev.physiol.54.1.97; Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; ZEIDEL ML, 1994, BIOCHEMISTRY-US, V33, P1606, DOI 10.1021/bi00172a042; Zeuthen T, 1999, J BIOL CHEM, V274, P21631, DOI 10.1074/jbc.274.31.21631	39	864	917	7	267	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2001	414	6866					872	878		10.1038/414872a	http://dx.doi.org/10.1038/414872a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780053	Green Submitted			2022-12-24	WOS:000172813300036
J	Lee, KB; Park, SJ; Mirkin, CA; Smith, JC; Mrksich, M				Lee, KB; Park, SJ; Mirkin, CA; Smith, JC; Mrksich, M			Protein nanoarrays generated by dip-pen nanolithography	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; FABRICATION; ADSORPTION; PARALLEL; PATTERNS	Dip-pen nanolithography was used to construct arrays of proteins with 100- to 350-nanometer features. These nanoarrays exhibit almost no detectable nonspecific binding of proteins to their passivated portions even in complex mixtures of proteins, and therefore provide the opportunity to study a variety of surface-mediated biological recognition processes. For example, reactions involving the protein features and antigens in complex solutions can be screened easily by atomic force microscopy. As further proof-of-concept, these arrays were used to study cellular adhesion at the submicrometer scale.	Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; Northwestern Univ, Ctr Nanofabricat & Mol Self Assembly, Evanston, IL 60208 USA; Univ Chicago, Dept Chem, Chicago, IL 60637 USA; Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	Northwestern University; Northwestern University; University of Chicago; University of Chicago	Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	camirkin@chem.northwestern.edu; mmrksich@midway.uchicago.edu	Mrksich, Milan/G-2469-2011; Park, So-Jung/F-9471-2017; Lee, KiBum/F-3702-2012; Lee, Ki-Bum/G-7503-2015; Mirkin, Chad A/E-3911-2010	Mrksich, Milan/0000-0002-4964-796X; LEE, Ki-Bum/0000-0002-8164-0047; Mirkin, Chad/0000-0002-6634-7627				Adams JC, 2001, CELL MOL LIFE SCI, V58, P371, DOI 10.1007/PL00000864; Bergman AA, 1998, LANGMUIR, V14, P6785, DOI 10.1021/la980642o; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4; BrowningKelley ME, 1997, LANGMUIR, V13, P343, DOI 10.1021/la960918x; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Hong SH, 2000, SCIENCE, V288, P1808, DOI 10.1126/science.288.5472.1808; Hong SH, 1999, SCIENCE, V286, P523, DOI 10.1126/science.286.5439.523; Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9; Kenseth JR, 2001, LANGMUIR, V17, P4105, DOI 10.1021/la0100744; KIMIZUKA F, 1991, J BIOCHEM-TOKYO, V110, P284, DOI 10.1093/oxfordjournals.jbchem.a123572; LOPEZ GP, 1993, J AM CHEM SOC, V115, P10774, DOI 10.1021/ja00076a038; MacBeath G, 2000, SCIENCE, V289, P1760; Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775; Nicolau DV, 1998, LANGMUIR, V14, P1927, DOI 10.1021/la970802g; Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661; PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164; Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614; SILVERTON EW, 1977, P NATL ACAD SCI USA, V74, P5140, DOI 10.1073/pnas.74.11.5140; Wadu-Mesthrige K, 1999, LANGMUIR, V15, P8580, DOI 10.1021/la991196n; Wadu-Mesthrige K, 2001, BIOPHYS J, V80, P1891, DOI 10.1016/S0006-3495(01)76158-9; Wilson DL, 2001, P NATL ACAD SCI USA, V98, P13660, DOI 10.1073/pnas.241323198	23	1028	1081	3	220	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2002	295	5560					1702	1705		10.1126/science.1067172	http://dx.doi.org/10.1126/science.1067172			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11834780				2022-12-24	WOS:000174212900043
J	Lacroix-Desmazes, S; Bayry, J; Misra, N; Horn, MP; Villard, S; Pashov, A; Stieltjes, N; d'Oiron, R; Saint-Remy, J; Hoebeke, J; Kazatchkine, MD; Kaveri, SV				Lacroix-Desmazes, S; Bayry, J; Misra, N; Horn, MP; Villard, S; Pashov, A; Stieltjes, N; d'Oiron, R; Saint-Remy, J; Hoebeke, J; Kazatchkine, MD; Kaveri, SV			The prevalence of proteolytic antibodies against factor VIII in hemophilia A.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; VON-WILLEBRAND-FACTOR; LIGHT-CHAIN; PROCOAGULANT ACTIVITY; MONOCLONAL-ANTIBODY; CATALYTIC ACTIVITY; C2 DOMAIN; FACTOR-IX; INHIBITOR; BINDING	Background: Factor VIII inhibitors are IgG alloantibodies that arise during replacement therapy in 25 to 50 percent of patients with severe hemophilia A. The hydrolysis of factor VIII by anti-factor VIII antibodies has been proposed as a mechanism of inactivation of factor VIII. Methods: We purified IgG from patients with severe hemophilia A. The proteolytic activity of the antibodies was assessed by incubating the IgG with biotinylated human factor VIII and analyzing patterns of factor VIII cleavage by sodium dodecyl sulfate-polyacrylamide-gel electrophoresis and immunoblotting. The controls were normal human IgG and IgG purified from plasma of patients with hemophilia who did not have inhibitory antibodies. Results: Significant proteolytic activity was detected in IgG from 13 of 24 inhibitor-positive patients. No hydrolytic activity was detected in control antibodies of IgG from patients without inhibitors. The rate of hydrolysis of factor VIII by purified IgG correlated positively with the factor VIII-neutralizing activity of IgG in plasma (r(sup 2)=0.67, P=0.029). Principal-component analysis of migration profiles of digestion fragments demonstrated the heterogeneity of the catalytic potential of factor VIII inhibitors among patients. Conclusions: Proteolysis is a mechanism by which IgG antibodies against factor VIII can inactivate factor VIII. (N Engl J Med 2002;346:662-7.) Copyright (C) 2002 Massachusetts Medical Society.	Hop Broussais, INSERM, U430, F-75014 Paris, France; Univ Paris 06, Hop Broussais, Paris, France; Fac Pharm Montpellier, CNRS, Unite Mixte Rech 5094, Montpellier, France; Hop Cochin & Bicetre, Ctr Hemophiles, F-75674 Paris, France; Katholieke Univ Leuven, Ctr Mol & Vasc Biol, Louvain, Belgium; Inst Biol Mol & Cellulaire, CNRS, Unite Propre Rech 9021, F-67084 Strasbourg, France; Inst Biol Mol & Cellulaire, CNRS, Unite Propre Rech 9002, F-67084 Strasbourg, France; Inst Immunohaematol, Mumbai, India	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; KU Leuven; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Indian Council of Medical Research (ICMR); ICMR - National Institute of Immunohaemotology (NIIH)	Lacroix-Desmazes, S (corresponding author), Hop Broussais, INSERM, U430, 96 Rue Didot, F-75014 Paris, France.		Pashov, Anastas/AAE-7997-2019; Bayry, Jagadeesh/A-6589-2011	Bayry, Jagadeesh/0000-0003-0498-9808; Pashov, Anastas/0000-0002-6033-3566; Lacroix-Desmazes, Sebastien/0000-0001-5625-8447; d'Oiron, Roseline/0000-0002-4843-7805				ARAI M, 1989, J CLIN INVEST, V83, P1978, DOI 10.1172/JCI114107; DEBIASI R, 1994, THROMB HAEMOSTASIS, V71, P544; EHRENFORTH S, 1992, LANCET, V339, P594, DOI 10.1016/0140-6736(92)90874-3; FOSTER PA, 1988, J CLIN INVEST, V82, P123, DOI 10.1172/JCI113559; GILLES JGG, 1993, BLOOD, V82, P2452; GOLOLOBOV GV, 1995, P NATL ACAD SCI USA, V92, P254, DOI 10.1073/pnas.92.1.254; Jobson J. D., 1991, APPL MULTIVARIATE DA; KASPER CK, 1975, THROMB DIATH HAEMOST, V34, P612; Lacroix-Desmazes S, 1999, NAT MED, V5, P1044, DOI 10.1038/12483; LI L, 1995, J IMMUNOL, V154, P3328; LUBAHN BC, 1989, BLOOD, V73, P497; Moreau A, 2000, BLOOD, V95, P3435, DOI 10.1182/blood.V95.11.3435.011k32_3435_3441; PAUL S, 1991, J BIOL CHEM, V266, P16128; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; SAENKO EL, 1994, J BIOL CHEM, V269, P11601; Saenko EL, 1996, J BIOL CHEM, V271, P27424, DOI 10.1074/jbc.271.44.27424; Schwaab R, 1995, THROMB HAEMOSTASIS, V74, P1402; SHIMA M, 1993, THROMB HAEMOSTASIS, V69, P240; SHUSTER AM, 1992, SCIENCE, V256, P665, DOI 10.1126/science.1585181; Stahl D, 2000, J IMMUNOL METHODS, V240, P1, DOI 10.1016/S0022-1759(00)00185-X; Thiagarajan P, 2000, BIOCHEMISTRY-US, V39, P6459, DOI 10.1021/bi992588w; Zhong DG, 1998, BLOOD, V92, P136, DOI 10.1182/blood.V92.1.136.413k35_136_142	22	87	92	0	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2002	346	9					662	667		10.1056/NEJMoa011979	http://dx.doi.org/10.1056/NEJMoa011979			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525HJ	11870243				2022-12-24	WOS:000174062800004
J	Hay, SI; Cox, J; Rogers, DJ; Randolph, SE; Stern, DI; Shanks, GD; Myers, MF; Snow, RW				Hay, SI; Cox, J; Rogers, DJ; Randolph, SE; Stern, DI; Shanks, GD; Myers, MF; Snow, RW			Climate change and the resurgence of malaria in the East African highlands	NATURE			English	Article							AUTOREGRESSIVE TIME-SERIES; UNIT-ROOT; EL-NINO; VARIABILITY; UGANDA	The public health and economic consequences of Plasmodium falciparum malaria are once again regarded as priorities for global development. There has been much speculation on whether anthropogenic climate change is exacerbating the malaria problem, especially in areas of high altitude where P. falciparum transmission is limited by low temperature(1-4). The International Panel on Climate Change has concluded that there is likely to be a net extension in the distribution of malaria and an increase in incidence within this range(5). We investigated long-term meteorological trends in four high-altitude sites in East Africa, where increases in malaria have been reported in the past two decades. Here we show that temperature, rainfall, vapour pressure and the number of months suitable for P. falciparum transmission have not changed significantly during the past century or during the period of reported malaria resurgence. A high degree of temporal and spatial variation in the climate of East Africa suggests further that claimed associations between local malaria resurgences and regional changes in climate are overly simplistic.	Univ Oxford, Dept Zool, TALA Res Grp, Oxford OX1 3PS, England; Kenya Med Res Inst Wellcome Trust Collaborat Prog, Nairobi, Kenya; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Univ Oxford, Dept Zool, Oxford Tick Res Grp, Oxford OX1 3PS, England; Australian Natl Univ, Ctr Resource & Environm Studies, Canberra, ACT 0200, Australia; USA, Med Res Unit Kenya, Nairobi, Kenya; Decis Syst Technol Inc, Rockville, MD 20850 USA; Univ Oxford, John Radcliffe Hosp, Ctr Trop Med, Oxford OX3 9DU, England	University of Oxford; Kenya Medical Research Institute; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; Australian National University; University of Oxford	Hay, SI (corresponding author), Univ Oxford, Dept Zool, TALA Res Grp, S Parks Rd, Oxford OX1 3PS, England.		Stern, David I/B-4700-2009; Snow, Robert William/AFR-1436-2022; Shanks, George Dennis/F-4056-2014; Randolph, Sarah/AAR-9346-2021; Hay, Simon Iain/F-8967-2015	Stern, David I/0000-0001-6595-4268; Snow, Robert William/0000-0003-3725-6088; Shanks, George Dennis/0000-0001-5763-8660; Hay, Simon Iain/0000-0002-0611-7272	Wellcome Trust [079080, 056642] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bodker R, 2000, GLOBAL CHANGE HUMAN, V1, P134, DOI DOI 10.1023/A:1010077105257; Box G., 1970, TIME SERIES ANAL FOR; DICKEY DA, 1981, ECONOMETRICA, V49, P1057, DOI 10.2307/1912517; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; DIXON S, 1950, E AFR MED J, V27, P10; Epstein PR, 1998, B AM METEOROL SOC, V79, P409, DOI 10.1175/1520-0477(1998)079<0409:BAPSOC>2.0.CO;2; Garnham P. C. C., 1948, Journal of the National Malaria Society, V7, P275; Granger CW., 1974, J ECONOMETRICS, V2, P111, DOI [DOI 10.1016/0304-4076(74)90034-7, 10.1016/0304-4076(74)90034-7]; Hay SI, 2000, P NATL ACAD SCI USA, V97, P9335, DOI 10.1073/pnas.97.16.9335; Houghton J. T., 2001, CLIMATE CHANGE 2001; Kilian AHD, 1999, T ROY SOC TROP MED H, V93, P22, DOI 10.1016/S0035-9203(99)90165-7; King'uyu SM, 2000, J CLIMATE, V13, P2876, DOI 10.1175/1520-0442(2000)013&lt;2876:RTOMAM&gt;2.0.CO;2; Lindblade KA, 1999, T ROY SOC TROP MED H, V93, P480, DOI 10.1016/S0035-9203(99)90344-9; LOEVINSOHN ME, 1994, LANCET, V343, P714, DOI 10.1016/S0140-6736(94)91586-5; MARIMBU J, 1993, B SOC PATHOL EXOT, V86, P399; Martens P, 1999, AM SCI, V87, P534, DOI 10.1511/1999.42.839; MATOLA YG, 1987, J TROP MED HYG, V90, P127; McCarthy J.J., 2001, CLIMATE CHANGE 2001; McMichael A.J., 1996, CLIMATE CHANGE HUMAN; Mouchet J, 1998, J AM MOSQUITO CONTR, V14, P121; Mouchet J, 1997, B SOC PATHOL EXOT, V90, P162; *NAT RES COUNC, 2001, WEATH CLIM EC INF DI; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; New M, 2000, J CLIMATE, V13, P2217, DOI 10.1175/1520-0442(2000)013<2217:RTCSTC>2.0.CO;2; Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853; Shanks GD, 2000, T ROY SOC TROP MED H, V94, P253, DOI 10.1016/S0035-9203(00)90310-9; Stern DI, 2000, CLIMATIC CHANGE, V47, P411, DOI 10.1023/A:1005672231474	27	328	337	1	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2002	415	6874					905	909		10.1038/415905a	http://dx.doi.org/10.1038/415905a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859368	Green Accepted			2022-12-24	WOS:000173941000044
J	Taylor, B; Miller, E; Lingam, R; Andrews, N; Simmons, A; Stowe, J				Taylor, B; Miller, E; Lingam, R; Andrews, N; Simmons, A; Stowe, J			Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: Population study	BRITISH MEDICAL JOURNAL			English	Article							CAUSAL ASSOCIATION; MMR; DISORDERS	Objectives To investigate whether measles, mumps, and rubella (MMR) vaccination is associated with bowel problems and developmental regression in children with autism, looking for evidence of a "new variant" form of autism. Design Population study with case note review linked to independently recorded vaccine data. Setting Five health districts in north east London. Participants 278 children with core autism and 195 with atypical autism, mainly identified froth computerised disability registers and born between 1979 and 1998. Main outcome measures Recorded bowel problems lasting at least three months, age of reported regression of the child's development where it was a feature, and relation of these to MMR vaccination. Results The proportion of children with developmental regression (25% overall) or bowel symptoms (17%) did not change significantly (P value for trend 0.50 and 0.47, respectively) during the 20 years from 197 9, a period which included the introduction of MMR vaccination in October 1988. No significant difference was found in rates of bowel problems or regression in children who received the MMR vaccine before their parents became concerned about their development (where MMR might have caused or triggered the autism with regression or bowel problem), compared with those who received it only after such concern and those who had not received the MMR vaccine. A possible association between non-specific bowel problems and regression in children with autism was seen but this was unrelated to MMR vaccination. Conclusions These findings provide no support for an MMR associated "new variant" form of autism with developmental regression and bowel problems, and further evidence against involvement of MMR vaccine in the initiation of autism.	UCL, Royal Free & Univ Coll Med Sch, Ctr Community Child Hlth, London NW3 2PF, England; Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, Immunisat Div, London NW9 5EQ, England	University of London; University College London; Public Health England	Taylor, B (corresponding author), UCL, Royal Free & Univ Coll Med Sch, Ctr Community Child Hlth, Royal Free Campus, London NW3 2PF, England.	b.taylor@rfc.ucl.ac.uk		Stowe, Julia/0000-0002-3999-6461				Dales L, 2001, JAMA-J AM MED ASSOC, V285, P1183, DOI 10.1001/jama.285.9.1183; DeWilde S, 2001, BRIT J GEN PRACT, V51, P226; Farrington CP, 2001, VACCINE, V19, P3632, DOI 10.1016/S0264-410X(01)00097-4; Fombonne E, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e58; Furlano RI, 2001, J PEDIATR-US, V138, P366, DOI 10.1067/mpd.2001.111323; Halsey NA, 2001, PEDIATRICS, V107, P1; Kaye JA, 2001, BRIT MED J, V322, P460, DOI 10.1136/bmj.322.7284.460; KURITA H, 1992, J AUTISM DEV DISORD, V22, P175, DOI 10.1007/BF01058149; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Taylor B, 1999, LANCET, V353, P2026, DOI 10.1016/S0140-6736(99)01239-8; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Wakefield AJ, 2000, AM J GASTROENTEROL, V95, P2285	12	210	213	0	77	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2002	324	7334					393	396		10.1136/bmj.324.7334.393	http://dx.doi.org/10.1136/bmj.324.7334.393			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524HC	11850369	Green Submitted, Green Published, Bronze, Green Accepted			2022-12-24	WOS:000174006300016
J	Klier, EM; Wang, HY; Constantin, AG; Crawford, JD				Klier, EM; Wang, HY; Constantin, AG; Crawford, JD			Midbrain control of three-dimensional head orientation	SCIENCE			English	Article							OCULAR TILT REACTION; INTERSTITIAL NUCLEUS; 3-DIMENSIONAL EYE; GAZE SHIFTS; MOTOR CONTROL; MOVEMENTS; CAJAL; COORDINATION; STRATEGIES; SIGNALS	Little is known about the neural mechanisms controlling head posture and why they fait in clinical syndromes like torticollis. It is well established, however, that the brain controls eye position by integrating eye velocity commands. By electrically stimulating and reversibly inactivating midbrain sites in the head-free (nonimmobilized) monkey, we found that the interstitial nucleus of Cajal functions as a neural integrator for head posture. We suggest that a bilateral imbalance in this structure, through either direct damage or inappropriate input, could be one of the mechanisms underlying torticollis.	York Univ, CIHR Grp Act & Percept, York Ctr Vis Res, Toronto, ON M3J 1P3, Canada; York Univ, Dept Psychol, Toronto, ON M3J 1P3, Canada; York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada; York Univ, Dept Kinesiol, Toronto, ON M3J 1P3, Canada	York University - Canada; York University - Canada; York University - Canada; York University - Canada	Crawford, JD (corresponding author), York Univ, CIHR Grp Act & Percept, York Ctr Vis Res, Toronto, ON M3J 1P3, Canada.	jdc@yorku.ca		Crawford, Doug/0000-0003-2288-1286				BUTTNERENNEVER JA, 1988, NEUROANATOMY OCULOMO, P137; CANNON SC, 1987, J NEUROPHYSIOL, V57, P1383, DOI 10.1152/jn.1987.57.5.1383; Ceylan M, 2000, J NEUROSCI, V20, P2719; Crawford JD, 1999, J NEUROPHYSIOL, V81, P1760, DOI 10.1152/jn.1999.81.4.1760; CRAWFORD JD, 1991, SCIENCE, V252, P1551, DOI 10.1126/science.2047862; Dauer WT, 1998, BRAIN, V121, P547, DOI 10.1093/brain/121.4.547; Freedman EG, 1996, J NEUROPHYSIOL, V76, P927, DOI 10.1152/jn.1996.76.2.927; FUKUSHIMA K, 1987, PROG NEUROBIOL, V29, P107, DOI 10.1016/0301-0082(87)90016-5; GUITTON D, 1992, TRENDS NEUROSCI, V15, P174, DOI 10.1016/0166-2236(92)90169-9; HALMAGYI GM, 1990, NEUROLOGY, V40, P1503, DOI 10.1212/WNL.40.10.1503; Helmchen C, 1998, EXP BRAIN RES, V119, P436, DOI 10.1007/s002210050359; KESHNER EA, 1988, PROG BRAIN RES, V76, P329; Klier EM, 2001, NAT NEUROSCI, V4, P627, DOI 10.1038/88450; Medendorp WP, 1999, J NEUROPHYSIOL, V82, P2833, DOI 10.1152/jn.1999.82.5.2833; Ohashi T, 1998, J NEURO-OPHTHALMOL, V18, P40; RADAU P, 1994, J NEUROPHYSIOL, V72, P2840, DOI 10.1152/jn.1994.72.6.2840; ROBINSON DA, 1989, ANNU REV NEUROSCI, V12, P33, DOI 10.1146/annurev.neuro.12.1.33; ROBINSON DA, 1971, CONTROL EYE MOVEMENT, P519; SCHOR RH, 1988, CONTROL HEAD MOVEMEN, P141; TWEED D, 1990, VISION RES, V30, P97, DOI 10.1016/0042-6989(90)90130-D	20	73	71	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2002	295	5558					1314	1316		10.1126/science.1067300	http://dx.doi.org/10.1126/science.1067300			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847347				2022-12-24	WOS:000173926000049
J	Theissen, G				Theissen, G			Secret life of genes	NATURE			English	Editorial Material									Univ Jena, Lehrstuhl Genet, D-07743 Jena, Germany	Friedrich Schiller University of Jena	Theissen, G (corresponding author), Univ Jena, Lehrstuhl Genet, Philosophenweg 12, D-07743 Jena, Germany.							Fitch WM, 2000, TRENDS GENET, V16, P227, DOI 10.1016/S0168-9525(00)02005-9; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Graur D., 2000, FUNDAMENTALS MOL EVO; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631	4	61	70	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					741	741		10.1038/415741a	http://dx.doi.org/10.1038/415741a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845189	Bronze			2022-12-24	WOS:000173833900028
J	Rezaie, T; Child, A; Hitchings, R; Brice, G; Miller, L; Coca-Prados, M; Heon, E; Krupin, T; Ritch, R; Kreutzer, D; Crick, RP; Sarfarazi, M				Rezaie, T; Child, A; Hitchings, R; Brice, G; Miller, L; Coca-Prados, M; Heon, E; Krupin, T; Ritch, R; Kreutzer, D; Crick, RP; Sarfarazi, M			Adult-onset primary open-angle glaucoma caused by mutations in optineurin	SCIENCE			English	Article							LOW-TENSION GLAUCOMA; PRIMARY CONGENITAL GLAUCOMA; NECROSIS-FACTOR-ALPHA; CYTOCHROME P4501B1; IDENTIFICATION; PREVALENCE; PROTEIN; REGION; LOCUS; 2P21	Primary open-angle glaucoma (POAG) affects 33 million individuals worldwide and is a leading cause of blindness. In a study of 54 families with autosomal dominantly inherited adult-onset POAG, we identified the causative gene on chromosome 10p14 and designated it OPTN (for "optineurin"). Sequence alterations in OPTN were found in 16.7% of families with hereditary POAG, including individuals with normal intraocular pressure. The OPTN gene codes for a conserved 66-kilodalton protein of unknown function that has been implicated in the tumor necrosis factor-alpha signaling pathway and that interacts with diverse proteins including Huntingtin, Ras-associated protein RABB, and transcription factor IIIA. Optineurin is expressed in trabecular meshwork, nonpigmented ciliary epithelium, retina, and brain, and we speculate that it plays a neuroprotective role.	Univ Connecticut, Ctr Hlth, Dept Surg, Surg Res Ctr,Mol Ophthalm Genet Lab, Farmington, CT 06030 USA; Univ London St Georges Hosp, Sch Med, Dept Cardiol Sci, London SW17 0RE, England; Moorfields Eye Hosp, Glaucoma Res Unit, London EC1V 2PD, England; Univ Connecticut, Ctr Hlth, Dept Pathol, Farmington, CT 06030 USA; Yale Univ, Dept Ophthalmol & Visual Sci, New Haven, CT 06520 USA; Vis Res Program UHN, Dept Ophthalmol, Toronto, ON M5T 2S8, Canada; Univ Eye Specialists, Chicago, IL 60611 USA; New York Eye & Ear Infirm, Valhalla, NY 10003 USA; New York Med Coll, Valhalla, NY 10003 USA; Int Glaucoma Assoc, London SE5 9HQ, England	University of Connecticut; St Georges University London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Connecticut; Yale University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; New York Eye & Ear Infirmary of Mount Sinai; New York Medical College	Sarfarazi, M (corresponding author), Univ Connecticut, Ctr Hlth, Dept Surg, Surg Res Ctr,Mol Ophthalm Genet Lab, Farmington, CT 06030 USA.		Quill, Barry/O-2614-2014	Quill, Barry/0000-0002-0578-5703	NEI NIH HHS [EY-09947] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009947] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; GROSSKREUTZ C, 1994, INT OPHTHALMOL CLIN, V34, P173, DOI 10.1097/00004397-199403430-00016; Hattula K, 2000, CURR BIOL, V10, P1603, DOI 10.1016/S0960-9822(00)00864-2; HITCHINGS RA, 1983, BRIT J OPHTHALMOL, V67, P818, DOI 10.1136/bjo.67.12.818; HITCHINGS RA, 1992, BRIT J OPHTHALMOL, V76, P494, DOI 10.1136/bjo.76.8.494; Li YG, 1998, MOL CELL BIOL, V18, P1601, DOI 10.1128/MCB.18.3.1601; Moreland RJ, 2000, NUCLEIC ACIDS RES, V28, P1986, DOI 10.1093/nar/28.9.1986; Quigley HA, 1997, INVEST OPHTH VIS SCI, V38, P83; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; REZAIE T, UNPUB; Sarfarazi M, 1998, AM J HUM GENET, V62, P641, DOI 10.1086/301767; Sarfarazi M, 1997, HUM MOL GENET, V6, P1667, DOI 10.1093/hmg/6.10.1667; Schwamborn K, 2000, J BIOL CHEM, V275, P22780, DOI 10.1074/jbc.M001500200; Stoilov I, 1998, AM J HUM GENET, V62, P573, DOI 10.1086/301764; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Tezel G, 2000, J NEUROSCI, V20, P8693; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; WERNER EB, 1996, GLAUCOMAS, V2, pCH36; Yuan L, 2000, GLIA, V32, P42, DOI 10.1002/1098-1136(200010)32:1<42::AID-GLIA40>3.3.CO;2-V	21	808	874	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1077	1079		10.1126/science.1066901	http://dx.doi.org/10.1126/science.1066901			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834836				2022-12-24	WOS:000173793000067
J	Smetacek, V				Smetacek, V			Balance: Mind-grasping gravity - Is the mind's balance, and hence its functioning, derived from that of the body?	NATURE			English	Editorial Material									Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Smetacek, V (corresponding author), Alfred Wegener Inst Polar & Marine Res, Handelshafen 12, D-27570 Bremerhaven, Germany.							Brandt T, 1999, ANN NY ACAD SCI, V871, P293, DOI 10.1111/j.1749-6632.1999.tb09193.x; HECK D, 2001, SPEKTRUM WISSENS OCT, P36; Lackner JR, 1999, EXP BRAIN RES, V126, P459, DOI 10.1007/s002210050753; Ramachandran V.S., 1999, PHANTOMS BRAIN PROBI	4	6	6	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					481	481		10.1038/415481a	http://dx.doi.org/10.1038/415481a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823838	Bronze			2022-12-24	WOS:000173564300026
J	Hsu, SY; Nakabayashi, K; Nishi, S; Kumagai, J; Kudo, M; Sherwood, OD; Hsueh, AJW				Hsu, SY; Nakabayashi, K; Nishi, S; Kumagai, J; Kudo, M; Sherwood, OD; Hsueh, AJW			Activation of orphan receptors by the hormone relaxin	SCIENCE			English	Article							THYROTROPIN RECEPTORS; BINDING; CELLS; IDENTIFICATION; CRYPTORCHIDISM; GONADOTROPIN; INSULIN; PEPTIDE; GROWTH; INSL3	Relaxin is a hormone important for the growth and remodeling of reproductive and other tissues during pregnancy. Although binding sites for relaxin are widely distributed, the nature of its receptor has been elusive. Here, we demonstrate that two orphan heterotrimeric guanine nucleotide binding protein (G protein)-coupled receptors, LGR7 and LGR8, are capable of mediating the action of relaxin through an adenosine 3',5'-monophosphate (cAMP)-dependent pathway distinct from that of the structurally related insulin and insulin-like growth factor family ligand. Treatment of antepartum mice with the soluble ligand-binding region of LGR7 caused parturition delay. The wide and divergent distribution of the two relaxin receptors implicates their roles in reproductive, brain, renal, cardiovascular, and other functions.	Stanford Univ, Dept Gynecol & Obstet, Sch Med, Div Reprod Biol, Stanford, CA 94305 USA; Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA	Stanford University; University of Illinois System; University of Illinois Urbana-Champaign	Hsueh, AJW (corresponding author), Stanford Univ, Dept Gynecol & Obstet, Sch Med, Div Reprod Biol, Stanford, CA 94305 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD023273, R37HD023273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK058534] Funding Source: NIH RePORTER; NICHD NIH HHS [HD23273] Funding Source: Medline; NIDDK NIH HHS [DK58534] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARTSCH O, 2001, MOL HUM REPROD, V7, P799; Bani D, 1997, GEN PHARMACOL-VASC S, V28, P13, DOI 10.1016/S0306-3623(96)00171-1; BATHGATE RA, 2001, J BIOL CHEM, V31, P31; CZECH MP, 1989, CELL, V59, P235, DOI 10.1016/0092-8674(89)90281-X; DAVOREN JB, 1985, BIOL REPROD, V33, P37, DOI 10.1095/biolreprod33.1.37; Dschietzig T, 2001, FASEB J, V15, P2187, DOI 10.1096/fj.01-0070com; EIGENBROT C, 1991, J MOL BIOL, V221, P15, DOI 10.1016/0022-2836(91)90796-9; GEDDES BJ, 1995, J NEUROENDOCRINOL, V7, P411, DOI 10.1111/j.1365-2826.1995.tb00777.x; HSU CJ, 1985, ENDOCRINOLOGY, V116, P2029, DOI 10.1210/endo-116-5-2029; Hsu SY, 1999, MOL ENDOCRINOL, V13, P2163, DOI 10.1210/me.13.12.2163; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; HWANG JJ, 1989, ENDOCRINOLOGY, V125, P260, DOI 10.1210/endo-125-1-260; Min G, 1996, BIOL REPROD, V55, P1243, DOI 10.1095/biolreprod55.6.1243; Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364; Novak J, 2001, J CLIN INVEST, V107, P1469, DOI 10.1172/JCI11975; OSHEROFF PL, 1992, P NATL ACAD SCI USA, V89, P2384, DOI 10.1073/pnas.89.6.2384; OSHEROFF PL, 1991, P NATL ACAD SCI USA, V88, P6413, DOI 10.1073/pnas.88.15.6413; Osuga Y, 1997, MOL ENDOCRINOL, V11, P1659, DOI 10.1210/me.11.11.1659; Overbeek PA, 2001, GENESIS, V30, P26, DOI 10.1002/gene.1029; SHERWOOD CD, 1974, ARCH BIOCHEM BIOPHYS, V160, P185, DOI 10.1016/S0003-9861(74)80025-1; SHERWOOD OD, 1994, PHYSL REPRODUCTION, V1, P861; Unemori EN, 1996, J CLIN INVEST, V98, P2739, DOI 10.1172/JCI119099; Zhao L, 1999, ENDOCRINOLOGY, V140, P445, DOI 10.1210/en.140.1.445; Zimmermann S, 1999, MOL ENDOCRINOL, V13, P681, DOI 10.1210/me.13.5.681	25	643	681	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					671	674		10.1126/science.1065654	http://dx.doi.org/10.1126/science.1065654			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809971				2022-12-24	WOS:000173560900043
J	Moore, JP				Moore, JP			On the trail of two trials	NATURE			English	Editorial Material									Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	Cornell University	Moore, JP (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA.								0	8	9	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					365	366		10.1038/415365a	http://dx.doi.org/10.1038/415365a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807523				2022-12-24	WOS:000173433600020
J	Marx, SO; Kurokawa, J; Reiken, S; Motoike, H; D'Armiento, J; Marks, AR; Kass, RS				Marx, SO; Kurokawa, J; Reiken, S; Motoike, H; D'Armiento, J; Marks, AR; Kass, RS			Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; NMDA RECEPTOR; ION CHANNELS; K(V)LQT1; YOTIAO; HEART; FORM	Sympathetic nervous system (SNS) regulation of cardiac action potential duration (APD) is mediated by beta adrenergic receptor (betaAR) activation, which increases the stow outward potassium ion current (I-Ks). Mutations in two human I-Ks channel subunits, hKCNQ1 and hKCNE1, prolong APD and cause inherited cardiac arrhythmias known as LQTS (long QT syndrome). We show that PAR modulation of I-Ks requires targeting of adenosine 3',5'-monophosphate (cAMP)dependent protein kinase (PKA) and protein phosphatase 1 (PP1) to hKCNQ1 through the targeting protein yotiao. Yotiao binds to hKCNQ1 by a leucine zipper motif, which is disrupted by an LQTS mutation (hKCNQ1-G589D). Identification of the hKCNQ1 macromolecular complex provides a mechanism for SNS modulation of cardiac APD through I-Ks.	Columbia Univ Coll Phys & Surg, Dept Med, Ctr Mol Cardiol, Dept Pharmacol, New York, NY 10032 USA	Columbia University	Kass, RS (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, Ctr Mol Cardiol, Dept Pharmacol, 630 W 168th St, New York, NY 10032 USA.	rsk20@columbia.edu	Kurokawa, Junko/ABF-7557-2021; Kurokawa, Junko/Q-6287-2017	Kurokawa, Junko/0000-0002-9098-0908; Kurokawa, Junko/0000-0002-9098-0908	NHLBI NIH HHS [R01-HL44365-07, R01-HL56810-05, P01HL67849-01, R01-HL61503, R01-HL56180, R01-HL68093] Funding Source: Medline; NIAID NIH HHS [R01-AI39794] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061503, R01HL056180, R01HL056810, P01HL067849, R01HL068093, R01HL044365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039794] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		An RH, 1999, J PHYSIOL-LONDON, V516, P19, DOI 10.1111/j.1469-7793.1999.019aa.x; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Feliciello A, 1999, FEBS LETT, V464, P174, DOI 10.1016/S0014-5793(99)01585-9; Gray PC, 1998, CURR OPIN NEUROBIOL, V8, P330, DOI 10.1016/S0959-4388(98)80057-3; GULICK J, 1991, J BIOL CHEM, V266, P9180; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; KASS RS, 1989, J GEN PHYSIOL, V93, P1109, DOI 10.1085/jgp.93.6.1109; KASS RS, 2000, CARDIAC ELECTROPHYSI, pCH11; Lin JW, 1998, J NEUROSCI, V18, P2017; Marx SO, 2001, J CELL BIOL, V153, P699, DOI 10.1083/jcb.153.4.699; MARX SO, UNPUB; MITRA R, 1985, AM J PHYSIOL, V249, P1056, DOI 10.1152/ajpheart.1985.249.5.H1056; Paavonen KJ, 2001, HEART, V86, P39, DOI 10.1136/heart.86.1.39; Piippo K, 2001, J AM COLL CARDIOL, V37, P562, DOI 10.1016/S0735-1097(00)01124-4; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schwartz PJ, 2001, CIRCULATION, V103, P89; Scott JN, 2000, SCI AM, V282, P72, DOI 10.1038/scientificamerican0600-72; Towbin JA, 2001, DRUG METAB DISPOS, V29, P574; WALSH KB, 1988, SCIENCE, V242, P67, DOI 10.1126/science.2845575; Wang WY, 1998, J BIOL CHEM, V273, P34069, DOI 10.1074/jbc.273.51.34069	20	545	576	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2002	295	5554					496	499		10.1126/science.1066843	http://dx.doi.org/10.1126/science.1066843			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799244				2022-12-24	WOS:000173350700050
J	Takasu, MA; Dalva, MB; Zigmond, RE; Greenberg, ME				Takasu, MA; Dalva, MB; Zigmond, RE; Greenberg, ME			Modulation of NMDA receptor-dependent calcium influx and gene expression through EphB receptors	SCIENCE			English	Article							D-ASPARTATE RECEPTOR; INCREASES TYROSINE PHOSPHORYLATION; LONG-TERM POTENTIATION; HIPPOCAMPAL-NEURONS; CELL-CONTACT; SUBUNIT 2B; KINASES; ACTIVATION; GROWTH; SITES	Protein-protein interactions and calcium entry through the N-methyl-D-aspartate (NMDA)-type glutamate receptor regulate synaptic development and plasticity in the central nervous system. The EphB receptor tyrosine kinases are localized at excitatory synapses where they cluster and associate with NMDA receptors. We identified a mechanism whereby EphBs modulate NMDA receptor function. EphrinB2 activation of EphB in primary cortical neurons potentiates NMDA receptor-dependent influx of calcium. Treatment of cells with ephrinB2 led to NMDA receptor tyrosine phosphorylation through activation of the Src family of tyrosine kinases. These ephrinB2-dependent events result in enhanced NMDA receptor-dependent gene expression. Our findings indicate that ephrin-B2 stimulation of EphB modulates the functional consequences of NMDA receptor activation and suggest a mechanism whereby activity-independent and activity-dependent signals converge to regulate the development and remodeling of synaptic connections.	Harvard Univ, Childrens Hosp, Sch Med, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Greenberg, ME (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.	michael.greenberg@tch.harvard.edu		Dalva, Matthew/0000-0002-7737-8787	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA043855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017512, R01NS045500, R01NS012651] Funding Source: NIH RePORTER; NCI NIH HHS [CA43855] Funding Source: Medline; NICHD NIH HHS [HD18655] Funding Source: Medline; NINDS NIH HHS [NS12651, NS17512, R01 NS045500] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BADING H, 1995, NEUROSCIENCE, V64, P653, DOI 10.1016/0306-4522(94)00462-E; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; DALVA MB, UNPUB; Di Luca M, 2001, NEUROREPORT, V12, P1301, DOI 10.1097/00001756-200105080-00049; Ellis C, 1996, ONCOGENE, V12, P1727; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Holland SJ, 1998, CURR OPIN NEUROBIOL, V8, P117, DOI 10.1016/S0959-4388(98)80015-9; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Klein R, 2001, CURR OPIN CELL BIOL, V13, P196, DOI 10.1016/S0955-0674(00)00197-6; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; Lin SY, 1998, MOL BRAIN RES, V55, P20, DOI 10.1016/S0169-328X(97)00349-5; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rosenblum K, 1996, P NATL ACAD SCI USA, V93, P10457, DOI 10.1073/pnas.93.19.10457; Rostas JAP, 1996, P NATL ACAD SCI USA, V93, P10452, DOI 10.1073/pnas.93.19.10452; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; TAKASU MA, UNPUB; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; Zisch AH, 1998, ONCOGENE, V16, P2657, DOI 10.1038/sj.onc.1201823; Zisch AH, 2000, ONCOGENE, V19, P177, DOI 10.1038/sj.onc.1203304; [No title captured]	32	389	410	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2002	295	5554					491	495		10.1126/science.1065983	http://dx.doi.org/10.1126/science.1065983			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799243				2022-12-24	WOS:000173350700049
J	Minokoshi, Y; Kim, YB; Peroni, OD; Fryer, LGD; Muller, C; Carling, D; Kahn, BB				Minokoshi, Y; Kim, YB; Peroni, OD; Fryer, LGD; Muller, C; Carling, D; Kahn, BB			Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase	NATURE			English	Article							INCREASES GLUCOSE-UPTAKE; SKELETAL-MUSCLE; INSULIN; COA; MECHANISM; OBESITY; STRESS; MICE	Leptin is a hormone secreted by adipocytes that plays a pivotal role in regulating food intake, energy expenditure and neuroendocrine function(1). Leptin stimulates the oxidation of fatty acids(2) and the uptake of glucose(3,4), and prevents the accumulation of lipids in nonadipose tissues, which can lead to functional impairments known as "lipotoxicity''(5). The signalling pathways that mediate the metabolic effects of leptin remain undefined. The 5'-AMP-activated protein kinase (AMPK) potently stimulates fatty-acid oxidation in muscle by inhibiting the activity of acetyl coenzyme A carboxylase (ACC)(6,7). AMPK is a heterotrimeric enzyme that is conserved from yeast to humans and functions as a 'fuel gauge' to monitor the status of cellular energy(6). Here we show that leptin selectively stimulates phosphorylation and activation of the alpha2 catalytic subunit of AMPK (alpha2 AMPK) in skeletal muscle, thus establishing a previously unknown signalling pathway for leptin. Early activation of AMPK occurs by leptin acting directly on muscle, whereas later activation depends on leptin functioning through the hypothalamic-sympathetic nervous system axis. In parallel with its activation of AMPK, leptin suppresses the activity of ACC, thereby stimulating the oxidation of fatty acids in muscle. Blocking AMPK activation inhibits the phosphorylation of ACC stimulated by leptin. Our data identify AMPK as a principal mediator of the effects of leptin on fatty-acid metabolism in muscle.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; Hammersmith Hosp, Imperial Coll Sch Med, MRC Clin Sci Ctr, Cellular Stress Grp, London W12 0NN, England	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Imperial College London	Kahn, BB (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.	bkahn@caregroup.harvard.edu	Carling, David/F-1943-2014	Carling, David/0000-0002-2316-1830; Minokoshi, Yasuhiko/0000-0002-7119-4805				Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; AKAIKE N, 1981, SCIENCE, V213, P1252, DOI 10.1126/science.6267696; CORTON JM, 1994, CURR BIOL, V4, P315, DOI 10.1016/S0960-9822(00)00070-1; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fryer LGD, 2000, DIABETES, V49, P1978, DOI 10.2337/diabetes.49.12.1978; Goodwin GW, 1999, AM J PHYSIOL-ENDOC M, V277, pE772, DOI 10.1152/ajpendo.1999.277.4.E772; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; Higaki Y, 2001, DIABETES, V50, P241, DOI 10.2337/diabetes.50.2.241; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kamohara S, 1997, NATURE, V389, P374, DOI 10.1038/38717; Kishi K, 2000, BIOCHEM BIOPH RES CO, V276, P16, DOI 10.1006/bbrc.2000.3417; Lee Y, 2001, J BIOL CHEM, V276, P5629, DOI 10.1074/jbc.M008553200; MARTIN WH, 1990, AM J PHYSIOL, V259, pH1402, DOI 10.1152/ajpheart.1990.259.5.H1402; Minokoshi Y, 1999, DIABETES, V48, P287, DOI 10.2337/diabetes.48.2.287; Muoio DM, 1997, DIABETES, V46, P1360, DOI 10.2337/diabetes.46.8.1360; Oakes ND, 1999, J LIPID RES, V40, P1155; Ponticos M, 1998, EMBO J, V17, P1688, DOI 10.1093/emboj/17.6.1688; Ruderman NB, 1999, AM J PHYSIOL-ENDOC M, V276, pE1, DOI 10.1152/ajpendo.1999.276.1.E1; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; STAFFORD IL, 1990, J NEUROSCI, V10, P91; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Unger RH, 1999, P NATL ACAD SCI USA, V96, P2327, DOI 10.1073/pnas.96.5.2327; Vavvas D, 1997, J BIOL CHEM, V272, P13255, DOI 10.1074/jbc.272.20.13255; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4	29	1547	1636	3	160	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 17	2002	415	6869					339	343		10.1038/415339a	http://dx.doi.org/10.1038/415339a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797013				2022-12-24	WOS:000173293500048
J	White, TW				White, TW			Unique and redundant connexin contributions to lens development	SCIENCE			English	Article							MOLECULAR-FEATURES; ALPHA(3) CONNEXIN; MICE; DIFFERENTIATION; EYE	Connexin genes encode intercellular channels that help to coordinate development. In mice, the targeted deletion of different connexins produces disparate effects on ocular growth and differentiation in the tens, and the need for multiple channel subunits is poorly understood. Knockout of Cx46 causes a loss of homeostasis and cataracts. Deletion of Cx50 results in reduced ocular growth and cataracts. Targeted replacement of Cx50 with Cx46 by genetic knock-in corrected defects in cellular differentiation and prevented cataracts, but did not restore normal growth. These data show that intrinsic properties of Cx50 were required for cellular growth, whereas nonspecific restoration of communication by Cx46 maintained differentiation.	SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	White, TW (corresponding author), SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA.		White, Thomas/GPG-4026-2022; White, Thomas W./R-3605-2019	White, Thomas/0000-0002-3285-7434; 	NEI NIH HHS [EY02430, EY13163] Funding Source: Medline; NIGMS NIH HHS [GM37751] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002430, R01EY013163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037751] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beebe DC, 2000, DEV BIOL, V220, P424, DOI 10.1006/dbio.2000.9638; Bevans CG, 1998, J BIOL CHEM, V273, P2808, DOI 10.1074/jbc.273.5.2808; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; Gong XH, 1998, P NATL ACAD SCI USA, V95, P15303, DOI 10.1073/pnas.95.26.15303; Hopperstad MG, 2000, BIOPHYS J, V79, P1954, DOI 10.1016/S0006-3495(00)76444-7; PIATIGORSKY J, 1981, DIFFERENTIATION, V19, P134, DOI 10.1111/j.1432-0436.1981.tb01141.x; Plum A, 2000, CURR BIOL, V10, P1083, DOI 10.1016/S0960-9822(00)00690-4; Simon AM, 1997, NATURE, V385, P525, DOI 10.1038/385525a0; Srinivas M, 1999, J PHYSIOL-LONDON, V517, P673, DOI 10.1111/j.1469-7793.1999.0673s.x; Temme A, 1997, CURR BIOL, V7, P713, DOI 10.1016/S0960-9822(06)00302-2; WHITE T, UNPUB; White TW, 1998, J CELL BIOL, V143, P815, DOI 10.1083/jcb.143.3.815; White TW, 2000, BRAIN RES REV, V32, P130, DOI 10.1016/S0165-0173(99)00072-7; Wride MA, 1996, DIFFERENTIATION, V61, P77, DOI 10.1046/j.1432-0436.1996.6120077.x	15	192	196	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					319	320		10.1126/science.1067582	http://dx.doi.org/10.1126/science.1067582			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786642				2022-12-24	WOS:000173278600047
J	Ranson, NA; Farr, GW; Roseman, AM; Gowen, B; Fenton, WA; Horwich, AL; Saibil, HR				Ranson, NA; Farr, GW; Roseman, AM; Gowen, B; Fenton, WA; Horwich, AL; Saibil, HR			ATP-bound states of GroEL captured by cryo-electron microscopy	CELL			English	Article							OLIGOMERIC CHAPERONIN GROEL; CRYSTAL-STRUCTURE; CRYOELECTRON MICROSCOPY; ESCHERICHIA-COLI; KINETIC-ANALYSIS; PROTEIN; BINDING; CYCLE; MECHANISM; POLYPEPTIDE	The chaperonin GroEL drives its protein-folding cycle by cooperatively binding ATP to one of its two rings, priming that ring to become folding-active upon GroES binding, while simultaneously discharging the previous folding chamber from the opposite ring. The GroEL-ATP structure, determined by cryo-EM and atomic structure fitting, shows that the intermediate domains rotate downward, switching their intersubunit salt bridge contacts from substrate binding to ATP binding domains. These observations, together with the effects of ATP binding to a GroEL-GroES-ADP complex, suggest structural models for the ATP-induced reduction in affinity for polypeptide and for cooperativity. The model for cooperativity, based on switching of intersubunit salt bridge interactions around the GroEL ring, may provide general insight into cooperativity in other ring complexes and molecular machines.	Univ London Birkbeck Coll, Dept Crystallog, London WC1E 7HX, England; Univ London Imperial Coll Sci Technol & Med, Dept Biochem, London SW7 2AY, England; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	University of London; Birkbeck University London; Imperial College London; Howard Hughes Medical Institute; Yale University; Yale University	Ranson, NA (corresponding author), Univ London Birkbeck Coll, Dept Crystallog, Malet St, London WC1E 7HX, England.		Roseman, Alan/AAE-6689-2019	Roseman, Alan/0000-0002-4783-2619; Ranson, Neil/0000-0002-3640-5275				Boisvert DC, 1996, NAT STRUCT BIOL, V3, P170, DOI 10.1038/nsb0296-170; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; BURSTON SG, 1995, J MOL BIOL, V249, P138, DOI 10.1006/jmbi.1995.0285; Burston SG, 1996, NATURE, V383, P96, DOI 10.1038/383096a0; CHANDRASEKHAR GN, 1986, J BIOL CHEM, V261, P2414; Chen JW, 2001, NAT STRUCT BIOL, V8, P721, DOI 10.1038/90443; Cliff MJ, 1999, J MOL BIOL, V293, P667, DOI 10.1006/jmbi.1999.3138; Conway JF, 1997, NATURE, V386, P91, DOI 10.1038/386091a0; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; GRAY TE, 1991, FEBS LETT, V292, P254, DOI 10.1016/0014-5793(91)80878-7; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; JACKSON GS, 1993, BIOCHEMISTRY-US, V32, P2554, DOI 10.1021/bi00061a013; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kad NM, 1998, J MOL BIOL, V278, P267, DOI 10.1006/jmbi.1998.1704; KANTROWITZ ER, 1990, TRENDS BIOCHEM SCI, V15, P53, DOI 10.1016/0968-0004(90)90176-C; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Ma JP, 2000, J MOL BIOL, V302, P303, DOI 10.1006/jmbi.2000.4014; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Ranson NA, 1998, BIOCHEM J, V333, P233, DOI 10.1042/bj3330233; Roseman AM, 2000, ACTA CRYSTALLOGR D, V56, P1332, DOI 10.1107/S0907444900010908; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Roseman AM, 2001, J STRUCT BIOL, V135, P115, DOI 10.1006/jsbi.2001.4374; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Shtilerman M, 1999, SCIENCE, V284, P822, DOI 10.1126/science.284.5415.822; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; STANIFORTH RA, 1994, BIOCHEM J, V300, P651, DOI 10.1042/bj3000651; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wang HY, 1998, NATURE, V396, P279, DOI 10.1038/24409; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; White HE, 1997, NAT STRUCT BIOL, V4, P690, DOI 10.1038/nsb0997-690; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yifrach O, 1998, BIOCHEMISTRY-US, V37, P7083, DOI 10.1021/bi980370o; YIFRACH O, 1994, J MOL BIOL, V243, P397, DOI 10.1006/jmbi.1994.1667; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001; Yifrach O, 1998, J AM CHEM SOC, V120, P13262, DOI 10.1021/ja983136u	46	233	234	2	24	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 28	2001	107	7					869	879		10.1016/S0092-8674(01)00617-1	http://dx.doi.org/10.1016/S0092-8674(01)00617-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779463	Bronze			2022-12-24	WOS:000173024200008
J	Zhang, L; Doudna, JA				Zhang, L; Doudna, JA			Structural insights into group II intron catalysis and branch-site selection	SCIENCE			English	Article							CRYSTAL-STRUCTURE; RIBOZYME DOMAIN; ACTIVE-SITE; RNA; SPLICEOSOME; CORE; SUPPORTS; BINDING; MODEL; SNRNA	Group II self-splicing introns catalyze autoexcision from precursor RNA transcripts by a mechanism strikingly similar to that of the spliceosome, an RNA-protein assembly responsible for splicing together the protein-coding parts of most eukaryotic pre-mRNAs. Splicing in both cases initiates via nucleophilic attack at the 5' splice site by the 2' OH of a conserved intron adenosine residue, creating a branched (lariat) intermediate. Here, we describe the crystal structure at 3.0 Angstrom resolution of a 70-nucleotide RNA containing the catalytically essential domains 5 and 6 of the yeast ai5gamma group II self-splicing intron, revealing an unexpected two-nucleotide bulged structure around the branch-point adenosine in domain 6.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Doudna, JA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.							Abramovitz DL, 1996, SCIENCE, V271, P1410, DOI 10.1126/science.271.5254.1410; Baugh C, 2000, J MOL BIOL, V301, P117, DOI 10.1006/jmbi.2000.3951; Berglund JA, 2001, RNA, V7, P682, DOI 10.1017/S1355838201002187; Boudvillain M, 2000, NATURE, V406, P315, DOI 10.1038/35018589; Boudvillain M, 1998, EMBO J, V17, P7091, DOI 10.1093/emboj/17.23.7091; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Cate JH, 1997, NAT STRUCT BIOL, V4, P553, DOI 10.1038/nsb0797-553; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; CHANFREAU G, 1994, SCIENCE, V266, P1383, DOI 10.1126/science.7973729; CHIN K, 1995, RNA, V1, P391; Chu VT, 2001, EMBO J, V20, P6866, DOI 10.1093/emboj/20.23.6866; Chu VT, 1998, RNA, V4, P1186, DOI 10.1017/S1355838298980724; Collins CA, 2000, NAT STRUCT BIOL, V7, P850; COSTA M, 1995, EMBO J, V14, P1276, DOI 10.1002/j.1460-2075.1995.tb07111.x; Costa M, 1998, RNA, V4, P1055, DOI 10.1017/S1355838298980670; Daniels DL, 1996, J MOL BIOL, V256, P31, DOI 10.1006/jmbi.1996.0066; Ferre-D'Amare AR, 1998, J MOL BIOL, V279, P621, DOI 10.1006/jmbi.1998.1789; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; Gordon PM, 2001, NAT STRUCT BIOL, V8, P893, DOI 10.1038/nsb1001-893; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Konforti BB, 1998, MOL CELL, V1, P433, DOI 10.1016/S1097-2765(00)80043-X; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; PARKER R, 1987, CELL, V49, P229, DOI 10.1016/0092-8674(87)90564-2; PEEBLES CL, 1995, P NATL ACAD SCI USA, V92, P4422, DOI 10.1073/pnas.92.10.4422; PEEBLES CL, 1986, CELL, V44, P213, DOI 10.1016/0092-8674(86)90755-5; Podar M, 1999, RNA, V5, P318, DOI 10.1017/S1355838299981724; PYLE AM, 1994, BIOCHEMISTRY-US, V33, P2716, DOI 10.1021/bi00175a047; PYLE AM, 1993, SCIENCE, V261, P709, DOI 10.1126/science.7688142; Qin PZ, 1998, CURR OPIN STRUC BIOL, V8, P301, DOI 10.1016/S0959-440X(98)80062-6; QUERY CC, 1994, GENE DEV, V8, P587, DOI 10.1101/gad.8.5.587; Sigel R. K. O., COMMUNICATION; Sigel RKO, 2000, NAT STRUCT BIOL, V7, P1111; Sontheimer EJ, 1999, GENE DEV, V13, P1729, DOI 10.1101/gad.13.13.1729; WU J, 1989, GENE DEV, V3, P1553, DOI 10.1101/gad.3.10.1553; Yean SL, 2000, NATURE, V408, P881, DOI 10.1038/35048617; Zhang L., UNPUB; ZHUANG Y, 1989, GENE DEV, V3, P1545, DOI 10.1101/gad.3.10.1545	37	94	97	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2002	295	5562					2084	2088		10.1126/science.1069268	http://dx.doi.org/10.1126/science.1069268			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532AY	11859154				2022-12-24	WOS:000174450500052
J	Olsen, SF; Secher, NJ				Olsen, SF; Secher, NJ			Low consumption of seafood in early pregnancy as a risk factor for preterm delivery: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							N-3 FATTY-ACIDS; BIRTH-WEIGHT; GESTATIONAL-AGE; FISH-OIL; FETAL GROWTH; MARINE FAT; INCREASE; SUPPLEMENTATION; DETERMINANT; DIETS	Objective To determine the relation between intake of seafood in pregnancy and risk of preterm delivery and low birth weight. Design Prospective cohort study. Setting Aarhus, Denmark. Participants 8729 pregnant,omen. Main outcome measures Preterm delivery and low birth weight. Results The occurrence of preterm delivery differed significantly across four groups of seafood intake, falling progressively from 7.1% in the group never consuming fish to 1.9% in the group consuming fish as a hot meal and an open sandwich with fish at least once a week. Adjusted odds for preterm delivery were increased by a Factor of 3.6 (95% confidence interval 1.2 to 11.2) in the zero consumption group compared with the highest consumption group, Analyses based on quantified intakes indicated that the working range of the dose-response relation is mainly from zero intake up to a daily intake of 15 g fish or 0.15 g n-3 fatty acids. Estimates of risk For low birth weight were similar to those for preterm delivery. Conclusions Low consumption of fish was a strong risk factor for preterm delivery and low birth weight. In women with zero or low intake of fish, small amounts of n-3 fatty acids-provided as fish or fish oil-may confer protection against preterm delivery and low birth weight.	Statens Serum Inst, Danish Epidemiol Sci Ctr, Matern Nutr Grp, DK-2300 Copenhagen S, Denmark; Skejby Univ Hosp, Dept Obstet & Gynaecol, Epidemiol Res Unit, DK-8200 Aarhus N, Denmark	Aarhus University; Statens Serum Institut; Aarhus University	Olsen, SF (corresponding author), Statens Serum Inst, Danish Epidemiol Sci Ctr, Matern Nutr Grp, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	sfo@ssi.dk		Olsen, Sjurdur/0000-0003-3017-7096				Andersen LT, 1996, SCAND J NUTR, V40, pS129; [Anonymous], 1946, J OBSTET GYN BRIT EM, V53, P498; Baguma-Nibasheka M, 1999, BIOL REPROD, V60, P698, DOI 10.1095/biolreprod60.3.698; DAGNELIE PC, 1988, EUR J CLIN NUTR, V42, P1007; DAR E, 1992, ENVIRON RES, V59, P189, DOI 10.1016/S0013-9351(05)80239-7; Kesmodel U, 1997, ACTA OBSTET GYN SCAN, V76, P38, DOI 10.3109/00016349709047782; Kesmodel U, 2000, EPIDEMIOLOGY, V11, P512, DOI 10.1097/00001648-200009000-00005; *LEBN, 1996, LEBN; Levnedsmiddelstyrelsen, 1996, LEVN; Olsen S F, 1987, Prog Clin Biol Res, V242, P51; OLSEN SF, 1994, AM J EPIDEMIOL, V139, P856; OLSEN SF, 1985, J EPIDEMIOL COMMUN H, V39, P27, DOI 10.1136/jech.39.1.27; OLSEN SF, 1995, BRIT J NUTR, V73, P387, DOI 10.1079/BJN19950041; Olsen SF, 2000, BRIT J OBSTET GYNAEC, V107, P382, DOI 10.1111/j.1471-0528.2000.tb13235.x; OLSEN SF, 1992, LANCET, V339, P1003, DOI 10.1016/0140-6736(92)90533-9; OLSEN SF, 1993, EPIDEMIOL REV, V15, P399, DOI 10.1093/oxfordjournals.epirev.a036127; OLSEN SF, 1990, INT J EPIDEMIOL, V19, P971, DOI 10.1093/ije/19.4.971; OLSEN SF, 1986, LANCET, V2, P367; OLSEN SF, 1994, J CLIN EPIDEMIOL, V47, P565, DOI 10.1016/0895-4356(94)90303-4; OLSEN SF, 1993, J EPIDEMIOL COMMUN H, V47, P436, DOI 10.1136/jech.47.6.436; OLSEN SF, 1990, PROSTAG LEUKOTR ESS, V40, P255, DOI 10.1016/0952-3278(90)90046-N; OLSEN SF, 1987, AGENTS ACTIONS, V22, P373, DOI 10.1007/BF02009084; OLSEN SF, 1990, BRIT J NUTR, V64, P599, DOI 10.1079/BJN19900063; OLSEN SF, 1991, AM J OBSTET GYNECOL, V164, P1203, DOI 10.1016/0002-9378(91)90683-I; *PEOPL LEAG HLTH, 1942, BMJ-BRIT MED J, V2, P77; *PEOPL LEAG HLTH, 1946, J OBSTET GYN BR COMM, V53, P198; People's League of Health, 1942, LANCET, V2, P10; SECHER NJ, 1986, BRIT J OBSTET GYNAEC, V93, P128, DOI 10.1111/j.1471-0528.1986.tb07877.x	28	224	231	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2002	324	7335					447	450		10.1136/bmj.324.7335.447	http://dx.doi.org/10.1136/bmj.324.7335.447			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526NJ	11859044	Bronze, Green Published			2022-12-24	WOS:000174136300014
J	Carr-Hill, RA; Jamison, JQ; O'Reilly, D; Stevenson, MR; Reid, J; Merriman, B				Carr-Hill, RA; Jamison, JQ; O'Reilly, D; Stevenson, MR; Reid, J; Merriman, B			Risk adjustment for hospital use using social security data: cross sectional small area analysis	BRITISH MEDICAL JOURNAL			English	Article							ALLOCATING RESOURCES; HEALTH AUTHORITIES; INPATIENT SERVICES; CARE; COMPETITION; REFORMS	Objectives To identify demographic and socioeconomic determinants of need for acute hospital treatment at small area level. To establish whether there is a relation between poverty and use of inpatient services. To devise a risk adjustment formula for distributing public funds for hospital services using, as far as possible, variables that can be updated between censuses. Design Cross sectional analysis. Spatial interactive modelling was used to quantify the proximity of the population to health service facilities. Two stage weighted least squares regression was used to model use against supply of hospital and community services and a wide range of potential needs drivers including health, socioeconomic census variables, uptake of income support and family credit, and religious denomination. Setting Northern Ireland. Main outcome measure Intensity of use of inpatient services. Results After endogeneity of supply and use was taken into account, a statistical model was produced that predicted use based on five variables: income support, family credit, elderly people living alone, all ages standardised mortality ratio, and low birth weight. The main effect of the formula produced is to move resources from urban to rural areas. Conclusions This work has produced a population risk adjustment formula for acute hospital treatment in which four of the five variables can be updated annually rather than relying on census derived data. Inclusion of the social security data makes a substantial difference to the model and to the results produced by the formula.	Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; Queens Univ Belfast, Inst Clin Sci, Hlth & Social Care Res Unit, Belfast BT12 6BJ, Antrim, North Ireland; Queens Univ Belfast, No Ireland Canc Registry, Belfast, Antrim, North Ireland	University of York - UK; Queens University Belfast; Queens University Belfast	Jamison, JQ (corresponding author), Queens Univ Belfast, Ctr Social Res, Belfast BT7 1NN, Antrim, North Ireland.							Armitage P., 1971, STAT METHODS MED RES, V1; Batty M., 1976, URBAN MODELLING ALGO; BRENNAN M, 1996, NO NEED WEIGHT COMMU; CARRHILL RA, 1994, BRIT MED J, V309, P1046, DOI 10.1136/bmj.309.6961.1046; Carstairs V, 1995, J EPIDEMIOL COMMUN H, V49, pS3, DOI 10.1136/jech.49.Suppl_2.S3; *DEP HLTH SOC SEC, 1976, SHAR RES HLTH ENG RE; Department of Health and Social Security, 1976, SHAR RES HLTH ENGL R; Elola J, 1996, INT J HEALTH SERV, V26, P239, DOI 10.2190/TC9K-VQBR-NR64-AGVQ; EYLES J, 1991, SOC SCI MED, V33, P489, DOI 10.1016/0277-9536(91)90331-6; GOLDSTEIN H, 1987, MLTILEVEL MODELS ED; JUDGE K, 1994, BRIT MED J, V309, P1031, DOI 10.1136/bmj.309.6961.1031; MADDALA G, 1987, ECONOMETRICS; Marquis MS, 1999, HEALTH AFFAIR, V18, P75, DOI 10.1377/hlthaff.18.6.75; MATSUOKA M, 1990, HEPATOLOGY, V11, P173, DOI 10.1002/hep.1840110204; MAYS N, 1989, COMMUNITY MED, V11, P173; *ORG EC COOP DEV, 1996, HLTH REF WILL CHANG; *ORG EC COOP DEV, 1990, SOC POL STUD, V7; *ORG EC COOP DEV, 1990, SOCIAL POLICY STUDIE, V7; *ORG EC COOP DEV, 1996, HLTH CAR REF WILL CH; Pampalon R, 1996, SOC SCI MED, V42, P909, DOI 10.1016/0277-9536(95)00189-1; Rice N, 1996, J Health Serv Res Policy, V1, P154; SMITH P, 1994, BRIT MED J, V309, P1050, DOI 10.1136/bmj.309.6961.1050; *STAND ADV COMM HU, 1990, REL POL DISCR EQ OPP; Taylor DH, 1998, SOC SCI MED, V47, P713, DOI 10.1016/S0277-9536(98)00109-9; VANDEVEN WPMM, 1994, HEALTH AFFAIR, V13, P120, DOI 10.1377/hlthaff.13.5.120; *WHO, 1978, INT CLASS DIS; *WHO, 1996, EUR HLTH REF AN CURR; Wysong JA, 1996, SOZ PRAVENTIV MED, V41, P212, DOI 10.1007/BF01299481	28	12	12	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2002	324	7334					390	392		10.1136/bmj.324.7334.390	http://dx.doi.org/10.1136/bmj.324.7334.390			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524HC	11850368	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000174006300015
J	Arnqvist, G; Rowe, L				Arnqvist, G; Rowe, L			Antagonistic coevolution between the sexes in a group of insects	NATURE			English	Article							SEXUAL CONFLICT; WATER STRIDERS; ARMS RACES; MATE CHOICE; EVOLUTION; COSTS; ADAPTATION; SPECIATION; SELECTION; MODEL	In coevolutionary 'arms races' between the sexes, the outcome of antagonistic interactions may remain at an evolutionary standstill. The advantage gained by one sex, with any evolutionary exaggeration of arms, is expected to be matched by analogous counteradaptations in the other sex(1,2). This fundamental coevolutionary process may thus be hidden from the evolutionist's eye(3,4), and no natural examples are known. We have studied the effects of male and female armament (clasping and anti-clasping morphologies) on the outcome of antagonistic mating interactions in 15 species of water strider, using a combination of experimental and phylogenetic comparative methods. Here we present, by assessing the independent effects of both species-specific level of arms escalation and small imbalances in the amounts of arms between the sexes within species, the consequences of a sexual arms race. Evolutionary change in the balance of armament between males and females, but not in the species-specific level of escalation, has resulted in evolutionary change in the outcome of sexually antagonistic interactions such as mating rate.	Univ Uppsala, Evolutionary Biol Ctr, Dept Anim Ecol, SE-75236 Uppsala, Sweden; Univ Toronto, Dept Zool, Toronto, ON M5S 1A1, Canada	Uppsala University; University of Toronto	Arnqvist, G (corresponding author), Univ Uppsala, Evolutionary Biol Ctr, Dept Anim Ecol, Norbyvagen 18D, SE-75236 Uppsala, Sweden.		Arnqvist, Göran/E-6782-2015	Arnqvist, Göran/0000-0002-3501-3376				ARNQVIST G, 1989, OIKOS, V56, P344, DOI 10.2307/3565619; Arnqvist G, 2000, P NATL ACAD SCI USA, V97, P10460, DOI 10.1073/pnas.97.19.10460; ARNQVIST G, 1995, P ROY SOC B-BIOL SCI, V261, P123, DOI 10.1098/rspb.1995.0126; Arnqvist G, 1998, NATURE, V393, P784, DOI 10.1038/31689; ARNQVIST G, IN PRESS EVOLUTION; Arnqvist Goran, 1997, P146, DOI 10.1017/CBO9780511721946.009; Chapman T, 1996, NATURE, V381, P189, DOI 10.1038/381189a0; Civetta A, 2000, P NATL ACAD SCI USA, V97, P13162, DOI 10.1073/pnas.230305397; Damgaard J, 2001, SYST ENTOMOL, V26, P241, DOI 10.1046/j.1365-3113.2001.00141.x; FELSENSTEIN J, 2001, PHYLOGENY INFERENCE; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Gavrilets S, 2001, P ROY SOC B-BIOL SCI, V268, P531, DOI 10.1098/rspb.2000.1382; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; GITTLEMAN JL, 1990, SYST ZOOL, V39, P227, DOI 10.2307/2992183; Hardling R, 1999, J THEOR BIOL, V196, P163, DOI 10.1006/jtbi.1998.0828; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Losos JB, 1999, ANIM BEHAV, V58, P1319, DOI 10.1006/anbe.1999.1261; Parker G.A., 1979, P123; Parker GA, 1998, PHILOS T R SOC B, V353, P261, DOI 10.1098/rstb.1998.0208; PARKER GA, 1983, J THEOR BIOL, V101, P619, DOI 10.1016/0022-5193(83)90019-X; Partridge L, 1998, SCIENCE, V281, P2003, DOI 10.1126/science.281.5385.2003; Rice WR, 2000, P NATL ACAD SCI USA, V97, P12953, DOI 10.1073/pnas.97.24.12953; Rice WR, 1998, ENDLESS FORMS, P261; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; ROWE L, 1994, TRENDS ECOL EVOL, V9, P289, DOI 10.1016/0169-5347(94)90032-9; ROWE L, 1994, ANIM BEHAV, V48, P1049, DOI 10.1006/anbe.1994.1338; ROWE L, IN PRESS EVOLUTION; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; Watson PJ, 1998, AM NAT, V151, P46, DOI 10.1086/286101	30	366	369	0	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					787	789		10.1038/415787a	http://dx.doi.org/10.1038/415787a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845208				2022-12-24	WOS:000173833900045
J	Friml, J; Wisniewska, J; Benkova, E; Mendgen, K; Palme, K				Friml, J; Wisniewska, J; Benkova, E; Mendgen, K; Palme, K			Lateral relocation of auxin efflux regulator PIN3 mediates tropism in Arabidopsis	NATURE			English	Article							TRANSPORT; GRAVITROPISM; THALIANA; ROOTS; SEEDLINGS	Long-standing models propose that plant growth responses to light or gravity are mediated by asymmetric distribution of the phytohormone auxin(1-3). Physiological studies implicated a specific transport system that relocates auxin laterally, thereby effecting differential growth(4); however, neither the molecular components of this system nor the cellular mechanism of auxin redistribution on light or gravity perception have been identified. Here, we show that auxin accumulates asymmetrically during differential growth in an efflux-dependent manner. Mutations in the Arabidopsis gene PIN3, a regulator of auxin efflux, alter differential growth. PIN3 is expressed in gravity-sensing tissues, with PIN3 protein accumulating predominantly at the lateral cell surface. PIN3 localizes to the plasma membrane and to vesicles that cycle in an actin-dependent manner. In the root columella, PIN3 is positioned symmetrically at the plasma membrane but rapidly relocalizes laterally on gravity stimulation. Our data indicate that PIN3 is a component of the lateral auxin transport system regulating tropic growth. In addition, actin-dependent relocalization of PIN3 in response to gravity provides a mechanism for redirecting auxin flux to trigger asymmetric growth.	Max Planck Gesell, Max Delbruck Lab, D-50829 Cologne, Germany; Univ Tubingen, Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany; Inst Gen & Mol Biol, Dept Biotechnol, PL-87100 Torun, Poland; Univ Konstanz, Lehrstuhl Phytopathol, D-78457 Constance, Germany; Univ Freiburg, Inst Biol 2, D-79104 Freiburg, Germany	Max Planck Society; Eberhard Karls University of Tubingen; Nicolaus Copernicus University; University of Konstanz; University of Freiburg	Friml, J (corresponding author), Max Planck Gesell, Max Delbruck Lab, D-50829 Cologne, Germany.	jiri.friml@zmbp.uni-tuebingen.de; palme@mpiz-koeln.mpg.de	Friml, Jiri/D-9511-2012; Palme, Klaus/A-9524-2013; Wisniewska, Justyna/D-4351-2009; Benkova, Eva/E-2910-2012	Friml, Jiri/0000-0002-8302-7596; Palme, Klaus/0000-0002-2728-3835; 				BJORKMAN T, 1988, PLANTA, V176, P513, DOI 10.1007/BF00397658; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Collings DA, 2001, PLANTA, V212, P392, DOI 10.1007/s004250000406; Darwin C., 1881, DARWINS GESAMMELTE W, V13; EPEL BL, 1992, J PLANT PHYSIOL, V140, P310, DOI 10.1016/S0176-1617(11)81084-9; FRIML J, IN PRESS CELL; FRIML J, IN PRESS PLANT MOL B; Fukaki H, 1998, PLANT J, V14, P425, DOI 10.1046/j.1365-313X.1998.00137.x; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Hart JW., 1990, PLANT TROPISM OTHER; Hasenstein KH, 1999, ADV SPACE RES-SERIES, V24, P677, DOI 10.1016/S0273-1177(99)00399-3; Jensen PJ, 1998, PLANT PHYSIOL, V116, P455, DOI 10.1104/pp.116.2.455; LI Y, 1991, PLANT CELL, V3, P1167, DOI 10.1105/tpc.3.11.1167; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Monshausen GB, 1996, PLANT CELL ENVIRON, V19, P1408, DOI 10.1111/j.1365-3040.1996.tb00019.x; MORRIS DA, 1978, J EXP BOT, V29, P147, DOI 10.1093/jxb/29.1.147; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Palme K, 1999, CURR OPIN PLANT BIOL, V2, P375, DOI 10.1016/S1369-5266(99)00008-4; Rashotte AM, 2000, PLANT PHYSIOL, V122, P481, DOI 10.1104/pp.122.2.481; RUBERY PH, 1974, PLANTA, V118, P101, DOI 10.1007/BF00388387; Ruegger M, 1997, PLANT CELL, V9, P745, DOI 10.1105/tpc.9.5.745; SIEVERS A, 1995, PLANTA, V197, P392, DOI 10.1007/BF00202662; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Wisman E, 1998, PLANT MOL BIOL, V37, P989, DOI 10.1023/A:1006082009151; [No title captured]	26	1008	1074	8	252	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2002	415	6873					806	809		10.1038/415806a	http://dx.doi.org/10.1038/415806a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845211	Green Published			2022-12-24	WOS:000173833900050
J	Feldbaum, C				Feldbaum, C			Biotechnology - Some history should be repeated	SCIENCE			English	Editorial Material									Biotechnol Ind Org, Washington, DC 20006 USA		Feldbaum, C (corresponding author), Biotechnol Ind Org, Washington, DC 20006 USA.								0	8	8	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					975	975		10.1126/science.1069614	http://dx.doi.org/10.1126/science.1069614			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834802				2022-12-24	WOS:000173793000027
J	Wang, L; Seeley, ES; Wickner, W; Merz, AJ				Wang, L; Seeley, ES; Wickner, W; Merz, AJ			Vacuole fusion at a ring of vertex docking sites leaves membrane fragments within the organelle	CELL			English	Article							SEC17P ALPHA-SNAP; SACCHAROMYCES-CEREVISIAE; HOMOTYPIC FUSION; T-SNARE; MULTIVESICULAR BODY; YEAST VACUOLES; GTPASE YPT7P; IN-VITRO; COMPLEX; PROTEIN	Three membrane microdomains can be identified on docked vacuoles: "outside" membrane, not in contact with other vacuoles, "boundary" membrane that contacts adjacent vacuoles, and "vertices," where boundary and outside membrane meet. In living cells and in vitro, vacuole fusion occurs at vertices rather than from a central pore expanding radially. Vertex fusion leaves boundary membrane within the fused organelle and is an unexpected pathway for the formation of intralumenal membranes. Proteins that regulate docking and fusion (Vac8p, the GTPase Ypt7p, its HOPS/Vps-C effector complex, the t-SNARE Vam3p, and protein phosphatase 1) accumulate at these vertices during docking. Their vertex enrichment requires cis-SNARE complex disassembly and is thus part of the normal fusion pathway.	Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Wang, L (corresponding author), Dartmouth Coll Sch Med, Dept Biochem, 7200 Vail Bldg, Hanover, NH 03755 USA.							Bone N, 1998, CURR BIOL, V8, P135, DOI 10.1016/S0960-9822(98)00060-8; Burgoyne RD, 1998, CELL CALCIUM, V24, P367, DOI 10.1016/S0143-4160(98)90060-4; CHERNOMORDIK LV, 1991, BIOPHYS J, V60, P1026, DOI 10.1016/S0006-3495(91)82140-3; CONRADT B, 1994, J CELL BIOL, V126, P99, DOI 10.1083/jcb.126.1.99; CONRADT B, 1992, J CELL BIOL, V119, P1469, DOI 10.1083/jcb.119.6.1469; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; Denzer K, 2000, J CELL SCI, V113, P3365; DUBLOVA I, 2001, NAT STRUCT BIOL, V8, P258; Eitzen G, 2000, EMBO J, V19, P6713, DOI 10.1093/emboj/19.24.6713; Guo W, 2001, NAT CELL BIOL, V3, P353, DOI 10.1038/35070029; HAAS A, 1994, J CELL BIOL, V126, P87, DOI 10.1083/jcb.126.1.87; HAAS A, 1995, EMBO J, V14, P5258, DOI 10.1002/j.1460-2075.1995.tb00210.x; Haas A, 1996, EMBO J, V15, P3296, DOI 10.1002/j.1460-2075.1996.tb00694.x; Haas Albert, 1995, Methods in Cell Science, V17, P283, DOI 10.1007/BF00986234; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HIRSCH JG, 1968, J CELL BIOL, V38, P629, DOI 10.1083/jcb.38.3.629; Kahana JA, 1998, GREEN FLUORESCENT PROTEIN: PROPERTIES, APPLICATIONS, AND PROTOCOLS, P139; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Mayer A, 1997, J CELL BIOL, V136, P307, DOI 10.1083/jcb.136.2.307; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; MILLER F, 1964, J CELL BIOL, V23, P519, DOI 10.1083/jcb.23.3.519; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; OLBRICHT K, 1984, EXP CELL RES, V151, P14, DOI 10.1016/0014-4827(84)90351-3; Pan XZ, 1998, J CELL SCI, V111, P2137; Peters C, 1999, SCIENCE, V285, P1084, DOI 10.1126/science.285.5430.1084; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Price A, 2000, J CELL BIOL, V148, P1231, DOI 10.1083/jcb.148.6.1231; Price A, 2000, J CELL BIOL, V148, P1223, DOI 10.1083/jcb.148.6.1223; Roberts RL, 1999, J CELL SCI, V112, P3667; Sato TK, 2000, MOL CELL, V6, P661, DOI 10.1016/S1097-2765(00)00064-2; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Sokal R. R., 1994, BIOMETRY PRINCIPLES; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; Ungermann C, 1999, P NATL ACAD SCI USA, V96, P11194, DOI 10.1073/pnas.96.20.11194; Ungermann C, 1999, J CELL BIOL, V145, P1435, DOI 10.1083/jcb.145.7.1435; Ungermann C, 1998, EMBO J, V17, P3269, DOI 10.1093/emboj/17.12.3269; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Ungermann C, 2000, P NATL ACAD SCI USA, V97, P8889, DOI 10.1073/pnas.160269997; Veit M, 2001, EMBO J, V20, P3145, DOI 10.1093/emboj/20.12.3145; Wang L, 2000, J BIOL CHEM, V275, P22862, DOI 10.1074/jbc.M001447200; Wang YX, 2001, J BIOL CHEM, V276, P35133, DOI 10.1074/jbc.M103937200; Wickner W, 2000, ANNU REV BIOCHEM, V69, P247, DOI 10.1146/annurev.biochem.69.1.247; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Xu ZY, 1998, CELL, V93, P1125, DOI 10.1016/S0092-8674(00)81457-9; YAMAMOTO A, 1995, MOL BIOL CELL, V6, P525, DOI 10.1091/mbc.6.5.525	50	176	179	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 8	2002	108	3					357	369		10.1016/S0092-8674(02)00632-3	http://dx.doi.org/10.1016/S0092-8674(02)00632-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	520VB	11853670	Bronze			2022-12-24	WOS:000173801600008
J	Walsh, CR; Larson, MG; Evans, JC; Djousse, L; Ellison, RC; Vasan, RS; Levy, D				Walsh, CR; Larson, MG; Evans, JC; Djousse, L; Ellison, RC; Vasan, RS; Levy, D			Alcohol consumption and risk for congestive heart failure in the Framingham Heart Study	ANNALS OF INTERNAL MEDICINE			English	Article							IDIOPATHIC DILATED CARDIOMYOPATHY; CIGARETTE-SMOKING; NATURAL-HISTORY; BLOOD-PRESSURE; MORTALITY; POPULATION; DISEASE; WOMEN; MEN; DYSFUNCTION	Background: Although excessive alcohol consumption can promote cardiomyopathy, little is known about the association between alcohol consumption and risk for congestive heart failure in the community. Objective: To determine the relation between alcohol consumption and risk for congestive heart failure in the community. Design: Community-based, prospective observational study. Setting: Framingham, Massachusetts. Participants: Participants in the Framingham Heart Study who were free of congestive heart failure and coronary heart disease. Measurements: Self-reported alcohol consumption; sex-specific rates of congestive heart failure per 1000 person-years of follow-up by level of alcohol consumption. Results: In men, 99 cases of congestive heart failure occurred during 26 035 person-years of follow-up. In women, 120 cases of congestive heart failure occurred during 35 563 person-years of follow-up. After adjustment for multiple confounders, risk for congestive heart failure was lower among men at all levels of alcohol consumption compared with men who consumed less than 1 drink/wk. The hazard ratio for congestive heart failure was lowest among men who consumed 8 to 14 drinks/wk (0.41 [95% CI, 0.21 to 0.81]) compared with those who consumed less than 1 drink/wk. In women, the age-adjusted hazard ratio for congestive heart failure was lowest among those who consumed 3 to 7 drinks/wk (0.49 [CI, 0.25 to 0.96]) compared with those who consumed less than 1 drink/wk. However, after adjustment for multiple predictors of congestive heart failure, this association was no longer statistically significant. Conclusions: In the community, alcohol consumption is not associated with increased risk for congestive heart failure, even among heavy drinkers (greater than or equal to15 drinks/wk in men and greater than or equal to8 drinks/wk in women). To the contrary, when consumed in moderation, alcohol appears to protect against congestive heart failure.	NHLBI, Framingham Heart Study, NIH, Framingham, MA 01702 USA; Boston Univ, Sch Med, Massachusetts Gen Hosp, Beth Israel Deaconess Med Ctr, Boston, MA 02118 USA; Harvard Univ, Sch Med, Boston, MA USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Harvard University; Beth Israel Deaconess Medical Center; Massachusetts General Hospital; Harvard University; Harvard Medical School	Levy, D (corresponding author), NHLBI, Framingham Heart Study, NIH, 5 Thurber St, Framingham, MA 01702 USA.		Levy, Daniel/ABB-2752-2021; Levy, Daniel/ABF-6873-2021; Ramachandran, Vasan/Y-2527-2019; Djousse, Luc/F-5033-2017	Levy, Daniel/0000-0003-1843-8724; Ramachandran, Vasan/0000-0001-7357-5970; Djousse, Luc/0000-0002-9902-3047; Ellison, Robert Curtis/0000-0002-0582-7467; Larson, Martin/0000-0002-9631-1254	NHLBI NIH HHS [N01-HC-38038, 1K24 HL04334] Funding Source: Medline; NIAMS NIH HHS [AR/AG 41398] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC038038] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041398] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abramson JL, 2001, JAMA-J AM MED ASSOC, V285, P1971, DOI 10.1001/jama.285.15.1971; ALEXANDE.CS, 1972, AM J MED, V53, P395, DOI 10.1016/0002-9343(72)90136-2; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; BERTOLET BD, 1991, DRUG ALCOHOL DEPEN, V28, P113, DOI 10.1016/0376-8716(91)90067-9; Black HR, 1997, ARCH INTERN MED, V157, P2413; BYRNEQUINN E, 1969, BMJ-BRIT MED J, V4, P25, DOI 10.1136/bmj.4.5674.25; Camargo CA, 1997, ARCH INTERN MED, V157, P79, DOI 10.1001/archinte.157.1.79; Cooper HA, 2000, J AM COLL CARDIOL, V35, P1753, DOI 10.1016/S0735-1097(00)00625-2; COX DR, 1972, J R STAT SOC B, V34, P187; CRIQUI MH, 1987, AM J EPIDEMIOL, V126, P629, DOI 10.1093/oxfordjournals.aje.a114702; DANCY M, 1985, LANCET, V1, P1122; Dawber, 1959, J CHRON DIS, V10, P186, DOI 10.1016/0021-9681(59)90002-5; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; ERIKSSON H, 1989, EUR HEART J, V10, P647, DOI 10.1093/oxfordjournals.eurheartj.a059542; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; FELSON DT, 1988, AM J EPIDEMIOL, V128, P1102; FernandezSola J, 1997, AM J CARDIOL, V80, P481, DOI 10.1016/S0002-9149(97)00399-8; FRIEDMAN LA, 1986, AM J EPIDEMIOL, V124, P481, DOI 10.1093/oxfordjournals.aje.a114418; FUCHS CS, 1995, NEW ENGL J MED, V332, P1245, DOI 10.1056/NEJM199505113321901; FUSTER V, 1981, AM J CARDIOL, V47, P525, DOI 10.1016/0002-9149(81)90534-8; GORDON T, 1983, ARCH INTERN MED, V143, P1366, DOI 10.1001/archinte.143.7.1366; HARRIS M, 1979, DIABETES, V28, P1039; HASKELL WL, 1984, NEW ENGL J MED, V310, P805, DOI 10.1056/NEJM198403293101301; KANNEL WB, 1991, AM HEART J, V121, P951, DOI 10.1016/0002-8703(91)90225-7; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; KANNEL WB, 1969, ANN INTERN MED, V71, P89, DOI 10.7326/0003-4819-71-1-89; KLATSKY AL, 1977, NEW ENGL J MED, V296, P1194, DOI 10.1056/NEJM197705262962103; KUPARI M, 1991, AM J CARDIOL, V67, P274, DOI 10.1016/0002-9149(91)90559-4; KUPARI M, 1993, AM J CARDIOL, V72, P1418, DOI 10.1016/0002-9149(93)90190-N; MANOLIO TA, 1991, J AM COLL CARDIOL, V17, P717, DOI 10.1016/S0735-1097(10)80189-5; MARANTZ PR, 1988, CIRCULATION, V77, P607, DOI 10.1161/01.CIR.77.3.607; MARMOT MG, 1994, BRIT MED J, V308, P1263, DOI 10.1136/bmj.308.6939.1263; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; McKenna CJ, 1998, AM HEART J, V135, P833, DOI 10.1016/S0002-8703(98)70042-0; Mosterd A, 1997, EUR J EPIDEMIOL, V13, P491; National Institute on Alcohol Abuse and Alcoholism, 1995, PUBL NIH; PATEL VB, 1995, BIOCHEM SOC T, V23, pS461, DOI 10.1042/bst023461s; Prazak P, 1996, EUR HEART J, V17, P251; REMES J, 1992, EUR HEART J, V13, P588, DOI 10.1093/oxfordjournals.eurheartj.a060220; *SAS I INC, 1996, SAS STAT SOFTW CHANG, P807; Senni M, 1998, CIRCULATION, V98, P2282, DOI 10.1161/01.CIR.98.21.2282; SUH I, 1992, ANN INTERN MED, V116, P881, DOI 10.7326/0003-4819-116-11-881; Thun MJ, 1997, NEW ENGL J MED, V337, P1705, DOI 10.1056/NEJM199712113372401; URBANOMARQUEZ A, 1995, JAMA-J AM MED ASSOC, V274, P149, DOI 10.1001/jama.274.2.149; URBANOMARQUEZ A, 1989, NEW ENGL J MED, V320, P409, DOI 10.1056/NEJM198902163200701; *USDA, 1999, USDA NUTR DAT STAND; WU CF, 1976, AM HEART J, V91, P281, DOI 10.1016/S0002-8703(76)80209-8	47	150	155	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2002	136	3					181	191		10.7326/0003-4819-136-3-200202050-00005	http://dx.doi.org/10.7326/0003-4819-136-3-200202050-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517YD	11827493				2022-12-24	WOS:000173637400001
J	Elinav, E; Chajek-Shaul, TA; Stern, M				Elinav, E; Chajek-Shaul, TA; Stern, M			Improvement in cholesterol emboli syndrome after iloprost therapy	BRITISH MEDICAL JOURNAL			English	Article									Hadassah Univ Hosp, Dept Med, IL-91240 Jerusalem, Israel; Hadassah Univ Hosp, Med Day Care Unit, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Chajek-Shaul, TA (corresponding author), Hadassah Univ Hosp, Dept Med, Mt Scopus, IL-91240 Jerusalem, Israel.		Elinav, Eran/C-8077-2011; Elinav, Eran/ABE-8881-2020	Elinav, Eran/0000-0002-5775-2110				GRANT SM, 1992, DRUGS, V43, P889, DOI 10.2165/00003495-199243060-00008; KARA HVK, 1993, J VASC SURG, V17, P328; OKEEFFE ST, 1992, ARCH INTERN MED, V152, P2197, DOI 10.1001/archinte.152.11.2197	3	46	50	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 2	2002	324	7332					268	269		10.1136/bmj.324.7332.268	http://dx.doi.org/10.1136/bmj.324.7332.268			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	519LT	11823357	Bronze, Green Published			2022-12-24	WOS:000173728300016
J	Liemann, S; Chandran, K; Baker, TS; Nibert, ML; Harrison, SC				Liemann, S; Chandran, K; Baker, TS; Nibert, ML; Harrison, SC			Structure of the reovirus membrane-penetration protein, mu 1, in a complex with its protector protein, sigma 3	CELL			English	Article							DOUBLE-STRANDED-RNA; MAMMALIAN REOVIRUSES; CHROMIUM RELEASE; CAPSID PROTEIN; SUBVIRION PARTICLES; M2 GENE; BINDING; SEQUENCE; ENTRY; CRYSTALLOGRAPHY	Cell entry by nonenveloped animal viruses requires membrane penetration without membrane fusion. The reovirus penetration agent is the outer-capsid protein, mu1. The structure of mu1, complexed with its "protector" protein, sigma3, and the fit of this mu1(3)sigma3(3) heterohexameric complex into the cryoEM image of an intact virion, reveal molecular events essential for viral penetration. Autolytic cleavage divides mu1 into myristoylated mu1N and mu1C. A long hydrophobic pocket can receive the myristoyl group. Dissociation of mu1N, linked to a major conformational change of the entire mu1 trimer, must precede myristoyl-group insertion into the cellular membrane. A myristoyl switch, coupling exposure of the fatty acid chain, autolytic cleavage of mu1N, and long-range molecular rearrangement of mu1C, thus appears to be part of the penetration mechanism.	Harvard Univ, Sch Med, Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Harrison, SC (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Howard Hughes Med Inst, 320 Longwood Ave, Boston, MA 02115 USA.	harrison@crystal.harvard.edu	Chandran, Kartik/I-2232-2012	, Timothy/0000-0001-6543-8968	NCI NIH HHS [R37 CA013202, CA-13202, R01 CA013202] Funding Source: Medline; NIAID NIH HHS [P01 AI045976, R01 AI046440, AI-46440] Funding Source: Medline; NIGMS NIH HHS [GM-33050, R01 GM033050, R37 GM033050] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA013202, R01CA013202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045976, R01AI046440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM033050, R01GM033050] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Bellizzi JJ, 1999, STRUCTURE, V7, pR263, DOI 10.1016/S0969-2126(00)80020-9; BORSA J, 1979, J GEN VIROL, V45, P161, DOI 10.1099/0022-1317-45-1-161; BORSA J, 1981, VIROLOGY, V111, P191, DOI 10.1016/0042-6822(81)90664-4; BOSSEMEYER D, 1994, TRENDS BIOCHEM SCI, V19, P201, DOI 10.1016/0968-0004(94)90022-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chandran K, 1998, J VIROL, V72, P467, DOI 10.1128/JVI.72.1.467-475.1998; Chandran K, 1999, J VIROL, V73, P3941, DOI 10.1128/JVI.73.5.3941-3950.1999; CHANDRAN K, 2001, THESIS U WISCONSIN M; CHANG CT, 1971, VIROLOGY, V46, P544, DOI 10.1016/0042-6822(71)90058-4; CHEN WY, 1991, J BIOL CHEM, V266, P9355; DRYDEN KA, 1993, J CELL BIOL, V122, P1023, DOI 10.1083/jcb.122.5.1023; Estes M.K., 2001, FIELDS VIROLOGY, V2., P1747; FIELDS BN, 1971, VIROLOGY, V43, P569, DOI 10.1016/0042-6822(71)90282-0; FURLONG DB, 1988, J VIROL, V62, P246, DOI 10.1128/JVI.62.1.246-256.1988; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Gouaux E, 1997, CURR OPIN STRUC BIOL, V7, P566, DOI 10.1016/S0959-440X(97)80123-6; GRIMES J, 1995, NATURE, V373, P167, DOI 10.1038/373167a0; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hooper JW, 1996, J VIROL, V70, P672, DOI 10.1128/JVI.70.1.672-677.1996; Hooper JW, 1996, J VIROL, V70, P459, DOI 10.1128/JVI.70.1.459-467.1996; HUISMANS H, 1976, VIROLOGY, V70, P411, DOI 10.1016/0042-6822(76)90282-8; IMANI F, 1988, P NATL ACAD SCI USA, V85, P7887, DOI 10.1073/pnas.85.21.7887; JAYASURIYA AK, 1988, VIROLOGY, V163, P591, DOI 10.1016/0042-6822(88)90300-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LEE PWK, 1981, VIROLOGY, V108, P156, DOI 10.1016/0042-6822(81)90535-3; Lesieur C, 1997, MOL MEMBR BIOL, V14, P45, DOI 10.3109/09687689709068435; LUCIAJANDRIS P, 1993, J VIROL, V67, P5339, DOI 10.1128/JVI.67.9.5339-5345.1993; Mathieu M, 2001, EMBO J, V20, P1485, DOI 10.1093/emboj/20.7.1485; MOSCUFO N, 1993, J VIROL, V67, P5075, DOI 10.1128/JVI.67.8.5075-5078.1993; NIBERT ML, 1991, J VIROL, V65, P1960, DOI 10.1128/JVI.65.4.1960-1967.1991; NIBERT ML, 1992, J VIROL, V66, P6408, DOI 10.1128/JVI.66.11.6408-6418.1992; Nibert ML., 2001, FIELDS VIROLOGY, P1679; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Olland AM, 2001, EMBO J, V20, P979, DOI 10.1093/emboj/20.5.979; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Racaniello V.R., 2001, FIELDS VIROLOGY, P455; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SCHIFF LA, 1988, MOL CELL BIOL, V8, P273, DOI 10.1128/MCB.8.1.273; SHARPE AH, 1982, VIROLOGY, V122, P381, DOI 10.1016/0042-6822(82)90237-9; SHATKIN AJ, 1972, J VIROL, V10, P698, DOI 10.1128/JVI.10.4.698-706.1972; Shing M, 1996, VIRUS RES, V46, P19, DOI 10.1016/S0168-1702(96)01372-X; SILVERSTEIN SC, 1970, P NATL ACAD SCI USA, V67, P275, DOI 10.1073/pnas.67.1.275; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; SPEIR JA, 1995, STRUCTURE, V3, P63, DOI 10.1016/S0969-2126(01)00135-6; TANAKA T, 1995, NATURE, V376, P444, DOI 10.1038/376444a0; TILLOTSON L, 1992, J VIROL, V66, P2180, DOI 10.1128/JVI.66.4.2180-2186.1992; TOSTESON MT, 1993, P NATL ACAD SCI USA, V90, P10549, DOI 10.1073/pnas.90.22.10549; WIENER JR, 1988, VIROLOGY, V163, P603, DOI 10.1016/0042-6822(88)90301-7; ZWEERINK HJ, 1970, VIROLOGY, V41, P501, DOI 10.1016/0042-6822(70)90171-6; [No title captured]	59	179	202	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2002	108	2					283	295		10.1016/S0092-8674(02)00612-8	http://dx.doi.org/10.1016/S0092-8674(02)00612-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832217	Green Accepted, Bronze			2022-12-24	WOS:000173521300014
J	Hyde, PS; Knudsen, EI				Hyde, PS; Knudsen, EI			The optic tectum controls visually guided adaptive plasticity in the owl's auditory space map	NATURE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; FREQUENCY-SPECIFIC ADJUSTMENTS; SUPERIOR COLLICULAR MAP; BARN OWL; INFERIOR COLLICULUS; NEURAL REPRESENTATION; LOCALIZATION CUES; GUINEA-PIG; CALIBRATION; DEPRIVATION	The midbrain contains an auditory map of space that is shaped by visual experience(1-3). When barn owls are raised wearing spectacles that horizontally displace the visual field, the auditory space map in the external nucleus of the inferior colliculus (ICX) shifts according to the optical displacement of the prisms(4). Topographic visual activity in the optic tectum could serve as the template that instructs the auditory space map(5). We studied the effects of a restricted, unilateral lesion in the portion of the optic tectum that represents frontal space. Here we show that such a lesion eliminates adaptive adjustments specifically in the portion of the auditory map that represents frontal space on the same side of the brain, while the rest of the map continues to adjust adaptively. Thus, activity in the tectum calibrates the auditory space map in a location-specific manner. Because the site of adaptive changes is the ICX4,6,7, the results also indicate that the tectum provides a topographic instructive signal that controls adaptive auditory plasticity in the ICX.	Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Knudsen, EI (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.							Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Brainard MS, 1998, J NEUROSCI, V18, P3929; BRAINARD MS, 1993, J NEUROSCI, V13, P4589; Cohen YE, 2000, NEURON, V27, P647, DOI 10.1016/S0896-6273(00)00073-8; DeBello WM, 2001, J NEUROSCI, V21, P3161, DOI 10.1523/JNEUROSCI.21-09-03161.2001; Feldman DE, 1997, J NEUROSCI, V17, P6820; Gold JI, 2000, J NEUROSCI, V20, P3469, DOI 10.1523/JNEUROSCI.20-09-03469.2000; Gold JI, 1999, J NEUROPHYSIOL, V82, P2197, DOI 10.1152/jn.1999.82.5.2197; Gold JI, 2000, J NEUROSCI, V20, P862, DOI 10.1523/JNEUROSCI.20-02-00862.2000; Hyde PS, 2000, J COMP NEUROL, V421, P146, DOI 10.1002/(SICI)1096-9861(20000529)421:2<146::AID-CNE2>3.0.CO;2-5; HYDE PS, IN PRESS J NEUROSCI; KING AJ, 1993, EXP BRAIN RES, V94, P444; KING AJ, 1993, EXP PHYSIOL, V78, P559, DOI 10.1113/expphysiol.1993.sp003708; KING AJ, 1988, NATURE, V332, P73, DOI 10.1038/332073a0; KING AJ, 1987, J NEUROPHYSIOL, V57, P596, DOI 10.1152/jn.1987.57.2.596; Klier EM, 2001, NAT NEUROSCI, V4, P627, DOI 10.1038/88450; KNUDSEN EI, 1983, J COMP NEUROL, V218, P187, DOI 10.1002/cne.902180206; KNUDSEN EI, 1995, J NEUROSCI, V15, P5139; KNUDSEN EI, 1982, J NEUROSCI, V2, P1177; KNUDSEN EI, 1991, J NEUROSCI, V11, P1727; KNUDSEN EI, 1995, ANNU REV NEUROSCI, V18, P19, DOI 10.1146/annurev.ne.18.030195.000315; KNUDSEN EI, 1991, SCIENCE, V253, P85, DOI 10.1126/science.2063209; KNUDSEN EI, 1992, J NEUROSCI, V12, P3485; LUSCH H, 2000, J NEUROSCI, V20, P1; MIDDLEBROOKS JC, 1984, J NEUROSCI, V4, P2621; Stein BE., 1993, MERGING SENSES; Troyer TW, 2000, J NEUROPHYSIOL, V84, P1204, DOI 10.1152/jn.2000.84.3.1204; WITHINGTONWRAY DJ, 1990, EUR J NEUROSCI, V2, P682, DOI 10.1111/j.1460-9568.1990.tb00458.x; WITHINGTONWRAY DJ, 1990, EUR J NEUROSCI, V2, P693, DOI 10.1111/j.1460-9568.1990.tb00459.x; Zheng WM, 2001, J NEUROSCI, V21, P4356, DOI 10.1523/JNEUROSCI.21-12-04356.2001	30	45	45	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					73	76		10.1038/415073a	http://dx.doi.org/10.1038/415073a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780119				2022-12-24	WOS:000173028800042
J	Galant, R; Carroll, SB				Galant, R; Carroll, SB			Evolution of a transcriptional repression domain in an insect Hox protein	NATURE			English	Article							FUNCTIONAL EQUIVALENCE; GENE-EXPRESSION; HOMEOTIC GENES; DNA-BINDING; EXTRADENTICLE; ULTRABITHORAX	Homeotic (Hox) genes code for principal transcriptional regulators of animal body regionalization(1). The duplication and divergence of Hox genes, changes in their regulation, and changes in the regulation of Hox target genes have all been implicated in the evolution of animal diversity(2-4). It is not known whether Hox proteins have also acquired new activities during the evolution of specific lineages. Amino-acid sequences outside the DNA-binding homeodomains of Hox orthologues diverge significantly. These sequence differences may be neutral with respect to protein function, or they could be involved in the functional divergence of Hox proteins and the evolutionary diversification of animals. Here, we identify a transcriptional repression domain in the carboxy-terminal region of the Drosophila Ultrabithorax (Ubx) protein. This domain is highly conserved among Ubx orthologues in other insects, but is absent from Ubx in other arthropods and onychophorans. The evolution of this domain may have facilitated the greater morphological diversification of posterior thoracic and anterior abdominal segments characteristic of modern insects.	Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 1525 Linden Dr, Madison, WI 53706 USA.	sbcarrol@facstgaff.wisc.edu						Alonso CR, 2001, CURR BIOL, V11, P1473, DOI 10.1016/S0960-9822(01)00425-0; BACHILLER D, 1994, EMBO J, V13, P1930, DOI 10.1002/j.1460-2075.1994.tb06462.x; Bennett RL, 1999, DEV GENES EVOL, V209, P608, DOI 10.1007/s004270050295; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carroll S. B., 2001, DNA DIVERSITY MOL GE; CARROLL SB, 1995, NATURE, V376, P479, DOI 10.1038/376479a0; CASTELLIGAIR J, 1994, DEVELOPMENT, V120, P1983; CHANG CP, 1995, GENE DEV, V9, P663, DOI 10.1101/gad.9.6.663; DALTON S, 1992, CELL, V68, P597, DOI 10.1016/0092-8674(92)90194-H; Dearden P, 1999, CURR BIOL, V9, pR591, DOI 10.1016/S0960-9822(99)80381-9; Gellon G, 1998, BIOESSAYS, V20, P116, DOI 10.1002/(SICI)1521-1878(199802)20:2<116::AID-BIES4>3.3.CO;2-N; Gibson G, 2000, CURR BIOL, V10, pR452, DOI 10.1016/S0960-9822(00)00531-5; Greer JM, 2000, NATURE, V403, P661, DOI 10.1038/35001077; Grenier JK, 2000, P NATL ACAD SCI USA, V97, P704, DOI 10.1073/pnas.97.2.704; HannaRose W, 1996, TRENDS GENET, V12, P229, DOI 10.1016/0168-9525(96)10022-6; Janody F, 2001, DEVELOPMENT, V128, P2281; JOHNSON FB, 1995, P NATL ACAD SCI USA, V92, P739, DOI 10.1073/pnas.92.3.739; KELSH R, 1994, DEV GENET, V15, P19, DOI 10.1002/dvg.1020150104; Lohr U, 2001, CURR BIOL, V11, P1403, DOI 10.1016/S0960-9822(01)00443-2; MANAK JR, 1994, DEVELOPMENT, V120, P3605; MCGINNIS N, 1990, CELL, V63, P969, DOI 10.1016/0092-8674(90)90500-E; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; RAUSKOLB C, 1994, EMBO J, V13, P3561, DOI 10.1002/j.1460-2075.1994.tb06663.x; RONSHAUGEN M, 2002, NATURE          0202; VACHON G, 1992, CELL, V71, P437, DOI 10.1016/0092-8674(92)90513-C; VANDIJK MA, 1994, CELL, V78, P617, DOI 10.1016/0092-8674(94)90526-6; White RAH, 2000, MECH DEVELOP, V91, P217, DOI 10.1016/S0925-4773(99)00306-8; Yeung K, 1997, MOL CELL BIOL, V17, P36, DOI 10.1128/MCB.17.1.36; Zakany J, 1996, DEV BIOL, V176, P325, DOI 10.1006/dbio.1996.0137; ZHAO JJ, 1993, GENE DEV, V7, P343, DOI 10.1101/gad.7.3.343	30	251	262	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2002	415	6874					910	913		10.1038/nature717	http://dx.doi.org/10.1038/nature717			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859369				2022-12-24	WOS:000173941000045
J	Henshilwood, CS; d'Errico, F; Yates, R; Jacobs, Z; Tribolo, C; Duller, GAT; Mercier, N; Sealy, JC; Valladas, H; Watts, I; Wintle, AG				Henshilwood, CS; d'Errico, F; Yates, R; Jacobs, Z; Tribolo, C; Duller, GAT; Mercier, N; Sealy, JC; Valladas, H; Watts, I; Wintle, AG			Emergence of modern human behavior: Middle Stone Age engravings from South Africa	SCIENCE			English	Article							LUMINESCENCE	In the Eurasian Upper Paleotithic after about 35,000 years ago, abstract or depictional images provide evidence for cognitive abilities considered integral to modern human behavior. Here we report on two abstract representations engraved on pieces of red ochre recovered from the Middle Stone Age layers at Blombos Cave in South Africa. A mean date of 77,000 years was obtained for the layers containing the engraved ochres by thermoluminescence dating of burnt lithics, and the stratigraphic integrity was confirmed by an optically stimulated luminescence age of 70,000 years on an overlying dune. These engravings support the emergence of modern human behavior in Africa at least 35,000 years before the start of the Upper Paleolithic.	S African Museum, Iziko Museums Cape Town, ZA-8000 Cape Town, South Africa; SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA; Univ Bergen, Ctr Dev Studies, N-5007 Bergen, Norway; CNRS, UMR 5808, Inst Prehist & Geol Quanternaire, F-33405 Talence, France; Univ Wales, Inst Geog & Earth Sci, Luminescence Dating Lab, Aberystwyth SY23 3DB, Dyfed, Wales; CEA, CNRS, UMR, Lab Sci Climat & Environm, F-91198 Gif Sur Yvette, France; Univ Cape Town, Dept Archaeol, ZA-7701 Rondebosch, South Africa	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Bergen; Centre National de la Recherche Scientifique (CNRS); Aberystwyth University; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); University of Cape Town	Henshilwood, CS (corresponding author), S African Museum, Iziko Museums Cape Town, POB 61, ZA-8000 Cape Town, South Africa.		Jacobs, Zenobia/B-2721-2012; Duller, Geoffrey/AAR-7494-2020; Henshilwood, Christopher S/K-3806-2014; Duller, Geoffrey A.T./D-5110-2015	Jacobs, Zenobia/0000-0001-5424-5837; Duller, Geoffrey/0000-0002-2694-4590; Henshilwood, Christopher S/0000-0002-2818-293X; Duller, Geoffrey A.T./0000-0002-2694-4590; TRIBOLO, Chantal/0000-0003-0506-2430; Sealy, Judith/0000-0001-5071-8211; Mercier, Norbert/0000-0002-6375-9108				AIELLO L, 1998, ORIGIN DIVERSIFICATI; BAHN P, 1997, J ICE AGE; Botter-Jensen L, 2000, RADIAT MEAS, V32, P523, DOI 10.1016/S1350-4487(00)00039-1; DEACON HJ, 1999, HUMAN BEGINNINGS S; DErrico F, 1997, J HUM EVOL, V33, P1, DOI 10.1006/jhev.1997.0141; Gibson K., 1996, MODELLING EARLY HUMA; Henshilwood C, 1997, CURR ANTHROPOL, V38, P890, DOI 10.1086/204678; Henshilwood CS, 2001, J HUM EVOL, V41, P631, DOI 10.1006/jhev.2001.0515; Henshilwood CS, 2001, J ARCHAEOL SCI, V28, P421, DOI 10.1006/jasc.2000.0638; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Joron J.-L., 1974, THESIS U PARIS SUD; Klein R.G., 1999, HUMAN CAREER; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Mercier N., 1992, ANCIENT TL, V10, P28; Murray AS, 2000, RADIAT MEAS, V32, P57, DOI 10.1016/S1350-4487(99)00253-X; Roberts R, 1998, NATURE, V393, P358, DOI 10.1038/30718; *SCAND COL I, 1999, NAT COL SYST IND; Stringer C.B., 1996, CONT ISSUES HUMAN EV, V21, P115; VALLADAS H, 1992, QUATERNARY SCI REV, V11, P1, DOI 10.1016/0277-3791(92)90034-6; Vogel JC, 1999, J ARCHAEOL SCI, V26, P729, DOI 10.1006/jasc.1999.0450; VOGEL JC, 2000, HUMANITY AFRICAN NAI, P261; Walter RC, 2000, NATURE, V405, P65, DOI 10.1038/35011048; WATTS J, 1999, EVOLUTION CULTURE, P113; Willermet C. M., 1997, CONCEPTUAL ISSUES MO; WURZ S, 2000, THESIS STELLENBOSCH; YELLEN JE, 1995, SCIENCE, V268, P553, DOI 10.1126/science.7725100	26	547	565	0	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1278	1280		10.1126/science.1067575	http://dx.doi.org/10.1126/science.1067575			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	522ZC	11786608				2022-12-24	WOS:000173926000039
J	Trainor, PA; Ariza-McNaughton, L; Krumlauf, R				Trainor, PA; Ariza-McNaughton, L; Krumlauf, R			Role of the isthmus and FGFs in resolving the paradox of neural crest plasticity and prepatterning	SCIENCE			English	Article							TIME-LAPSE ANALYSIS; HOMEOTIC TRANSFORMATION; GENE-EXPRESSION; CELL-MIGRATION; HINDBRAIN; EMBRYO; HOXA-2; DISRUPTION; RHOMBOMERE; MESENCHYME	Cranial neural crest cells generate the distinctive bone and connective tissues in the vertebrate head. Classical models of craniofacial development argue that the neural crest is prepatterned or preprogrammed to make specific head structures before its migration from the neural tube. In contrast, recent studies in several vertebrates have provided evidence for plasticity in patterning neural crest populations. Using tissue transposition and molecular analyses in avian embryos, we reconcile these findings by demonstrating that classical manipulation experiments, which form the basis of the prepatterning model, involved transplantation of a local signaling center, the isthmic organizer. FGF8 signaling from the isthmus alters Hoxa2 expression and consequently branchial. arch patterning, demonstrating that neural crest cells are patterned by environmental signals.	Stowers Inst Med Res, Kansas City, MO 64110 USA; Natl Inst Med Res, Div Dev Neurobiol, London NW7 1AX, England	Stowers Institute for Medical Research; MRC National Institute for Medical Research	Krumlauf, R (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.		Krumlauf, Robb/AAH-5012-2019	Krumlauf, Robb/0000-0001-9102-7927; Trainor, Paul/0000-0003-2774-3624				CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; Couly G, 1996, DEVELOPMENT, V122, P3393; Couly G, 1998, DEVELOPMENT, V125, P3445; Crossley PH, 1996, CELL, V84, P127, DOI 10.1016/S0092-8674(00)80999-X; GENDRONMAGUIRE M, 1993, CELL, V75, P1317, DOI 10.1016/0092-8674(93)90619-2; Grammatopoulos GA, 2000, DEVELOPMENT, V127, P5355; GRAPINBOTTON A, 1995, DEVELOPMENT, V121, P2707; Hunt P, 1998, DEV BIOL, V198, P82, DOI 10.1006/dbio.1998.8886; Irving C, 2000, DEVELOPMENT, V127, P177; Itasaki N, 1996, NEURON, V16, P487, DOI 10.1016/S0896-6273(00)80069-0; Joyner AL, 1996, TRENDS GENET, V12, P15, DOI 10.1016/0168-9525(96)81383-7; Kanzler B, 1998, DEVELOPMENT, V125, P2587; Kulesa P, 2000, DEVELOPMENT, V127, P2843; Kulesa PM, 2000, DEVELOPMENT, V127, P1161; Le Douarin N., 1999, DEV CELL BIOL SERIES, V2nd, DOI [10.1017/CBO9780511897948, DOI 10.1017/CBO9780511897948, 10.1017/cbo9780511897948]; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; NODEN DM, 1988, DEVELOPMENT, V103, P121; OSUMIYAMASHITA N, 1994, DEV BIOL, V164, P409, DOI 10.1006/dbio.1994.1211; Pasqualetti M, 2000, DEVELOPMENT, V127, P5367; RIJLI FM, 1993, CELL, V75, P1333, DOI 10.1016/0092-8674(93)90620-6; Saldivar JR, 1997, DEVELOPMENT, V124, P2729; Saldivar JR, 1996, DEVELOPMENT, V122, P895; Schilling TF, 2001, DEV BIOL, V231, P201, DOI 10.1006/dbio.2000.9997; SCHILLING TF, 1994, DEVELOPMENT, V120, P483; SECHRIST J, 1993, DEVELOPMENT, V118, P691; SERBEDZIJA GN, 1992, DEVELOPMENT, V116, P297; Trainor P, 2000, NAT CELL BIOL, V2, P96, DOI 10.1038/35000051; Trainor PA, 2000, NAT REV NEUROSCI, V1, P116, DOI 10.1038/35039056	30	132	137	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1288	1291		10.1126/science.1064540	http://dx.doi.org/10.1126/science.1064540			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847340				2022-12-24	WOS:000173926000042
J	Houchmandzadeh, B; Wieschaus, E; Leibler, S				Houchmandzadeh, B; Wieschaus, E; Leibler, S			Establishment of developmental precision and proportions in the early Drosophila embryo	NATURE			English	Article							DEPENDENT MANNER; BICOID PROTEIN; GAP GENES; HUNCHBACK; GRADIENT; STAUFEN	During embryonic development, orderly patterns of gene expression eventually assign each cell in the embryo its particular fate. For the anteroposterior axis of the Drosophila embryo, the first step in this process depends on a spatial gradient of the maternal morphogen Bicoid (Bcd). Positional information of this gradient is transmitted to downstream gap genes, each occupying a well defined spatial domain(1-4). We determined the precision of the initial process by comparing expression domains in different embryos. Here we show that the Bcd gradient displays a high embryo-to-embryo variability, but that this noise in the positional information is strongly decreased ('filtered') at the level of hunchback (hb) gene expression. In contrast to the Bcd gradient, the hb expression pattern already includes the information about the scale of the embryo. We show that genes known to interact directly with Hb are not responsible for its spatial precision, but that the maternal gene staufen may be crucial.	Princeton Univ, Howard Hughes Med Inst, Dept Mol Biol, Princeton, NJ 08544 USA; Univ Grenoble 1, Spectrometrie Phys Lab, CNRS, F-38402 St Martin Dheres, France; Princeton Univ, Dept Phys, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; Princeton University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Princeton University	Wieschaus, E (corresponding author), Princeton Univ, Howard Hughes Med Inst, Dept Mol Biol, Princeton, NJ 08544 USA.		Houchmandzadeh, Bahram/F-9199-2012	Houchmandzadeh, Bahram/0000-0001-8104-2576				DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; HULSKAMP M, 1994, GENETICS, V138, P125; JACKLE H, 1986, NATURE, V324, P668, DOI 10.1038/324668a0; KOSSMAN D, 1908, DEV GENES EVOL, V208, P290; Lacalli T.C., 1991, Seminars in Developmental Biology, V2, P107; MERRILL PT, 1988, DEVELOPMENT, V104, P495; Press WH., 1992, NUMERICAL RECIPES C; Roberts D. B., 1998, DROSOPHILA PRACTICAL; Segel I.H., 1975, ENZYME KINETICS; SIMPSONBROSE M, 1994, CELL, V78, P855, DOI 10.1016/S0092-8674(94)90622-X; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; STRUHL G, 1992, CELL, V69, P237, DOI 10.1016/0092-8674(92)90405-2; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; TREISMAN J, 1989, NATURE, V341, P335, DOI 10.1038/341335a0; Wimmer EA, 2000, SCIENCE, V287, P2476, DOI 10.1126/science.287.5462.2476; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0	18	364	373	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					798	802		10.1038/415798a	http://dx.doi.org/10.1038/415798a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845210				2022-12-24	WOS:000173833900048
J	Beja, O; Suzuki, MT; Heidelberg, JF; Nelson, WC; Preston, CM; Hamada, T; Eisen, JA; Fraser, CM; DeLong, EF				Beja, O; Suzuki, MT; Heidelberg, JF; Nelson, WC; Preston, CM; Hamada, T; Eisen, JA; Fraser, CM; DeLong, EF			Unsuspected diversity among marine aerobic anoxygenic phototrophs	NATURE			English	Article							PHOTOSYNTHESIS GENE-CLUSTER; RHODOBACTER-CAPSULATUS; BACTERIOCHLOROPHYLL ALPHA; BACTERIA; ORGANIZATION; SUBUNIT; REGION	Aerobic, anoxygenic, phototrophic bacteria containing bacteriochlorophyll a (Bchla) require oxygen for both growth and Bchla synthesis(1-6). Recent reports suggest that these bacteria are widely distributed in marine plankton, and that they may account for up to 5% of surface ocean photosynthetic electron transport 7 and 11% of the total microbial community(8). Known planktonic anoxygenic phototrophs belong to only a few restricted groups within the Proteobacteria a-subclass. Here we report genomic analyses of the photosynthetic gene content and operon organization in naturally occurring marine bacteria. These photosynthetic gene clusters included some that most closely resembled those of Proteobacteria from the beta-subclass, which have never before been observed in marine environments. Furthermore, these photosynthetic genes were broadly distributed in marine plankton, and actively expressed in neritic bacterioplankton assemblages, indicating that the newly identified phototrophs were photosynthetically competent. Our data demonstrate that planktonic bacterial assemblages are not simply composed of one uniform, widespread class of anoxygenic phototrophs, as previously proposed(8); rather, these assemblages contain multiple, distantly related, photosynthetically active bacterial groups, including some unrelated to known and cultivated types.	Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Inst Genom Res, Rockville, MD 20850 USA; Marine Biotechnol Inst, Kamaishi Labs, Kamaishi, Iwate 0260001, Japan	Monterey Bay Aquarium Research Institute; J. Craig Venter Institute	DeLong, EF (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.		Suzuki, Marcelino/D-3329-2009; chen, qi/C-8585-2011; Eisen, Jonathan A./H-2706-2019; Nelson, William C/E-9263-2016	Suzuki, Marcelino/0000-0003-3868-6362; Eisen, Jonathan A./0000-0002-0159-2197; Nelson, William C/0000-0002-1873-3929; Fraser, Claire/0000-0003-1462-2428; Heidelberg, John/0000-0003-0673-3224				Achenbach LA, 2001, APPL ENVIRON MICROB, V67, P2922, DOI 10.1128/AEM.67.7.2922-2926.2001; Alberti M, 1995, ANOXYGENIC PHOTOSYNT, P1083; BAUER CE, 1991, MOL GEN GENET, V228, P433, DOI 10.1007/BF00260637; Beja O, 2000, ENVIRON MICROBIOL, V2, P516, DOI 10.1046/j.1462-2920.2000.00133.x; BURKE DH, 1993, J BACTERIOL, V175, P2414, DOI 10.1128/JB.175.8.2414-2422.1993; Choudhary M, 2000, NUCLEIC ACIDS RES, V28, P862, DOI 10.1093/nar/28.4.862; Felsenstein J, 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fenchel T, 2001, SCIENCE, V292, P2444, DOI 10.1126/science.1062799; Hahn FM, 1996, J BACTERIOL, V178, P619, DOI 10.1128/jb.178.3.619-624.1996; Harashima K., 1989, AEROBIC PHOTOSYNTHET; Igarashi N, 2001, J MOL EVOL, V52, P333, DOI 10.1007/s002390010163; Karl DM, 1996, DEEP-SEA RES PT II, V43, P129, DOI 10.1016/0967-0645(96)00005-7; Kolber ZS, 2000, NATURE, V407, P177, DOI 10.1038/35025044; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; Massana R, 1997, APPL ENVIRON MICROB, V63, P50, DOI 10.1128/AEM.63.1.50-56.1997; Nagashima KVP, 1997, J MOL EVOL, V45, P131, DOI 10.1007/PL00006212; Naylor GW, 1999, PHOTOSYNTH RES, V62, P121, DOI 10.1023/A:1006350405674; Petersen BL, 1998, HEREDITAS, V129, P131, DOI 10.1111/j.1601-5223.1998.00131.x; SHIBA T, 1991, APPL ENVIRON MICROB, V57, P295, DOI 10.1128/AEM.57.1.295-300.1991; SHIBA T, 1979, APPL ENVIRON MICROB, V38, P43, DOI 10.1128/AEM.38.1.43-45.1979; Suzuki MT, 1997, APPL ENVIRON MICROB, V63, P983, DOI 10.1128/AEM.63.3.983-989.1997; Suzuki MT, 2001, AQUAT MICROB ECOL, V24, P117, DOI 10.3354/ame024117; Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724; YURKOV V, 1994, INT J SYST BACTERIOL, V44, P427, DOI 10.1099/00207713-44-3-427; Yurkov VV, 1998, MICROBIOL MOL BIOL R, V62, P695, DOI 10.1128/MMBR.62.3.695-724.1998	25	317	339	2	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					630	633		10.1038/415630a	http://dx.doi.org/10.1038/415630a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832943	hybrid			2022-12-24	WOS:000173709100043
J	Chiu, CH; Wu, TL; Su, LH; Chu, CS; Chia, JH; Kuo, AJ; Chien, MS; Lin, TY				Chiu, CH; Wu, TL; Su, LH; Chu, CS; Chia, JH; Kuo, AJ; Chien, MS; Lin, TY			The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype choleraesuis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FIELD GEL-ELECTROPHORESIS; VIRULENCE PLASMIDS; UNITED-STATES; QUINOLONE; CIPROFLOXACIN; BACTEREMIA; MUTATIONS; OUTBREAK; SEROVARS; HUMANS	Background Salmonella enterica: serotype choleraesuis is a cause of serious systemic infections. Because fluoroquinolones are the drug of choice for the treatment of severe salmonella infections, the emergence and dissemination of fluoroquinolone-resistant S. enterica serotype choleraesuis have clinical consequences. Methods: In Taiwan, a hospital-based surveillance system has been in place since 1987 to monitor the incidence of S. enterica serotype choleraesuis infections and the antimicrobial susceptibility of the isolates. We investigated the rapid emergence of fluoroquinolone resistance in this serotype in 2000 and 2001. Pigs in Taiwan were evaluated as a potential source of the resistant salmonella. Results: A total of 501 clinical isolates of S. enterica serotype choleraesuis were recovered in our hospital from 1987 through 2000. The proportion of total salmonella isolates made up by S. enterica serotype choleraesuis decreased from an average of 8.4 percent before 1995 to 2.7 percent in 1996 through 1998. During 1999 and 2000, this proportion increased significantly, to an average of 5.0 percent. Ciprofloxacin resistance in S. enterica serotype choleraesuis has been observed since 2000. In the third quarter of 2001, 60 percent of isolates were resistant to ciprofloxacin. Molecular typing indicated that the primary source of S. enterica serotype choleraesuis isolates was herds of swine. All the resistant isolates from humans and swine had mutations that led to the substitution of phenylalanine for serine at position 83 and asparagine for aspartic acid at position 87 in the gene for DNA gyrase A. Conclusions: This investigation in Taiwan indicates that fluoroquinolone-resistant S. enterica serotype choleraesuis can spread from swine to humans. The use of fluoroquinolones in food animals should be prohibited.	Chang Gung Childrens Hosp, Dept Pediat, Div Pediat Infect Dis, Tao Yuan, Taiwan; Chang Gung Mem Hosp, Dept Clin Pathol, Tao Yuan, Taiwan; Chang Gung Univ, Coll Med, Dept Microbiol & Immunol, Tao Yuan, Taiwan; Natl Chung Hsing Univ, Grad Inst Vet Pathol, Taichung 40227, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; National Chung Hsing University	Chiu, CH (corresponding author), Chang Gung Childrens Hosp, Dept Pediat, Div Pediat Infect Dis, 5 Pu Hsin St,Kweishan 333, Tao Yuan, Taiwan.	chchiu@adm.cgmh.org.tw						Bender JB, 2001, NEW ENGL J MED, V344, P189, DOI 10.1056/NEJM200101183440305; Chiu CH, 1996, J CLIN MICROBIOL, V34, P2619, DOI 10.1128/JCM.34.10.2619-2622.1996; Chiu CH, 1999, MICROBIOL IMMUNOL, V43, P899, DOI 10.1111/j.1348-0421.1999.tb01225.x; Chiu CH, 1999, INT J CLIN PRACT, V53, P161; Chu C, 2001, ANTIMICROB AGENTS CH, V45, P2299, DOI 10.1128/AAC.45.8.2299-2303.2001; COHEN JI, 1987, MEDICINE, V66, P349, DOI 10.1097/00005792-198709000-00003; COHEN ML, 1986, SCIENCE, V234, P964, DOI 10.1126/science.3535069; Farmer J. J. Iii, 1995, P438; Frost JA, 1996, J ANTIMICROB CHEMOTH, V37, P85, DOI 10.1093/jac/37.1.85; Giraud E, 1999, ANTIMICROB AGENTS CH, V43, P2131, DOI 10.1128/AAC.43.9.2131; Gorbach SL, 2001, NEW ENGL J MED, V345, P1202, DOI 10.1056/NEJM200110183451610; Griggs DJ, 1996, ANTIMICROB AGENTS CH, V40, P1009, DOI 10.1128/AAC.40.4.1009; GULIG PA, 1993, MOL MICROBIOL, V7, P825, DOI 10.1111/j.1365-2958.1993.tb01172.x; Herikstad H, 1997, EMERG INFECT DIS, V3, P371, DOI 10.3201/eid0303.970316; HOOPER DC, 1991, NEW ENGL J MED, V324, P384, DOI 10.1056/NEJM199102073240606; JACOBSON MA, 1989, ANN INTERN MED, V110, P1027, DOI 10.7326/0003-4819-110-12-1027; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; LEE LA, 1994, J INFECT DIS, V170, P128, DOI 10.1093/infdis/170.1.128; McDonald Lawrence Clifford, 2001, Journal of Microbiology Immunology and Infection, V34, P97; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Molbak K, 1999, NEW ENGL J MED, V341, P1420, DOI 10.1056/NEJM199911043411902; Moller FM, 1998, APMIS, V106, P606, DOI 10.1111/j.1699-0463.1998.tb01391.x; National Archives, 2000, M7A5 NCCLS, P1; National Heart L.a.B.I, 2000, PRACTICAL GUIDE IDEN, P1; Olsen SJ, 2001, NEW ENGL J MED, V344, P1572, DOI 10.1056/NEJM200105243442102; PIDDOCK LJV, 1993, ANTIMICROB AGENTS CH, V37, P662, DOI 10.1128/AAC.37.4.662; Su LH, 2000, J HOSP INFECT, V46, P110, DOI 10.1053/jhin.2000.0815; Tauxe RV, 1997, EMERG INFECT DIS, V3, P425, DOI 10.3201/eid0304.970403; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; White DG, 2001, NEW ENGL J MED, V345, P1147, DOI 10.1056/NEJMoa010315; Wiuff C, 2000, MICROB DRUG RESIST, V6, P11, DOI 10.1089/mdr.2000.6.11	31	200	210	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2002	346	6					413	419		10.1056/NEJMoa012261	http://dx.doi.org/10.1056/NEJMoa012261			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UN	11832529				2022-12-24	WOS:000173686400004
J	Merz, JF; Kriss, AG; Leonard, DGB; Cho, MK				Merz, JF; Kriss, AG; Leonard, DGB; Cho, MK			Diagnostic testing fails the test - The pitfalls of patents are illustrated by the case of haemochromatosis.	NATURE			English	Editorial Material							GENE; HEMOCHROMATOSIS		Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA; George Mason Univ, Sch Law, Arlington, VA 22201 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Stanford Univ, Ctr Biomed Eth, Palo Alto, CA 94304 USA	University of Pennsylvania; Pennsylvania Medicine; George Mason University; University of Pennsylvania; Stanford University	Merz, JF (corresponding author), Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA.			Merz, Jon/0000-0002-0612-7104	NHGRI NIH HHS [R01 HG002034-01A1S2, R01 HG002034-03, R01 HG002034-01A1S1, R01 HG002034, R01 HG002034-01A1, R01 HG002034-02] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002034] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Blumenthal D, 1997, JAMA-J AM MED ASSOC, V277, P1224, DOI 10.1001/jama.277.15.1224; Cho M. K., 1998, PREPARING MILLENNIUM, P47; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Gochee PA, 2001, CURR OPIN HEMATOL, V8, P98, DOI 10.1097/00062752-200103000-00007; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; Merz JF, 1999, CLIN CHEM, V45, P324; Pointon JJ, 2000, GENET TEST, V4, P151, DOI 10.1089/10906570050114867; Schissel A, 1999, NATURE, V402, P118, DOI 10.1038/45907; Thomas SM, 1996, NATURE, V380, P387, DOI 10.1038/380387a0; Thomas SM, 1997, NATURE, V388, P709, DOI 10.1038/41853; Thorstensen K, 2000, GENET TEST, V4, P371, DOI 10.1089/109065700750065117; Wadman M, 2001, NATURE, V413, P443, DOI 10.1038/35097228	12	97	98	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					577	579		10.1038/415577a	http://dx.doi.org/10.1038/415577a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832913	Green Accepted			2022-12-24	WOS:000173709100016
J	Morgan, D; Mahe, C; Mayanja, B; Whitworth, JAG				Morgan, D; Mahe, C; Mayanja, B; Whitworth, JAG			Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NATURAL-HISTORY; RAPID PROGRESSION; SURVIVAL; ADULTS; KIGALI; RWANDA; WOMEN; PREDICTORS; MORTALITY	Objectives To estimate the rate of progression from seroconversion to symptomatic disease in adults infected with HIV-1, and to establish whether the background level of signs and symptoms commonly associated with HIV-1 in uninfected controls are likely to affect progression rates. Design Longitudinal, prospective cohort study of people infected with HIV-1 and randomly selected subjects negative for HIV-1 antibodies identified during population studies. Setting Study clinic with basic medical care in rural Uganda. Subjects 275 patients infected with HIV-1 (107 prevalent cases and 168 incident cases) and 246 controls negative for HIV-1 antibodies. Main outcome measures Signs and symptoms of HIV disease, as determined by stages 2 and 3 of the World Health Organization clinical staging system. Results The median time front seroconversion to WHO stage 2 was 25.4 months and to stage 3 was 45.5 months. 43% of the participants infected with HIV-1 had signs or symptoms by two years after seroconversion. The most common clinical conditions used to define progression of disease were weight loss, mucocutaneous manifestations, bacterial infections, chronic fever, and chronic diarrhoea. Although the rates of these conditions (apart from minor weight loss) were significantly higher in the participants infected with HIV-1, they were also relatively frequent. in the control group. Herpes zoster, oral candidiasis, and pulmonary tuberculosis were not common events in the control group and therefore were more indicative of infection with HIV-1. Conclusions Disease progression associated with infection with HIV-1 seems to be rapid in rural Uganda. This is most likely due to the high prevalence of conditions in the general population that could be taken as symptoms and signs of infection with HIV-1.	Uganda Virus Res Inst, Programme AIDS, MRC, Entebbe, Uganda	Uganda Virus Research Institute	Morgan, D (corresponding author), Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England.		Mayanja, Billy/AAL-5087-2021					ANZALA OA, 1995, J INFECT DIS, V171, P686, DOI 10.1093/infdis/171.3.686; Brettle RP, 1996, INT J STD AIDS, V7, P110, DOI 10.1258/0956462961917302; COLEBUNDERS R, 1991, J INFECT DIS, V164, P450, DOI 10.1093/infdis/164.3.450; Deschamps MM, 2000, AIDS, V14, P2515, DOI 10.1097/00002030-200011100-00014; FLEGG PJ, 1994, J INFECTION, V29, P311, DOI 10.1016/S0163-4453(94)91266-1; French N, 1999, J ACQ IMMUN DEF SYND, V22, P509; HOLMBERG SD, 1995, AM J EPIDEMIOL, V141, P395, DOI 10.1093/oxfordjournals.aje.a117441; Kamali A, 2000, AIDS, V14, P427, DOI 10.1097/00002030-200003100-00017; KERLIKOWSKE KM, 1994, AIDS, V8, P963, DOI 10.1097/00002030-199407000-00014; LEE CA, 1991, BMJ-BRIT MED J, V303, P1093, DOI 10.1136/bmj.303.6810.1093; LEROY V, 1995, J ACQ IMMUN DEF SYND, V9, P415; LINDAN CP, 1992, ANN INTERN MED, V116, P320, DOI 10.7326/0003-4819-116-4-320; MANN JM, 1986, LANCET, V2, P707; MARLINK R, 1994, SCIENCE, V265, P1587, DOI 10.1126/science.7915856; MILLER WC, 1995, J ACQ IMMUN DEF SYND, V9, P408; Morgan D, 1997, AIDS, V11, P633, DOI 10.1097/00002030-199705000-00011; NAGELKERKE NJD, 1990, AIDS, V4, P743, DOI 10.1097/00002030-199008000-00005; NGALY B, 1988, NEW ENGL J MED, V319, P1123, DOI 10.1056/NEJM198810273191704; WHITTLE H, 1992, AIDS, V6, P685, DOI 10.1097/00002030-199207000-00011; *WHO, 1990, WKLY EPIDEMIOL REC, V65, P221	20	83	84	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2002	324	7331					193	196		10.1136/bmj.324.7331.193	http://dx.doi.org/10.1136/bmj.324.7331.193			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517HJ	11809639	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000173604800013
J	Clark, C; Buchwald, D; MacIntyre, A; Sharpe, M; Wessely, S				Clark, C; Buchwald, D; MacIntyre, A; Sharpe, M; Wessely, S			Chronic fatigue syndrome: a step towards agreement	LANCET			English	Editorial Material									Act ME, London EC4V 5AA, England; Univ Washington, Harborview Med Ctr, Chron Fatigue Cooperat Res Ctr, Seattle, WA 98195 USA; Univ Edinburgh, Dept Psychiat, Edinburgh EH8 9YL, Midlothian, Scotland; Guys Kings & St Thomas Sch Med, Dept Psychol Med, London, England	Harborview Medical Center; University of Washington; University of Washington Seattle; University of Edinburgh; University of London; King's College London	Clark, C (corresponding author), Act ME, 4 Deans Court,St Pauls Churchyard, London EC4V 5AA, England.		Wessely, Simon C/A-8713-2008	sharpe, michael/0000-0002-6474-9980				*ROY COLL PHYS PSY, 1996, CHRON FAT SYNDR; Straus SE, 1996, BRIT MED J, V313, P831; Whiting P, 2001, JAMA-J AM MED ASSOC, V286, P1360, DOI 10.1001/jama.286.11.1360; 1996, LANCET, V348, P971	4	18	20	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 12	2002	359	9301					97	98		10.1016/S0140-6736(02)07336-1	http://dx.doi.org/10.1016/S0140-6736(02)07336-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510MT	11809249				2022-12-24	WOS:000173212400006
J	Szabo, SJ; Sullivan, BM; Stemmann, C; Satoskar, AR; Sleckman, BP; Glimcher, LH				Szabo, SJ; Sullivan, BM; Stemmann, C; Satoskar, AR; Sleckman, BP; Glimcher, LH			Distinct effects of T-bet in T(H)1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells	SCIENCE			English	Article							INTERFERON-GAMMA; TARGETED DISRUPTION; RECEPTOR DEFICIENCY; LEISHMANIA-MAJOR; MICE; INFECTION; STAT1; GENE; ACTIVATION; EXPRESSION	T-bet is a member of the T-box family of transcription factors that appears to regulate lineage commitment in CD4 T helper (T-H) lymphocytes in part by activating the hallmark T(H)1 cytokine, interferon-gamma (IFN-gamma), IFN-gamma is aLso produced by natural killer (NK) cells and most prominently by CD8 cytotoxic T cells, and is vital. for the control of microbial pathogens. Although T-bet is expressed in all these cell types, it is required for control of IFN-gamma production in CD4 and NK cells, but not in CD8 cells. This difference is aLso apparent in the function of these cell subsets. Thus, the regulation of a single cytokine, IFN-gamma, is controlled by distinct transcriptional mechanisms within the T cell lineage.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; University System of Ohio; Ohio State University; Washington University (WUSTL)	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.		Satoskar, Abhay/AAB-7748-2019					Asnagli H, 2001, CURR OPIN IMMUNOL, V13, P242, DOI 10.1016/S0952-7915(00)00210-7; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; COICO R, 1994, PROTOCOLS IMMUNOLOGY; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dupuis S, 2001, SCIENCE, V293, P300, DOI 10.1126/science.1061154; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Lee CK, 2000, J IMMUNOL, V165, P3571, DOI 10.4049/jimmunol.165.7.3571; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Monteforte GM, 2000, J IMMUNOL, V164, P5890, DOI 10.4049/jimmunol.164.11.5890; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; O'Garra A, 2000, TRENDS CELL BIOL, V10, P542, DOI 10.1016/S0962-8924(00)01856-0; Papaioannou VE, 1997, TRENDS GENET, V13, P212, DOI 10.1016/S0168-9525(97)01144-X; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; PierreAudigier C, 1997, CLIN INFECT DIS, V24, P982, DOI 10.1093/clinids/24.5.982; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Smith J, 1997, CURR OPIN GENET DEV, V7, P474, DOI 10.1016/S0959-437X(97)80073-1; SZABO S, UNPUB; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tomasello E, 2000, IMMUNITY, V13, P355, DOI 10.1016/S1074-7613(00)00035-2	30	933	1011	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					338	342		10.1126/science.1065543	http://dx.doi.org/10.1126/science.1065543			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786644				2022-12-24	WOS:000173278600053
J	Hamad-Schifferli, K; Schwartz, JJ; Santos, AT; Zhang, SG; Jacobson, JM				Hamad-Schifferli, K; Schwartz, JJ; Santos, AT; Zhang, SG; Jacobson, JM			Remote electronic control of DNA hybridization through inductive coupling to an attached metal nanocrystal antenna	NATURE			English	Article							SINGLE-MOLECULE; SPECIFICITY; AZOBENZENE; PROBES; DESIGN	Increasingly detailed structural(1) and dynamic(2,3) studies are highlighting the precision with which biomolecules execute often complex tasks at the molecular scale. The efficiency and versatility of these processes have inspired many attempts to mimic or harness them. To date, biomolecules have been used to perform computational operations(4) and actuation(5), to construct artificial transcriptional loops that behave like simple circuit elements(6,7) and to direct the assembly of nanocrystals(8). Further development of these approaches requires new tools for the physical and chemical manipulation of biological systems. Biomolecular activity has been triggered optically through the use of chromophores(9-14), but direct electronic control over biomolecular 'machinery' in a specific and fully reversible manner has not yet been achieved. Here we demonstrate remote electronic control over the hybridization behaviour of DNA molecules, by inductive coupling of a radio-frequency magnetic field to a metal nanocrystal covalently linked to DNA(15). Inductive coupling to the nanocrystal increases the local temperature of the bound DNA, thereby inducing denaturation while leaving surrounding molecules relatively unaffected. Moreover, because dissolved biomolecules dissipate heat in less than 50 picoseconds (ref. 16), the switching is fully reversible. Inductive heating of macroscopic samples is widely used(17-19), but the present approach should allow extension of this concept to the control of hybridization and thus of a broad range of biological functions on the molecular scale.	MIT, Media Lab, Cambridge, MA 02139 USA; MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA; Engenos, Waltham, MA 02451 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Jacobson, JM (corresponding author), MIT, Media Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.			Jacobson, Joseph/0000-0002-1332-3197; Zhang, Shuguang/0000-0002-3856-3752				Asanuma H, 1999, TETRAHEDRON LETT, V40, P7995, DOI 10.1016/S0040-4039(99)01547-6; Ashkenazi G, 1997, BIOSENS BIOELECTRON, V12, P85, DOI 10.1016/S0956-5663(97)87054-6; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bonnet G, 1998, P NATL ACAD SCI USA, V95, P8602, DOI 10.1073/pnas.95.15.8602; Bonnet G, 1999, P NATL ACAD SCI USA, V96, P6171, DOI 10.1073/pnas.96.11.6171; Cantor C.R., 1980, BIOPHYS CHEM; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; Deniz AA, 2000, P NATL ACAD SCI USA, V97, P5179, DOI 10.1073/pnas.090104997; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; HAMADSCHIFFERLI K, 2001, MAT RES SOC P; Haupts U, 1999, ANNU REV BIOPH BIOM, V28, P367, DOI 10.1146/annurev.biophys.28.1.367; Hergt R, 1998, IEEE T MAGN, V34, P3745, DOI 10.1109/20.718537; Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ; LIAN TQ, 1994, J PHYS CHEM-US, V98, P11648, DOI 10.1021/j100096a005; Liu D, 1997, BIOORG MED CHEM LETT, V7, P2677, DOI 10.1016/S0960-894X(97)10044-0; Loweth CJ, 1999, ANGEW CHEM INT EDIT, V38, P1808, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1808::AID-ANIE1808>3.0.CO;2-C; Mao CD, 2000, NATURE, V407, P493, DOI 10.1038/35035038; Mattoussi H, 2000, J AM CHEM SOC, V122, P12142, DOI 10.1021/ja002535y; McAdams HH, 2000, CURR BIOL, V10, pR318, DOI 10.1016/S0960-9822(00)00440-1; Monroe WT, 1999, J BIOL CHEM, V274, P20895, DOI 10.1074/jbc.274.30.20895; Orfeuil M., 1987, ELECT PROCESS HEATIN; Probst JC, 2000, METHODS, V22, P271, DOI 10.1006/meth.2000.1079; REARDON JE, 1984, BIOCHEMISTRY-US, V23, P3849, DOI 10.1021/bi00312a009; Taton TA, 2000, SCIENCE, V289, P1757, DOI 10.1126/science.289.5485.1757; Telford JR, 1998, ACCOUNTS CHEM RES, V31, P755, DOI 10.1021/ar970078t; Whaley SR, 2000, NATURE, V405, P665, DOI 10.1038/35015043; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zanchet D, 2001, NANO LETT, V1, P32, DOI 10.1021/nl005508e; Zinn S., 1988, ELEMENTS INDUCTION H	30	317	335	0	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					152	155		10.1038/415152a	http://dx.doi.org/10.1038/415152a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805829				2022-12-24	WOS:000173159300036
J	Peng, LC; Kawagoe, Y; Hogan, P; Delmer, D				Peng, LC; Kawagoe, Y; Hogan, P; Delmer, D			Sitosterol-beta-glucoside as primer for cellulose synthesis in plants	SCIENCE			English	Article							MOLECULAR DIRECTIONALITY; SYNTHASE; ARABIDOPSIS; ENDO-1,4-BETA-GLUCANASE; BIOSYNTHESIS; HERBICIDES; KORRIGAN	Cellulose synthesis in plants requires beta -1,4-glucan chain initiation, elongation, and termination. The process of chain elongation is likely to be distinct from the process of chain initiation. We demonstrate that a CesA glucosyltransferase initiates glucan polymerization by using sitosterol-beta -glucoside (SG) as primer. Cotton fiber membranes synthesize sitosterol-cellodextrins (SCDs) from SG and uridine 5'-diphosphate-glucose (UDP-Glc) under conditions that also favor cellulose synthesis. The cellulase encoded by the Korrigan (Kor) gene, required for cellulose synthesis in plants, may function to cleave SG from the growing polymer chain.	Univ Calif Davis, Plant Biol Sect, Davis, CA 95616 USA	University of California System; University of California Davis	Delmer, D (corresponding author), Univ Calif Davis, Plant Biol Sect, 1 Shields Ave, Davis, CA 95616 USA.	dpdelmer@ucdavis.edu						BLAKENEY AB, 1983, CARBOHYD RES, V113, P291, DOI 10.1016/0008-6215(83)88244-5; BULONE V, 1995, PLANT J, V8, P213, DOI 10.1046/j.1365-313X.1995.08020213.x; CALLAGHAN T, 1988, PLANT PHYSIOL, V86, P1104, DOI 10.1104/pp.86.4.1104; Cantatore JL, 2000, BIOCHEM SOC T, V28, P748, DOI 10.1042/BST0280748; DeAngelis PL, 1999, J BIOL CHEM, V274, P26557, DOI 10.1074/jbc.274.37.26557; Delmer DP, 1999, ANNU REV PLANT PHYS, V50, P245, DOI 10.1146/annurev.arplant.50.1.245; ELBEIN AD, 1975, LIPIDS, V10, P427, DOI 10.1007/BF02532449; Fagard M, 2000, PLANT CELL, V12, P2409, DOI 10.1105/tpc.12.12.2409; FUJINO Y, 1979, BIOCHIM BIOPHYS ACTA, V574, P94; Kamst E, 1999, BIOCHEMISTRY-US, V38, P4045, DOI 10.1021/bi982531u; Koyama M, 1997, P NATL ACAD SCI USA, V94, P9091, DOI 10.1073/pnas.94.17.9091; Lane DR, 2001, PLANT PHYSIOL, V126, P278, DOI 10.1104/pp.126.1.278; Lugemwa FN, 1996, J BIOL CHEM, V271, P19159, DOI 10.1074/jbc.271.32.19159; Molhoj M, 2001, PLANT PHYSIOL, V127, P674, DOI 10.1104/pp.010269; PENG L, UNPUB; Peng LC, 2001, PLANT PHYSIOL, V126, P981, DOI 10.1104/pp.126.3.981; Perrin RM, 2001, CURR BIOL, V11, pR213, DOI 10.1016/S0960-9822(01)00108-7; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Sabba RP, 1999, WEED SCI, V47, P757, DOI 10.1017/S004317450009144X; Sato S, 2001, PLANT CELL PHYSIOL, V42, P251, DOI 10.1093/pcp/pce045; Schaeffer A, 2001, PLANT J, V25, P605, DOI 10.1046/j.1365-313x.2001.00994.x; Scheible WR, 2001, P NATL ACAD SCI USA, V98, P10079, DOI 10.1073/pnas.191361598; Schrick K, 2000, GENE DEV, V14, P1471; Taylor NG, 2000, PLANT CELL, V12, P2529, DOI 10.1105/tpc.12.12.2529; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6	25	296	336	4	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2002	295	5552					147	150		10.1126/science.1064281	http://dx.doi.org/10.1126/science.1064281			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509HV	11778054				2022-12-24	WOS:000173143100055
J	Calfon, M; Zeng, HQ; Urano, F; Till, JH; Hubbard, SR; Harding, HP; Clark, SG; Ron, D				Calfon, M; Zeng, HQ; Urano, F; Till, JH; Hubbard, SR; Harding, HP; Clark, SG; Ron, D			IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA	NATURE			English	Article							UNFOLDED PROTEIN RESPONSE; STRESS; ER; REQUIRES; COORDINATION; INDUCTION; CLEAVAGE; PATHWAY; ATF6	The unfolded protein response (UPR), caused by stress, matches the folding capacity of endoplasmic reticulum (ER) to the load of client proteins in the organelle(1,2). In yeast, processing of HAC1 mRNA by activated Ire1 leads to synthesis of the transcription factor Hac1 and activation of the UPR3. The responses to activated IRE1 in metazoans are less well understood. Here we demonstrate that mutations in either ire-1 or the transcription-factor-encoding xbp-1 gene abolished the UPR in Caenorhabditis elegans. Mammalian XBP-1 is essential for immunoglobulin secretion and development of plasma cells(4), and high levels of XBP-1 messenger RNA are found in specialized secretory cells(5). Activation of the UPR causes IRE1-dependent splicing of a small intron from the XBP-1 mRNA both in C. elegans and mice. The protein encoded by the processed murine XBP-1 mRNA accumulated during the UPR, whereas the protein encoded by unprocessed mRNA did not. Purified mouse IRE1 accurately cleaved XBP-1 mRNA in vitro, indicating that XBP-1 mRNA is a direct target of IRE1 endonucleolytic activity. Our findings suggest that physiological ER load regulates a developmental decision in higher eukaryotes.	NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA	New York University	Ron, D (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA.	ron@saturn.med.nyu.edu	Longo, Kenneth A/A-5631-2010; Urano, Fumihiko/AAF-4492-2020	Ron, David/0000-0002-3014-5636; Harding, Heather P/0000-0002-7359-7974				Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; CLARK SG, 1994, GENETICS, V137, P987; CLAUSS IM, 1993, DEV DYNAM, V197, P146, DOI 10.1002/aja.1001970207; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kawahara T, 1998, J BIOL CHEM, V273, P1802, DOI 10.1074/jbc.273.3.1802; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Niwa M, 1999, CELL, V99, P691, DOI 10.1016/S0092-8674(00)81667-0; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Shamu CE, 1998, CURR BIOL, V8, pR121, DOI 10.1016/S0960-9822(98)70986-8; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	21	2022	2107	6	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2002	415	6867					92	96		10.1038/415092a	http://dx.doi.org/10.1038/415092a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780124				2022-12-24	WOS:000173028800047
J	Gestwicki, JE; Kiessling, LL				Gestwicki, JE; Kiessling, LL			Inter-receptor communication through arrays of bacterial chemoreceptors	NATURE			English	Article							SINGLE CYTOPLASMIC DOMAIN; ESCHERICHIA-COLI; KINASE ACTIVATION; CHEMOTAXIS; COMPLEX; DIMER; SENSITIVITY; MECHANISM; LOCATION; LATTICE	The sensing mechanisms of chemotactic bacteria allow them to respond sensitively to stimuli. Escherichia coli, for example, respond to changes in chemoattractant concentration of less than 10% over a range spanning six orders of magnitude(1,2). Sensitivity over this range depends on a nonlinear relationship between ligand concentration and output response(3). At low ligand concentrations, substantial amplification of the chemotactic signal is required; however, the mechanism responsible for this amplification remains unclear. Here we demonstrate that inter-receptor communication within a lattice(4,5) acts to amplify and integrate sensory information. Synthetic multivalent ligands that interact through the low-abundance, galactose-sensing receptor Trg stabilize large clusters of chemoreceptors and markedly enhance signal output from these enforced clusters. On treatment with multivalent ligands, the response to the attractant serine is amplified by at least 100-fold. This amplification requires a full complement of chemoreceptors; deletion of the aspartate (Tar) or dipeptide (Tap) receptors diminishes the amplification of the serine response. These results demonstrate that the entire array is involved in sensing. This mode of information exchange has general implications for the processing of signals by cellular receptors.	Univ Wisconsin, Dept Chem & Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Kiessling, LL (corresponding author), Univ Wisconsin, Dept Chem & Biochem, Madison, WI 53706 USA.		Kiessling, Laura L/A-4074-2008	Kiessling, Laura/0000-0001-6829-1500				ADLER J, 1973, J BACTERIOL, V115, P824, DOI 10.1128/JB.115.3.824-847.1973; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Barnakov AN, 1998, J BACTERIOL, V180, P6713, DOI 10.1128/JB.180.24.6713-6718.1998; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Bren A, 2000, J BACTERIOL, V182, P6865, DOI 10.1128/JB.182.24.6865-6873.2000; Chan C, 2001, P NATL ACAD SCI USA, V98, P5758, DOI 10.1073/pnas.101113698; Delon J, 2000, CURR BIOL, V10, pR923, DOI 10.1016/S0960-9822(00)00870-8; Duke TAJ, 1999, P NATL ACAD SCI USA, V96, P10104, DOI 10.1073/pnas.96.18.10104; Gardina PJ, 1996, SCIENCE, V274, P425, DOI 10.1126/science.274.5286.425; GEGNER JA, 1992, CELL, V70, P975, DOI 10.1016/0092-8674(92)90247-A; Gestwicki JE, 2000, J BACTERIOL, V182, P6499, DOI 10.1128/JB.182.22.6499-6502.2000; Gestwicki JE, 2000, CHEM BIOL, V7, P583, DOI 10.1016/S1074-5521(00)00002-8; Gestwicki JE, 2001, BIOORGAN MED CHEM, V9, P2387, DOI 10.1016/S0968-0896(01)00162-6; HAZELBAU.GL, 1969, P NATL ACAD SCI USA, V64, P1300, DOI 10.1073/pnas.64.4.1300; HAZELBAUER GL, 1981, J BACTERIOL, V145, P35, DOI 10.1128/JB.145.1.35-42.1981; Jasuja R, 1999, P NATL ACAD SCI USA, V96, P11346, DOI 10.1073/pnas.96.20.11346; Li JY, 1997, BIOCHEMISTRY-US, V36, P11851, DOI 10.1021/bi971510h; Liu Y, 1997, EMBO J, V16, P7231, DOI 10.1093/emboj/16.24.7231; MADDOCK JR, 1993, SCIENCE, V259, P1717; Matsuuchi L, 2001, CURR OPIN IMMUNOL, V13, P270, DOI 10.1016/S0952-7915(00)00215-6; MESIBOV R, 1973, J GEN PHYSIOL, V62, P203, DOI 10.1085/jgp.62.2.203; Ottemann KM, 1999, SCIENCE, V285, P1751, DOI 10.1126/science.285.5434.1751; PARKINSON JS, 1982, J BACTERIOL, V151, P106, DOI 10.1128/JB.151.1.106-113.1982; SAGER BM, 1988, ANAL BIOCHEM, V173, P271, DOI 10.1016/0003-2697(88)90189-3; SCHUSTER SC, 1993, NATURE, V365, P343, DOI 10.1038/365343a0; SLOCUM MK, 1983, J BACTERIOL, V155, P565, DOI 10.1128/JB.155.2.565-577.1983; Tatsuno I, 1996, SCIENCE, V274, P423, DOI 10.1126/science.274.5286.423; Trnka TM, 2001, ACCOUNTS CHEM RES, V34, P18, DOI 10.1021/ar000114f; YEH JI, 1993, J BIOL CHEM, V268, P9787; Yin CC, 2000, NAT CELL BIOL, V2, P669, DOI 10.1038/35023625	30	205	207	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					81	84		10.1038/415081a	http://dx.doi.org/10.1038/415081a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780121				2022-12-24	WOS:000173028800044
J	Cooper, G; Kimmich, N; Belisle, W; Sarinana, J; Brabham, K; Garrel, L				Cooper, G; Kimmich, N; Belisle, W; Sarinana, J; Brabham, K; Garrel, L			Carbonaceous meteorites as a source of sugar-related organic compounds for the early Earth	NATURE			English	Article							MURCHISON METEORITE; MASS SPECTROMETRY; CARBOXYLIC-ACIDS; AMINO-ACIDS; CHROMATOGRAPHY; DERIVATIVES; EVOLUTION; COMETS	The much-studied Murchison meteorite is generally used as the standard reference for organic compounds in extraterrestrial material. Amino acids and other organic compounds(1) important in contemporary biochemistry are thought to have been delivered to the early Earth by asteroids and comets, where they may have played a role in the origin of life(2-4). Polyhydroxylated compounds (polyols) such as sugars, sugar alcohols and sugar acids are vital to all known lifeforms-they are components of nucleic acids (RNA, DNA), cell membranes and also act as energy sources. But there has hitherto been no conclusive evidence for the existence of polyols in meteorites, leaving a gap in our understanding of the origins of biologically important organic compounds on Earth. Here we report that a variety of polyols are present in, and indigenous to, the Murchison and Murray meteorites in amounts comparable to amino acids. Analyses of water extracts indicate that extraterrestrial processes including photolysis and formaldehyde chemistry could account for the observed compounds. We conclude from this that polyols were present on the early Earth and therefore at least available for incorporation into the first forms of life.	NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Univ G DAnnunzio, IRSPS, I-65127 Pescara, Italy	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; G d'Annunzio University of Chieti-Pescara	Cooper, G (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.	gcooper@mail.arc.nasa.gov						AGARWAL VK, 1985, ORIGINS LIFE EVOL B, V16, P21, DOI 10.1007/BF01808047; Amelung W, 1996, SOIL BIOL BIOCHEM, V28, P1631, DOI 10.1016/S0038-0717(96)00248-9; ANDERS E, 1989, NATURE, V342, P255, DOI 10.1038/342255a0; BRIMACOMBE JS, 1972, CARBOHYDRATES CHEM B, P479; Bruijn J.M.de, 1986, SUGAR TECHN REV, V13, P21; BUNCH TE, 1980, GEOCHIM COSMOCHIM AC, V44, P1543, DOI 10.1016/0016-7037(80)90118-0; CHYBA C, 1992, NATURE, V355, P125, DOI 10.1038/355125a0; CODY GD, 1999, LUNAR PLANET SCI C, V30, P1582; COLEMAN ML, 1978, ANAL CHEM, V50, P1594, DOI 10.1021/ac50033a056; COOPER GW, 1995, GEOCHIM COSMOCHIM AC, V59, P1003, DOI 10.1016/0016-7037(95)00018-6; CRONIN JR, 1993, NATO ADV SCI INST SE, V416, P209; DEGENS ET, 1962, NATURWISSENSCHAFTEN, V49, P605, DOI 10.1007/BF01178050; Des Marais DJ, 1997, ORG GEOCHEM, V27, P185, DOI 10.1016/S0146-6380(97)00061-2; EPSTEIN S, 1987, NATURE, V326, P477, DOI 10.1038/326477a0; GILBART J, 1987, EUR J CLIN MICROBIOL, V6, P715, DOI 10.1007/BF02013084; HAYES JM, 1967, GEOCHIM COSMOCHIM AC, V31, P1395, DOI 10.1016/0016-7037(67)90019-1; Hollis JM, 2000, ASTROPHYS J, V540, pL107, DOI 10.1086/312881; Irvine WM, 1999, SPACE SCI REV, V90, P203, DOI 10.1023/A:1005258300558; Jungclaus G. A., 1976, Meteoritics, V11, P231, DOI 10.1111/j.1945-5100.1976.tb00324.x; KAPLAN IR, 1963, GEOCHIM COSMOCHIM AC, V27, P805, DOI 10.1016/0016-7037(63)90045-0; Langenbeck W, 1942, NATURWISSENSCHAFTEN, V30, P30, DOI 10.1007/BF01475765; LARRALDE R, 1995, P NATL ACAD SCI USA, V92, P8158, DOI 10.1073/pnas.92.18.8158; LOWENDAHL L, 1976, TAPPI, V59, P118; McDonald GD, 1996, ICARUS, V122, P107, DOI 10.1006/icar.1996.0112; ORO J, 1961, NATURE, V190, P389, DOI 10.1038/190389a0; PETERSSO.G, 1970, TETRAHEDRON, V26, P3413, DOI 10.1016/S0040-4020(01)92918-7; Pigman W., 1972, CARBOHYDRATES CHEM A, V1, P165; WEBER AL, 1992, J MOL EVOL, V35, P1, DOI 10.1007/BF00160255; Zolensky M., 1988, METEORITES EARLY SOL, P114	29	316	321	4	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					879	883		10.1038/414879a	http://dx.doi.org/10.1038/414879a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780054	Green Published			2022-12-24	WOS:000172813300037
J	Roger, T; David, J; Glauser, MP; Calandra, T				Roger, T; David, J; Glauser, MP; Calandra, T			MIF regulates innate immune responses through modulation of Toll-like receptor 4	NATURE			English	Article							MIGRATION-INHIBITORY FACTOR; BINDING-PROTEIN; CUTTING EDGE; LIPOPOLYSACCHARIDE-BINDING; LETHAL ENDOTOXEMIA; MACROPHAGE; GENE; LPS; EXPRESSION; ACTIVATION	Macrophages are pivotal effector cells of the innate immune system, which is vital for recognizing and eliminating invasive microbial pathogens(1,2). When microbial products bind to pathogen-recognition receptors, macrophages become activated and release a broad array of cytokines(3) that orchestrate the host innate and adaptive immune responses. Initially identified as a T-cell cytokine(4,5), macrophage migration inhibitory factor (MIF) is also a macrophage cytokine and an important mediator of inflammation and sepsis(6-12). Here we report that MIF is an essential regulator of macrophage responses to endotoxin (lipopolysaccharide) and Gram-negative bacteria. Compared with wild-type cells, MIF-deficient macrophages are hyporesponsive to lipopolysaccharide and Gram-negative bacteria, as shown by a profound reduction in the activity of NF-kappaB and the production of tumour-necrosis factor-alpha. This reduction is due to a downregulation of Toll-like receptor 4 (TLR4), the signal-transducing molecule of the lipopolysaccharide receptor complex, and is associated with decreased activity of transcription factor PU.1, which is required for optimal expression of the Tlr4 gene in myeloid cells. These findings identify an important role for MIF in innate immunity and provide a molecular basis for the resistance of MIF-dercient mice to endotoxic shock.	CHU Vaudois, Dept Internal Med, Div Infect Dis, CH-1011 Lausanne, Switzerland; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Harvard University; Harvard T.H. Chan School of Public Health	Calandra, T (corresponding author), CHU Vaudois, Dept Internal Med, Div Infect Dis, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.		Roger, Thierry/G-2007-2012; Calandra, Thierry/D-9017-2015	Roger, Thierry/0000-0002-9358-0109; Calandra, Thierry/0000-0003-3051-1285				Adachi Y, 1999, J ENDOTOXIN RES, V5, P139, DOI 10.1179/096805199101531642; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Akashi S, 2000, J IMMUNOL, V164, P3471, DOI 10.4049/jimmunol.164.7.3471; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Bacher M, 1996, P NATL ACAD SCI USA, V93, P7849, DOI 10.1073/pnas.93.15.7849; Bacher M, 1997, AM J PATHOL, V150, P235; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calandra T, 1998, P NATL ACAD SCI USA, V95, P11383, DOI 10.1073/pnas.95.19.11383; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Heine H, 1999, J IMMUNOL, V162, P6971; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Le Roy D, 1999, J IMMUNOL, V162, P7454; Matsumura I, 2000, BLOOD, V96, P2440; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Waeber G, 1997, P NATL ACAD SCI USA, V94, P4782, DOI 10.1073/pnas.94.9.4782; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	30	471	502	0	31	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					920	924		10.1038/414920a	http://dx.doi.org/10.1038/414920a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780066				2022-12-24	WOS:000172813300049
J	Azevedo, C; Sadanandom, A; Kitagawa, K; Freialdenhoven, A; Shirasu, K; Schulze-Lefert, P				Azevedo, C; Sadanandom, A; Kitagawa, K; Freialdenhoven, A; Shirasu, K; Schulze-Lefert, P			The RAR1 interactor SGT1, an essential component of R gene-triggered disease resistance	SCIENCE			English	Article							COP9 SIGNALOSOME; PROTEIN; ARABIDOPSIS; EXPRESSION; BARLEY	Plant disease resistance (R) genes trigger innate immune responses upon pathogen attack. RAR1 is an early convergence: point in a signaling pathway engaged by multiple R genes. Here, vie show that RAR1 interacts with plant orthologs of the yeast protein SGT1, an essential regulator in the cell cycle. Silencing the barley gene Sgt1 reveals its role in R gene-triggered, Rar1-dependent disease resistance. SGT1 associates with SKP1 and CUL1, subunits of the SCF (Skp1-Cullin-F-box) ubiquitin ligase complex. Furthermore, the RAR1-SGT1 complex also interacts with two COP9 signalosome components. The interactions among RAR1, SGT1, SCF, and signalosome subunits indicate a link between disease resistance and ubiquitination.	John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; St Jude Childrens Res Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA; Max Planck Inst Zuchtungsforsch, Biochem Abt, D-50829 Cologne, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; St Jude Children's Research Hospital; Max Planck Society	Shirasu, K (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Colney Lane, Norwich NR4 7UH, Norfolk, England.	ken.shirasu@bbrsc.ac.uk	Schulze-Lefert, Paul/B-6707-2011; Shirasu, Ken/ABF-5306-2020; Shirasu, Ken/A-4455-2010; Schulze-Lefert, Paul/A-7746-2008; Azevedo, Cristina/Y-4296-2019	Shirasu, Ken/0000-0002-0349-3870; Shirasu, Ken/0000-0002-0349-3870; Azevedo, Cristina/0000-0002-6997-1265				Baker B, 1997, SCIENCE, V276, P726, DOI 10.1126/science.276.5313.726; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.3.CO;2-E; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; Brancaccio M, 1999, J BIOL CHEM, V274, P29282, DOI 10.1074/jbc.274.41.29282; Century KS, 1997, SCIENCE, V278, P1963, DOI 10.1126/science.278.5345.1963; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; del Pozo JC, 1999, P NATL ACAD SCI USA, V96, P15342, DOI 10.1073/pnas.96.26.15342; Falk A, 1999, P NATL ACAD SCI USA, V96, P3292, DOI 10.1073/pnas.96.6.3292; Ferrando A, 2000, PLANT J, V22, P553, DOI 10.1046/j.1365-313x.2000.00763.x; Halterman D, 2001, PLANT J, V25, P335, DOI 10.1046/j.1365-313x.2001.00982.x; Jorgensen JH, 1996, GENOME, V39, P492, DOI 10.1139/g96-063; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Schwechheimer C, 2001, TRENDS CELL BIOL, V11, P420, DOI 10.1016/S0962-8924(01)02091-8; Schweizer P, 2000, PLANT J, V24, P895, DOI 10.1046/j.1365-313x.2000.00941.x; Shirasu K, 1999, PLANT J, V17, P293, DOI 10.1046/j.1365-313X.1999.00376.x; Shirasu K, 1999, CELL, V99, P355, DOI 10.1016/S0092-8674(00)81522-6; Shirasu K, 2000, PLANT MOL BIOL, V44, P371, DOI 10.1023/A:1026552827716; Zhou FS, 2001, PLANT CELL, V13, P337, DOI 10.1105/tpc.13.2.337	23	470	512	3	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2002	295	5562					2073	2076		10.1126/science.1067554	http://dx.doi.org/10.1126/science.1067554			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532AY	11847307				2022-12-24	WOS:000174450500049
J	Wood, V; Gwilliam, R; Rajandream, MA; Lyne, M; Lyne, R; Stewart, A; Sgouros, J; Peat, N; Hayles, J; Baker, S; Basham, D; Bowman, S; Brooks, K; Brown, D; Brown, S; Chillingworth, T; Churcher, C; Collins, M; Connor, R; Cronin, A; Davis, P; Feltwell, T; Fraser, A; Gentles, S; Goble, A; Hamlin, N; Harris, D; Hidalgo, J; Hodgson, G; Holroyd, S; Hornsby, T; Howarth, S; Huckle, EJ; Hunt, S; Jagels, K; James, K; Jones, L; Jones, M; Leather, S; McDonald, S; McLean, J; Mooney, P; Moule, S; Mungall, K; Murphy, L; Niblett, D; Odell, C; Oliver, K; O'Neil, S; Pearson, D; Quail, MA; Rabbinowitsch, E; Rutherford, K; Rutter, S; Saunders, D; Seeger, K; Sharp, S; Skelton, J; Simmonds, M; Squares, R; Squares, S; Stevens, K; Taylor, K; Taylor, RG; Tivey, A; Walsh, S; Warren, T; Whitehead, S; Woodward, J; Volckaert, G; Aert, R; Robben, J; Grymonprez, B; Weltjens, I; Vanstreels, E; Rieger, M; Schafer, M; Muller-Auer, S; Gabel, C; Fuchs, M; Fritzc, C; Holzer, E; Moestl, D; Hilbert, H; Borzym, K; Langer, I; Beck, A; Lehrach, H; Reinhardt, R; Pohl, TM; Eger, P; Zimmermann, W; Wedler, H; Wambutt, R; Purnelle, B; Goffeau, A; Cadieu, E; Dreano, S; Gloux, S; Lelaure, V; Mottier, S; Galibert, F; Aves, SJ; Xiang, Z; Hunt, C; Moore, K; Hurst, SM; Lucas, M; Rochet, M; Gaillardin, C; Tallada, VA; Garzon, A; Thode, G; Daga, RR; Cruzado, L; Jimenez, J; Sanchez, M; del Rey, F; Benito, J; Dominguez, A; Revuelta, JL; Moreno, S; Armstrong, J; Forsburg, SL; Cerrutti, L; Lowe, T; McCombie, WR; Paulsen, I; Potashkin, J; Shpakovski, GV; Ussery, D; Barrell, BG; Nurse, P				Wood, V; Gwilliam, R; Rajandream, MA; Lyne, M; Lyne, R; Stewart, A; Sgouros, J; Peat, N; Hayles, J; Baker, S; Basham, D; Bowman, S; Brooks, K; Brown, D; Brown, S; Chillingworth, T; Churcher, C; Collins, M; Connor, R; Cronin, A; Davis, P; Feltwell, T; Fraser, A; Gentles, S; Goble, A; Hamlin, N; Harris, D; Hidalgo, J; Hodgson, G; Holroyd, S; Hornsby, T; Howarth, S; Huckle, EJ; Hunt, S; Jagels, K; James, K; Jones, L; Jones, M; Leather, S; McDonald, S; McLean, J; Mooney, P; Moule, S; Mungall, K; Murphy, L; Niblett, D; Odell, C; Oliver, K; O'Neil, S; Pearson, D; Quail, MA; Rabbinowitsch, E; Rutherford, K; Rutter, S; Saunders, D; Seeger, K; Sharp, S; Skelton, J; Simmonds, M; Squares, R; Squares, S; Stevens, K; Taylor, K; Taylor, RG; Tivey, A; Walsh, S; Warren, T; Whitehead, S; Woodward, J; Volckaert, G; Aert, R; Robben, J; Grymonprez, B; Weltjens, I; Vanstreels, E; Rieger, M; Schafer, M; Muller-Auer, S; Gabel, C; Fuchs, M; Fritzc, C; Holzer, E; Moestl, D; Hilbert, H; Borzym, K; Langer, I; Beck, A; Lehrach, H; Reinhardt, R; Pohl, TM; Eger, P; Zimmermann, W; Wedler, H; Wambutt, R; Purnelle, B; Goffeau, A; Cadieu, E; Dreano, S; Gloux, S; Lelaure, V; Mottier, S; Galibert, F; Aves, SJ; Xiang, Z; Hunt, C; Moore, K; Hurst, SM; Lucas, M; Rochet, M; Gaillardin, C; Tallada, VA; Garzon, A; Thode, G; Daga, RR; Cruzado, L; Jimenez, J; Sanchez, M; del Rey, F; Benito, J; Dominguez, A; Revuelta, JL; Moreno, S; Armstrong, J; Forsburg, SL; Cerrutti, L; Lowe, T; McCombie, WR; Paulsen, I; Potashkin, J; Shpakovski, GV; Ussery, D; Barrell, BG; Nurse, P			The genome sequence of Schizosaccharomyces pombe	NATURE			English	Article							TRANSFER-RNA GENES; FISSION YEAST; NUCLEOTIDE-SEQUENCE; FUNCTIONAL-ANALYSIS; MOLECULAR EVIDENCE; DNA; ORGANIZATION; CENTROMERE; DATABASE; REPEAT	We have sequenced and annotated the genome of fission yeast (Schizosaccharomyces pombe), which contains the smallest number of protein-coding genes yet recorded for a eukaryote: 4,824. The centromeres are between 35 and 110 kilobases (kb) and contain related repeats including a highly conserved 1.8-kb element. Regions upstream of genes are longer than in budding yeast (Saccharomyces cerevisiae), possibly reflecting more-extended control regions. Some 43% of the genes contain introns, of which there are 4,730. Fifty genes have significant similarity with human disease genes; half of these are cancer related. We identify highly conserved genes important for eukaryotic cell organization including those required for the cytoskeleton, compartmentation, cell-cycle control, proteolysis, protein phosphorylation and RNA splicing. These genes may have originated with the appearance of eukaryotic life. Few similarly conserved genes that are important for multicellular organization were identified, suggesting that the transition from prokaryotes to eukaryotes required more new genes than did the transition from unicellular to multicellular organization.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Canc Res UK London Res Inst, Computat Genome Anal Lab, London WC2A 3PX, England; Canc Res UK London Res Inst, Cell Cycle Lab, London WC2A 3PX, England; Katholieke Univ Leuven, Fac Agr & Appl Biol Sci, Lab Gene Technol, B-3001 Louvain, Belgium; Genotype GmbH, Mol Biol & Biotech Res, D-69259 Wilhelmsfeld, Germany; QIAGEN GmbH, D-40724 Hilden, Germany; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; GATC Biotech AG, D-78467 Constance, Germany; AGOWA GmbH, D-12489 Berlin, Germany; Catholic Univ Louvain, Unite Biochim Physiol, B-1348 Louvain, Belgium; Fac Med, UMR CNRS Genet & Dev 6061, F-35043 Rennes, France; Univ Exeter, Sch Biol Sci, Washington Singer Labs, Exeter EX4 4QG, Devon, England; Inst Natl Agron Paris Grignon, INRA, CNRS, URA1925,UMR216, F-78850 Thiverval Grignon, France; Univ Malaga, Fac Ciencias, Dept Genet, E-29071 Malaga, Spain; Univ Pablo de Olavide, Lab Andaluz Biol, Seville, Spain; Univ Salamanca, Edificio Dept, CSIC, Dept Microbiol & Genet,Inst Microbiol & Bioquim, Salamanca 37007, Spain; Univ Sussex, Brighton BN1 9QG, E Sussex, England; Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; TIGR, Rockville, MD 20850 USA; Finch Univ Hlth Sci Chicago Med Sch, N Chicago, IL 60064 USA; Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; Tech Univ Denmark, Bioctr DTU, Ctr Biol Sequence Anal, DK-2800 Kgs Lyngby, Denmark	Wellcome Trust Sanger Institute; Cancer Research UK; The Genome Analysis Centre (TGAC); Cancer Research UK; KU Leuven; QIAGEN GmbH; Max Planck Society; Universite Catholique Louvain; University of Exeter; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Universidad de Malaga; Universidad Pablo de Olavide; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; University of Sussex; Salk Institute; Stanford University; Cold Spring Harbor Laboratory; J. Craig Venter Institute; Chicago Medical School; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Technical University of Denmark	Rajandream, MA (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	mar@sanger.ac.uk	del Rey, Francisco/L-7132-2014; Quail, michael/ABE-6131-2020; Revuelta, Jose Luis/ABG-1502-2020; Vanstreels, Els/I-2366-2018; Daga, Rafael/P-8340-2014; Garzon, Andres/F-7009-2016; Shpakovski, George V. Вячеславович/AAU-7443-2020; MARTINEZ, J JIMENEZ/I-7959-2017; Rutherford, Kim/Y-7995-2018; Revuelta, Jose L/C-2324-2012; Tallada, Victor/F-5454-2016; Wood, Valerie/Y-7759-2018; Ussery, David/J-2026-2019; Moreno, Sergio/K-3671-2014; Lyne, Rachel/AAE-2189-2020; jimenez, juan/AAB-5357-2019; Lowe, Todd Michael/ABJ-5261-2022; Paulsen, Ian T/K-3832-2012	del Rey, Francisco/0000-0002-6517-7400; Revuelta, Jose Luis/0000-0001-7838-5308; Vanstreels, Els/0000-0002-7814-8035; Daga, Rafael/0000-0001-5726-761X; Garzon, Andres/0000-0003-4299-7198; Shpakovski, George V. Вячеславович/0000-0003-2851-7020; MARTINEZ, J JIMENEZ/0000-0002-3851-7393; Rutherford, Kim/0000-0001-6277-726X; Revuelta, Jose L/0000-0001-7838-5308; Tallada, Victor/0000-0001-9526-5957; Wood, Valerie/0000-0001-6330-7526; Ussery, David/0000-0003-3632-5512; Moreno, Sergio/0000-0002-8039-1413; Lyne, Rachel/0000-0001-8050-402X; jimenez, juan/0000-0002-3851-7393; Paulsen, Ian T/0000-0001-9015-9418; Davis, Paul/0000-0001-5545-0824; McCombie, W. Richard/0000-0003-1899-0682; Forsburg, Susan L/0000-0002-4895-8598; Baker, Stephen/0000-0003-1308-5755; Sgouros, John G./0000-0002-9141-5257; Hunt, Sarah/0000-0002-8350-1235; Reinhardt, Richard/0000-0001-9376-2132; Murphy, Lee/0000-0001-6467-7449; Aves, Stephen/0000-0002-5600-900X				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], 1997, NATURE, V387, pS; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Ashburner M, 1999, GENETICS, V153, P179; Bairoch A, 1999, NUCLEIC ACIDS RES, V27, P49, DOI 10.1093/nar/27.1.49; BARNITZ JT, 1982, FEBS LETT, V143, P129, DOI 10.1016/0014-5793(82)80288-3; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; BAUM M, 1994, MOL BIOL CELL, V5, P747, DOI 10.1091/mbc.5.7.747; Birney E, 1996, NUCLEIC ACIDS RES, V24, P2730, DOI 10.1093/nar/24.14.2730; Blandin G, 2000, FEBS LETT, V487, P31, DOI 10.1016/S0014-5793(00)02275-4; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CARR AM, 1989, MOL GEN GENET, V218, P41, DOI 10.1007/BF00330563; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Chervitz SA, 1998, SCIENCE, V282, P2022, DOI 10.1126/science.282.5396.2022; CHIKASHIGE Y, 1989, CELL, V57, P739, DOI 10.1016/0092-8674(89)90789-7; CLARKE L, 1990, MOL CELL BIOL, V10, P1863, DOI 10.1128/MCB.10.5.1863; Costanzo MC, 2000, NUCLEIC ACIDS RES, V28, P73, DOI 10.1093/nar/28.1.73; Davis L, 2001, P NATL ACAD SCI USA, V98, P8395, DOI 10.1073/pnas.121005598; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; EGEL R, 1993, CURR GENET, V24, P179, DOI 10.1007/BF00324684; Erickson HP, 1998, TRENDS CELL BIOL, V8, P133, DOI 10.1016/S0962-8924(98)01237-9; FANTES P, 2000, YEAST NUCL; FINK GR, 1987, CELL, V49, P5, DOI 10.1016/0092-8674(87)90746-X; FISHEL B, 1988, MOL CELL BIOL, V8, P754, DOI 10.1128/MCB.8.2.754; Fisher DL, 1996, EMBO J, V15, P850, DOI 10.1002/j.1460-2075.1996.tb00420.x; FUNK M, 1989, MOL GEN GENET, V219, P153, DOI 10.1007/BF00261171; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gomez M, 1999, EMBO J, V18, P5683, DOI 10.1093/emboj/18.20.5683; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Gu ZL, 2000, GENE, V259, P81, DOI 10.1016/S0378-1119(00)00434-0; Harris DE, 2001, METH MOL B, V175, P217; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; HIETER P, 1985, CELL, V42, P913, DOI 10.1016/0092-8674(85)90287-9; HOHEISEL JD, 1993, CELL, V73, P109, DOI 10.1016/0092-8674(93)90164-L; Humphrey T, 2000, MUTAT RES-FUND MOL M, V451, P211, DOI 10.1016/S0027-5107(00)00051-8; Hunt C, 2001, YEAST, V18, P355, DOI 10.1002/1097-0061(20010315)18:4<355::AID-YEA676>3.0.CO;2-P; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Hyman AA, 1995, ANNU REV CELL DEV BI, V11, P471, DOI 10.1146/annurev.cb.11.110195.002351; Itoh T, 1999, DNA Res, V6, P299, DOI 10.1093/dnares/6.5.299; KABSCH W, 1995, FASEB J, V9, P167, DOI 10.1096/fasebj.9.2.7781919; Kaneko T, 2000, DNA RES, V7, P381, DOI 10.1093/dnares/7.6.381; Kim JM, 1998, GENOME RES, V8, P464, DOI 10.1101/gr.8.5.464; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LANG BF, 1987, EUR J BIOCHEM, V169, P527, DOI 10.1111/j.1432-1033.1987.tb13641.x; LEUPOLD U., 1950, Comptes rendus des Travaux du Laboratoire Carlsberg, V24, P381; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Lopez JB, 1999, INT J BIOL MARKER, V14, P172, DOI 10.1177/172460089901400309; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lundin LG, 1999, SEMIN CELL DEV BIOL, V10, P523, DOI 10.1006/scdb.1999.0333; MANIATIS T, 1987, NATURE, V325, P673, DOI 10.1038/325673a0; MAO J, 1982, NUCLEIC ACIDS RES, V10, P487, DOI 10.1093/nar/10.2.487; Mewes HW, 2000, NUCLEIC ACIDS RES, V28, P37, DOI 10.1093/nar/28.1.37; MITCHISON JM, 1957, EXP CELL RES, V13, P244, DOI 10.1016/0014-4827(57)90005-8; MIZUSAKI J, 1993, SENSOR ACTUAT B-CHEM, V13, P121, DOI 10.1016/0925-4005(93)85340-G; MORIMYO M, 1998, BIODEFENCE MECH ENV, P115; MURAKAMI S, 1991, CHROMOSOMA, V101, P214, DOI 10.1007/BF00365153; NAGAWA F, 1985, P NATL ACAD SCI USA, V82, P8557, DOI 10.1073/pnas.82.24.8557; NAKASEKO Y, 1986, EMBO J, V5, P1011, DOI 10.1002/j.1460-2075.1986.tb04316.x; Partridge JF, 2000, GENE DEV, V14, P783; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Robertson HM, 2000, GENOME RES, V10, P192, DOI 10.1101/gr.10.2.192; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; RUSSELL PR, 1985, GENE, V40, P125, DOI 10.1016/0378-1119(85)90031-9; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SCHAAK J, 1982, NUCLEIC ACIDS RES, V10, P2851, DOI 10.1093/nar/10.9.2851; Sipiczki M, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-2-reviews1011, DOI 10.1186/GB-2000-1-2-REVIEWS1011]; SMITH CL, 1987, NUCLEIC ACIDS RES, V15, P4481, DOI 10.1093/nar/15.11.4481; SONNHAMMER ELL, 1994, COMPUT APPL BIOSCI, V10, P301; Stoesser G, 1999, NUCLEIC ACIDS RES, V27, P18, DOI 10.1093/nar/27.1.18; TAKAHASHI K, 1991, J MOL BIOL, V218, P13, DOI 10.1016/0022-2836(91)90867-6; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wood V, 2001, COMP FUNCT GENOM, V2, P143, DOI 10.1002/cfg.86	78	1183	6417	1	192	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 21	2002	415	6874					871	880		10.1038/nature724	http://dx.doi.org/10.1038/nature724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859360	Bronze, Green Published			2022-12-24	WOS:000173941000036
J	Martin, A; Bardwell, PD; Woo, CJ; Fan, MX; Shulman, MJ; Scharff, MD				Martin, A; Bardwell, PD; Woo, CJ; Fan, MX; Shulman, MJ; Scharff, MD			Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas	NATURE			English	Article							B-CELL LINE; MSH2-DEFICIENT MICE; MISMATCH REPAIR; IMMUNE-RESPONSE; IN-VITRO; SEQUENCES; GENES; NUCLEOTIDE; INDUCTION; MUTATION	The production of high-affinity protective antibodies requires somatic hypermutation (SHM) of the antibody variable (V) region genes. SHM is characterized by a high frequency of point mutations that occur only during the centroblast stage of B-cell differentiation. Activation-induced cytidine deaminase (AID), which is expressed specifically in germinal-centre centroblasts(1), is required for this process, but its exact role is unknown(2). Here we show that AID is required for SHM in the centroblast-like Ramos cells, and that expression of AID is sufficient to induce SHM in hybridoma cells, which represent a later stage of B-cell differentiation that does not normally undergo SHM. In one hybridoma, mutations were exclusively in G.C base pairs that were mostly within RGYW or WRCY motifs, suggesting that AID has primary responsibility for mutations at these nucleotides. The activation of SHM in hybridomas indicates that AID does not require other centroblast-specific cofactors to induce SHM, suggesting either that it functions alone or that the factors it requires are expressed at other stages of B-cell differentiation.	Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada	Yeshiva University; Albert Einstein College of Medicine; University of Toronto	Scharff, MD (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave Chanin 403, Bronx, NY 10461 USA.		Martin, Alberto/B-1421-2008; Bardwell, Philip/H-2219-2014; Bardwell, Philip D./K-8442-2013	Bardwell, Philip/0000-0002-3835-255X; Bardwell, Philip D./0000-0002-3835-255X; Martin, Alberto/0000-0002-0795-0418				Bachl J, 2001, J IMMUNOL, V166, P5051, DOI 10.4049/jimmunol.166.8.5051; CONNOR A, 1994, J BIOL CHEM, V269, P25178; Denepoux S, 1997, IMMUNITY, V6, P35, DOI 10.1016/S1074-7613(00)80240-X; Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033; KOBRIN BJ, 1990, SOMATIC HYPERMUTATIO, V5, P11; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lin MMQ, 1997, P NATL ACAD SCI USA, V94, P5284, DOI 10.1073/pnas.94.10.5284; Luria SE, 1943, GENETICS, V28, P491; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Phung QH, 1998, J EXP MED, V187, P1745, DOI 10.1084/jem.187.11.1745; Rada C, 1997, EUR J IMMUNOL, V27, P3115, DOI 10.1002/eji.1830271206; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Rada C, 2001, EMBO J, V20, P4570, DOI 10.1093/emboj/20.16.4570; Reynaud CA, 1999, IMMUNOL TODAY, V20, P522, DOI 10.1016/S0167-5699(99)01540-6; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Sack SZ, 2001, MOL IMMUNOL, V38, P303, DOI 10.1016/S0161-5890(01)00058-X; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Spencer J, 1999, J IMMUNOL, V162, P6596; TAO W, 1990, J IMMUNOL, V145, P3216; Vora KA, 1999, J EXP MED, V189, P471, DOI 10.1084/jem.189.3.471; WAGNER SD, 1995, NATURE, V376, P732, DOI 10.1038/376732a0; Wiesendanger M, 2000, J EXP MED, V191, P579, DOI 10.1084/jem.191.3.579; Zan H, 1999, J IMMUNOL, V162, P3437; Zan H, 2001, IMMUNITY, V14, P643, DOI 10.1016/S1074-7613(01)00142-X; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740; Zhang W, 2001, INT IMMUNOL, V13, P1175, DOI 10.1093/intimm/13.9.1175	27	211	226	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					802	806		10.1038/nature714	http://dx.doi.org/10.1038/nature714			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11823785				2022-12-24	WOS:000173833900049
J	Xu, HE; Stanley, TB; Montana, VG; Lambert, MH; Shearer, BG; Cobb, JE; McKee, DD; Galardi, CM; Plunket, KD; Nolte, RT; Parks, DJ; Moore, JT; Kliewer, SA; Willson, TM; Stimmel, JB				Xu, HE; Stanley, TB; Montana, VG; Lambert, MH; Shearer, BG; Cobb, JE; McKee, DD; Galardi, CM; Plunket, KD; Nolte, RT; Parks, DJ; Moore, JT; Kliewer, SA; Willson, TM; Stimmel, JB			Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPAR alpha	NATURE			English	Article							ACTIVATED RECEPTOR-GAMMA; HISTONE DEACETYLASE; TRANSCRIPTIONAL REPRESSION; PROMYELOCYTIC LEUKEMIA; HORMONE RECEPTORS; BINDING; COACTIVATOR; RECOGNITION; SMRT; COREPRESSORS	Repression of gene transcription by nuclear receptors is mediated by interactions with co-repressor proteins such as SMRT and NCoR1,2, which in turn recruit histone deacetylases to the chromatin(3-5). Aberrant interactions between nuclear receptors and co-repressors contribute towards acute promyelocytic leukaemia and thyroid hormone resistance syndrome (6-8). The binding of co-repressors to nuclear receptors occurs in the unliganded state, and can be stabilized by antagonists(9). Here we report the crystal structure of a ternary complex containing the peroxisome proliferator-activated receptor-alpha ligand-binding domain bound to the antagonist GW6471 and a SMRT co-repressor motif. In this structure, the co-repressor motif adopts a three-turn alpha-helix that prevents the carboxy-terminal activation helix (AF-2) of the receptor from assuming the active conformation. Binding of the co-repressor motif is further reinforced by the antagonist, which blocks the AF-2 helix from adopting the active position. Biochemical analyses and structure-based mutagenesis indicate that this mode of co-repressor binding is highly conserved across nuclear receptors.	GlaxoSmithKline, Nucl Receptor Discovery Res, Res Triangle Pk, NC 27709 USA	GlaxoSmithKline	Xu, HE (corresponding author), GlaxoSmithKline, Nucl Receptor Discovery Res, Res Triangle Pk, NC 27709 USA.	ex11957@gsk.com	feinstein, doug/M-9414-2019; ID, IMCACAT/D-5867-2014					Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hong SH, 1997, P NATL ACAD SCI USA, V94, P9028, DOI 10.1073/pnas.94.17.9028; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Jackson TA, 1997, MOL ENDOCRINOL, V11, P693, DOI 10.1210/me.11.6.693; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Nagy L, 1999, GENE DEV, V13, P3209, DOI 10.1101/gad.13.24.3209; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; NAVAZA J, 1992, MOL REPLACEMENT, P87; Nolte RT, 1998, P NATL ACAD SCI USA, V95, P2938, DOI 10.1073/pnas.95.6.2938; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Oberfield JL, 1999, P NATL ACAD SCI USA, V96, P6102, DOI 10.1073/pnas.96.11.6102; ONATE SA, 1995, SCIENCE, V270, P1354; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; ULLMAN EF, 1994, P NATL ACAD SCI USA, V91, P5426, DOI 10.1073/pnas.91.12.5426; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Yang W, 2000, MOL CELL BIOL, V20, P8008, DOI 10.1128/MCB.20.21.8008-8017.2000; Yoh SM, 1997, MOL ENDOCRINOL, V11, P470, DOI 10.1210/me.11.4.470; Zhou GC, 1998, MOL ENDOCRINOL, V12, P1594, DOI 10.1210/me.12.10.1594	30	499	523	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2002	415	6873					813	817		10.1038/415813a	http://dx.doi.org/10.1038/415813a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845213				2022-12-24	WOS:000173833900052
J	Turner, CF; Rogers, SM; Miller, HG; Miller, WC; Gribble, JN; Chromy, JR; Leone, PA; Quinn, TC; Zenilman, JM				Turner, CF; Rogers, SM; Miller, HG; Miller, WC; Gribble, JN; Chromy, JR; Leone, PA; Quinn, TC; Zenilman, JM			Untreated gonococcal and chlamydial infection in a probability sample of adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEXUALLY-TRANSMITTED DISEASES; LIGASE CHAIN-REACTION; TRACHOMATIS INFECTION; NEISSERIA-GONORRHOEAE; DIAGNOSIS; URINE; MEN; WOMEN; PREVALENCE; BEHAVIOR	Context The prevalence and distribution of gonococcal and chlamydial infections in the general population are poorly understood. Development of nucleic acid amplification tests, such as the ligase chain reaction assay, provides new opportunities to estimate the prevalence of untreated infections in the population. Objective To estimate the overall prevalence of untreated gonococcal and chlamydial infections and to describe patterns of infection within specific demographic subgroups of the young adult population in Baltimore, Md. Design and Setting Cross-sectional behavioral survey based on a probability sample of Baltimore households with collection of urine specimens between January 1997 and September 1998. Participants A total of 728 adults aged 18 to 35 years completed the interview portion of the study, and 579 of these respondents also provided a urine specimen adequate for testing. Main Outcome Measure Prevalence of untreated infection, as measured by the percentage of specimens testing positive for gonococcal and chlamydial infection by ligase chain reaction, weighted to reflect variations in probabilities of sample selection from the population. Alternate estimates of the prevalence of recent treated infection were derived from clinically diagnosed cases reported to the Baltimore City Health Department and by diagnoses reported by participants in the survey. Results An estimated 5.3% (SE, 1.4%) of the population aged 18 to 35 years has an untreated gonococcal infection, and 3.0% (SE, 0.8%) is estimated to have an untreated chlamydial infection. While 7.9% (SE, 1.6%) of the population is estimated to have either an untreated gonococcal or chlamydial infection, estimated prevalence is substantially higher among black women (15.0%; SE, 3.7%). Few participants with untreated infections reported dysuria or discharge during the 6 months preceding testing. The estimated number of untreated gonococcal infections in the population (9241; SE, 2441) substantially exceeds both the number of such infections diagnosed among Baltimore adults aged 18 to 35 years and reported to the Baltimore City Health Department during 1998 (4566), and the estimated number of diagnoses derived using participants' reports for the 12 months prior to the survey (4708 [SE, 1918] to 5231 [SE, 2092]). The estimated number of untreated chlamydial infections (5231; SE, 1395) is also greater than the number of cases reported to the health department in 1998 (3664) but is slightly less than the estimated number of diagnoses derived using participants' reports of chlamydial infections diagnosed during the 12 months prior to the survey (5580 [SE, 1918] to 6975 [SE, 2441]). Conclusion In 1997-1998, the estimated number of undiagnosed gonococcal and chlamydial infections prevalent in the population of Baltimore adults aged 18 to 35 years approached or exceeded the number of infections that were diagnosed and treated annually.	Res Triangle Inst, Program Hlth & Behav Measurement, Washington, DC 20036 USA; CUNY Queens Coll, Flushing, NY 11367 USA; CUNY, Grad Ctr, Flushing, NY USA; Res Triangle Inst, Div Stat Res, Res Triangle Pk, NC 27709 USA; Res Triangle Inst, Res Comp Div, Res Triangle Pk, NC 27709 USA; Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC USA; Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA; NIAID, Bethesda, MD 20892 USA	Research Triangle Institute; City University of New York (CUNY) System; Queens College NY (CUNY); City University of New York (CUNY) System; Research Triangle Institute; Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Turner, CF (corresponding author), Res Triangle Inst, Program Hlth & Behav Measurement, 1615 M St NW, Washington, DC 20036 USA.		Quinn, Thomas/A-2494-2010; Miller, William C/H-4800-2014	Miller, William C/0000-0002-1934-7827	NCRR NIH HHS [RR00046] Funding Source: Medline; NIAID NIH HHS [K24-AI01633, U19-AI38533] Funding Source: Medline; NICHD NIH HHS [R01-HD31067] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD031067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI038533, ZIAAI000358, Z01AI000358, K24AI001633] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brodine SK, 1998, J INFECT DIS, V178, P1202, DOI 10.1086/515685; CHERNESKY MA, 1994, J CLIN MICROBIOL, V32, P2682, DOI 10.1128/JCM.32.11.2682-2685.1994; Dean D, 2000, J INFECT DIS, V182, P909, DOI 10.1086/315778; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; *I MED, 1996, HIDD EP CONFR SEX TR; Ku L, 1997, SEX TRANSM DIS, V24, P299, DOI 10.1097/00007435-199705000-00012; KU L, IN PRESS AM J PUBLIC; LAGA M, 1994, LANCET, V344, P246, DOI 10.1016/S0140-6736(94)93005-8; LEE HH, 1995, LANCET, V345, P213, DOI 10.1016/S0140-6736(95)90221-X; MCNAGNY SE, 1992, J INFECT DIS, V165, P573, DOI 10.1093/infdis/165.3.573; Mehta SD, 2000, SEX TRANSM DIS, V27, P154, DOI 10.1097/00007435-200003000-00007; Pack RP, 2000, SEX TRANSM DIS, V27, P175, DOI 10.1097/00007435-200003000-00011; Parks KS, 1997, SEX TRANSM DIS, V24, P229, DOI 10.1097/00007435-199704000-00008; POTTERAT JJ, 1981, JAMA-J AM MED ASSOC, V245, P578, DOI 10.1001/jama.245.6.578; Quinn TC, 1996, J CLIN MICROBIOL, V34, P1401, DOI 10.1128/JCM.34.6.1401-1406.1996; QUINN TC, 1994, SEX TRANSM DIS, V21, P19; Rogers SM, 1999, POPULATION, V54, P231, DOI 10.2307/1534900; ROGERS SM, 2001, TRANSMISSIBILITY GC; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Shah BV, 1996, SUDAAN USERS MANUAL; SMITH KR, 1995, J CLIN MICROBIOL, V33, P455, DOI 10.1128/JCM.33.2.455-457.1995; Stary A, 1997, J CLIN MICROBIOL, V35, P239, DOI 10.1128/JCM.35.1.239-242.1997; *STAT CORP, 1999, STAT STAT SOFTW REL; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; TURNER CF, 1998, COMPUTER ASSISTED SU; TURNER CF, TECHNICAL PAPERS HLT; TURNER CF, 1999, 13 M INT SOC SEX TRA; *US BUR CENS, 2000, POP EST COUNT AG SEX; Whittington WLH, 2000, J INFECT DIS, V181, P1044, DOI 10.1086/315343; Zenilman JM, 1997, SEX TRANSM DIS, V24, P310, DOI 10.1097/00007435-199705000-00013	30	153	157	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2002	287	6					726	733		10.1001/jama.287.6.726	http://dx.doi.org/10.1001/jama.287.6.726			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520XR	11851539	Bronze			2022-12-24	WOS:000173809500029
J	Wilson, RS; de Leon, CFM; Barnes, LL; Schneider, JA; Bienias, JL; Evans, DA; Bennett, DA				Wilson, RS; de Leon, CFM; Barnes, LL; Schneider, JA; Bienias, JL; Evans, DA; Bennett, DA			Participation in cognitively stimulating activities and risk of incident Alzheimer disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DEFINED POPULATION; OLDER PERSONS; LIFE-STYLE; DEMENTIA; EDUCATION; IMPAIRMENT; DECLINE; INDIVIDUALS; ASSOCIATION; CONSORTIUM	Context Frequent participation in cognitively stimulating activities has been hypothesized to reduce risk of Alzheimer disease (AD), but prospective data regarding an association are lacking. Objective To test the hypothesis that frequent participation in cognitive activities is associated with a reduced risk of AD. Design Longitudinal cohort study with baseline evaluations performed between January 1994 and July 2001 and mean follow-up of 4.5 years. Participants and Setting A total of 801 older Catholic nuns, priests, and brothers without dementia at enrollment, recruited from 40 groups across the United States. At baseline, they rated frequency of participation in common cognitive activities (eg, reading a newspaper), from which a previously validated composite measure of cognitive activity frequency was derived. Main Outcome Measures Clinical diagnosis of AD by a board-certified neurologist using National Institute of Neurological and Communicative Disorders and Stroke/Alzheimer's Disease and Related Disorders Association criteria and change in global and specific measures of cognitive function, compared by cognitive activity scare at baseline. Results Baseline scores on the composite measure of cognitive activity ranged from 1.57 to 4.71 (mean, 3.57; SD, 0.55), with higher scores indicating more frequent activity. During an average of 4.5 years of follow-up, 111 persons developed AD. In a proportional hazards model that controlled for age, sex, and education, a 1-point increase in cognitive activity score was associated with a 33% reduction in risk of AD (hazard ratio, 0.67; 95% confidence interval, 0.49-0.92). Results were comparable when persons with memory impairment at baseline were excluded and when terms for the apolipoprotein E epsilon4 allele and other medical conditions were added. in random-effects models that controlled for age, sex, education, and baseline level of cognitive function, a 1-point increase in cognitive activity was associated with reduced decline in global cognition (by 47%), working memory (by 60%), and perceptual speed (by 30%). Conclusion These results suggest that frequent participation in cognitively stimulating activities is associated with reduced risk of AD.	Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; Rush Inst Healthy Aging, Chicago, IL USA; Rush Presbyterian St Lukes Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; Rush Presbyterian St Lukes Med Ctr, Dept Psychol, Chicago, IL 60612 USA; Rush Presbyterian St Lukes Med Ctr, Dept Med, Chicago, IL 60612 USA	Rush University; Rush University; Rush University; Rush University; Rush University	Wilson, RS (corresponding author), Rush Alzheimers Dis Ctr, 1645 W Jackson Blvd,Suite 675, Chicago, IL 60612 USA.	rwilson@rush.edu	Kennedy, Kristen M/B-4699-2008	Kennedy, Kristen M/0000-0001-5373-9026	NATIONAL INSTITUTE ON AGING [P30AG010161, R01AG015819, K08AG000849] Funding Source: NIH RePORTER; NIA NIH HHS [KO8 AG00849, P30 AG10161, R01 AG15819] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALBERT M, 1991, INT J NEUROSCI, V57, P167, DOI 10.3109/00207459109150691; Alexander GE, 1997, AM J PSYCHIAT, V154, P165; [Anonymous], 1994, ASSESSMENT CLIN MANU; BICKEL H, 1994, PSYCHOL MED, V24, P179, DOI 10.1017/S0033291700026945; Bowen J, 1997, LANCET, V349, P763, DOI 10.1016/S0140-6736(96)08256-6; Broe GA, 1998, AUST NZ J PUBL HEAL, V22, P621, DOI 10.1111/j.1467-842X.1998.tb01449.x; CHRISTENSEN H, 1993, AGE AGEING, V22, P175, DOI 10.1093/ageing/22.3.175; COBB JL, 1995, NEUROLOGY, V45, P1707, DOI 10.1212/WNL.45.9.1707; COOPER JA, 1991, BRAIN, V114, P2095, DOI 10.1093/brain/114.5.2095; COX DR, 1972, J R STAT SOC B, V34, P187; Craik F. I. M., 1986, HUMAN MEMORY COGNITI, P409; Ekstrom R., 1976, MANUAL KIT FACTOR RE; Evans DA, 1997, ARCH NEUROL-CHICAGO, V54, P1399, DOI 10.1001/archneur.1997.00550230066019; FABRIGOULE C, 1995, J AM GERIATR SOC, V43, P485, DOI 10.1111/j.1532-5415.1995.tb06093.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friedland RP, 2001, P NATL ACAD SCI USA, V98, P3440, DOI 10.1073/pnas.061002998; FRIEDLAND RP, 1993, NEUROLOGY, V43, P246, DOI 10.1212/WNL.43.2.246; Hertzog C, 1999, PSYCHOL AGING, V14, P528, DOI 10.1037/0882-7974.14.3.528; HIXSON JE, 1990, J LIPID RES, V31, P545; Howieson DB, 1997, J AM GERIATR SOC, V45, P584, DOI 10.1111/j.1532-5415.1997.tb03091.x; Hultsch DF, 1999, PSYCHOL AGING, V14, P245, DOI 10.1037/0882-7974.14.2.245; HULTSCH DF, 1993, J GERONTOL, V48, pP1, DOI 10.1093/geronj/48.1.P1; KATZMAN R, 1993, NEUROLOGY, V43, P13, DOI 10.1212/WNL.43.1_Part_1.13; Kohout F J, 1993, J Aging Health, V5, P179, DOI 10.1177/089826439300500202; KONDO K, 1994, DEMENTIA, V5, P314, DOI 10.1159/000106741; Kordower JH, 2001, ANN NEUROL, V49, P202, DOI 10.1002/1531-8249(20010201)49:2<202::AID-ANA40>3.3.CO;2-V; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MCPHILLIPS JB, 1989, AM J PREV MED, V5, P65, DOI 10.1016/S0749-3797(18)31107-3; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Mortimer JA, 1997, GERIATRICS, V52, pS50; Mufson EJ, 1999, EXP NEUROL, V158, P469, DOI 10.1006/exnr.1999.7086; Nelson HE., 1982, NATL ADULT READING T; Ott A, 1999, NEUROLOGY, V52, P663, DOI 10.1212/WNL.52.3.663; PAYKEL ES, 1994, ARCH GEN PSYCHIAT, V51, P325; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raven JC., 1992, MANUAL RAVENS PROGR; SAS, 1997, SAS STAT US GUID VER; Smith A., 1982, SYMBOL DIGIT MODALIT; Snowdon DA, 1996, JAMA-J AM MED ASSOC, V275, P528, DOI 10.1001/jama.275.7.528; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; WELSH KA, 1994, NEUROLOGY, V44, P609, DOI 10.1212/WNL.44.4.609; Weschler D, 1987, WECHSLER MEMORY SCAL; Whalley LJ, 2000, NEUROLOGY, V55, P1455, DOI 10.1212/WNL.55.10.1455; Wilson RS, 2000, ARCH NEUROL-CHICAGO, V57, P1718, DOI 10.1001/archneur.57.12.1718; Wilson RS, 2000, PSYCHOL AGING, V15, P18, DOI 10.1037/0882-7974.15.1.18; Wilson RS, 1999, J GERONTOL B-PSYCHOL, V54, pP155, DOI 10.1093/geronb/54B.3.P155; WILSON RS, IN PRESS PSYCHOL AGI; YOSHITAKE T, 1995, NEUROLOGY, V45, P1161, DOI 10.1212/WNL.45.6.1161	51	839	864	2	75	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2002	287	6					742	748		10.1001/jama.287.6.742	http://dx.doi.org/10.1001/jama.287.6.742			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	520XR	11851541				2022-12-24	WOS:000173809500031
J	Cheour, M; Martynova, O; Naatanen, R; Erkkola, R; Sillanpaa, M; Kero, P; Raz, A; Kaipio, ML; Hiltunen, J; Aaltonen, O; Savela, J; Hamalainen, H				Cheour, M; Martynova, O; Naatanen, R; Erkkola, R; Sillanpaa, M; Kero, P; Raz, A; Kaipio, ML; Hiltunen, J; Aaltonen, O; Savela, J; Hamalainen, H			Psychobiology - Speech sounds learned by sleeping newborns	NATURE			English	Article							CHILDREN		Univ Turku, Ctr Cognit Neurosci, Language & Dev Brain Lab, Turku 20100, Finland; Univ Turku, Dept Psychol, Turku 20100, Finland; Univ Turku, Dept Phonet, Turku 20100, Finland; Univ Helsinki, Cent Hosp, BioMag Lab, Helsinki 00029, Finland; Univ Helsinki, Dept Psychol, Cognit Brain Res Unit, FIN-00014 Helsinki, Finland; Univ Helsinki, Helsinki Brain Res Ctr, FIN-00014 Helsinki, Finland; Turku Univ, Cent Hosp, Dept Obstet & Gynaecol, Turku 20100, Finland; Turku Univ, Cent Hosp, Dept Child Neurol, Turku 20100, Finland; Turku Univ, Cent Hosp, Dept Pediat, Turku 20100, Finland; Cornell Univ, Weill Med Coll, Dept Psychiat, Sackler Inst Dev Psychobiol, New York, NY 10021 USA	University of Turku; University of Turku; University of Turku; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Turku; University of Turku; University of Turku; Cornell University	Cheour, M (corresponding author), Univ Turku, Ctr Cognit Neurosci, Language & Dev Brain Lab, Turku 20100, Finland.	marie.cheour@utu.fi	Sillanpaa, Matti L/G-4708-2015; Martynova, Olga V/K-3900-2012	Sillanpaa, Matti L/0000-0003-4190-3698; Martynova, Olga V/0000-0001-9047-2893; Sillanpaa, Matti/0000-0002-1521-3602				Cheour M, 1998, NAT NEUROSCI, V1, P351, DOI 10.1038/1561; Cheour M, 1998, INT J PSYCHOPHYSIOL, V29, P217, DOI 10.1016/S0167-8760(98)00017-8; Cheour M, 2000, CLIN NEUROPHYSIOL, V111, P4, DOI 10.1016/S1388-2457(99)00191-1; Dave AS, 1998, SCIENCE, V282, P2250, DOI 10.1126/science.282.5397.2250; Kraus N, 1996, SCIENCE, V273, P971, DOI 10.1126/science.273.5277.971; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; van Heteren CF, 2000, LANCET, V356, P1169, DOI 10.1016/S0140-6736(00)02766-5	8	132	140	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2002	415	6872					599	600		10.1038/415599b	http://dx.doi.org/10.1038/415599b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832930				2022-12-24	WOS:000173709100030
J	Kuznedelov, K; Minakhin, L; Niedziela-Majka, A; Dove, SL; Rogulja, D; Nickels, BE; Hochschild, A; Heyduk, T; Severinov, K				Kuznedelov, K; Minakhin, L; Niedziela-Majka, A; Dove, SL; Rogulja, D; Nickels, BE; Hochschild, A; Heyduk, T; Severinov, K			A role for interaction of the RNA polymerase flap domain with the sigma subunit in promoter recognition	SCIENCE			English	Article							ESCHERICHIA-COLI; TRANSCRIPTION; ACTIVATION; BINDING; PROTEIN; SITE	In bacteria, promoter recognition depends on the RNA polymerase sigma subunit, which combines with the catalytically proficient RNA polymerase core to form the holoenzyme. The major class of bacterial promoters is defined by two conserved elements (the -10 and -35 elements, which are 10 and 35 nucleotides upstream of the initiation point, respectively) that are contacted by sigma the holoenzyme. We show that recognition of promoters of this class depends on the "flexible flap" domain of the RNA polymerase beta subunit. The flap interacts with conserved region 4 of sigmaand triggers:a conformational change that moves region 4 into the correct position for interaction with the -35 element. Because the flexible flap is evolutionarily conserved, this domain may facilitate promoter recognition by specificity factors in eukaryotes as well.	Rutgers State Univ, Waksman Inst, Dept Genet, Piscataway, NJ 08854 USA; St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Rutgers State University New Brunswick; Saint Louis University; Harvard University; Harvard Medical School	Severinov, K (corresponding author), Rutgers State Univ, Waksman Inst, Dept Genet, POB 759, Piscataway, NJ 08854 USA.	severik@waksman.rutgers.edu	Nickels, Bryce/AAF-2549-2020; Severinov, Konstantin/C-8545-2016	Nickels, Bryce/0000-0001-7449-8831	NIGMS NIH HHS [GM44025, GM50514] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arthur TM, 1998, J BIOL CHEM, V273, P31381, DOI 10.1074/jbc.273.47.31381; Barne KA, 1997, EMBO J, V16, P4034, DOI 10.1093/emboj/16.13.4034; Callaci S, 1999, MOL CELL, V3, P229, DOI 10.1016/S1097-2765(00)80313-5; Colland F, 2001, MOL MICROBIOL, V41, P477, DOI 10.1046/j.1365-2958.2001.02537.x; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Dove SL, 2000, P NATL ACAD SCI USA, V97, P13215, DOI 10.1073/pnas.97.24.13215; Dove SL, 1997, NATURE, V386, P627, DOI 10.1038/386627a0; Gerber JS, 1996, J BACTERIOL, V178, P6133, DOI 10.1128/jb.178.21.6133-6139.1996; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Heyduk T, 2001, ANAL BIOCHEM, V289, P60, DOI 10.1006/abio.2000.4925; Kashlev M, 1996, METHOD ENZYMOL, V274, P326; Severinov K, 1997, J BIOL CHEM, V272, P24137, DOI 10.1074/jbc.272.39.24137; Severinova E, 1998, J MOL BIOL, V279, P9, DOI 10.1006/jmbi.1998.1742; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; Young BA, 2001, CELL, V105, P935, DOI 10.1016/S0092-8674(01)00398-1; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	16	148	152	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2002	295	5556					855	857		10.1126/science.1066303	http://dx.doi.org/10.1126/science.1066303			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823642				2022-12-24	WOS:000173733000045
J	Day, JJ; Norman, DB; Upchurch, P; Powell, HP				Day, JJ; Norman, DB; Upchurch, P; Powell, HP			Biomechanics - Dinosaur locomotion from a new trackway	NATURE			English	Article									Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Univ Oxford, Museum Nat Hist, Oxford OXD1 3PW, England	University of Cambridge; University of Oxford	Day, JJ (corresponding author), Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England.		Upchurch, Paul/C-1654-2008	Day, Julia/0000-0002-6765-7782				ALEXANDER RM, 1976, NATURE, V261, P129, DOI 10.1038/261129a0; ALEXANDER RM, 1986, ZOOL J LINN SOC-LOND, V83, P1; Cope J.C.W., 1980, SPECIAL PUBLICATIONS, V15, P109; PADIAN K, 1984, COPEIA, P662, DOI 10.2307/1445147; THULBORN RA, 1981, NATURE, V292, P273, DOI 10.1038/292273c0; Thulborn RA., 1990, DINOSAUR TRACKS	6	51	55	8	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					494	495		10.1038/415494a	http://dx.doi.org/10.1038/415494a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823849	Green Published			2022-12-24	WOS:000173564300035
J	Griffiths, CEM				Griffiths, CEM			Immunotherapy for psoriasis: from serendipity to selectivity	LANCET			English	Editorial Material							PLAQUE-TYPE PSORIASIS; QUALITY-OF-LIFE; T-CELLS; ANTIBODY		Univ Manchester, Hope Hosp, Sch Med, Dermatol Ctr, Manchester M6 8HD, Lancs, England	University of Manchester	Griffiths, CEM (corresponding author), Univ Manchester, Hope Hosp, Sch Med, Dermatol Ctr, Manchester M6 8HD, Lancs, England.	christopher.griffiths@man.ac.uk	Griffiths, Christopher E.M./P-5448-2014	Griffiths, Christopher E.M./0000-0001-5371-4427				Abrams JR, 2000, J EXP MED, V192, P681, DOI 10.1084/jem.192.5.681; Asadullah K, 1999, ARCH DERMATOL, V135, P187, DOI 10.1001/archderm.135.2.187; Chaudhari U, 2001, LANCET, V357, P1842, DOI 10.1016/S0140-6736(00)04954-0; Ellis CN, 2001, NEW ENGL J MED, V345, P248, DOI 10.1056/NEJM200107263450403; ELLIS CN, 1991, NEW ENGL J MED, V324, P277, DOI 10.1056/NEJM199101313240501; Fortune DG, 1997, BRIT J DERMATOL, V137, P755; Krueger G, 2001, ARCH DERMATOL, V137, P280; Krueger JG, 2000, J AM ACAD DERMATOL, V43, P448, DOI 10.1067/mjd.2000.106515; Mease PJ, 2000, LANCET, V356, P385, DOI 10.1016/S0140-6736(00)02530-7; MUELLER W, 1979, NEW ENGL J MED, V301, P555; Oh CJ, 2000, J AM ACAD DERMATOL, V42, P829, DOI 10.1067/mjd.2000.105948; Papp K, 2001, J AM ACAD DERMATOL, V45, P665, DOI 10.1067/mjd.2001.117850; Richards HL, 1999, J AM ACAD DERMATOL, V41, P581, DOI 10.1016/S0190-9622(99)70301-4; SCHLAAK JF, 1994, J INVEST DERMATOL, V102, P145, DOI 10.1111/1523-1747.ep12371752; VALDIMARSSON H, 1995, IMMUNOL TODAY, V16, P145, DOI 10.1016/0167-5699(95)80132-4; Yawalkar N, 1998, J INVEST DERMATOL, V111, P1053, DOI 10.1046/j.1523-1747.1998.00446.x	16	21	24	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 26	2002	359	9303					279	280		10.1016/S0140-6736(02)07536-0	http://dx.doi.org/10.1016/S0140-6736(02)07536-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517AC	11830192				2022-12-24	WOS:000173588100006
J	Aurelio, O; Hall, DH; Hobert, O				Aurelio, O; Hall, DH; Hobert, O			Immunoglobulin-domain proteins required for maintenance of ventral nerve cord organization	SCIENCE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; C-ELEGANS; NEURONS; SYSTEM; UNC-6	During development, neurons extend axons along defined routes to specific target cells. We show that additional mechanisms ensure that axons maintain their correct positioning in defined axonal tracts. After termination of axonal outgrowth and target recognition, axons in the ventral nerve cord (VNC) of Caenorhabditis elegans require the presence of a specific VNC neuron, PVT, to maintain their correct positioning in the left and right fascicles of the VNC. PVT may exert its stabilizing function by the temporally tightly controlled secretion of 2-immunoglobulin (Ig)-domain proteins encoded by the zig genes. Dedicated axon maintenance mechanisms may be widely used to ensure the preservation of functional neuronal circuitries.	Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Ctr C Elegans Anat, Bronx, NY 10461 USA	Columbia University; Yeshiva University; Albert Einstein College of Medicine	Hobert, O (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, 722 W 168th St, New York, NY 10032 USA.			Hobert, Oliver/0000-0002-7634-2854	NCRR NIH HHS [RR12596, R24 RR012596] Funding Source: Medline; NIH HHS [R24 OD010943] Funding Source: Medline; NINDS NIH HHS [5F32NS11107-02] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR012596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS011107] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; DURBIN RM, 1987, THESIS U CAMBRIDGE; HALL DH, 1991, J NEUROSCI, V11, P1; Hobert O, 1999, J CELL BIOL, V144, P45, DOI 10.1083/jcb.144.1.45; LEWIS JA, 1980, GENETICS, V95, P905; MILLER DM, 1995, DEVELOPMENT, V121, P2877; PODBILEWICZ B, 1994, DEV BIOL, V161, P408, DOI 10.1006/dbio.1994.1041; Ren XC, 1999, J NEUROBIOL, V39, P107, DOI 10.1002/(SICI)1097-4695(199904)39:1&lt;107::AID-NEU9&gt;3.0.CO;2-7; SONDEREGGER P, 1998, IG SUPERFAMILY MOL N; SULSTON JE, 1976, PHILOS T ROY SOC B, V275, P287, DOI 10.1098/rstb.1976.0084; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zallen JA, 1999, DEVELOPMENT, V126, P3679	13	88	105	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					686	690		10.1126/science.1066642	http://dx.doi.org/10.1126/science.1066642			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809975				2022-12-24	WOS:000173560900048
J	Kaufman, DW; Kelly, JP; Rosenberg, L; Anderson, TE; Mitchell, AA				Kaufman, DW; Kelly, JP; Rosenberg, L; Anderson, TE; Mitchell, AA			Recent patterns of medication use in the ambulatory adult population of the United States - The Slone survey	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVERSE DRUG-REACTIONS; SUPPLEMENT USE; PRESCRIPTION; MEDICINE; EPESE	Context Data on the range of prescription and over-the-counter drug use in the United States are not available. Objective To provide recent population-based information on use of all medications, including prescription and over-the-counter drugs, vitamins and minerals, and herbal preparations/natural supplements in the United States. Design, Setting, and Participants Ongoing telephone survey of a random sample of the noninstitutionalized US population in the 48 continental states and the District of Columbia; data analyzed here were collected from February 1998 through December 1999. Main Outcome Measure Use of medications, by type, during the preceding week, compared by demographic characteristics. Results Among 2590 participants aged at least 18 years, 81% used at least 1 medication in the preceding week; 50% took at least 1 prescription drug; and 7% took 5 or more. The highest overall prevalence of medication use was among women aged at least 65 years, of whom 12% took at least 10 medications and 23% took at least 5 prescription drugs. Herbals/supplements were taken by 14% of the population. Among prescription drug users, 16% also took an herbal/supplement; the rate of concurrent use was highest for fluoxetine users, at 22%. Reasons for drug use varied widely, with hypertension and headache mentioned most often (9% for each). Vitamins/minerals were frequently used for nonspecific reasons such as "health" (35%); herbals/supplements were also most commonly used for "health" (16%). Conclusions In any given week, most US adults take at least 1 medication, and many take multiple agents. The substantial overlap between use of prescription medications and herbals/supplements raises concern about unintended interactions. Documentation of usage patterns can provide a basis for improving the safety of medication use.	Boston Univ, Sch Publ Hlth, Slone Epidemiol Unit, Boston, MA 02215 USA	Boston University	Kaufman, DW (corresponding author), Boston Univ, Sch Publ Hlth, Slone Epidemiol Unit, 1010 Commonwealth Ave, Boston, MA 02215 USA.			Rosenberg, Lynn/0000-0003-2760-2987; Mitchell, Allen/0000-0003-0950-6799; Kaufman, David/0000-0002-2150-5070				Balluz LS, 2000, ARCH FAM MED, V9, P258, DOI 10.1001/archfami.9.3.258; Bates DW, 1998, JAMA-J AM MED ASSOC, V279, P1216, DOI 10.1001/jama.279.15.1216; Baugh DK, 1999, HEALTH CARE FINANC R, V20, P79; Caces MF, 1998, J SUBST ABUSE, V10, P115, DOI 10.1016/S0899-3289(99)80128-X; COPELAND C, 1999, EBRI ISSUE BRIEF, V208, P1; EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Ernst E, 2000, EUR J CLIN PHARMACOL, V56, P523, DOI 10.1007/s002280000194; Ervin RB., 1999, USE DIETARY SUPPLEME; Espino DV, 1998, J AM GERIATR SOC, V46, P1228, DOI 10.1111/j.1532-5415.1998.tb04538.x; Gotto Antonio M., 1999, American Journal of Medicine, V107, p36S; Gray SL, 1996, PHARMACOTHERAPY, V16, P715; Handa VL, 1996, J AM GERIATR SOC, V44, P1; Harris MI, 1999, DIABETES CARE, V22, P403, DOI 10.2337/diacare.22.3.403; Lassila HC, 1996, ANN PHARMACOTHER, V30, P589, DOI 10.1177/106002809603000604; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Mehl B, 2000, AM J HEALTH-SYST PH, V57, P129, DOI 10.1093/ajhp/57.2.129; OROURKE D, 1999, SURVEY RES, V30, P1; Petrini J. R., 1999, Morbidity and Mortality Weekly Report, V48, P325; Pradel FG, 1999, ANN PHARMACOTHER, V33, P400, DOI 10.1345/aph.18247; Radimer KL, 2000, J AM DIET ASSOC, V100, P447, DOI 10.1016/S0002-8223(00)00137-1; Stoehr GP, 1997, J AM GERIATR SOC, V45, P158, DOI 10.1111/j.1532-5415.1997.tb04501.x; THORNBERRY OT, 1987, VITAL HLTH STAT, V2, P106; *US CENS BUR, 2000, CURR POP REP 1998; *US CENS BUR, 2000, HOUS TYP SEL CHAR 19; *US CENS BUR, 2001, NAT POP PROJ 2000 HI; *US CENS BUR, 2000, PROJ TOT RES POP 5 Y; *US CENS BUR, 2000, CURR POP REP MON INC; *US DEP COMM EC ST, 1993, 1990 CENS POP HOUS S; WAKSBERG J, 1978, J AM STAT ASSOC, V73, P40, DOI 10.2307/2286513; 2000, SCOTTLEVINS SOURCE P; 2000, IMS AM NPA 20K MONTH	32	1294	1335	0	52	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2002	287	3					337	344		10.1001/jama.287.3.337	http://dx.doi.org/10.1001/jama.287.3.337			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	511YQ	11790213	Bronze			2022-12-24	WOS:000173294700028
J	Rhee, JS; Betz, A; Pyott, S; Reim, K; Varoqueaux, F; Augustin, I; Hesse, D; Sudhof, TC; Takahashi, M; Rosenmund, C; Brose, N				Rhee, JS; Betz, A; Pyott, S; Reim, K; Varoqueaux, F; Augustin, I; Hesse, D; Sudhof, TC; Takahashi, M; Rosenmund, C; Brose, N			beta phorbol ester- and diacylglycerol-induced augmentation of transmitter release is mediated by Munc13s and not by PKCs	CELL			English	Article							PROTEIN-KINASE-C; NEUROTRANSMITTER RELEASE; SYNAPTIC TRANSMISSION; HIPPOCAMPAL SYNAPSES; PROBABILITY; UNC-13; POTENTIATION; VESICLES; CELLS; POOL	Munc13-1 is a presynaptic protein with an essential role in synaptic vesicle priming. It contains a diacylglycerol (DAG)/beta phorbol ester binding C-1 domain and is a potential target of the DAG second messenger pathway that may act in parallel with PKCs. Using genetically modified mice that express a DAG/beta phorbol ester binding-deficient Munc13-1(H567K) variant instead of the wild-type protein, we determined the relative contribution of PKCs and Munc13-1 to DAG/beta phorbol ester-dependent regulation of neurotransmitter release. We show that Munc13s are the main presynaptic DAG/beta phorbol ester receptors in hippocampal neurons. Modulation of Munc13-1 activity by second messengers via the DAG/beta phorbol ester binding C-1 domain is essential for use-dependent alterations of synaptic efficacy and survival.	Max Planck Inst Biophys Chem, Abt Membranbiophys, D-37077 Gottingen, Germany; Max Planck Inst Expt Med, Abt Mol Neurobiol, D-37075 Gottingen, Germany; Max Planck Inst Expt Med, Abt Neurogenet, D-37075 Gottingen, Germany; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Ctr Basic Neurosci,Dept Mol Genet, Dallas, TX 75390 USA; Mitsubishi Kasei Inst Life Sci, Tokyo 1948511, Japan	Max Planck Society; Max Planck Society; Max Planck Society; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Rosenmund, C (corresponding author), Max Planck Inst Biophys Chem, Abt Membranbiophys, Fassberg 11, D-37077 Gottingen, Germany.		Varoqueaux, Frederique/AAC-1834-2021; Rosenmund, Christian/AAC-3596-2020; Pyott, Sonja/AAW-8789-2020	Varoqueaux, Frederique/0000-0002-3614-3121; Rosenmund, Christian/0000-0002-3905-2444; Pyott, Sonja/0000-0001-7750-2437				Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Augustin I, 1999, BIOCHEM J, V337, P363, DOI 10.1042/0264-6021:3370363; Augustin I, 2001, J NEUROSCI, V21, P10, DOI 10.1523/JNEUROSCI.21-01-00010.2001; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Betz A, 1997, J BIOL CHEM, V272, P2520; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; DEGRAAN PNE, 1994, NEUROTOXICOLOGY, V15, P41; FABBRI M, 1994, J BIOL CHEM, V269, P26848; Goda Y, 1996, LEARN MEMORY, V3, P182, DOI 10.1101/lm.3.2-3.182; HAWKINS RD, 1993, ANNU REV NEUROSCI, V16, P625, DOI 10.1146/annurev.ne.16.030193.003205; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Honda I, 2000, J PHYSIOL-LONDON, V529, P763, DOI 10.1111/j.1469-7793.2000.00763.x; Hori T, 1999, J NEUROSCI, V19, P7262, DOI 10.1523/JNEUROSCI.19-17-07262.1999; Iwasaki S, 2000, J BIOCHEM-TOKYO, V128, P407, DOI 10.1093/oxfordjournals.jbchem.a022768; Kawakami M, 2000, BIOCHEM BIOPH RES CO, V279, P293, DOI 10.1006/bbrc.2000.3926; Kazanietz MG, 2000, BIOCHEM PHARMACOL, V60, P1417, DOI 10.1016/S0006-2952(00)00470-6; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Majewski H, 1998, PROG NEUROBIOL, V55, P463, DOI 10.1016/S0301-0082(98)00017-3; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Minami N, 1998, J PHYSIOL-LONDON, V512, P219, DOI 10.1111/j.1469-7793.1998.219bf.x; NAYAK A, 1999, ADV NEUROL, V79, P6545; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Oleskevich S, 2000, J PHYSIOL-LONDON, V524, P513, DOI 10.1111/j.1469-7793.2000.00513.x; Oleskevich S, 2000, J PHYSIOL-LONDON, V526, P349, DOI 10.1111/j.1469-7793.2000.t01-1-00349.x; PARFITT KD, 1993, J PHYSIOL-LONDON, V471, P245, DOI 10.1113/jphysiol.1993.sp019900; Redman RS, 1997, J PHYSIOL-LONDON, V501, P41, DOI 10.1111/j.1469-7793.1997.041bo.x; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROSENMUND C, 1995, J NEUROSCI, V15, P2788; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; ROSENMUND C, 2002, IN PRESS NEURON; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Shimazaki Y, 1996, J BIOL CHEM, V271, P14548, DOI 10.1074/jbc.271.24.14548; SKABA T, 2001, P NATL ACAD SCI USA, V98, P331; Song Y, 1998, KIDNEY INT, V53, P1689, DOI 10.1046/j.1523-1755.1998.00942.x; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; Waters J, 2000, J NEUROSCI, V20, P7863; Yawo H, 1999, J PHYSIOL-LONDON, V515, P169, DOI 10.1111/j.1469-7793.1999.169ad.x; Yawo H, 1999, J PHYSIOL-LONDON, V516, P461, DOI 10.1111/j.1469-7793.1999.0461v.x	48	365	377	1	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 11	2002	108	1					121	133		10.1016/S0092-8674(01)00635-3	http://dx.doi.org/10.1016/S0092-8674(01)00635-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792326	Bronze			2022-12-24	WOS:000173280700013
J	Ganeshram, RS; Pedersen, TF; Calvert, SE; Francois, R				Ganeshram, RS; Pedersen, TF; Calvert, SE; Francois, R			Reduced nitrogen fixation in the glacial ocean inferred from changes in marine nitrogen and phosphorus inventories	NATURE			English	Article							CONTINENTAL-MARGIN SEDIMENTS; ARABIAN SEA; INTERGLACIAL VARIABILITY; DENITRIFICATION; ACCUMULATION; PACIFIC; APATITE; PERU	To explain the lower atmospheric CO(2) concentrations during glacial periods, it has been suggested that the productivity of marine phytoplankton was stimulated by an increased flux of iron-bearing dust to the oceans(1,2). One component of this theory is that iron-an essential element/nutrient for nitrogen-fixing organisms-will increase the rate of marine nitrogen fixation, fuelling the growth of other marine phytoplankton and increasing CO(2) uptake. Here we present data that questions this hypothesis. From a sediment core off the northwestern continental margin of Mexico, we show that denitrification and phosphorite formation-processes that occur in oxygen-deficient upwelling regions, removing respectively nitrogen and phosphorus from the ocean-declined in glacial periods, thus increasing marine inventories of nitrogen and phosphorus. But increases in phosphorus were smaller and less rapid, leading to increased N/P ratios in the oceans. Acknowledging that phytoplankton require nitrogen and phosphorus in constant proportions, the Redfield ratio(3), and that N/P ratios greater than the Redfield ratio are likely to suppress nitrogen fixation(4,5), we suggest therefore that marine productivity did not increase in glacial periods in response to either increased nutrient inventories or greater iron supply.	Univ Edinburgh, Dept Geol & Geophys, Edinburgh EH9 3JW, Midlothian, Scotland; Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada; Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02540 USA	University of Edinburgh; University of British Columbia; Woods Hole Oceanographic Institution	Ganeshram, RS (corresponding author), Univ Edinburgh, Dept Geol & Geophys, W Mains Rd, Edinburgh EH9 3JW, Midlothian, Scotland.	Raja.Ganeshram@glg.ed.ac.uk						ALTABET MA, 1995, NATURE, V373, P506, DOI 10.1038/373506a0; Brandes JA, 1998, LIMNOL OCEANOGR, V43, P1680, DOI 10.4319/lo.1998.43.7.1680; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; BURNETT WC, 1980, J GEOL SOC LONDON, V137, P757, DOI 10.1144/gsjgs.137.6.0757; CODISPOTI LA, 1985, MAR CHEM, V16, P277, DOI 10.1016/0304-4203(85)90051-9; CODISPOTI LA, 1989, LIFE SCI R, V44, P377; Delaney ML, 1998, GLOBAL BIOGEOCHEM CY, V12, P563, DOI 10.1029/98GB02263; FALKOWSKI P. G., 1997, NATURE, V342, P637; Filippelli GM, 1997, MAR GEOL, V139, P231, DOI 10.1016/S0025-3227(96)00113-2; FROELICH PN, 1988, MAR GEOL, V80, P309, DOI 10.1016/0025-3227(88)90095-3; GANESHRAM RS, 1995, NATURE, V376, P755, DOI 10.1038/376755a0; Ganeshram RS, 2000, PALEOCEANOGRAPHY, V15, P361, DOI 10.1029/1999PA000422; Ganeshram RS, 1998, PALEOCEANOGRAPHY, V13, P634, DOI 10.1029/98PA02508; Garrison R.E., 1990, P OCEAN DRILLING PRO, V112, P111, DOI DOI 10.2973/ODP.PROC.SR.112.145.1990.; Heggie D., 1988, EOS T AM GEOPHYS UN, V69, P2, DOI DOI 10.1029/88E000007; HOOD RR, 2000, EOS, V81, P1; JAHNKE RA, 1983, GEOCHIM COSMOCHIM AC, V47, P259, DOI 10.1016/0016-7037(83)90138-2; LAMBOURN L, 1991, 110 U WASH SCH OC; PRICE NB, 1978, CHEM GEOL, V23, P151, DOI 10.1016/0009-2541(78)90072-4; REDFIELD AC, 1963, SEA, V2, P36; RUTTENBERG KC, 1993, CHEM GEOL, V107, P405, DOI 10.1016/0009-2541(93)90220-D; Sanudo-Wilhelmy SA, 2001, NATURE, V411, P66, DOI 10.1038/35075041; Schenau S, 2000, MAR GEOL, V169, P1, DOI 10.1016/S0025-3227(00)00083-9; Schuffert JD, 1998, MAR GEOL, V146, P21, DOI 10.1016/S0025-3227(97)00122-9; SHIMMIELD G, 1991, P OCEAN DRILLING PRO, V0117; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941	26	106	124	3	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					156	159		10.1038/415156a	http://dx.doi.org/10.1038/415156a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805830				2022-12-24	WOS:000173159300037
J	Osmond, DH; Buchbinder, S; Cheng, A; Graves, A; Vittinghoff, E; Cossen, CK; Forghani, B; Martin, JN				Osmond, DH; Buchbinder, S; Cheng, A; Graves, A; Vittinghoff, E; Cossen, CK; Forghani, B; Martin, JN			Prevalence of kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BISEXUAL MEN; SEXUAL TRANSMISSION; RISK-FACTORS; HUMAN-HERPESVIRUS-8; SEROCONVERSION; COHORT; HEALTH; ANTIBODIES; RATES	Context Some studies have inferred that an epidemic of Kaposi sarcoma-associated herpesvirus (KSHV) infection in homosexual men in the United States occurred concurrently with that of human immunodeficiency virus (HIV), but there have been no direct measurements of KSHV prevalence at the beginning of the HIV epidemic. Objectives To determine the prevalence of KSHV infection in homosexual men in San Francisco, Calif, at the beginning of the HIV epidemic in 1978 and 1979 and to examine changes in prevalence of KSHV at time points from 1978 through 1996 in light of changes in sexual behavior. Design, Setting, and Participants Analysis of a clinic-based sample (n=398) derived from the San Francisco City Clinic Cohort (ages 18-66 years) (n=2666 for analyses herein) and from population-based samples from the San Francisco Men's Health Study (MHS) (ages 25-54 years) (n=825 and 252) and the San Francisco Young Men's Health Study (YMHS) (ages 18-29 years) (n=428-976, and 557); behavioral studies were longitudinal and KSHV prevalence studies were cross-sectional. Main Outcome Measures Antibodies against KSHV and HIV; sexual behaviors. Results The prevalence of KSHV infection in 1978 and 1979 was 26.5% of 235 (a random sample) overall (weighted for HIV infection) vs 6.9% (128/1842) for HIV in the San Francisco City Clinic Cohort sample. The prevalence of KSHV infection remained essentially unchanged between an MHS sample of 252 in 1984 and 1985 (29.6%) and a YMHS sample of 557 in 1995 and 1996 (26.4%), while HIV prevalence dropped from 49.5% of 825 in 1984 and 1985 (MHS) to 17.6% of 428 in 1992 and 1993 (YMHS). The proportion of men practicing unprotected receptive anal intercourse with 1 or more partners declined from 54% to 11% during the 1984 through 1993 period (MHS) with similar though slightly higher values in the YMHS in 1992 and 1993; whereas for unprotected oral intercourse it ranged between 60% and 90% in the 1984 through 1996 period (PANS and YMHS). Conclusions Infection with KSHV was already highly prevalent in homosexual men when the HIV epidemic began in San Francisco, and its prevalence has been maintained at a nearly constant level. Any declines in the incidence of Kaposi sarcoma do not appear to be caused by a decline in KSHV transmission.	Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA; Calif Dept Hlth Serv, Div Communicable Dis Control, Viral & Rickettsial Dis Lab, Viral Immunoserol Sect, Richmond, CA USA	University of California System; University of California San Francisco; San Francisco Department of Public Health; California Department of Health Care Services	Osmond, DH (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, Box 0886, San Francisco, CA 94143 USA.				NCI NIH HHS [U01 CA78124] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA078124] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chandran B, 1998, VIROLOGY, V243, P208, DOI 10.1006/viro.1998.9055; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Diamond C, 1997, J INFECT DIS, V176, P775, DOI 10.1086/517299; Dore GJ, 1996, AIDS, V10, P1401, DOI 10.1097/00002030-199610000-00013; Dukers NHTM, 2000, AM J EPIDEMIOL, V151, P213, DOI 10.1093/oxfordjournals.aje.a010195; Ekstrand ML, 1999, AIDS, V13, P1525, DOI 10.1097/00002030-199908200-00013; Fusaro RE, 1996, BIOMETRICS, V52, P211, DOI 10.2307/2533157; Gao SJ, 1996, NEW ENGL J MED, V335, P233, DOI 10.1056/NEJM199607253350403; Grulich AE, 1997, AM J EPIDEMIOL, V145, P673, DOI 10.1093/aje/145.8.673; Hayward GS, 1999, SEMIN CANCER BIOL, V9, P187, DOI 10.1006/scbi.1998.0116; Jacobson L.P., 2000, 3 INT WORKSH KAP SAR; Jones JL, 1999, J ACQ IMMUN DEF SYND, V21, pS11; Kedes DH, 1996, NAT MED, V2, P918, DOI 10.1038/nm0896-918; Koelle DM, 1997, J INFECT DIS, V176, P94, DOI 10.1086/514045; MARTIN J, 2000, 3 INT WORKSH KAP SAR; Martin JN, 2000, J CLIN MICROBIOL, V38, P696, DOI 10.1128/JCM.38.2.696-701.2000; Martin JN, 1998, NEW ENGL J MED, V338, P948, DOI 10.1056/NEJM199804023381403; Melbye M, 1998, INT J CANCER, V77, P543, DOI 10.1002/(SICI)1097-0215(19980812)77:4&lt;543::AID-IJC12&gt;3.0.CO;2-7; O'Brien TR, 1999, J INFECT DIS, V180, P1010, DOI 10.1086/315039; OSMOND DH, 1994, AM J PUBLIC HEALTH, V84, P1933, DOI 10.2105/AJPH.84.12.1933; Pauk J, 2000, NEW ENGL J MED, V343, P1369, DOI 10.1056/NEJM200011093431904; Renwick N, 1998, AIDS, V12, P2481, DOI 10.1097/00002030-199818000-00018; RUTHERFORD GW, 1990, BRIT MED J, V301, P1183, DOI 10.1136/bmj.301.6762.1183; RUTHERFORD GW, 1990, J ACQ IMMUN DEF SYND, V3, pS4; SAMUEL MC, 1993, J ACQ IMMUN DEF SYND, V6, P303; Simpson GR, 1996, LANCET, V348, P1133, DOI 10.1016/S0140-6736(96)07560-5; VEUGELERS PJ, 1995, EPIDEMIOLOGY, V6, P382, DOI 10.1097/00001648-199507000-00009; WINKELSTEIN W, 1987, AM J PUBLIC HEALTH, V77, P685, DOI 10.2105/AJPH.77.6.685; WINKELSTEIN W, 1988, AM J PUBLIC HEALTH, V78, P1472, DOI 10.2105/AJPH.78.11.1472; WINKELSTEIN W, 1987, JAMA-J AM MED ASSOC, V257, P321, DOI 10.1001/jama.257.3.321	30	71	72	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2002	287	2					221	225		10.1001/jama.287.2.221	http://dx.doi.org/10.1001/jama.287.2.221			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508XK	11779265				2022-12-24	WOS:000173114900025
J	Weinger, MB; Ancoli-Israel, S				Weinger, MB; Ancoli-Israel, S			Sleep deprivation and clinical performance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICAL HOUSE STAFF; COGNITIVE PERFORMANCE; WORKING HOURS; PATIENT-CARE; FATIGUE; NIGHT; MOOD; METAANALYSIS; VIGILANCE; IMPACT		Univ Calif San Diego, Dept Anesthesiol, San Diego Ctr Patient Safety, San Diego, CA 92103 USA; Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; Vet Affairs San Diego Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Weinger, MB (corresponding author), Vet Affairs Med Ctr, 125,3350 La Jolla Village Dr, La Jolla, CA 92161 USA.				AHRQ HHS [R01-HS11375, P20-HS11521] Funding Source: Medline; NCI NIH HHS [R01-CA85264] Funding Source: Medline; NIA NIH HHS [R01-AG08415] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [P20HS011521, R01HS011375] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA085264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008415] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 2000, PRINCIPLES PRACTICE; Dawson D, 1997, NATURE, V388, P235, DOI 10.1038/40775; Dinges DF, 1997, SLEEP, V20, P267; ENGLUND CE, 1985, BEHAV RES METH INS C, V17, P75, DOI 10.3758/BF03200899; FRIEDMAN RC, 1971, NEW ENGL J MED, V285, P201, DOI 10.1056/NEJM197107222850405; GABA DM, 1998, ENHANCING PATIENT SA, P302; GOTTLIEB DJ, 1991, ARCH INTERN MED, V151, P2065, DOI 10.1001/archinte.151.10.2065; Grantcharov TP, 2001, BRIT MED J, V323, P1222, DOI 10.1136/bmj.323.7323.1222; HOWARD SK, IN PRESS ACAD MED; KOSLOWSKY M, 1992, CHRONOBIOL INT, V9, P132, DOI 10.3109/07420529209064524; LAINE C, 1993, JAMA-J AM MED ASSOC, V269, P374, DOI 10.1001/jama.269.3.374; LEES DE, 1988, APSF NEWSLETTER, V3, P18; Leonard C, 1998, IRISH J MED SCI, V167, P22, DOI 10.1007/BF02937548; LEUNG L, 1992, J OCCUP ENVIRON MED, V34, P1153; Nelson C S, 1995, J Am Osteopath Assoc, V95, P600; OU JC, 2001, ANESTHESIOLOGY, V95, pA1196; Owens JA, 2001, SLEEP, V24, P493, DOI 10.1093/sleep/24.5.493; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; Richardson GS, 1996, SLEEP, V19, P718; SAMKOFF JS, 1991, ACAD MED, V66, P687, DOI 10.1097/00001888-199111000-00013; SMITHCOGGINS R, 1994, ANN EMERG MED, V24, P928, DOI 10.1016/S0196-0644(94)70209-8; SmithCoggins R, 1997, ACAD EMERG MED, V4, P951, DOI 10.1111/j.1553-2712.1997.tb03658.x; Taffinder NJ, 1998, LANCET, V352, P1191, DOI 10.1016/S0140-6736(98)00034-8; WEINGER MB, 1990, ANESTHESIOLOGY, V73, P995; WEINGER MB, 1998, ENHANCING PATIENT SA, P306; Wesnes KA, 1997, BRIT J SURG, V84, P493	26	248	257	0	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2002	287	8					955	957		10.1001/jama.287.8.955	http://dx.doi.org/10.1001/jama.287.8.955			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525CX	11866625				2022-12-24	WOS:000174052100001
J	Wengelnik, K; Vidal, V; Ancelin, ML; Cathiard, AM; Morgat, JL; Kocken, CH; Calas, M; Herrera, S; Thomas, AW; Vial, HJ				Wengelnik, K; Vidal, V; Ancelin, ML; Cathiard, AM; Morgat, JL; Kocken, CH; Calas, M; Herrera, S; Thomas, AW; Vial, HJ			A class of potent antimalarials and their specific accumulation in infected erythrocytes	SCIENCE			English	Article							FALCIPARUM PHOSPHOLIPID-METABOLISM; PLASMODIUM-FALCIPARUM; MALARIA; CHLORIDE	During asexual development within erythrocytes, malaria parasites synthesize considerable amounts of membrane. This activity provides an attractive target for chemotherapy because it is absent from mature erythrocytes. We found that compounds that inhibit phosphatidylcholine biosynthesis de novo from choline were potent antimalarial drugs. The lead compound, G25, potently inhibited in vitro growth of the human malaria parasites Plasmodium falciparum and P. vivax and was 1000-fold less toxic to mammalian cell lines. A radioactive derivative specifically accumulated in infected erythrocytes to levels several hundredfold higher than in the surrounding medium, and very low dose G25 therapy completely cured monkeys infected with P. falciparum and A cynomolgi.	Univ Montpellier 2, CNRS, UMR 5539, F-34095 Montpellier 5, France; Univ Montpellier 2, CNRS, UMR 5810, F-34095 Montpellier, France; Univ Montpellier 1, Fac Pharm, CRBA, CNRS UMR 5473, F-34060 Montpellier, France; Biomed Primate Res Ctr, Dept Parasitol, NL-2280 GH Rijswijk, Netherlands; Univ Valle, Fdn Ctr Primates, Cali, Colombia	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; Universidad del Valle	Vial, HJ (corresponding author), Univ Montpellier 2, CNRS, UMR 5539, CP 107,Pl E Bataillon, F-34095 Montpellier 5, France.		Ancelin, Marie-Laure/L-1198-2019; Ancelin, Marie-Laure/F-3079-2013	Ancelin, Marie-Laure/0000-0002-1149-4320; Ancelin, Marie-Laure/0000-0002-1149-4320; Kocken, Clemens/0000-0002-4784-1734; Wengelnik, Kai/0000-0002-4547-4205				AMES BN, 1975, MUTAT RES, V31, P347, DOI 10.1016/0165-1161(75)90046-1; Ancelin ML, 1998, BLOOD, V91, P1426, DOI 10.1182/blood.V91.4.1426; Bannister LH, 2000, PARASITOL TODAY, V16, P427, DOI 10.1016/S0169-4758(00)01755-5; BEAUMELLE BD, 1987, J PARASITOL, V73, P743, DOI 10.2307/3282405; Bray PG, 1998, MOL PHARMACOL, V54, P170, DOI 10.1124/mol.54.1.170; Calas M, 2000, J MED CHEM, V43, P505, DOI 10.1021/jm9911027; Calas M, 1997, J MED CHEM, V40, P3557, DOI 10.1021/jm9701886; CAMPBELL CC, 1979, LANCET, V2, P1151; Coatney GR, 1971, PRIMATE MALARIAS; Gumila C, 1996, ANTIMICROB AGENTS CH, V40, P602, DOI 10.1128/AAC.40.3.602; HERRERA S, 1990, P NATL ACAD SCI USA, V87, P4017, DOI 10.1073/pnas.87.10.4017; Kirk K, 2001, PHYSIOL REV, V81, P495, DOI 10.1152/physrev.2001.81.2.495; KIRK K, 1994, J BIOL CHEM, V269, P3339; KOCKEN C, UNPUB; Kocken CHM, 1996, EXP PARASITOL, V84, P439, DOI 10.1006/expr.1996.0132; KUTNER S, 1985, J CELL PHYSIOL, V125, P521, DOI 10.1002/jcp.1041250323; Peters W, 1970, CHEMOTHERAPY DRUG RE; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Stead AMW, 2001, MOL PHARMACOL, V59, P1298, DOI 10.1124/mol.59.5.1298; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; VANDEENEN LLM, 1975, RED BLOOD CELL, P147; Vial H., 1998, MALARIA PARASITE BIO, P159; Vial H J, 1999, Novartis Found Symp, V226, P74; VIAL HJ, UNPUB; Winstanley PA, 2000, PARASITOL TODAY, V16, P146, DOI 10.1016/S0169-4758(99)01622-1	26	144	150	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1311	1314		10.1126/science.1067236	http://dx.doi.org/10.1126/science.1067236			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847346				2022-12-24	WOS:000173926000048
J	Adini, Y; Sagi, D; Tsodyks, M				Adini, Y; Sagi, D; Tsodyks, M			Context-enabled learning in the human visual system	NATURE			English	Article							SYNAPTIC PLASTICITY; CORTEX; DISCRIMINATION; EXPERIENCE; NEURONS; VISION	Training was found to improve the performance of humans on a variety of visual perceptual tasks(1,2). However, the ability to detect small changes in the contrast of simple visual stimuli could not be improved by repetition(3). Here we show that the performance of this basic task could be modified after the discrimination of the stimulus contrast was practised in the presence of similar laterally placed stimuli, suggesting a change in the local neuronal circuit involved in the task. On the basis of a combination of hebbian and anti-hebbian synaptic learning rules compatible with our results, we propose a mechanism of plasticity in the visual cortex that is enabled by a change in the context.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Sagi, D (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	dov.sagi@weizmann.ac.il	Sagi, Dov/A-5454-2008; tsodyks, misha/J-4430-2013	Sagi, Dov/0000-0002-8446-9230; Tsodyks, Misha/0000-0002-5661-4349				Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Adini Y, 1997, P NATL ACAD SCI USA, V94, P10426, DOI 10.1073/pnas.94.19.10426; Adini Y, 2001, J OPT SOC AM A, V18, P2228, DOI 10.1364/JOSAA.18.002228; ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; Dorais A, 1997, VISION RES, V37, P1725, DOI 10.1016/S0042-6989(96)00329-X; FAHLE M, 1995, VISION RES, V35, P3003, DOI 10.1016/0042-6989(95)00044-Z; FOLEY JM, 1994, J OPT SOC AM A, V11, P1710, DOI 10.1364/JOSAA.11.001710; Gabor D., 1946, J I ELECT ENG LOND, V93, P429, DOI DOI 10.1049/JI-3-2.1946.0074; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Karni A, 1996, COGNITIVE BRAIN RES, V5, P39, DOI 10.1016/S0926-6410(96)00039-0; LEGGE GE, 1981, VISION RES, V21, P457, DOI 10.1016/0042-6989(81)90092-4; MARCELJA S, 1980, J OPT SOC AM, V70, P1297, DOI 10.1364/JOSA.70.001297; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P587, DOI 10.1113/jphysiol.1966.sp008003; POLAT U, 1994, P NATL ACAD SCI USA, V91, P1206, DOI 10.1073/pnas.91.4.1206; POLLEN DA, 1983, IEEE T SYST MAN CYB, V13, P907, DOI 10.1109/TSMC.1983.6313086; SAGI D, 1994, CURR OPIN NEUROBIOL, V4, P195, DOI 10.1016/0959-4388(94)90072-8; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Senn W, 2001, NEURAL COMPUT, V13, P35, DOI 10.1162/089976601300014628; Somers DC, 1998, CEREB CORTEX, V8, P204, DOI 10.1093/cercor/8.3.204; Tsodyks MV, 1997, J NEUROSCI, V17, P4382; Walker GA, 2000, VISUAL NEUROSCI, V17, P369, DOI 10.1017/S0952523800173055; WILSON HR, 1993, VISION RES, V33, P1133, DOI 10.1016/0042-6989(93)90248-U; WILSON HR, 1973, KYBERNETIK, V13, P55, DOI 10.1007/BF00288786; Zenger B, 2002, PERCEPTUAL LEARNING, P177; Zenger-Landolt B, 2001, VISION RES, V41, P3663, DOI 10.1016/S0042-6989(01)00175-4	31	128	130	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2002	415	6873					790	793		10.1038/415790a	http://dx.doi.org/10.1038/415790a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845209				2022-12-24	WOS:000173833900046
J	Gadek, TR; Burdick, DJ; McDowell, RS; Stanley, MS; Marsters, JC; Paris, KJ; Oare, DA; Reynolds, ME; Ladner, C; Zioncheck, KA; Lee, WP; Gribling, P; Dennis, MS; Skelton, NJ; Tumas, DB; Clark, KR; Keating, SM; Beresini, MH; Tilley, JW; Presta, LG; Bodary, SC				Gadek, TR; Burdick, DJ; McDowell, RS; Stanley, MS; Marsters, JC; Paris, KJ; Oare, DA; Reynolds, ME; Ladner, C; Zioncheck, KA; Lee, WP; Gribling, P; Dennis, MS; Skelton, NJ; Tumas, DB; Clark, KR; Keating, SM; Beresini, MH; Tilley, JW; Presta, LG; Bodary, SC			Generation of an LFA-1 antagonist by the transfer of the ICAM-1 immunoregulatory epitope to a small molecule	SCIENCE			English	Article							FUNCTION-ASSOCIATED ANTIGEN-1; MONOCLONAL-ANTIBODY; AUTOIMMUNE-DISEASES; ADHESION MOLECULES; BINDING; DOMAINS; POTENT; RHINOVIRUS; INHIBITION; NONPEPTIDE	The protein-protein interaction between leukocyte functional antigen-1 (LFA-1) and intercellular adhesion molecule-1 (ICAM-1) is critical to lymphocyte and immune system function. Here, we report on the transfer of the contiguous, nonlinear epitope of ICAM-1, responsible for its association with LFA-1, to a small-molecule framework. These LFA-1 antagonists bound LFA-1, blocked binding of ICAM-1, and inhibited a mixed lymphocyte reaction (MLR) with potency significantly greater than that of cyclosporine A. Furthermore, in comparison to an antibody to LFA-1, they exhibited significant anti-inflammatory effects in vivo. These results demonstrate the utility of small-molecule mimics of nonlinear protein epitopes and the protein epitopes themselves as leads in the identification of novel pharmaceutical agents.	Genentech Inc, Dept Bioorgan Chem, San Francisco, CA 94080 USA; Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; Genentech Inc, Dept Small Mol Pharmacol, San Francisco, CA 94080 USA; Genentech Inc, Dept Antibody Technol, San Francisco, CA 94080 USA; Hoffmann La Roche Inc, Roche Res Ctr, Nutley, NJ 07110 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding	Gadek, TR (corresponding author), Genentech Inc, Dept Bioorgan Chem, 1 DNA Way, San Francisco, CA 94080 USA.							ADLER M, 1993, BIOCHEMISTRY-US, V32, P282, DOI 10.1021/bi00052a036; Bella J, 1998, P NATL ACAD SCI USA, V95, P4140, DOI 10.1073/pnas.95.8.4140; BODARY SC, UNPUB; BURDICK DJ, 1999, Patent No. 9949856; Casasnovas JM, 1998, P NATL ACAD SCI USA, V95, P4134, DOI 10.1073/pnas.95.8.4134; CONNOLLY MK, 1994, CLIN IMMUNOL IMMUNOP, V72, P198, DOI 10.1006/clin.1994.1130; DENNIS MS, 1993, PROTEINS, V15, P312, DOI 10.1002/prot.340150308; DENNIS MS, 1990, P NATL ACAD SCI USA, V87, P2471, DOI 10.1073/pnas.87.7.2471; Fisher KL, 1997, MOL BIOL CELL, V8, P501, DOI 10.1091/mbc.8.3.501; Gottlieb A, 2000, J AM ACAD DERMATOL, V42, P428, DOI 10.1016/S0190-9622(00)90214-7; GRANLUND H, 2000, CURR OPIN ANTIINFLAM, V2, P332; KAKIMOTO K, 1992, CELL IMMUNOL, V142, P326, DOI 10.1016/0008-8749(92)90294-Y; Kallen J, 1999, J MOL BIOL, V292, P1, DOI 10.1006/jmbi.1999.3047; Kelly TA, 1999, J IMMUNOL, V163, P5173; Liu G, 2001, EXPERT OPIN THER PAT, V11, P1383, DOI 10.1517/13543776.11.9.1383; Liu G, 2001, J MED CHEM, V44, P1202, DOI 10.1021/jm000503f; MCDOWELL RS, 1994, J AM CHEM SOC, V116, P5077, DOI 10.1021/ja00091a008; MCDOWELL RS, 1994, J AM CHEM SOC, V116, P5069, DOI 10.1021/ja00091a007; MCDOWELL RS, 1992, J AM CHEM SOC, V114, P9245, DOI 10.1021/ja00050a001; McMurray RW, 1996, SEMIN ARTHRITIS RHEU, V25, P215, DOI 10.1016/S0049-0172(96)80034-5; NAKAKURA EK, 1993, TRANSPLANTATION, V55, P412; OppenheimerMarks N, 1996, CLIN IMMUNOL IMMUNOP, V79, P203, DOI 10.1006/clin.1996.0069; SPRAGG JH, 1996, MOL MED SCI, P131; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; Werther WA, 1996, J IMMUNOL, V157, P4986	25	143	159	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1086	1089		10.1126/science.295.5557.1086	http://dx.doi.org/10.1126/science.295.5557.1086			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834839				2022-12-24	WOS:000173793000070
J	Piazzesi, G; Reconditi, M; Linari, M; Lucii, L; Sun, YB; Narayanan, T; Boesecke, P; Lombardi, V; Irving, M				Piazzesi, G; Reconditi, M; Linari, M; Lucii, L; Sun, YB; Narayanan, T; Boesecke, P; Lombardi, V; Irving, M			Mechanism of force generation by myosin heads in skeletal muscle	NATURE			English	Article							STRIATED-MUSCLE; ISOMETRIC CONTRACTION; FINE-STRUCTURE; POWER STROKE; LIGHT-CHAIN; FIBERS; FROG; ACTIN; MOTOR; CONFORMATION	Muscles generate force and shortening in a cyclical interaction between the myosin head domains projecting from the myosin filaments and the adjacent actin filaments. Although many features of the dynamic performance of muscle are determined by the rates of attachment and detachment of myosin and actin 1, the primary event in force generation is thought to be a conformational change or 'working stroke' in the actin-bound myosin head(2-8). According to this hypothesis, the working stroke is much faster than attachment or detachment, but can be observed directly in the rapid force transients that follow step displacement of the filaments(3). Although many studies of the mechanism of muscle contraction(9-13) have been based on this hypothesis, the alternative view-that the fast force transients are caused by fast components of attachment and detachment(14-17) has not been excluded definitively. Here we show that measurements of the axial motions of the myosin heads at angstrom resolution by a new X-ray interference technique(18) rule out the rapid attachment/detachment hypothesis, and provide compelling support for the working stroke model of force generation.	Kings Coll London, Sch Biomed Sci, Randall Ctr, London SE1 1UL, England; Univ Florence, I-50134 Florence, Italy; European Synchrotron Radiat Facil, F-38043 Grenoble, France	University of London; King's College London; University of Florence; European Synchrotron Radiation Facility (ESRF)	Irving, M (corresponding author), Kings Coll London, Sch Biomed Sci, Randall Ctr, London SE1 1UL, England.	malcolm.irving@kcl.ac.uk	Sun, Yin-Biao/F-9988-2018	Sun, Yin-Biao/0000-0002-4992-8198; Narayanan, Theyencheri/0000-0003-1957-1041; LINARI, MARCO/0000-0001-6512-4897; RECONDITI, MASSIMO/0000-0001-5065-924X	Telethon [625] Funding Source: Medline	Telethon(Fondazione Telethon)		BOESECKE P, 1995, REV SCI INSTRUM, V66, P1636; BRENNER B, 1991, P NATL ACAD SCI USA, V88, P10490, DOI 10.1073/pnas.88.23.10490; Corrie JET, 1999, NATURE, V400, P425, DOI 10.1038/22704; CRAIG R, 1977, J MOL BIOL, V109, P69, DOI 10.1016/S0022-2836(77)80046-6; Dobbie I, 1998, NATURE, V396, P383, DOI 10.1038/24647; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; FORD LE, 1977, J PHYSIOL-LONDON, V269, P441, DOI 10.1113/jphysiol.1977.sp011911; FORD LE, 1981, J PHYSIOL-LONDON, V311, P219, DOI 10.1113/jphysiol.1981.sp013582; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; HASELGROVE JC, 1975, J MOL BIOL, V92, P113, DOI 10.1016/0022-2836(75)90094-7; Howard J., 2001, MECH MOTOR PROTEINS; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; HUXLEY AF, 1981, J PHYSIOL-LONDON, V317, pP12; HUXLEY AF, 1974, J PHYSIOL-LONDON, V243, P1; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; HUXLEY HE, 1983, J MOL BIOL, V169, P469, DOI 10.1016/S0022-2836(83)80062-X; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; Irving M, 2000, NAT STRUCT BIOL, V7, P482, DOI 10.1038/75890; IRVING M, 1992, NATURE, V357, P156, DOI 10.1038/357156a0; Kitamura K, 1999, NATURE, V397, P129, DOI 10.1038/16403; Linari M, 2000, P NATL ACAD SCI USA, V97, P7226, DOI 10.1073/pnas.97.13.7226; Linari M, 1998, BIOPHYS J, V74, P2459, DOI 10.1016/S0006-3495(98)77954-8; LOMBARDI V, 1990, J PHYSIOL-LONDON, V431, P141, DOI 10.1113/jphysiol.1990.sp018324; LOMBARDI V, 1992, NATURE, V355, P638, DOI 10.1038/355638a0; Piazzesi G, 1999, J PHYSIOL-LONDON, V514, P305, DOI 10.1111/j.1469-7793.1999.305ae.x; PODOLSKY RJ, 1973, COLD SPRING HARB SYM, V37, P661, DOI 10.1101/SQB.1973.037.01.080; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; SJOSTROM M, 1977, J MOL BIOL, V109, P49, DOI 10.1016/S0022-2836(77)80045-4; THORSON J, 1969, BIOPHYS J, V9, P360, DOI 10.1016/S0006-3495(69)86392-7	30	116	119	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					659	662		10.1038/415659a	http://dx.doi.org/10.1038/415659a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832949	Green Published			2022-12-24	WOS:000173709100051
J	Nenner, F				Nenner, F			The knapsack	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2002	287	4					417	418		10.1001/jama.287.4.417	http://dx.doi.org/10.1001/jama.287.4.417			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	513VX	11798342				2022-12-24	WOS:000173401900001
J	Reardon, DC; Cougle, JR				Reardon, DC; Cougle, JR			Depression and unintended pregnancy in the National Longitudinal Survey of Youth: a cohort study	BRITISH MEDICAL JOURNAL			English	Article							ABORTION; WOMEN		Elliot Inst, Springfield, IL 62791 USA		Reardon, DC (corresponding author), Elliot Inst, POB 7348, Springfield, IL 62791 USA.			Reardon, David/0000-0002-4478-6231				COSTELLO EJ, 1982, J CLIN PSYCHOL, V38, P340, DOI 10.1002/1097-4679(198204)38:2<340::AID-JCLP2270380220>3.0.CO;2-D; JONES EF, 1992, DEMOGRAPHY, V29, P113, DOI 10.2307/2061366; Major B, 2000, ARCH GEN PSYCHIAT, V57, P777, DOI 10.1001/archpsyc.57.8.777; Major B, 1999, J PERS SOC PSYCHOL, V77, P735, DOI 10.1037/0022-3514.77.4.735	4	87	89	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 19	2002	324	7330					151	152		10.1136/bmj.324.7330.151	http://dx.doi.org/10.1136/bmj.324.7330.151			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	514ZH	11799033	Green Published, Bronze			2022-12-24	WOS:000173470600020
J	Ebert, D; Haag, C; Kirkpatrick, M; Riek, M; Hottinger, JW; Pajunen, VI				Ebert, D; Haag, C; Kirkpatrick, M; Riek, M; Hottinger, JW; Pajunen, VI			A selective advantage to immigrant genes in a Daphnia metapopulation	SCIENCE			English	Article							INBREEDING DEPRESSION; SUBDIVIDED POPULATIONS; DELETERIOUS MUTATIONS; CYCLICAL PARTHENOGEN; ROCK POOLS; EXTINCTION; LOAD; CONSEQUENCES; ENVIRONMENT; DIVERSITY	Immigrants to habitats occupied by conspecific organisms are usually expected to be competitively inferior, because residents may be locally adapted. If residents are inbred, however, mating between immigrants and residents results in offspring that may enjoy a fitness advantage from hybrid vigor. We demonstrate this effect experimentally in a natural Daphnia metapopulation in which genetic bottlenecks and local inbreeding are common. We estimate that in this metapopulation, hybrid vigor amplifies the rate of gene flow several times more than would be predicted from the nominal migration rate. This can affect the persistence of local populations and the entire metapopulation.	Univ Basel, Inst Zool, CH-4051 Basel, Switzerland; Tvarminne Zool Stn, SF-10900 Hango, Finland; Univ Fribourg, Dept Biol, Unite Ecol & Evolut, CH-1700 Fribourg, Switzerland; Univ Texas, Sect Integrat Biol, Austin, TX 78712 USA; Univ Helsinki, Dept Systemat & Ecol, Div Populat Biol, FIN-00014 Helsinki, Finland	University of Basel; University of Fribourg; University of Texas System; University of Texas Austin; University of Helsinki	Ebert, D (corresponding author), Univ Basel, Inst Zool, Rheinsprung 9, CH-4051 Basel, Switzerland.		Haag, Christoph/B-6488-2009; Ebert, Dieter/B-5502-2009; Ebert, Dieter/P-6134-2019	Haag, Christoph/0000-0002-8817-1431; Ebert, Dieter/0000-0003-2653-3772; Ebert, Dieter/0000-0003-2653-3772				As S, 1992, ECOLOGICAL PRINCIPLE, P201; BARRETT SCH, 1991, NATURE, V352, P522, DOI 10.1038/352522a0; BRYANT EH, 1990, AM NAT, V136, P542, DOI 10.1086/285112; Charlesworth B, 1997, GENET RES, V70, P155, DOI 10.1017/S0016672397002954; CHARLESWORTH B, 1990, NATURE, V347, P380, DOI 10.1038/347380a0; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.ecolsys.18.1.237; Darwin CR, 1876, EFFECTS CROSS SELF F; De Meester L, 1999, P ROY SOC B-BIOL SCI, V266, P2471; DEMEESTER L, 1993, OECOLOGIA, V96, P80, DOI 10.1007/BF00318033; Deng HW, 1997, GENETICS, V147, P147; EBERT D, 1994, SCIENCE, V265, P1084, DOI 10.1126/science.265.5175.1084; EHRLICH PR, 1969, SCIENCE, V165, P1228, DOI 10.1126/science.165.3899.1228; Frankham R, 1998, CONSERV BIOL, V12, P665, DOI 10.1046/j.1523-1739.1998.96456.x; HANSKI I, 1983, J ANIM ECOL, V52, P263, DOI 10.2307/4599; Hebert PDN, 1993, METHODOLOGIES ALLOZY; Ingvarsson PK, 2000, P ROY SOC B-BIOL SCI, V267, P1321, DOI 10.1098/rspb.2000.1145; INNES DJ, 1989, J HERED, V80, P6, DOI 10.1093/oxfordjournals.jhered.a110791; JONES CS, 1995, P ROY SOC B-BIOL SCI, V260, P251, DOI 10.1098/rspb.1995.0088; KELLER LF, 1994, NATURE, V372, P356, DOI 10.1038/372356a0; LANDE R, 1985, EVOLUTION, V39, P24, DOI 10.1111/j.1558-5646.1985.tb04077.x; LANDE R, 1994, EVOLUTION, V48, P1460, DOI [10.2307/2410240, 10.1111/j.1558-5646.1994.tb02188.x]; LYNCH M, 1994, AM NAT, V144, P242, DOI 10.1086/285673; LYNCH M, 1995, AM NAT, V146, P489, DOI 10.1086/285812; Madsen T, 1999, NATURE, V402, P34, DOI 10.1038/46941; Mayr E., 1963, ANIMAL SPECIES EVOLU; Olivieri Isabelle, 1997, P293, DOI 10.1016/B978-012323445-2/50017-1; PAJUNEN VI, 1986, ANN ZOOL FENN, V23, P131; PAJUNEN VI, UNPUB; Pamilo P, 1999, HEREDITAS, V130, P257, DOI 10.1111/j.1601-5223.1999.00257.x; RANTA E, 1979, ARCH HYDROBIOL, V87, P205; Richards CM, 2000, AM NAT, V155, P383, DOI 10.1086/303324; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; SINNOCK P, 1970, AM NAT, V104, P469, DOI 10.1086/282681; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Westemeier RL, 1998, SCIENCE, V282, P1695, DOI 10.1126/science.282.5394.1695; Whitlock MC, 2000, HEREDITY, V84, P452, DOI 10.1046/j.1365-2540.2000.00693.x; WILSON CC, 1992, ECOLOGY, V73, P1462, DOI 10.2307/1940690; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8	38	191	195	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					485	488		10.1126/science.1067485	http://dx.doi.org/10.1126/science.1067485			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799241	Green Submitted			2022-12-24	WOS:000173350700047
J	Ford, ES; Giles, WH; Dietz, WH				Ford, ES; Giles, WH; Dietz, WH			Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INSULIN-RESISTANCE SYNDROME; DIABETES-MELLITUS; AFRICAN-AMERICANS; SYNDROME-X; RISK; ATHEROSCLEROSIS; PREVENTION; MORTALITY; EXERCISE; WHITES	Context The Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III) highlights the importance of treating patients with the metabolic syndrome to prevent cardiovascular disease. Limited information is available about the prevalence of the metabolic syndrome in the United States, however. Objective To estimate the prevalence of the metabolic syndrome in the United States as defined by the ATP III report. Design, Setting, and Participants Analysis of data on 8814 men and women aged 20 years or older from the Third National Health and Nutrition Examination Survey (1988-1994), a cross-sectional health survey of a nationally representative sample of the noninstitutionalized civilian US population. Main Outcome Measures Prevalence of the metabolic syndrome as defined by ATP III (greater than or equal to3 of the following abnormalities): waist circumference greater than 102 cm in men and 88 cm in women; serum triglycerides level of at least 150 mg/dL (1.69 mmol/L); high-density lipoprotein cholesterol level of less than 40 mg/dL (1.04 mmol/L) in men and 50 mg/dL (1.29 mmol/L) in women; blood pressure of at least 130/85 mm Hg; or serum glucose level of at least 110 mg/dL (6.1 mmol/L). Results The unadjusted and age-adjusted prevalences of the metabolic syndrome were 21.8% and 23.7%, respectively. The prevalence increased from 6.7% among participants aged 20 through 29 years to 43.5% and 42.0% for participants aged 60 through 69 years and aged at least 70 years, respectively. Mexican Americans had the highest age-adjusted prevalence of the metabolic syndrome (31.9%). The age-adjusted prevalence was similar for men (24.0%) and women (23.4%). However, among African Americans, women had about a 57% higher prevalence than men did and among Mexican Americans, women had about a 26% higher prevalence than men did. Using 2000 census data, about 47 million US residents have the metabolic syndrome. Conclusions These results from a representative sample of US adults show that the metabolic syndrome is highly prevalent. The large numbers of US residents with the metabolic syndrome may have important implications for the health care sector.	Ctr Dis Control & Prevent, Div Nutr & Phys Act, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Div Adult & Community Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Ford, ES (corresponding author), Ctr Dis Control & Prevent, Div Nutr & Phys Act, Natl Ctr Chron Dis Prevent & Hlth Promot, 1600 Clifton Rd NE,Mailstop E-17, Atlanta, GA 30333 USA.	esf2@cdc.gov						Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; [Anonymous], VITAL HLTH STAT; Bonora E, 1998, DIABETES, V47, P1643, DOI 10.2337/diabetes.47.10.1643; *CDCP, 1996, 3RD NATL HLTH NUTR E; ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196; Grundy SM, 1999, AM J CARDIOL, V83, p25F; Haffner SM, 1997, DIABETES, V46, P63, DOI 10.2337/diabetes.46.1.63; HAFFNER SM, 1992, DIABETES, V41, P715, DOI 10.2337/diabetes.41.6.715; Hulthe J, 2000, ARTERIOSCL THROM VAS, V20, P2140, DOI 10.1161/01.ATV.20.9.2140; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Kannel WB, 2000, AM J HYPERTENS, V13, p3S, DOI 10.1016/S0895-7061(99)00252-6; Lebovitz HE, 2001, EXP CLIN ENDOCR DIAB, V109, pS135, DOI 10.1055/s-2001-18576; Liese AD, 1997, ANN EPIDEMIOL, V7, P407, DOI 10.1016/S1047-2797(97)00047-1; Meigs JB, 1997, DIABETES, V46, P1594, DOI 10.2337/diabetes.46.10.1594; Meigs JB, 2000, AM J EPIDEMIOL, V152, P908, DOI 10.1093/aje/152.10.908; Mokdad AH, 2000, JAMA-J AM MED ASSOC, V284, P1650, DOI 10.1001/jama.284.13.1650; *NIH, 2001, 013670 NIH; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Rantala AO, 1999, J INTERN MED, V245, P163, DOI 10.1046/j.1365-2796.1999.00429.x; Schmidt MI, 1996, DIABETES CARE, V19, P414, DOI 10.2337/diacare.19.5.414; Shah BV, 1997, SUDAAN USERS MANUAL; Trevisan M, 1998, AM J EPIDEMIOL, V148, P958; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801	23	4835	5264	9	346	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2002	287	3					356	359		10.1001/jama.287.3.356	http://dx.doi.org/10.1001/jama.287.3.356			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511YQ	11790215	Bronze			2022-12-24	WOS:000173294700030
J	Nakamura, T; Lozano, PR; Ikeda, Y; Iwanaga, Y; Hinek, A; Minamisawa, S; Cheng, CF; Kobuke, K; Dalton, N; Takada, Y; Tashiro, K; Ross, J; Honjo, T; Chien, KR				Nakamura, T; Lozano, PR; Ikeda, Y; Iwanaga, Y; Hinek, A; Minamisawa, S; Cheng, CF; Kobuke, K; Dalton, N; Takada, Y; Tashiro, K; Ross, J; Honjo, T; Chien, KR			Fibulin-5/DANCE is essential for elastogenesis in vivo	NATURE			English	Article							EXTRACELLULAR-MATRIX; ELASTIN; ARTERIES	The elastic fibre system has a principal role in the structure and function of various types of organs that require elasticity, such as large arteries, lung and skin(1,2). Although elastic fibres are known to be composed of microfibril proteins (for example, fibrillins and latent transforming growth factor (TGF)-beta -binding proteins) and polymerized elastin, the mechanism of their assembly and development is not well understood. Here we report that fibulin-5 (also known as DANCE), a recently discovered integrin ligand(3), is an essential determinant of elastic fibre organization. fibulin-5(-/-) mice generated by gene targeting exhibit a severely disorganized elastic fibre system throughout the body. fibulin-5(-/-) mice survive to adulthood, but have a tortuous aorta with loss of compliance, severe emphysema, and loose skin (cutis laxa). These tissues contain fragmented elastin without an increase of elastase activity, indicating defective development of elastic fibres. Fibulin-5 interacts directly with elastic fibres in vitro, and serves as a ligand for cell surface integrins alphav beta3, alphav beta5 and alpha9 beta1 through its aminoterminal domain. Thus, fibulin-5 may provide anchorage of elastic fibres to cells, thereby acting to stabilize and organize elastic fibres in the skin, lung and vasculature.	Univ Calif San Diego, UCSD Salk Program Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, UCSD Inst Mol Med, La Jolla, CA 92093 USA; Scripps Res Inst, La Jolla, CA 92037 USA; Hosp Sick Children, Div Cardiovasc Res, Toronto, ON M5G 1X8, Canada; Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan; Kyoto Univ, Ctr Mol Biol & Genet, Kyoto 6068501, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Kyoto University; Kyoto University	Chien, KR (corresponding author), Univ Calif San Diego, UCSD Salk Program Mol Med, La Jolla, CA 92093 USA.		Hinek, Aleksander/V-8790-2019; Nakamura, Tomoyuki/AAX-9340-2020; CHENG, Ching-Feng/AAB-8861-2019; Honjo, Tasuku/N-4470-2016	CHENG, Ching-Feng/0000-0003-0104-0146; Minamisawa, Susumu/0000-0003-4728-2116; Ikeda, Yasuhiro/0000-0002-2970-7304; takada, yoshikazu/0000-0001-5481-9589				Bailey AJ, 2001, MECH AGEING DEV, V122, P735, DOI 10.1016/S0047-6374(01)00225-1; Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3; Dietz HC, 2000, MATRIX BIOL, V19, P481, DOI 10.1016/S0945-053X(00)00101-3; DOBRIN PB, 1990, J SURG RES, V48, P116, DOI 10.1016/0022-4804(90)90202-D; Eto B, 2000, J BIOL CHEM, V275, P34922, DOI 10.1074/jbc.M001953200; FAZIO MJ, 1989, CUTIS, V43, P437; FEIGENBAUM H, 1995, ECOCARDIOGRAPHY; LABATROBERT J, 1988, EXP GERONTOL, V23, P5, DOI 10.1016/0531-5565(88)90015-0; Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522; Milewicz DM, 2000, MATRIX BIOL, V19, P471, DOI 10.1016/S0945-053X(00)00099-8; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Nakamura T, 1999, J BIOL CHEM, V274, P22476, DOI 10.1074/jbc.274.32.22476; Pashmforoush M, 2001, NAT MED, V7, P591, DOI 10.1038/87920; PIQUETTE CA, 2000, TXB RESP MED, P1187; RAPAPORT E, 2000, TXB RESP MED, P1631; Robb BW, 1999, MOL BIOL CELL, V10, P3595, DOI 10.1091/mbc.10.11.3595; Robert L, 1998, GERONTOLOGY, V44, P307, DOI 10.1159/000022034; ROSENBLOOM J, 1993, FASEB J, V7, P1208, DOI 10.1096/fasebj.7.13.8405806; SENIOR RM, 1998, PULMONARY DIS DISORD, P659; Shattil SJ, 1997, J CLIN INVEST, V100, pS91; Taooka Y, 1999, J CELL BIOL, V145, P413, DOI 10.1083/jcb.145.2.413; YOKOSAKI Y, 1994, J BIOL CHEM, V269, P26691; Zhang XP, 1998, J BIOL CHEM, V273, P7345, DOI 10.1074/jbc.273.13.7345	23	472	513	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					171	175		10.1038/415171a	http://dx.doi.org/10.1038/415171a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805835				2022-12-24	WOS:000173159300042
J	Jagust, W				Jagust, W			Untangling vascular dementia	LANCET			English	Editorial Material							ALZHEIMERS-DISEASE		Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA	University of California System; University of California Davis	Jagust, W (corresponding author), Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA.		Jagust, William/ABE-6426-2020					Esiri MM, 1999, LANCET, V354, P919, DOI 10.1016/S0140-6736(99)02355-7; GALASKO D, 1994, ARCH NEUROL-CHICAGO, V51, P888, DOI 10.1001/archneur.1994.00540210060013; Haan MN, 1999, JAMA-J AM MED ASSOC, V282, P40, DOI 10.1001/jama.282.1.40; HACHINSKI VC, 1974, LANCET, V2, P207; Henon H, 2001, NEUROLOGY, V57, P1216, DOI 10.1212/WNL.57.7.1216; Henon H, 1997, STROKE, V28, P2429, DOI 10.1161/01.STR.28.12.2429; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; Lim A, 1999, J AM GERIATR SOC, V47, P564, DOI 10.1111/j.1532-5415.1999.tb02571.x; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; TOMLINSON BE, 1970, J NEUROL SCI, V11, P205, DOI 10.1016/0022-510X(70)90063-8; VICTOROFF J, 1995, AM J PSYCHIAT, V152, P1476	11	39	40	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 22	2001	358	9299					2097	2098		10.1016/S0140-6736(01)07230-0	http://dx.doi.org/10.1016/S0140-6736(01)07230-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505GV	11784618				2022-12-24	WOS:000172905800003
J	Li, JM; Nam, KH				Li, JM; Nam, KH			Regulation of brassinosteroid signaling by a GSK3/SHAGGY-like kinase	SCIENCE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; ARABIDOPSIS; FAMILY; GENE; EXPRESSION; GROWTH	GSK3/SHAGGY is a highly conserved serine/threonine kinase implicated in many signaling pathways in eukaryotes. Although many GSK3/SHAGGY-like kinases have been identified in plants, little is known about their functions in plant growth and development. Here we show that the Arabidopsis BRASSINOSTEROID-INSENSITIVE 2 (BIN2) gene encodes a GSK3/SHAGGY-like kinase. Gain-of-function mutations within its coding sequence or its overexpression inhibit brassinosteroid (BR) signaling, resulting in plants that resemble BR-deficient and BR-response mutants. In contrast, reduced BIN2 expression via cosuppression partially rescues a weak BR-signaling mutation. Thus, BIN2 acts as a negative regulator to control steroid signaling in plants.	Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Li, JM (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.		Li, Jianming/O-1772-2014	Li, Jianming/0000-0003-3231-0778	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060519] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM060519, GM60519, R01 GM060519-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Clouse SD, 1996, PLANT PHYSIOL, V111, P671, DOI 10.1104/pp.111.3.671; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Dornelas MC, 1998, GENE, V212, P249, DOI 10.1016/S0378-1119(98)00147-4; Dornelas MC, 1999, PLANT MOL BIOL, V39, P137, DOI 10.1023/A:1006102812280; Dornelas MC, 2000, PLANT J, V21, P419, DOI 10.1046/j.1365-313x.2000.00691.x; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Jonak C, 2000, PLANT CELL, V12, P1467, DOI 10.1105/tpc.12.8.1467; Li J. P. H., UNPUB; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 2001, PLANT PHYSIOL, V127, P14, DOI 10.1104/pp.127.1.14; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; Mozo T, 1999, NAT GENET, V22, P271, DOI 10.1038/10334; Piao HL, 1999, PLANT PHYSIOL, V119, P1527, DOI 10.1104/pp.119.4.1527; PIERCE SB, 1995, DEVELOPMENT, V121, P755; SIEGFRIED E, 1990, NATURE, V345, P825, DOI 10.1038/345825a0; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x	22	445	481	14	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1299	1301						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847343				2022-12-24	WOS:000173926000045
J	Willis, KJ; Whittaker, RJ				Willis, KJ; Whittaker, RJ			Ecology - Species diversity - Scale matters	SCIENCE			English	Editorial Material									Univ Oxford, Sch Geog & Environm, Oxford OX1 3TB, England	University of Oxford	Willis, KJ (corresponding author), Univ Oxford, Sch Geog & Environm, Oxford OX1 3TB, England.		Whittaker, Robert J/H-1548-2015	Whittaker, Robert J/0000-0001-7775-3383; Willis, Katherine/0000-0002-6763-2489				Briggs J.C., 1995, GLOBAL BIOGEOGRAPHY, V14, P442; Clarke A, 2000, J ANIM ECOL, V69, P799, DOI 10.1046/j.1365-2656.2000.00440.x; Crawley MJ, 2001, SCIENCE, V291, P864, DOI 10.1126/science.291.5505.864; Godfray HCJ, 2001, TRENDS ECOL EVOL, V16, P400, DOI 10.1016/S0169-5347(01)02150-4; Gould SJ, 1998, PHILOS T R SOC B, V353, P307, DOI 10.1098/rstb.1998.0211; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; Richardson JE, 2001, NATURE, V412, P181, DOI 10.1038/35084067; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x	10	392	452	4	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1245	+		10.1126/science.1067335	http://dx.doi.org/10.1126/science.1067335			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847328				2022-12-24	WOS:000173926000028
J	Gelber, AC; Wigley, FM				Gelber, AC; Wigley, FM			Disease severity as a predictor of outcome in scleroderma	LANCET			English	Editorial Material							SYSTEMIC-SCLEROSIS; DOUBLE-BLIND; TRIAL		Johns Hopkins Univ, Div Mol & Clin Rheumatol, Baltimore, MD 21205 USA	Johns Hopkins University	Wigley, FM (corresponding author), Johns Hopkins Univ, Div Mol & Clin Rheumatol, Baltimore, MD 21205 USA.							Badesch DB, 2000, ANN INTERN MED, V132, P425, DOI 10.7326/0003-4819-132-6-200003210-00002; Binks M, 2001, ANN RHEUM DIS, V60, P577, DOI 10.1136/ard.60.6.577; Bryan C, 1999, ARTHRITIS RHEUM-US, V42, P2660, DOI 10.1002/1529-0131(199912)42:12<2660::AID-ANR23>3.0.CO;2-N; Clements PJ, 1999, ARTHRITIS RHEUM-US, V42, P1194, DOI 10.1002/1529-0131(199906)42:6<1194::AID-ANR16>3.0.CO;2-7; Geirsson AJ, 2001, ANN RHEUM DIS, V60, P1117, DOI 10.1136/ard.60.12.1117; LOPEZOVEJERO JA, 1979, NEW ENGL J MED, V300, P1417, DOI 10.1056/NEJM197906213002505; Medsger TA, 2000, CURR OPIN RHEUMATOL, V12, P545, DOI 10.1097/00002281-200011000-00012; Medsger TA, 1999, J RHEUMATOL, V26, P2159; Steen VD, 2000, ARTHRITIS RHEUM-US, V43, P2437, DOI 10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U; White B, 2000, ANN INTERN MED, V132, P947, DOI 10.7326/0003-4819-132-12-200006200-00004; WIGLEY FM, 1994, ANN INTERN MED, V120, P199, DOI 10.7326/0003-4819-120-3-199402010-00004	11	7	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 26	2002	359	9303					277	279		10.1016/S0140-6736(02)07535-9	http://dx.doi.org/10.1016/S0140-6736(02)07535-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517AC	11830191				2022-12-24	WOS:000173588100005
J	Patricelli, GL; Uy, JAC; Walsh, G; Borgia, G				Patricelli, GL; Uy, JAC; Walsh, G; Borgia, G			Male displays adjusted to female's response - Macho courtship by the satin bowerbird is tempered to avoid frightening the female.	NATURE			English	Article							PTILONORHYNCHUS-VIOLACEUS; THREAT REDUCTION; TRAITS		Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Patricelli, GL (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	borgia@umail.umd.edu	Patricelli, Gail L/L-3730-2017	Uy, J. Albert C./0000-0002-8437-5525; Patricelli, Gail/0000-0003-3397-8390				Andersson Malte, 1994; Berglund A, 1996, BIOL J LINN SOC, V58, P385, DOI 10.1111/j.1095-8312.1996.tb01442.x; BORGIA G, 1985, ANIM BEHAV, V33, P266, DOI 10.1016/S0003-3472(85)80140-8; BORGIA G, 1995, EMU, V95, P1, DOI 10.1071/MU9950001; Borgia G, 1998, ANIM BEHAV, V56, P1121, DOI 10.1006/anbe.1998.0908; BORGIA G, 1995, AM SCI, V83, P542; Borgia G., 1979, SEXUAL SELECTION REP, P27; Mateos C, 1999, BEHAV ECOL SOCIOBIOL, V45, P235, DOI 10.1007/s002650050558; Uy JAC, 2000, P ROY SOC B-BIOL SCI, V267, P251, DOI 10.1098/rspb.2000.0994	9	213	215	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2002	415	6869					279	280		10.1038/415279a	http://dx.doi.org/10.1038/415279a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11796996				2022-12-24	WOS:000173293500031
J	Deo, RC; Groft, CM; Rajashankar, KR; Burley, SK				Deo, RC; Groft, CM; Rajashankar, KR; Burley, SK			Recognition of the rotavirus mRNA 3 ' consensus by an asymmetric NSP3 homodimer	CELL			English	Article							POLY(A) BINDING-PROTEIN; ANGSTROM RESOLUTION; CONSENSUS SEQUENCE; CRYSTAL-STRUCTURE; 3 END; TRANSLATION; DOMAINS; NS34; DNA; EQUIVALENT	Rotaviruses, the cause of life-threatening diarrhea in humans and cattle, utilize a functional homolog of poly(A) binding protein (PABP) known as nonstructural protein 3 (NSP3) for translation of viral mRNAs. NSP3 binds to viral mRNA 3' consensus sequences and circularizes the mRNA via interactions with eIF4G. The X-ray structure of the NSP3 RNA binding domain bound to a rotaviral mRNA 3' end has been determined. NSP3 is a novel, heart-shaped homodimer with a medial RNA binding cleft. The homodimer is asymmetric, and contains two similar N-terminal segments plus two structurally different C-terminal segments that intertwine to create a tunnel enveloping the mRNA 31 end. Biophysical studies demonstrate high affinity binding leading to increased thermal stability and slow dissociation kinetics, consistent with NSP3 function.	Rockefeller Univ, Labs Mol Biophys, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Burley, SK (corresponding author), Rockefeller Univ, Labs Mol Biophys, 1230 York Ave, New York, NY 10021 USA.	burley@rockvax.rockefeller.edu		Burley, Stephen K./0000-0002-2487-9713				Allers J, 2001, J MOL BIOL, V311, P75, DOI 10.1006/jmbi.2001.4857; BAER BW, 1983, J CELL BIOL, V96, P717, DOI 10.1083/jcb.96.3.717; BICAN P, 1982, J VIROL, V43, P1113, DOI 10.1128/JVI.43.3.1113-1117.1982; BOTH GW, 1984, NUCLEIC ACIDS RES, V12, P1621, DOI 10.1093/nar/12.3.1621; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN GM, 1985, LANCET, V2, P1123; Deardorff JA, 1997, J MOL BIOL, V269, P67, DOI 10.1006/jmbi.1997.1013; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; EIDEN JJ, 1993, VIROLOGY, V196, P298, DOI 10.1006/viro.1993.1479; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Estes M.K., 1996, FIELDS VIROLOGY, P1625; GILSON MK, 1988, J COMPUT CHEM, V9, P327, DOI 10.1002/jcc.540090407; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; King DA, 1999, NAT STRUCT BIOL, V6, P64; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Kuhn U, 1996, J MOL BIOL, V256, P20, DOI 10.1006/jmbi.1996.0065; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le H, 1997, J BIOL CHEM, V272, P16247, DOI 10.1074/jbc.272.26.16247; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Michel YM, 2000, J BIOL CHEM, V275, P32268, DOI 10.1074/jbc.M004304200; Miller RT, 1996, FASEB J, V10, P171, DOI 10.1096/fasebj.10.1.8566539; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace C. N., 1997, PROTEIN STRUCTURE PR, V2, P299; Patton JT, 1996, J VIROL, V70, P7940, DOI 10.1128/JVI.70.11.7940-7947.1996; Patton JT, 2001, J VIROL, V75, P2076, DOI 10.1128/JVI.75.5.2076-2086.2001; Patton JT, 2000, VIROLOGY, V277, P217, DOI 10.1006/viro.2000.0645; Piron M, 1999, J VIROL, V73, P5411, DOI 10.1128/JVI.73.7.5411-5421.1999; Piron M, 1998, EMBO J, V17, P5811, DOI 10.1093/emboj/17.19.5811; PONCET D, 1994, EMBO J, V13, P4165, DOI 10.1002/j.1460-2075.1994.tb06734.x; PONCET D, 1993, J VIROL, V67, P3159, DOI 10.1128/JVI.67.6.3159-3165.1993; Preiss T, 1998, RNA, V4, P1321, DOI 10.1017/S1355838298980669; QIAN Y, 1991, VIROLOGY, V184, P752, DOI 10.1016/0042-6822(91)90446-I; RAUMANN BE, 1994, NATURE, V367, P754, DOI 10.1038/367754a0; Sachs A, 2000, COLD SPRING HARBOR M, V39, P447; SILVERSTEIN SC, 1976, ANNU REV BIOCHEM, V45, P375, DOI 10.1146/annurev.bi.45.070176.002111; Valdar WSJ, 2001, PROTEINS, V42, P108; Vende P, 2000, J VIROL, V74, P7064, DOI 10.1128/JVI.74.15.7064-7071.2000; WANG J, 1994, P NATL ACAD SCI USA, V91, P7242, DOI 10.1073/pnas.91.15.7242; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025	45	84	90	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2002	108	1					71	81		10.1016/S0092-8674(01)00632-8	http://dx.doi.org/10.1016/S0092-8674(01)00632-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792322	Bronze			2022-12-24	WOS:000173280700009
J	Toth, LJ; Assad, JA				Toth, LJ; Assad, JA			Dynamic coding of behaviourally relevant stimuli in parietal cortex	NATURE			English	Article							PRIMATE PREFRONTAL CORTEX; NEURAL ACTIVITY; AREA LIP; MOTOR; TRANSFORMATIONS; REPRESENTATION; SELECTIVITY; MOVEMENTS; MACAQUES; SPACE	A general function of cerebral cortex is to allow the flexible association of sensory stimuli with specific behaviours. Many neurons in parietal(1,2), prefrontal(3,4) and motor(5-7) cortical areas are activated both by particular movements and by sensory cues that trigger these movements, suggesting a role in linking sensation to action. For example, neurons in the lateral intraparietal area (LIP) encode both the location of visual stimuli and the direction of saccadic eye movements(8,9). LIP is not believed to encode nonspatial stimulus attributes such as colour(10,11). Here we investigated whether LIP would encode colour if colour was behaviourally linked to the eye movement. We trained monkeys to make an eye movement in one of two directions based alternately on the colour or location of a visual cue. When cue colour was relevant for directing eye movement, we found a substantial fraction of LIP neurons selective for cue colour. However, when cue location was relevant, colour selectivity was virtually absent in LIP. These results demonstrate that selectivity of cortical neurons can change as a function of the required behaviour.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Toth, LJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.			Toth, Louis/0000-0003-4986-7046				ABRAMSON N, 1963, INFORMATION THEORY C; Andersen R A, 1993, Curr Opin Neurobiol, V3, P171, DOI 10.1016/0959-4388(93)90206-E; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; Colby CL, 1996, COGNITIVE BRAIN RES, V5, P105, DOI 10.1016/S0926-6410(96)00046-8; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Eskandar EN, 1999, NAT NEUROSCI, V2, P88, DOI 10.1038/4594; Georgopoulos AP, 2000, CURR OPIN NEUROBIOL, V10, P238, DOI 10.1016/S0959-4388(00)00072-6; Johnson MTV, 1999, J NEUROPHYSIOL, V81, P875, DOI 10.1152/jn.1999.81.2.875; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; LYNCH JC, 1985, J COMP NEUROL, V235, P241, DOI 10.1002/cne.902350207; Mazzoni P, 1996, J NEUROPHYSIOL, V75, P1233, DOI 10.1152/jn.1996.75.3.1233; Murray EA, 2000, EXP BRAIN RES, V133, P114, DOI 10.1007/s002210000406; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Thier P, 1998, J NEUROPHYSIOL, V80, P1713, DOI 10.1152/jn.1998.80.4.1713; Ungerleider LG., 1982, ANAL VISUAL BEHAV, P549; Zhang MS, 2000, NATURE, V408, P971, DOI 10.1038/35050097	22	208	210	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					165	168		10.1038/415165a	http://dx.doi.org/10.1038/415165a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805833				2022-12-24	WOS:000173159300040
J	Echtay, KS; Roussel, D; St-Pierre, J; Jekabsons, MB; Cadenas, S; Stuart, JA; Harper, JA; Roebuck, SJ; Morrison, A; Pickering, S; Clapham, JC; Brand, MD				Echtay, KS; Roussel, D; St-Pierre, J; Jekabsons, MB; Cadenas, S; Stuart, JA; Harper, JA; Roebuck, SJ; Morrison, A; Pickering, S; Clapham, JC; Brand, MD			Superoxide activates mitochondrial uncoupling proteins	NATURE			English	Article							BROWN ADIPOSE-TISSUE; SKELETAL-MUSCLE; FATTY-ACIDS; RAT; NUCLEOTIDES; EXPRESSION; GENERATION; GENE; MICE; UCP2	Uncoupling protein 1 (UCP1) diverts energy from ATP synthesis to thermogenesis in the mitochondria of brown adipose tissue by catalysing a regulated leak of protons across the inner membrane(1,2). The functions of its homologues, UCP2 and UCP3, in other tissues are debated(3,4). UCP2 and UCP3 are present at much lower abundance than UCP1, and the uncoupling with which they are associated is not significantly thermogenic(5,6). Mild uncoupling would, however, decrease the mitochondrial production of reactive oxygen species, which are important mediators of oxidative damage(7,8). Here we show that superoxide increases mitochondrial proton conductance through effects on UCP1, UCP2 and UCP3. Superoxide-induced uncoupling requires fatty acids and is inhibited by purine nucleotides. It correlates with the tissue expression of UCPs, appears in mitochondria from yeast expressing UCP1, and is absent in skeletal muscle mitochondria from UCP3 knockout mice. Our findings indicate that the interaction of superoxide with UCPs may be a mechanism for decreasing the concentrations of reactive oxygen species inside mitochondria.	MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England; GlaxoSmithKline, Dept Comparat Genome, Harlow CM19 5AW, Essex, England; GlaxoSmithKline, Dept Vasc Biol, Harlow CM19 5AW, Essex, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; GlaxoSmithKline; GlaxoSmithKline	Brand, MD (corresponding author), MRC, Dunn Human Nutr Unit, Hills Rd, Cambridge CB2 2XY, England.		St-Pierre, Julie/AGB-3651-2022; Brand, Martin D/A-9423-2012; Cadenas, Susana/D-1523-2016; Clapham, John/AAK-4715-2020	St-Pierre, Julie/0000-0002-2815-7099; Brand, Martin D/0000-0003-4418-6153; Roussel, Damien/0000-0002-8865-5428; Cadenas, Susana/0000-0003-0726-0369				Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; BATHGATE B, 1992, MOL MICROBIOL, V6, P363, DOI 10.1111/j.1365-2958.1992.tb01479.x; Brand M. D., 1995, BIOENERGETICS, V154, P62; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; Cadenas S, 2000, BIOCHEM J, V351, P307, DOI 10.1042/0264-6021:3510307; Cadenas S, 1999, FEBS LETT, V462, P257, DOI 10.1016/S0014-5793(99)01540-9; Echtay KS, 2000, NATURE, V408, P609, DOI 10.1038/35046114; Echtay KS, 2001, P NATL ACAD SCI USA, V98, P1416, DOI 10.1073/pnas.98.4.1416; Echtay KS, 1997, BIOCHEMISTRY-US, V36, P8253, DOI 10.1021/bi970513r; Echtay KS, 2001, BIOCHEM SOC T, V29, P763; Halliwell B, 1989, FREE RADICALS BIOL M, VUK; JEZEK P, 1994, J BIOL CHEM, V269, P26184; Klingenberg M, 2001, BBA-BIOENERGETICS, V1504, P128, DOI 10.1016/S0005-2728(00)00242-5; Kowaltowski AJ, 1998, FEBS LETT, V425, P213, DOI 10.1016/S0014-5793(98)00231-2; Laloi M, 1997, NATURE, V389, P135, DOI 10.1038/38156; Liu SS, 1997, BIOSCIENCE REP, V17, P259, DOI 10.1023/A:1027328510931; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Nicholls DG, 1999, J BIOENERG BIOMEMBR, V31, P399, DOI 10.1023/A:1005436121005; Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427; Pastore D, 2000, FEBS LETT, V470, P88, DOI 10.1016/S0014-5793(00)01292-8; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; ROLFE DFS, 1994, BBA-BIOENERGETICS, V1188, P405, DOI 10.1016/0005-2728(94)90062-0; RUCH W, 1983, J IMMUNOL METHODS, V63, P347, DOI 10.1016/S0022-1759(83)80008-8; SCANDALIOS JG, 1993, PLANT PHYSIOL, V101, P7, DOI 10.1104/pp.101.1.7; Stuart JA, 2001, BIOCHEM J, V356, P779, DOI 10.1042/0264-6021:3560779; Stuart JA, 2001, BBA-BIOENERGETICS, V1504, P144, DOI 10.1016/S0005-2728(00)00243-7; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	30	1081	1130	2	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					96	99		10.1038/415096a	http://dx.doi.org/10.1038/415096a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780125				2022-12-24	WOS:000173028800048
J	Kerp, H				Kerp, H			Palaeobotany - Atmospheric CO2 from fossil plant cuticles	NATURE			English	Article							PERMIAN PALEOBOTANY; PALYNOLOGY		Univ Munster, Inst Geol & Palaeontol, Forschungsstelle Palaobot, D-48143 Munster, Germany	University of Munster	Kerp, H (corresponding author), Univ Munster, Inst Geol & Palaeontol, Forschungsstelle Palaobot, D-48143 Munster, Germany.		Kerp, Hans/AAJ-1102-2020					BARTHEL M., 1980, SCHRIFTENREIHE GEOLO, V16, P49; Boy J.A., 1982, Z DTSCH GEOL GES, V133, P607; KERP H, 1993, REV PALAEOBOT PALYNO, V78, P1, DOI 10.1016/0034-6667(93)90014-L; KERP JHF, 1988, REV PALAEOBOT PALYNO, V54, P249, DOI 10.1016/0034-6667(88)90017-6; LIPPOLT HJ, 1989, JB GEOL PALAONT MH, P553; Naugolnykh SV, 1996, REV PALAEOBOT PALYNO, V91, P35, DOI 10.1016/0034-6667(95)00066-6; Poole I, 1996, PLANT CELL ENVIRON, V19, P705, DOI 10.1111/j.1365-3040.1996.tb00405.x; Poole I, 2000, NEW PHYTOL, V145, P511, DOI 10.1046/j.1469-8137.2000.00589.x; Retallack GJ, 2001, NATURE, V411, P287, DOI 10.1038/35077041	9	7	13	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					38	38		10.1038/415038a	http://dx.doi.org/10.1038/415038a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780108	Bronze			2022-12-24	WOS:000173028800031
J	Lee, KH; Holdorf, AD; Dustin, ML; Chan, AC; Allen, PM; Shaw, AS				Lee, KH; Holdorf, AD; Dustin, ML; Chan, AC; Allen, PM; Shaw, AS			T cell receptor signaling precedes immunological synapse formation	SCIENCE			English	Article							ANTIGEN RECEPTOR; ACTIVATION; STIMULATION; ZAP-70; COMMITMENT; COMPLEXES; MOLECULE; ZETA; CD28; TCR	The area of contact between a T cell and an antigen-presenting cell (APC) is known as the immunological synapse. Although its exact function is unknown, one model suggests that it allows for T cell receptor (TCR) clustering and for sustained signaling in T cells for many hours. Here we demonstrate that TCR-mediated tyrosine kinase signaling in naive T cells occurred primarily at the periphery of the synapse and was largely abated before mature immunological synapses had formed. These data suggest that many hours of TCR signaling are not required for T cell activation. These observations challenge current ideas about the role of immunological synapses in T cell activation.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Skirbal Inst Biomol Med, Program Mol Pathogenesis, New York, NY 10016 USA; Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA	Washington University (WUSTL); Roche Holding; Genentech	Shaw, AS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid,Box 8118, St Louis, MO 63110 USA.		Dustin, Michael/AAM-4611-2020	Holdorf, Amy/0000-0001-5699-4081; Dustin, Michael/0000-0003-4983-6389; Lee, Kyeong-Hee/0000-0002-9455-4201				Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; CENCIARELLI C, 1992, SCIENCE, V257, P795, DOI 10.1126/science.1323144; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; Davis SJ, 2001, CURR BIOL, V11, pR289, DOI 10.1016/S0960-9822(01)00165-8; Delon J, 2000, CURR BIOL, V10, pR923, DOI 10.1016/S0960-9822(00)00870-8; GAUEN LKT, 1994, MOL CELL BIOL, V14, P3729, DOI 10.1128/MCB.14.6.3729; GOLDSMITH MA, 1988, SCIENCE, V240, P1029, DOI 10.1126/science.3259335; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; HOLDORF AD, IN PRESS NATURE IMMU; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Itoh Y, 1999, J IMMUNOL, V162, P2073; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Lee K. T., UNPUB; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; LINSLEY PS, 1992, J EXP MED, V176, P1595, DOI 10.1084/jem.176.6.1595; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Parish CR, 1999, IMMUNOL CELL BIOL, V77, P499, DOI 10.1046/j.1440-1711.1999.00877.x; PONT S, 1986, J IMMUNOL, V136, P3750; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; Valitutti S, 1997, IMMUNOL TODAY, V18, P299, DOI 10.1016/S0167-5699(97)01075-X; Valitutti S, 1997, J EXP MED, V185, P1859, DOI 10.1084/jem.185.10.1859; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; WEISS A, 1987, J IMMUNOL, V138, P2169; Williams BL, 1999, EMBO J, V18, P1832, DOI 10.1093/emboj/18.7.1832	28	548	576	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2002	295	5559					1539	1542		10.1126/science.1067710	http://dx.doi.org/10.1126/science.1067710			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859198				2022-12-24	WOS:000173981300058
J	Bouillet, P; Purton, JF; Godfrey, DI; Zhang, LC; Coultas, L; Puthalakath, H; Pellegrini, M; Cory, S; Adams, JM; Strasser, A				Bouillet, P; Purton, JF; Godfrey, DI; Zhang, LC; Coultas, L; Puthalakath, H; Pellegrini, M; Cory, S; Adams, JM; Strasser, A			BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes	NATURE			English	Article							T-CELL-RECEPTOR; INHIBITS MULTIPLE FORMS; NEGATIVE SELECTION; TRANSGENIC MICE; CLONAL DELETION; EXPRESSION; LYMPHOCYTES; ACTIVATION; SURVIVAL; DEATH	During lymphocyte development, the assembly of genes coding for antigen receptors occurs by the combinatorial linking of gene segments. The stochastic nature of this process gives rise to lymphocytes that can recognize self-antigens, thereby having the potential to induce autoimmune disease. Such autoreactive lymphocytes can be silenced by developmental arrest or unresponsiveness (anergy)(1), or can be deleted from the repertoire by cell death(1). In the thymus, developing T lymphocytes (thymocytes) bearing a T-cell receptor (TCR)-CD3 complex that engages self-antigens are induced to undergo programmed cell death (apoptosis)(2-4), but the mechanisms ensuring this 'negative selection' are unclear. We now report that thymocytes lacking the pro-apoptotic Bcl-2 family member Bim(5,6) (also known as Bcl2l11) are refractory to apoptosis induced by TCR-CD3 stimulation. Moreover, in transgenic mice expressing autoreactive TCRs that provoke widespread deletion, Bim deficiency severely impaired thymocyte killing. TCR ligation upregulated Bim expression and promoted interaction of Bim with Bcl-X-L, inhibiting its survival function. These findings identify Bim as an essential initiator of apoptosis in thymocyte-negative selection.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Monash Univ, Sch Med, Dept Pathol & Immunol, Prahran, Vic 3181, Australia	Walter & Eliza Hall Institute; Monash University	Strasser, A (corresponding author), Walter & Eliza Hall Inst Med Res, PO Royal Melbourne Hosp, Melbourne, Vic 3050, Australia.		Strasser, Andreas/C-7581-2013; Pellegrini, Marc/F-7670-2014; Cory, Suzanne/E-1642-2013; Bouillet, Philippe/E-1241-2013; Puthalakath, Hamsa/B-8541-2011; Adams, Jerry M/E-1199-2013	Strasser, Andreas/0000-0002-5020-4891; Cory, Suzanne/0000-0002-6818-3451; Bouillet, Philippe/0000-0002-9012-6058; Pellegrini, Marc/0000-0003-3627-3126; Adams, Jerry/0000-0002-4360-8628; Godfrey, Dale/0000-0002-3009-5472				Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bouillet P, 2001, DEV CELL, V1, P645, DOI 10.1016/S1534-5807(01)00083-1; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; CALNAN BJ, 1995, IMMUNITY, V3, P273; Clayton LK, 1997, EMBO J, V16, P2282, DOI 10.1093/emboj/16.9.2282; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; GRILLOT DAM, 1995, J EXP MED, V182, P1973, DOI 10.1084/jem.182.6.1973; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; JENKINSON EJ, 1990, EUR J IMMUNOL, V20, P2517, DOI 10.1002/eji.1830201125; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; Martin S, 1997, EUR J IMMUNOL, V27, P2726, DOI 10.1002/eji.1830271037; NAKAYAMA T, 1992, SCIENCE, V257, P96, DOI 10.1126/science.1621102; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Smith KGC, 1996, EMBO J, V15, P5167, DOI 10.1002/j.1460-2075.1996.tb00901.x; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; STRASSER A, 1994, P NATL ACAD SCI USA, V91, P1376, DOI 10.1073/pnas.91.4.1376; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; SWAT W, 1991, NATURE, V351, P150, DOI 10.1038/351150a0; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; Walsh CM, 1998, IMMUNITY, V8, P439, DOI 10.1016/S1074-7613(00)80549-X; Zhou T, 1996, J EXP MED, V183, P1879, DOI 10.1084/jem.183.4.1879; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	30	619	630	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2002	415	6874					922	926		10.1038/415922a	http://dx.doi.org/10.1038/415922a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859372				2022-12-24	WOS:000173941000048
J	Dekker, J; Rippe, K; Dekker, M; Kleckner, N				Dekker, J; Rippe, K; Dekker, M; Kleckner, N			Capturing chromosome conformation	SCIENCE			English	Article							HIGHER-ORDER STRUCTURE; SACCHAROMYCES-CEREVISIAE; CHROMATIN FIBER; IN-VIVO; YEAST; MEIOSIS; ORGANIZATION; RECOMBINATION	We describe an approach to detect the frequency of interaction between any two genomic loci. Generation of a matrix of interaction frequencies between sites on the same or different chromosomes reveals their relative spatial disposition and provides information about the physical properties of the chromatin fiber. This methodology can be applied to the spatial organization of entire genomes in organisms from bacteria to human. Using the yeast Saccharomyces cerevisiae, we could confirm known qualitative features of chromosome organization within the nucleus and dynamic changes in that organization during meiosis. We also analyzed yeast chromosome III at the G(1) stage of the cell cycle. We found that chromatin is highly flexible throughout. Furthermore, functionally distinct AT- and GC-rich domains were found to exhibit different conformations, and a population-average 3D model of chromosome III could be determined. Chromosome III emerges as a contorted ring.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany; Univ Heidelberg, Kirchhoff Inst Phys, Phys Mol Biol Prozesse, D-69120 Heidelberg, Germany	Harvard University; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Dekker, J (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.		Rippe, Karsten/A-3562-2012	Rippe, Karsten/0000-0001-9951-9395	NIGMS NIH HHS [GM44794, R01 GM025326, GM25326] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025326, R37GM025326] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Burgess SM, 1999, GENE DEV, V13, P1871, DOI 10.1101/gad.13.14.1871; Burgess SM, 1999, GENE DEV, V13, P1627, DOI 10.1101/gad.13.12.1627; Cimbora DM, 2001, CELL, V104, P643, DOI 10.1016/S0092-8674(01)00260-4; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Cui Y, 2000, P NATL ACAD SCI USA, V97, P127, DOI 10.1073/pnas.97.1.127; Dujon B, 1996, TRENDS GENET, V12, P263, DOI 10.1016/0168-9525(96)10027-5; Flory P. J., 1969, STAT MECH CHAIN MOL, V8, P699, DOI [10.1002/bip.1969.360080514, DOI 10.1002/BIP.1969.360080514]; Gasser SM, 2001, CELL, V104, P639, DOI 10.1016/S0092-8674(01)00259-8; GERCHMAN SE, 1987, P NATL ACAD SCI USA, V84, P7802, DOI 10.1073/pnas.84.22.7802; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; HAHNFELDT P, 1993, P NATL ACAD SCI USA, V90, P7857; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Jin QW, 2000, J CELL SCI, V113, P1903; Jin QW, 1998, J CELL BIOL, V141, P21, DOI 10.1083/jcb.141.1.21; Keeney S, 1996, GENES CELLS, V1, P475, DOI 10.1046/j.1365-2443.1996.d01-257.x; KRATKY O, 1949, RECL TRAV CHIM PAY B, V68, P1106; LATORAYA S, 2000, J CELL BIOL, V151, P1047; MOENS PB, 1988, BIOESSAYS, V9, P151, DOI 10.1002/bies.950090503; OSTASHEVSKY JY, 1994, J BIOMOL STRUCT DYN, V11, P813, DOI 10.1080/07391102.1994.10508034; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Ringrose L, 1999, EMBO J, V18, P6630, DOI 10.1093/emboj/18.23.6630; Rippe K, 2001, TRENDS BIOCHEM SCI, V26, P733, DOI 10.1016/S0968-0004(01)01978-8; RIPPE K, 1995, TRENDS BIOCHEM SCI, V20, P500, DOI 10.1016/S0968-0004(00)89117-3; SHARP PM, 1993, NUCLEIC ACIDS RES, V21, P179, DOI 10.1093/nar/21.2.179; Trelles-Sticken E, 2000, J CELL BIOL, V151, P95, DOI 10.1083/jcb.151.1.95; van Holde KE., 1989, SPRINGER SERIES MOL; WEINER BM, 1994, CELL, V77, P977, DOI 10.1016/0092-8674(94)90438-3; Wolffe AP., 1998, CHROMATIN STRUCTURE; Woodcock CL, 2001, CURR OPIN GENET DEV, V11, P130, DOI 10.1016/S0959-437X(00)00169-6; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	36	2359	2517	20	316	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1306	1311		10.1126/science.1067799	http://dx.doi.org/10.1126/science.1067799			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847345				2022-12-24	WOS:000173926000047
J	Casadevall, N; Nataf, J; Viron, B; Kolta, A; Kiladjian, J; Martin-Dupont, P; Michaud, P; Papo, T; Ugo, V; Teyssandier, I; Varet, B; Mayeux, P				Casadevall, N; Nataf, J; Viron, B; Kolta, A; Kiladjian, J; Martin-Dupont, P; Michaud, P; Papo, T; Ugo, V; Teyssandier, I; Varet, B; Mayeux, P			Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECEPTOR; ANEMIA; CDNA	Background: Within a period of three years, we identified 13 patients in whom pure red-cell aplasia developed during treatment with recombinant human erythropoietin (epoetin). We investigated whether there was an immunologic basis for the anemia in these patients. Methods: Serum samples from the 13 patients with pure red-cell aplasia were tested for neutralizing antibodies that could inhibit erythroid-colony formation by normal bone marrow cells in vitro. The presence of antierythropoietin antibodies was identified by means of binding assays with the use of radiolabeled intact, deglycosylated, or denatured epoetin. Results: Serum from all 13 patients blocked the formation of erythroid colonies by normal bone marrow cells. The inhibition was reversed by epoetin. Antibodies from 12 of the 13 patients bound only conformational epitopes in the protein moiety of epoetin; serum from the remaining patient bound to both conformational and linear epitopes in erythropoietin. In all the patients, the antibody titer slowly decreased after the discontinuation of treatment with epoetin. Conclusions: Neutralizing antierythropoietin antibodies and pure red-cell aplasia can develop in patients with the anemia of chronic renal failure during treatment with epoetin. (N Engl J Med 2002;346:469-75.) Copyright (C) 2002 Massachusetts Medical Society.	Hop Hotel Dieu, Dept Hematol, F-75181 Paris 04, France; Hop Hotel Dieu, Dept Nucl Med, Paris, France; INSERM, U362, Paris, France; Hop Bichat, Dept Nephrol, F-75877 Paris, France; Hop Bichat, Dept Internal Med, F-75877 Paris, France; Assoc Utilisat Rein Artificiel Reg Parisienne, St Ouen, France; Hop Beaujon, Dept Hematol, Clichy, France; Ctr Treitement Malad Renales St Augustin, Bordeaux, France; Polyclin Lagny, Lagny Sur Marne, France; Univ Paris 05, Ctr Hosp Univ Necker Enfants Malad, Dept Hematol, Paris, France; Inst Cochin Genet Mol, INSERM, U363, F-75014 Paris, France; Inst Cochin Genet Mol, Dept Hematol, F-75014 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Casadevall, N (corresponding author), Hop Hotel Dieu, Dept Hematol, F-75181 Paris 04, France.		Kiladjian, Jean-Jacques/K-5345-2019	Kiladjian, Jean-Jacques/0000-0002-8121-438X; Ugo, Valerie/0000-0002-4678-2138				Casadevall N, 1996, NEW ENGL J MED, V334, P630, DOI 10.1056/NEJM199603073341004; DESSYPRIS EN, 1991, SEMIN HEMATOL, V28, P275; ESCHBACH JW, 1985, KIDNEY INT, V28, P1, DOI 10.1038/ki.1985.109; JACOBS K, 1985, NATURE, V313, P806, DOI 10.1038/313806a0; LIN FK, 1985, P NATL ACAD SCI USA, V82, P7580, DOI 10.1073/pnas.82.22.7580; MAYEUX P, 1987, J BIOL CHEM, V262, P13985; MAYEUX P, 1990, FEBS LETT, V269, P167, DOI 10.1016/0014-5793(90)81145-E; MAYEUX P, 1991, J BIOL CHEM, V266, P23380; Peces R, 1996, NEW ENGL J MED, V335, P523, DOI 10.1056/NEJM199608153350717; Prabhakar SS, 1997, CLIN NEPHROL, V47, P331; SASAKI H, 1987, J BIOL CHEM, V262, P12059; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Storring PL, 1998, BRIT J HAEMATOL, V100, P79; Stridsberg M., 1993, ERYTHROPOIETIN MOL P, P266; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1	15	863	923	1	23	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2002	346	7					469	475		10.1056/NEJMoa011931	http://dx.doi.org/10.1056/NEJMoa011931			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521AE	11844847				2022-12-24	WOS:000173815300002
J	Di Croce, L; Raker, VA; Corsaro, M; Fazi, F; Fanelli, M; Faretta, M; Fuks, F; Lo Coco, F; Kouzarides, T; Nervi, C; Minucci, S; Pelicci, PG				Di Croce, L; Raker, VA; Corsaro, M; Fazi, F; Fanelli, M; Faretta, M; Fuks, F; Lo Coco, F; Kouzarides, T; Nervi, C; Minucci, S; Pelicci, PG			Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor	SCIENCE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; HISTONE DEACETYLASE; RAR-ALPHA; FUSION PROTEINS; DIFFERENTIATION; METHYLATION; CANCER; GENE; EPIGENETICS; REPRESSION	DNA methylation of tumor suppressor genes is a frequent mechanism of transcriptional silencing in cancer. The molecular mechanisms underlying the specificity of methylation are unknown. We report here that the leukemia-promoting PML-RAR fusion protein induces gene hypermethylation and silencing by recruiting DNA methyltransferases to target promoters and that hypermethylation contributes to its leukemogenic potential. Retinoic acid treatment induces promoter demethylation, gene reexpression, and reversion of the transformed phenotype. These results establish a mechanistic link between genetic and epigenetic changes during transformation and suggest that hypermethylation contributes to the early steps of carcinogenesis.	European Inst Oncol, Dept Expt Oncol, Milan, Italy; Univ Roma La Sapienza, Dept Histol & Med Embryol, Rome, Italy; Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Rome, Italy; Univ Cambridge, Wellcome CRC Inst, Cambridge, England; Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; Univ Camerino, Dept Morphol Sci, I-62032 Camerino, Italy; Italian Fdn Canc Res, Inst Mol Oncol, Milan, Italy	IRCCS European Institute of Oncology (IEO); Sapienza University Rome; Sapienza University Rome; University of Cambridge; University of Cambridge; University of Camerino; IFOM - FIRC Institute of Molecular Oncology	Pelicci, PG (corresponding author), European Inst Oncol, Dept Expt Oncol, Milan, Italy.		Pelicci, Pier Giuseppe/AAL-6572-2020; Fazi, Francesco/K-5304-2018; Di Croce, Luciano/E-7759-2015; Minucci, Saverio/J-9669-2012; Fanelli, Mirco/F-2665-2011; Faretta, Mario/H-8946-2012	Fazi, Francesco/0000-0003-2910-7912; Di Croce, Luciano/0000-0003-3488-6228; Fanelli, Mirco/0000-0002-9649-8661; Faretta, Mario/0000-0003-1678-5781; Kouzarides, Tony/0000-0002-8918-4162; NERVI, Clara/0000-0001-9341-0188				Alcalay M, 1998, MOL CELL BIOL, V18, P1084, DOI 10.1128/MCB.18.2.1084; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Benedetti L, 1996, BLOOD, V87, P1939; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Casini T, 1999, ONCOGENE, V18, P3235, DOI 10.1038/sj.onc.1202630; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; DICROCE L, UNPUB; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; Grignani F, 1996, EMBO J, V15, P4949, DOI 10.1002/j.1460-2075.1996.tb00875.x; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Knoepfler PS, 1999, CELL, V99, P447, DOI 10.1016/S0092-8674(00)81531-7; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Minucci S, 2000, MOL CELL, V5, P811, DOI 10.1016/S1097-2765(00)80321-4; Momparler RL, 2000, J CELL PHYSIOL, V183, P145, DOI 10.1002/(SICI)1097-4652(200005)183:2<145::AID-JCP1>3.0.CO;2-V; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; PELICCI PG, UNPUB; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Ruthardt M, 1997, MOL CELL BIOL, V17, P4859, DOI 10.1128/MCB.17.8.4859; Widschwendter M, 2000, J NATL CANCER I, V92, P826, DOI 10.1093/jnci/92.10.826	25	619	638	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1079	1082		10.1126/science.1065173	http://dx.doi.org/10.1126/science.1065173			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834837				2022-12-24	WOS:000173793000068
J	Hu, K; Carroll, J; Fedorovich, S; Rickman, C; Sukhodub, A; Davletov, B				Hu, K; Carroll, J; Fedorovich, S; Rickman, C; Sukhodub, A; Davletov, B			Vesicular restriction of synaptobrevin suggests a role for calcium in membrane fusion	NATURE			English	Article							PHOSPHOLIPID-BINDING; SPEED LIMIT; SYNAPTOTAGMIN; PROTEIN; COMPLEX; SYNAPTOPHYSIN; EXOCYTOSIS; VESICLES; TETANUS; RELEASE	Release of neurotransmitter occurs when synaptic vesicles fuse with the plasma membrane. This neuronal exocytosis is triggered by calcium and requires three SNARE (soluble-N-ethylmaleimide-sensitive factor attachment protein receptors) proteins: synaptobrevin (also known as VAMP) on the synaptic vesicle, and syntaxin and SNAP-25 on the plasma membrane(1-4). Neuronal SNARE proteins form a parallel four-helix bundle that is thought to drive the fusion of opposing membranes(5,6). As formation of this SNARE complex in solution does not require calcium, it is not clear what function calcium has in triggering SNARE-mediated membrane fusion. We now demonstrate that whereas syntaxin and SNAP-25 in target membranes are freely available for SNARE complex formation, availability of synaptobrevin on synaptic vesicles is very limited. Calcium at micromolar concentrations triggers SNARE complex formation and fusion between synaptic vesicles and reconstituted target membranes. Although calcium does promote interaction of SNARE proteins between opposing membranes, it does not act by releasing synaptobrevin from synaptic vesicle restriction. Rather, our data suggest a mechanism in which calcium-triggered membrane apposition enables syntaxin and SNAP-25 to engage synaptobrevin, leading to membrane fusion.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Davletov, B (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	baz@mrc-lmb.cam.ac.uk	Davletov, Bazbek/ABA-8569-2021; Fedorovich, Sergei/N-4315-2013	Rickman, Colin/0000-0001-8938-524X				Bai JH, 2000, J BIOL CHEM, V275, P25427, DOI 10.1074/jbc.M906729199; CALAKOS N, 1994, J BIOL CHEM, V269, P24534; Capogna M, 1997, J NEUROSCI, V17, P7190; Davletov B, 1998, J BIOL CHEM, V273, P19093, DOI 10.1074/jbc.273.30.19093; Davletov BA, 1998, EMBO J, V17, P3909, DOI 10.1093/emboj/17.14.3909; Elferink LA, 1995, PROG BRAIN RES, V105, P79; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fernandez-Chacon R, 1999, ANNU REV PHYSIOL, V61, P753, DOI 10.1146/annurev.physiol.61.1.753; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005; KELLY RB, 1999, FR MOLEC B, V23, P1; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; McCammon JA, 1996, P NATL ACAD SCI USA, V93, P11426, DOI 10.1073/pnas.93.21.11426; McMahon HT, 1996, P NATL ACAD SCI USA, V93, P4760, DOI 10.1073/pnas.93.10.4760; Meyuhas D, 1996, BIOPHYS J, V71, P2602, DOI 10.1016/S0006-3495(96)79452-3; Montecucco C, 1995, Q REV BIOPHYS, V28, P423, DOI 10.1017/S0033583500003292; PERIN MS, 1991, J BIOL CHEM, V266, P615; POPOV SV, 1993, CELL, V73, P1247, DOI 10.1016/0092-8674(93)90352-Q; Quetglas S, 2000, P NATL ACAD SCI USA, V97, P9695, DOI 10.1073/pnas.97.17.9695; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Schikorski T, 1997, J NEUROSCI, V17, P5858; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tolar LA, 1998, J NEUROSCI, V18, P10250; VIGUERA AR, 1993, BIOCHEMISTRY-US, V32, P3708, DOI 10.1021/bi00065a024; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wittung-Stafshede P, 1999, P NATL ACAD SCI USA, V96, P6587, DOI 10.1073/pnas.96.12.6587; Zhang XY, 1998, BIOCHEMISTRY-US, V37, P12395, DOI 10.1021/bi9807512	30	149	152	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2002	415	6872					646	650		10.1038/415646a	http://dx.doi.org/10.1038/415646a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832947				2022-12-24	WOS:000173709100048
J	Masumoto, H; Muramatsu, S; Kamimura, Y; Araki, H				Masumoto, H; Muramatsu, S; Kamimura, Y; Araki, H			S-Cdk-dependent phosphorylation of Sld2 essential for chromosomal DNA replication in budding yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; POLYMERASE-ALPHA; SHUTTLE VECTORS; KINASE; PHASE; ORIGINS; COMPLEX; PROTEIN; CDC45P	Cyclin-dependent protein kinases (Cdks) in eukaryotic cells work as a key enzyme at various points in the cell cycle(1,2). At the onset of S phase, active S-phase Cdks (S-Cdks) are essential for chromosomal DNA replication(3). Although several replication proteins are phosphorylated in a Cdk-dependent manner(3), the biological effects of phosphorylation of these proteins on the activation of DNA replication have not been elucidated. Here we show that Sld2 (ref. 4) (also known as Drc1; ref. 5), one of the replication proteins of budding yeast (Saccharomyces cerevisiae), is phosphorylated in S phase in an S-Cdk-dependent manner, and mutant Sld2 lacking all the preferred Cdk phosphorylation sites (All-A) is defective in chromosomal DNA replication. Moreover, the complex that contains, at least, Sld2 and Dpb11 (ref. 6) (the Sld2-Dpb11 complex(4)) is formed predominantly in S phase; the All-A protein is defective in this complex formation. Because this complex is suggested to be essential for chromosomal DNA replication 4,5, it seems likely that S-Cdk positively regulates formation of the Sld2-Dpb11 complex and, consequently, chromosomal DNA replication.	Grad Univ Adv Studies, Dept Genet, Natl Inst Genet, Div Microbial Genet, Shizuoka 4118540, Japan; JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Japan Science & Technology Agency (JST)	Araki, H (corresponding author), Grad Univ Adv Studies, Dept Genet, Natl Inst Genet, Div Microbial Genet, Yata 1111, Shizuoka 4118540, Japan.	hiaraki@lab.nig.ac.jp	Kamimura, Yoichiro/M-2585-2017					Aparicio OM, 1999, P NATL ACAD SCI USA, V96, P9130, DOI 10.1073/pnas.96.16.9130; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Calzada A, 2000, J BIOL CHEM, V275, P9734, DOI 10.1074/jbc.275.13.9734; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Diffley JFX, 1995, J CELL SCI, P67; Drury LS, 2000, CURR BIOL, V10, P231, DOI 10.1016/S0960-9822(00)00355-9; Elsasser S, 1999, MOL BIOL CELL, V10, P3263, DOI 10.1091/mbc.10.10.3263; FOIANI M, 1995, MOL CELL BIOL, V15, P883; Johnston LH, 1999, TRENDS CELL BIOL, V9, P249, DOI 10.1016/S0962-8924(99)01586-X; Kamimura Y, 1998, MOL CELL BIOL, V18, P6102, DOI 10.1128/MCB.18.10.6102; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; Masumoto H, 2000, MOL CELL BIOL, V20, P2809, DOI 10.1128/MCB.20.8.2809-2817.2000; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; Nguyen VQ, 2000, CURR BIOL, V10, P195, DOI 10.1016/S0960-9822(00)00337-7; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Nurse P, 2000, CELL, V100, P71, DOI 10.1016/S0092-8674(00)81684-0; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; PONDAVEN P, 1990, GENE DEV, V4, P9, DOI 10.1101/gad.4.1.9; SALAHUDDIN, 1990, GENE DEV, V4, P968, DOI 10.1101/gad.4.6.968; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; SIKORSKI RS, 1989, GENETICS, V122, P19; Tanaka TU, 1998, EMBO J, V17, P5182, DOI 10.1093/emboj/17.17.5182; Wang H, 1999, P NATL ACAD SCI USA, V96, P3824, DOI 10.1073/pnas.96.7.3824; Zachariae W, 1998, SCIENCE, V279, P1216, DOI 10.1126/science.279.5354.1216; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000; Zou L, 1998, SCIENCE, V280, P593, DOI 10.1126/science.280.5363.593	30	164	169	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2002	415	6872					651	655		10.1038/nature713	http://dx.doi.org/10.1038/nature713			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11807498				2022-12-24	WOS:000173709100049
J	Fraser, PJ; Shelmerdine, RL				Fraser, PJ; Shelmerdine, RL			Fish physiology - Dogfish hair cells sense hydrostatic pressure	NATURE			English	Article									Univ Aberdeen, Dept Zool, Aberdeen AB24 2TZ, Scotland	University of Aberdeen	Fraser, PJ (corresponding author), Univ Aberdeen, Dept Zool, Tillydrone Ave, Aberdeen AB24 2TZ, Scotland.			Shelmerdine, Richard L./0000-0003-2135-3326				BLAXTER JHS, 1980, ENV PHYSL FISHES, P369; Conradi P, 1999, ORL J OTO-RHINO-LARY, V61, P57, DOI 10.1159/000027642; DIGBY PS, 1961, NATURE, V191, P366, DOI 10.1038/191366a0; DOWSE HB, 1994, BIOL RHYTHM RES, V25, P1; FRASER PJ, 1994, NATURE, V371, P383, DOI 10.1038/371383b0; HARDY AC, 1951, NATURE, V168, P327; LOWENSTEIN O, 1978, PROC R SOC SER B-BIO, V202, P313, DOI 10.1098/rspb.1978.0070; Macdonald AG, 1999, COMP BIOCHEM PHYS A, V122, P13, DOI 10.1016/S1095-6433(98)10173-3; Pavlov DS, 2000, J FISH BIOL, V57, P69, DOI 10.1006/jfbi.2000.1287	9	31	31	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					495	496		10.1038/415495a	http://dx.doi.org/10.1038/415495a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823850				2022-12-24	WOS:000173564300036
J	Al-Olayan, EM; Beetsma, AL; Butcher, GA; Sinden, RE; Hurd, H				Al-Olayan, EM; Beetsma, AL; Butcher, GA; Sinden, RE; Hurd, H			Complete development of mosquito phases of the malaria parasite in vitro	SCIENCE			English	Article							PLASMODIUM-BERGHEI; SPOROGONIC DEVELOPMENT; ANOPHELES-STEPHENSI; IN-VITRO; TRANSMISSION; GALLINACEUM; INVITRO; EXPRESSION; HEMOLYMPH; PROTEINS	Methods for reproducible in vitro development of the mosquito stages of malaria parasites to produce infective sporozoites have been elusive for over 40 years. We have cultured gametocytes of Plasmodium berghei through to infectious sporozoites with efficiencies similar to those recorded in vivo and without the need for salivary gland invasion. Oocysts developed extracellularly in a system whose essential elements include co-cultured Drosophila S2 cells, basement membrane matrix, and insect tissue culture medium. Sporozoite production required the presence of para-aminobenzoic acid. The entire life cycle of P. berghei, a useful model malaria parasite, can now be achieved in vitro.	Univ Keele, Sch Life Sci, Ctr Appl Entomol & Parasitol, Keele ST5 5BG, Staffs, England; Univ London Imperial Coll Sci Technol & Med, Dept Biol, London SW7 2AZ, England	Keele University; Imperial College London	Hurd, H (corresponding author), Univ Keele, Sch Life Sci, Ctr Appl Entomol & Parasitol, Keele ST5 5BG, Staffs, England.							Adini A, 1999, PARASITOLOGY, V119, P331, DOI 10.1017/S0031182099004874; ALOLAYAN EM, UNPUB J CELL BIOL; Arrighi RBG, 2002, INT J PARASITOL, V32, P91, DOI 10.1016/S0020-7519(01)00298-3; BALL GH, 1964, J PARASITOL, V50, P3, DOI 10.2307/3276018; Billingsley PF, 1997, PARASITOL TODAY, V13, P297, DOI 10.1016/S0169-4758(97)01094-6; Billker O, 2000, PARASITOLOGY, V120, P547, DOI 10.1017/S0031182099005946; BOULANGER N, 1995, PARASITOL RES, V81, P58, DOI 10.1007/BF00932418; Butcher GA, 1997, INT J PARASITOL, V27, P975, DOI 10.1016/S0020-7519(97)00079-9; Dessens JT, 1999, EMBO J, V18, P6221, DOI 10.1093/emboj/18.22.6221; Ghosh A, 2000, PARASITOL TODAY, V16, P196, DOI 10.1016/S0169-4758(99)01626-9; MACK SR, 1978, J PARASITOL, V64, P918, DOI 10.2307/3279531; PETERS W, 1980, ANN TROP MED PARASIT, V74, P275, DOI 10.1080/00034983.1980.11687345; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Shahabuddin M, 1998, P NATL ACAD SCI USA, V95, P3385, DOI 10.1073/pnas.95.7.3385; Siden-Kiamos I, 2000, J CELL SCI, V113, P3419; Sinden R. E., 1997, The molecular biology of insect disease vectors: a methods manual., P67; Sinden RE, 2001, TRENDS PARASITOL, V17, P209, DOI 10.1016/S1471-4922(01)01928-6; SINDEN RE, 1987, PROC R SOC SER B-BIO, V230, P443, DOI 10.1098/rspb.1987.0028; SYAFRUDDIN RA, 1992, J PROTOZOOL, V39, P333; UCHIDA K, 1990, J MED ENTOMOL, V27, P302, DOI 10.1093/jmedent/27.3.302; VANDERBERG JP, 1975, J PARASITOL, V61, P43, DOI 10.2307/3279102; VANDERBERG JP, 1977, B WORLD HEALTH ORGAN, V55, P377; VARMA MGR, 1969, J MED ENTOMOL, V6, P432, DOI 10.1093/jmedent/6.4.432; VAUGHAN JA, 1994, J PARASITOL, V80, P674, DOI 10.2307/3283245; Vlachou D, 2001, MOL BIOCHEM PARASIT, V112, P229, DOI 10.1016/S0166-6851(00)00371-6; WARBURG A, 1993, EXP PARASITOL, V76, P121, DOI 10.1006/expr.1993.1014; WARBURG A, 1992, SCIENCE, V255, P448, DOI 10.1126/science.1734521; WINGER LA, 1992, PARASITOL RES, V78, P427, DOI 10.1007/BF00931700; YEON SH, 2000, EMBO J, V19, P6030; Yuda M, 1999, J EXP MED, V189, P1947, DOI 10.1084/jem.189.12.1947; Zieler H, 2000, P NATL ACAD SCI USA, V97, P11516, DOI 10.1073/pnas.97.21.11516	31	80	86	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					677	679		10.1126/science.1067159	http://dx.doi.org/10.1126/science.1067159			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809973				2022-12-24	WOS:000173560900045
J	Lloyd, TE; Atkinson, R; Wu, MN; Zhou, Y; Pennetta, G; Bellen, HJ				Lloyd, TE; Atkinson, R; Wu, MN; Zhou, Y; Pennetta, G; Bellen, HJ			Hrs regulates endosome membrane invagination and tyrosine kinase receptor signaling in Drosophila	CELL			English	Article							EMBRYONIC VENTRAL ECTODERM; GROWTH-FACTOR RECEPTOR; ZINC-FINGER DOMAIN; EGF RECEPTOR; NEUROTRANSMITTER RELEASE; MULTIVESICULAR BODY; PROTEIN; ENDOCYTOSIS; MELANOGASTER; INTERACTS	Signaling through tyrosine kinase receptors (TKRs) is thought to be modulated by receptor-mediated endocytosis and degradation of the receptor in the lysosome. However, factors that regulate endosomal sorting of TKRs are largely unknown. Here, we demonstrate that Hrs ((H) under bar epatocyte growth factor-(r) under bar egulated tyrosine kinase (s) under bar ubstrate) is one such factor. Electron microscopy studies of hrs mutant larvae reveal an impairment in endosome membrane invagination and formation of multivesicular bodies (MVBs). hrs mutant animals fail to degrade active epidermal growth factor (EGF) and Torso TKRs, leading to enhanced signaling and altered embryonic patterning. These data suggest that Hrs and MVB formation function to downregulate TKR signaling.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Bellen, HJ (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.			Bellen, Hugo/0000-0001-5992-5989; Lloyd, Thomas/0000-0003-4756-3700				Asao H, 1997, J BIOL CHEM, V272, P32785, DOI 10.1074/jbc.272.52.32785; Bean AJ, 1997, NATURE, V385, P826, DOI 10.1038/385826a0; Bean AJ, 2000, J BIOL CHEM, V275, P15271, DOI 10.1074/jbc.275.20.15271; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; Chin LS, 2001, J BIOL CHEM, V276, P7069, DOI 10.1074/jbc.M004129200; CHOU TB, 1993, DEVELOPMENT, V119, P1359; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; DOYLE HJ, 1993, GENE DEV, V7, P633, DOI 10.1101/gad.7.4.633; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; Fergestad T, 1999, J NEUROSCI, V19, P5847, DOI 10.1523/JNEUROSCI.19-14-05847.1999; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; Gabay L, 1996, DEVELOPMENT, V122, P3355; Gabay L, 1997, DEVELOPMENT, V124, P3535; Ghiglione C, 1999, DEV BIOL, V205, P181, DOI 10.1006/dbio.1998.9102; Golembo M, 1996, DEVELOPMENT, V122, P3363; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; HONEGGER AM, 1990, J CELL BIOL, V110, P1541, DOI 10.1083/jcb.110.5.1541; KOENIG JH, 1990, CELL TISSUE RES, V262, P233, DOI 10.1007/BF00309878; KOMADA M, 1995, MOL CELL BIOL, V15, P6213; Komada M, 1999, GENE DEV, V13, P1475, DOI 10.1101/gad.13.11.1475; Komada M, 2001, BIOCHEM BIOPH RES CO, V281, P1065, DOI 10.1006/bbrc.2001.4441; Komada M, 1997, J BIOL CHEM, V272, P20538, DOI 10.1074/jbc.272.33.20538; KOSAKA T, 1983, J CELL BIOL, V97, P499, DOI 10.1083/jcb.97.2.499; Kwong J, 2000, J CELL SCI, V113, P2273; LEPTIN M, 1992, DEVELOPMENT, P23; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; LITTLETON JT, 1994, GENETICS, V138, P111; Lohi O, 1998, FEBS LETT, V440, P255, DOI 10.1016/S0014-5793(98)01401-X; Mao YX, 2000, CELL, V100, P447, DOI 10.1016/S0092-8674(00)80680-7; Miura S, 2000, MOL CELL BIOL, V20, P9346, DOI 10.1128/MCB.20.24.9346-9355.2000; NARITA K, 1989, J CELL PHYSIOL, V141, P383, DOI 10.1002/jcp.1041410220; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; PERRIMON N, 1993, CELL, V74, P219, DOI 10.1016/0092-8674(93)90412-J; PERRIMON N, 1986, GENETICS, V113, P695; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Raiborg C, 2001, EMBO J, V20, P5008, DOI 10.1093/emboj/20.17.5008; RAZ E, 1993, GENE DEV, V7, P1937, DOI 10.1101/gad.7.10.1937; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; Seaman MNJ, 1996, CURR OPIN CELL BIOL, V8, P549, DOI 10.1016/S0955-0674(96)80034-2; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9; SPRENGER F, 1992, CELL, V71, P987, DOI 10.1016/0092-8674(92)90394-R; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; STURTEVANT MA, 1994, DEVELOPMENT, V120, P2593; Urbe S, 2000, MOL CELL BIOL, V20, P7685, DOI 10.1128/MCB.20.20.7685-7692.2000; WIDES RJ, 1990, EUR J BIOCHEM, V189, P637, DOI 10.1111/j.1432-1033.1990.tb15532.x; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Wurmser AE, 1999, J BIOL CHEM, V274, P9129, DOI 10.1074/jbc.274.14.9129	53	359	363	2	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 25	2002	108	2					261	269		10.1016/S0092-8674(02)00611-6	http://dx.doi.org/10.1016/S0092-8674(02)00611-6			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832215	Bronze			2022-12-24	WOS:000173521300012
J	Pluk, H; Dorey, K; Superti-Furga, G				Pluk, H; Dorey, K; Superti-Furga, G			Autoinhibition of c-Abl	CELL			English	Article							TYROSINE KINASE-ACTIVITY; BCR-ABL; SH3 DOMAINS; SRC-FAMILY; POSITIVE CELLS; HUMAN LEUKEMIA; PROTEIN; GROWTH; TRANSFORMATION; INHIBITOR	Despite years of investigation, the molecular mechanism responsible for regulation of the c-Abl tyrosine kinase has remained elusive. We now report inhibition of the catalytic activity of purified c-Abl in vitro, demonstrating that regulation is an intrinsic property of the molecule. We show that the interaction of the N-terminal 80 residues with the rest of the protein mediates autoregulation. This N-terminal "cap" is required to achieve and maintain inhibition, and its loss turns c-Abl into an oncogenic protein and contributes to deregulation of BCR-Abl.	European Mol Biol Lab, Dev Biol Programme, D-69117 Heidelberg, Germany; Cellzome AG, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); GlaxoSmithKline; Cellzome GmbH	Superti-Furga, G (corresponding author), European Mol Biol Lab, Dev Biol Programme, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Superti-Furga, Giulio/F-4755-2015; Superti-Furga, Giulio/AAE-5681-2019	Superti-Furga, Giulio/0000-0002-0570-1768; Dorey, Karel/0000-0003-0846-5286				Alexandropoulos K, 1996, SIN GENES DEV, V10, P1341; Barila D, 2000, EMBO J, V19, P273, DOI 10.1093/emboj/19.2.273; Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Cong F, 2000, MOL CELL, V6, P1413, DOI 10.1016/S1097-2765(00)00138-6; Dorey K, 2001, ONCOGENE, V20, P8075, DOI 10.1038/sj.onc.1205017; Dorey K, 1999, BIOL CHEM, V380, P223; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; FRANZ WM, 1989, EMBO J, V8, P137, DOI 10.1002/j.1460-2075.1989.tb03358.x; GOGA A, 1993, MOL CELL BIOL, V13, P4967, DOI 10.1128/MCB.13.8.4967; Golub TR, 1996, MOL CELL BIOL, V16, P4107; Gonfloni S, 2000, NAT STRUCT BIOL, V7, P281; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hardin JD, 1996, ONCOGENE, V12, P2669; JACKSON P, 1989, EMBO J, V8, P449, DOI 10.1002/j.1460-2075.1989.tb03397.x; Koegl M, 1995, ONCOGENE, V11, P2317; MAYER BJ, 1994, MOL CELL BIOL, V14, P2883, DOI 10.1128/MCB.14.5.2883; McCormick F, 2001, NATURE, V412, P281, DOI 10.1038/35085665; MCWHIRTER JR, 1993, EMBO J, V12, P1533, DOI 10.1002/j.1460-2075.1993.tb05797.x; MCWHIRTER JR, 1993, MOL CELL BIOL, V13, P7587, DOI 10.1128/MCB.13.12.7587; MUSACCHIO A, 1994, NAT STRUCT BIOL, V1, P546, DOI 10.1038/nsb0894-546; PENDERGAST AM, 1991, P NATL ACAD SCI USA, V88, P5927, DOI 10.1073/pnas.88.13.5927; PENDERGAST AM, 1993, MOL CELL BIOL, V13, P1728, DOI 10.1128/MCB.13.3.1728; PENDERGAST AM, 1993, CELL, V75, P175, DOI 10.1016/S0092-8674(05)80094-7; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Raitano A. B., 1997, BIOCHIM BIOPHYS ACTA, V1333, P201, DOI 10.1016/S0304-419X(97)00023-1; RAITANO AB, 1995, P NATL ACAD SCI USA, V92, P11746, DOI 10.1073/pnas.92.25.11746; REN RB, 1994, GENE DEV, V8, P783, DOI 10.1101/gad.8.7.783; RENSHAW MW, 1995, MOL CELL BIOL, V15, P1286; Renshaw MW, 1996, CURR BIOL, V6, P76, DOI 10.1016/S0960-9822(02)00424-4; RENSHAW MW, 1992, EMBO J, V11, P3941, DOI 10.1002/j.1460-2075.1992.tb05488.x; SAWYERS CL, 1992, CANCER SURV, V15, P37; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; SHTIVELMAN E, 1986, CELL, V47, P277, DOI 10.1016/0092-8674(86)90450-2; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Smith KM, 2001, J BIOL CHEM, V276, P24372, DOI 10.1074/jbc.M100786200; SUPERTIFURGA G, 1995, BIOESSAYS, V17, P321, DOI 10.1002/bies.950170408; SUPERTIFURGA G, 1993, EMBO J, V12, P2625, DOI 10.1002/j.1460-2075.1993.tb05923.x; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Thiesing JT, 2000, BLOOD, V96, P3195, DOI 10.1182/blood.V96.9.3195.h8003195_3195_3199; Van Etten RA, 1999, TRENDS CELL BIOL, V9, P179, DOI 10.1016/S0962-8924(99)01549-4; VANETTEN RA, 1994, J CELL BIOL, V124, P325, DOI 10.1083/jcb.124.3.325; Vigneri P, 2001, NAT MED, V7, P228, DOI 10.1038/84683; Walkenhorst J, 1996, ONCOGENE, V12, P1513; WANG JYJ, 1988, ONCOGENE RES, V3, P293; Wang JYJ, 2000, ONCOGENE, V19, P5643, DOI 10.1038/sj.onc.1203878; Woodring PJ, 2001, J BIOL CHEM, V276, P27104, DOI 10.1074/jbc.M100559200	48	184	200	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 25	2002	108	2					247	259		10.1016/S0092-8674(02)00623-2	http://dx.doi.org/10.1016/S0092-8674(02)00623-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832214	Bronze			2022-12-24	WOS:000173521300011
J	Ferguson, NM; Ghani, AC; Donnelly, CA; Hagenaars, TJ; Anderson, RM				Ferguson, NM; Ghani, AC; Donnelly, CA; Hagenaars, TJ; Anderson, RM			Estimating the human health risk from possible BSE infection of the British sheep flock	NATURE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; GREAT-BRITAIN; PRION PROTEIN; SCRAPIE; EPIDEMIOLOGY; TRANSMISSION; ACCUMULATION; DYNAMICS; VCJD	Following the controversial failure of a recent study(1) and the small numbers of animals yet screened for infection(2), it remains uncertain whether bovine spongiform encephalopathy (BSE) was transmitted to sheep in the past via feed supplements and whether it is still present. Well grounded mathematical and statistical models are therefore essential to integrate the limited and disparate data, to explore uncertainty, and to define data-collection priorities. We analysed the implications of different scenarios of BSE spread in sheep for relative human exposure levels and variant Creutzfeldt-Jakob disease (vCJD) incidence. Here we show that, if BSE entered the sheep population and a degree of transmission occurred, then ongoing public health risks from ovine BSE are likely to be greater than those from cattle, but that any such risk could be reduced by up to 90% through additional restrictions on sheep products entering the food supply. Extending the analysis to consider absolute risk, we estimate the 95% confidence interval for future vCJD mortality to be 50 to 50,000 human deaths considering exposure to bovine BSE alone, with the upper bound increasing to 150,000 once we include exposure from the worst-case ovine BSE scenario examined.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, London W2 1PG, England	Imperial College London	Ferguson, NM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, St Marys Campus,Norfolk Pl, London W2 1PG, England.	neil.ferguson@ic.ac.uk	Ghani, Azra/B-8560-2009; Ferguson, Neil/B-8578-2008	Ferguson, Neil/0000-0002-1154-8093; Anderson, Roy/0000-0002-9528-3175; Donnelly, Christl/0000-0002-0195-2463; Ghani, Azra/0000-0002-0007-4910				Anderson RM, 1996, NATURE, V382, P779, DOI 10.1038/382779a0; Andreoletti O, 2000, J GEN VIROL, V81, P3115, DOI 10.1099/0022-1317-81-12-3115; Baylis M, 2000, P ROY SOC B-BIOL SCI, V267, P2029, DOI 10.1098/rspb.2000.1245; d'Aignaux JNH, 2001, SCIENCE, V294, P1729, DOI 10.1126/science.1064748; DONNELLY CA, 2000, STAT ASPECTS BSE VCI; Ferguson NM, 1997, PHILOS T R SOC B, V352, P803, DOI 10.1098/rstb.1997.0063; Foster JD, 2001, J GEN VIROL, V82, P2319, DOI 10.1099/0022-1317-82-10-2319; Frankish H, 2001, LANCET, V358, P1436, DOI 10.1016/S0140-6736(01)06544-8; FRASER H, 1992, J GEN VIROL, V73, P1891, DOI 10.1099/0022-1317-73-8-1891; Ghani AC, 2000, NATURE, V406, P583, DOI 10.1038/35020688; Gravenor MB, 2001, P ROY SOC B-BIOL SCI, V268, P587, DOI 10.1098/rspb.2000.1462; HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657; Hagenaars TJ, 2001, EPIDEMIOL INFECT, V127, P157, DOI 10.1017/S0950268801005738; Hart R. J, 1997, AUDIT BOVINE OVINE S; Hill AF, 1998, NEUROSCI LETT, V255, P159, DOI 10.1016/S0304-3940(98)00736-8; Hoinville LJ, 1996, REV SCI TECH OIE, V15, P827, DOI 10.20506/rst.15.3.959; Hoinville LJ, 2000, VET REC, V146, P455, DOI 10.1136/vr.146.16.455; Hunter N, 2000, ARCH VIROL, P181; Hunter N, 1997, NATURE, V386, P137, DOI 10.1038/386137a0; Hunter N, 1997, TRENDS MICROBIOL, V5, P331, DOI 10.1016/S0966-842X(97)01081-0; Jeffrey M, 2001, J COMP PATHOL, V124, P280, DOI 10.1053/jcpa.2001.0465; JEFFREY M, UNPUB J COMP PATHOL; Maissen M, 2001, LANCET, V357, P2026, DOI 10.1016/S0140-6736(00)05110-2; *MEAT LIV COMM, 1998, C782506 MEAT LIV COM; Valleron AJ, 2001, SCIENCE, V294, P1726, DOI 10.1126/science.1066838; van Keulen LJM, 1999, J COMP PATHOL, V121, P55, DOI 10.1053/jcpa.1998.0300; van Keulen LJM, 2000, ARCH VIROL, P57; WELLS GAH, 1994, VET REC, V135, P40, DOI 10.1136/vr.135.2.40; Woolhouse MEJ, 1999, PHILOS T R SOC B, V354, P751, DOI 10.1098/rstb.1999.0427	29	81	82	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2002	415	6870					420	424		10.1038/nature709	http://dx.doi.org/10.1038/nature709			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11786878				2022-12-24	WOS:000173433600047
J	Matsumoto, Y; Maller, JL				Matsumoto, Y; Maller, JL			Calcium, calmodulin, and CaMKII requirement for initiation of centrosome duplication in Xenopus egg extracts	SCIENCE			English	Article							PROTEIN-KINASE-II; MAMMALIAN-CELLS	Aberrant centrosome duplication is observed in many tumor cells and may contribute to genomic instability through the formation of multipolar mitotic spindles. Cyclin-dependent kinase 2 (Cdk2) is required for multiple rounds of centrosome duplication in Xenopus egg extracts but not for the initial round of replication. Egg extracts undergo periodic oscillations in the level of free calcium. We show here that chelation of calcium in egg extracts or specific inactivation of calcium/calmodulin-dependent protein kinase 11 (CaMKII) blocks even initial centrosome duplication, whereas inactivation of Cdk2 does not. Duplication can be restored to inhibited extracts by addition of CaMKII and calmodulin. These results indicate that calcium, calmodulin, and CaMKII are required for an essential step in initiation of centrosome duplication. Our data suggest that calcium oscillations in the cell cycle may be linked to centrosome duplication.	Univ Colorado, Sch Med, Howard Hughes Med Inst, Denver, CO 80262 USA; Univ Colorado, Sch Med, Dept Pharmacol, Denver, CO 80262 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Maller, JL (corresponding author), Univ Colorado, Sch Med, Howard Hughes Med Inst, Denver, CO 80262 USA.				NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NCI NIH HHS [CA46934] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; EVANS L, 1985, J CELL BIOL, V100, P1185, DOI 10.1083/jcb.100.4.1185; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; GHOSH TK, 1988, J BIOL CHEM, V263, P11075; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Kim SH, 1999, DEV BIOL, V212, P381, DOI 10.1006/dbio.1999.9361; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; LORCA T, 1993, NATURE, V366, P270, DOI 10.1038/366270a0; Marx J, 2001, SCIENCE, V292, P426, DOI 10.1126/science.292.5516.426; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; Matsumoto Y., UNPUB; MEANS AR, 1994, FEBS LETT, V347, P1, DOI 10.1016/0014-5793(94)00492-7; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; MILLER SG, 1988, NEURON, V1, P593, DOI 10.1016/0896-6273(88)90109-2; Nayak AS, 1996, P NATL ACAD SCI USA, V93, P15451, DOI 10.1073/pnas.93.26.15451; OHTA Y, 1990, P NATL ACAD SCI USA, V87, P5341, DOI 10.1073/pnas.87.14.5341; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; PIETROMONACO SF, 1995, BLOOD CELL MOL DIS, V21, P34, DOI 10.1006/bcmd.1995.0006; SANDERS MA, 1994, J CELL BIOL, V124, P795, DOI 10.1083/jcb.124.5.795; Schiebel E, 2000, CURR OPIN CELL BIOL, V12, P113, DOI 10.1016/S0955-0674(99)00064-2; SCHMIDTZACHMANN MS, 1987, EMBO J, V6, P1881, DOI 10.1002/j.1460-2075.1987.tb02447.x; Schulman H, 1993, CURR OPIN CELL BIOL, V5, P247, DOI 10.1016/0955-0674(93)90111-3; SU JY, 1995, P NATL ACAD SCI USA, V92, P10187, DOI 10.1073/pnas.92.22.10187; Swanson CA, 1997, P NATL ACAD SCI USA, V94, P1194, DOI 10.1073/pnas.94.4.1194; Tokmakov AA, 2001, J CELL BIOCHEM, V82, P89, DOI 10.1002/jcb.1140.abs; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018	27	79	82	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					499	502		10.1126/science.1065693	http://dx.doi.org/10.1126/science.1065693			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799245				2022-12-24	WOS:000173350700051
J	Chang, A; Tourtellotte, WW; Rudick, R; Trapp, BD				Chang, A; Tourtellotte, WW; Rudick, R; Trapp, BD			Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RAT OPTIC-NERVE; GLIAL PROGENITOR-CELL; PDGF ALPHA-RECEPTOR; ADULT HUMAN CNS; NG2 PROTEOGLYCAN; PRECURSOR CELLS; SPINAL-CORD; REMYELINATION; SURVIVAL; BRAIN	Background: Multiple sclerosis is an inflammatory disease of the central nervous system that destroys myelin, oligodendrocytes, and axons. Since most of the lesions of multiple sclerosis are not remyelinated, enhancement of remyelination is a possible therapeutic strategy that could perhaps be achieved with the transplantation of oligodendrocyte-producing cells into the lesions. We investigated the frequency distribution and configuration of oligodendrocytes in chronic lesions of multiple sclerosis to determine whether these factors limit remyelination. Methods: Forty-eight chronic lesions obtained at autopsy from 10 patients with multiple sclerosis were examined immunocytochemically for oligodendrocytes and oligodendrocyte progenitor cells. Using confocal microscopy, we examined the three-dimensional relations between axons and the processes of premyelinating oligodendrocytes. Results: Thirty-four of the 48 chronic lesions of multiple sclerosis contained oligodendrocytes with multiple extended processes that associated with demyelinated axons but failed to myelinate them. These axons were dystrophic and contained multiple swellings. In some regions, the densities of premyelinating oligodendrocytes (25 per square millimeter of tissue) were similar to those in the developing rodent brain (23 per square millimeter). In the patients with disease of long duration (more than 20 years), there were fewer lesions with premyelinating oligodendrocytes (P<0.001). Conclusions: Premyelinating oligodendrocytes are present in chronic lesions of multiple sclerosis, so remyelination is not limited by an absence of oligodendrocyte progenitors or their failure to generate oligodendrocytes. Our findings suggest that in the chronic lesions of multiple sclerosis, the axons are not receptive for remyelination. Understanding the cellular interactions between premyelinating oligodendrocytes, axons, and the microenvironment of lesions of multiple sclerosis may lead to effective strategies for enhancing remyelination. (N Engl J Med 2002;346:165-73.) Copyright (C) 2002 Massachusetts Medical Society.	Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, NC30, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Mellen Ctr Multiple Sclerosis, Cleveland, OH 44195 USA; W Los Angeles Vet Affairs Med Ctr, Dept Neurol, Los Angeles, CA 90073 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center	Trapp, BD (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, NC30, 9500 Euclid Ave, Cleveland, OH 44195 USA.		Messier, Claude/A-2322-2008; Calabrese, Massimiliano/I-6195-2012	Messier, Claude/0000-0002-4791-1763; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038667, R01NS035058] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS35058, P01 NS38667] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARMSTRONG RC, 1992, J NEUROSCI, V12, P1538; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARRES BA, 1993, CURR BIOL, V3, P489, DOI 10.1016/0960-9822(93)90039-Q; BRUCK W, 1994, ANN NEUROL, V35, P65, DOI 10.1002/ana.410350111; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Duncan ID, 1997, MOL MED TODAY, V3, P554, DOI 10.1016/S1357-4310(97)01162-3; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; FFRENCHCONSTANT C, 1986, NATURE, V319, P499, DOI 10.1038/319499a0; GOGATE N, 1994, J NEUROSCI, V14, P4571; Jeffery ND, 1997, BRAIN, V120, P27, DOI 10.1093/brain/120.1.27; Keirstead HS, 1997, J NEUROPATH EXP NEUR, V56, P1191, DOI 10.1097/00005072-199711000-00003; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lucchinetti C, 1999, BRAIN, V122, P2279, DOI 10.1093/brain/122.12.2279; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Murray PD, 2001, BRAIN, V124, P1403, DOI 10.1093/brain/124.7.1403; Nishiyama A, 1996, J NEUROSCI RES, V43, P315, DOI 10.1002/(SICI)1097-4547(19960201)43:3<315::AID-JNR6>3.0.CO;2-M; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; OZAWA K, 1994, BRAIN, V117, P1311, DOI 10.1093/brain/117.6.1311; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; PRINEAS JW, 1979, ANN NEUROL, V5, P22, DOI 10.1002/ana.410050105; PRINEAS JW, 1989, LAB INVEST, V61, P489; PRINEAS JW, 1984, ANN NY ACAD SCI, V436, P11, DOI 10.1111/j.1749-6632.1984.tb14773.x; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RAINE CS, 1993, J NEUROPATH EXP NEUR, V52, P199, DOI 10.1097/00005072-199305000-00003; RAINE CS, 1994, J NEUROPATH EXP NEUR, V53, P328, DOI 10.1097/00005072-199407000-00002; Scolding N, 1998, BRAIN, V121, P2221, DOI 10.1093/brain/121.12.2221; Shi JY, 1998, J NEUROSCI, V18, P4627; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Trapp BD, 1999, NEUROSCIENTIST, V5, P48, DOI 10.1177/107385849900500107; Trapp BD, 1997, J CELL BIOL, V137, P459, DOI 10.1083/jcb.137.2.459; Ueda H, 1999, J CELL BIOL, V146, P1365, DOI 10.1083/jcb.146.6.1365; Waxman SG, 1998, NEW ENGL J MED, V338, P323, DOI 10.1056/NEJM199801293380510; WEINSHENKER BG, 1989, BRAIN, V112, P133, DOI 10.1093/brain/112.1.133; Wolswijk G, 2000, BRAIN, V123, P105, DOI 10.1093/brain/123.1.105; Wolswijk G, 1998, J NEUROSCI, V18, P601; WOLSWIJK G, 1989, DEVELOPMENT, V105, P387	38	730	780	1	35	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2002	346	3					165	173		10.1056/NEJMoa010994	http://dx.doi.org/10.1056/NEJMoa010994			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511NZ	11796850				2022-12-24	WOS:000173273600004
J	Conley, LJ; Ellerbrock, TV; Bush, TJ; Chiasson, MA; Sawo, D; Wright, TC				Conley, LJ; Ellerbrock, TV; Bush, TJ; Chiasson, MA; Sawo, D; Wright, TC			HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS INFECTION; UNITED-STATES; WOMEN; PREVALENCE; DISEASE; TRENDS; DISORDERS; CARCINOMA; CANCERS	Background Information about vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia in women infected with HIV-1 is needed to develop guidelines for clinical care. Our aim was to investigate the incidence of these lesions in HIV-1-positive and HIV-1-negative women and to examine risk factors for disease. Methods In a prospective cohort study, 925 women had a gynaecological examination twice yearly-including colposcopy and tests for human papillomavirus DNA in cervicovaginal lavage-for a median follow-up of 3.2 years (IQR 0.98-4.87). Findings Vulvovaginal and perianal condylomata acuminata or intraepithelial neoplasia were present in 30 (6%) of 481 HIV-1-positive and four (1%) of 437 HIV-1-negative women (p < 0.0001) at enrolment. Women without lesions at enrolment were included in an incidence analysis. 33 (9%) of 385 HIV-1-positive and two (1%) of 341 HIV-1-negative women developed vulvovaginal or perianal lesions, resulting in an incidence of 2.6 and 0.16 cases per 100 person-years, respectively (relative risk 16, 95% Cl 12.9-20.5; p < 0.0001). Risk factors for incident lesions included HIV-1 infection (p = 0.013), human papillomavirus infection (p = 0.0013), lower CD4 T lymphocyte count (p = 0.0395), and history of frequent injection of drugs (P = 0.0199). Interpretation Our results suggest that HIV-1-positive women are at increased risk of development of invasive vulvar carcinoma. Thus, we recommend that, as part of every gynaecological examination, HIV-1-positive women should have a thorough inspection of the vulva and perianal region, and women with abnormalities-except for typical, exophytic condylomata acuminata-should undergo colposcopy and biopsy.	Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; CDCP, Div HIV AIDS Prevent Surveillance & Epidemiol, Natl Ctr HIV STD & TB Prevent, Publ Hlth Serv,US Dept Hlth & Human Serv, Atlanta, GA USA; New York City Dept Hlth, Bur Dis Intervent Res, New York, NY 10013 USA	Columbia University; Centers for Disease Control & Prevention - USA; United States Public Health Service; New York City Department of Health & Mental Hygiene	Wright, TC (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pathol, Room 16-402,630 W 168th St, New York, NY 10032 USA.				ODCDC CDC HHS [U64/CCU206822] Funding Source: Medline	ODCDC CDC HHS		Bersoff-Matcha SJ, 1998, J INFECT DIS, V178, P1174, DOI 10.1086/515678; BLOHME I, 1985, TRANSPLANTATION, V39, P23; BYRNE MA, 1989, AIDS, V3, P379, DOI 10.1097/00002030-198906000-00007; *CDCP, 1993, MMWR-MORBID MORTAL W, V41, P1; CHIASSON M, 1998, P 2 AIDS MAL C APR B; Chiasson MA, 1997, OBSTET GYNECOL, V89, P690, DOI 10.1016/S0029-7844(97)00069-0; Chin KM, 1998, OBSTET GYNECOL, V92, P83, DOI 10.1016/S0029-7844(98)00140-9; Ellerbrock TV, 2000, JAMA-J AM MED ASSOC, V283, P1031, DOI 10.1001/jama.283.8.1031; FENNEMA JSA, 1995, AIDS, V9, P1071, DOI 10.1097/00002030-199509000-00014; Frankel RE, 1997, CLIN INFECT DIS, V25, P706, DOI 10.1086/513775; Frisch M, 2000, JNCI-J NATL CANCER I, V92, P1500, DOI 10.1093/jnci/92.18.1500; GHYS PD, 1995, J INFECT DIS, V172, P1371, DOI 10.1093/infdis/172.5.1371; JONES RW, 1995, BRIT J OBSTET GYNAEC, V102, P764, DOI 10.1111/j.1471-0528.1995.tb10839.x; Jones RW, 1997, OBSTET GYNECOL, V90, P448, DOI 10.1016/S0029-7844(97)00298-6; JONES RW, 1994, OBSTET GYNECOL, V84, P741; Karon JM, 1996, JAMA-J AM MED ASSOC, V276, P126, DOI 10.1001/jama.276.2.126; KAUFMAN RH, 1995, GYNECOL ONCOL, V56, P8, DOI 10.1006/gyno.1995.1003; KOULOS JP, 1993, GYNECOL ONCOL, V48, P364, DOI 10.1006/gyno.1993.1064; KURMAN RJ, 1994, BLAUSTEINS PATHOLOGY, P229; LAGA M, 1992, INT J CANCER, V50, P45, DOI 10.1002/ijc.2910500110; MAIMAN M, 1990, GYNECOL ONCOL, V38, P377, DOI 10.1016/0090-8258(90)90077-X; Minkoff HL, 1999, AM J OBSTET GYNECOL, V180, P824, DOI 10.1016/S0002-9378(99)70653-8; PENN I, 1986, CANCER-AM CANCER SOC, V58, P611, DOI 10.1002/1097-0142(19860801)58:3<611::AID-CNCR2820580303>3.0.CO;2-M; STURGEON SR, 1992, AM J OBSTET GYNECOL, V166, P1482, DOI 10.1016/0002-9378(92)91623-I; Sun XW, 1997, NEW ENGL J MED, V337, P1343, DOI 10.1056/NEJM199711063371903; SUN XW, 1995, OBSTET GYNECOL, V85, P681; Wortley PM, 1997, JAMA-J AM MED ASSOC, V278, P911, DOI 10.1001/jama.278.11.911; WRIGHT TC, 1994, OBSTET GYNECOL, V84, P591	28	119	127	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 12	2002	359	9301					108	113		10.1016/S0140-6736(02)07368-3	http://dx.doi.org/10.1016/S0140-6736(02)07368-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510MT	11809252				2022-12-24	WOS:000173212400009
J	Yacubova, E; Komuro, H				Yacubova, E; Komuro, H			Stage-specific control of neuronal migration by somatostatin	NATURE			English	Article							CEREBELLAR GRANULE CELLS; RAT CEREBELLUM; RECEPTORS; EXPRESSION; CORTEX; K+; PATTERNS; BLOCKS; SYSTEM	Developing neurons transiently express somatostatin and its receptors(1-3), but little is known about their function at these early stages. As we thought that endogenous somatostatin might control the migratory behaviour of immature neurons, we have examined the effects of somatostatin in cerebellar granule cells of early postnatal mice, because these cells express all five types of somatostatin receptors before the initiation of their migration(4,5). Here we show that somatostatin has opposite and stage-specific effects on the migration of cerebellar granule cells. Activation of somatostatin receptors increases the rate of granule cell migration near their birthplace, but decreases the rate near their final destination. Furthermore, somatostatin enhances the size and frequency of spontaneous Ca2+ fluctuations in the early phase of migration, whereas it eliminates spike-like Ca2+ transients in the late phase. Somatostatin-induced changes at both early and late phases are reversed by a blockade of K+ channel activity. These results indicate that somatostatin may provide an essential cue for accelerating the movement of granule cells in the early phase and for terminating the movement in the late phase through altering intracellular Ca2+ concentrations and K+ channel activity.	Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Komuro, H (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, 9500 Euclid Ave, Cleveland, OH 44195 USA.							Baumbach WR, 1998, MOL PHARMACOL, V54, P864, DOI 10.1124/mol.54.5.864; Bologna E, 2000, J COMP NEUROL, V420, P466, DOI 10.1002/(SICI)1096-9861(20000515)420:4<466::AID-CNE5>3.0.CO;2-W; DAngelo E, 1997, J NEUROPHYSIOL, V78, P1631, DOI 10.1152/jn.1997.78.3.1631; GONZALEZ B, 1992, P NATL ACAD SCI USA, V89, P9627, DOI 10.1073/pnas.89.20.9627; GONZALEZ BJ, 1988, DEV BRAIN RES, V40, P154, DOI 10.1016/0165-3806(88)90018-1; Hendriks R, 1999, J NEUROSCI RES, V58, P805, DOI 10.1002/(SICI)1097-4547(19991215)58:6<805::AID-JNR7>3.0.CO;2-V; IKEDA SR, 1989, J PHYSIOL-LONDON, V409, P221, DOI 10.1113/jphysiol.1989.sp017494; INAGAKI S, 1989, MOL BRAIN RES, V6, P289, DOI 10.1016/0169-328X(89)90074-0; KOMURO H, 1995, J NEUROSCI, V15, P1110; KOMURO H, 1992, SCIENCE, V257, P806, DOI 10.1126/science.1323145; Komuro H, 1998, J NEUROSCI, V18, P1478; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; KOMURO H, 1993, SCIENCE, V260, P95, DOI 10.1126/science.8096653; Komuro H, 2001, J NEUROSCI, V21, P527, DOI 10.1523/JNEUROSCI.21-02-00527.2001; KUHAR SG, 1993, DEVELOPMENT, V117, P97; MAUBERT E, 1994, NEUROSCIENCE, V62, P317, DOI 10.1016/0306-4522(94)90335-2; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; NAGATA I, 1990, DEV BRAIN RES, V52, P63, DOI 10.1016/0165-3806(90)90222-K; Patel YC, 1997, J ENDOCRINOL INVEST, V20, P348, DOI 10.1007/BF03350317; REISINE T, 1995, ENDOCR REV, V16, P427, DOI 10.1210/er.16.4.427; Rhie DJ, 1999, DEV BRAIN RES, V112, P267, DOI 10.1016/S0165-3806(98)00175-8; Schindler M, 1996, PROG NEUROBIOL, V50, P9; Shibata R, 2000, J NEUROSCI, V20, P4145; SIMS SM, 1991, J PHYSIOL-LONDON, V441, P615, DOI 10.1113/jphysiol.1991.sp018770; TANIWAKI T, 1995, DEV BRAIN RES, V88, P109, DOI 10.1016/0165-3806(95)00090-Z; Thoss VS, 1996, EUR J PHARMACOL, V297, P145, DOI 10.1016/0014-2999(95)00736-9; VILLAR MJ, 1989, ANAT EMBRYOL, V179, P257, DOI 10.1007/BF00326591; Viollet C, 1997, J NEUROCHEM, V68, P2263	28	87	87	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					77	81		10.1038/415077a	http://dx.doi.org/10.1038/415077a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780120				2022-12-24	WOS:000173028800043
J	Chaudhari, N; Kinnamon, SC				Chaudhari, N; Kinnamon, SC			Molecular basis of the sweet tooth?	LANCET			English	Editorial Material							RECEPTOR GENE; TASTE; SACCHARIN; IDENTIFICATION; TRANSDUCTION; MICE; SAC		Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33101 USA; Univ Miami, Sch Med, Program Neurosci, Miami, FL 33101 USA; Univ Colorado, Hlth Sci Ctr, Rocky Mt Taste & Smell Ctr, Denver, CO USA; Colorado State Univ, Dept Anat & Neurobiol, Ft Collins, CO 80523 USA	University of Miami; University of Miami; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Colorado State University	Chaudhari, N (corresponding author), Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33101 USA.	NChaudhari@miami.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P01DC003013] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bachmanov AA, 1997, MAMM GENOME, V8, P545, DOI 10.1007/s003359900500; Bachmanov AA, 2001, CHEM SENSES, V26, P925, DOI 10.1093/chemse/26.7.925; GLENDINNING JI, 2000, NEUROBIOLOGY TASTE S, P315; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Li X, 2001, MAMM GENOME, V12, P13, DOI 10.1007/s003350010236; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; LUSH IE, 1989, GENET RES, V53, P95, DOI 10.1017/S0016672300027968; Masters-Harte LD, 2001, ANN PHARMACOTHER, V35, P947; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Sainz E, 2001, J NEUROCHEM, V77, P896, DOI 10.1046/j.1471-4159.2001.00292.x; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0	13	6	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 22	2001	358	9299					2101	2102		10.1016/S0140-6736(01)07233-6	http://dx.doi.org/10.1016/S0140-6736(01)07233-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505GV	11784621				2022-12-24	WOS:000172905800006
J	Paddock, S				Paddock, S			Optical sectioning - Slices of life	SCIENCE			English	Editorial Material							MICROSCOPY		Univ Wisconsin, Mol Biol Lab, Howard Hughes Med Inst, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison	Paddock, S (corresponding author), Univ Wisconsin, Mol Biol Lab, Howard Hughes Med Inst, Madison, WI 53706 USA.	paddock@facstaff.wisc.edu						BRELJE TC, 1993, METHOD CELL BIOL, V38, P97; Brunetti CR, 2001, CURR BIOL, V11, P1578, DOI 10.1016/S0960-9822(01)00502-4; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Dickinson ME, 2001, BIOTECHNIQUES, V31, P1272, DOI 10.2144/01316bt01; Fan GY, 1999, BIOPHYS J, V76, P2412, DOI 10.1016/S0006-3495(99)77396-0; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; HAUGHLAND RP, 2001, HDB FLUORESCENT PROB; Klarreich E, 2001, NATURE, V413, P450, DOI 10.1038/35097256; MADDOX P, 2001, MICROSC MICROANAL, V7, P8; Mohler WA, 1999, MOL BIOL CELL, V10, P3061, DOI 10.1091/mbc.10.10.3061; Paddock S, 2001, BIOTECHNIQUES, V30, P756, DOI 10.2144/01304bt01; Paddock SW, 1999, CONFOCAL MICROSCOPY, V122; Piston DW, 1999, TRENDS CELL BIOL, V9, P66, DOI 10.1016/S0962-8924(98)01432-9; Smallcombe A, 2001, BIOTECHNIQUES, V30, P1240, DOI 10.2144/01306bt01; Squirrell JM, 1999, NAT BIOTECHNOL, V17, P763, DOI 10.1038/11698; van Roessel P, 2002, NAT CELL BIOL, V4, pE15, DOI 10.1038/ncb0102-e15; Wallace W, 2001, BIOTECHNIQUES, V31, P1076, DOI 10.2144/01315bi01; Waterman-Storer C, 2000, J CELL BIOL, V150, P361, DOI 10.1083/jcb.150.2.361; WHITE JG, 1987, NATURE, V328, P183, DOI 10.1038/328183a0	19	3	5	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2002	295	5558					1319	1321		10.1126/science.295.5558.1319	http://dx.doi.org/10.1126/science.295.5558.1319			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847348				2022-12-24	WOS:000173926000050
J	Bryk, R; Lima, CD; Erdjument-Bromage, H; Tempst, P; Nathan, C				Bryk, R; Lima, CD; Erdjument-Bromage, H; Tempst, P; Nathan, C			Metabolic enzymes of mycobacteria linked to antioxidant defense by a thioredoxin-like protein	SCIENCE			English	Article							ALKYL HYDROPEROXIDE REDUCTASE; SALMONELLA-TYPHIMURIUM; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; TUBERCULOSIS; AHPC; ACETYLTRANSFERASE; DEHYDROGENASE; BACTERIAL	Mycobacterium tuberculosis (Mtb) mounts a stubborn defense against oxidative and nitrosative components of the immune response. Dihydrolipoamide dehydrogenase (Lpd) and dihydrolipoamide succinyltransferase (SucB) are components of alpha-ketoacid dehydrogenase complexes that are central to intermediary metabolism. We find that Lpd and SucB support Mtb's antioxidant defense. The peroxiredoxin alkyl hydroperoxide reductase (AhpC) is linked to Lpd and SucB by an adaptor protein, AhpD. The 2.0 angstrom AhpD crystal structure reveals a thioredoxin-like active site that is responsive to lipoamide. We propose that Lpd, SucB (the only lipoyl protein detected in Mtb), AhpD, and AhpC together constitute a nicotinamide adenine dinucleotide (reduced)-dependent peroxidase and peroxynitrite reductase. AhpD thus represents a class of thioredoxin-like molecules that enables an antioxidant defense.	Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Sloan Kettering Inst, Prot Ctr, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Program Immunol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Program Struct Biol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Program Mol Biol, New York, NY 10021 USA	Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University	Nathan, C (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, Box 65,1300 York Ave, New York, NY 10021 USA.			Lima, Christopher/0000-0002-9163-6092; Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594	NCI NIH HHS [P30 CA08748] Funding Source: Medline; NHLBI NIH HHS [HL61241] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061241] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Argyrou A, 2001, BIOCHEMISTRY-US, V40, P11353, DOI 10.1021/bi010575o; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; CHAN J, 1999, NITRIC OXIDE INFECT, P281; Chen L, 1998, MOL CELL, V1, P795, DOI 10.1016/S1097-2765(00)80079-9; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; DANSON MJ, 1988, BIOCHEM SOC T, V16, P87, DOI 10.1042/bst0160087; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P13349, DOI 10.1021/bi9713658; ERJUMENTBROMAGE H, 1998, J CHROMATOGR A, V826, P167; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Haramaki N, 1997, FREE RADICAL BIO MED, V22, P535, DOI 10.1016/S0891-5849(96)00400-5; Hillas PJ, 2000, J BIOL CHEM, V275, P18801, DOI 10.1074/jbc.M001001200; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; Lee SP, 2001, J BIOL CHEM, V276, P29826, DOI 10.1074/jbc.M101822200; MANN M, 1993, BIOL MASS SPECTROM, V22, P338, DOI 10.1002/bms.1200220605; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; MURTHY PS, 1973, AM REV RESPIR DIS, V108, P689; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; SPENCER ME, 1984, EUR J BIOCHEM, V141, P361, DOI 10.1111/j.1432-1033.1984.tb08200.x; Springer B, 2001, INFECT IMMUN, V69, P5967, DOI 10.1128/IAI.69.10.5967-5973.2001; STEPHENS PE, 1983, EUR J BIOCHEM, V133, P481, DOI 10.1111/j.1432-1033.1983.tb07490.x; STORZ G, 1989, J BACTERIOL, V171, P2049, DOI 10.1128/jb.171.4.2049-2055.1989	23	299	327	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1073	1077		10.1126/science.1067798	http://dx.doi.org/10.1126/science.1067798			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11799204				2022-12-24	WOS:000173793000066
J	Eagle, KA; Goodman, SG; Avezum, A; Budaj, A; Sullivan, CM; Lopez-Sendon, J				Eagle, KA; Goodman, SG; Avezum, A; Budaj, A; Sullivan, CM; Lopez-Sendon, J		GRACE Investigators	Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE)	LANCET			English	Article							THROMBOLYTIC THERAPY; COMBINATION THERAPY; NATIONAL REGISTRY; ELDERLY-PATIENTS; ANGIOPLASTY; INHIBITION; ELIGIBILITY; MANAGEMENT; BENEFIT	Background The benefits of reperfusion therapy for patients with acute coronary syndromes have been established, but there is much variation in the type of reperfusion given and decisions about which patients are eligible. This study assessed current practices in relation to reperfusion therapy of ST-segment-elevation myocardial infarction from data collected in the multinational, prospective Global Registry of Acute Coronary Events. Methods 94 hospitals in 14 countries are recruiting patients for the registry, Hospitals are organised into population-based clusters that reflect the population characteristics of the region. Information about patients' demographic characteristics, presenting symptoms, medical history, time between symptom onset and presentation, and clinical and electrocardiographic features is recorded in a standard case record. Findings Of the 9251 patients enrolled, 1763 presented within 12 h of symptom onset with ST-segment-elevation myocardial infarction. Of these, 30% did not receive reperfusion therapy. Elderly patients (75 years and older), those presenting without chest pain, and those with a history of diabetes, congestive heart failure, myocardial infarction, or coronary bypass surgery were less likely to receive reperfusion therapy. The rate of primary percutaneous coronary intervention was highest in the USA and lowest in Australia, New Zealand, and Canada. The rate at sites with a catheterisation laboratory was 19% compared with zero at sites without this facility. Interpretation A substantial proportion of patients who are eligible for reperfusion therapy still do not receive this treatment. These typically high-risk patients can be identified in advance, and reasons for the underuse of these beneficial treatments need to be clarified.	Univ Michigan Hosp, Div Cardiol, Ann Arbor, MI 48109 USA; Univ Toronto, St Michaels Hosp, Div Cardiol, Canadian Heart Res Ctr, Toronto, ON M5B 1W8, Canada; Univ Toronto, St Michaels Hosp, Div Cardiol, Terrence Donnelly Heart Ctr, Toronto, ON M5B 1W8, Canada; CTIA Hosp Albert Einstein, Sao Paulo, Brazil; Grochowski Hosp, Dept Cardiol, Warsaw, Poland; Univ Massachusetts, Sch Med, Ctr Outcomes Res, Worcester, MA USA; Hosp Univ Gregorio Maranon, Dept Cardiol, Madrid, Spain	University of Michigan System; University of Michigan; Canadian Heart Research Centre; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Hospital Israelita Albert Einstein; Centre of Postgraduate Medical Education - Poland; University of Massachusetts System; University of Massachusetts Worcester; General University Gregorio Maranon Hospital	Eagle, KA (corresponding author), Univ Michigan Hosp, Div Cardiol, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	keagle@umich.edu	Avezum, Alvaro AA/K-6137-2016; Avezum, Alvaro/AAP-7687-2020	Avezum, Alvaro AA/0000-0002-3073-6890; Budaj, Andrzej/0000-0002-6395-2098				Agnelli G, 2001, AM HEART J, V141, P190, DOI 10.1067/mhj.2001.112404; Akkerhuis KM, 2000, EUR HEART J, V21, P371, DOI 10.1053/euhj.1999.1743; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Berger AK, 1999, JAMA-J AM MED ASSOC, V282, P341, DOI 10.1001/jama.282.4.341; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; Califf RM, 2000, AM HEART J, V139, pS33, DOI 10.1067/mhj.2000.104090; Cannon CP, 2000, J THROMB THROMBOLYS, V9, P235, DOI 10.1023/A:1018714627681; Cariou A, 1997, EUR HEART J, V18, P1583; French WJ, 2000, AM J CARDIOL, V85, p5B; Gibson CM, 1999, ANN INTERN MED, V130, P841, DOI 10.7326/0003-4819-130-10-199905180-00019; GRINES CL, 1993, NEW ENGL J MED, V328, P673, DOI 10.1056/NEJM199303113281001; HIMBERT D, 1994, EUR HEART J, V15, P483, DOI 10.1093/oxfordjournals.eurheartj.a060531; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Holmes DR, 1997, LANCET, V349, P75, DOI 10.1016/S0140-6736(96)03031-0; Julian DG, 1996, EUR HEART J, V17, P43; Juliard JM, 1997, J AM COLL CARDIOL, V30, P157, DOI 10.1016/S0735-1097(97)00119-8; Krumholz HM, 1997, JAMA-J AM MED ASSOC, V277, P1683, DOI 10.1001/jama.277.21.1683; Rogers WJ, 2000, J AM COLL CARDIOL, V35, P371, DOI 10.1016/S0735-1097(99)00505-7; ROGERS WJ, 1994, CIRCULATION, V90, P2103, DOI 10.1161/01.CIR.90.4.2103; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; Ryan TJ, 1999, J AM COLL CARDIOL, V34, P890, DOI 10.1016/S0735-1097(99)00351-4; Thiemann DR, 2000, CIRCULATION, V101, P2239, DOI 10.1161/01.CIR.101.19.2239; Tresch DD, 1996, ARCH INTERN MED, V156, P1089, DOI 10.1001/archinte.156.10.1089; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; Weaver WD, 1997, JAMA-J AM MED ASSOC, V278, P2093, DOI 10.1001/jama.278.23.2093; White HD, 2000, LANCET, V356, P2028, DOI 10.1016/S0140-6736(00)03397-3; White HD, 1998, AM J CARDIOL, V82, p57P, DOI 10.1016/S0002-9149(98)00663-8; Zijlstra F, 2000, EUR HEART J, V21, P1487, DOI 10.1053/euhj.2000.2192	28	414	447	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2002	359	9304					373	377		10.1016/S0140-6736(02)07595-5	http://dx.doi.org/10.1016/S0140-6736(02)07595-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UP	11844506				2022-12-24	WOS:000173686500006
J	Vrijheid, M; Dolk, H; Armstrong, B; Abramsky, L; Bianchi, F; Fazarinc, I; Garne, E; Ide, R; Nelen, V; Robert, E; Scott, JES; Stone, D; Tenconi, R				Vrijheid, M; Dolk, H; Armstrong, B; Abramsky, L; Bianchi, F; Fazarinc, I; Garne, E; Ide, R; Nelen, V; Robert, E; Scott, JES; Stone, D; Tenconi, R			Chromosomal congenital anomalies and residence near hazardous waste landfill sites	LANCET			English	Article							RISK	Previous findings of the EUROHAZCON study showed a 33% Increase In risk of non-chromosomal anomalies near hazardous waste landfill sites. Here, we studied 245 cases of chromosomal anomalies and 2412 controls who lived near 23 such sites In Europe, After adjustment for confounding by maternal age and socioeconomic status, we noted a higher risk of chromosomal anomalies In people who lived close to sites (0-3 km) than In those who lived further away (3-7 km; odds ratio 1.41, 95% CI 1.00-1.99). Our results suggest an increase in risk of chromosomal anomalies similar to that found for non-chromosomal anomalies.	Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Environm Epidemiol Unit, EUROCAT Cent Registry, London WC1E 7HT, England; Univ Ulster, Fac Life & Hlth Sci, EUROCAT Registry, Belfast, Antrim, North Ireland; Northwick Pk Hosp & Clin Res Ctr, N Thames Perinatal Publ Hlth Unit, N Thames W Congenital Malformat Register, London, England; CNR, Inst Clin Physiol, Epidemiol Unit, Tuscany EUROCAT Register, I-56100 Pisa, Italy; Inst Publ Hlth, Ljubljana, Slovenia; Univ So Denmark, Inst Publ Hlth, Funen Cty Eurocat Register, Odense, Denmark; St Bartholomews & London Sch Med & Dent, Wolfson Inst Prevent Med, Natl Down Syndrome Cytogenet Register, London, England; Prov Inst Hyg, Antwerp Eurocat Register, Antwerp, Belgium; Inst Europeen Genomutat, France Cent E Register Congenital Malformat, Lyon, France; Univ Newcastle Upon Tyne, Matern Survey Off, No Congenital Abnormal Survey, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Glasgow, Dept Child Hlth, Paediat Epidemiol & Community Hlth Unit, Glasgow EUROCAT Register, Glasgow, Lanark, Scotland; Univ Padua, NE Italy Registry Congenital Malformat, Padua, Italy	University of London; London School of Hygiene & Tropical Medicine; Ulster University; Imperial College London; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Southern Denmark; University of London; Queen Mary University London; Newcastle University - UK; University of Glasgow; University of Padua	Vrijheid, M (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Environm Epidemiol Unit, EUROCAT Cent Registry, Keppel St, London WC1E 7HT, England.		Bianchi, Fabrizio/F-7900-2015; Vrijheid, Martine/H-2702-2014	Bianchi, Fabrizio/0000-0002-3459-9301; Vrijheid, Martine/0000-0002-7090-1758; armstrong, benedict/0000-0003-4407-0409				Dolk H, 1998, LANCET, V352, P423, DOI 10.1016/S0140-6736(98)01352-X; DOLK H, 1999, DIS MAPPING RISK ASS; GESCHWIND SA, 1992, AM J EPIDEMIOL, V135, P1197, DOI 10.1093/oxfordjournals.aje.a116226; VJIJHEID M, 2000, THESIS U LONDON LOND; Vrijheid M, 2000, ARCH DIS CHILD, V82, P349, DOI 10.1136/adc.82.5.349	5	54	56	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 26	2002	359	9303					320	322		10.1016/S0140-6736(02)07531-1	http://dx.doi.org/10.1016/S0140-6736(02)07531-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517AC	11830202				2022-12-24	WOS:000173588100016
J	Huang, JK; Rozelle, S; Pray, C; Wang, QF				Huang, JK; Rozelle, S; Pray, C; Wang, QF			Plant biotechnology in China	SCIENCE			English	Article								A survey of China's plant biotechnologists shows that China is developing the largest plant biotechnology capacity outside of North America. The list of genetically modified plant technologies in trials, including rice, wheat, potatoes, and peanuts, is impressive and differs from those being worked on in other countries. Poor farmers in China are cultivating more area of genetically modified plants than are small farmers in any other developing country. A survey of agricultural producers in China demonstrates that Bacillus thuringiensis cotton adoption increases production efficiency and improves farmer health.	Univ Calif Davis, Dept Agr & Resource Econ, Davis, CA 95616 USA; Chinese Acad Sci, Inst Geog Sci & Nat Resource Res, Ctr Chinese Agr Policy, Beijing 100101, Peoples R China; Rutgers State Univ, Dept Agr Food & Resource Econ, New Brunswick, NJ 08901 USA; Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100081, Peoples R China	University of California System; University of California Davis; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Rutgers State University New Brunswick; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Rozelle, S (corresponding author), Univ Calif Davis, Dept Agr & Resource Econ, 1 Shields Ave, Davis, CA 95616 USA.							BYLERLEE D, 2000, 4 INT C EC AGR BIOT; COURTMANCHE A, 2001, IMPROTANCE INTELLECT; HUANG J, 2000, CHINAS AGR RES INVES, P105; HUANG J, 2001, SMALL HOLDERS TRANSG; HUANG J, 2001, BIOTECHNOLOGY ALTERN; HUANG JK, 2001, AGR BIOTECHNOLOGY DE; JAMES C, 2000, ISAAA BRIEFS, V17, P65; PAARLBERG RL, 2001, 16 20 20 VIS PEAC EN; Pray C, 2001, WORLD DEV, V29, P813, DOI 10.1016/S0305-750X(01)00010-9; PRAY CE, 2001, 2001 AM AGR EC ASS A; PRAY CE, 2001, PRIVATE SECTOR INVES; QAIM M, 2001, SITUATION AGR BIOTEC; *WORLD BANK, 2000, ENT 21 CENT WORLD DE, P821; XU Z, 2000, BIOL ENG PROGR, V20, P20	14	273	329	8	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					674	677		10.1126/science.1067226	http://dx.doi.org/10.1126/science.1067226			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809972				2022-12-24	WOS:000173560900044
J	Reynolds, T				Reynolds, T			Switching from prescription to over the counter	ANNALS OF INTERNAL MEDICINE			English	Article																			0	6	6	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2002	136	2					177	180		10.7326/0003-4819-136-2-200201150-00026	http://dx.doi.org/10.7326/0003-4819-136-2-200201150-00026			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512PZ	11790082				2022-12-24	WOS:000173333900019
J	Salina, D; Bodoor, K; Eckley, DM; Schroer, TA; Rattner, JB; Burke, B				Salina, D; Bodoor, K; Eckley, DM; Schroer, TA; Rattner, JB; Burke, B			Cytoplasmic dynein as a facilitator of nuclear envelope breakdown	CELL			English	Article							INTEGRAL MEMBRANE-PROTEINS; RAT KANGAROO CELLS; PHOSPHORYLATION SITES; MAMMALIAN-CELLS; CYSTEINE-RICH; LIVING CELLS; LAMIN-A; DYNACTIN; MITOSIS; END	During prophase in higher cells, centrosomes localize to deep invaginations in the nuclear envelope in a microtubule-dependent process. Loss of nuclear membranes In prometaphase commences in regions of the nuclear envelope that lie outside of these invaginations. Dynein and dynactin complex components concentrate on the nuclear envelope prior to any changes in nuclear envelope organization. These observations suggest a model in which dynein facilitates nuclear envelope breakdown by pulling nuclear membranes and associated proteins poleward along astral microtubules leading to nuclear membrane detachment. Support for this model is provided by the finding that interference with dynein function drastically alters nuclear membrane dynamics in prophase and prometaphase.	Univ Calgary, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	University of Calgary; Johns Hopkins University	Burke, B (corresponding author), Univ Calgary, Dept Cell Biol & Anat, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	bburke@anatomy.med.ufl.edu	Eckley, Mark/M-3526-2014; Eckley, David Mark/I-9245-2019	Eckley, Mark/0000-0003-2296-5164; Schroer, Trina/0000-0002-5065-1835	NIGMS NIH HHS [R01 GM044589] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLAN V, 1995, J CELL BIOL, V128, P879, DOI 10.1083/jcb.128.5.879; ASH JF, 1977, P NATL ACAD SCI USA, V74, P5584, DOI 10.1073/pnas.74.12.5584; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; Bodoor K, 1999, J CELL SCI, V112, P2253; BURKE B, 1990, EXP CELL RES, V186, P169, DOI 10.1016/0014-4827(90)90223-W; BURKE B, 1986, CELL, V44, P639, DOI 10.1016/0092-8674(86)90273-4; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; CHAUDHARY N, 1993, J CELL BIOL, V122, P295, DOI 10.1083/jcb.122.2.295; Collas P, 2000, TRENDS CELL BIOL, V10, P5, DOI 10.1016/S0962-8924(99)01697-9; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Eckley DM, 1999, J CELL BIOL, V147, P307, DOI 10.1083/jcb.147.2.307; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; FOISNER R, 1993, CELL, V73, P1267, DOI 10.1016/0092-8674(93)90355-T; FURUKAWA K, 1995, EMBO J, V14, P1626, DOI 10.1002/j.1460-2075.1995.tb07151.x; Gant TM, 1997, ANNU REV CELL DEV BI, V13, P669, DOI 10.1146/annurev.cellbio.13.1.669; Garces JA, 1999, CURR BIOL, V9, P1497, DOI 10.1016/S0960-9822(00)80122-0; Georgatos SD, 1997, J CELL SCI, V110, P2129; GERACE L, 1980, CELL, V19, P277, DOI 10.1016/0092-8674(80)90409-2; GERACE L, 1988, ANNU REV CELL BIOL, V4, P335, DOI 10.1146/annurev.cb.04.110188.002003; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Gruenbaum Y, 2000, J STRUCT BIOL, V129, P313, DOI 10.1006/jsbi.2000.4216; HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Karki S, 2000, J BIOL CHEM, V275, P4834, DOI 10.1074/jbc.275.7.4834; Khodjakov A, 2001, J CELL BIOL, V153, P237, DOI 10.1083/jcb.153.1.237; Lee IH, 2001, MOL BIOL CELL, V12, P2195, DOI 10.1091/mbc.12.7.2195; Lee KK, 2000, MOL BIOL CELL, V11, P3089, DOI 10.1091/mbc.11.9.3089; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; Mack GJ, 1998, ARTHRITIS RHEUM, V41, P551; MIAKELYE R, 1985, CELL, V41, P165, DOI 10.1016/0092-8674(85)90071-6; NEWPORT J, 1987, CELL, V48, P219, DOI 10.1016/0092-8674(87)90425-9; NEWPORT JW, 1990, J CELL BIOL, V111, P2247, DOI 10.1083/jcb.111.6.2247; NUSSE M, 1984, CELL TISSUE KINET, V17, P13, DOI 10.1111/j.1365-2184.1984.tb00564.x; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; PFALLER R, 1995, J BIOL CHEM, V270, P19066, DOI 10.1074/jbc.270.32.19066; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; RATTNER JB, 1976, CYTOBIOS, V15, P37; RATTNER JB, 1976, CHROMOSOMA, V54, P387, DOI 10.1007/BF00292817; Reinsch S, 1997, CURR BIOL, V7, P211, DOI 10.1016/S0960-9822(97)70092-7; Reinsch S, 1998, J CELL SCI, V111, P2283; ROBBINS E, 1964, J CELL BIOL, V21, P429, DOI 10.1083/jcb.21.3.429; Robinson JT, 1999, J CELL BIOL, V146, P597, DOI 10.1083/jcb.146.3.597; ROOS UP, 1973, CHROMOSOMA, V40, P43, DOI 10.1007/BF00319836; SNOW CM, 1987, J CELL BIOL, V104, P1143, DOI 10.1083/jcb.104.5.1143; STICK R, 1988, J CELL BIOL, V107, P397, DOI 10.1083/jcb.107.2.397; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Terasaki M, 2001, MOL BIOL CELL, V12, P503, DOI 10.1091/mbc.12.2.503; Vierula PJ, 1997, MOL MICROBIOL, V24, P331, DOI 10.1046/j.1365-2958.1997.3461704.x; VIGERS GPA, 1991, J CELL BIOL, V112, P545, DOI 10.1083/jcb.112.4.545; WARD GE, 1990, CELL, V61, P561, DOI 10.1016/0092-8674(90)90469-U; WATERMANSTORER CM, 1993, CELL MOTIL CYTOSKEL, V26, P19, DOI 10.1002/cm.970260104; Whitehead CM, 1996, ARTHRITIS RHEUM, V39, P1635, DOI 10.1002/art.1780391005; Wilson KL, 2000, TRENDS CELL BIOL, V10, P125, DOI 10.1016/S0962-8924(99)01708-0; Wilson KL, 2001, CELL, V104, P647, DOI 10.1016/S0092-8674(02)01452-6; Yang L, 1997, J CELL BIOL, V137, P1199, DOI 10.1083/jcb.137.6.1199; Young A, 2000, MOL BIOL CELL, V11, P2047, DOI 10.1091/mbc.11.6.2047; ZELIGS JD, 1979, J ULTRA MOL STRUCT R, V66, P53, DOI 10.1016/S0022-5320(79)80065-9	59	280	292	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2002	108	1					97	107		10.1016/S0092-8674(01)00628-6	http://dx.doi.org/10.1016/S0092-8674(01)00628-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792324	Bronze			2022-12-24	WOS:000173280700011
J	Mehilli, J; Kastrati, A; Dirschinger, J; Pache, J; Seyfarth, M; Blasini, R; Hall, D; Neumann, FJ; Schomig, A				Mehilli, J; Kastrati, A; Dirschinger, J; Pache, J; Seyfarth, M; Blasini, R; Hall, D; Neumann, FJ; Schomig, A			Sex-based analysis of outcome in patients with acute myocardial infarction treated predominantly with percutaneous coronary intervention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLYCOPROTEIN IIB/IIIA BLOCKADE; THROMBOLYTIC THERAPY; PRIMARY ANGIOPLASTY; NATIONAL REGISTRY; WOMEN; MORTALITY; MEN; SURVIVAL; REVASCULARIZATION; MANAGEMENT	Context A higher mortality risk for women with acute myocardial infarction (AMI) is a common finding in studies that compare the postinfarction outcome of women vs men. It is not clear, however, whether sex is an independent predictor of death among patients systematically treated with aggressive reperfusion and medical strategies. Objective To assess the impact of patient's sex on outcome in a consecutive series of patients with AMI treated with a reperfusion strategy largely based on percutaneous coronary interventions. Design, Setting, and Patients Inception cohort of 1937 patients (502 women and 1435 men) who were admitted with a diagnosis of AMI to a tertiary referral institution between January 1995 and December 2000. Main Outcome Measures Mortality at 1 year after AMI. Results Compared with men, women were older (70 vs 61 years; P<.001) and had known diabetes or hypertension more often. Both men and women received essentially identical therapy with the majority of patients (86%) receiving reperfusion therapy via percutaneous coronary interventions. There were no significant differences in 1-year Kaplan-Meier death rates with 13.8% (68 cases) among women and 12.9% (184 cases) among men (unadjusted hazard ratio, 1.06; 95% confidence interval, 0.80-1.39; P=.70). After age adjustment, women had a lower risk of death (hazard ratio, 0.65; 95% confidence interval, 0.49-0.87; P=.004). Conclusion Despite their more advanced age and greater prevalence of diabetes or hypertension, women with AMI who were treated with a reperfusion strategy largely based on percutaneous coronary interventions show a similar outcome as men.	Deutsch Herzzentrum Munich, D-80636 Munich, Germany; Tech Univ Munich, Med Klin Rechts Isar 1, D-8000 Munich, Germany	German Heart Centre Munich; Technical University of Munich	Kastrati, A (corresponding author), Deutsch Herzzentrum Munich, Lazarettstr 36, D-80636 Munich, Germany.	kastrati@dhm.mhn.de	Mehilli, Julinda/F-2629-2016; , Kastrati/Y-2389-2019					*AM HEART ASS, 2000, 2001 HEART STROK STA, P6; [Anonymous], 1986, LANCET, V2, P57; Antoniucci D, 2001, AM J CARDIOL, V87, P289, DOI 10.1016/S0002-9149(00)01360-6; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Barakat K, 2000, AM HEART J, V140, P740, DOI 10.1067/mhj.2000.110089; Barron HV, 1998, CIRCULATION, V97, P1150, DOI 10.1161/01.CIR.97.12.1150; BECKER RC, 1994, ANN INTERN MED, V120, P638, DOI 10.7326/0003-4819-120-8-199404150-00003; Bell DM, 2000, PHARMACOTHERAPY, V20, P1034, DOI 10.1592/phco.20.13.1034.35034; Brener SJ, 1998, CIRCULATION, V98, P734, DOI 10.1161/01.CIR.98.8.734; Cho L, 2000, J WOMEN HEALTH GEN-B, V9, P741, DOI 10.1089/15246090050147718; FIEBACH NH, 1990, JAMA-J AM MED ASSOC, V263, P1092, DOI 10.1001/jama.263.8.1092; French JK, 1996, BMJ-BRIT MED J, V312, P1637, DOI 10.1136/bmj.312.7047.1637; Gottlieb S, 2000, CIRCULATION, V102, P2484, DOI 10.1161/01.CIR.102.20.2484; GREENLAND P, 1991, CIRCULATION, V83, P484, DOI 10.1161/01.CIR.83.2.484; Hannan EL, 2000, J AM COLL CARDIOL, V36, P1194, DOI 10.1016/S0735-1097(00)00866-4; HARRELL FE, 1997, PREDICTING OUTCOMES, P290; Hochman JS, 1999, NEW ENGL J MED, V341, P226, DOI 10.1056/NEJM199907223410402; KOSTIS JB, 1994, CIRCULATION, V90, P1715, DOI 10.1161/01.CIR.90.4.1715; KRUMHOLZ HM, 1992, ANN INTERN MED, V116, P785, DOI 10.7326/0003-4819-116-10-785; LINCOFF AM, 1993, J AM COLL CARDIOL, V22, P1780, DOI 10.1016/0735-1097(93)90757-R; Malacrida R, 1998, NEW ENGL J MED, V338, P8, DOI 10.1056/NEJM199801013380102; Mehilli J, 2000, JAMA-J AM MED ASSOC, V284, P1799, DOI 10.1001/jama.284.14.1799; Montalescot G, 2001, NEW ENGL J MED, V344, P1895, DOI 10.1056/NEJM200106213442503; Neumann FJ, 1998, CIRCULATION, V98, P2695, DOI 10.1161/01.CIR.98.24.2695; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; Schomig A, 2000, NEW ENGL J MED, V343, P385, DOI 10.1056/NEJM200008103430602; Stenestrand U, 2001, JAMA-J AM MED ASSOC, V285, P430, DOI 10.1001/jama.285.4.430; STONE GW, 1995, AM J CARDIOL, V75, P987, DOI 10.1016/S0002-9149(99)80709-7; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; TunstallPedoe H, 1996, CIRCULATION, V93, P1981, DOI 10.1161/01.CIR.93.11.1981; Vaccarino V, 1998, ARCH INTERN MED, V158, P2054, DOI 10.1001/archinte.158.18.2054; VACCARINO V, 1995, CIRCULATION, V91, P1861, DOI 10.1161/01.CIR.91.6.1861; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; Vaccarino V, 2001, ANN INTERN MED, V134, P173, DOI 10.7326/0003-4819-134-3-200102060-00007; VACEK JL, 1995, AM J CARDIOL, V76, P226, DOI 10.1016/S0002-9149(99)80070-8; VACEK JL, 1993, AM HEART J, V126, P521, DOI 10.1016/0002-8703(93)90399-T; Weaver WD, 1996, JAMA-J AM MED ASSOC, V275, P777, DOI 10.1001/jama.275.10.777; Weaver WD, 1997, JAMA-J AM MED ASSOC, V278, P2093, DOI 10.1001/jama.278.23.2093; WHITE HD, 1993, CIRCULATION, V88, P2097, DOI 10.1161/01.CIR.88.5.2097	40	124	130	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2002	287	2					210	215		10.1001/jama.287.2.210	http://dx.doi.org/10.1001/jama.287.2.210			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508XK	11779263				2022-12-24	WOS:000173114900023
J	Tregenza, T; Wedell, N				Tregenza, T; Wedell, N			Polyandrous females avoid costs of inbreeding	NATURE			English	Article							GRYLLUS-BIMACULATUS; FIELD CRICKET; GENETIC INCOMPATIBILITY; SPERM SELECTION; CHOICE; EVOLUTION; BENEFITS; RECOGNITION; CONFLICT; SUCCESS	Why do females typically mate with more than one male? Female mating patterns have broad implications for sexual selection(1,2), speciation(3) and conflicts of interest between the sexes(4), and yet they are poorly understood. Matings inevitably have costs(5), and for females, the benefits of taking more than one mate are rarely obvious. One possible explanation is that females gain benefits because they can avoid using sperm from genetically incompatible males, or invest less in the offspring of such males(6,7). It has been shown that mating with more than one male can increase offspring viability(8-12), but we present the first clear demonstration that this occurs because females with several mates avoid the negative effects of genetic incompatibility(13). We show that in crickets, the eggs of females that mate only with siblings have decreased hatching success. However, if females mate with both a sibling and a non-sibling they avoid altogether the low egg viability associated with sibling matings. If similar effects occur in other species, inbreeding avoidance may be important in understanding the prevalence of multiple mating.	Univ Leeds, Sch Biol, Ecol & Evolut Grp, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Tregenza, T (corresponding author), Univ Leeds, Sch Biol, Ecol & Evolut Grp, Leeds LS2 9JT, W Yorkshire, England.	T.Tregenza@leeds.ac.uk	Tregenza, Tom/B-1078-2014	Tregenza, Tom/0000-0003-4182-2222				Andersson Malte, 1994; Arnqvist G, 2000, P NATL ACAD SCI USA, V97, P10460, DOI 10.1073/pnas.97.19.10460; DALY M, 1978, AM NAT, V112, P771, DOI 10.1086/283319; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Howard DJ, 1999, ANNU REV ECOL SYST, V30, P109, DOI 10.1146/annurev.ecolsys.30.1.109; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Keil A, 1998, ETHOLOGY, V104, P897; Lorenz MW, 1998, ARCH INSECT BIOCHEM, V38, P32, DOI 10.1002/(SICI)1520-6327(1998)38:1&lt;32::AID-ARCH4&gt;3.0.CO;2-X; MADSEN T, 1992, NATURE, V355, P440, DOI 10.1038/355440a0; Markow T.A., 1982, P273; Markow TA, 1997, P NATL ACAD SCI USA, V94, P7756, DOI 10.1073/pnas.94.15.7756; Newcomer SD, 1999, P NATL ACAD SCI USA, V96, P10236, DOI 10.1073/pnas.96.18.10236; Olsson M, 1996, J EVOLUTION BIOL, V9, P229, DOI 10.1046/j.1420-9101.1996.9020229.x; Olsson M, 1996, NATURE, V383, P585, DOI 10.1038/383585a0; OLSSON M, 1994, NATURE, V369, P528, DOI 10.1038/369528b0; Parker G.A., 1979, P123; QAYYUM H A, 1969, Pakistan Journal of Scientific Research, V21, P112; Simmons LW, 2001, J EVOLUTION BIOL, V14, P585, DOI 10.1046/j.1420-9101.2001.00309.x; SIMMONS LW, 1987, BEHAV ECOL SOCIOBIOL, V21, P197, DOI 10.1007/BF00303211; SIMMONS LW, 1989, ANIM BEHAV, V38, P68, DOI 10.1016/S0003-3472(89)80066-1; SIMMONS LW, 1986, ANIM BEHAV, V34, P1463, DOI 10.1016/S0003-3472(86)80217-2; SIMMONS LW, 1990, ANIM BEHAV, V40, P192, DOI 10.1016/S0003-3472(05)80683-9; SIMMONS LW, 1987, BEHAV ECOL SOCIOBIOL, V21, P313, DOI 10.1007/BF00299969; Stockley P, 1999, P ROY SOC B-BIOL SCI, V266, P1663, DOI 10.1098/rspb.1999.0829; Thornhill N.W., 1993, NATURAL HIST INBREED; Tregenza T, 1998, EVOLUTION, V52, P1726, DOI [10.1111/j.1558-5646.1998.tb02252.x, 10.2307/2411345]; Tregenza T, 1997, ANIM BEHAV, V54, P979, DOI 10.1006/anbe.1997.0500; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Zeh JA, 1997, P ROY SOC B-BIOL SCI, V264, P69, DOI 10.1098/rspb.1997.0010; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250	30	415	424	0	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2002	415	6867					71	73		10.1038/415071a	http://dx.doi.org/10.1038/415071a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780118	Green Accepted			2022-12-24	WOS:000173028800041
J	Shen, XH; Ellis, RE; Lee, K; Liu, CY; Yang, K; Solomon, A; Yoshida, H; Morimoto, R; Kurnit, DM; Mori, K; Kaufman, RJ				Shen, XH; Ellis, RE; Lee, K; Liu, CY; Yang, K; Solomon, A; Yoshida, H; Morimoto, R; Kurnit, DM; Mori, K; Kaufman, RJ			Complementary signaling pathways regulate the unfolded protein response and are required for C-elegans development	CELL			English	Article							ENDOPLASMIC-RETICULUM; MESSENGER-RNA; CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTOR; TRANSMEMBRANE PROTEIN; STRESS; KINASE; IRE1; ER; IDENTIFICATION	The unfolded protein response (UPR) is a transcriptional and translational intracellular signaling pathway activated by the accumulation of unfolded proteins in the lumen of the endoplasmic reticulum (ER). We have used C. elegans as a genetic model system to dissect UPR signaling in a multicellular organism. C. elegans requires ire-l-mediated splicing of xbp-1 mRNA for UPR gene transcription and survival upon ER stress. In addition, ire-1/xbp-1 acts with pek-1, a protein kinase that mediates translation attenuation, in complementary pathways that are essential for worm development and survival. We propose that UPR transcriptional activation by ire-1 as well as translational attenuation by pek-1 maintain ER homeostasis. The results demonstrate that the UPR and ER homeostasis are essential for metazoan development.	Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; Northwestern Univ, Rice Inst Biomed Res, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068304, Japan	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Northwestern University; Kyoto University	Kaufman, RJ (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.			Yoshida, Hiderou/0000-0002-5773-1408	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042394] Funding Source: NIH RePORTER; NIAID NIH HHS [5R01 AI-42394-04] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aridor M, 1999, NAT MED, V5, P745, DOI 10.1038/10466; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; BRENNER S, 1974, GENETICS, V77, P71; Chapman RE, 1997, CURR BIOL, V7, P850, DOI 10.1016/S0960-9822(06)00373-3; Chen PJ, 2000, DEV BIOL, V217, P77, DOI 10.1006/dbio.1999.9521; Clauss IM, 1996, NUCLEIC ACIDS RES, V24, P1855, DOI 10.1093/nar/24.10.1855; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hall DH, 1997, J NEUROSCI, V17, P1033; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Iwawaki T, 2001, NAT CELL BIOL, V3, P158, DOI 10.1038/35055065; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kawahara T, 1997, MOL BIOL CELL, V8, P1845, DOI 10.1091/mbc.8.10.1845; Kokame K, 2001, J BIOL CHEM, V276, P9199, DOI 10.1074/jbc.M010486200; KOLDIN B, 1995, NUCLEIC ACIDS RES, V23, P4162, DOI 10.1093/nar/23.20.4162; Kopito RR, 2000, NAT CELL BIOL, V2, pE207, DOI 10.1038/35041139; LEE K, 2002, IN PRESS GENES DEV; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; Masaki T, 1999, BIOCHEM BIOPH RES CO, V261, P350, DOI 10.1006/bbrc.1999.0972; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Mori K, 2000, P NATL ACAD SCI USA, V97, P4660, DOI 10.1073/pnas.050010197; MORI K, 1993, CELL, V74, P743; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; NIKAWA JI, 1992, MOL MICROBIOL, V6, P1441, DOI 10.1111/j.1365-2958.1992.tb00864.x; Reimold AM, 2000, GENE DEV, V14, P152; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schroder M, 2000, GENE DEV, V14, P2962, DOI 10.1101/gad.852300; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; SIGURDSON DC, 1984, GENETICS, V108, P331; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Urano F, 2000, J CELL SCI, V113, P3697; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wyllie A.H., 1981, CELL DEATH BIOL PATH, P9; Xu KL, 2001, NEURON, V31, P957, DOI 10.1016/S0896-6273(01)00432-9; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	53	524	552	0	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 28	2001	107	7					893	903		10.1016/S0092-8674(01)00612-2	http://dx.doi.org/10.1016/S0092-8674(01)00612-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779465	Bronze			2022-12-24	WOS:000173024200010
J	Washington, MT; Prakash, L; Prakash, S				Washington, MT; Prakash, L; Prakash, S			Yeast DNA polymerase eta utilizes an induced-fit mechanism of nucleotide incorporation	CELL			English	Article							PIGMENTOSUM VARIANT CELLS; THYMINE-THYMINE DIMER; XERODERMA-PIGMENTOSUM; KINETIC MECHANISM; I KLENOW; CRYSTAL-STRUCTURE; BASE-PAIRS; FIDELITY; REPLICATION; BYPASS	DNA polymerase eta (Pol eta) is unique among eukaryotic DNA polymerases in its proficient ability to replicate through distorting DNA lesions, and Pol eta synthesizes DNA with a low fidelity. Here, we use pre-steady-state kinetics to investigate the mechanism of nucleotide incorporation by Pol eta and show that it utilizes an induced-fit mechanism to selectively incorporate the correct nucleotide. Pol eta discriminates poorly between the correct and incorrect nucleotide at both the initial nucleotide binding step and at the subsequent induced-fit conformational change step, which precedes the chemical step of phosphodiester bond formation. This property enables Pol eta to bypass lesions with distorted DNA geometries, and it bestows upon the enzyme a low fidelity.	Univ Texas, Med Branch, Sealy Ctr Mol Sci, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Prakash, S (corresponding author), Univ Texas, Med Branch, Sealy Ctr Mol Sci, 6-104 Blocker Med Res Bldg,11th & Mech St, Galveston, TX 77555 USA.	sprakash@scms.utmb.edu	Prakash, Satya/C-6420-2013	Washington, Todd/0000-0001-8680-2992; Prakash, Satya/0000-0001-7228-1444; Prakash, Louise/0000-0001-9143-6261	NIGMS NIH HHS [GM 19261] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn J, 1997, BIOCHEMISTRY-US, V36, P1100, DOI 10.1021/bi961653o; ANDERSON KS, 1988, BIOCHEMISTRY-US, V27, P7395, DOI 10.1021/bi00419a034; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; Berg BJV, 2001, J BIOL CHEM, V276, P3408, DOI 10.1074/jbc.M002884200; CAPSON TL, 1992, BIOCHEMISTRY-US, V31, P10984, DOI 10.1021/bi00160a007; CIARROCCHI G, 1982, J MOL BIOL, V155, P177, DOI 10.1016/0022-2836(82)90445-4; CordeiroStone M, 1997, J BIOL CHEM, V272, P13945, DOI 10.1074/jbc.272.21.13945; DAHLBERG ME, 1991, BIOCHEMISTRY-US, V30, P4835, DOI 10.1021/bi00234a002; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Doublie S, 1998, CURR OPIN STRUC BIOL, V8, P704, DOI 10.1016/S0959-440X(98)80089-4; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; Einolf HJ, 2000, J BIOL CHEM, V275, P16316, DOI 10.1074/jbc.M001291200; FREY MW, 1995, BIOCHEMISTRY-US, V34, P9185, DOI 10.1021/bi00028a031; Haracska L, 2000, NAT GENET, V25, P458, DOI 10.1038/78169; Haracska L, 2001, J BIOL CHEM, V276, P6861, DOI 10.1074/jbc.M008021200; Haracska L, 2000, MOL CELL BIOL, V20, P8001, DOI 10.1128/MCB.20.21.8001-8007.2000; HERSCHLAG D, 1991, BIOCHEMISTRY-US, V30, P4844, DOI 10.1021/bi00234a003; HUSAIN I, 1988, P NATL ACAD SCI USA, V85, P2558, DOI 10.1073/pnas.85.8.2558; Johnson K. A., 1992, ENZYMES, V20, P1, DOI DOI 10.1016/S1874-6047(08)60019-0; Johnson KA, 1998, CURR OPIN BIOTECH, V9, P87, DOI 10.1016/S0958-1669(98)80089-X; JOHNSON KA, 1995, METHOD ENZYMOL, V249, P38; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; Johnson RE, 1999, J BIOL CHEM, V274, P15975, DOI 10.1074/jbc.274.23.15975; Johnson RE, 2001, MOL CELL BIOL, V21, P3558, DOI 10.1128/MCB.21.10.3558-3563.2001; KATI WM, 1992, J BIOL CHEM, V267, P25988; KEMMINK J, 1987, NUCLEIC ACIDS RES, V15, P4645, DOI 10.1093/nar/15.11.4645; KIM JK, 1995, PHOTOCHEM PHOTOBIOL, V62, P44, DOI 10.1111/j.1751-1097.1995.tb05236.x; KOUCHAKDJIAN M, 1991, BIOCHEMISTRY-US, V30, P1403, DOI 10.1021/bi00219a034; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; KUCHTA RD, 1988, BIOCHEMISTRY-US, V27, P6716, DOI 10.1021/bi00418a012; LEHMANN AR, 1975, P NATL ACAD SCI USA, V72, P219, DOI 10.1073/pnas.72.1.219; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; LIPSCOMB LA, 1995, P NATL ACAD SCI USA, V92, P719, DOI 10.1073/pnas.92.3.719; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; MCAULEYHECHT KE, 1994, BIOCHEMISTRY-US, V33, P10266, DOI 10.1021/bi00200a006; McDonald JP, 1997, GENETICS, V147, P1557; Minko IG, 2001, J BIOL CHEM, V276, P2517, DOI 10.1074/jbc.M007867200; MIZRAHI V, 1985, BIOCHEMISTRY-US, V24, P4010, DOI 10.1021/bi00336a031; ODA Y, 1991, NUCLEIC ACIDS RES, V19, P1407, DOI 10.1093/nar/19.7.1407; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; PETRUSKA J, 1988, P NATL ACAD SCI USA, V85, P6252, DOI 10.1073/pnas.85.17.6252; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; WANG YC, 1993, MOL CELL BIOL, V13, P4276, DOI 10.1128/MCB.13.7.4276; Washington MT, 2000, P NATL ACAD SCI USA, V97, P3094, DOI 10.1073/pnas.050491997; Washington MT, 1999, J BIOL CHEM, V274, P36835, DOI 10.1074/jbc.274.52.36835; WATERS HL, 1993, J INVEST DERMATOL, V101, P744, DOI 10.1111/1523-1747.ep12371686; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Yu SL, 2001, MOL CELL BIOL, V21, P185, DOI 10.1128/MCB.21.1.185-188.2001; Zhong XJ, 1997, BIOCHEMISTRY-US, V36, P11891, DOI 10.1021/bi963181j; Zhou BL, 2001, MOL CELL, V8, P427, DOI 10.1016/S1097-2765(01)00310-0	53	111	118	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2001	107	7					917	927		10.1016/S0092-8674(01)00613-4	http://dx.doi.org/10.1016/S0092-8674(01)00613-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779467	Bronze			2022-12-24	WOS:000173024200012
J	Lee, WH; Boyer, TG				Lee, WH; Boyer, TG			BRCA1 and BRCA2 in breast cancer	LANCET			English	Article									Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA	University of Texas System; University of Texas Health San Antonio	Lee, WH (corresponding author), Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Dept Mol Med, 15355 Lambda Dr, San Antonio, TX 78245 USA.								0	6	6	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2001				S			S5	S5		10.1016/S0140-6736(01)07018-0	http://dx.doi.org/10.1016/S0140-6736(01)07018-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505HK	11784554	Bronze			2022-12-24	WOS:000172907200005
J	Enninga, J; Levy, DE; Blobel, G; Fontoura, BMA				Enninga, J; Levy, DE; Blobel, G; Fontoura, BMA			Role of nucleoporin induction in releasing an mRNA nuclear export block	SCIENCE			English	Article							VESICULAR STOMATITIS-VIRUS; PORE COMPLEX; MATRIX PROTEIN; NUP98; BIOGENESIS; EXPRESSION; TRANSPORT; DOMAIN; SITE; RAN	Signal-mediated nuclear import and export proceed through the nuclear pore complex (NPC). Some NPC components, such as the nucleoporins (Nups) Nup98 and Nup96, are also associated with the nuclear interior. Nup98 is a target of the vesicular stomatitis virus (VSV) matrix (M) protein-mediated inhibition of messenger RNA (mRNA) nuclear export. Here, Nup98 and Nup96 were found to be up-regulated by interferon (IFN). M protein-mediated inhibition of mRNA nuclear export was reversed when cells were treated with IFN-gamma or transfected with a complementary DNA (cDNA) encoding Nup98 and Nup96. Thus, increased Nup98 and Nup96 expression constitutes an IFN-mediated mechanism that reverses M protein-mediated inhibition of gene expression.	Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, New York, NY 10021 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; NYU, Sch Med, Kaplan Comprehens Canc Ctr, New York, NY 10016 USA; Univ Miami, Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; Univ Miami, Sch Med, Sylvester Canc Ctr, Miami, FL 33136 USA	Howard Hughes Medical Institute; Rockefeller University; New York University; New York University; University of Miami; University of Miami	Blobel, G (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, New York, NY 10021 USA.		Levy, David/AAG-6202-2019; Levy, David/GPS-4945-2022	Levy, David/0000-0002-7320-7788; 	NIAID NIH HHS [AI28900, AI46503, AI48204] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028900, P01AI048204, R01AI046503] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahuja HG, 2001, GENE CHROMOSOME CANC, V30, P410, DOI 10.1002/1098-2264(2001)9999:9999<::AID-GCC1108>3.0.CO;2-9; Bachi A, 2000, RNA, V6, P136, DOI 10.1017/S1355838200991994; Bluyssen Hans A. R., 1996, Cytokine and Growth Factor Reviews, V7, P11, DOI 10.1016/1359-6101(96)00005-6; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; CHILAKAMARTI V, 2001, P NATL ACAD SCI USA, V98, P6674; Dasso M, 2001, CELL, V104, P321, DOI 10.1016/S0092-8674(01)00218-5; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; FIELDS BN, 1996, FUNDAMENTAL VIROLOGY, P561; Fontoura BMA, 2000, J BIOL CHEM, V275, P31289, DOI 10.1074/jbc.M004651200; Fontoura BMA, 1999, J CELL BIOL, V144, P1097, DOI 10.1083/jcb.144.6.1097; Fontoura BMA, 2001, P NATL ACAD SCI USA, V98, P3208, DOI 10.1073/pnas.061014698; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; Gustin KE, 2001, EMBO J, V20, P240, DOI 10.1093/emboj/20.1.240; Her LS, 1997, SCIENCE, V276, P1845, DOI 10.1126/science.276.5320.1845; Hofmann W, 2001, J CELL BIOL, V152, P895, DOI 10.1083/jcb.152.5.895; Kroon E, 2001, EMBO J, V20, P350, DOI 10.1093/emboj/20.3.350; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; Paulson M, 1999, J BIOL CHEM, V274, P25343, DOI 10.1074/jbc.274.36.25343; Petersen JM, 2001, P NATL ACAD SCI USA, V98, P8590, DOI 10.1073/pnas.151240998; Powers MA, 1997, J CELL BIOL, V136, P241, DOI 10.1083/jcb.136.2.241; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; Rosenblum JS, 1999, P NATL ACAD SCI USA, V96, P11370, DOI 10.1073/pnas.96.20.11370; Tan W, 2000, RNA, V6, P1762, DOI 10.1017/S1355838200000832; von Kobbe C, 2000, MOL CELL, V6, P1243, DOI 10.1016/S1097-2765(00)00120-9; Wu XS, 2001, P NATL ACAD SCI USA, V98, P3191, DOI 10.1073/pnas.051631598; YANG SD, 1995, MOL IMMUNOL, V32, P733, DOI 10.1016/0161-5890(95)00035-D	27	131	141	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2002	295	5559					1523	1525		10.1126/science.1067861	http://dx.doi.org/10.1126/science.1067861			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11809937				2022-12-24	WOS:000173981300053
J	Ge, BX; Gram, H; Di Padova, F; Huang, B; New, L; Ulevitch, RJ; Luo, Y; Han, JH				Ge, BX; Gram, H; Di Padova, F; Huang, B; New, L; Ulevitch, RJ; Luo, Y; Han, JH			MAPKK-independent activation of p38 alpha mediated by TAB1-dependent autophosphorylation of p38 alpha	SCIENCE			English	Article							PROTEIN-KINASE; SIGNAL-TRANSDUCTION; P38; TAK1; APOPTOSIS; PATHWAYS; TYROSINE; INVITRO; CELLS	Phosphorylation of mitogen-activated protein kinases (MAPKs) on specific tyrosine and threonine sites by MAP kinase kinases (MAPKKs) is thought to be the sole activation mechanism. Here, we report an unexpected activation mechanism for p38alpha MAPK that does not involve the prototypic kinase cascade. Rather it depends on interaction of p38alpha with TAB1 [transforming growth factor-beta-activated protein kinase 1 (TAK1)-binding protein 1] leading to autophosphorylation and activation of p38alpha. We detected formation of a TRAF6-TAB1-p38alpha complex and showed stimulus-specific TAB1-dependent and TAB1-independent p38alpha activation. These findings suggest that alternative activation pathways contribute to the biological responses of p38alpha to various stimuli.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Novartis Pharma AG, CH-4002 Basel, Switzerland; Rigel Inc, San Francisco, CA 94080 USA; Shanghai Genom Inc, Shanghai, Peoples R China	Scripps Research Institute; Novartis	Han, JH (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Ulevitch, Richard J/Q-3393-2017; Han, J/G-4671-2010		NHLBI NIH HHS [HL07195] Funding Source: Medline; NIAID NIH HHS [AI41637] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041637] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BLUMER KJ, 1994, TRENDS BIOCHEM SCI, V19, P263; Cuenda A, 1996, EMBO J, V15, P4156, DOI 10.1002/j.1460-2075.1996.tb00790.x; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Frantz B, 1998, BIOCHEMISTRY-US, V37, P13846, DOI 10.1021/bi980832y; Galan A, 2000, J BIOL CHEM, V275, P11418, DOI 10.1074/jbc.275.15.11418; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; HER JH, 1993, BIOCHEM J, V296, P25, DOI 10.1042/bj2960025; Imler JL, 2001, TRENDS CELL BIOL, V11, P304, DOI 10.1016/S0962-8924(01)02004-9; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; Matsuguchi T, 2000, J IMMUNOL, V165, P5767, DOI 10.4049/jimmunol.165.10.5767; MORGUCHI T, 1996, J BIOL CHEM, V271, P26981; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; ROSSOMANDO AJ, 1992, P NATL ACAD SCI USA, V89, P5779, DOI 10.1073/pnas.89.13.5779; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; WU J, 1991, P NATL ACAD SCI USA, V88, P9508, DOI 10.1073/pnas.88.21.9508; Zhuang SG, 2000, J BIOL CHEM, V275, P25939, DOI 10.1074/jbc.M001185200	21	410	445	3	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1291	1294		10.1126/science.1067289	http://dx.doi.org/10.1126/science.1067289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847341				2022-12-24	WOS:000173926000043
J	Seshadri, S; Beiser, A; Selhub, J; Jacques, PF; Rosenberg, IH; D'Agostino, RB; Wilson, PWF; Wolf, PA				Seshadri, S; Beiser, A; Selhub, J; Jacques, PF; Rosenberg, IH; D'Agostino, RB; Wilson, PWF; Wolf, PA			Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							APOLIPOPROTEIN-E; CARDIOVASCULAR-DISEASE; COGNITIVE PERFORMANCE; COBALAMIN DEFICIENCY; UNITED-STATES; POPULATION; SERUM; FOLATE; VITAMIN-B12; ROTTERDAM	Background: In cross-sectional studies, elevated plasma homocysteine levels have been associated with poor cognition and dementia. Studies of newly diagnosed dementia are required in order to establish whether the elevated homocysteine levels precede the onset of dementia or result from dementia-related nutritional and vitamin deficiencies. Methods: A total of 1092 subjects without dementia (667 women and 425 men; mean age, 76 years) from the Framingham Study constituted our study sample. We examined the relation of the plasma total homocysteine level measured at base line and that measured eight years earlier to the risk of newly diagnosed dementia on follow-up. We used multivariable proportional-hazards regression to adjust for age, sex, apolipoprotein E genotype, vascular risk factors other than homocysteine, and plasma levels of folate and vitamins B(sub 12) and B(sub 6). Results: Over a median follow-up period of eight years, dementia developed in 111 subjects, including 83 given a diagnosis of Alzheimer's disease. The multivariable-adjusted relative risk of dementia was 1.4 (95 percent confidence interval, 1.1 to 1.9) for each increase of 1 SD in the log-transformed homocysteine value either at base line or eight years earlier. The relative risk of Alzheimer's disease was 1.8 (95 percent confidence interval, 1.3 to 2.5) per increase of 1 SD at base line and 1.6 (95 percent confidence interval, 1.2 to 2.1) per increase of 1 SD eight years before base line. With a plasma homocysteine level greater than 14 micromol per liter, the risk of Alzheimer's disease nearly doubled. Conclusions: An increased plasma homocysteine level is a strong, independent risk factor for the development of dementia and Alzheimer's disease. (N Engl J Med 2002;346:476-83.) Copyright (C) 2002 Massachusetts Medical Society.	Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Boston, MA USA; Tufts Univ, Human Nutr Res Ctr Aging, Jean Mayer US Dept Agr, Boston, MA 02111 USA; Boston Univ, Dept Math & Stat, Boston, MA 02215 USA	Boston University; Boston University; Boston University; Tufts University; United States Department of Agriculture (USDA); Boston University	Wolf, PA (corresponding author), Boston Univ, Sch Med, Dept Neurol Neurol Epidemiol & Genet, 715 Albany St,B-608, Boston, MA 02118 USA.		Wilson, Peter W.F./J-2455-2016; Friedland, Robert/A-2834-2010	Friedland, Robert/0000-0001-5721-1843; Seshadri, Sudha/0000-0001-6135-2622; Beiser, Alexa/0000-0001-8551-7778; Wolf, Philip/0000-0002-3628-301X	NHLBI NIH HHS [N01-HC-38038] Funding Source: Medline; NIA NIH HHS [5R01-AG16495-02, 5R01-AG08122-11] Funding Source: Medline; NINDS NIH HHS [R01 NS017950, 5R01-NS17950-19] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC038038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008122, R01AG016495] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		American Psychiatric Association, 1994, DIAGN STAT MAN MENT, P143; ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; BACHMAN DL, 1993, NEUROLOGY, V43, P515, DOI 10.1212/WNL.43.3_Part_1.515; BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; BELL IR, 1992, ACTA PSYCHIAT SCAND, V86, P386, DOI 10.1111/j.1600-0447.1992.tb03285.x; BERG L, 1988, PSYCHOPHARMACOL BULL, V24, P637; Bostom AG, 1999, ANN INTERN MED, V131, P352, DOI 10.7326/0003-4819-131-5-199909070-00006; Bostom AG, 1999, ARCH INTERN MED, V159, P1077, DOI 10.1001/archinte.159.10.1077; Bots ML, 1997, J INTERN MED, V242, P339, DOI 10.1046/j.1365-2796.1997.00239.x; Brattstrom L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894; Breteler MMB, 2000, NEUROBIOL AGING, V21, P153, DOI 10.1016/S0197-4580(99)00110-4; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Chao CL, 2000, CIRCULATION, V101, P485, DOI 10.1161/01.CIR.101.5.485; Clarke R, 1998, ARCH NEUROL-CHICAGO, V55, P1449, DOI 10.1001/archneur.55.11.1449; COLE MG, 1984, AGE AGEING, V13, P101, DOI 10.1093/ageing/13.2.101; Cox D. R., 1984, ANAL SURVIVAL DATA; Diaz-Arrastia R, 1998, ARCH NEUROL-CHICAGO, V55, P1407, DOI 10.1001/archneur.55.11.1407; Elias PK, 1999, AM J EPIDEMIOL, V150, P580; Fassbender K, 1999, LANCET, V353, P1586; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Food and Drug Administration, 1996, FED REGISTER, V61, P8781; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; HORNE DW, 1988, CLIN CHEM, V34, P2357; IKEDA T, 1990, ACTA PSYCHIAT SCAND, V82, P327, DOI 10.1111/j.1600-0447.1990.tb01395.x; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Kalmijn S, 1999, AM J EPIDEMIOL, V150, P283, DOI 10.1093/oxfordjournals.aje.a010000; KARNAZE DS, 1987, ARCH INTERN MED, V147, P429, DOI 10.1001/archinte.147.3.429; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; Lehmann M, 1999, DEMENT GERIATR COGN, V10, P12, DOI 10.1159/000017092; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; LEVITT AJ, 1992, ACTA PSYCHIAT SCAND, V86, P301, DOI 10.1111/j.1600-0447.1992.tb03270.x; LINDENBAUM J, 1988, NEW ENGL J MED, V318, P1720, DOI 10.1056/NEJM198806303182604; Lipton SA, 1997, P NATL ACAD SCI USA, V94, P5923, DOI 10.1073/pnas.94.11.5923; McCaddon A, 1998, INT J GERIATR PSYCH, V13, P235, DOI 10.1002/(SICI)1099-1166(199804)13:4<235::AID-GPS761>3.0.CO;2-8; McCann SM, 1997, EXP GERONTOL, V32, P431, DOI 10.1016/S0531-5565(96)00154-4; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Morris MS, 2001, AM J CLIN NUTR, V73, P927; Myers RH, 1996, NEUROLOGY, V46, P673, DOI 10.1212/WNL.46.3.673; Nilsson K, 1996, EUR J CLIN INVEST, V26, P853, DOI 10.1111/j.1365-2362.1996.tb02129.x; ORDOVAS JM, 1987, J LIPID RES, V28, P371; Perry DJ, 1999, BEST PRACT RES CL HA, V12, P451, DOI 10.1053/beha.1999.0036; PERRY IJ, 1995, LANCET, V346, P1395, DOI 10.1016/S0140-6736(95)92407-8; Rasmussen K, 1996, CLIN CHEM, V42, P630; Riggs KM, 1996, AM J CLIN NUTR, V63, P306, DOI 10.1093/ajcn/63.3.306; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; SELHUB J, 1995, NEW ENGL J MED, V332, P286, DOI 10.1056/NEJM199502023320502; Seshadri S, 1997, NEUROLOGY, V49, P1498, DOI 10.1212/WNL.49.6.1498; SHIN YS, 1983, CLIN CHIM ACTA, V127, P77, DOI 10.1016/0009-8981(83)90077-3; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; STAMPFER MJ, 1992, JAMA-J AM MED ASSOC, V268, P877, DOI 10.1001/jama.268.7.877; STARKEBAUM G, 1986, J CLIN INVEST, V77, P1370, DOI 10.1172/JCI112442; Wald DS, 2001, ARCH INTERN MED, V161, P695, DOI 10.1001/archinte.161.5.695; Wang HX, 2001, NEUROLOGY, V56, P1188, DOI 10.1212/WNL.56.9.1188; Welch GN, 1998, NEW ENGL J MED, V338, P1042, DOI 10.1056/NEJM199804093381507; Welty FK, 1998, ARTERIOSCL THROM VAS, V18, P1745, DOI 10.1161/01.ATV.18.11.1745; White AR, 2001, J NEUROCHEM, V76, P1509, DOI 10.1046/j.1471-4159.2001.00178.x	56	2553	2678	2	280	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2002	346	7					476	483		10.1056/NEJMoa011613	http://dx.doi.org/10.1056/NEJMoa011613			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521AE	11844848				2022-12-24	WOS:000173815300003
J	Liu, YF; Xu, LG; Opalka, N; Kappler, J; Shu, HB; Zhang, GY				Liu, YF; Xu, LG; Opalka, N; Kappler, J; Shu, HB; Zhang, GY			Crystal structure of sTALL-1 reveals a virus-like assembly of TNF family ligands	CELL			English	Article							NECROSIS-FACTOR FAMILY; B-CELL MATURATION; AUTOIMMUNE-DISEASE; FACTOR-ALPHA; RECEPTOR; PROTEIN; BAFF; MEMBER; TACI; BCMA	TALL-1/BAFF/BLyS was recently identified as a member of the tumor necrosis factor (TNF) ligand family. The crystal structure of the functional soluble TALL-1 (sTALL-1) has been determined at 3.0 Angstrom. sTALL-1 forms a virus-like assembly with 200 Angstrom diameter in the crystals, containing 60 sTALL-1 monomers. The cluster formation is mediated by a "flap" region of the sTALL-1 monomer. The virus-like assembly was also detected in solution using gel filtration and electron microscopy. Deletion of the flap region disrupted the formation of the virus-like assembly. The mutant sTALL-1 still bound its receptor but could not activate NF-kappaB and did not stimulate B lymphocyte proliferation. Finally, we found the virus-like cluster of sTALL-1 exists in physiological condition. We propose that this virus-like assembly of sTALL-1 is the functional unit for TALL-1 in vivo.	Univ Colorado, Hlth Sci Ctr, Natl Jewish Med & Res Ctr, Integrated Dept Immunol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Ctr Canc, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Sch Med, Howard Hughes Med Inst, Denver, CO 80206 USA; Rockefeller Univ, New York, NY 10021 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Rockefeller University	Zhang, GY (corresponding author), Univ Colorado, Hlth Sci Ctr, Natl Jewish Med & Res Ctr, Integrated Dept Immunol, 1400 Jackson St, Denver, CO 80206 USA.	zhangg@njc.org		Xu, Liangguo/0000-0003-1991-2889	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065341] Funding Source: NIH RePORTER; NIAID NIH HHS [AI49992] Funding Source: Medline; NIGMS NIH HHS [GM65341] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bodmer JL, 2000, J BIOL CHEM, V275, P20632, DOI 10.1074/jbc.M909721199; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Cha SS, 1999, IMMUNITY, V11, P253, DOI 10.1016/S1074-7613(00)80100-4; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; CORTI A, 1992, BIOCHEM J, V284, P905, DOI 10.1042/bj2840905; ECK MJ, 1992, J BIOL CHEM, V267, P2119; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Fesik SW, 2000, CELL, V103, P273, DOI 10.1016/S0092-8674(00)00119-7; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; JONES EY, 1989, NATURE, V338, P225, DOI 10.1038/338225a0; JONES TA, 1984, J MOL BIOL, V177, P735, DOI 10.1016/0022-2836(84)90047-0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanakaraj P, 2001, CYTOKINE, V13, P25, DOI 10.1006/cyto.2000.0793; KARPUSAS M, 1995, STRUCTURE, V3, P1031, DOI 10.1016/S0969-2126(01)00239-8; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mongkolsapaya J, 1999, NAT STRUCT BIOL, V6, P1048; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Mukhopadhyay A, 1999, J BIOL CHEM, V274, P15978, DOI 10.1074/jbc.274.23.15978; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Shu HB, 2000, P NATL ACAD SCI USA, V97, P9156, DOI 10.1073/pnas.160213497; Shu HB, 1999, J LEUKOCYTE BIOL, V65, P680, DOI 10.1002/jlb.65.5.680; Siegel RM, 2000, NAT IMMUNOL, V1, P469, DOI 10.1038/82712; TERWILLIGER TC, 1987, ACTA CRYSTALLOGR A, V43, P34; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137; Xu SL, 2001, MOL CELL BIOL, V21, P4067, DOI 10.1128/MCB.21.12.4067-4074.2001; Yan MH, 2000, NAT IMMUNOL, V1, P37, DOI 10.1038/76889; Yan MH, 2001, CURR BIOL, V11, P1547, DOI 10.1016/S0960-9822(01)00481-X; Yu G, 2000, NAT IMMUNOL, V1, P252, DOI 10.1038/79802	45	161	196	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2002	108	3					383	394		10.1016/S0092-8674(02)00631-1	http://dx.doi.org/10.1016/S0092-8674(02)00631-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	520VB	11853672	Bronze			2022-12-24	WOS:000173801600010
J	Watanabe, N; Mitchison, TJ				Watanabe, N; Mitchison, TJ			Single-molecule speckle analysis of Aactin filament turnover in lamellipodia	SCIENCE			English	Article							ACTIN POLYMERIZATION; ARP2/3 COMPLEX; LEADING-EDGE; BARBED ENDS; CELLS; DYNAMICS; FIBROBLASTS; JASPLAKINOLIDE; MICROTUBULES; ADF/COFILIN	Lamellipodia are thin, veil-like extensions at the edge of cells that contain a dynamic array of actin filaments. We describe an approach for analyzing spatial regulation of actin polymerization and depolymerization in vivo in which we tracked single molecules of actin fused to the green fluorescent protein. Polymerization and the lifetime of actin filaments in lamellipodia were measured with high spatial precision. Basal polymerization and depolymerization occurred throughout lamellipodia with largely constant kinetics, and polymerization was promoted within one micron of the lamellipodium tip. Most of the actin filaments in the lamellipodium were generated by polymerization away from the tip.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Inst Chem & Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Watanabe, N (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.				NIGMS NIH HHS [GM48027] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham VC, 1999, BIOPHYS J, V77, P1721, DOI 10.1016/S0006-3495(99)77018-9; Bailly M, 1999, J CELL BIOL, V145, P331, DOI 10.1083/jcb.145.2.331; Ballestrem C, 1998, J CELL SCI, V111, P1649; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Blanchoin L, 2000, CURR BIOL, V10, P1273, DOI 10.1016/S0960-9822(00)00749-1; BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Chan AY, 2000, J CELL BIOL, V148, P531, DOI 10.1083/jcb.148.3.531; Cramer LP, 1999, CURR BIOL, V9, P1095, DOI 10.1016/S0960-9822(99)80478-3; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Hahne P, 2001, FEBS LETT, V492, P215, DOI 10.1016/S0014-5793(01)02239-6; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; HITCHCOCKDEGREG.SE, 1988, BIOCHEMISTRY-US, V27, P9183; Hotchin NA, 1995, J CELL BIOL, V131, P1857, DOI 10.1083/jcb.131.6.1857; Kwiatkowski DJ, 1999, CURR OPIN CELL BIOL, V11, P103, DOI 10.1016/S0955-0674(99)80012-X; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; McGrath JL, 1998, BIOPHYS J, V75, P2070, DOI 10.1016/S0006-3495(98)77649-0; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nakagawa H, 2001, J CELL SCI, V114, P1555; OKABE S, 1989, J CELL BIOL, V109, P1581, DOI 10.1083/jcb.109.4.1581; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; PESKIN CS, 1993, BIOPHYS J, V65, P316, DOI 10.1016/S0006-3495(93)81035-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; SYMONS MH, 1991, J CELL BIOL, V114, P503, DOI 10.1083/jcb.114.3.503; Tardy Y, 1995, BIOPHYS J, V69, P1674, DOI 10.1016/S0006-3495(95)80085-8; THERIOT JA, 1992, J CELL BIOL, V119, P367, DOI 10.1083/jcb.119.2.367; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; Waterman-Storer CM, 1998, BIOPHYS J, V75, P2059, DOI 10.1016/S0006-3495(98)77648-9; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417	31	350	354	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1083	1086		10.1126/science.1067470	http://dx.doi.org/10.1126/science.1067470			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834838				2022-12-24	WOS:000173793000069
J	Cibelli, JB; Grant, KA; Chapman, KB; Cunniff, K; Worst, T; Green, HL; Walker, SJ; Gutin, PH; Vilner, L; Tabar, V; Dominko, T; Kane, J; Wettstein, PJ; Lanza, RP; Studer, L; Vrana, KE; West, MD				Cibelli, JB; Grant, KA; Chapman, KB; Cunniff, K; Worst, T; Green, HL; Walker, SJ; Gutin, PH; Vilner, L; Tabar, V; Dominko, T; Kane, J; Wettstein, PJ; Lanza, RP; Studer, L; Vrana, KE; West, MD			Development - Parthenogenetic stem cells in nonhuman primates	SCIENCE			English	Article							EMBRYOS		Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA; Adv Cell Technol, Worcester, MA 01605 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA	Wake Forest University; Wake Forest Baptist Medical Center; Memorial Sloan Kettering Cancer Center; Mayo Clinic	Grant, KA (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.		Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987; West, Michael/0000-0002-4842-5468; Vrana, Kent/0000-0003-4902-7733; Lanza, Robert/0000-0002-3047-3074; Cibelli, Jose/0000-0002-2176-3854	NIAAA NIH HHS [T32-AA07565, P50-AA11997] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011997, T32AA007565] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Boediono A, 1999, MOL REPROD DEV, V53, P159, DOI 10.1002/(SICI)1098-2795(199906)53:2&lt;159::AID-MRD5&gt;3.0.CO;2-X; Carroll J, 2001, SEMIN CELL DEV BIOL, V12, P37, DOI 10.1006/scdb.2000.0215; FUKUI Y, 1992, MOL REPROD DEV, V33, P357, DOI 10.1002/mrd.1080330318; KAUFMAN MH, 1977, NATURE, V265, P53, DOI 10.1038/265053a0; Lanza RP, 1999, NAT BIOTECHNOL, V17, P1171, DOI 10.1038/70709; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Mitalipov SM, 2001, BIOL REPROD, V65, P253, DOI 10.1095/biolreprod65.1.253	8	240	270	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					819	819		10.1126/science.1065637	http://dx.doi.org/10.1126/science.1065637			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823632				2022-12-24	WOS:000173733000034
J	Hua, W; Chung, J; Gelles, J				Hua, W; Chung, J; Gelles, J			Distinguishing inchworm and hand-over-hand processive kinesin movement by neck rotation measurements	SCIENCE			English	Article							STIMULATED ATP HYDROLYSIS; DIMERIC KINESIN; MICROTUBULE MOVEMENT; HEADED KINESIN; MOTOR; DERIVATIVES; MOLECULES; MECHANISM; BINDING; KIF1A	The motor enzyme kinesin makes hundreds of unidirectional 8-nanometer steps without detaching from or freely sliding along the microtubule on which it moves. We investigated the kinesin stepping mechanism by immobilizing a Drosophila kinesin derivative through the carboxyl-terminal end of the neck coiled-coil domain and measuring orientations of microtubules moved by single enzyme molecules at submicromolar adenosine triphosphate concentrations. The kinesin-mediated microtubule-surface linkage was sufficiently torsionally stiff (greater than or equal to2.0+/-0.9 x 10(-20) Newton meters per radian(2)) that stepping by the hypothesized symmetric hand-over-hand mechanism would produce 180degrees rotations of the microtubule relative to the immobilized kinesin neck. In fact, there were no rotations, a finding that is inconsistent with symmetric hand-over-hand movement, An alternative "inch-worm" mechanism is consistent with our experimental results.	Brandeis Univ, Biophys & Struct Biol Program, Waltham, MA 02454 USA; Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Gelles, J (corresponding author), Brandeis Univ, Biophys & Struct Biol Program, Waltham, MA 02454 USA.							BERLINER E, 1995, NATURE, V373, P718, DOI 10.1038/373718a0; BERLINER E, 1994, J BIOL CHEM, V269, P8610; BLOCK SM, 1995, BIOPHYS J, V68, P23055; Chung J.-H., UNPUB; CROSS RA, 1995, J MUSCLE RES CELL M, V16, P91, DOI 10.1007/BF00122526; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; HACKNEY DD, 1995, NATURE, V377, P448, DOI 10.1038/377448a0; Hancock WO, 1998, J CELL BIOL, V140, P1395, DOI 10.1083/jcb.140.6.1395; Hoenger A, 2000, J MOL BIOL, V297, P1087, DOI 10.1006/jmbi.2000.3627; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Howard J, 1997, NATURE, V389, P561, DOI 10.1038/39247; Howard J, 1996, ANNU REV PHYSIOL, V58, P703, DOI 10.1146/annurev.ph.58.030196.003415; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; Hua W, UNPUB; HUNT AJ, 1993, P NATL ACAD SCI USA, V90, P11653, DOI 10.1073/pnas.90.24.11653; Inoue Y, 2001, BIOPHYS J, V81, P2838, DOI 10.1016/S0006-3495(01)75925-5; Kikkawa M, 2000, CELL, V100, P241, DOI 10.1016/S0092-8674(00)81562-7; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; SCHNAPP BJ, 1990, P NATL ACAD SCI USA, V87, P10053, DOI 10.1073/pnas.87.24.10053; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; WONG I, 1992, SCIENCE, V256, P350, DOI 10.1126/science.256.5055.350; Young EC, 1998, BIOCHEMISTRY-US, V37, P3467, DOI 10.1021/bi972172n; YOUNG EC, 1995, J BIOL CHEM, V270, P3926, DOI 10.1074/jbc.270.8.3926	31	165	170	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					844	848		10.1126/science.1063089	http://dx.doi.org/10.1126/science.1063089			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823639				2022-12-24	WOS:000173733000042
J	Seemann, J; Pypaert, M; Taguchi, T; Malsam, J; Warren, G				Seemann, J; Pypaert, M; Taguchi, T; Malsam, J; Warren, G			Partitioning of the matrix fraction of the Golgi apparatus during mitosis in animal cells	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; HELA-CELLS; IN-VIVO; TRANSPORT; PROTEIN; COMPLEX; GM130; DYNAMICS; PATHWAY; REVEALS	The Golgi apparatus is partitioned during mitosis in animal cells by a process of fragmentation, dispersal, and reassembly in each daughter cell. We fractionated the Golgi apparatus in vivo using the drug brefeldin A or a dominant-negative mutant of the Sar1p protein. After these treatments, Golgi enzymes moved back to the endoplasmic reticulum, leaving behind a matrix of Golgi structural proteins. Under these conditions, cells still entered and exited mitosis normally, and their Golgi matrix partitioned in a manner very similar to that of the complete organelle. Thus, the matrix may be the partitioning unit of the Golgi apparatus and may carry the Golgi enzyme-containing membranes into the daughter cells.	Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Cell Biol, New Haven, CT 06520 USA	Ludwig Institute for Cancer Research; Yale University	Warren, G (corresponding author), Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Cell Biol, 333 Cedar St,POB 208002, New Haven, CT 06520 USA.		Taguchi, Tomohiko/I-5014-2019	Taguchi, Tomohiko/0000-0003-0464-6370				BALCH WE, 1985, ARCH BIOCHEM BIOPHYS, V240, P413, DOI 10.1016/0003-9861(85)90046-3; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; Hammond AT, 2000, MOL BIOL CELL, V11, P3013, DOI 10.1091/mbc.11.9.3013; Jesch SA, 1998, MOL BIOL CELL, V9, P623, DOI 10.1091/mbc.9.3.623; Jesch SA, 2001, TRAFFIC, V2, P873, DOI 10.1034/j.1600-0854.2001.21203.x; Jokitalo E, 2001, J CELL BIOL, V154, P317, DOI 10.1083/jcb.200104073; Lowe M, 2000, J CELL BIOL, V149, P341, DOI 10.1083/jcb.149.2.341; LUCOCQ JM, 1989, J CELL BIOL, V109, P463, DOI 10.1083/jcb.109.2.463; Marra P, 2001, NAT CELL BIOL, V3, P1101, DOI 10.1038/ncb1201-1101; Miles S, 2001, J CELL BIOL, V155, P543, DOI 10.1083/jcb.200103104; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Pelletier L, 2000, NAT CELL BIOL, V2, P840, DOI 10.1038/35041089; PEPPERKOK R, 1993, CELL, V74, P71, DOI 10.1016/0092-8674(93)90295-2; Pfeffer SR, 2001, J CELL BIOL, V155, P873, DOI 10.1083/jcb.200109095; Prescott AR, 2001, TRAFFIC, V2, P321, DOI 10.1034/j.1600-0854.2001.002005321.x; RABOUILLE C, 1995, J CELL SCI, V108, P1617; Rossanese OW, 2001, J CELL BIOL, V153, P47, DOI 10.1083/jcb.153.1.47; ROWE T, 1995, METHOD ENZYMOL, V257, P49; Seemann J, 2000, NATURE, V407, P1022, DOI 10.1038/35039538; Seemann J, 2000, MOL BIOL CELL, V11, P635, DOI 10.1091/mbc.11.2.635; Shima DT, 1998, J CELL BIOL, V141, P955, DOI 10.1083/jcb.141.4.955; Storrie B, 1998, J CELL BIOL, V143, P1505, DOI 10.1083/jcb.143.6.1505; Terasaki M, 2000, MOL BIOL CELL, V11, P897, DOI 10.1091/mbc.11.3.897; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Yoshimura S, 2001, J CELL SCI, V114, P4105; Zaal KJM, 1999, CELL, V99, P589, DOI 10.1016/S0092-8674(00)81548-2	27	103	108	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					848	851		10.1126/science.1068064	http://dx.doi.org/10.1126/science.1068064			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823640				2022-12-24	WOS:000173733000043
J	Kanamaru, S; Leiman, PG; Kostyuchenko, VA; Chipman, PR; Mesyanzhinov, VV; Arisaka, F; Rossmann, MG				Kanamaru, S; Leiman, PG; Kostyuchenko, VA; Chipman, PR; Mesyanzhinov, VV; Arisaka, F; Rossmann, MG			Structure of the cell-puncturing device of bacteriophage T4	NATURE			English	Article							TAIL LYSOZYME; BASEPLATE; PROGRAM; PROTEIN	Bacteriophage T4 has a very efficient mechanism for infecting cells(1). The key component of this process is the baseplate, located at the end of the phage tail, which regulates the interaction of the tail fibres and the DNA ejection machine(2). A complex of gene product (gp) 5 (63K) and gp27 (44K), the central part of the baseplate, is required to penetrate the outer cell membrane of Escherichia coli and to disrupt the intermembrane peptidoglycan layer, promoting subsequent entry of phage DNA into the host. We present here a crystal structure of the (gp5-gp27)(3) 321K complex, determined to 2.9 Angstrom resolution and fitted into a cryoelectron microscopy map at 17 Angstrom resolution of the baseplate-tail tube assembly. The carboxy-terminal domain of gp5 is a triple-stranded beta-helix that forms an equilateral triangular prism, which acts as a membrane-puncturing needle. The middle lysozyme domain of gp5, situated on the periphery of the prism, serves to digest the peptidoglycan layer. The amino-terminal, antiparallel beta-barrel domain of gp5 is inserted into a cylinder formed by three gp27 monomers, which may serve as a channel for DNA ejection.	Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Shemyakin Ovchinnikov Inst Bioorgan Chem, Lab Mol Bioengn, Moscow, Russia; Tokyo Inst Technol, Fac Biosci & Biotechnol, Dept Life Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Tokyo Institute of Technology	Rossmann, MG (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	mgr@indiana.bio.purdue.edu	Kanamaru, Shuji/R-4049-2017; Leiman, Petr G/E-5120-2010	Kanamaru, Shuji/0000-0002-2765-531X; Leiman, Petr G/0000-0002-9091-0918; Chipman, Paul/0000-0003-3652-4087; Kostyuchenko, Victor/0000-0001-9751-307X				BOVA R, 1990, NUCLEIC ACIDS RES, V18, P3046, DOI 10.1093/nar/18.10.3046; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Coombs D, 1994, MOL BIOL BACTERIOPHA, P259; EISERLING FA, 1994, MOL BIOL BACTERIOP T, V4, P209; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Goldberg Edward, 1994, P347; Kanamaru S, 1999, J BACTERIOL, V181, P2739, DOI 10.1128/JB.181.9.2739-2744.1999; KIKUCHI Y, 1975, J MOL BIOL, V99, P695, DOI 10.1016/S0022-2836(75)80180-X; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUROKI R, 1993, SCIENCE, V262, P2030, DOI 10.1126/science.8266098; MATTHEWS BW, 1974, P NATL ACAD SCI USA, V71, P4178, DOI 10.1073/pnas.71.10.4178; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MOSIG G, 1989, New Biologist, V1, P171; MURZIN AG, 1992, CURR OPIN STRUC BIOL, V2, P895; NAKAGAWA H, 1985, J VIROL, V54, P460, DOI 10.1128/JVI.54.2.460-466.1985; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Seckler R, 1998, J STRUCT BIOL, V122, P216, DOI 10.1006/jsbi.1998.3974; SHELDRICK GM, 2001, INT TABLES CRYSTALLO, VF, P734; STEINBACHER S, 1994, SCIENCE, V265, P383, DOI 10.1126/science.8023158; Takeda S, 1998, BBA-PROTEIN STRUCT M, V1384, P243, DOI 10.1016/S0167-4838(98)00016-8; van Raaij MJ, 1999, NATURE, V401, P935, DOI 10.1038/44880; VANDERSLICE RW, 1974, VIROLOGY, V60, P265, DOI 10.1016/0042-6822(74)90384-5	23	299	307	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2002	415	6871					553	557		10.1038/415553a	http://dx.doi.org/10.1038/415553a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823865				2022-12-24	WOS:000173564300053
J	Bahn, S; Mimmack, M; Ryan, M; Caldwell, MA; Jaunlaux, E; Starkey, M; Svendsen, CN; Emson, P				Bahn, S; Mimmack, M; Ryan, M; Caldwell, MA; Jaunlaux, E; Starkey, M; Svendsen, CN; Emson, P			Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study	LANCET			English	Article							GROWTH-ASSOCIATED PROTEIN; ALZHEIMERS-DISEASE; PRECURSOR CELLS; SYNAPSIN I; SCG10; MICE; L1; REPRESSOR; SYSTEM; GAP-43	Background Identification of genes and characterisation of their function is an essential step towards understanding complex pathophysiological abnormalities in Down's syndrome. We did a study to investigate abnormalities in gene expression in human neuronal stem cells and progenitor cells from Down's syndrome and control post-mortem human fetal tissue. Methods Indexing-based differential display PCR was done on neuronal precursor cells derived from the cortex of a fetus with Down's syndrome, and findings were compared with those of two control samples. Findings were validated against neurosphere preparations from three independent Down's syndrome fetuses and five independent controls by real-time quantitative PCR. Findings Results of differential display PCR analysis showed that SCG10-a neuron-specific growth-associated protein regulated by the neuron-restrictive silencer factor REST-was almost undetectable in the Down's syndrome sample. This finding was validated by real-time PCR. We also found that other genes regulated by the REST transcription factor were selectively repressed, whereas non-REST-regulated genes with similar functions were unaffected. Changes in expression of several key developmental genes in the Down's syndrome stem-cell and progenitor-cell pool correlated with striking changes in neuron morphology after differentiation. Interpretation Our findings suggest a link between dysregulation of the REST transcription factor and some of the neurological deficits seen in Down's syndrome. Experimental REST downregulation has been shown to trigger apoptosis, which could account for the striking and selective loss of neurons in the differentiated Down's syndrome cell preparations.	Babraham Inst, Dept Neurobiol, Cambridge CB2 4AT, England; UK Human Genome Mapping Project Resource Ctr, Cambridge, England; Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Cambridge CB2 1TN, England; Univ Cambridge, MRC, Cambridge Ctr Brain Repair, Cambridge CB2 1TN, England; UCL, Dept Obstet & Gynaecol, London WC1E 6BT, England; Univ Wisconsin, Waisman Ctr Stem Cell Res Program, Dept Anat, Madison, WI USA; Univ Wisconsin, Waisman Ctr Stem Cell Res Program, Dept Neurol, Madison, WI USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of London; University College London; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Bahn, S (corresponding author), Babraham Inst, Dept Neurobiol, Cambridge CB2 4AT, England.	sabine.bahn@bbsrc.ac.uk	Caldwell, Maeve/HHN-1986-2022	Caldwell, Maeve/0000-0001-7442-711X				CHIN LS, 1995, P NATL ACAD SCI USA, V92, P9230, DOI 10.1073/pnas.92.20.9230; Cohen NR, 1998, CURR BIOL, V8, P26, DOI 10.1016/S0960-9822(98)70017-X; CROME L, 1972, PATHOLOGY MENTAL RET, P200; Demyanenko GP, 1999, J NEUROSCI, V19, P4907; Ferreira A, 1998, MOL MED, V4, P22, DOI 10.1007/BF03401726; GOLDEN JA, 1994, J NEUROPATH EXP NEUR, V53, P513, DOI 10.1097/00005072-199409000-00011; Haydar TF, 2000, J NEUROSCI, V20, P4156; HAYES A, 1993, PEDIATR CLIN N AM, V40, P523; Higo N, 2000, J NEUROSCI, V20, P6030, DOI 10.1523/JNEUROSCI.20-16-06030.2000; HOOK EG, 1982, DOWN SYNDROME ADV BI; Kallunki P, 1998, P NATL ACAD SCI USA, V95, P3233, DOI 10.1073/pnas.95.6.3233; Lawinger P, 2000, NAT MED, V6, P826, DOI 10.1038/77565; Mahadeva H, 1998, J MOL BIOL, V284, P1391, DOI 10.1006/jmbi.1998.2292; OKAZAKI T, 1995, NEUROBIOL AGING, V16, P883, DOI 10.1016/0197-4580(95)02001-2; Ostenfeld T, 2000, EXP NEUROL, V164, P215, DOI 10.1006/exnr.2000.7427; Palm K, 1998, J NEUROSCI, V18, P1280; Riederer BM, 1997, P NATL ACAD SCI USA, V94, P741, DOI 10.1073/pnas.94.2.741; ROSS MH, 1984, NEUROLOGY, V34, P909, DOI 10.1212/WNL.34.7.909; Saito Y, 2000, ACTA NEUROPATHOL, V100, P654, DOI 10.1007/s004010000230; Shimojo M, 1999, MOL CELL BIOL, V19, P6788; Sugiura Y, 1995, DEV BRAIN RES, V90, P73, DOI 10.1016/0165-3806(96)83488-2; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Svendsen CN, 1999, TRENDS NEUROSCI, V22, P357, DOI 10.1016/S0166-2236(99)01428-9; WISNIEWSKI KE, 1985, NEUROLOGY, V35, P957, DOI 10.1212/WNL.35.7.957	24	167	174	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 26	2002	359	9303					310	315		10.1016/S0140-6736(02)07497-4	http://dx.doi.org/10.1016/S0140-6736(02)07497-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517AC	11830198				2022-12-24	WOS:000173588100012
J	Niwa, R; Nagata-Ohashi, K; Takeichi, M; Mizuno, K; Uemura, T				Niwa, R; Nagata-Ohashi, K; Takeichi, M; Mizuno, K; Uemura, T			Control of actin reorganization by Slingshot, a family of phosphatases that dephosphorylate ADF/cofilin	CELL			English	Article							LIM-KINASE 1; COFILIN PHOSPHORYLATION; DEPOLYMERIZING FACTOR; DROSOPHILA BRISTLES; FILAMENT DYNAMICS; BINDING PROTEIN; CELL POLARITY; GENE; EXPRESSION; BUNDLES	The ADF (actin-depolymerizing factor)/cofilin family is a stimulus-responsive mediator of actin dynamics. In contrast to the mechanisms of inactivation of ADF/cofilin by kinases such as LIM-kinase 1 (LIMK1), much less is known about its reactivation through dephosphorylation. Here we report Slingshot (SSH), a family of phosphatases that have the property of F actin binding. In Drosophila, loss of ssh function dramatically increased levels of both F actin and phospho-cofilin (P cofilin) and disorganized epidermal cell morphogenesis. In mammalian cells, human SSH homologs (hSSHs) suppressed LIMK1-induced actin reorganization. Furthermore, SSH and the hSSHs dephosphorylated P cofilin in cultured cells and in cell-free assays. Our results strongly suggest that the SSH family plays a pivotal role in actin dynamics by reactivating ADF/cofilin in vivo.	Kyoto Univ, Inst Virus Res, Dept Mol Genet, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan; Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; Japan Sci & Technol Corp, CREST, Tsukuba, Ibaraki, Japan	Kyoto University; Kyoto University; Kyoto University; Tohoku University; Japan Science & Technology Agency (JST)	Uemura, T (corresponding author), Kyoto Univ, Inst Virus Res, Dept Mol Genet, Kyoto 6068507, Japan.	tuemura@virus.kyoto-u.ac.jp	Mizuno, Kensaku/G-8631-2015; Takeichi, Masatoshi/G-5903-2012	Takeichi, Masatoshi/0000-0002-9931-3378; UEMURA, Tadashi/0000-0001-7204-3606				ABE H, 1989, J BIOCHEM-TOKYO, V106, P696, DOI 10.1093/oxfordjournals.jbchem.a122919; Abe H, 1996, J CELL BIOL, V132, P871, DOI 10.1083/jcb.132.5.871; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Amano T, 2001, BIOCHEM J, V354, P149, DOI 10.1042/0264-6021:3540149; Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; AXTON JM, 1990, CELL, V63, P33, DOI 10.1016/0092-8674(90)90286-N; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Baum B, 2000, CURR BIOL, V10, P964, DOI 10.1016/S0960-9822(00)00640-0; Baum B, 2001, NAT CELL BIOL, V3, P883, DOI 10.1038/ncb1001-883; Benlali A, 2000, CELL, V101, P271, DOI 10.1016/S0092-8674(00)80837-5; Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chen H, 2000, TRENDS BIOCHEM SCI, V25, P19, DOI 10.1016/S0968-0004(99)01511-X; Chen J, 2001, NAT CELL BIOL, V3, P204, DOI 10.1038/35055120; COHEN P, 1990, ADV SEC MESS PHOSPH, V24, P230; Cong JL, 2001, DEVELOPMENT, V128, P2793; COOLEY L, 1992, CELL, V69, P173, DOI 10.1016/0092-8674(92)90128-Y; DeRosier DJ, 2000, J CELL BIOL, V148, P1; EDWARDS KA, 1994, P NATL ACAD SCI USA, V91, P4589, DOI 10.1073/pnas.91.10.4589; Geng W, 2000, GENETICS, V156, P1817; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; HAY BA, 1994, DEVELOPMENT, V120, P2121; He B, 2001, MECH DEVELOP, V104, P69, DOI 10.1016/S0925-4773(01)00368-9; Hopmann R, 1996, J CELL BIOL, V133, P1293, DOI 10.1083/jcb.133.6.1293; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; KEYSE SM, 1995, BBA-MOL CELL RES, V1265, P152, DOI 10.1016/0167-4889(94)00211-V; KLAES A, 1994, CELL, V78, P149, DOI 10.1016/0092-8674(94)90581-9; Lu BW, 1999, CURR BIOL, V9, P1247, DOI 10.1016/S0960-9822(99)80505-3; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Meberg PJ, 1998, CELL MOTIL CYTOSKEL, V39, P172, DOI 10.1002/(SICI)1097-0169(1998)39:2<172::AID-CM8>3.0.CO;2-8; MITCHELL HK, 1990, DEV GENET, V11, P133, DOI 10.1002/dvg.1020110203; MOON A, 1995, MOL BIOL CELL, V6, P1423, DOI 10.1091/mbc.6.11.1423; Moriyama K, 1996, GENES CELLS, V1, P73, DOI 10.1046/j.1365-2443.1996.05005.x; NAGAOKA R, 1995, CELL MOTIL CYTOSKEL, V30, P1, DOI 10.1002/cm.970300102; Newsome TP, 2000, DEVELOPMENT, V127, P851; Ohashi K, 2000, BIOCHEM BIOPH RES CO, V276, P1178, DOI 10.1006/bbrc.2000.3599; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; OVERTON J, 1967, J MORPHOL, V122, P367, DOI 10.1002/jmor.1051220406; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; ROBERTSON HM, 1988, GENETICS, V118, P461; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; SPRADLING AC, 1995, P NATL ACAD SCI USA, V92, P10824, DOI 10.1073/pnas.92.24.10824; Spradling AC, 1999, GENETICS, V153, P135; STREULI M, 1989, P NATL ACAD SCI USA, V86, P8698, DOI 10.1073/pnas.86.22.8698; Sumida J, 1998, VICTORIAN STUD, V42, P147, DOI 10.2979/VIC.1998.42.1.147; Sutherland JD, 1999, CURR OPIN CELL BIOL, V11, P142, DOI 10.1016/S0955-0674(99)80018-0; Tanoue T, 1999, J BIOL CHEM, V274, P19949, DOI 10.1074/jbc.274.28.19949; Theriot JA, 1997, J CELL BIOL, V136, P1165, DOI 10.1083/jcb.136.6.1165; Tilney LG, 2000, J CELL SCI, V113, P1255; Tilney LG, 1996, J CELL BIOL, V135, P1291, DOI 10.1083/jcb.135.5.1291; TILNEY LG, 1995, J CELL BIOL, V130, P629, DOI 10.1083/jcb.130.3.629; Toshima J, 2001, J BIOL CHEM, V276, P31449, DOI 10.1074/jbc.M102988200; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Toshima J, 1999, J BIOL CHEM, V274, P12171, DOI 10.1074/jbc.274.17.12171; Toshima JY, 2001, J BIOL CHEM, V276, P43471, DOI 10.1074/jbc.M104620200; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; VERHEYEN EM, 1994, DEVELOPMENT, V120, P717; Wassarman DA, 1996, GENE DEV, V10, P272, DOI 10.1101/gad.10.3.272; Welch MD, 1997, CURR OPIN CELL BIOL, V9, P54, DOI 10.1016/S0955-0674(97)80152-4; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; XU T, 1993, DEVELOPMENT, V117, P1223; Yahara I, 1996, CELL STRUCT FUNCT, V21, P421, DOI 10.1247/csf.21.421; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735	71	526	553	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2002	108	2					233	246		10.1016/S0092-8674(01)00638-9	http://dx.doi.org/10.1016/S0092-8674(01)00638-9			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832213	Bronze			2022-12-24	WOS:000173521300010
J	Chapelle, FH; O'Neill, K; Bradley, PM; Methe, BA; Ciufo, SA; Knobel, LL; Lovley, DR				Chapelle, FH; O'Neill, K; Bradley, PM; Methe, BA; Ciufo, SA; Knobel, LL; Lovley, DR			A hydrogen-based subsurface microbial community dominated by methanogens	NATURE			English	Article							ECOSYSTEMS; DEEP; INDICATOR; DIVERSITY; BACTERIA; ENERGY	The search for extraterrestrial life may be facilitated if ecosystems can be found on Earth that exist under conditions analogous to those present on other planets or moons. It has been proposed, on the basis of geochemical and thermodynamic considerations, that geologically derived hydrogen might support subsurface microbial communities on Mars and Europa in which methanogens form the base of the ecosystem(1-5). Here we describe a unique subsurface microbial community in which hydrogen-consuming, methane-producing Archaea far outnumber the Bacteria. More than 90% of the 16S ribosomal DNA sequences recovered from hydrothermal waters circulating through deeply buried igneous rocks in Idaho are related to hydrogen-using methanogenic microorganisms. Geochemical characterization indicates that geothermal hydrogen, not organic carbon, is the primary energy source for this methanogen-dominated microbial community. These results demonstrate that hydrogen-based methanogenic communities do occur in Earth's subsurface, providing an analogue for possible subsurface microbial ecosystems on other planets.	US Geol Survey, Columbia, SC 29210 USA; Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; US Geol Survey, Idaho Falls, ID 83402 USA	United States Department of the Interior; United States Geological Survey; University of Massachusetts System; University of Massachusetts Amherst; United States Department of Energy (DOE); Idaho National Laboratory; United States Department of the Interior; United States Geological Survey	Chapelle, FH (corresponding author), US Geol Survey, Columbia, SC 29210 USA.	dlovley@microbio.umass.edu	Bradley, Paul M./AAC-2451-2020	Bradley, Paul M./0000-0001-7522-8606				AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Anderson RT, 1998, SCIENCE, V281, P976, DOI 10.1126/science.281.5379.976; BARNS SM, 1994, P NATL ACAD SCI USA, V91, P1609, DOI 10.1073/pnas.91.5.1609; BOSTON PJ, 1992, ICARUS, V95, P300, DOI 10.1016/0019-1035(92)90045-9; Carr MH, 1996, CIBA F SYMP, V202, P249; Chapelle FH, 1997, ENVIRON SCI TECHNOL, V31, P2873, DOI 10.1021/es970085c; Embree G. F., 1982, IDAHO BUREAU MINES G, V26, P333; Farmer J.D., 2000, GEOLOGICAL SOC AM TO, V10, P1; Fisk MR, 1999, J GEOPHYS RES-PLANET, V104, P11805, DOI 10.1029/1999JE900010; Fry NK, 1997, APPL ENVIRON MICROB, V63, P1498, DOI 10.1128/AEM.63.4.1498-1504.1997; HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225, DOI 10.1128/AEM.33.5.1225-1228.1977; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Knobel LL, 1999, 99246 US GEOL SURV; LILLEY MD, 2001, LPI CONTRIBUTION, V1088; LOVLEY DR, 1988, GEOCHIM COSMOCHIM AC, V52, P2993, DOI 10.1016/0016-7037(88)90163-9; Massana R, 1997, APPL ENVIRON MICROB, V63, P50, DOI 10.1128/AEM.63.1.50-56.1997; McCollom TM, 1999, J GEOPHYS RES-PLANET, V104, P30729, DOI 10.1029/1999JE001126; McKay CP, 2001, WILEY S ECO, P315; MOYER CL, 1994, APPL ENVIRON MICROB, V60, P871, DOI 10.1128/AEM.60.3.871-879.1994; Orphan VJ, 2000, APPL ENVIRON MICROB, V66, P700, DOI 10.1128/AEM.66.2.700-711.2000; PICARD C, 1992, APPL ENVIRON MICROB, V58, P2717, DOI 10.1128/AEM.58.9.2717-2722.1992; PIERCE KL, 1982, GEOL SOC AM MEM, V179; Shock EL, 1996, CIBA F SYMP, V202, P40; STEVENS TO, 1995, SCIENCE, V270, P450, DOI 10.1126/science.270.5235.450; SUGISAKI R, 1986, J GEOPHYS RES-SOLID, V91, P2296, DOI 10.1029/JB091iB12p12296; WAKITA H, 1980, SCIENCE, V210, P188, DOI 10.1126/science.210.4466.188	26	318	347	9	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2002	415	6869					312	315		10.1038/415312a	http://dx.doi.org/10.1038/415312a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797006				2022-12-24	WOS:000173293500041
J	Sigala, N; Logothetis, NK				Sigala, N; Logothetis, NK			Visual categorization shapes feature selectivity in the primate temporal cortex	NATURE			English	Article							INFEROTEMPORAL CORTEX; RHESUS-MONKEYS; RECOGNITION; SIMILARITY; REPRESENTATION; EXPERTISE; IMAGES; EYE	The way that we perceive and interact with objects depends on our previous experience with them. For example, a bird expert is more likely to recognize a bird as a sparrow, a sandpiper or a cockatiel than a non-expert(1). Neurons in the inferior temporal cortex have been shown to be important in the representation of visual objects; however, it is unknown which object features are represented and how these representations are affected by categorization training. Here we show that feature selectivity in the macaque inferior temporal cortex is shaped by categorization of objects on the basis of their visual features. Specifically, we recorded from single neurons while monkeys performed a categorization task with two sets of parametric stimuli. Each stimulus set consisted of four varying features, but only two of the four were important for the categorization task (diagnostic features). We found enhanced neuronal representation of the diagnostic features relative to the non-diagnostic ones. These findings demonstrate that stimulus features important for categorization are instantiated in the activity of single units (neurons) in the primate inferior temporal cortex.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany	Max Planck Society	Sigala, N (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	natasha.sigala@tuebingen.mpg.de	Sigala, Natasha/K-1750-2013; Sigala, Natasha/ABH-3181-2020; Logothetis, Nikos/U-9282-2019	Sigala, Natasha/0000-0002-9456-6093; Sigala, Natasha/0000-0002-9456-6093; 				BRUNER JS, 1957, PSYCHOL REV, V64, P123, DOI 10.1037/h0043805; Delorme A, 2000, VISION RES, V40, P2187, DOI 10.1016/S0042-6989(00)00083-3; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; NOSOFSKY RM, 1986, J EXP PSYCHOL GEN, V115, P39, DOI 10.1037/0096-3445.115.1.39; SANDS SF, 1982, J EXP PSYCHOL GEN, V111, P369, DOI 10.1037/0096-3445.111.4.369; SCHILLER PH, 1971, J NEUROPHYSIOL, V34, P920, DOI 10.1152/jn.1971.34.5.920; Schyns PG, 1998, COGNITION, V67, P147, DOI 10.1016/S0010-0277(98)00016-X; Sheinberg DL, 2001, J NEUROSCI, V21, P1340; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; SIGALA N, 2001, J COGNITIVE NEUROSCI, V14, P1; Sugihara T, 1998, BIOL CYBERN, V78, P1, DOI 10.1007/s004220050407; TANAKA JW, 1991, COGNITIVE PSYCHOL, V23, P457, DOI 10.1016/0010-0285(91)90016-H; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Vogels R, 1999, EUR J NEUROSCI, V11, P1239, DOI 10.1046/j.1460-9568.1999.00531.x; Vogels R, 1999, EUR J NEUROSCI, V11, P1223, DOI 10.1046/j.1460-9568.1999.00530.x	20	417	421	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2002	415	6869					318	320		10.1038/415318a	http://dx.doi.org/10.1038/415318a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	511YC	11797008				2022-12-24	WOS:000173293500043
J	Richards, AM; Lainchbury, JG; Nicholls, MG; Cameron, AV; Yandle, TG				Richards, AM; Lainchbury, JG; Nicholls, MG; Cameron, AV; Yandle, TG			Dendroaspis natriuretic peptide: endogenous or dubious?	LANCET			English	Editorial Material							SEQUENCE-ANALYSIS; BRAIN; PRECURSOR; CLONING; MEMBER; FAMILY		Christchurch Sch Med & Hlth Sci, Christchurch Cardioendocrine Res Grp, Christchurch, New Zealand	University of Otago	Richards, AM (corresponding author), Christchurch Sch Med & Hlth Sci, Christchurch Cardioendocrine Res Grp, POB 4345, Christchurch, New Zealand.			Cameron, Vicky/0000-0003-3147-683X				Collins E, 2000, J CARDIOVASC PHARM, V35, P614, DOI 10.1097/00005344-200004000-00015; Fabrega E, 2001, AM J GASTROENTEROL, V96, P2724; Lisy O, 2001, HYPERTENSION, V37, P1089, DOI 10.1161/01.HYP.37.4.1089; Lisy O, 1999, KIDNEY INT, V56, P502, DOI 10.1046/j.1523-1755.1999.00573.x; MUKOYAMA M, 1991, J CLIN INVEST, V87, P1402, DOI 10.1172/JCI115146; OIKAWA S, 1984, NATURE, V309, P724, DOI 10.1038/309724a0; Schirger JA, 1999, MAYO CLIN PROC, V74, P126, DOI 10.4065/74.2.126; SCHWEITZ H, 1992, J BIOL CHEM, V267, P13928; SUDOH T, 1990, BIOCHEM BIOPH RES CO, V168, P863, DOI 10.1016/0006-291X(90)92401-K; SUDOH T, 1989, BIOCHEM BIOPH RES CO, V159, P1427, DOI 10.1016/0006-291X(89)92269-9; SUDOH T, 1988, NATURE, V332, P76	11	30	34	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 5	2002	359	9300					5	6		10.1016/S0140-6736(02)07270-7	http://dx.doi.org/10.1016/S0140-6736(02)07270-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809176				2022-12-24	WOS:000173143500005
J	El-Omar, EM; Carrington, M; Chow, WH; McColl, KEL; Bream, JH; Young, HA; Herrera, J; Lissowska, J; Yuan, CC; Rothman, N; Lanyon, G; Martin, M; Fraumeni, JF; Rabkin, CS				El-Omar, EM; Carrington, M; Chow, WH; McColl, KEL; Bream, JH; Young, HA; Herrera, J; Lissowska, J; Yuan, CC; Rothman, N; Lanyon, G; Martin, M; Fraumeni, JF; Rabkin, CS			The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer (vol 404, pg 398, 2000)	NATURE			English	Correction							HELICOBACTER-PYLORI INFECTION; NECROSIS-FACTOR-ALPHA; DUODENAL-ULCER DISEASE; ACID-SECRETION; STOMACH-CANCER; RECEPTOR; GENE; CELLS; RISK; ASSOCIATION	Helicobacter pylori infection is associated with a variety of clinical outcomes including gastric cancer and duodenal ulcer disease(1). The reasons for this variation are not clear, but the gastric physiological response is influenced by the severity and anatomical distribution of gastritis induced by H. pylori. Thus, individuals with gastritis predominantly localized to the antrum retain normal (or even high) acid secretion(2), whereas individuals with extensive corpus gastritis develop hypochlorhydria and gastric atrophy(3), which are presumptive precursors of gastric cancer(4). Here we report that interleukin-1 gene cluster polymorphisms suspected of enhancing production of interleukin-1-beta are associated with an increased risk of both hypochlorhydria induced by H. pylori and gastric cancer. Two of these polymorphism are in near-complete linkage disequilibrium and one is a TATA-box polymorphism that markedly affects DNA-protein interactions in vitro. The association with disease may be explained by the biological properties of interleukin-1-beta, which is an important pro-inflammatory cytokine(5) and a powerful inhibitor of gastric acid secretion(6,7). Host genetic factors that affect interleukin-1-beta may determine why some individuals infected with H. pylori develop gastric cancer while others do not.					Lissowska, Jolanta/AAH-3252-2020; El-Omar, Emad/AAT-7780-2021; Young, Howard/A-6350-2008	Lissowska, Jolanta/0000-0003-2695-5799; El-Omar, Emad/0000-0002-0011-3924; Young, Howard/0000-0002-3118-5111; Bream, Jay/0000-0002-9149-7643				Andus T, 1997, GUT, V41, P651, DOI 10.1136/gut.41.5.651; Basso D, 1996, INT J CLIN LAB RES, V26, P207, DOI 10.1007/BF02592984; Beales ILP, 1998, GUT, V42, P227, DOI 10.1136/gut.42.2.227; BIDWELL JL, CYTOKINE GENE POLYM; Blaser MJ, 1998, BRIT MED J, V316, P1507, DOI 10.1136/bmj.316.7143.1507; Chow WH, 1999, INT J CANCER, V81, P871, DOI 10.1002/(SICI)1097-0215(19990611)81:6&lt;871::AID-IJC6&gt;3.0.CO;2-#; CORREA P, 1992, CANCER RES, V52, P6735; Cox A, 1998, AM J HUM GENET, V62, P1180, DOI 10.1086/301817; DANIS VA, 1995, CLIN EXP IMMUNOL, V99, P303; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; El-Omar EM, 2000, GASTROENTEROLOGY, V118, P22, DOI 10.1016/S0016-5085(00)70410-0; ElOmar EM, 1997, GASTROENTEROLOGY, V113, P15, DOI 10.1016/S0016-5085(97)70075-1; ELOMAR EM, 1995, GASTROENTEROLOGY, V109, P681, DOI 10.1016/0016-5085(95)90374-7; Hamajima N, 2001, JPN J CANCER RES, V92, P383, DOI 10.1111/j.1349-7006.2001.tb01106.x; Hansson LE, 1996, NEW ENGL J MED, V335, P242, DOI 10.1056/NEJM199607253350404; Jung HC, 1997, J GASTROEN HEPATOL, V12, P473, DOI 10.1111/j.1440-1746.1997.tb00469.x; Kuipers EJ, 1996, NEW ENGL J MED, V334, P1018, DOI 10.1056/NEJM199604183341603; NOACH LA, 1994, SCAND J GASTROENTERO, V29, P425, DOI 10.3109/00365529409096833; Parkin DM, 1999, INT J CANCER, V80, P827, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;827::AID-IJC6&gt;3.0.CO;2-P; POCIOT F, 1992, EUR J CLIN INVEST, V22, P396, DOI 10.1111/j.1365-2362.1992.tb01480.x; ROYALL RM, 1986, INT STAT REV, V54, P221, DOI 10.2307/1403146; RUIZ B, 1994, AM J GASTROENTEROL, V89, P533; Santtila S, 1998, SCAND J IMMUNOL, V47, P195; SIPPONEN P, 1994, SCAND J GASTROENTERO, V29, P24, DOI 10.3109/00365529409105356; STOCKBRUEGGER RW, 1984, SCAND J GASTROENTERO, V19, P355, DOI 10.1080/00365521.1984.12005735; Tountas NA, 1999, GASTROENTEROLOGY, V117, P806, DOI 10.1016/S0016-5085(99)70338-0; WALLACE JL, 1991, AM J PHYSIOL, V261, pG559, DOI 10.1152/ajpgi.1991.261.4.G559; Wolfe M M, 1992, Gastroenterology, V102, P2177; Yamaoka Y, 1999, J CLIN MICROBIOL, V37, P2274, DOI 10.1128/JCM.37.7.2274-2279.1999; Yu CR, 1996, J IMMUNOL, V157, P126; [No title captured]	32	227	231	0	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2001	412	6842					99	+		10.1038/35083631	http://dx.doi.org/10.1038/35083631			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448TB	11808612	Bronze			2022-12-24	WOS:000169644900053
J	Slom, TJ; Cortese, MM; Gerber, SI; Jones, RC; Holtz, TH; Lopez, AS; Zambrano, CH; Sufit, RL; Sakolvaree, Y; Chaicumpa, W; Herwaldt, BL; Johnson, S				Slom, TJ; Cortese, MM; Gerber, SI; Jones, RC; Holtz, TH; Lopez, AS; Zambrano, CH; Sufit, RL; Sakolvaree, Y; Chaicumpa, W; Herwaldt, BL; Johnson, S			An outbreak of eosinophilic meningitis caused by Angiostrongylus cantonensis in travelers returning from the Caribbean.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							1ST RECORD; MENINGOENCEPHALITIS; CUBA; JAMAICA; SNAILS	Background: Outbreaks of eosinophilic meningitis caused by the roundworm Angiostrongylus cantonensis are rarely reported, even in regions of endemic infection such as Southeast Asia and the Pacific Basin. We report an outbreak of A. cantonensis meningitis among travelers returning from the Caribbean. Methods: We conducted a retrospective cohort study among 23 young adults who had traveled to Jamaica. We used a clinical definition of eosinophilic meningitis that included headache that began within 35 days after the trip plus at least one of the following: neck pain, nuchal rigidity, altered cutaneous sensations, photophobia, or visual disturbances. Results: Twelve travelers met the case definition for eosinophilic meningitis. The symptoms began a median of 11 days (range, 6 to 31) after their return to the United States. Eosinophilia was eventually documented in all nine patients who were hospitalized, although on initial evaluation, it was present in the peripheral blood of only four of the nine (44 percent) and in the cerebrospinal fluid of five (56 percent). Repeated lumbar punctures and corticosteroid therapy led to improvement in symptoms in two of three patients with severe headache, and intracranial pressure decreased during corticosteroid therapy in all three. Consumption of one meal (P=0.001) and of a Caesar salad at that meal (P=0.007) were strongly associated with eosinophilic meningitis. Antibodies against an A. cantonensis-specific 31-kD antigen were detected in convalescent-phase serum samples from 11 patients. Conclusions: Among travelers at risk, the presence of headache, elevated intracranial pressure, and pleocytosis, with or without eosinophilia, particularly in association with paresthesias or hyperesthesias, should alert clinicians to the possibility of A. cantonensis infection. (N Engl J Med 2002;346:668-75.) Copyright (C) 2002 Massachusetts Medical Society.	VA Chicago HCS, Med Serv, Lakeside Div, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Dept Infect Dis, Chicago, IL USA; Northwestern Univ, Sch Med, Dept Neurol, Chicago, IL 60611 USA; Ctr Dis Control & Prevent, Epidem Inteligence Serv, Epidemiol Program Off, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Parasit Dis, Atlanta, GA USA; Chicago Dept Publ Hlth, Chicago, IL USA; Atlanta Res & Educ Fdn, Atlanta, GA USA; Mahidol Univ, Fac Trop Med, Bangkok, Thailand	Northwestern University; Northwestern University; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Chicago Department of Public Health; Mahidol University	Johnson, S (corresponding author), VA Chicago HCS, Med Serv, Lakeside Div, 333 E Huron, Chicago, IL 60611 USA.	stu-johnson@northwestern.edu		Johnson, Stuart/0000-0001-9548-229X				AGUIAR PH, 1981, AM J TROP MED HYG, V30, P963, DOI 10.4269/ajtmh.1981.30.963; ANDERSEN E, 1986, AM J TROP MED HYG, V35, P319, DOI 10.4269/ajtmh.1986.35.319; ASH L R, 1976, Revista de Biologia Tropical, V24, P163; Barrow KO, 1996, W INDIAN MED J, V45, P70; BOWDEN DK, 1981, AM J TROP MED HYG, V30, P1141, DOI 10.4269/ajtmh.1981.30.1141; Brown FM, 1996, LANCET, V348, P964, DOI 10.1016/S0140-6736(05)65382-2; CAMPBELL BG, 1988, AM J TROP MED HYG, V38, P568, DOI 10.4269/ajtmh.1988.38.568; Chotmongkol V, 2000, CLIN INFECT DIS, V31, P660, DOI 10.1086/314036; EAMSOBHANA P, 1996, MOL BIOL IMMUNOLOGY, P159; GARDINER CH, 1990, AM J TROP MED HYG, V42, P70, DOI 10.4269/ajtmh.1990.42.70; HEATON DC, 1980, AUST NZ J MED, V10, P255, DOI 10.1111/j.1445-5994.1980.tb03725.x; Hwang K P, 1991, Southeast Asian J Trop Med Public Health, V22 Suppl, P194; KLIKS MM, 1992, SOC SCI MED, V34, P199, DOI 10.1016/0277-9536(92)90097-A; KLIKS MM, 1982, AM J TROP MED HYG, V31, P1114, DOI 10.4269/ajtmh.1982.31.1114; KO RC, 1984, T ROY SOC TROP MED H, V78, P354, DOI 10.1016/0035-9203(84)90119-6; LINDO JF, IN PRESS EMERG INFEC; Martinez-Delgado JF, 2000, REV NEUROLOGIA, V31, P417, DOI 10.33588/rn.3105.2000146; NEW D, 1995, NEW ENGL J MED, V332, P1105, DOI 10.1056/NEJM199504203321619; NOSKIN GA, 1992, NEUROLOGY, V42, P1423, DOI 10.1212/WNL.42.7.1423; NOZAIS JP, 1980, B SOC PATHOL EXOT, V73, P179; Nuamtanong Supaporn, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P291; Ogawa K, 1998, Rinsho Shinkeigaku, V38, P22; Pascual Gispert J E, 1981, Rev Cubana Med Trop, V33, P92; PASCUAL JE, 1981, AM J TROP MED HYG, V30, P960, DOI 10.4269/ajtmh.1981.30.960; PETITHORY J, 1977, B SOC PATHOL EXOT, V70, P151; PROCIV P, 1987, MED J AUSTRALIA, V147, P294; Prociv P, 2000, INT J PARASITOL, V30, P1295, DOI 10.1016/S0020-7519(00)00133-8; PUNYAGUPTA S, 1975, AM J TROP MED HYG, V24, P921, DOI 10.4269/ajtmh.1975.24.921; RACHFORD FW, 1975, J PARASITOL, V61, P1117, DOI 10.2307/3279394; RENAPURKAR DM, 1982, J HELMINTHOL, V56, P345, DOI 10.1017/S0022149X00034751; ROSEN L, 1967, AM J EPIDEMIOL, V85, P17, DOI 10.1093/oxfordjournals.aje.a120673; Steffen R, 1999, JAMA-J AM MED ASSOC, V281, P811, DOI 10.1001/jama.281.9.811; Tsai HC, 2001, AM J MED, V111, P109, DOI 10.1016/S0002-9343(01)00766-5; UCHIKAWA R, 1984, J HELMINTHOL, V58, P231, DOI 10.1017/S0022149X00027024; VARGAS M, 1992, TROP MED PARASITOL, V43, P253; WALLACE GD, 1967, AM J EPIDEMIOL, V85, P395, DOI 10.1093/oxfordjournals.aje.a120701; Wilson Marianna, 1995, P1159; YII CY, 1975, AM J TROP MED HYG, V24, P447, DOI 10.4269/ajtmh.1975.24.447	38	184	200	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 28	2002	346	9					668	675		10.1056/NEJMoa012462	http://dx.doi.org/10.1056/NEJMoa012462			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525HJ	11870244				2022-12-24	WOS:000174062800005
J	Sharma, A; Scott, JH; Cody, GD; Fogel, ML; Hazen, RM; Hemley, RJ; Huntress, WT				Sharma, A; Scott, JH; Cody, GD; Fogel, ML; Hazen, RM; Hemley, RJ; Huntress, WT			Microbial activity at gigapascal pressures	SCIENCE			English	Article							DIAMOND-ANVIL CELL; ESCHERICHIA-COLI; LAKE VOSTOK; ICE; LIFE; METABOLISM; GROWTH	We observed physiological and metabolic activity of Shewanella oneidensis strain MR1 and Escherichia coli strain MG1655 at pressures of 68 to 1680 megapascals (MPa) in diamond anvil cells. We measured biological formate oxidation at high pressures(68 to 1060 MPa). At pressures of 1200 to 1600 MPa, living bacteria resided in fluid inclusions in ice-VI crystals and continued to be viable upon subsequent release to ambient pressures (0.1 MPa). Evidence of microbial viability and activity at these extreme pressures expands by an order of magnitude the range of conditions representing the habitable zone in the solar system.	Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA	Carnegie Institution for Science	Sharma, A (corresponding author), Carnegie Inst Sci, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.	sharma@gl.ciw.edu; j.scott@gl.ciw.edu	Fogel, Marilyn L/M-2395-2015	Fogel, Marilyn L/0000-0002-1176-3818				Abe F, 1999, TRENDS MICROBIOL, V7, P447, DOI 10.1016/S0966-842X(99)01608-X; Abe F, 2001, TRENDS BIOTECHNOL, V19, P102, DOI 10.1016/S0167-7799(00)01539-0; BARTLETT DH, 1992, SCI PROG, V76, P479; BASSETT WA, 1993, REV SCI INSTRUM, V64, P2340, DOI 10.1063/1.1143931; BROCK TD, 1967, SCIENCE, V158, P1012, DOI 10.1126/science.158.3804.1012; CARPENTER JF, 1992, P NATL ACAD SCI USA, V89, P8953, DOI 10.1073/pnas.89.19.8953; Carr MH, 1998, NATURE, V391, P363, DOI 10.1038/34857; Chyba CF, 2001, P NATL ACAD SCI USA, V98, P801, DOI 10.1073/pnas.98.3.801; DEMING JW, 1993, GEOCHIM COSMOCHIM AC, V57, P3219, DOI 10.1016/0016-7037(93)90535-5; ENOCH HG, 1975, J BIOL CHEM, V250, P6693; FERRY JG, 1990, FEMS MICROBIOL LETT, V87, P377, DOI 10.1111/j.1574-6968.1990.tb04940.x; Haselton HT, 1995, AM MINERAL, V80, P1302; Hauben KJA, 1997, APPL ENVIRON MICROB, V63, P945, DOI 10.1128/AEM.63.3.945-950.1997; JONES KM, 1969, DATA BIOCH RES, P436; Karl DM, 1999, SCIENCE, V286, P2144, DOI 10.1126/science.286.5447.2144; LIBEREK K, 1992, P NATL ACAD SCI USA, V89, P3516, DOI 10.1073/pnas.89.8.3516; Price PB, 2000, P NATL ACAD SCI USA, V97, P1247, DOI 10.1073/pnas.97.3.1247; Priscu JC, 1998, SCIENCE, V280, P2095, DOI 10.1126/science.280.5372.2095; Priscu JC, 1999, SCIENCE, V286, P2141, DOI 10.1126/science.286.5447.2141; Royer CA, 2000, HIGH PRESSURE RES, V19, P603; SCOTT JH, 1994, J BACTERIOL, V176, P3408, DOI 10.1128/jb.176.11.3408-3411.1994; WELCH TJ, 1993, J BACTERIOL, V175, P7170, DOI 10.1128/JB.175.22.7170-7177.1993; Wirsen CO, 1999, APPL ENVIRON MICROB, V65, P5314; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Yano Y, 1998, APPL ENVIRON MICROB, V64, P479; Yayanos AA, 1998, WILEY S ECO, P47; ZOBELL CE, 1964, J BACTERIOL, V87, P710, DOI 10.1128/JB.87.3.710-719.1964; ZOBELL CE, 1952, SCIENCE, V115, P507, DOI 10.1126/science.115.2993.507; ZOBELL CE, 1962, J BACTERIOL, V84, P1228, DOI 10.1128/JB.84.6.1228-1236.1962; ZOBELL CE, 1964, K SUGAWARA RESTIVAL, P83	30	156	170	0	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2002	295	5559					1514	1516		10.1126/science.1068018	http://dx.doi.org/10.1126/science.1068018			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859192				2022-12-24	WOS:000173981300050
J	Jordt, SE; Julius, D				Jordt, SE; Julius, D			Molecular basis for species-specific sensitivity to "hot" chili peppers	CELL			English	Article							ACTIVATED ION-CHANNEL; CHICK SENSORY NEURONS; CAPSAICIN-RECEPTOR; POTASSIUM CHANNEL; K+ CHANNEL; BINDING; HEAT; SITE; THRESHOLD; FAMILY	Chili peppers produce the pungent vanilloid compound capsaicin, which offers protection from predatory mammals. Birds are indifferent to the pain-producing effects of capsaicin and therefore serve as vectors for seed dispersal. Here, we determine the molecular basis for this species-specific behavioral response by identifying a domain of the rat vanilloid receptor that confers sensitivity to capsaicin to the normally insensitive chicken ortholog. Like its mammalian counterpart, the chicken receptor is activated by heat or protons, consistent with the fact that both mammals and birds detect noxious heat and experience thermal hypersensitivity. Our findings provide a molecular basis for the ecological phenomenon of directed deterrence and suggest that the capacity to detect capsaicin-like inflammatory substances is a recent acquisition of mammalian vanilloid receptors.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Julius, D (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.		Jordt, Sven-Eric/ABE-6517-2020	Jordt, Sven-Eric/0000-0001-6171-5622				Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Clapham DE, 1999, CELL, V97, P547, DOI 10.1016/S0092-8674(00)80765-5; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; Gauldie SD, 2001, BRIT J PHARMACOL, V132, P617, DOI 10.1038/sj.bjp.0703890; GENTLE MJ, 1993, COMP BIOCHEM PHYS C, V105, P459, DOI 10.1016/0742-8413(93)90086-Z; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; HAWKINS NS, 1991, COMP BIOCHEM PHYS C, V99, P513, DOI 10.1016/0742-8413(91)90279-3; Hofmann T, 2000, J MOL MED, V78, P14, DOI 10.1007/s001090050378; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; Horn R, 2000, NEURON, V25, P511, DOI 10.1016/S0896-6273(00)81055-7; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; JAVITCH JA, 1995, NEURON, V14, P825, DOI 10.1016/0896-6273(95)90226-0; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Jung J, 1999, J NEUROSCI, V19, P529; Kare M, 1961, Patent, Patent No. [2967128, US2967128]; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P2560, DOI 10.1152/jn.1997.78.5.2560; LEETENG E, 1966, P NATL ACAD SCI USA, V56, P926, DOI 10.1073/pnas.56.3.926; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Marin-Burgin A, 2000, EUR J NEUROSCI, V12, P3560, DOI 10.1046/j.1460-9568.2000.00275.x; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; MOORE KR, 1994, BIOTECHNIQUES, V17, P130; Nagy I, 2000, REGUL PEPTIDES, V96, P3, DOI 10.1016/S0167-0115(00)00193-2; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; PEROZO E, 1994, BIOPHYS J, V66, P345, DOI 10.1016/S0006-3495(94)80783-0; Piomelli D, 2001, TRENDS PHARMACOL SCI, V22, P17, DOI 10.1016/S0165-6147(00)01602-3; Richard S, 2000, PHYSIOL BEHAV, V70, P521, DOI 10.1016/S0031-9384(00)00298-5; Scott K, 1998, CURR OPIN NEUROBIOL, V8, P383, DOI 10.1016/S0959-4388(98)80065-2; Sprague J, 2001, EUR J PHARMACOL, V423, P121, DOI 10.1016/S0014-2999(01)01123-2; Spyridaki A, 2000, BBA-BIOENERGETICS, V1459, P69, DOI 10.1016/S0005-2728(00)00114-6; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Szallasi A, 1999, MOL PHARMACOL, V56, P581, DOI 10.1124/mol.56.3.581; Szallasi A, 1999, PHARMACOL REV, V51, P159; Tewksbury JJ, 1999, CONSERV BIOL, V13, P98, DOI 10.1046/j.1523-1739.1999.97399.x; Tewksbury JJ, 2001, NATURE, V412, P403, DOI 10.1038/35086653; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tominaga M, 2001, P NATL ACAD SCI USA, V98, P6951, DOI 10.1073/pnas.111025298; Vannier B, 1998, J BIOL CHEM, V273, P8675, DOI 10.1074/jbc.273.15.8675; WOOD JN, 1988, J NEUROSCI, V8, P3208; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	53	676	707	4	89	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 8	2002	108	3					421	430		10.1016/S0092-8674(02)00637-2	http://dx.doi.org/10.1016/S0092-8674(02)00637-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	520VB	11853675	Bronze			2022-12-24	WOS:000173801600013
J	Hoegh-Guldberg, O; Jones, RJ; Ward, S; Loh, WK				Hoegh-Guldberg, O; Jones, RJ; Ward, S; Loh, WK			Ecology - Is coral bleaching really adaptive?	NATURE			English	Article							HYPOTHESIS		Univ Queensland, Ctr Marine Studies, Brisbane, Qld 4072, Australia	University of Queensland	Hoegh-Guldberg, O (corresponding author), Univ Queensland, Ctr Marine Studies, Brisbane, Qld 4072, Australia.		Hoegh-Guldberg, Ove/H-6169-2011; Jones, Ross/N-4651-2013; Hoegh-Guldberg, Ove/ABA-5420-2020	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Jones, Ross/0000-0003-1661-4149; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Baker, Andrew/0000-0002-7866-2587				Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; FALKOWSKI PG, 1981, NATURE, V289, P172, DOI 10.1038/289172a0; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Jones RJ, 2001, PLANT CELL ENVIRON, V24, P89, DOI 10.1046/j.1365-3040.2001.00648.x; MUSCATINE L, 1969, BIOL BULL-US, V137, P506, DOI 10.2307/1540172; Ware JR, 1996, ECOL MODEL, V84, P199, DOI 10.1016/0304-3800(94)00132-4	7	84	89	5	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					601	602		10.1038/415601a	http://dx.doi.org/10.1038/415601a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832932				2022-12-24	WOS:000173709100032
J	Gaudet, J; Mango, SE				Gaudet, J; Mango, SE			Regulation of organogenesis by the Caenorhabditis elegans, FoxA protein PHA-41	SCIENCE			English	Article							HEAVY-CHAIN ISOFORMS; C-ELEGANS; FORK HEAD; DROSOPHILA EMBRYO; GENE-EXPRESSION; CELL LINEAGE; IDENTIFICATION; LOCALIZATION; HNF-3-BETA; HOMOLOG	The pha-4 locus encodes a forkhead box A (FoxA/HNF3) transcription factor homolog that specifies organ identity for Caenorhabditis elegans pharyngeal cells. We used microarrays to identify pharyngeal genes and analyzed those genes to determine which were direct PHA-4 targets. Our data suggest that PHA-4 directly activates most or all pharyngeal genes. Furthermore, the relative affinity of PHA-4 for different TRTTKRY (R=A/G, K=T/G, Y=T/C) elements modulates the onset of gene expression, providing a mechanism to activate pharyngeal genes at different developmental stages. We suggest that direct transcriptional regulation of entire gene networks may be a common feature of organ identity genes.	Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Mango, SE (corresponding author), Univ Utah, Huntsman Canc Inst, 2000 Circle Hope, Salt Lake City, UT 84112 USA.	susan.mango@hci.utah.edu		Mango, Susan/0000-0002-2146-3237	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056264] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM056264] Funding Source: Medline; ODCDC CDC HHS [CCSG 2P30CA42014] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ODCDC CDC HHS		ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; ARDIZZI JP, 1987, J CELL BIOL, V105, P2763, DOI 10.1083/jcb.105.6.2763; AVERY L, 1993, GENETICS, V133, P897; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Guss KA, 2001, SCIENCE, V292, P1164, DOI 10.1126/science.1058312; Horner MA, 1998, GENE DEV, V12, P1947, DOI 10.1101/gad.12.13.1947; IP YT, 1992, J CELL SCI, P33; JURGENS G, 1988, ROUX ARCH DEV BIOL, V197, P345, DOI 10.1007/BF00375954; Kalb JM, 1998, DEVELOPMENT, V125, P2171; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Labouesse M, 1999, TRENDS GENET, V15, P307, DOI 10.1016/S0168-9525(99)01750-3; Lehmann M, 1996, EMBO J, V15, P4825, DOI 10.1002/j.1460-2075.1996.tb00863.x; MANGO SE, 1994, DEVELOPMENT, V120, P3019; MILLER DM, 1986, P NATL ACAD SCI USA, V83, P2305, DOI 10.1073/pnas.83.8.2305; OKKEMA PG, 1994, DEVELOPMENT, V120, P2175; OVERDIER DG, 1994, MOL CELL BIOL, V14, P2755, DOI 10.1128/MCB.14.4.2755; Portereiko MF, 2001, DEV BIOL, V233, P482, DOI 10.1006/dbio.2001.0235; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Rusch J, 1996, CURR OPIN GENET DEV, V6, P416, DOI 10.1016/S0959-437X(96)80062-1; Schnabel R., 1997, C ELEGANS, P361; Shibata Y, 2000, GENETICS, V154, P635; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Thatcher JD, 2001, DEV BIOL, V229, P480, DOI 10.1006/dbio.2000.9978; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; Zaret K, 1999, DEV BIOL, V209, P1, DOI 10.1006/dbio.1999.9228	31	299	302	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2002	295	5556					821	825		10.1126/science.1065175	http://dx.doi.org/10.1126/science.1065175			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823633				2022-12-24	WOS:000173733000035
J	Seidemann, E; Arieli, A; Grinvald, A; Slovin, H				Seidemann, E; Arieli, A; Grinvald, A; Slovin, H			Dynamics of depolarization and hyperpolarization in the frontal cortex and saccade goat	SCIENCE			English	Article							VOLTAGE-SENSITIVE DYES; EYE FIELDS; ELECTRICAL-STIMULATION; SUPERIOR COLLICULUS; VISUAL-CORTEX; MOVEMENTS; MICROSTIMULATION; REVEAL; MONKEY; SIGNAL	The frontal eye field and neighboring area 8Ar of the primate cortex are involved in programming and execution of saccades. Electrical microstimulation in these regions elicits short-latency contralateral saccades. To determine how spatiotemporal dynamics of microstimulation-evoked activity are converted into saccade plans, we used a combination of real-time optical imaging and microstimulation in behaving monkeys. Short stimulation trains evoked a rapid and widespread wave of depolarization followed by unexpected large and prolonged hyperpolarization. During this hyperpolarization saccades are almost exclusively ipsilateral, suggesting an important role for hyperpolarization in determining saccade goal.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Grodetsky Ctr Studies Higher Brain Funct, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Seidemann, E (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	eyal.seidemann@weizmann.ac.il		Seidemann, Eyal/0000-0003-2841-5948; Slovin, Hamutal/0000-0001-6350-8141				ALBOWITZ B, 1993, EUR J NEUROSCI, V5, P1349, DOI 10.1111/j.1460-9568.1993.tb00921.x; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; BRUCE CJ, 1990, NEUROSCI IN, P261; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; DOBELLE WH, 1979, NEUROSURGERY, V5, P521, DOI 10.1227/00006123-197910000-00022; Ferrier David, 1875, PHIL T LONDON CROONI, V165, P433, DOI DOI 10.1098/RSTL.1875.0016; GOLDBERG ME, 1986, EXP BRAIN RES, V61, P579; GOLDBERG ME, 1990, J NEUROPHYSIOL, V64, P489, DOI 10.1152/jn.1990.64.2.489; Grinvald A, 1999, MODERN TECHNIQUES NE, P893, DOI 10.1007/978-3-642-58552-4_34; PETERSEN CCH, 2001, SOC NEUR ABSTR, V27; PREUSS TM, 1991, J COMP NEUROL, V310, P475, DOI 10.1002/cne.903100403; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; ROBINSON DA, 1969, J NEUROPHYSIOL, V32, P637, DOI 10.1152/jn.1969.32.5.637; SCHALL JD, 1995, REV NEUROSCIENCE, V6, P63; Schall JD, 1997, CEREBR CORT, V12, P527; SCHILLER PH, 1983, EXP BRAIN RES, V49, P381; SCHLAG J, 1990, TRENDS NEUROSCI, V13, P410, DOI 10.1016/0166-2236(90)90122-Q; Schlag J, 1998, J NEUROPHYSIOL, V79, P64, DOI 10.1152/jn.1998.79.1.64; Schmidt EM, 1996, BRAIN, V119, P507, DOI 10.1093/brain/119.2.507; SEIDEMANN DE, 1999, SOC NEUR ABSTR, V25, P784; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; Shtoyerman E, 2000, J NEUROSCI, V20, P8111; Slovin H, 2000, EUR J NEUROSCI, V12, P126; Slovin H., 1999, Society for Neuroscience Abstracts, V25, P784; Stanford TR, 1996, J NEUROPHYSIOL, V76, P3360, DOI 10.1152/jn.1996.76.5.3360; TANIFUJI M, 1994, SCIENCE, V266, P1057, DOI 10.1126/science.7973662; Tehovnik EJ, 2000, BRAIN RES REV, V32, P413, DOI 10.1016/S0165-0173(99)00092-2; Tehovnik EJ, 1996, J NEUROSCI METH, V65, P1, DOI 10.1016/0165-0270(95)00131-X	28	105	105	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					862	865		10.1126/science.1066641	http://dx.doi.org/10.1126/science.1066641			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823644	Green Submitted			2022-12-24	WOS:000173733000047
J	Aussel, L; Barre, FX; Aroyo, M; Stasiak, A; Stasiak, AZ; Sherratt, D				Aussel, L; Barre, FX; Aroyo, M; Stasiak, A; Stasiak, AZ; Sherratt, D			FtsK is a DNA motor protein that activates chromosome dimer resolution by switching the catalytic state of the XerC and XerD recombinases	CELL			English	Article							SITE-SPECIFIC RECOMBINATION; CELL-DIVISION PROTEIN; ESCHERICHIA-COLI; TOPOLOGICAL SELECTIVITY; DIF; TERMINUS; LOCALIZATION; SEGREGATION; TRANSPORT; SEPTUM	FtsK acts at the bacterial division septum to couple chromosome segregation with cell division. We demonstrate that a truncated FtsK derivative, FtsK(50C), uses ATP hydrolysis to translocate along duplex DNA as a multimer in vitro, consistent with FtsK having an in vivo role in pumping DNA through the closing division septum. FtsK(50C) also promotes a complete Xer recombination reaction between dif sites by switching the state of activity of the XerCD recombinases so that XerD makes the first pair of strand exchanges to form Holliday junctions that are then resolved by XerC. The reaction between directly repeated dif sites in circular DNA leads to the formation of uncatenated circles and is equivalent to the formation of chromosome monomers from dimers.	Univ Oxford, Dept Biochem, Div Mol Genet, Oxford OX1 3QU, England; Univ Lausanne, Lab Anal Ultrastruct, CH-1015 Lausanne, Switzerland	University of Oxford; University of Lausanne	Sherratt, D (corresponding author), Univ Oxford, Dept Biochem, Div Mol Genet, Oxford OX1 3QU, England.	sherratt@bioch.ox.ac.uk	Stasiak, Andrzej/E-5551-2010; Barre, François-Xavier/F-6767-2019	Stasiak, Andrzej/0000-0002-0398-1989; Aussel, Laurent/0000-0001-5239-4556				ABREMSKI K, 1983, CELL, V32, P1301, DOI 10.1016/0092-8674(83)90311-2; ARCISZEWSKA LK, 1995, EMBO J, V14, P2112, DOI 10.1002/j.1460-2075.1995.tb07203.x; Barre F.-X., 2002, MOBILE DNA, P149; Barre FX, 2000, GENE DEV, V14, P2976, DOI 10.1101/gad.188700; Barre FX, 2001, P NATL ACAD SCI USA, V98, P8189, DOI 10.1073/pnas.111008998; Bath J, 2000, SCIENCE, V290, P995, DOI 10.1126/science.290.5493.995; BLAKELY G, 1991, NEW BIOL, V3, P789; BLAKELY G, 1993, CELL, V75, P351, DOI 10.1016/0092-8674(93)80076-Q; Chen JC, 2001, MOL MICROBIOL, V42, P395, DOI 10.1046/j.1365-2958.2001.02640.x; Colloms SD, 1997, CELL, V88, P855, DOI 10.1016/S0092-8674(00)81931-5; COLLOMS SD, 1990, J BACTERIOL, V172, P6973, DOI 10.1128/jb.172.12.6973-6980.1990; Colloms SD, 1996, EMBO J, V15, P1172, DOI 10.1002/j.1460-2075.1996.tb00456.x; Cornet F, 1996, GENE DEV, V10, P1152, DOI 10.1101/gad.10.9.1152; Diez AA, 1997, J BACTERIOL, V179, P5878, DOI 10.1128/jb.179.18.5878-5883.1997; Draper GC, 1998, J BACTERIOL, V180, P4621, DOI 10.1128/JB.180.17.4621-4627.1998; Errington J, 2001, NAT REV MOL CELL BIO, V2, P538, DOI 10.1038/35080005; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; Hallet B, 1999, MOL CELL, V4, P949, DOI 10.1016/S1097-2765(00)80224-5; Havas K, 2000, CELL, V103, P1133, DOI 10.1016/S0092-8674(00)00215-4; Hendricks EC, 2000, MOL MICROBIOL, V36, P973, DOI 10.1046/j.1365-2958.2000.01920.x; Hojgaard A, 1999, MOL MICROBIOL, V33, P1027, DOI 10.1046/j.1365-2958.1999.01545.x; Huang J, 2001, P NATL ACAD SCI USA, V98, P968, DOI 10.1073/pnas.98.3.968; Kilbride E, 1999, J MOL BIOL, V289, P1219, DOI 10.1006/jmbi.1999.2864; KUEMPEL PL, 1991, NEW BIOL, V3, P799; Liu GW, 1998, MOL MICROBIOL, V29, P893, DOI 10.1046/j.1365-2958.1998.00986.x; Maurizi Michael R., 2001, EMBO Reports, V2, P980, DOI 10.1093/embo-reports/kve229; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; Neilson L, 1999, MOL MICROBIOL, V31, P915, DOI 10.1046/j.1365-2958.1999.01231.x; Niki H, 2000, GENE DEV, V14, P212; PARSONS CA, 1995, NATURE, V374, P375, DOI 10.1038/374375a0; Perals K, 2000, MOL MICROBIOL, V36, P33, DOI 10.1046/j.1365-2958.2000.01847.x; Recchia GD, 1999, EMBO J, V18, P5724, DOI 10.1093/emboj/18.20.5724; Recchia GD, 1999, MOL MICROBIOL, V34, P1146, DOI 10.1046/j.1365-2958.1999.01668.x; Sherratt DJ, 2001, CURR OPIN MICROBIOL, V4, P653, DOI 10.1016/S1369-5274(01)00265-X; SOGO JM, 1987, ELECTRON MICROS, P61; Steiner W, 1999, MOL MICROBIOL, V31, P579, DOI 10.1046/j.1365-2958.1999.01198.x; Steiner WW, 1998, MOL MICROBIOL, V27, P257, DOI 10.1046/j.1365-2958.1998.00651.x; Steiner WW, 1998, J BACTERIOL, V180, P6269; Wang LL, 1998, MOL MICROBIOL, V29, P731, DOI 10.1046/j.1365-2958.1998.00958.x; Yu XC, 1998, J BACTERIOL, V180, P6424; Yu XC, 1998, J BACTERIOL, V180, P1296, DOI 10.1128/JB.180.5.1296-1304.1998	41	255	261	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2002	108	2					195	205		10.1016/S0092-8674(02)00624-4	http://dx.doi.org/10.1016/S0092-8674(02)00624-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832210	Bronze			2022-12-24	WOS:000173521300007
J	Stegmeier, F; Visintin, R; Amon, A				Stegmeier, F; Visintin, R; Amon, A			Separase, polo kinase, the kinetochore protein Slk19 and Spo12 function in a network that controls Cdc14 localization during early anaphase	CELL			English	Article							SINGLE-DIVISION MEIOSIS; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; MITOTIC EXIT; PHOSPHATASE CDC14; CYCLIN DESTRUCTION; SISTER CHROMATIDS; PROMOTING COMPLEX; MITOSIS; PHOSPHORYLATION	In budding yeast, the phosphatase Cdc14, a key regulator of exit from mitosis, is released from its inhibitor Cfi1/Net1 in the nucleolus during anaphase. A signaling cascade, known as the mitotic exit network (MEN), controls this release. We have identified a regulatory network, the FEAR (Cdc fourteen early anaphase release) network that promotes Cdc14 release from the nucleolus during early anaphase. The FEAR network is comprised of the polo kinase CdG5, the separase Esp1, the kinetochore-associated protein Slk19, and Spo12. We also show that the FEAR network initiates Cdc14 release from Cfi1/Net1 during early anaphase, and MEN maintains Cdc14 in the released state during late anaphase. We propose that one function of Cdc14 released by the FEAR network is to stimulate MEN activity.	MIT, Ctr Canc Res, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, Ctr Canc Res, Howard Hughes Med Inst, E17-233,40 Ames St, Cambridge, MA 02139 USA.		Visintin, Rosella/J-9690-2012	Amon, Angelika/0000-0001-9837-0314; Visintin, Rosella/0000-0001-6758-9946	NIGMS NIH HHS [GM 56800] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM056800, R01GM056800] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Bardin AJ, 2001, NAT REV MOL CELL BIO, V2, P815, DOI 10.1038/35099020; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Cohen-Fix O, 1999, GENE DEV, V13, P1950, DOI 10.1101/gad.13.15.1950; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Cueille N, 2001, J CELL SCI, V114, P2649; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Gardner RD, 2000, TRENDS CELL BIOL, V10, P154, DOI 10.1016/S0962-8924(00)01727-X; Hu FH, 2001, CELL, V107, P655, DOI 10.1016/S0092-8674(01)00580-3; Jaspersen SL, 2000, CURR BIOL, V10, P615, DOI 10.1016/S0960-9822(00)00491-7; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; Kamieniecki RJ, 2000, CURR BIOL, V10, P1182, DOI 10.1016/S0960-9822(00)00723-5; KLAPHOLZ S, 1980, GENETICS, V96, P589; Lee SE, 2001, J CELL SCI, V114, P2345; Lee SE, 2001, CURR BIOL, V11, P784, DOI 10.1016/S0960-9822(01)00228-7; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Mah AS, 2001, P NATL ACAD SCI USA, V98, P7325, DOI 10.1073/pnas.141098998; McCollum D, 2001, TRENDS CELL BIOL, V11, P89, DOI 10.1016/S0962-8924(00)01901-2; MCGREW JT, 1992, MOL BIOL CELL, V3, P1443, DOI 10.1091/mbc.3.12.1443; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; PARKES V, 1992, NUCLEIC ACIDS RES, V20, P5617, DOI 10.1093/nar/20.21.5617; Severin F, 2001, J CELL BIOL, V155, P711, DOI 10.1083/jcb.200104096; SHARON G, 1990, GENETICS, V125, P487; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; SHIRAYAMA M, 1994, YEAST, V10, P451, DOI 10.1002/yea.320100404; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Sullivan M, 2001, NAT CELL BIOL, V3, P771, DOI 10.1038/ncb0901-771; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Taylor GS, 1997, J BIOL CHEM, V272, P24054, DOI 10.1074/jbc.272.38.24054; Tinker-Kulberg RL, 1999, GENE DEV, V13, P1936, DOI 10.1101/gad.13.15.1936; TOYN JH, 1994, EMBO J, V13, P1103, DOI 10.1002/j.1460-2075.1994.tb06359.x; Trautmann S, 2001, CURR BIOL, V11, P931, DOI 10.1016/S0960-9822(01)00268-8; Traverso EE, 2001, J BIOL CHEM, V276, P21924, DOI 10.1074/jbc.M011689200; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2001, CURR OPIN CELL BIOL, V13, P754, DOI 10.1016/S0955-0674(00)00279-9; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 2001, MOL BIOL CELL, V12, P2961, DOI 10.1091/mbc.12.10.2961; Xu SC, 2000, CURR BIOL, V10, P329, DOI 10.1016/S0960-9822(00)00382-1; YEH E, 1995, J CELL BIOL, V130, P687, DOI 10.1083/jcb.130.3.687; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zeng XM, 1999, J CELL BIOL, V146, P415, DOI 10.1083/jcb.146.2.415	45	368	379	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 25	2002	108	2					207	220		10.1016/S0092-8674(02)00618-9	http://dx.doi.org/10.1016/S0092-8674(02)00618-9			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832211	Bronze			2022-12-24	WOS:000173521300008
J	Helenius, J; Ng, DTW; Marolda, CL; Walter, P; Valvano, MA; Aebi, M				Helenius, J; Ng, DTW; Marolda, CL; Walter, P; Valvano, MA; Aebi, M			Translocation of lipid-linked oligosaccharides across the ER membrane requires Rft1 protein	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; GLYCOSYLATION REACTIONS; TRANSMEMBRANE MOVEMENT; BIOSYNTHESIS; TRANSPORT; CLONING; GLYCOPROTEINS; TOPOGRAPHY	N-linked glycosylation of proteins in eukaryotic cells follows a highly conserved pathway. The tetradecasaccharide substrate (Glc(3)Man(9)GlcNAc(2)) is first assembled at the membrane of the endoplasmic reticulum (ER) as a dolichylpyrophosphate (DolPP)-linked intermediate, and then transferred to nascent polypeptide chains in the lumen of the ER1. The assembly of the oligosaccharide starts on the cytoplasmic side of the ER membrane with the synthesis of a Man(5)GlcNAc(2)-PP-Dol intermediate. This lipid-linked intermediate is then translocated across the membrane so that the oligosaccharides face the lumen of the ER, where the biosynthesis of Glc(3)Man(9)GlcNAc(2)-PP-Dol continues to completion. The fully assembled oligosaccharide is transferred to selected asparagine residues of target proteins. The transmembrane movement of lipid-linked Man(5)GlcNAc(2) oligosaccharide is of fundamental importance in this biosynthetic pathway, and similar processes involving phospholipids and glycolipids are essential in all types of cells(2-4). The process is predicted to be catalysed by proteins, termed flippases, which to date have remained elusive(2-4). Here we provide evidence that yeast RFT1 encodes an evolutionarily conserved protein required for the translocation of Man(5)GlcNAc(2)-PP-Dol from the cytoplasmic to the lumenal leaflet of the ER membrane.	Swiss Fed Inst Technol, Inst Microbiol, CH-8092 Zurich, Switzerland; Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Western University (University of Western Ontario); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Aebi, M (corresponding author), Swiss Fed Inst Technol, Inst Microbiol, CH-8092 Zurich, Switzerland.	aebi@micro.biol.ethz.ch	Valvano, Miguel A/G-8759-2012	Valvano, Miguel A/0000-0001-8229-3641				ABEIJON C, 1992, TRENDS BIOCHEM SCI, V17, P32, DOI 10.1016/0968-0004(92)90424-8; Aebi M, 1996, GLYCOBIOLOGY, V6, P439, DOI 10.1093/glycob/6.4.439; Borst P, 2000, BBA-MOL CELL BIOL L, V1486, P128, DOI 10.1016/S1388-1981(00)00053-6; BUGG TDH, 1994, FEMS MICROBIOL LETT, V119, P255; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Cipollo JF, 2001, J BIOL CHEM, V276, P21828, DOI 10.1074/jbc.M010896200; Davidson EA, 2001, BIOCHIMIE, V83, P601, DOI 10.1016/S0300-9084(01)01316-5; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; Guthrie C, 1991, METHOD ENZYMOL, V194, P3; HANOVER JA, 1979, J BIOL CHEM, V254, P9237; HASILIK A, 1978, EUR J BIOCHEM, V91, P567, DOI 10.1111/j.1432-1033.1978.tb12710.x; Hettema EH, 2000, BBA-MOL CELL BIOL L, V1486, P18, DOI 10.1016/S1388-1981(00)00045-7; HIGGINS CF, 1994, CELL, V79, P393, DOI 10.1016/0092-8674(94)90248-8; HUFFAKER TC, 1983, P NATL ACAD SCI-BIOL, V80, P7466, DOI 10.1073/pnas.80.24.7466; JELINEKKELLY S, 1988, J BIOL CHEM, V263, P14757; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; MCCLOSKEY MA, 1980, BIOCHEMISTRY-US, V19, P2056, DOI 10.1021/bi00551a008; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; ORLEAN P, 1990, MOL CELL BIOL, V10, P5796, DOI 10.1128/MCB.10.11.5796; ORLEAN P, 1991, METHOD ENZYMOL, V194, P682; PEREZ M, 1986, J BIOL CHEM, V261, P6822; RUSH JS, 1995, J CELL BIOL, V130, P529, DOI 10.1083/jcb.130.3.529; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; SNIDER MD, 1984, CELL, V36, P753, DOI 10.1016/0092-8674(84)90355-6; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Wach A, 1998, METHOD MICROBIOL, V26, P67; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240; ZUFFEREY R, 1995, EMBO J, V14, P4949, DOI 10.1002/j.1460-2075.1995.tb00178.x	28	200	205	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2002	415	6870					447	450		10.1038/415447a	http://dx.doi.org/10.1038/415447a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807558				2022-12-24	WOS:000173433600054
J	Green, J; Forster, A; Bogle, S; Young, J				Green, J; Forster, A; Bogle, S; Young, J			Physiotherapy for patients with mobility, problems more than 1 year after stroke: a randomised controlled trial	LANCET			English	Article							REHABILITATION	Background Community physiotherapy is often prescribed for stroke patients with long-term mobility problems. We aimed to assess the effectiveness of this treatment in patients who had mobility problems 1 year after stroke. Methods We screened 359 patients older than 50 years for a single-masked, randomised controlled trial to assess the effects of community physiotherapy. Assessments were made at baseline, 3, 6, and 9 months in 170 eligible patients assigned treatment or no intervention. The primary outcome measure was mobility measured by the Rivermead mobility index. Secondary outcome measures were gait speed, number of falls, daily activity (Barthel index scores), social activity (Frenchay activities index), hospital anxiety and depression scale, and emotional stress of carers (general health questionnaire 28). Analyses were by intention to treat. Findings Follow-up was available for 146 patients (86%). Changes in scores on the Rivermead mobility index (score range 0-15) differed significantly between treatment and control groups at 3 months (p=0.018), but only by a median of 1 point (95% CI 0.1), with an interpolated value of 0.55 (0.08-1.04). Gait speed was 2.6 m/min (0.30-4.95) higher in the treatment group at 3 months. Neither treatment effect persisted at 6-months' and 9-months' follow-up. Treatment had no effect on patients' daily activity, social activity, anxiety, depression, and number of falls, or on emotional stress of carers. Interpretation Community physiotherapy treatment for patients with mobility problems 1 year after stroke leads to significant, but clinically small, improvements in mobility and gait speed that are not sustained after treatment ends.	St Lukes Hosp, Dept Hlth Care Elderly, Bradford BD5 0NA, W Yorkshire, England; Bradford Community NHS Trust, Rehabil Serv, Bradford, W Yorkshire, England; Aysgarth Stat, Beaconsfield, England		Green, J (corresponding author), St Lukes Hosp, Dept Hlth Care Elderly, Bradford BD5 0NA, W Yorkshire, England.			Forster, Anne/0000-0001-7466-4414; young, john/0000-0003-4085-9306				Collen F M, 1991, Int Disabil Stud, V13, P50; Collen F M, 1991, Int Disabil Stud, V13, P12; Collen F M, 1990, Int Disabil Stud, V12, P6; Collin C, 1988, Int Disabil Stud, V10, P61; Corr S, 1995, CLIN REHABIL, V9, P291; DAM M, 1993, STROKE, V24, P1186, DOI 10.1161/01.STR.24.8.1186; DOWSWELL G, IN PRESS B J THER RE; Enderby P M, 1987, Int Rehabil Med, V8, P166; FORSTER A, 1995, BRIT MED J, V311, P83, DOI 10.1136/bmj.311.6997.83; GLADMAN JRF, 1995, CLIN REHABIL, V9, P245; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; GREEN J, 1999, BR J THER REHABIL, V6, P216; HODKINSON H M, 1972, Age and Ageing, V1, P233, DOI 10.1093/ageing/1.4.233; HOLBROOK M, 1983, AGE AGEING, V12, P166, DOI 10.1093/ageing/12.2.166; HOLDEN MK, 1986, PHYS THER, V66, P1530, DOI 10.1093/ptj/66.10.1530; LEHMANN JF, 1975, ARCH PHYS MED REHAB, V56, P375; Rodriquez AA, 1996, ARCH PHYS MED REHAB, V77, P801, DOI 10.1016/S0003-9993(96)90260-9; TANGEMAN PT, 1990, ARCH PHYS MED REHAB, V71, P876; WADE D, 2000, NATL CLIN GUIDELINES, P64; WADE DT, 1992, BRIT MED J, V304, P609, DOI 10.1136/bmj.304.6827.609; WALKER MF, 1996, CLIN REHABIL, V10, P23, DOI DOI 10.1177/026921559601000105; Werner RA, 1996, AM J PHYS MED REHAB, V75, P114, DOI 10.1097/00002060-199603000-00006; Wilkinson PR, 1997, STROKE, V28, P507, DOI 10.1161/01.STR.28.3.507; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	24	139	145	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 19	2002	359	9302					199	203		10.1016/S0140-6736(02)07443-3	http://dx.doi.org/10.1016/S0140-6736(02)07443-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512YH	11812553				2022-12-24	WOS:000173350800009
J	Lewis, JD; Brown, A; Localio, AR; Schwartz, JS				Lewis, JD; Brown, A; Localio, AR; Schwartz, JS			Initial evaluation of rectal bleeding in young persons: A cost-effectiveness analysis	ANNALS OF INTERNAL MEDICINE			English	Article							CONTRAST BARIUM-ENEMA; COLORECTAL-CANCER; FLEXIBLE SIGMOIDOSCOPY; GENERAL-PRACTICE; COLONOSCOPIC POLYPECTOMY; ASYMPTOMATIC ADULTS; PREDICTIVE-VALUE; LARGE-BOWEL; FOLLOW-UP; POLYPS	Background: Evaluation of rectal bleeding in young patients is a frequent diagnostic challenge. Objective: To determine the relative cost-effectiveness of alternative diagnostic strategies for young patients with rectal bleeding. Design: Cost-effectiveness analysis using a Markov model. Data Sources: Probability estimates were based on published medical literature. Cost estimates were based on Medicare reimbursement rates and published medical literature. Target Population: Persons 25 to 45 years of age with otherwise asymptomatic rectal bleeding. Time Horizon: The patient's lifetime. Perspective: Modified societal perspective. Interventions: Diagnostic strategies included no evaluation, colonoscopy, flexible sigmoidoscopy, barium enema, anoscopy, or any feasible combination of these procedures. Outcome Measures: Life expectancy and costs, Results of Base-Case Analysis: For 35-year-old patients, the no-evaluation strategy yielded the least life expectancy. The incremental cost-effectiveness of flexible sigmoidoscopy compared with no evaluation or with any strategy incorporating anoscopy (followed by further evaluation if no anal disease was found on anoscopy) was less than $5300 per year of life gained. A strategy of flexible sigmoidoscopy plus barium enema yielded the greatest life expectancy, with an incremental cost of $23 918 per additional life-year gained compared with flexible sigmoidoscopy alone. Results of Sensitivity Analysis: As patient age at presentation of rectal bleeding increased, evaluation of the entire colon became more cost-effective. The incremental cost-effectiveness of flexible sigmoidoscopy plus barium enema compared with colonoscopy was sensitive to estimates of the sensitivity of the tests. In a probabilistic sensitivity analysis comparing flexible sigmoidoscopy with anoscopy followed by flexible sigmoidoscopy if needed, the middle 95th percentile of the distribution of the incremental cost-effectiveness ratios ranged from flexible sigmoidoscopy yielding an increased life expectancy at reduced cost to $52 158 per year of life. gained (mean, $11 461 per year of life saved). Conclusions: Evaluation of the colon of persons 25 to 45 years of age with otherwise asymptomatic rectal bleeding increases the life expectancy at a cost comparable to that of colon cancer screening.	Univ Penn, Ctr Canc, Ctr Clin Epidemiol & Biostat, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Lewis, JD (corresponding author), Univ Penn, Ctr Canc, Ctr Clin Epidemiol & Biostat, Leonard Davis Inst Hlth Econ, Blockley Hall,9th Floor,423 Guardian Dr, Philadelphia, PA 19104 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002589] Funding Source: NIH RePORTER; NIDDK NIH HHS [1-K08-DK02589-0] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACOSTA JA, 1994, AM SURGEON, V60, P903; Blatt LJ., 1961, DIS COLON RECTUM, V4, P277; BRAND EJ, 1980, ANN SURG, V192, P111, DOI 10.1097/00000658-198007000-00019; CHAPUIS PH, 1985, BRIT MED J, V290, P1546, DOI 10.1136/bmj.290.6481.1546; CROSLAND A, 1995, BRIT MED J, V311, P486, DOI 10.1136/bmj.311.7003.486; DENT OF, 1986, DIS COLON RECTUM, V29, P243, DOI 10.1007/BF02553027; FARQUHARSON SM, 1994, LANCET, V344, P751, DOI 10.1016/S0140-6736(94)92241-1; FIJTEN GH, 1995, FAM PRACT, V12, P279, DOI 10.1093/fampra/12.3.279; FIJTEN GH, 1994, BRIT J GEN PRACT, V44, P320; FIJTEN GH, 1993, FAM PRACT, V10, P283, DOI 10.1093/fampra/10.3.283; Fine KD, 1999, AM J GASTROENTEROL, V94, P3202, DOI 10.1016/S0002-9270(99)00578-X; Fireman BH, 1997, HEALTH CARE FINANC R, V18, P51; Frazier AL, 2000, JAMA-J AM MED ASSOC, V284, P1954, DOI 10.1001/jama.284.15.1954; GOULSTON KJ, 1986, LANCET, V2, P261; GUILLEM JG, 1987, ANN SURG, V206, P606; Helfand M, 1997, JAMA-J AM MED ASSOC, V277, P44, DOI 10.1001/jama.277.1.44; HIXSON LJ, 1989, EUR J RADIOL, V9, P254; HOFF G, 1986, SCAND J GASTROENTERO, V21, P853, DOI 10.3109/00365528609011130; Hoff G, 1996, SCAND J GASTROENTERO, V31, P1006, DOI 10.3109/00365529609003121; HOFF G, 1986, SCAND J GASTROENTERO, V21, P848, DOI 10.3109/00365528609011129; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; IRVINE EJ, 1988, GUT, V29, P1188, DOI 10.1136/gut.29.9.1188; JARAMILLO E, 1992, GASTROINTEST RADIOL, V17, P81, DOI 10.1007/BF01888514; Kewenter J, 1996, DIS COLON RECTUM, V39, P676, DOI 10.1007/BF02056949; KORETZ RL, 1993, ANN INTERN MED, V118, P63, DOI 10.7326/0003-4819-118-1-199301010-00011; KORKIS AM, 1995, DIGEST DIS SCI, V40, P1520, DOI 10.1007/BF02285201; LEWIS J, IN PRESS DIG DIS SCI; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; LIEBERMAN DA, 1995, GASTROENTEROLOGY, V109, P1781, DOI 10.1016/0016-5085(95)90744-0; MAKELA JT, 1993, SCAND J GASTROENTERO, V28, P1062, DOI 10.3109/00365529309098310; MANT A, 1989, DIS COLON RECTUM, V32, P191, DOI 10.1007/BF02554525; Metcalf JV, 1996, BRIT J GEN PRACT, V46, P161; Parkin D.M., 1992, CANC INCIDENCE 5 CON; Podolsky DK, 2000, NEW ENGL J MED, V343, P207, DOI 10.1056/NEJM200007203430309; PROVENZALE D, 1990, ANN INTERN MED, V113, P760, DOI 10.7326/0003-4819-113-10-760; RAFTERY TL, 1980, AM SURGEON, V46, P600; REX DK, 1990, GASTROENTEROLOGY, V98, P855, DOI 10.1016/0016-5085(90)90007-N; RICKERT RR, 1979, CANCER-AM CANCER SOC, V43, P1847, DOI 10.1002/1097-0142(197905)43:5<1847::AID-CNCR2820430538>3.0.CO;2-L; Ries L, 1998, SEER CANC STAT REV 1; ROSEN L, 1993, DIS COLON RECTUM, V36, P1126, DOI 10.1007/BF02052261; Shennak MM, 1997, DIS COLON RECTUM, V40, P208, DOI 10.1007/BF02054990; SHINYA H, 1982, SURG CLIN N AM, V62, P897; SINGARAM C, 1995, AM J GASTROENTEROL, V90, P146; Sonnenberg A, 2000, ANN INTERN MED, V133, P573, DOI 10.7326/0003-4819-133-8-200010170-00007; STANILAND JR, 1976, GASTROENTEROLOGY, V70, P22; STRYKER SJ, 1987, GASTROENTEROLOGY, V93, P1009, DOI 10.1016/0016-5085(87)90563-4; Talley NJ, 1998, AM J GASTROENTEROL, V93, P2179; THOENI RF, 1983, RADIOLOGY, V146, P603, DOI 10.1148/radiology.146.3.6600844; VENTURA S, 1996, BIRTHS DEATHS US 199; Waye J D, 1993, Gastroenterologist, V1, P158; Waye J D, 1996, Gastrointest Endosc Clin N Am, V6, P343; WAYE JD, 1988, AM J GASTROENTEROL, V83, P120; WAYE JD, 1992, J CLIN GASTROENTEROL, V15, P347, DOI 10.1097/00004836-199212000-00018; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Winawer SJ, 2000, NEW ENGL J MED, V342, P1766, DOI 10.1056/NEJM200006153422401; Wright JC, 1998, NEW ENGL J MED, V339, P380, DOI 10.1056/NEJM199808063390606; 1999, MMWR MORB MORTAL WKL, V48, P116	60	29	31	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2002	136	2					99	110		10.7326/0003-4819-136-2-200201150-00007	http://dx.doi.org/10.7326/0003-4819-136-2-200201150-00007			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512PZ	11790061				2022-12-24	WOS:000173333900002
J	Tucker, J; Mccabe, C; McCabe, C; Nicolson, P; Tarnow-Mordi, W; Marlow, N; Baumer, H; Boen, M; Hamilton, K; Meran, JA; Milligan, D; Nicoll, J; Redshaw, M; Rowan, K; Scott, J; Smith, J				Tucker, J; Mccabe, C; McCabe, C; Nicolson, P; Tarnow-Mordi, W; Marlow, N; Baumer, H; Boen, M; Hamilton, K; Meran, JA; Milligan, D; Nicoll, J; Redshaw, M; Rowan, K; Scott, J; Smith, J		UK Neonatgal Staffing Study Grp	Patient volume, staffing, and workload in relation to risk-adjusted outcomes in a random stratified sample of UK neonatal intensive care units: a prospective evaluation	LANCET			English	Article							BIRTH; MORTALITY	Background UK recommendations suggest that large neonatal intensive-care units (NICUs) have better outcomes than small units, although this suggestion remains unproven. We assessed whether patient volume, staffing levels, and workload are associated with risk-adjusted outcomes, and with costs or staff wellbeing. Methods 186 UK NICUs were stratified according to volume of patients, nursing provision, and neonatal consultant provision. Primary outcomes were hospital mortality, mortality or cerebral damage, and nosocomial bacteraemia. We studied 13 515 infants of all birthweights consecutively admitted to 54 randomly selected NICUs. Multiple logistic regression analyses were done with every primary outcome as the dependent variable. Staff wellbeing and stress were assessed by anonymous mental health index (MHI)-5 questionnaires. Findings Data were available for 13 334 (99%) infants. High-volume NICUs treated the sickest infants and had highest crude mortality. Risk-adjusted mortality and mortality or cerebral damage were unrelated to patient volume or staffing provision; however, nosocomial bacteraemia was less frequent in NICUs with low neonatal consultant provision (odds ratio 0.65, 95% Cl 0.43-0.98). Mortality was raised with increasing workload in all types of NICUs. Infants admitted at full capacity versus half capacity were about 50% more likely to die, but there was wide uncertainty around this estimate. Most staff had MHI-5 scores that suggested good mental health. Interpretation The implications of this report for staffing policy, medicolegal risk management, and ethical practice remain to be tested. Centralisation of only the sickest infants could improve efficiency, provided that this does not create excessive workload for staff. Assessment of increased staffing levels that are closer to those in adult intensive care might be appropriate.	Univ Aberdeen, Dept Obstet & Gynaecol, Dugald Baird Ctr Res Womens Hlth, Aberdeen AB25 2ZL, Scotland; Univ Sheffield, ScHARR, Med Care Res Unit, Sheffield S10 2TN, S Yorkshire, England; Univ Sheffield, ScHARR, Sheffield Hlth Econ Grp, Sheffield S10 2TN, S Yorkshire, England; Univ Sydney, Westmead & New Childrens Hosp, Sydney, NSW 2006, Australia	University of Aberdeen; University of Sheffield; University of Sheffield; University of Sydney	Tucker, J (corresponding author), Univ Aberdeen, Dept Obstet & Gynaecol, Dugald Baird Ctr Res Womens Hlth, Aberdeen AB25 2ZL, Scotland.	j.s.tucker@abdn.ac.uk	Parry, Gareth/CAF-6975-2022; Marlow, Neil/D-2918-2009; McCabe, Christopher/E-2051-2016	Marlow, Neil/0000-0001-5890-2953; 				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; *BRIT ASS PER MED, 1996, STAND HOSP PROV NEON; Brodie SB, 2000, PEDIATR INFECT DIS J, V19, P56, DOI 10.1097/00006454-200001000-00012; COCKBURN F, 1993, LANCET, V342, P193; Costeloe K, 2000, PEDIATRICS, V106, P659, DOI 10.1542/peds.106.4.659; FIELD D, 1991, ARCH DIS CHILD-FETAL, V66, P408, DOI 10.1136/adc.66.4_Spec_No.408; Field D, 1999, ARCH DIS CHILD-FETAL, V80, pF111, DOI 10.1136/fn.80.2.F111; Goldfrad C, 2000, LANCET, V355, P1138, DOI 10.1016/S0140-6736(00)02062-6; GOLDFRAD C, 2000, J EPIDEMIOL COMMUN H, pA9; Jones J, 1995, INT J TECHNOL ASSESS, V11, P762, DOI 10.1017/S0266462300009193; McCabe CJ, 1996, BRIT J PSYCHIAT, V169, P517, DOI 10.1192/bjp.169.4.516; MCFARLANE A, 2000, BIRTH COUNTS STAT PR, P544; Mugford M, 1998, ARCH DIS CHILD-FETAL, V78, pF179; Murphy E., 1998, HEALTH TECHNOL ASSES, V2, pI, DOI [10.3310/hta2030, DOI 10.3310/HTA2030]; *NHS CTR REV DISS, 1996, EFFECTIVE HLTH CARE, V2, P1; O'Neill C, 2000, J PUBLIC HEALTH MED, V22, P108, DOI 10.1093/pubmed/22.1.108; Parmanum J, 2000, BMJ-BRIT MED J, V321, P727, DOI 10.1136/bmj.321.7263.727; Parry GJ, 1998, BRIT MED J, V316, P1931, DOI 10.1136/bmj.316.7149.1931; Pearson G, 1997, LANCET, V349, P1213, DOI 10.1016/S0140-6736(96)12396-5; Phibbs CS, 1996, JAMA-J AM MED ASSOC, V276, P1054, DOI 10.1001/jama.276.13.1054; PICKERING J, 1993, ARCH DIS CHILD-FETAL, V68, P539; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 1999, ANN INTERN MED, V130, P126, DOI 10.7326/0003-4819-130-2-199901190-00006; POLLACK MM, 1994, JAMA-J AM MED ASSOC, V272, P941, DOI 10.1001/jama.272.12.941; Redshaw M., 1996, DELIVERING NEONATAL; RICHARDSON DK, 1993, PEDIATRICS, V91, P969; SEPKOWITZ S, 1993, LANCET, V342, P938, DOI 10.1016/0140-6736(93)91992-U; *SOC SERV COMM, 1980, PER NEON MORT 2 REP; Tarnow-Mordi W, 2000, ARCH DIS CHILD-FETAL, V82, pF118; Tarnow-Mordi WO, 2000, LANCET, V356, P185, DOI 10.1016/S0140-6736(00)02478-8; TarnowMordi W, 1997, LANCET, V350, P66, DOI 10.1016/S0140-6736(05)66269-1; TARNOWMORDI W, 2002, RISK ADJUSTED OUTCOM; TARNOWMORDI WO, 1997, SEMIN NEONATOL, V2, P171; Tilford JM, 2000, PEDIATRICS, V106, P289, DOI 10.1542/peds.106.2.289; Tucker J, 1999, ARCH DIS CHILD-FETAL, V80, pF233, DOI 10.1136/fn.80.3.F233; UKOUMUNNE OC, 1999, HEALTH TECHNOL ASSES, V3, P33; WHEELER RHB, 1995, ARCH DIS CHILD, V73, pF32; *WORK GROUP NEON I, 1995, NEON INT CAR ACC AV; 1986, LANCET, V1, P777	39	194	196	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 12	2002	359	9301					99	107						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	510MT	11809250				2022-12-24	WOS:000173212400007
J	Gavin, AC; Bosche, M; Krause, R; Grandi, P; Marzioch, M; Bauer, A; Schultz, J; Rick, JM; Michon, AM; Cruciat, CM; Remor, M; Hofert, C; Schelder, M; Brajenovic, M; Ruffner, H; Merino, A; Klein, K; Hudak, M; Dickson, D; Rudi, T; Gnau, V; Bauch, A; Bastuck, S; Huhse, B; Leutwein, C; Heurtier, MA; Copley, RR; Edelmann, A; Querfurth, E; Rybin, V; Drewes, G; Raida, M; Bouwmeester, T; Bork, P; Seraphin, B; Kuster, B; Neubauer, G; Superti-Furga, G				Gavin, AC; Bosche, M; Krause, R; Grandi, P; Marzioch, M; Bauer, A; Schultz, J; Rick, JM; Michon, AM; Cruciat, CM; Remor, M; Hofert, C; Schelder, M; Brajenovic, M; Ruffner, H; Merino, A; Klein, K; Hudak, M; Dickson, D; Rudi, T; Gnau, V; Bauch, A; Bastuck, S; Huhse, B; Leutwein, C; Heurtier, MA; Copley, RR; Edelmann, A; Querfurth, E; Rybin, V; Drewes, G; Raida, M; Bouwmeester, T; Bork, P; Seraphin, B; Kuster, B; Neubauer, G; Superti-Furga, G			Functional organization of the yeast proteome by systematic analysis of protein complexes	NATURE			English	Article							LARGE-SCALE ANALYSIS; SACCHAROMYCES-CEREVISIAE; MASS-SPECTROMETRY; GENOMIC ANALYSIS; GENE-EXPRESSION; IDENTIFICATION; SUBUNITS; PURIFICATION; GENERATION; NETWORK	Most cellular processes are carried out by multiprotein complexes. The identification and analysis of their components provides insight into how the ensemble of expressed proteins (proteome) is organized into functional units. We used tandem-affinity purification (TAP) and mass spectrometry in a large-scale approach to characterize multiprotein complexes in Saccharomyces cerevisiae. We processed 1,739 genes, including 1,143 human orthologues of relevance to human biology, and purified 589 protein assemblies. Bioinformatic analysis of these assemblies defined 232 distinct multiprotein complexes and proposed new cellular roles for 344 proteins, including 231 proteins with no previous functional annotation. Comparison of yeast and human complexes showed that conservation across species extends from single proteins to their molecular environment. Our analysis provides an outline of the eukaryotic proteome as a network of protein complexes at a level of organization beyond binary interactions. This higher-order map contains fundamental biological information and offers the context for a more reasoned and informed approach to drug discovery.	Cellzome AG, D-69117 Heidelberg, Germany; European Mol Biol Lab, D-69117 Heidelberg, Germany; CNRS, CGM, F-91198 Gif Sur Yvette, France	GlaxoSmithKline; Cellzome GmbH; European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Gavin, AC (corresponding author), Cellzome AG, Meyerhofstr 1, D-69117 Heidelberg, Germany.	anne-claude.gavin@cellzome.com; giulio.superti-furga@cellzome.com	Kuster, Bernhard/Q-6031-2016; Bork, Peer/F-1813-2013; Schultz, Joerg/B-9346-2008; Superti-Furga, Giulio/F-4755-2015; Superti-Furga, Giulio/AAE-5681-2019	Kuster, Bernhard/0000-0002-9094-1677; Bork, Peer/0000-0002-2627-833X; Superti-Furga, Giulio/0000-0002-0570-1768; Drewes, Gerard/0000-0003-0575-6766; Bauch, Angela/0000-0002-8712-4414; Krause, Roland/0000-0001-9938-7126; Gavin, Anne-Claude/0000-0003-4917-2340; Seraphin, Bertrand/0000-0002-5168-1921				Albert TK, 2000, NUCLEIC ACIDS RES, V28, P809, DOI 10.1093/nar/28.3.809; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barabino SML, 1999, CELL, V99, P9, DOI 10.1016/S0092-8674(00)80057-4; Bassett DE, 1996, NATURE, V379, P589, DOI 10.1038/379589a0; Blackstock WP, 1999, TRENDS BIOTECHNOL, V17, P121, DOI 10.1016/S0167-7799(98)01245-1; Costanzo MC, 2001, NUCLEIC ACIDS RES, V29, P75, DOI 10.1093/nar/29.1.75; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Garrels JI, 1997, ELECTROPHORESIS, V18, P1347, DOI 10.1002/elps.1150180810; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Huynen M, 2000, GENOME RES, V10, P1204, DOI 10.1101/gr.10.8.1204; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Liu HY, 1998, EMBO J, V17, P1096, DOI 10.1093/emboj/17.4.1096; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; Neubauer G, 1997, P NATL ACAD SCI USA, V94, P385, DOI 10.1073/pnas.94.2.385; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Roses AD, 2000, NATURE, V405, P857, DOI 10.1038/35015728; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Sacher M, 2000, EUR J CELL BIOL, V79, P71, DOI 10.1078/S0171-9335(04)70009-6; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	46	3686	3843	3	287	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					141	147		10.1038/415141a	http://dx.doi.org/10.1038/415141a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805826				2022-12-24	WOS:000173159300033
J	Himanen, JP; Rajashankar, KR; Lackmann, M; Cowan, CA; Henkemeyer, M; Nikolov, DB				Himanen, JP; Rajashankar, KR; Lackmann, M; Cowan, CA; Henkemeyer, M; Nikolov, DB			Crystal structure of an Eph receptor-ephrin complex	NATURE			English	Article							LIGAND-BINDING; TRANSMEMBRANE LIGANDS; TYROSINE KINASES; SAM DOMAIN; NUK; DIMERIZATION; ATTACHMENT; PROTEINS; BRAIN; AXONS	The Eph family of receptor tyrosine kinases and their membrane-anchored ephrin ligands are important in regulating cell-cell interactions as they initiate a unique bidirectional signal transduction cascade whereby information is communicated into both the Eph-expressing and the ephrin-expressing cells. Initially identified as regulators of axon pathfinding and neuronal cell migration, Ephs and ephrins are now known to have roles in many other cell-cell interactions, including those of vascular endothelial cells and specialized epithelia(1,2). Here we report the crystal structure of the complex formed between EphB2 and ephrin-B2, determined at 2.7 Angstrom resolution. Each Eph receptor binds an ephrin ligand through an expansive dimerization interface dominated by the insertion of an extended ephrin loop into a channel at the surface of the receptor. Two Eph-Ephrin dimers then join to form a tetramer, in which each ligand interacts with two receptors and each receptor interacts with two ligands. The Eph and ephrin molecules are precisely positioned and orientated in these complexes, promoting higher-order clustering and the initiation of bidirectional signalling.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Brookhaven Natl Lab, Upton, NY 11973 USA; Royal Melbourne Hosp, Ludwig Inst Canc Res, Parkville, Vic 3050, Australia; Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Kent Waldrep Fdn Ctr Basic Res Nerve Growth & Reg, Dallas, TX 75390 USA	Memorial Sloan Kettering Cancer Center; United States Department of Energy (DOE); Brookhaven National Laboratory; Ludwig Institute for Cancer Research; Royal Melbourne Hospital; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Nikolov, DB (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.			Henkemeyer, Mark/0000-0002-7525-1061				[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; BRUNGER AT, 1993, XPLOR V 3 1 MANUAL; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Cowan CA, 2000, NEURON, V26, P417, DOI 10.1016/S0896-6273(00)81174-5; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Flanagan JG, 1997, CELL, V90, P403; Frisen J, 1999, EMBO J, V18, P5159, DOI 10.1093/emboj/18.19.5159; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; HENKEMEYER M, 1994, ONCOGENE, V9, P1001; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Himanen JP, 1998, NATURE, V396, P486, DOI 10.1038/24904; Hockley D, 1998, JAVA REP, V3, P6; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Labrador JP, 1997, EMBO J, V16, P3889, DOI 10.1093/emboj/16.13.3889; Lackmann M, 1997, J BIOL CHEM, V272, P16521, DOI 10.1074/jbc.272.26.16521; Lackmann M, 1998, J BIOL CHEM, V273, P20228, DOI 10.1074/jbc.273.32.20228; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Otwinowski Z., 1993, DATA COLLECTION PROC, P556; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Toth J, 2001, DEV CELL, V1, P83, DOI 10.1016/S1534-5807(01)00002-8	29	261	274	0	16	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					933	938		10.1038/414933a	http://dx.doi.org/10.1038/414933a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780069				2022-12-24	WOS:000172813300052
J	Jacobs, SA; Khorasanizadeh, S				Jacobs, SA; Khorasanizadeh, S			Structure of HP1 chromodomain bound to a lysine 9-methylated histone H3 tail	SCIENCE			English	Article							NUCLEOSOME CORE PARTICLE; METHYLATION; DOMAIN; RECOGNITION	The chromodomain of the HP1 family of proteins recognizes histone tails with specifically methylated lysines. Here, we present structural, energetic, and mutational analyses of the complex between the Drosophila HP1 chromodomain and the histone H3 tail with a methyllysine at residue 9, a modification associated with epigenetic silencing. The histone tail inserts as a beta strand, completing the beta-sandwich architecture of the chromodomain. The methylammonium group is caged by three aromatic side chains, whereas adjacent residues form discerning contacts with one face of the chromodomain. Comparison of dimethyl- and trimethyllysine-containing complexes suggests a role for cation-pi and van der Waals interactions, with trimethylation slightly improving the binding affinity.	Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Khorasanizadeh, S (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	khorasan@virginia.edu			NIGMS NIH HHS [GM63959-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063959] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; Ball LJ, 1997, EMBO J, V16, P2473, DOI 10.1093/emboj/16.9.2473; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BLACK SD, 1991, ANAL BIOCHEM, V193, P72, DOI 10.1016/0003-2697(91)90045-U; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Harp JM, 2000, ACTA CRYSTALLOGR D, V56, P1513, DOI 10.1107/S0907444900011847; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; JACOBS SA, UNPUB; JANIN J, 1988, J MOL BIOL, V204, P155, DOI 10.1016/0022-2836(88)90606-7; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967	18	632	644	3	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2002	295	5562					2080	2083		10.1126/science.1069473	http://dx.doi.org/10.1126/science.1069473			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532AY	11859155				2022-12-24	WOS:000174450500051
J	Dubrova, YE; Bersimbaev, RI; Djansugurova, LB; Tankimanova, MK; Mamyrbaeva, ZZ; Mustonen, R; Lindholm, C; Hulten, M; Salomaa, S				Dubrova, YE; Bersimbaev, RI; Djansugurova, LB; Tankimanova, MK; Mamyrbaeva, ZZ; Mustonen, R; Lindholm, C; Hulten, M; Salomaa, S			Nuclear weapons tests and human germline mutation rate	SCIENCE			English	Article									Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Kazakh State Natl Univ, Almaty 480121, Kazakhstan; Inst Gen Genet & Cytol, Almaty 480060, Kazakhstan; STUK Radiat & Nucl Safety Author, Helsinki 00881, Finland; Univ Warwick, Dept Biol Sci, Coventry CV4 7A1, W Midlands, England	University of Leicester; Al-Farabi Kazakh National University; Institute of Genetics & Physiology of the Ministry of Science & Higher Education; Radiation & Nuclear Safety Authority (STUK); University of Warwick	Dubrova, YE (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.		Leyla, Djansugurova/AAZ-1063-2020; Dubrova, Yuri/ABA-7148-2020	Leyla, Djansugurova/0000-0002-6745-9903; Dubrova, Yuri/0000-0001-5281-7539				Dubrova YE, 1997, MUTAT RES-FUND MOL M, V381, P267; Dubrova YE, 1996, NATURE, V380, P683, DOI 10.1038/380683a0; Gusev BI, 1997, RADIAT ENVIRON BIOPH, V36, P201, DOI 10.1007/s004110050072; MATSUSCHENKO M, 1998, NUCL TESTS LONG TERM, P89	4	108	123	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1037	1037		10.1126/science.1068102	http://dx.doi.org/10.1126/science.1068102			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834827				2022-12-24	WOS:000173793000055
J	Holt, JR; Gillespie, SKH; Provance, DW; Shah, K; Shokat, KM; Corey, DP; Mercer, JA; Gillespie, PG				Holt, JR; Gillespie, SKH; Provance, DW; Shah, K; Shokat, KM; Corey, DP; Mercer, JA; Gillespie, PG			A chemical-genetic strategy implicates myosin-1c in adaptation by hair cells	CELL			English	Article							MECHANOELECTRICAL TRANSDUCTION; BULLFROGS SACCULUS; I-BETA; BLOCK ADAPTATION; MOUSE UTRICLE; INNER-EAR; TIP LINKS; LOCALIZATION; KINASE; IDENTIFICATION	Myosin-1c (also known as myosin-1beta) has been proposed to mediate the slow component of adaptation by hair cells, the sensory cells of the inner ear. To test this hypothesis, we mutated tyrosine-61 of myosin-1c to glycine, conferring susceptibility to inhibition by N-6-modified ADP analogs. We expressed the mutant myosin-1c in utricular hair cells of transgenic, mice, delivered an ADP analog through a whole-cell recording pipette, and found that the analog rapidly blocked adaptation to positive and negative deflections in transgenic cells but not in wild-type cells. The speed and specificity of inhibition suggests that myosin-1c participates in adaptation in hair cells.	Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02114 USA; Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA; McLaughlin Res Inst, Great Falls, MT 59405 USA; Genom Inst Novartis Res Fdn, San Diego, CA 92121 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Virginia; McLaughlin Research Institute for Biomedical Sciences, Inc.; Novartis; University of California System; University of California San Francisco; Oregon Health & Science University	Gillespie, PG (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	gillespp@ohsu.edu	Provance, David W/D-5294-2013	Provance, David W/0000-0002-9824-0672; Corey, David/0000-0003-4497-6016; Barr-Gillespie, Peter/0000-0002-9787-5860; Mercer, John/0000-0003-0307-4438	NATIONAL CANCER INSTITUTE [R01CA070331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002368, R01DC003279] Funding Source: NIH RePORTER; NCI NIH HHS [CA70331] Funding Source: Medline; NIDCD NIH HHS [DC02368, DC03279, R01 DC002368-06, R01 DC003279-04, DC00304] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ASSAD JA, 1992, J NEUROSCI, V12, P3291; Benser ME, 1996, J NEUROSCI, V16, P5629; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Bishop A, 2000, ANNU REV BIOPH BIOM, V29, P577, DOI 10.1146/annurev.biophys.29.1.577; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; CANDE WZ, 1986, METHOD ENZYMOL, V134, P473; COOKE R, 1985, BIOPHYS J, V48, P789, DOI 10.1016/S0006-3495(85)83837-6; COREY DP, 1983, J NEUROSCI, V3, P962; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; DUMONT, 2002, IN PRESS J ASS RES O, V3; Eatock RA, 2000, ANNU REV NEUROSCI, V23, P285, DOI 10.1146/annurev.neuro.23.1.285; EATOCK RA, 1987, J NEUROSCI, V7, P2821; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; FLOCK A, 1981, J NEUROCYTOL, V10, P133, DOI 10.1007/BF01181749; Garcia JA, 1998, J NEUROSCI, V18, P8637; GILLESPIE PG, 1993, NEURON, V11, P581, DOI 10.1016/0896-6273(93)90071-X; GILLESPIE PG, 1991, J CELL BIOL, V112, P625, DOI 10.1083/jcb.112.4.625; GILLESPIE PG, 1993, P NATL ACAD SCI USA, V90, P2710, DOI 10.1073/pnas.90.7.2710; Gillespie PG, 1997, NEURON, V19, P955, DOI 10.1016/S0896-6273(00)80387-6; Gillespie PG, 2001, J CELL BIOL, V155, P703, DOI 10.1083/jcb.200110032; Gillespie PG, 1999, J BIOL CHEM, V274, P31373, DOI 10.1074/jbc.274.44.31373; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hamilton BA, 1997, NEURON, V18, P711, DOI 10.1016/S0896-6273(00)80312-8; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Holt JR, 1999, ANN NY ACAD SCI, V871, P15, DOI 10.1111/j.1749-6632.1999.tb09172.x; Holt JR, 1997, J NEUROSCI, V17, P8739; Holt JR, 2000, P NATL ACAD SCI USA, V97, P11730, DOI 10.1073/pnas.97.22.11730; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; Kapoor TM, 1999, P NATL ACAD SCI USA, V96, P9106, DOI 10.1073/pnas.96.16.9106; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; Pestic-Dragovich L, 2000, SCIENCE, V290, P337, DOI 10.1126/science.290.5490.337; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; RUPPERT C, 1995, J CELL SCI, V108, P3775; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; SHEPHERD GMG, 1994, J NEUROSCI, V14, P6217; SHERR EH, 1993, J CELL BIOL, V120, P1405, DOI 10.1083/jcb.120.6.1405; SHIODA T, 1991, BIOCHIM BIOPHYS ACTA, V1115, P30, DOI 10.1016/0304-4165(91)90007-4; Steyger PS, 1998, J NEUROSCI, V18, P4603; Walker RG, 1996, P NATL ACAD SCI USA, V93, P2203, DOI 10.1073/pnas.93.5.2203; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171; Yamoah EN, 1996, NEURON, V17, P523, DOI 10.1016/S0896-6273(00)80184-1	44	251	261	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2002	108	3					371	381		10.1016/S0092-8674(02)00629-3	http://dx.doi.org/10.1016/S0092-8674(02)00629-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	520VB	11853671	Bronze			2022-12-24	WOS:000173801600009
J	Auluck, PK; Chan, HYE; Trojanowski, JQ; Lee, VMY; Bonini, NM				Auluck, PK; Chan, HYE; Trojanowski, JQ; Lee, VMY; Bonini, NM			Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease	SCIENCE			English	Article							LEWY BODIES; HSP70; EXPRESSION; NEURODEGENERATION; DEGENERATION; INCLUSIONS; DEMENTIA; MUTATION; NEURONS; HSP104	Parkinson's disease is a movement disorder characterized by degeneration of dopaminergic neurons in the substantia nigra pars compacta. Dopaminergic neuronal loss also occurs in Drosophila melanogaster upon directed expression of alpha-synuclein, a protein implicated in the pathogenesis of Parkinson's disease and a major component of proteinaceous Lewy bodies. We report that directed expression of the molecular chaperone, Hsp70 prevented dopaminergic neuronal loss associated with alpha-synuclein in Drosophila and that interference with endogenous chaperone activity accelerated alpha-synuclein toxicity. Furthermore, Lewy bodies in human postmortem tissue immunostained for molecular chaperones, also suggesting that chaperones may play a role in Parkinson's disease progression.	Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Univ Penn, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Bonini, NM (corresponding author), Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.		Chan, Edwin/A-9478-2011; Auluck, Pavan K/A-1160-2010	Chan, Edwin/0000-0003-4307-474X; 				Baba M, 1998, AM J PATHOL, V152, P879; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Elefant F, 1999, MOL BIOL CELL, V10, P2101, DOI 10.1091/mbc.10.7.2101; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; VELAZQUEZ JM, 1984, CELL, V36, P655, DOI 10.1016/0092-8674(84)90345-3; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3	21	995	1058	2	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					865	868		10.1126/science.1067389	http://dx.doi.org/10.1126/science.1067389			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823645				2022-12-24	WOS:000173733000048
J	Dawson, CR; Schachter, J				Dawson, CR; Schachter, J			Should trachoma be treated with antibiotics?	LANCET			English	Editorial Material									Univ Calif San Francisco, Francis I Proctor Fdn Res Ophthalmol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Lab Med, Chlamydia Res Lab, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Dawson, CR (corresponding author), Univ Calif San Francisco, Francis I Proctor Fdn Res Ophthalmol, San Francisco, CA 94143 USA.							Dawson C., 1990, CHLAMYDIAL INFECT, P271; DAWSON CR, 1981, GUIDE TRACHOMA CONTR, P1; Fraser-Hurt N, 2001, B WORLD HEALTH ORGAN, V79, P632; Hoechsmann A, 2001, Ophthalmic Epidemiol, V8, P145, DOI 10.1076/opep.8.2.145.4169; Schachter J, 1999, LANCET, V354, P630, DOI 10.1016/S0140-6736(98)12387-5; TIELSCH JM, 1988, AM J TROP MED HYG, V38, P393, DOI 10.4269/ajtmh.1988.38.393; TIELSCH JM, 1987, BRIT J OPHTHALMOL, V71, P371, DOI 10.1136/bjo.71.5.371	7	12	12	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 19	2002	359	9302					184	185		10.1016/S0140-6736(02)07463-9	http://dx.doi.org/10.1016/S0140-6736(02)07463-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512YH	11812548				2022-12-24	WOS:000173350800004
J	Hack, M; Shah, D				Hack, M; Shah, D			Periventricular haemorrhage and tocolytic therapies	LANCET			English	Editorial Material							OUTCOMES; NETWORK		Case Western Reserve Univ, Univ Hosp Cleveland, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Univ Hosp Cleveland, Sch Med, Dept Reprod Biol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland	Hack, M (corresponding author), Case Western Reserve Univ, Univ Hosp Cleveland, Sch Med, Dept Pediat, Cleveland, OH 44106 USA.							Gyetvai K, 1999, OBSTET GYNECOL, V94, P869, DOI 10.1016/S0029-7844(99)00329-4; HACK M, 1995, FUTURE CHILD, V5, P176, DOI 10.2307/1602514; HORBAR JD, 1995, SEMIN PERINATOL, V19, P124, DOI 10.1016/S0146-0005(05)80032-1; Hoyert DL, 2001, PEDIATRICS, V108, P1241, DOI 10.1542/peds.108.6.1241; KEIRSE MJN, 1989, EFFECTIVE CARE PREGN, V1; Lee SK, 2000, PEDIATRICS, V106, P1070, DOI 10.1542/peds.106.5.1070; PHILIP AGS, 1995, J PEDIATR-US, V126, P427, DOI 10.1016/S0022-3476(95)70463-9; Stevenson DK, 1998, AM J OBSTET GYNECOL, V179, P1632, DOI 10.1016/S0002-9378(98)70037-7; Volpe JJ., 2001, NEUROLOGY NEWBORN, V4; Weintraub Z, 2001, ARCH DIS CHILD-FETAL, V85, pF13, DOI 10.1136/fn.85.1.F13	10	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 19	2002	359	9302					185	186		10.1016/S0140-6736(02)07464-0	http://dx.doi.org/10.1016/S0140-6736(02)07464-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512YH	11812549				2022-12-24	WOS:000173350800005
J	Dutzler, R; Campbell, EB; Cadene, M; Chait, BT; MacKinnon, R				Dutzler, R; Campbell, EB; Cadene, M; Chait, BT; MacKinnon, R			X-ray structure of a CIC chloride channel at 3.0 angstrom reveals the molecular basis of anion selectivity	NATURE			English	Article							ELECTRON-DENSITY MAPS; TORPEDO ELECTROPLAX; ION-CHANNEL; CLC-0; PERMEATION; TRANSMEMBRANE; CONDUCTION; EXPRESSION; MUTATIONS; PORES	The ClC chloride channels catalyse the selective flow of Cl- ions across cell membranes, thereby regulating electrical excitation in skeletal muscle and the flow of salt and water across epithelial barriers. Genetic defects in ClC Cl- channels underlie several familial muscle and kidney diseases. Here we present the X-ray structures of two prokaryotic ClC Cl- channels from Salmonella enterica serovar typhimurium and Escherichia coli at 3.0 and 3.5 Angstrom, respectively. Both structures reveal two identical pores, each pore being formed by a separate subunit contained within a homodimeric membrane protein. Individual subunits are composed of two roughly repeated halves that span the membrane with opposite orientations. This antiparallel architecture defines a selectivity filter in which a Cl- ion is stabilized by electrostatic interactions with a-helix dipoles and by chemical coordination with nitrogen atoms and hydroxyl groups. These findings provide a structural basis for further understanding the function of ClC Cl- channels, and establish the physical and chemical basis of their anion selectivity.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.			Cadene, Martine/0000-0003-4936-2662				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; ANDERSEN OS, 1975, BIOPHYS J, V15, P795, DOI 10.1016/S0006-3495(75)85856-5; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen TY, 1996, J GEN PHYSIOL, V108, P237, DOI 10.1085/jgp.108.4.237; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DELAFORTELLE E, 1997, METHODS ENZYMOLOGY; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fahlke C, 1997, P NATL ACAD SCI USA, V94, P2729, DOI 10.1073/pnas.94.6.2729; Fahlke C, 2001, AM J PHYSIOL-RENAL, V280, pF748, DOI 10.1152/ajprenal.2001.280.5.F748; Fahlke C, 1997, NATURE, V390, P529, DOI 10.1038/37391; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; Jentsch TJ, 1999, PFLUG ARCH EUR J PHY, V437, P783, DOI 10.1007/s004240050847; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORDAN PC, 1983, BIOPHYS J, V41, P189, DOI 10.1016/S0006-3495(83)84419-1; Kleywegt G. J., 1994, P CCP4 STUD WEEK 1 M, P59; Kleywegt GJ, 1997, STRUCTURE, V5, P1557, DOI 10.1016/S0969-2126(97)00305-5; Ludewig U, 1997, J PHYSIOL-LONDON, V498, P691, DOI 10.1113/jphysiol.1997.sp021893; Ludewig U, 1997, J GEN PHYSIOL, V110, P165, DOI 10.1085/jgp.110.2.165; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maduke M, 1998, BIOCHEMISTRY-US, V37, P1315, DOI 10.1021/bi972418o; Maduke M, 2000, ANNU REV BIOPH BIOM, V29, P411, DOI 10.1146/annurev.biophys.29.1.411; Maduke M, 1999, J GEN PHYSIOL, V114, P713, DOI 10.1085/jgp.114.5.713; MCLAUGHLIN S, 1977, CURR TOP MEMBR TRANS, V9, P71; Middleton RE, 1996, NATURE, V383, P337, DOI 10.1038/383337a0; MILLER C, 1984, P NATL ACAD SCI-BIOL, V81, P2772, DOI 10.1073/pnas.81.9.2772; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Mindell JA, 2001, NATURE, V409, P219, DOI 10.1038/35051631; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; RICHARD EA, 1990, SCIENCE, V247, P1208, DOI 10.1126/science.2156338; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; Rychkov GY, 2001, J PHYSIOL-LONDON, V530, P379, DOI 10.1111/j.1469-7793.2001.0379k.x; Rychkov GY, 1998, J GEN PHYSIOL, V111, P653, DOI 10.1085/jgp.111.5.653; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; STEINMEYER K, 1994, EMBO J, V13, P737, DOI 10.1002/j.1460-2075.1994.tb06315.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vonrhein C, 1999, ACTA CRYSTALLOGR D, V55, P225, DOI 10.1107/S0907444998007914; Weinreich F, 2001, J BIOL CHEM, V276, P2347, DOI 10.1074/jbc.M005733200; WHITE MM, 1981, J GEN PHYSIOL, V78, P1, DOI 10.1085/jgp.78.1.1; WHITE MM, 1979, J BIOL CHEM, V254, P161; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	49	1257	1292	1	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2002	415	6869					287	294		10.1038/415287a	http://dx.doi.org/10.1038/415287a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11796999				2022-12-24	WOS:000173293500034
J	Fellay, J; Marzolini, C; Meaden, ER; Back, DJ; Buclin, T; Chave, JP; Decosterd, LA; Furrer, H; Opravil, M; Pantaleo, G; Retelska, D; Ruiz, L; Schinkel, AH; Vernazza, P; Eap, CB; Telenti, A				Fellay, J; Marzolini, C; Meaden, ER; Back, DJ; Buclin, T; Chave, JP; Decosterd, LA; Furrer, H; Opravil, M; Pantaleo, G; Retelska, D; Ruiz, L; Schinkel, AH; Vernazza, P; Eap, CB; Telenti, A		Swiss HIV Cohort Study	Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study	LANCET			English	Article							HIV PROTEASE INHIBITORS; PERFORMANCE LIQUID-CHROMATOGRAPHY; P-GLYCOPROTEIN; EXPRESSION; MICE; GENES; MDR1; NELFINAVIR; METABOLISM; THYMOCYTES	Background HIV-1-infected patients vary considerably by their response to antiretroviral treatment, drug concentrations in plasma, toxic events, and rate of immune recovery. This variability could have a genetic basis. We did a pharmacogenetics study to analyse the association between response to antiretroviral treatment and allelic variants of several genes. Methods In 123 patients, we did PCR analyses of the gene for the multidrug-resistance transporter (MDR1), which codes for P-glycoprotein, of genes coding for isoenzymes of cytochrome P450, CYP3A4, CYP3A5, CYP2D6, and CYP2C19, and of the gene for the chemokine receptor CCR5. We measured concentrations in plasma of the antiretroviral agents efavirenz and nelfinavir by high-performance liquid-chromatography, and measured levels of P-glycoprotein expression, CD4-cell count, and HIV-1 viraemia. Findings Median drug concentrations in patients with the MDR1 3435 TT, CT, and CC genotypes were at the 30th, 50th, and 75th percentiles, respectively (p=0.0001). In patients with CYP2D6 extensive-metaboliser or poor-metaboliser alleles, median drug concentrations were at percentiles 45 and 62.5, respectively (p=0.04). Patients with the MDR1 TT genotype 6 months after starting treatment had a greater rise in CD4-cell count (257 cells/muL) than patients with the CT (165 cells/muL) and CC (121 cells/muL) genotype (p=0.0048), and the best recovery of naive CD4-cells. Interpretation The polymorphism MDR1 3435 C/T predicts immune recovery after initiation of antiretroviral treatment. This finding suggests that P-glycoprotein has an important role in admittance of antiretroviral drugs to restricted compartments in vivo.	Univ Lausanne Hosp, Div Infect Dis, Lausanne, Switzerland; Univ Lausanne Hosp, Div Clin Pharmacol, Lausanne, Switzerland; Univ Lausanne Hosp, Div Immunol, Lausanne, Switzerland; Univ Lausanne Hosp, Unit Biochem & Clin Psychopharmacol, Lausanne, Switzerland; Univ Hosp Bern, CH-3010 Bern, Switzerland; Univ Zurich Hosp, CH-8091 Zurich, Switzerland; Hosp La Source, Lausanne, Switzerland; Hosp St Gallen, St Gallen, Switzerland; Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3BX, Merseyside, England; Univ Hosp Germans Trias & Pujol, Retrovirol Lab, Barcelona, Spain; Netherlands Canc Inst, Div Expt Therapy, NL-1066 CX Amsterdam, Netherlands	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; University Hospital of Bern; University of Zurich; University Zurich Hospital; Kantonsspital St. Gallen; University of Liverpool; Netherlands Cancer Institute	Telenti, A (corresponding author), CHU Vaudois, Div Infect Dis, CH-1011 Lausanne, Switzerland.		Telenti, Amalio/AAY-1674-2021; VALLET, Yannick/F-9979-2011; Fellay, Jacques/A-6681-2009; Pantaleo, Giuseppe/K-6163-2016; Decosterd, Laurent/E-8494-2019; Buclin, Thierry/P-1640-2014; Furrer, Hansjakob/G-6768-2013; Marzolini, Catia/C-8253-2019	Fellay, Jacques/0000-0002-8240-939X; Decosterd, Laurent/0000-0002-9840-1325; Buclin, Thierry/0000-0003-0639-5536; Furrer, Hansjakob/0000-0002-1375-3146; Eap, Chin/0000-0002-5439-0230				Ameyaw MM, 2001, PHARMACOGENETICS, V11, P217, DOI 10.1097/00008571-200104000-00005; Bardsley-Elliot A, 2000, DRUGS, V59, P581, DOI 10.2165/00003495-200059030-00014; Carrillo JA, 1998, THER DRUG MONIT, V20, P319, DOI 10.1097/00007691-199806000-00013; CHAUDHARY PM, 1991, CELL, V66, P85, DOI 10.1016/0092-8674(91)90141-K; Choo EF, 2000, DRUG METAB DISPOS, V28, P655; DEMORAIS SMF, 1994, J BIOL CHEM, V269, P15419; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Gutmann H, 1999, MOL PHARMACOL, V56, P383, DOI 10.1124/mol.56.2.383; HEIM M, 1990, LANCET, V336, P529, DOI 10.1016/0140-6736(90)92086-W; Hitzl M, 2001, PHARMACOGENETICS, V11, P293, DOI 10.1097/00008571-200106000-00003; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Huang LY, 2001, DRUG METAB DISPOS, V29, P754; Huisman MT, 2000, AIDS, V14, P237, DOI 10.1097/00002030-200002180-00005; Johansson I, 1996, PHARMACOGENETICS, V6, P351, DOI 10.1097/00008571-199608000-00008; Jones K, 2001, AIDS, V15, P675, DOI 10.1097/00002030-200104130-00002; Kim RB, 1998, J CLIN INVEST, V101, P289, DOI 10.1172/JCI1269; Kim RB, 2001, CLIN PHARMACOL THER, V70, P189, DOI 10.1067/mcp.2001.117412; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lavie Y, 2000, GLYCOCONJUGATE J, V17, P253, DOI 10.1023/A:1026553626537; Lee CGL, 2000, FASEB J, V14, P516, DOI 10.1096/fasebj.14.3.516; Li XL, 1999, ADV DRUG DELIVER REV, V39, P81, DOI 10.1016/S0169-409X(99)00021-6; MACDONALD HR, 1995, EUR J IMMUNOL, V25, P1457, DOI 10.1002/eji.1830250549; Marzolini C, 2000, J CHROMATOGR B, V740, P43, DOI 10.1016/S0378-4347(99)00573-3; PILARSKI LM, 1995, AM J HEMATOL, V49, P323, DOI 10.1002/ajh.2830490411; Ramratnam B, 2000, NAT MED, V6, P82, DOI 10.1038/71577; Sata F, 2000, CLIN PHARMACOL THER, V67, P48, DOI 10.1067/mcp.2000.104391; Schaeffeler E, 2001, LANCET, V358, P383, DOI 10.1016/S0140-6736(01)05579-9; SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214; Schuetz EG, 2000, MOL PHARMACOL, V57, P188; Schuetz EG, 1996, P NATL ACAD SCI USA, V93, P4001, DOI 10.1073/pnas.93.9.4001; Smit JW, 1998, BRIT J PHARMACOL, V124, P416, DOI 10.1038/sj.bjp.0701845; Srinivas RV, 1998, ANTIMICROB AGENTS CH, V42, P3157, DOI 10.1128/AAC.42.12.3157; Tanabe M, 2001, J PHARMACOL EXP THER, V297, P1137; Yamashita TE, 2001, AIDS, V15, P735, DOI 10.1097/00002030-200104130-00009	34	533	561	0	18	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 5	2002	359	9300					30	36		10.1016/S0140-6736(02)07276-8	http://dx.doi.org/10.1016/S0140-6736(02)07276-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809184				2022-12-24	WOS:000173143500013
J	Horsey, P				Horsey, P			Albumin and hypovolaemia: is the Cochrane evidence to be trusted?	LANCET			English	Editorial Material							PRESSURE; TRAUMA; TRIAL				Horsey, P (corresponding author), Old Manor, Stockbridge SO20 6RH, Berks, England.							Bell Ewan, 1999, Adverse Drug Reactions and Toxicological Reviews, V18, P149; CASH JD, 1981, HAEMOSTASIS THROMBOS, P475; Chalmers I, 1998, BRIT MED J, V317, P885; Drummond G, 1999, LANCET, V354, P1038, DOI 10.1016/S0140-6736(05)76653-8; Gotzsche PC, 2000, BRIT MED J, V321, P585, DOI 10.1136/bmj.321.7261.585; GRUNDMANN R, 1982, INTENS CARE MED, V8, P179, DOI 10.1007/BF01725735; Horsey PJ, 1997, ANAESTHESIA, V52, P1027, DOI 10.1111/j.1365-2044.1997.266-az0392.x; LEDGERWOOD AM, 1974, ARCH SURG-CHICAGO, V108, P531; LOWE RJ, 1977, SURGERY, V81, P676; LUCAS CE, 1978, J TRAUMA, V18, P564, DOI 10.1097/00005373-197808000-00002; McClelland B, 1998, BRIT MED J, V317, P829, DOI 10.1136/bmj.317.7162.829; Offringa M, 1998, BMJ-BRIT MED J, V317, P223, DOI 10.1136/bmj.317.7153.223; Roberts I, 1998, BMJ-BRIT MED J, V317, P235; So KW, 1997, ARCH DIS CHILD-FETAL, V76, pF43, DOI 10.1136/fn.76.1.F43; WOITTIEZ AJ, 1998, COCHRANE LIB; WOODS MS, 1993, AM SURGEON, V59, P758; ZETTERSTROM H, 1981, ACTA ANAESTH SCAND, V25, P133, DOI 10.1111/j.1399-6576.1981.tb01623.x	17	18	18	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 5	2002	359	9300					70	72		10.1016/S0140-6736(02)07285-9	http://dx.doi.org/10.1016/S0140-6736(02)07285-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809206				2022-12-24	WOS:000173143500035
J	Headon, DJ; Emmal, SA; Ferguson, BM; Tucker, AS; Justice, MJ; Sharpe, PT; Zonana, J; Overbeek, PA				Headon, DJ; Emmal, SA; Ferguson, BM; Tucker, AS; Justice, MJ; Sharpe, PT; Zonana, J; Overbeek, PA			Gene defect in ectodermal dysplasia implicates a death domain adapter in development	NATURE			English	Article							NF-KAPPA-B; TNF RECEPTOR; EDA GENE; PROTEIN; HOMOLOG; MOUSE; FAMILY; INVOLVEMENT; APOPTOSIS; MUTATIONS	Members of the tumour-necrosis factor receptor (TNFR) family that contain an intracellular death domain initiate signalling by recruiting cytoplasmic death domain adapter proteins(1,2). Edar is a death domain protein of the TNFR family that is required for the development of hair, teeth and other ectodermal derivatives(3,4). Mutations in Edar-or its ligand, Eda-cause hypohidrotic ectodermal dysplasia in humans and mice(3-7). This disorder is characterized by sparse hair, a lack of sweat glands and malformation of teeth(8). Here we report the identification of a death domain adapter encoded by the mouse crinkled locus. The crinkled mutant has an hypohidrotic ectodermal dysplasia phenotype identical to that of the edar (downless) and eda (Tabby) mutants(9). This adapter, which we have called Edaradd (for Edar-associated death domain), interacts with the death domain of Edar and links the receptor to downstream signalling pathways. We also identify a missense mutation in its human orthologue, EDARADD, that is present in a family affected with hypohidrotic ectodermal dysplasia. Our findings show that the death receptor/adapter signalling mechanism is conserved in developmental, as well as apoptotic, signalling.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Guys Hosp, Univ London Kings Coll, MRC, Ctr Dev Neurobiol, London SE1 1UL, England; Guys Hosp, Univ London Kings Coll, GKT Dent Inst, Dept Craniofacial Dev, London SE1 9RT, England	Baylor College of Medicine; Baylor College of Medicine; Oregon Health & Science University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Overbeek, PA (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.		Tucker, Abigail S/K-1788-2016	Tucker, Abigail S/0000-0001-8871-6094; Sharpe, Paul/0000-0003-2116-9561; Overbeek, Paul/0000-0001-9784-2084	MRC [G9800001] Funding Source: UKRI; Medical Research Council [G9800001] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Blake JA, 2001, NUCLEIC ACIDS RES, V29, P91, DOI 10.1093/nar/29.1.91; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; CLARKE A, 1987, J MED GENET, V24, P659, DOI 10.1136/jmg.24.11.659; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; FALCONER DS, 1951, J GENET, V50, P324, DOI 10.1007/BF02996227; Ferguson BM, 1998, J MED GENET, V35, P112, DOI 10.1136/jmg.35.2.112; Ferguson BM, 1997, HUM MOL GENET, V6, P1589, DOI 10.1093/hmg/6.9.1589; Galibert L, 1998, J BIOL CHEM, V273, P34120, DOI 10.1074/jbc.273.51.34120; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Hofmann K, 1999, CELL MOL LIFE SCI, V55, P1113, DOI 10.1007/s000180050361; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kumar A, 2001, J BIOL CHEM, V276, P2668, DOI 10.1074/jbc.M008356200; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; LYON MF, 1996, GENETIC VARIANTS STR; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Monreal AW, 1999, NAT GENET, V22, P366, DOI 10.1038/11937; Munoz F, 1997, AM J HUM GENET, V61, P94; Pan GH, 1998, FEBS LETT, V431, P351, DOI 10.1016/S0014-5793(98)00791-1; Perou CM, 1997, GENOMICS, V39, P136, DOI 10.1006/geno.1996.4478; Srivastava AK, 1997, P NATL ACAD SCI USA, V94, P13069, DOI 10.1073/pnas.94.24.13069; Tucker AS, 2000, DEVELOPMENT, V127, P4691; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523	28	268	283	0	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					913	916		10.1038/414913a	http://dx.doi.org/10.1038/414913a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780064				2022-12-24	WOS:000172813300047
J	in 't Veld, BA; Ruitenberg, A; Hofman, A; Launer, LJ; van Duijn, CM; Stijnen, T; Breteler, MMB; Stricker, BHC				in 't Veld, BA; Ruitenberg, A; Hofman, A; Launer, LJ; van Duijn, CM; Stijnen, T; Breteler, MMB; Stricker, BHC			Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OCCUPATIONAL EPIDEMIOLOGY; RHEUMATOID-ARTHRITIS; VASCULAR DEMENTIA; RECEPTOR-GAMMA; MENTAL STATE; ROTTERDAM; POPULATION; DIAGNOSIS; INFLAMMATION; ASSOCIATION	Background: Previous studies have suggested that the use of nonsteroidal antiinflammatory drugs (NSAIDs) may help to prevent Alzheimer's disease. The results, however, have been inconsistent. Methods: We studied the association between the use of NSAIDs and Alzheimer's disease and vascular dementia in a prospective, population-based cohort study of 6989 subjects 55 years of age or older who were free of dementia at base line. The risk of Alzheimer's disease was estimated in relation to the use of NSAIDs as documented in pharmacy records. We defined four mutually exclusive categories of use: nonuse, short-term use (1 month or less of cumulative use), intermediate-term use (more than 1 but less than 24 months of cumulative use), and long-term use (24 months or more of cumulative use). Adjustments were made by Cox regression analysis for age, sex, education, smoking status, and the use or nonuse of salicylates, histamine H(sub 2)-receptor antagonists, antihypertensive agents, and hypoglycemic agents. Results: During an average follow-up period of 6.8 years, dementia developed in 394 subjects, of whom 293 had Alzheimer's disease, 56 vascular dementia, and 45 other types of dementia. The relative risk of Alzheimer's disease was 0.95 (95 percent confidence interval, 0.70 to 1.29) in subjects with short-term use of NSAIDs, 0.83 (95 percent confidence interval, 0.62 to 1.11) in those with intermediate-term use, and 0.20 (95 percent confidence interval, 0.05 to 0.83) in those with long-term use. The risk did not vary according to age. The use of NSAIDs was not associated with a reduction in the risk of vascular dementia. Conclusions: The long-term use of NSAIDs may protect against Alzheimer's disease but not against vascular dementia. (N Engl J Med 2001;345:1515-21.) Copyright (C) 2001 Massachusetts Medical Society.	Erasmus MC, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; NIA, Epidemiol Demog & Biometry Program, NIH, Bethesda, MD 20892 USA; Inspectorate Hlth Care, The Hague, Netherlands	Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Stricker, BHC (corresponding author), Erasmus MC, Dept Epidemiol & Biostat, POB 1738, NL-3000 DR Rotterdam, Netherlands.		Breteler, Monique M.B./J-5058-2014	Breteler, Monique M.B./0000-0002-0626-9305				Aisen PS, 1996, MOL CHEM NEUROPATHOL, V28, P83, DOI 10.1007/BF02815208; Aisen PS, 1997, GERONTOLOGY, V43, P143; AMADUCCI LA, 1986, NEUROLOGY, V36, P922, DOI 10.1212/WNL.36.7.922; ANDERSEN K, 1995, NEUROLOGY, V45, P1441, DOI 10.1212/WNL.45.8.1441; Anthony JC, 2000, NEUROLOGY, V54, P2066, DOI 10.1212/WNL.54.11.2066; BEARD CM, 1991, LANCET, V337, P1426, DOI 10.1016/0140-6736(91)93122-P; Beard CM, 1998, MAYO CLIN PROC, V73, P951, DOI 10.4065/73.10.951; Breitner JCS, 1996, NEUROBIOL AGING, V17, P789; BREITNER JCS, 1995, NEUROBIOL AGING, V16, P523, DOI 10.1016/0197-4580(95)00049-K; BREITNER JCS, 1994, NEUROLOGY, V44, P227, DOI 10.1212/WNL.44.2.227; BROE GA, 1990, NEUROLOGY, V40, P1698, DOI 10.1212/WNL.40.11.1698; BROOKS W, 1998, NEUROBIOL AGING, V19, pS140; CHECKOWAY H, 1990, ARCH ENVIRON HEALTH, V45, P95, DOI 10.1080/00039896.1990.9935932; CHECKOWAY H, 1989, AM J IND MED, V15, P375, DOI 10.1002/ajim.4700150403; CLAYTON D, 1993, STAT MODELS EPIDEMIO, P307; COPELAND JRM, 1976, PSYCHOL MED, V6, P439, DOI 10.1017/S0033291700015889; CORNELIUS C, 1998, NEUROBIOL AGING, V19, pS28; COX DR, 1972, J R STAT SOC B, V34, P187; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fourrier A, 1996, J CLIN EPIDEMIOL, V49, P1201, DOI 10.1016/0895-4356(96)00202-8; FRENCH LR, 1985, AM J EPIDEMIOL, V121, P414, DOI 10.1093/oxfordjournals.aje.a114013; GILBERT ES, 1979, RADIAT RES, V79, P122, DOI 10.2307/3575027; GRAVES AB, 1990, ANN NEUROL, V28, P766, DOI 10.1002/ana.410280607; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; HENDERSON AS, 1992, PSYCHOL MED, V22, P429, DOI 10.1017/S0033291700030373; Henderson AS, 1997, INT J GERIATR PSYCH, V12, P926, DOI 10.1002/(SICI)1099-1166(199709)12:9<926::AID-GPS665>3.3.CO;2-P; HEYMAN A, 1984, ANN NEUROL, V15, P335, DOI 10.1002/ana.410150406; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; JENKINSON ML, 1989, BRIT J RHEUMATOL, V28, P86; KUKULL WA, 1994, NEUROLOGY, V44, pA237; Lehmann JM, 1997, J BIOL CHEM, V272, P3406, DOI 10.1074/jbc.272.6.3406; LEVEUGLE B, 1994, MOL NEUROBIOL, V9, P25, DOI 10.1007/BF02816102; LI G, 1992, NEUROLOGY, V42, P1481, DOI 10.1212/WNL.42.8.1481; MCDOWELL I, 1994, NEUROLOGY, V44, P2073; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; MCGEER PL, 1990, LANCET, V335, P1037, DOI 10.1016/0140-6736(90)91101-F; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; OTT A, 1995, BRIT MED J, V310, P970, DOI 10.1136/bmj.310.6985.970; Ott A, 1998, AM J EPIDEMIOL, V147, P574; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Slooter AJC, 1997, JAMA-J AM MED ASSOC, V277, P818, DOI 10.1001/jama.277.10.818; Stewart WF, 1997, NEUROLOGY, V48, P626, DOI 10.1212/WNL.48.3.626; Veld BAI, 1998, NEUROBIOL AGING, V19, P607, DOI 10.1016/S0197-4580(98)00096-7; *WHO, 1994, AN THER CLASS ATC IN	46	955	1008	2	80	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2001	345	21					1515	1521		10.1056/NEJMoa010178	http://dx.doi.org/10.1056/NEJMoa010178			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494DC	11794217	Green Published, Bronze			2022-12-24	WOS:000172265200001
J	Kuhnle, A; Linderoth, TR; Hammer, B; Besenbacher, F				Kuhnle, A; Linderoth, TR; Hammer, B; Besenbacher, F			Chiral recognition in dimerization of adsorbed cysteine observed by scanning tunnelling microscopy	NATURE			English	Article							TUNNELING-MICROSCOPY; MOLECULES; SEPARATION; SURFACES; AU(111)	Stereochemistry plays a central role in controlling molecular recognition and interaction: the chemical and biological properties of molecules depend not only on the nature of their constituent atoms but also on how these atoms are positioned in space. Chiral specificity is consequently fundamental in chemical biology and pharmacology(1,2) and has accordingly been widely studied. Advances in scanning probe microscopies now make it possible to probe chiral phenomena at surfaces at the molecular level. These methods have been used to determine the chirality of adsorbed molecules(3-5), and to provide direct evidence for chiral discrimination in molecular interactions(6) and the spontaneous resolution of adsorbates into extended enantiomerically pure overlayers(3,7-9). Here we report scanning tunnelling microscopy studies of cysteine adsorbed to a (110) gold surface, which show that molecular pairs formed from a racemic mixture of this naturally occurring amino acid are exclusively homochiral, and that their binding to the gold surface is associated with local surface restructuring. Density-functional theory(10) calculations indicate that the chiral specificity of the dimer formation process is driven by the optimization of three bonds on each cysteine molecule. These findings thus provide a clear molecular-level illustration of the well known three-point contact model(11,12) for chiral recognition in a simple bimolecular system.	Aarhus Univ, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus C, Denmark; Aarhus Univ, Inst Phys & Astron, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University	Besenbacher, F (corresponding author), Aarhus Univ, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus C, Denmark.		Besenbacher, Flemming/A-9623-2010; Hammer, Bjørk/C-3701-2013; Kuhnle, Angelika/C-5080-2011	Hammer, Bjørk/0000-0002-7849-6347; 				Bohringer M, 1999, ANGEW CHEM INT EDIT, V38, P821, DOI 10.1002/(SICI)1521-3773(19990315)38:6<821::AID-ANIE821>3.0.CO;2-A; Booth TD, 1997, CHIRALITY, V9, P96; CHEN Q, 1999, PHYS CHEM COMM, V9; Easson LH, 1933, BIOCHEM J, V27, P1257, DOI 10.1042/bj0271257; ECKHARDT CJ, 1993, NATURE, V362, P614, DOI 10.1038/362614a0; Fang HB, 1998, J PHYS CHEM B, V102, P7311, DOI 10.1021/jp981960z; Gottschalck J, 2002, J CHEM PHYS, V116, P784, DOI 10.1063/1.1424292; GRITSCH T, 1991, SURF SCI, V257, P297, DOI 10.1016/0039-6028(91)90800-8; Gronbeck H, 2000, J AM CHEM SOC, V122, P3839, DOI 10.1021/ja993622x; LAEGSGAARD E, 1988, J MICROSC-OXFORD, V152, P663, DOI 10.1111/j.1365-2818.1988.tb01435.x; Lopinski GP, 1998, NATURE, V392, P909, DOI 10.1038/31913; Lorenzo MO, 2000, NATURE, V404, P376, DOI 10.1038/35006031; McKendry R, 1998, NATURE, V391, P566, DOI 10.1038/35339; PAYNE MC, 1992, REV MOD PHYS, V64, P1045, DOI 10.1103/RevModPhys.64.1045; PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671; Poirier GE, 1996, SCIENCE, V272, P1145, DOI 10.1126/science.272.5265.1145; Sheldon R. A., 1993, CHIROTECHNOLOGY, P39; TERSOFF J, 1985, PHYS REV B, V31, P805, DOI 10.1103/PhysRevB.31.805; Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357; [No title captured]	20	513	522	5	235	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2002	415	6874					891	893		10.1038/415891a	http://dx.doi.org/10.1038/415891a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859364	Green Published			2022-12-24	WOS:000173941000040
J	Woudstra, EC; Gilbert, C; Fellows, J; Jansen, L; Brouwer, J; Erdjument-Bromage, H; Tempst, P; Svejstrup, JQ				Woudstra, EC; Gilbert, C; Fellows, J; Jansen, L; Brouwer, J; Erdjument-Bromage, H; Tempst, P; Svejstrup, JQ			A Rad26-Def1 complex coordinates repair and RNA pol II proteolysis in response to DNA damage	NATURE			English	Article							TRANSCRIPTION-COUPLED REPAIR; NUCLEOTIDE EXCISION-REPAIR; ELONGATION-FACTOR TFIIS; POLYMERASE-II; COCKAYNE-SYNDROME; SACCHAROMYCES-CEREVISIAE; INDUCED UBIQUITINATION; LARGE SUBUNIT; CELLS; DEGRADATION	Eukaryotic cells use multiple, highly conserved mechanisms to contend with ultraviolet-light-induced DNA damage(1). One important response mechanism is transcription-coupled repair (TCR), during which DNA lesions in the transcribed strand of an active gene are repaired much faster than in the genome overall(2). In mammalian cells, defective TCR gives rise to the severe human disorder Cockayne's syndrome (CS)(3). The best-studied CS gene, CSB, codes for a Swi/Snf-like DNA-dependent ATPase, whose yeast homologue is called Rad26 (ref. 4). Here we identify a yeast protein, termed Def1, which forms a complex with Rad26 in chromatin. The phenotypes of cells lacking DEF1 are consistent with a role for this factor in the DNA damage response, but Def1 is not required for TCR. Rather, def1 cells are compromised for transcript elongation, and are unable to degrade RNA polymerase II (RNAPII) in response to DNA damage. Our data suggest that RNAPII stalled at a DNA lesion triggers a coordinated rescue mechanism that requires the Rad26-Def1 complex, and that Def1 enables ubiquitination and proteolysis of RNAPII when the lesion cannot be rapidly removed by Rad26-promoted DNA repair.	Canc Res UK, Clare Hall Labs, Mech Gene Transcript Lab, S Mimms EN6 3LD, Herts, England; Leiden Univ, Leiden Inst Chem, MGC Dept Mol Genet, NL-2300 RA Leiden, Netherlands; Mem Sloan Kettering Canc Ctr, Mol Biol Programme, New York, NY 10021 USA	Cancer Research UK; Leiden University; Leiden University - Excl LUMC; Memorial Sloan Kettering Cancer Center	Svejstrup, JQ (corresponding author), Canc Res UK, Clare Hall Labs, Mech Gene Transcript Lab, Blanche Lane, S Mimms EN6 3LD, Herts, England.	j.svejstrup@cancer.org.uk		Jansen, Lars/0000-0002-2158-0345; Svejstrup, Jesper/0000-0003-4964-6147; Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594				ARCHAMBAULT J, 1992, MOL CELL BIOL, V12, P4142, DOI 10.1128/MCB.12.9.4142; Beaudenon SL, 1999, MOL CELL BIOL, V19, P6972; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Conaway JW, 2000, TRENDS BIOCHEM SCI, V25, P375, DOI 10.1016/S0968-0004(00)01615-7; de Boer J, 2000, CARCINOGENESIS, V21, P453, DOI 10.1093/carcin/21.3.453; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Friedberg E.C., 2016, DNA REPAIR MUTAGENES, V33, P35; Gillette TG, 2001, GENE DEV, V15, P1528, DOI 10.1101/gad.869601; Hanawalt PC, 2001, MUTAT RES-DNA REPAIR, V485, P3, DOI 10.1016/S0921-8777(00)00071-9; Hilt W, 1996, TRENDS BIOCHEM SCI, V21, P96, DOI 10.1016/S0968-0004(96)10012-8; Jansen LET, 2000, EMBO J, V19, P6498, DOI 10.1093/emboj/19.23.6498; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Le Page F, 2000, CELL, V101, P159, DOI 10.1016/S0092-8674(00)80827-2; Lommel L, 2000, P NATL ACAD SCI USA, V97, P9088, DOI 10.1073/pnas.150130197; Luo ZH, 2001, MUTAT RES-DNA REPAIR, V486, P259, DOI 10.1016/S0921-8777(01)00097-0; MAYNE LV, 1982, CANCER RES, V42, P1473; McKay BC, 2001, MUTAT RES-DNA REPAIR, V485, P93, DOI 10.1016/S0921-8777(00)00064-1; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Ratner JN, 1998, J BIOL CHEM, V273, P5184, DOI 10.1074/jbc.273.9.5184; Russell SJ, 1999, MOL CELL, V3, P687, DOI 10.1016/S1097-2765(01)80001-0; SCHMICKEL RD, 1977, PEDIATRICS, V60, P135; Thompson NE, 1996, METHOD ENZYMOL, V274, P513; vanGool AJ, 1997, EMBO J, V16, P4155, DOI 10.1093/emboj/16.14.4155; VANGOOL AJ, 1994, EMBO J, V13, P5361, DOI 10.1002/j.1460-2075.1994.tb06871.x; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; Verhage RA, 1996, MOL CELL BIOL, V16, P496; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Winkler GS, 2001, J BIOL CHEM, V276, P32743, DOI 10.1074/jbc.M105303200; Wu JS, 1996, P NATL ACAD SCI USA, V93, P11552, DOI 10.1073/pnas.93.21.11552; Yu AD, 2000, MOL CELL, V5, P801, DOI 10.1016/S1097-2765(00)80320-2	30	175	177	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2002	415	6874					929	933		10.1038/415929a	http://dx.doi.org/10.1038/415929a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859374				2022-12-24	WOS:000173941000050
J	Weinberg, PD; Hounshell, J; Sherman, LA; Godwin, J; Ali, S; Tomori, C; Bennett, CL				Weinberg, PD; Hounshell, J; Sherman, LA; Godwin, J; Ali, S; Tomori, C; Bennett, CL			Legal, financial, and public health consequences of HIV contamination of blood and blood products in the 1980s and 1990s	ANNALS OF INTERNAL MEDICINE			English	Article							SAFETY; IMPACT	Ensuring the safety of the blood supply connects politics and science. The business and service sectors share responsibility for the collection and processing of blood donations, and government agencies perform regulatory and surveillance roles. The onset of the AIDS epidemic has challenged the interface among these systems, leading to widespread fears about compromised safety of the blood supply. Because of public concern about blood-supply decisions made in the 1980s, developed countries in the 1990s established reimbursement programs for persons with transfusion-acquired viral infections from blood or blood products, adopted diagnostic tests and procedures that improved the safety of the blood supply, and held criminal judicial investigations of government officials and industry leaders accused of delaying implementation of potential blood-safety measures. In contrast, developing countries continue to struggle with blood-supply safety issues. This paper summarizes the current status of these safety concerns in developed countries, where viral transmission from contaminated blood or blood products is extremely rare, and in developing countries, where up to 10% of HIV infections result from transfusion of blood or blood products.	Vet Affairs Chicago Healthcare Syst, Lakeside Div, Chicago, IL USA; Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA; Northwestern Univ, Chicago, IL 60611 USA; Loyola Univ, Sch Med, Mid W Ctr Hlth Serv & Policy Res, Maywood, IL 60153 USA; Loyola Univ, Sch Med, Cardinal Bernardin Canc Ctr, Maywood, IL 60153 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Loyola University Chicago; Loyola University Chicago	Bennett, CL (corresponding author), Vet Affairs Med Sci Bldg,400 E Ontario St,Suite 2, Chicago, IL 60611 USA.	cbenne@nwu.edu	Tomori, Cecilia/C-5147-2018; Bennett, Charles L/C-2050-2008	Tomori, Cecilia/0000-0003-4235-1821; 				ABBOTT A, 1995, NATURE, V376, P628; ABBOTT A, 1993, NATURE, V366, P98; ABBOTT A, 1993, NATURE, V365, P594, DOI 10.1038/365594b0; ALTER HJ, 1972, ANN INTERN MED, V77, P691, DOI 10.7326/0003-4819-77-5-691; AuBuchon JP, 1997, ANN INTERN MED, V127, P904, DOI 10.7326/0003-4819-127-10-199711150-00009; Barker S, 1996, NATURE, V379, P663, DOI 10.1038/379663a0; Bayer R, 1999, BLOOD FEUDS, P1; BERNTORP E, 1994, THROMB HAEMOSTASIS, V71, P678; BLAKESLEE S, 2000, NY TIMES        0725, P1; BRUNO S, 1998, LANCET, V352, P1916; BUTLER D, 1993, NATURE, V364, P269; BUTLER D, 1995, NATURE, V375, P526, DOI 10.1038/375526a0; BUTLER D, 1994, NATURE, V371, P548; BUTLER D, 1994, NATURE, V370, P404, DOI 10.1038/370404b0; BUTLER D, 1994, NATURE, V370, P319, DOI 10.1038/370319a0; BUTLER D, 1992, NATURE, V359, P764, DOI 10.1038/359764a0; BUTLER D, 1994, NATURE, V367, P304; *CDCP, 1981, MORB MORT WEEKL 0605, P5; *CDCP, 1982, MORB MORT WEEKL 0716; DUNN K, 1993, CAN MED ASSOC J, V148, P609; EFRON S, 2000, LOS ANGELES TIM 0225, pA1; ESMONDE TFG, 1993, LANCET, V341, P205, DOI 10.1016/0140-6736(93)90068-R; HUTCHCRAFT C, 1996, CHICAGO TRIBUNE 0531, P1; JAYARAMAN KS, 1995, NATURE, V376, P285, DOI 10.1038/376285b0; Kapoor D, 2000, Indian J Gastroenterol, V19, P64; KING M, 2000, GAZETTE MONTREA 0312, pA5; Klein MA, 1997, NATURE, V390, P687, DOI 10.1038/37789; Kondro W, 1997, LANCET, V350, P1688, DOI 10.1016/S0140-6736(05)64294-8; Kondro W, 1996, LANCET, V348, P52, DOI 10.1016/S0140-6736(05)64368-1; KREVER H, 1995, COMMISSION INQUIRY B; LACKRITZ EM, 1993, AIDS, V7, P995, DOI 10.1097/00002030-199307000-00014; Leveton Lauren B., 1995, HIV BLOOD SUPPLY ANA, P49; McGregor A, 1998, LANCET, V352, P1916, DOI 10.1016/S0140-6736(05)60413-8; Murray T, 1998, NAT MED, V4, P10, DOI 10.1038/nm0198-010a; *NAT BLOOD DON RES, 1999, REP BLOOD DON TRANSF; Pomfret J., 2001, WASHINGTON POST 0109, pA1; *REUT HLTH INF SER, 1996, HIV AIDS NEWSL  1028; *REUT HLTH INF SER, 1996, HIV AIDS NEWSLI 0924; ROSENDAAL FR, 1991, ANN HEMATOL, V62, P5, DOI 10.1007/BF01714977; Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601; Sherman LA, 2000, TRANSFUSION, V40, P1268, DOI 10.1046/j.1537-2995.2000.40101268.x; Simons M, 1994, NY TIMES, pA1; STARR DP, 1998, EPIC HIST MED COMMER, P304; STARR DP, 1998, EPIC HIST MED COMMER, P303; STARR DP, 1998, BLOOD EPIC HIST MED, P283; STARR DP, 1998, BLOOD EPIC HIST MED, P320; STARR DP, 1998, EPIC HIST MED COMMER, P327; Swinbanks D, 1996, NATURE, V383, P291, DOI 10.1038/383291a0; TASTEMAIN C, 1995, NATURE, V375, P349, DOI 10.1038/375349a0; Tomlinson R, 1997, BRIT MED J, V314, P93; Trebilcock M, 1996, VA LAW REV, V82, P1407, DOI 10.2307/1073680; Warden J, 1998, BRIT MED J, V317, P1548, DOI 10.1136/bmj.317.7172.1548b; WHITNEY CR, 1998, NY TIMES        0718, pA4; WHITNEY CR, 1999, NY TIMES        0611, pA1; *WHO, 2000, SAF BLOOD STARTS ME; *WORLD BANK GROUP, 2001, IND NAT AIDS CONTR P; Zuck TF, 1996, TRANSFUSION, V36, P928, DOI 10.1046/j.1537-2995.1996.361097017181.x; 1997, WASHINGTON TIME 0729, pA12; 2001, SUMMARY RATIONALE DR; 1997, MACLEANS        1020, P110; R RAY HEMOPHILIA REL; 1996, NATURE, V383, P9; 1997, NATURE, V387, P840; 2001, GUILTY VERDIC UPHELD; 1997, IPS WIRE        098; 1997, REUTERS         1017; 1997, UNITED PRESS IN 0730	67	51	56	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2002	136	4					312	319		10.7326/0003-4819-136-4-200202190-00011	http://dx.doi.org/10.7326/0003-4819-136-4-200202190-00011			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	523FQ	11848729				2022-12-24	WOS:000173943700008
J	Berkman, DS; Lescano, AG; Gilman, RH; Lopez, S; Black, MM				Berkman, DS; Lescano, AG; Gilman, RH; Lopez, S; Black, MM			Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in late childhood: a follow-up study	LANCET			English	Article							GIARDIA-LAMBLIA; PERUVIAN CHILDREN; PHYSICAL GROWTH; SCHOOL-CHILDREN; PUEBLO-JOVEN; RISK-FACTORS; MALNUTRITION; CRYPTOSPORIDIOSIS; ASSOCIATION; PERFORMANCE	Background Chronic malnutrition during infancy, marked by stunting, has been associated with poor cognitive function. We assessed the effect of stunting, diarrhoeal disease, and parasitic infections during infancy on cognitive function in late childhood. Methods We followed up from birth to 2 years, a cohort of 239 Peruvian children for anthropometrics, stool samples, and diarrhoeal status. At 9 years of age, we assessed cognitive function in 143 (69%) with the full-scale intelligence quotient of the Wechsler intelligence scale for children-revised (WISC-R). Findings All findings were adjusted for socioeconomic status and schooling; in addition, findings related to diarrhoea prevalence, Giardia lamblia, and Cryptosporidium parvum were adjusted for severe stunting. During the first 2 years of life, 46 (32%) of 143 children were stunted. Children with severe stunting in the second year of life scored 10 points lower on the WISC-R test (95% CI 2.4-17.5) than children without severe stunting. Children with more than one episode of G lamblia per year scored 4.1 points (0.2-8.0) lower than children with one episode or fewer per year. Neither diarrhoea prevalence nor C parvum infection was associated with WISC-R scores. Interpretation Malnutrition in early childhood, indexed by stunting, and potentially G lamblia, are associated with poor cognitive function at age 9 years. If the observed associations are causal, then intervention programmes designed to prevent malnutrition and G lamblia, early in life could lead to significant improvement in cognitive function of children in similar lower-income communities throughout the less-developed world.	Johns Hopkins Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; AB PRISMA, Lima, Peru; Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; Univ Peruana Cayetano Heredia, Lima, Peru	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University System of Maryland; University of Maryland Baltimore; Universidad Peruana Cayetano Heredia	Gilman, RH (corresponding author), Johns Hopkins Sch Publ Hlth, Dept Int Hlth, 615 N Wolfe St,Room W3503, Baltimore, MD 21205 USA.	rgilman@jhsph.edu	Lescano, Andres G/B-8479-2008; Lescano, Andres G./M-9849-2019	Lescano, Andres G/0000-0001-9779-633X; Lescano, Andres G./0000-0001-9779-633X; Black, Maureen/0000-0002-6427-4639				ARROWOOD MJ, 1989, J CLIN MICROBIOL, V27, P1490, DOI 10.1128/JCM.27.7.1490-1495.1989; *AS BEN PRISMA, 1994, VIG NUTR REG LIM 199; Black MM, 1998, AM J CLIN NUTR, V68, p464S, DOI 10.1093/ajcn/68.2.464S; BLACK RE, 1984, AM J CLIN NUTR, V39, P87, DOI 10.1093/ajcn/39.1.87; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX; BROOKMEYER R, 1982, BIOMETRICS, V38, P29, DOI 10.2307/2530286; Brown JL, 1996, SCI AM, V274, P38, DOI 10.1038/scientificamerican0296-38; Checkley W, 1998, AM J EPIDEMIOL, V148, P497, DOI 10.1093/oxfordjournals.aje.a009675; Checkley W, 1997, AM J EPIDEMIOL, V145, P156, DOI 10.1093/oxfordjournals.aje.a009086; CONNOLLY KJ, 1993, PARASITOLOGY, V107, pS187, DOI 10.1017/S0031182000075612; DEONIS M, 1993, B WORLD HEALTH ORGAN, V71, P703; FARTHING MJG, 1986, AM J CLIN NUTR, V43, P395, DOI 10.1093/ajcn/43.3.395; FERNANDEZCONCHA D, 1991, T ROY SOC TROP MED H, V85, P809, DOI 10.1016/0035-9203(91)90465-B; Fraser D, 2000, CLIN INFECT DIS, V30, P419, DOI 10.1086/313722; GILMAN RH, 1988, LANCET, V1, P343, DOI 10.1016/S0140-6736(88)91131-2; GILMAN RH, 1993, AM J PUBLIC HEALTH, V83, P1554, DOI 10.2105/AJPH.83.11.1554; Guerrant DI, 1999, AM J TROP MED HYG, V61, P707, DOI 10.4269/ajtmh.1999.61.707; GUERRANT RL, 1983, J INFECT DIS, V148, P986, DOI 10.1093/infdis/148.6.986; GUERRANT RL, 1992, AM J TROP MED HYG, V47, P28, DOI 10.4269/ajtmh.1992.47.28; Halterman JS, 2001, PEDIATRICS, V107, P1381, DOI 10.1542/peds.107.6.1381; Lunn PG, 1999, J NUTR, V129, P872, DOI 10.1093/jn/129.4.872; Mendez MA, 1999, J NUTR, V129, P1555, DOI 10.1093/jn/129.8.1555; NASH TE, 1993, P NATL ACAD SCI USA, V90, P5489, DOI 10.1073/pnas.90.12.5489; NOKES C, 1992, PARASITOLOGY, V104, P539, DOI 10.1017/S0031182000063800; Ortega YR, 1997, CLIN INFECT DIS, V25, P545, DOI 10.1086/513745; POWELL CA, 1995, ACTA PAEDIATR, V84, P22, DOI 10.1111/j.1651-2227.1995.tb13479.x; Sakti H, 1999, TROP MED INT HEALTH, V4, P322, DOI 10.1046/j.1365-3156.1999.00410.x; SEPULVEDA J, 1988, AM J EPIDEMIOL, V127, P365, DOI 10.1093/oxfordjournals.aje.a114810; Stephensen CB, 1999, J NUTR, V129, p534S, DOI 10.1093/jn/129.2.534S; STERLING CR, 1991, J PROTOZOOL, V38, pS23; VIDAL MFC, 1991, J CLIN MICROBIOL, V29, P636, DOI 10.1128/JCM.29.3.636-637.1991; Watkins WE, 1996, T ROY SOC TROP MED H, V90, P156, DOI 10.1016/S0035-9203(96)90121-2; Wechsler DW., 1999, INTELLIGENCE SCALE C	33	490	516	1	37	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2002	359	9306					564	571		10.1016/S0140-6736(02)07744-9	http://dx.doi.org/10.1016/S0140-6736(02)07744-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523FP	11867110				2022-12-24	WOS:000173943600009
J	Petricoin, EF; Ardekani, AM; Hitt, BA; Levine, PJ; Fusaro, VA; Steinberg, SM; Mills, GB; Simone, C; Fishman, DA; Kohn, EC; Liotta, LA				Petricoin, EF; Ardekani, AM; Hitt, BA; Levine, PJ; Fusaro, VA; Steinberg, SM; Mills, GB; Simone, C; Fishman, DA; Kohn, EC; Liotta, LA			Use of proteomic patterns in serum to identify ovarian cancer	LANCET			English	Article								Background New technologies for the detection of early-stage ovarian cancer are urgently needed. Pathological changes within an organ might be reflected in proteomic patterns in serum. We developed a bioinformatics tool and used it to identify proteomic patterns in serum that distinguish neoplastic from non-neoplastic disease within the ovary. Methods Proteomic spectra were generated by mass spectroscopy (surface-enhanced laser desorption and ionisation). A preliminary "training" set of spectra derived from analysis of serum from 50 unaffected women and 50 patients with ovarian cancer were analysed by an iterative searching algorithm that identified a proteomic pattern that completely discriminated cancer from non-cancer. The discovered pattern was then used to classify an independent set of 116 masked serum samples: 50 from women with ovarian cancer, and 66 from unaffected women or those with non-malignant disorders. Findings The algorithm identified a cluster pattern that, in the training set, completely segregated cancer from non-cancer. The discriminatory pattern correctly identified all 50 ovarian cancer cases in the masked set, including all 18 stage I cases. Of the 66 cases of non-malignant disease, 63 were recognised as not cancer. This result yielded a sensitivity of 100% (95% CI 93-100), specificity of 95% (87-99), and positive predictive, value of 94% (84-99). Interpretation These findings justify a prospective population-based assessment of proteomic pattern technology as a screening tool for all stages of ovarian cancer in high-risk and general populations.	US FDA, Natl Inst Hlth Clin Proteom Program, Dept Therapeut Prot, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; NCI, Biostat & Data Management Sect, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; Correlog Syst Inc, Bethesda, MD USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Therapeut, Div Canc Med, Houston, TX 77030 USA; Simone Protect Canc Inst, Lawrenceville, NJ USA; Northwestern Univ, Sch Med, Natl Ovarian Canc Early Detect Program, Chicago, IL USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center; Northwestern University	Petricoin, EF (corresponding author), Bldg 29A,Room 2B02,8800 Rockville Pike, Bethesda, MD 20892 USA.							Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Cohen LS, 2001, GYNECOL ONCOL, V82, P40, DOI 10.1006/gyno.2001.6253; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Herbert B.R., 1997, PROTEOME RES NEW FRO, P13; HOLLAND J, 1994, ADAPTATION NATURAL A; HOLLANDER M, 1999, NONPARAMETRIC STAT M, P189; Jacobs IJ, 1999, LANCET, V353, P1207, DOI 10.1016/S0140-6736(98)10261-1; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; Lapuerta P, 1998, MED DECIS MAKING, V18, P70, DOI 10.1177/0272989X9801800114; Lindahl D, 1999, CLIN PHYSIOL, V19, P497; Menon U, 2000, CURR OPIN OBSTET GYN, V12, P39, DOI 10.1097/00001703-200002000-00007; Menon U., 2000, PRINCIPLES PRACTICE, P165; Ozols RF, 2000, PRINCIPLES PRACTICE, P981; Paweletz CP, 2000, DRUG DEVELOP RES, V49, P34, DOI 10.1002/(SICI)1098-2299(200001)49:1<34::AID-DDR6>3.3.CO;2-N; Richter R, 1999, J CHROMATOGR B, V726, P25, DOI 10.1016/S0378-4347(99)00012-2; Tou JT, 1974, PATTERN RECOGN, P75	20	2399	2690	6	224	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 16	2002	359	9306					572	577		10.1016/S0140-6736(02)07746-2	http://dx.doi.org/10.1016/S0140-6736(02)07746-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523FP	11867112				2022-12-24	WOS:000173943600011
J	He, GS; Markowicz, PP; Lin, TC; Prasad, PN				He, GS; Markowicz, PP; Lin, TC; Prasad, PN			Observation of stimulated emission by direct three-photon excitation	NATURE			English	Article							OPTICAL-DATA STORAGE; 2-PHOTON ABSORPTION; 2-PHOTON-ABSORBING CHROMOPHORES; FLUORESCENCE; DESIGN; PHOTON; DYES	Multiphoton processes, predicted(1) theoretically in 1931, were for a long time considered to be mainly of academic interest. This view changed when it was shown(2,3) that a two-photon absorption process could, because of a quadratic dependence of excitation on intensity, produce a spatially confined excitation useful for three-dimensional data storage and imaging. Two-photon absorption has received considerable attention recently because of the development of highly efficient two-photon-sensitive materials, leading to numerous technological applications(4-28). These successes have created interest in exploring applications based on three-photon excitations(29). For a three-photon process, a longer excitation wavelength such as those common in optical communications can be used. Also, the cubic dependence of the three-photon process on the input light intensity provides a stronger spatial confinement, so that a higher contrast in imaging can be obtained. Here we report the observation of a highly directional and up-converted stimulated emission as an amplified spontaneous emission, produced in an organic chromophore solution by a strong simultaneous three-photon absorption at 1.3 mum. This achievement suggests opportunities for a three-photon process in frequency-upconversion lasing, short-pulse optical communications, and the emerging field of biophotonics.	SUNY Buffalo, Inst Laser Photon & Biophoton, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Prasad, PN (corresponding author), SUNY Buffalo, Inst Laser Photon & Biophoton, Buffalo, NY 14260 USA.	pnprasad@acsu.buffalo.edu	Prasad, Paras N/U-2269-2019					Adronov A, 2000, CHEM MATER, V12, P2838, DOI 10.1021/cm000586o; Albota M, 1998, SCIENCE, V281, P1653, DOI 10.1126/science.281.5383.1653; Belfield KD, 2000, J ORG CHEM, V65, P4475, DOI 10.1021/jo991950+; Bhawalkar J D, 1997, J Clin Laser Med Surg, V15, P201; Bhawalkar JD, 1997, POLYMER, V38, P4551, DOI 10.1016/S0032-3861(97)00125-0; Cumpston BH, 1999, NATURE, V398, P51, DOI 10.1038/17989; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dvornikov AS, 1997, OPT COMMUN, V136, P1, DOI 10.1016/S0030-4018(96)00645-1; Ehrlich JE, 1997, OPT LETT, V22, P1843, DOI 10.1364/OL.22.001843; GOPPERTMEYER M, 1931, ANN PHYS, V9, P275; Gura T, 1997, SCIENCE, V276, P1988, DOI 10.1126/science.276.5321.1988; HE GS, 1995, OPT LETT, V20, P1524, DOI 10.1364/OL.20.001524; He GS, 1997, J APPL PHYS, V81, P2529, DOI 10.1063/1.364303; He GS, 1998, IEEE J QUANTUM ELECT, V34, P7, DOI 10.1109/3.655001; He GS, 1998, IEEE J QUANTUM ELECT, V34, P2279, DOI 10.1109/3.736090; He GS, 1997, J OPT SOC AM B, V14, P1079, DOI 10.1364/JOSAB.14.001079; HE GS, 1995, OPT LETT, V20, P435, DOI 10.1364/OL.20.000435; HE GS, 1995, OPT LETT, V20, P2393, DOI 10.1364/OL.20.002393; Joshi MP, 1999, APPL PHYS LETT, V74, P170, DOI 10.1063/1.123283; Kannan R, 2001, CHEM MATER, V13, P1896, DOI 10.1021/cm000747o; Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130; Kim OK, 2000, CHEM MATER, V12, P284, DOI 10.1021/cm990662r; PARTHENOPOULOS DA, 1990, J APPL PHYS, V68, P5814, DOI 10.1063/1.346953; PARTHENOPOULOS DA, 1989, SCIENCE, V245, P843, DOI 10.1126/science.245.4920.843; Pudavar HE, 1999, APPL PHYS LETT, V74, P1338, DOI 10.1063/1.123543; Reinhardt BA, 1998, CHEM MATER, V10, P1863, DOI 10.1021/cm980036e; STRICKLER JH, 1991, OPT LETT, V16, P1780, DOI 10.1364/OL.16.001780; Wang XP, 1999, P NATL ACAD SCI USA, V96, P11081, DOI 10.1073/pnas.96.20.11081; ZHAO CF, 1995, CHEM MATER, V7, P1979, DOI 10.1021/cm00058a032	29	365	377	8	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2002	415	6873					767	770		10.1038/415767a	http://dx.doi.org/10.1038/415767a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845202				2022-12-24	WOS:000173833900039
J	Bond, AB; Kamil, AC				Bond, AB; Kamil, AC			Visual predators select for crypticity and polymorphism in virtual prey	NATURE			English	Article							SEARCH IMAGE; BLUE JAYS; REFLEXIVE SELECTION; APOSTATIC SELECTION; CYANOCITTA-CRISTATA; NATURAL-SELECTION; HYPOTHESIS; ATTENTION; PATTERNS; STIMULI	Cryptically coloured animals commonly occur in several distinct pattern variants. Such phenotypic diversity may be promoted by frequency-dependent predation, in which more abundant variants are attacked disproportionately often, but the hypothesis has never been explicitly tested. Here we report the first controlled experiment on the effects of visual predators on prey crypticity and phenotypic variance, in which blue jays (Cyanocitta cristata) searched for digital moths on computer monitors. Moth phenotypes evolved via a genetic algorithm in which individuals detected by the jays were much less likely to reproduce. Jays often failed to detect atypical cryptic moths, confirming frequency-dependent selection and suggesting the use of searching images, which enhance the detection of common prey. Over successive generations, the moths evolved to become significantly harder to detect, and they showed significantly greater phenotypic variance than non-selected or frequency-independent selected controls.	Univ Nebraska, Sch Biol Sci, Nebraska Behav Biol Grp, Lincoln, NE 68588 USA; Univ Nebraska, Dept Psychol, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Bond, AB (corresponding author), Univ Nebraska, Sch Biol Sci, Nebraska Behav Biol Grp, Lincoln, NE 68588 USA.							ALLEN JA, 1988, PHILOS T R SOC B, V319, P485, DOI 10.1098/rstb.1988.0061; ALLEN JA, 1988, OIKOS, V51, P251, DOI 10.2307/3565651; Back T, 1996, EVOLUTIONARY ALGORIT; Barnes W., 1918, Mem Amer mus NH New York, V3; Bond AB, 1998, NATURE, V395, P594, DOI 10.1038/26961; BOND AB, 1983, J EXP PSYCHOL ANIM B, V9, P292, DOI 10.1037/0097-7403.9.3.292; BOND AB, 1991, ETHOLOGY, V87, P203; Bond AB, 1999, ANIM LEARN BEHAV, V27, P461, DOI 10.3758/BF03209981; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; CARROLL SB, 1994, SCIENCE, V265, P109, DOI 10.1126/science.7912449; Clarke B., 1962, TAXONOMY GEOGRAPHY, P47; COMMON IFB, 1954, AUST J ZOOL, V2, P223, DOI 10.1071/ZO9540223; Cott H. B, 1957, ADAPTIVE COLORATION; DARLINGTON CD, 1950, ELEMENTS GENETICS; Dearn J.M., 1990, P517; Edmunds M., 1990, P3; Endler J.A., 1991, P169; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; ENDLER JA, 1984, BIOL J LINN SOC, V22, P187, DOI 10.1111/j.1095-8312.1984.tb01677.x; Fleishman LJ, 1998, ANIM BEHAV, V56, P1035, DOI 10.1006/anbe.1998.0894; FORD EB, 1961, INSECT POLYMORPHISM, V1, P11; GUILDORD T, 1987, ANIM BEHAV, V35, P1838, DOI 10.1016/S0003-3472(87)80076-3; HALKKA O, 1990, EVOL BIOL, V24, P149; Kaufman L., 2009, FINDING GROUPS DATA; Kono H, 1998, ANIM BEHAV, V56, P963, DOI 10.1006/anbe.1998.0847; Langley CM, 1996, J EXP PSYCHOL ANIM B, V22, P152, DOI 10.1037/0097-7403.22.2.152; MOMENT GB, 1962, SCIENCE, V136, P262, DOI 10.1126/science.136.3512.262; Nabours RK, 1933, GENETICS, V18, P0159; Nijhout H.F., 1991, DEV EVOLUTION BUTTER; OWEN DF, 1986, OIKOS, V47, P117, DOI 10.2307/3565927; PIETREWICZ AT, 1977, SCIENCE, V195, P580, DOI 10.1126/science.195.4278.580; PIETREWICZ AT, 1979, SCIENCE, V204, P1332, DOI 10.1126/science.204.4399.1332; PLAISTED KC, 1995, ANIM BEHAV, V50, P1219, DOI 10.1016/0003-3472(95)80039-5; Poulton E.B., 1890, COLOUR ANIMALS; PRUESS KP, 1967, ANN ENTOMOL SOC AM, V60, P910, DOI 10.1093/aesa/60.5.910; Rand AS, 1967, ATAS S SOBRE BIOTA A, V5, P73; REID PJ, 1992, J EXP PSYCHOL ANIM B, V18, P273, DOI 10.1037/0097-7403.18.3.273; RICKLEFS RE, 1975, EVOLUTION, V29, P313, DOI 10.1111/j.1558-5646.1975.tb00211.x; Robinson M. H., 1969, EVOL BIOL, VIII, P225; ROBINSON R, 1971, LEPIDOPTERAN GENETIC; SARGENT T.D., 1976, LEGION NIGHT UNDERWI; SARGENT TD, 1978, EVOLUTION, V32, P424, DOI 10.1111/j.1558-5646.1978.tb00657.x; Sneath P. H. A., 1973, NUMERICAL TAXONOMY P; TINBERGEN L., 1960, ARCH NEERLAND ZOOL, V13, P265; WALLACE AR, 1891, DARWINISM EXPOSITION; Whiteley DAA, 1997, BIOL J LINN SOC, V62, P475, DOI 10.1006/bijl.1997.0168	47	212	221	6	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					609	613		10.1038/415609a	http://dx.doi.org/10.1038/415609a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	519DC	11832937	Green Published			2022-12-24	WOS:000173709100037
J	Clutton-Brock, TH; Coulson, TN; Milner-Gulland, EJ; Thomson, D; Armstrong, HM				Clutton-Brock, TH; Coulson, TN; Milner-Gulland, EJ; Thomson, D; Armstrong, HM			Sex differences in emigration and mortality affect optimal management of deer populations	NATURE			English	Article							DENSITY-RELATED CHANGES; FEMALE RED DEER; CERVUS-ELAPHUS; HABITAT SEGREGATION; RATIO; HIGHLANDS; SHEEP	Populations of red deer that are limited by food, like those of many other ungulates(1-3), commonly include more females than males(4-7). We assessed the contribution of variation in sex- and age-specific rates of mortality and emigration to density-dependent changes in the adult sex ratio, using long-term observations and demographic experiments involving the red deer population on Rum, Scotland(4,5). We incorporated these effects in a stochastic model of local populations under different management regimes to show here that, when female numbers are allowed to increase to more than 60% of the ecological carrying capacity, the sustainable annual harvest of males from local deer populations will fall. Because males are typically culled by fee-paying hunters and generate more income than females(5,8,9), income will decrease as the male harvest falls. Because numbers of female deer throughout much of the Highlands probably exceed the threshold at which male density starts to be affected(5), many managers might be able to raise income from local deer populations by reducing female numbers, with potential benefits to the vegetation of Scottish Highland environments(10).	Univ Cambridge, Dept Zool, Large Anim Res Grp, Cambridge CB2 3EJ, England; Univ London Imperial Coll Sci Technol & Med, Royal Sch Mines, TH Huxley Sch Environm Earth Sci & Engn, London SW7 2BP, England; Scottish Nat Heritage, Edinburgh EH6 5NP, Midlothian, Scotland	University of Cambridge; Imperial College London	Clutton-Brock, TH (corresponding author), Univ Cambridge, Dept Zool, Large Anim Res Grp, Downing St, Cambridge CB2 3EJ, England.		Coulson, Tim/AAL-8148-2021	Coulson, Tim/0000-0001-9371-9003				Buckland ST, 1996, J APPL ECOL, V33, P118, DOI 10.2307/2405021; CHARLES WN, 1977, J APPL ECOL, V14, P55, DOI 10.2307/2401826; CLUTTONBROCK TH, 1987, J ZOOL, V211, P275, DOI 10.1111/j.1469-7998.1987.tb01534.x; CLUTTONBROCK TH, 1985, J ANIM ECOL, V54, P831, DOI 10.2307/4381; CLUTTONBROCK TH, 1985, NATURE, V313, P131, DOI 10.1038/313131a0; CLUTTONBROCK TH, 1994, J APPL ECOL, V31, P521, DOI 10.2307/2404447; CLUTTONBROCK TH, 1991, J ANIM ECOL, V60, P593, DOI 10.2307/5300; CLUTTONBROCK TH, 1992, NATURE, V358, P11; CluttonBrock TH, 1997, P ROY SOC B-BIOL SCI, V264, P1509, DOI 10.1098/rspb.1997.0209; Conradt L, 2000, ANIM BEHAV, V59, P1049, DOI 10.1006/anbe.2000.1409; Conradt L, 1999, OECOLOGIA, V119, P367, DOI 10.1007/s004420050797; KLEIN DR, 1968, J WILDLIFE MANAGE, V32, P350, DOI 10.2307/3798981; Kruuk LEB, 1999, NATURE, V399, P459, DOI 10.1038/20917; Langvatn R, 1999, WILDLIFE BIOL, V5, P213; LOWE VPW, 1969, J ANIM ECOL, V38, P425, DOI 10.2307/2782; Lubow BC, 1996, J WILDLIFE MANAGE, V60, P787, DOI 10.2307/3802378; McCullough D. R., 1990, WILDLIFE MONOGR, V112, P1; McCullough DR, 2001, WILDLIFE BIOL, V7, P161, DOI 10.2981/wlb.2001.020; OSBORNE BC, 1984, J APPL ECOL, V21, P497, DOI 10.2307/2403424; [No title captured]; [No title captured]; [No title captured]; [No title captured]	23	121	133	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 7	2002	415	6872					633	637		10.1038/415633a	http://dx.doi.org/10.1038/415633a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832944				2022-12-24	WOS:000173709100044
J	Ye, KQ; Aghdasi, B; Luo, HBR; Moriarity, JL; Wu, FY; Hong, JJ; Hurt, KJ; Bae, SS; Suh, PG; Snyder, SH				Ye, KQ; Aghdasi, B; Luo, HBR; Moriarity, JL; Wu, FY; Hong, JJ; Hurt, KJ; Bae, SS; Suh, PG; Snyder, SH			Phospholipase C gamma 1 is a physiological guanine nucleotide exchange factor for the nuclear GTPase PIKE	NATURE			English	Article							NERVE GROWTH-FACTOR; SH3 DOMAINS; CELL-DIFFERENTIATION; STRUCTURAL BASIS; FRIEND-CELLS; PROTEIN 4.1N; PC12 CELLS; C-GAMMA; RAS; ACTIVATION	Phospholipase Cgamma1 (PLC-gamma1) hydrolyses phosphatidylinositol-4,5-bisphosphate to the second messengers inositol-1,4,5-trisphosphate and diacylglycerol. PLC-gamma1 also has mitogenic activity upon growth-factor-dependent tyrosine phophorylation(1,2); however, this activity is not dependent on the phospholipase activity of PLC-gamma1, but requires an SH3 domain(3,4). Here, we demonstrate that PLC-gamma1 acts as a guanine nucleotide exchange factor (GEF) for PIKE (phosphatidylinositol-3-OH kinase (PI(3)K) enhancer). PIKE is a nuclear GTPase that activates nuclear PI(3)K activity, and mediates the physiological activation by nerve growth factor (NGF) of nuclear PI(3)K activity(5). This enzymatic activity accounts for the mitogenic properties of PLC-gamma1.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; Pohang Univ Sci & Technol, Dept Life Sci, Div Mol Life Sci, Pohang 790784, South Korea	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Pohang University of Science & Technology (POSTECH)	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.		Suh, Pann-Ghill/F-3610-2010; Hurt, K. Joseph/J-8266-2019	Hurt, K. Joseph/0000-0001-6906-350X				Bae SS, 1998, J NEUROCHEM, V71, P178; Bertagnolo V, 1998, FEBS LETT, V441, P480, DOI 10.1016/S0014-5793(98)01593-2; BERTAGNOLO V, 1995, CELL SIGNAL, V7, P669, DOI 10.1016/0898-6568(95)00036-O; Carpenter G, 1999, EXP CELL RES, V253, P15, DOI 10.1006/excr.1999.4671; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; HUANG KJ, 1995, CHINESE J CHEM ENG, V3, P1; Irvin BJ, 2000, MOL CELL BIOL, V20, P9149, DOI 10.1128/MCB.20.24.9149-9161.2000; Kim MJ, 2000, BIOCHEMISTRY-US, V39, P8674, DOI 10.1021/bi992558t; LAI SHY, 1993, COMPUT IND ENG, V25, P13, DOI 10.1016/0360-8352(93)90209-G; MARMIROLI S, 1994, J BIOL CHEM, V269, P13; MARTELLI AM, 1994, CANCER RES, V54, P2536; MUNDER T, 1992, MOL CELL BIOL, V12, P2091, DOI 10.1128/MCB.12.5.2091; Neri LM, 1998, J BIOL CHEM, V273, P29738, DOI 10.1074/jbc.273.45.29738; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; Pei ZD, 1997, ARCH BIOCHEM BIOPHYS, V345, P103, DOI 10.1006/abbi.1997.0245; QUILLIAM LA, 1995, BIOESSAYS, V17, P395, DOI 10.1002/bies.950170507; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; Scholler JK, 2000, EUR J IMMUNOL, V30, P2378, DOI 10.1002/1521-4141(2000)30:8<2378::AID-IMMU2378>3.0.CO;2-E; SHOU C, 1992, NATURE, V358, P351, DOI 10.1038/358351a0; Smith MR, 1998, CARCINOGENESIS, V19, P177, DOI 10.1093/carcin/19.1.177; SMITH MR, 1994, P NATL ACAD SCI USA, V91, P6554, DOI 10.1073/pnas.91.14.6554; Smith MR, 1996, BIOCHEM BIOPH RES CO, V222, P186, DOI 10.1006/bbrc.1996.0719; Ye KQ, 2000, CELL, V103, P919, DOI 10.1016/S0092-8674(00)00195-1; Ye KQ, 1999, J NEUROSCI, V19, P10747, DOI 10.1523/JNEUROSCI.19-24-10747.1999; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; ZINI N, 1995, EUR J CELL BIOL, V68, P25	28	137	143	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					541	544		10.1038/415541a	http://dx.doi.org/10.1038/415541a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823862				2022-12-24	WOS:000173564300050
J	Ben-Asouli, Y; Banai, Y; Pel-Or, Y; Shir, A; Kaempfer, R				Ben-Asouli, Y; Banai, Y; Pel-Or, Y; Shir, A; Kaempfer, R			Human interferon-gamma mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKR	CELL			English	Article							DOUBLE-STRANDED-RNA; DSRNA-BINDING DOMAIN; SECONDARY STRUCTURE; CELLS; PHOSPHORYLATION; RECOGNITION; REGION	PKR, an interferon (IFN)-inducible protein kinase activated by double-stranded RNA, inhibits translation by phosphorylating the initiation factor eIF2alpha chain. We show that human IFN-gamma mRNA uses local activation of PKR in the cell to control its own translation yield. IFN-gamma mRNA activates PKR through a pseudoknot in its 5' untranslated region. Mutations that impair pseudoknot stability reduce the ability to activate PKR and strongly increase the translation efficiency of IFN-gamma mRNA. Nonphosphorylatable mutant eIF2alpha, knockout of PKR and PKR inhibitors 2-aminopurine, transdominant-negative PKR, or vaccinia E3L correspondingly enhances translation of IFN-gamma mRNA. The potential to form the pseudoknot is phylogenetically conserved. We propose that the RNA pseudoknot acts to adjust translation of IFN-gamma mRNA to the PKR level expressed in the cell.	Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Virol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Kaempfer, R (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Virol, IL-91120 Jerusalem, Israel.	kaempfer@cc.huji.ac.il		Kaempfer, Raymond/0000-0002-5865-4619				Arad G, 2000, NAT MED, V6, P414, DOI 10.1038/74672; Ben-Asouli Y, 2000, NUCLEIC ACIDS RES, V28, P1011, DOI 10.1093/nar/28.4.1011; Bevilacqua PC, 1998, BIOCHEMISTRY-US, V37, P6303, DOI 10.1021/bi980113j; Bevilacqua PC, 1996, BIOCHEMISTRY-US, V35, P9983, DOI 10.1021/bi9607259; Billiau A, 1996, ADV IMMUNOL, V62, P61, DOI 10.1016/S0065-2776(08)60428-9; BYCROFT M, 1995, EMBO J, V14, P3563, DOI 10.1002/j.1460-2075.1995.tb07362.x; Chu WM, 1998, MOL CELL BIOL, V18, P58, DOI 10.1128/MCB.18.1.58; Circle DA, 1997, RNA, V3, P438; Davis S, 1996, P NATL ACAD SCI USA, V93, P508, DOI 10.1073/pnas.93.1.508; DIRKS W, 1994, GENE, V149, P389, DOI 10.1016/0378-1119(94)90187-2; Donahue TF, 2000, COLD SPRING HARBOR M, V39, P487; EDERY I, 1989, CELL, V56, P303, DOI 10.1016/0092-8674(89)90904-5; EFRAT S, 1982, NATURE, V297, P236, DOI 10.1038/297236a0; FARRELL PJ, 1977, CELL, V11, P187, DOI 10.1016/0092-8674(77)90330-0; Fernandez J, 2002, J BIOL CHEM, V277, P2050, DOI 10.1074/jbc.M109199200; GREEN SR, 1992, GENE DEV, V6, P2478, DOI 10.1101/gad.6.12b.2478; HARROD R, 1994, GENE, V140, P79, DOI 10.1016/0378-1119(94)90734-X; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Jarrous N, 1996, MOL CELL BIOL, V16, P2814; Kaufman RJ, 2000, COLD SPRING HARBOR M, V39, P503; Kaufman RJ, 1999, P NATL ACAD SCI USA, V96, P11693, DOI 10.1073/pnas.96.21.11693; KOROMILAS AE, 1995, J BIOL CHEM, V270, P25426, DOI 10.1074/jbc.270.43.25426; KOROMILAS AE, 1992, SCIENCE, V257, P1685, DOI 10.1126/science.1382315; MAITRA RK, 1994, VIROLOGY, V204, P823, DOI 10.1006/viro.1994.1601; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Mathews MB, 2000, COLD SPRING HARBOR M, V39, P1; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Nanduri S, 2000, EMBO J, V19, P5567, DOI 10.1093/emboj/19.20.5567; Osman F, 1999, GENE DEV, V13, P3280, DOI 10.1101/gad.13.24.3280; Romano PR, 1998, MOL CELL BIOL, V18, P7304, DOI 10.1128/MCB.18.12.7304; ROSEN H, 1982, J BIOL CHEM, V257, P946; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; SCHMEDT C, 1995, J MOL BIOL, V249, P29, DOI 10.1006/jmbi.1995.0278; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Wong AHT, 1997, EMBO J, V16, P1291, DOI 10.1093/emboj/16.6.1291; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x	39	165	170	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2002	108	2					221	232		10.1016/S0092-8674(02)00616-5	http://dx.doi.org/10.1016/S0092-8674(02)00616-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832212	Bronze			2022-12-24	WOS:000173521300009
J	Beutler, E; Felitti, VJ; Koziol, JA; Ho, NJ; Gelbart, T				Beutler, E; Felitti, VJ; Koziol, JA; Ho, NJ; Gelbart, T			Penetrance of 845G -> A (C282Y) HFE hereditary haemochromatosis mutation in the USA	LANCET			English	Article; Proceedings Paper	42nd Annual Meeting of the American-Society-of-Hematology	DEC 01-05, 2000	SAN FRANCISCO, CALIFORNIA	Amer Soc Hematol			HEMOCHROMATOSIS GENE; HOMOZYGOTES; DISEASE; POPULATION; ALLELE; COST; H63D	Background There has been much interest in screening populations for disease-associated mutations. A favoured candidate has been the HFE gene, mutations of which are the most common cause of haemochromatosis in the European population. About five people in 1000 are homozygotes for the 845G-->A mutation, but little is known of how many have mutation-caused clinical manifestations. Methods We screened 41038 individuals attending a health appraisal clinic in the USA for the 845G-->A and 187C-->G HFE mutations, and analysed laboratory data and data on signs and symptoms of haemochromatosis as elicited by questionnaire. Findings The most common symptoms of haemochromatosis, including poor general health, diabetes, arthropathies, arrhythmias, impotence, and skin pigmentation were no more prevalent among the 152 identified homozygotes than among the controls. The age distribution of homozygotes and compound heterozygotes did not differ significantly from that of controls: there was no measurable loss of such individuals from the population during ageing. However, there was a significantly increased prevalence of a history of hepatitis or "liver trouble" among homozygotes and in the proportion of homozygotes with increased concentrations of serum aspartate aminotransferase and collagen IV; these changes were not related to iron burden or to age. Only one of the 152 homozygotes had signs and symptoms that would suggest a diagnosis of haemochromatosis. Interpretation The normal age distribution of people with the haemochromatosis genotype, and the lack of symptoms in patients of all ages, indicate that the penetrance of hereditary haemochromatosis is much lower than generally thought. The clinical penetrance of a disorder is an essential consideration in screening for genetic disease; disorders with low penetrance are more expensive candidates for screening than disorders with high penetrance. Our best estimate is that less than 1% of homozygotes develop frank clinical haemochromatosis.	Scripps Res Inst, Res Inst, Dept Mol & Expt Med, Div Hematol, La Jolla, CA 92037 USA; Scripps Res Inst, Res Inst, Dept Mol & Expt Med, Div Biomath, La Jolla, CA 92037 USA; Kaiser Permanente, Dept Prevent Med, San Diego, CA USA	Scripps Research Institute; Scripps Research Institute; Kaiser Permanente	Beutler, E (corresponding author), Scripps Res Inst, Res Inst, Dept Mol & Expt Med, Div Hematol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Gelbart, Terri/0000-0002-7863-1262	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00833] Funding Source: Medline; NIDDK NIH HHS [DK53505-03] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams P, 2000, J HEPATOL, V33, P487, DOI 10.1016/S0168-8278(01)80874-6; Adams PC, 1995, HEPATOLOGY, V22, P1720, DOI 10.1016/0270-9139(95)90197-3; Adams PC, 2000, MOL GENET METAB, V71, P81, DOI 10.1006/mgme.2000.3037; Bach G, 2001, AM J MED GENET, V99, P70, DOI 10.1002/1096-8628(20010215)99:1<70::AID-AJMG1120>3.0.CO;2-0; Barton JC, 1996, NAT MED, V2, P394, DOI 10.1038/nm0496-394; Beutler E, 1997, AM J HUM GENET, V61, P762; BEUTLER E, 1992, SCIENCE, V256, P794, DOI 10.1126/science.1589760; Beutler E, 2001, BLOOD, V98, P2597, DOI 10.1182/blood.V98.9.2597; Beutler E, 2000, ANN INTERN MED, V133, P329, DOI 10.7326/0003-4819-133-5-200009050-00008; Beutler E, 2000, GENET TEST, V4, P131, DOI 10.1089/10906570050114830; Beutler Ernest, 1996, Blood Cells Molecules and Diseases, V22, P187, DOI 10.1006/bcmd.1996.0027; Bradley L A, 1996, J Med Screen, V3, P178; Bulaj ZJ, 2000, NEW ENGL J MED, V343, P1529, DOI 10.1056/NEJM200011233432104; Edwards CQ, 1998, SEMIN HEMATOL, V35, P72; Fairbanks VF, 1998, GUT, V43, P441, DOI 10.1136/gut.43.3.441; Fasouliotis S J, 2000, Obstet Gynecol Surv, V55, P373, DOI 10.1097/00006254-200006000-00023; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; George DK, 1999, J HEPATOL, V31, P47, DOI 10.1016/S0168-8278(99)80162-7; Guyader D, 1998, GASTROENTEROLOGY, V115, P929, DOI 10.1016/S0016-5085(98)70265-3; Jazwinska EC, 1996, NAT GENET, V14, P249, DOI 10.1038/ng1196-249; Jouanolle AM, 1996, NAT GENET, V14, P251, DOI 10.1038/ng1196-251; LINDMARK B, 1985, ACTA MED SCAND, V218, P299; Lubin IM, 1999, ARCH PATHOL LAB MED, V123, P1177; McDonnell SM, 1999, AM J MED, V106, P619, DOI 10.1016/S0002-9343(99)00120-5; Olynyk JK, 1999, NEW ENGL J MED, V341, P718, DOI 10.1056/NEJM199909023411002; Sheldon J. H., 1935, HAEMOCHROMATOSIS; STEINBERG MH, 1989, BRIT J HAEMATOL, V71, P297, DOI 10.1111/j.1365-2141.1989.tb04274.x; WILK MB, 1968, BIOMETRIKA, V55, P1; Willis G, 2000, GUT, V46, P401, DOI 10.1136/gut.46.3.401; Willis G, 1999, LANCET, V354, P221, DOI 10.1016/S0140-6736(99)02195-9; Witte DL, 1996, CLIN CHIM ACTA, V245, P139, DOI 10.1016/0009-8981(95)06212-2; Yang QH, 1998, ANN INTERN MED, V129, P946, DOI 10.7326/0003-4819-129-11_Part_2-199812011-00005; Yapp TR, 2001, INTERN MED J, V31, P48, DOI 10.1046/j.1445-5994.2001.00005.x	33	630	643	1	31	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 19	2002	359	9302					211	218		10.1016/S0140-6736(02)07447-0	http://dx.doi.org/10.1016/S0140-6736(02)07447-0			8	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512YH	11812557				2022-12-24	WOS:000173350800013
J	Kirwan, JMJ; Tincello, DG; Herod, JJO; Frost, O; Kingston, RE				Kirwan, JMJ; Tincello, DG; Herod, JJO; Frost, O; Kingston, RE			Effect of delays in primary care referral on survival of women with epithelial ovarian cancer: retrospective audit	BRITISH MEDICAL JOURNAL			English	Article							CARCINOMA; DIAGNOSIS	Objective To examine referral pathways from primary care for patients with epithelial ovarian cancer and to identify, factors related to survival at 18 months. Design Retrospective,e review of patient notes. Setting General practices and receiving hospitals within Mersey region. Subjects 135 patients with epithelial ovarian cancer identified from an audit in the Mersey area between 1992 and 1994. Main outcome measures Delays between onset of symptoms and treatment attributable to patient, general practitioner, and hospital. Results 105 (78%) women first presented to their general practitioner, within four weeks of the onset of symptoms. 99 (73%) women were referred to hospital by their general practitioners within four weeks of presentation, mad 95 (70%) were seen in hospital within two weeks of referral. Multivariate analysis With survival as the dependent variable identified age (odds ratio 0.96, 95% confidence interval 0.93 to 0.99) cancer stage III or more (0.15, 0.05 to 0.43), and non-specific symptoms (0.36, 0.14 to 0.89) as significant variables. Conclusion Most patients attended their general practitioner within four weeks and were referred within two weeks. No evidence was found that delays in referral or diagnosis adversely affected survival at IS months. Stage of disease at surgery was the most important adverse factor. An effective screening programme is the most likely method to improve survival.	Liverpool Womens Hosp, Liverpool L8 7SS, Merseyside, England; Univ Liverpool, Dept Obstet & Gynaecol, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool	Kirwan, JMJ (corresponding author), Liverpool Womens Hosp, Liverpool L8 7SS, Merseyside, England.							Bell R, 1998, BRIT J OBSTET GYNAEC, V105, P1136, DOI 10.1111/j.1471-0528.1998.tb09966.x; Berrino F, 1999, SURVIVAL CANC PATIEN; FIGO Cancer Committee, 1986, GYNECOL ONCOL, V25, P383; FLAM F, 1988, EUR J OBSTET GYN R B, V27, P53, DOI 10.1016/S0028-2243(88)80010-8; Goff BA, 2000, CANCER, V89, P2068, DOI 10.1002/1097-0142(20001115)89:10<2068::AID-CNCR6>3.0.CO;2-Z; Jacobs IJ, 1999, LANCET, V353, P1207, DOI 10.1016/S0140-6736(98)10261-1; Kjellgren O, 1977, Lakartidningen, V74, P3333; LEIDERKEN BMJ, 1997, BR J GEN PRACT, V47, P505; LYNN RB, 1995, MED CLIN N AM, V79, P373, DOI 10.1016/S0025-7125(16)30074-8; *NCI, 1998, SEER STAT CANC INC P; *OFF NAT STAT, 1999, CANC 1971 1997; OMURA GA, 1991, J CLIN ONCOL, V9, P1138, DOI 10.1200/JCO.1991.9.7.1138; Richards MA, 1999, LANCET, V353, P1119, DOI 10.1016/S0140-6736(99)02143-1; Secretary of State for Health, 1997, CM380; SUMMERTON N, 1999, DIAGNOSING CANC PRIM; Wikborn C, 1996, INT J GYNECOL OBSTET, V52, P263, DOI 10.1016/0020-7292(95)02588-X; WIKBORN C, 1993, INT J GYNECOL OBSTET, V42, P261, DOI 10.1016/0020-7292(93)90222-I	17	47	48	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 19	2002	324	7330					148	151		10.1136/bmj.324.7330.148	http://dx.doi.org/10.1136/bmj.324.7330.148			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514ZH	11799032	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000173470600019
J	Barouch, DH; Kunstman, J; Kuroda, MJ; Schmitz, JE; Santra, S; Peyerl, FW; Krivulka, GR; Beaudry, K; Lifton, MA; Gorgone, DA; Montefiori, DC; Lewis, MG; Wolinsky, SM; Letvin, NL				Barouch, DH; Kunstman, J; Kuroda, MJ; Schmitz, JE; Santra, S; Peyerl, FW; Krivulka, GR; Beaudry, K; Lifton, MA; Gorgone, DA; Montefiori, DC; Lewis, MG; Wolinsky, SM; Letvin, NL			Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes	NATURE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; MHC CLASS-I; ANTIRETROVIRAL THERAPY; PRIMARY INFECTION; VIREMIA; VARIANTS; SELECTION; PEPTIDE; EPITOPE; PROGRESSION	Potent virus-specific cytotoxic T lymphocyte (CTL) responses elicited by candidate AIDS vaccines have recently been shown to control viral replication and prevent clinical disease progression after pathogenic viral challenges in rhesus monkeys(1-4). Here we show that viral escape from CTL recognition can result in the eventual failure of this partial immune protection. Viral mutations that escape from CTL recognition have been previously described in humans infected with human immunodeficiency virus (HIV)(5-10) and monkeys infected with simian immunodeficiency virus (SIV)(11-13). In a cohort of rhesus monkeys that were vaccinated and subsequently infected with a pathogenic hybrid simian-human immunodeficiency virus (SHIV), the frequency of viral sequence mutations within CTL epitopes correlated with the level of viral replication. A single nucleotide mutation within an immunodominant Gag CTL epitope in an animal with undetectable plasma viral RNA resulted in viral escape from CTLs, a burst of viral replication, clinical disease progression, and death from AIDS-related complications. These data indicate that viral escape from CTL recognition may be a major limitation of the CTL-based AIDS vaccines that are likely to be administered to large human populations over the next several years.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Northwestern Univ, Sch Med, Dept Med, Chicago, IL 60611 USA; Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; So Res Inst, Frederick, MD 21701 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Northwestern University; Duke University	Barouch, DH (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Res E Room 113,330 Brookline Ave, Boston, MA 02215 USA.		Barouch, Dan/Y-3918-2019; Schmitz, Joern/A-4929-2018; Wolinsky, Steven/B-2893-2012	Schmitz, Joern/0000-0001-8803-0922; Wolinsky, Steven/0000-0002-9625-6697	NCI NIH HHS [R01 CA050139] Funding Source: Medline; NIAID NIH HHS [P01 AI035351, U01 AI035351] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA050139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035351, U01AI035351] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Allen TM, 1998, J IMMUNOL, V160, P6062; Allen TM, 2001, J VIROL, V75, P738, DOI 10.1128/JVI.75.2.738-749.2001; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Chen ZW, 2000, J IMMUNOL, V164, P6474, DOI 10.4049/jimmunol.164.12.6474; Crawford JM, 1999, J VIROL, V73, P10199, DOI 10.1128/JVI.73.12.10199-10207.1999; Egan MA, 1999, J VIROL, V73, P5466, DOI 10.1128/JVI.73.7.5466-5472.1999; Evans DT, 1999, NAT MED, V5, P1270, DOI 10.1038/15224; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kalams SA, 1999, J VIROL, V73, P6721, DOI 10.1128/JVI.73.8.6721-6728.1999; KOENIG S, 1995, NAT MED, V1, P330, DOI 10.1038/nm0495-330; Kuroda MJ, 1998, J EXP MED, V187, P1373, DOI 10.1084/jem.187.9.1373; MILLER MD, 1991, J IMMUNOL, V147, P320; Ogg GS, 1999, J VIROL, V73, P797, DOI 10.1128/JVI.73.1.797-800.1999; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Polacino P, 1999, J VIROL, V73, P618, DOI 10.1128/JVI.73.1.618-630.1999; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Reimann KA, 1996, J VIROL, V70, P6922, DOI 10.1128/JVI.70.10.6922-6928.1996; Rose NF, 2001, CELL, V106, P539, DOI 10.1016/S0092-8674(01)00482-2; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537	27	577	609	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2002	415	6869					335	339		10.1038/415335a	http://dx.doi.org/10.1038/415335a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797012				2022-12-24	WOS:000173293500047
J	Gallup, CD; Cheng, H; Taylor, FW; Edwards, RL				Gallup, CD; Cheng, H; Taylor, FW; Edwards, RL			Direct determination of the timing of sea level change during termination II	SCIENCE			English	Article							PENULTIMATE DEGLACIATION; HUON PENINSULA; DEVILS-HOLE; CLIMATE; RECORD; TEMPERATURE; BARBADOS; TERRACES; ISOTOPES; CALCITE	An outcrop within the last interglacial terrace on Barbados contains corals that grew during the penultimate deglaciation, or Termination II. We used combined Th-230 and Pa-231 dating to determine that they grew 135.8+/-0.8 thousand years ago, indicating that sea level was 18+/-3 meters below present sea level at the time. This suggests that sea level had risen to within 20% of its peak last-interglacial value by 136 thousand years ago, in conflict with Milankovitch theory predictions. Orbital forcing may have played a rote in the deglaciation, as may have isostatic adjustments due to large ice sheets, Other corals in the same outcrop grew during oxygen isotope (delta(18)O) substage 6e, indicating that sea level was 38+/-5 meters below present sea level, about 168.0 thousand years ago. When compared to the delta(18)O signal in the benthic V19-30/V19-28 record at that time, the coral data extend to the previous glacial cycle the conclusion that deep-water temperatures were colder during glacial periods.	Univ Minnesota, Dept Geol Sci, Duluth, MN 55812 USA; Univ Minnesota, Dept Geol & Geophys, Minnesota Isotope Lab, Minneapolis, MN 55455 USA; Univ Texas, Inst Geophys, Austin, TX 78712 USA	University of Minnesota System; University of Minnesota Duluth; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Austin	Gallup, CD (corresponding author), Univ Minnesota, Dept Geol Sci, Duluth, MN 55812 USA.	cgallup@d.umn.edu	Edwards, R. Lawrence/I-3124-2014; CHENG, HAI/H-3413-2017; Taylor, Frederick/A-2195-2009	Edwards, R. Lawrence/0000-0002-7027-5881; CHENG, HAI/0000-0002-5305-9458; 				BENDER ML, 1979, GEOL SOC AM BULL, V90, P577, DOI 10.1130/0016-7606(1979)90<577:UDOTPR>2.0.CO;2; BERGER AL, 1978, QUATERNARY RES, V9, P139, DOI 10.1016/0033-5894(78)90064-9; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; CHAPPELL J, 1986, NATURE, V324, P137, DOI 10.1038/324137a0; Chappell J, 1996, EARTH PLANET SC LETT, V141, P227, DOI 10.1016/0012-821X(96)00062-3; Cheng H, 2000, CHEM GEOL, V169, P17, DOI 10.1016/S0009-2541(99)00157-6; EDWARDS RL, 1987, SCIENCE, V236, P1547, DOI 10.1126/science.236.4808.1547; Edwards RL, 1997, SCIENCE, V276, P782, DOI 10.1126/science.276.5313.782; EDWARDS RL, 1987, EARTH PLANET SC LETT, V81, P175, DOI 10.1016/0012-821X(87)90154-3; Esat TM, 1999, SCIENCE, V283, P197, DOI 10.1126/science.283.5399.197; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; GALLUP CD, 1994, SCIENCE, V263, P796, DOI 10.1126/science.263.5148.796; Gildor H, 2000, PALEOCEANOGRAPHY, V15, P605, DOI 10.1029/1999PA000461; Henderson GM, 2000, NATURE, V404, P61, DOI 10.1038/35003541; Herbert TD, 2001, SCIENCE, V293, P71, DOI 10.1126/science.1059209; Imbrie J, 1992, PALEOCEANOGRAPHY, V7, P701, DOI 10.1029/92PA02253; JOHNSON RG, 1991, GEOLOGY, V19, P686, DOI 10.1130/0091-7613(1991)019<0686:MNHDCB>2.3.CO;2; Karner DB, 2000, SCIENCE, V288, P2143, DOI 10.1126/science.288.5474.2143; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; LUDWIG KR, 1992, SCIENCE, V258, P284, DOI 10.1126/science.258.5080.284; MARTINSON DG, 1987, QUATERNARY RES, V27, P1, DOI 10.1016/0033-5894(87)90046-9; McCulloch MT, 2000, CHEM GEOL, V169, P107, DOI 10.1016/S0009-2541(00)00260-6; MESOLELL.KJ, 1969, J GEOL, V77, P250, DOI 10.1086/627434; MUHS DR, QUAT SCI REV; PELTIER WR, 1986, J ATMOS SCI, V44, P1351; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; STEIN M, 1993, GEOCHIM COSMOCHIM AC, V57, P2541, DOI 10.1016/0016-7037(93)90416-T; TAYLOR FW, 1991, GEOLOGY, V19, P103, DOI 10.1130/0091-7613(1991)019<0103:LQFOCR>2.3.CO;2; WINOGRAD IJ, 1992, SCIENCE, V258, P255, DOI 10.1126/science.258.5080.255; Winograd IJ, 1997, QUATERNARY RES, V48, P141, DOI 10.1006/qres.1997.1918; [No title captured]	32	176	186	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2002	295	5553					310	313		10.1126/science.1065494	http://dx.doi.org/10.1126/science.1065494			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786639				2022-12-24	WOS:000173278600044
J	Dale, GL; Friese, P; Batar, P; Hamilton, SF; Reed, GL; Jackson, KW; Clemetson, KJ; Alberio, L				Dale, GL; Friese, P; Batar, P; Hamilton, SF; Reed, GL; Jackson, KW; Clemetson, KJ; Alberio, L			Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface	NATURE			English	Article							CROSS-LINKING ENZYMES; FACTOR-XIII; TRANSGLUTAMINASES; ACTIVATION; TRYPTOPHAN; CONVULXIN; COLLAGEN; RECEPTOR; TISSUES; BINDING	Activated platelets bind numerous adhesive and procoagulant proteins by receptor-mediated processes(1). Although there is little evidence to suggest that these processes are heterogeneous in platelets, we previously found that platelets co-stimulated with collagen and thrombin express functional alpha -granule factor V only on a subpopulation of cells(2). Here we show that these cells, referred to as 'COAT-platelets', bind additional alpha -granule proteins, including fibrinogen, von Willebrand factor, thrombospondin, fibronectin and alpha (2)-antiplasmin. These proteins are all transglutaminase substrates, and inhibitors of transglutaminase prevent the production of COAT-platelets. A synthetic transglutaminase substrate (CP15) also binds to COAT-platelets, and analysis by high performance liquid chromatography/mass spectrometry shows that a product is formed with a relative molecular mass (M-r) equal to CP15 plus 176. Serotonin, an abundant component of platelet-dense granules(3), has an M-r of 176, and fibrinogen isolated from COAT-platelets contains covalently linked serotonin. Synthetic bovine serum albumin-(serotonin)(6) binds selectively to COAT-platelets and also inhibits the retention of procoagulant proteins on COAT-platelets. These data indicate that COAT-platelets use serotonin conjugation to augment the retention of procoagulant proteins on their cell surface through an as yet unidentified serotonin receptor.	Univ Oklahoma, Hlth Sci Ctr, WK Warren Med Res Inst, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Oklahoma City, OK 73104 USA; Harvard Univ, Sch Publ Hlth, Cardiovasc Biol Lab, Boston, MA 02115 USA; Univ Bern, Theodor Kocher Inst, CH-3012 Bern, Switzerland	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Harvard University; Harvard T.H. Chan School of Public Health; University of Bern	Dale, GL (corresponding author), Univ Oklahoma, Hlth Sci Ctr, WK Warren Med Res Inst, Oklahoma City, OK 73104 USA.			Alberio, Lorenzo/0000-0001-9686-9920				AESCHLIMANN D, 1994, THROMB HAEMOSTASIS, V71, P402; Alberio L, 2000, BLOOD, V95, P1694, DOI 10.1182/blood.V95.5.1694.005k24_1694_1702; CLARKE DD, 1959, ARCH BIOCHEM BIOPHYS, V79, P338, DOI 10.1016/0003-9861(59)90413-8; GORMAN JJ, 1981, J BIOL CHEM, V256, P2712; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; HUANG MM, 1993, J CELL BIOL, V122, P473, DOI 10.1083/jcb.122.2.473; LAAKSO JT, 1983, SCAND J CLIN LAB INV, V43, P463; Lorand L, 1998, EXP EYE RES, V66, P531, DOI 10.1006/exer.1997.0463; MAEDA K, 1984, H-S Z PHYSIOL CHEM, V365, P1183, DOI 10.1515/bchm2.1984.365.2.1183; McNicol A, 1999, THROMB RES, V95, P1, DOI 10.1016/S0049-3848(99)00015-8; Mousa SA, 1998, J CARDIOVASC PHARM, V32, P169, DOI 10.1097/00005344-199808000-00001; Muszbek L, 1996, CRIT REV CL LAB SCI, V33, P357, DOI 10.3109/10408369609084691; PARAMESWARAN KN, 1990, P NATL ACAD SCI USA, V87, P8472, DOI 10.1073/pnas.87.21.8472; PIDARD D, 1983, J BIOL CHEM, V258, P2582; PINCUS JH, 1968, ARCH BIOCHEM BIOPHYS, V126, P44, DOI 10.1016/0003-9861(68)90557-2; Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576; PUSZKIN EG, 1985, J BIOL CHEM, V260, P6012; REED GL, 1992, THROMB HAEMOSTASIS, V68, P315; REED GL, 1995, THROMB HAEMOSTASIS, V74, P680; SHATTIL SJ, 1987, BLOOD, V70, P307; WAGNER A, 1990, J AFFECT DISORDERS, V20, P101, DOI 10.1016/0165-0327(90)90123-P; [No title captured]	22	246	255	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					175	179		10.1038/415175a	http://dx.doi.org/10.1038/415175a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805836				2022-12-24	WOS:000173159300043
J	Shore, EM; Ahn, J; de Beur, SJ; Li, M; Xu, MQ; Gardner, RJM; Zasloff, MA; Whyte, MP; Levine, MA; Kaplan, FS				Shore, EM; Ahn, J; de Beur, SJ; Li, M; Xu, MQ; Gardner, RJM; Zasloff, MA; Whyte, MP; Levine, MA; Kaplan, FS			Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GS-ALPHA GENE; ALBRIGHT HEREDITARY OSTEODYSTROPHY; STIMULATORY G-PROTEIN; SUBUNIT; LOCUS; OSSIFICATION	Background Progressive osseous heteroplasia (POH), an autosomal dominant disorder, is characterized by extensive dermal ossification during childhood, followed by disabling and widespread heterotopic ossification of skeletal muscle and deep connective tissue. Occasional reports of mild heterotopic ossification in Albright's hereditary osteodystrophy (AHO) and a recent report of two patients with AHO who had atypically extensive heterotopic ossification suggested a common genetic basis for the two disorders. AHO is caused by heterozygous inactivating mutations in the GNAS1 gene that result in decreased expression or function of the alpha subunit of the stimulatory G protein (G(s)alpha) of adenylyl cyclase. Methods We tested the hypothesis that GNAS1 mutations cause POH, using the polymerase chain reaction to amplify GNAS1 exons and exon-intron boundaries in 18 patients with sporadic or familial POH. Results Heterozygous inactivating GNAS1 mutations were identified in 13 of the 18 probands with POH. The defective allele in POH is inherited exclusively from fathers, a result consistent with a model of imprinting for GNAS1. Direct evidence that the same mutation can cause either POH or AHO was observed within a single family, in which the phenotype correlated with the parental origin of the mutant allele. Conclusions Paternally inherited inactivating GNAS1 mutations cause POH. This finding extends the range of phenotypes derived from haploinsufficiency of GNAS1, provides evidence that imprinting is a regulatory mechanism for GNAS1 expression, and suggests that G,a is a critical negative regulator of osteogenic commitment in nonosseous connective tissues. (N Engl J Med 2002;346:99-106.) Copyright (C) 2002 Massachusetts Medical Society.	Univ Penn, Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Johns Hopkins Univ, Sch Med, Ilyssa Ctr Mol & Cellular Endocrinol, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; Royal Childrens Hosp, Victoria & Murdoch Childrens Res Inst, Genet Hlth Serv, Melbourne, Vic, Australia; Washington Univ, Sch Med, Shriners Hosp Children, Ctr Metab Bone Dis & Mol Res, St Louis, MO USA; Washington Univ, Sch Med, Div Bone & Mineral Dis, St Louis, MO USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Washington University (WUSTL); Washington University (WUSTL)	Shore, EM (corresponding author), Univ Penn, Sch Med, Dept Orthopaed Surg, 424 Stemmler Hall,36th & Hamilton Walk, Philadelphia, PA 19104 USA.		Shore, Eileen/D-2593-2009	Levine, Michael/0000-0003-0036-7809	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041916, R01AR046831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034281] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01-AR46831, R01-AR41916, R01 AR046831] Funding Source: Medline; NIDDK NIH HHS [R01-DK34281] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ATHANASOU NA, 1994, BONE, V15, P471, DOI 10.1016/8756-3282(94)90269-0; CAMPBELL R, 1994, J MED GENET, V31, P607, DOI 10.1136/jmg.31.8.607; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; DEBEUR SMJ, 2001, PARATHYROIDS BASIC C, P807; Eddy MC, 2000, J BONE MINER RES, V15, P2074, DOI 10.1359/jbmr.2000.15.11.2074; Farfel Z, 1999, NEW ENGL J MED, V340, P1012, DOI 10.1056/NEJM199904013401306; GARDNER RJM, 1988, J MED GENET, V25, P113, DOI 10.1136/jmg.25.2.113; Hayward BE, 2000, HUM MOL GENET, V9, P835, DOI 10.1093/hmg/9.5.835; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P15475, DOI 10.1073/pnas.95.26.15475; Hayward BE, 2001, J CLIN INVEST, V107, pR31, DOI 10.1172/JCI11887; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P10038, DOI 10.1073/pnas.95.17.10038; Kaplan FS, 1996, ARCH DERMATOL, V132, P815, DOI 10.1001/archderm.132.7.815; Kaplan FS, 2000, J BONE MINER RES, V15, P2084, DOI 10.1359/jbmr.2000.15.11.2084; KAPLAN FS, 1994, J BONE JOINT SURG AM, V76A, P425, DOI 10.2106/00004623-199403000-00013; KOZASA T, 1988, P NATL ACAD SCI USA, V85, P2081, DOI 10.1073/pnas.85.7.2081; Liu J, 2000, MOL CELL BIOL, V20, P5808, DOI 10.1128/MCB.20.16.5808-5817.2000; McKusick V.A., 1998, MENDELIAN INHERITANC; MIRIC A, 1993, J CLIN ENDOCR METAB, V76, P1560, DOI 10.1210/jc.76.6.1560; NUSSBAUM RL, 2001, THOMPSON THOMPSON GE; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; PISANI V, 1985, PEDIAT DERMATOL NEWS, V4, P170; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; RODRIGUEZJURADO R, 1995, PEDIATR PATHOL LAB M, V15, P813, DOI 10.3109/15513819509027017; ROSENFELD SR, 1995, CLIN ORTHOP RELAT R, P243; SCHMIDT AH, 1994, J BONE JOINT SURG AM, V76A, P907, DOI 10.2106/00004623-199406000-00016; Shapira H, 1996, HUM GENET, V97, P73; Urtizberea JA, 1998, J BONE JOINT SURG BR, V80B, P768, DOI 10.1302/0301-620X.80B5.8626; WEINSTEIN LS, 1992, GENOMICS, V13, P1319, DOI 10.1016/0888-7543(92)90056-X; WHYTE MP, 1999, PRIMER METABOLIC BON, P384; Yeh GL, 2000, J BONE MINER RES, V15, P2063, DOI 10.1359/jbmr.2000.15.11.2063; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715	31	211	220	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2002	346	2					99	106		10.1056/NEJMoa011262	http://dx.doi.org/10.1056/NEJMoa011262			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509EM	11784876				2022-12-24	WOS:000173133400005
J	Yoshida, H; Matsui, T; Yamamoto, A; Okada, T; Mori, K				Yoshida, H; Matsui, T; Yamamoto, A; Okada, T; Mori, K			XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor	CELL			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA; TRANSMEMBRANE PROTEIN; ACTIVATION; PROTEOLYSIS; INDUCTION; PATHWAY; BINDS	In yeast, the transmembrane protein kinase/endoribonuclease Ire1p activated by endoplasmic reticulum stress cleaves HAC1 mRNA, leading to production of the transcription factor Hac1p that activates the unfolded protein response (UPR). In mammals, no Hac1p counterpart has yet been discovered despite the presence of Ire1p homologs in the endoplasmic reticulum. Instead, the transcription factor ATF6 specific to the mammalian UPR is regulated by intramembrane proteolysis. Here, we identified the transcription factor XBP1, a target of ATF6, as a mammalian substrate of such an unconventional mRNA splicing system and showed that only the spliced form of XBP1 can activate the UPR efficiently. Our results reveal features of the UPR conserved during evolution and clarify the relationship between IRE1- and ATF6-dependent pathways.	Kyoto Univ, Grad Sch Biostudies, Kyoto 6068304, Japan	Kyoto University	Mori, K (corresponding author), Kyoto Univ, Grad Sch Biostudies, Kyoto 6068304, Japan.		Longo, Kenneth A/A-5631-2010; Mori, Kazutoshi/K-6106-2015	Yoshida, Hiderou/0000-0002-5773-1408				Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Haze K, 2001, BIOCHEM J, V355, P19, DOI 10.1042/0264-6021:3550019; Iwawaki T, 2001, NAT CELL BIOL, V3, P158, DOI 10.1038/35055065; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kawahara T, 1998, J BIOL CHEM, V273, P1802, DOI 10.1074/jbc.273.3.1802; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Mori K, 2000, P NATL ACAD SCI USA, V97, P4660, DOI 10.1073/pnas.050010197; Niwa M, 1999, CELL, V99, P691, DOI 10.1016/S0092-8674(00)81667-0; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Reimold AM, 2000, GENE DEV, V14, P152; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Urano F, 2000, J CELL SCI, V113, P3697; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wang Y, 2000, J BIOL CHEM, V275, P27013; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; YOSHIMURA T, 1990, EMBO J, V9, P2537, DOI 10.1002/j.1460-2075.1990.tb07434.x	27	2809	2937	13	242	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 28	2001	107	7					881	891		10.1016/S0092-8674(01)00611-0	http://dx.doi.org/10.1016/S0092-8674(01)00611-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779464	Bronze			2022-12-24	WOS:000173024200009
J	Alekseev, V; Lampert, W				Alekseev, V; Lampert, W			Maternal control of resting-egg production in Daphnia	NATURE			English	Article							SEXUAL REPRODUCTION; DIAPAUSING EGGS	Many planktonic organisms produce 'resting' stages when the environmental conditions deteriorate. Like seeds, resting stages can survive unfavourable conditions. The crustacean Daphnia normally reproduces by means of parthenogenetically produced normal, not resting, eggs-but occasionally switches to bisexual reproduction, which results in two resting eggs encased in a robust structure carried on the back of the female. This 'ephippium' is shed with the next moult, and can survive dormant for many years. The induction of resting-egg production requires multiple environmental stimuli, one of them being photoperiod(1,2). The switch from production of parthenogenetic eggs to resting eggs in Daphnia has recently been shown to be influenced by a maternal food effect(3). Here we present evidence that female Daphnia transmit information not only about food but also on photoperiod to their offspring, and influence the production of resting eggs in the next generation. The combined maternal effects can be relevant for the correct timing of resting-egg production-for example, in discriminating between spring and autumn conditions.	Max Planck Inst Limnol, Dept Physiol Ecol, D-24302 Plon, Germany	Max Planck Society	Alekseev, V (corresponding author), Max Planck Inst Limnol, Dept Physiol Ecol, Postfach 165, D-24302 Plon, Germany.		Alekseev, Victor/X-7437-2019; alekseev, victor r/C-7086-2014	Alekseev, Victor/0000-0002-1968-2609; alekseev, victor r/0000-0002-1968-2609				Agrawal AA, 1999, NATURE, V401, P60, DOI 10.1038/43425; Caceres CE, 1998, ECOLOGY, V79, P1699, DOI 10.1890/0012-9658(1998)079[1699:IVITAP]2.0.CO;2; Cousyn C, 2001, P NATL ACAD SCI USA, V98, P6256, DOI 10.1073/pnas.111606798; Danilevskii A.S., 1965, PHOTOPERIODISM SEASO; Fox CW, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P159; Hairston NG, 1999, NATURE, V401, P446, DOI 10.1038/46731; HAIRSTON NG, 1995, ECOLOGY, V76, P1706, DOI 10.2307/1940704; HEBERT PDN, 1983, HEREDITY, V51, P353, DOI 10.1038/hdy.1983.40; Hill J.C., 1965, SCIENCE, V150, P1463; KLEIVEN OT, 1992, OIKOS, V65, P197, DOI 10.2307/3545010; LaMontagne JM, 2001, ECOL LETT, V4, P64, DOI 10.1046/j.1461-0248.2001.00197.x; LAMPERT W, 1988, B MAR SCI, V43, P620; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; SPAAK P, 1995, OECOLOGIA, V104, P501, DOI 10.1007/BF00341348; Tauber M.J., 1986, SEASONAL ADAPTATIONS; Webb MLZ, 1998, PHYSIOL ENTOMOL, V23, P184, DOI 10.1046/j.1365-3032.1998.232073.x	17	158	169	2	68	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					899	901		10.1038/414899a	http://dx.doi.org/10.1038/414899a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780060				2022-12-24	WOS:000172813300043
J	Morris, RH				Morris, RH			Thriving with chronic myeloid leukaemia	LANCET			English	Article											Morris, RH (corresponding author), 492 Fulton Court, W New York, NJ 07093 USA.	RMorris@aol.com							0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2001				S			S12	S12		10.1016/S0140-6736(01)07025-8	http://dx.doi.org/10.1016/S0140-6736(01)07025-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505HK	11784561				2022-12-24	WOS:000172907200012
J	van der Merwe, PA; Davis, SJ				van der Merwe, PA; Davis, SJ			The immunological synapse - a multitasking system	SCIENCE			English	Editorial Material							ACTIVATION		Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England	University of Oxford; University of Oxford	van der Merwe, PA (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.		van der Merwe, P. Anton/F-8539-2011					Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Davis SJ, 2001, CURR BIOL, V11, pR289, DOI 10.1016/S0960-9822(01)00165-8; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Lang P, 2001, SCIENCE, V291, P1537, DOI 10.1126/science.291.5508.1537; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Linsley PS, 1996, IMMUNITY, V4, P535, DOI 10.1016/S1074-7613(00)80480-X; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203	10	56	58	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2002	295	5559					1479	1480		10.1126/science.1069896	http://dx.doi.org/10.1126/science.1069896			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859183				2022-12-24	WOS:000173981300039
J	Falck-Ytter, Y; Kale, H; Mullen, KD; Sarbah, SA; Sorescu, L; McCullough, AJ				Falck-Ytter, Y; Kale, H; Mullen, KD; Sarbah, SA; Sorescu, L; McCullough, AJ			Surprisingly small effect of antiviral treatment in patients with hepatitis C	ANNALS OF INTERNAL MEDICINE			English	Article							VIRUS-INFECTION; LIVER FIBROSIS; INTERFERON-ALPHA-2B; RIBAVIRIN; PROGRESSION	Background: The effect and applicability of interferon-based antiviral therapies in the general population of persons with hepatitis C virus (HCV) infection are unknown. Objective: To determine the applicability and usefulness of antiviral therapy in a metropolitan clinic population. Design: Retrospective case series of consecutively referred patients. Setting: A teaching county hospital in Cleveland, Ohio. Patients: 327 patients referred to a liver clinic after a positive result for antibody against HCV on enzyme-linked immunosorbent assay (ELISA). Measurements: Treatment rates; reasons for nontreatment. Results: 34 patients had no detectable HCV RNA. Of the remaining 293 patients, 72% were not treated for the following reasons: 37% did not adhere to evaluation procedures, 34% had medical or psychiatric contraindications, 13% had ongoing substance or alcohol abuse, 11% preferred no treatment, and 5% had normal liver enzyme levels. Only 83 patients (28%) were treated; 13% had a sustained viral response. Conclusion: Most patients with HCV infection are not candidates for interferon-based therapies; alternative interventions should be sought for these patients.	Metrohlth Med Ctr, Div Gastroenterol, Cleveland, OH 44109 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA	MetroHealth System; Case Western Reserve University	McCullough, AJ (corresponding author), Metrohlth Med Ctr, Div Gastroenterol, 2500 MetroHlth Dr, Cleveland, OH 44109 USA.	ajm3@po.cwru.edu	Falck-Ytter, Yngve/GZH-0993-2022; Yngve Falck-Ytter, AGAF/AAC-5362-2019	Yngve Falck-Ytter, AGAF/0000-0002-4688-3211				Aalto M, 2000, ALCOHOL CLIN EXP RES, V24, P1680, DOI 10.1097/00000374-200011000-00010; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Brienza RS, 2000, J SUBST ABUSE TREAT, V18, P331, DOI 10.1016/S0740-5472(99)00084-7; Davis GL, 1999, SEMIN LIVER DIS, V19, P103; Hourigan LF, 1999, HEPATOLOGY, V29, P1215, DOI 10.1002/hep.510290401; Kinzie JL, 1999, HEPATOLOGY, V30, p266A; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; McHutchison John, 1999, American Journal of Medicine, V107, p56S; *NIH CONS DEV C PA, 1997, HEPATOLOGY S1, V26, P25; Poynard T, 2000, HEPATOLOGY, V32, P1131, DOI 10.1053/jhep.2000.19347; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Poynard T, 1998, LANCET, V352, P1426, DOI 10.1016/S0140-6736(98)07124-4; Reindollar Robert W., 1999, American Journal of Medicine, V107, p100S; Schiff Eugene R., 1999, American Journal of Medicine, V107, p95S; Shad Javaid, 2000, Hepatology, V32, p283A; SWANSON GM, 1995, J NATL CANCER I, V87, P1747, DOI 10.1093/jnci/87.23.1747; VIAL T, 1994, DRUG SAFETY, V10, P115, DOI 10.2165/00002018-199410020-00003; Zeuzem S, 2000, NEW ENGL J MED, V343, P1666, DOI 10.1056/NEJM200012073432301; 1998, MMWR MORB MORTAL WKL, V471, P39	20	265	274	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2002	136	4					288	292		10.7326/0003-4819-136-4-200202190-00008	http://dx.doi.org/10.7326/0003-4819-136-4-200202190-00008			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523FQ	11848726				2022-12-24	WOS:000173943700005
J	Zepik, H; Shavit, E; Tang, M; Jensen, TR; Kjaer, K; Bolbach, G; Leiserowitz, L; Weissbuch, I; Lahav, M				Zepik, H; Shavit, E; Tang, M; Jensen, TR; Kjaer, K; Bolbach, G; Leiserowitz, L; Weissbuch, I; Lahav, M			Chiral amplification of oligopeptides in two-dimensional crystalline self-assemblies on water	SCIENCE			English	Article							OLIGOMERIZATION; ARCHITECTURES; POLYPEPTIDES; INTERFACE; DESIGN	Differences in the two-dimensional packing arrangements of racemic and enantiomeric crystalline self-assemblies on the water surface of amphiphilic activated analogs of lysine and glutamic acid have been used to prepare oligopeptides of homochiral sequence and oligopeptides of single handedness from chiral nonracemic mixtures. The crystalline structures on the water surface were determined by grazing incidence x-ray diffraction and the diastereomeric composition of the oligopeptides by matrix-assisted laser desorption time-of-flight mass spectrometry with enantio-labeling. These results suggest that reactivity of ordered clusters at interfaces might have played a role in the generation of early homochiral biopolymers.	Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel; Riso Natl Lab, Mat Res Dept, DK-4000 Roskilde, Denmark; Univ Paris 06, Lab Chim Struct Organ & Biol, F-75252 Paris 05, France	Weizmann Institute of Science; Technical University of Denmark; UDICE-French Research Universities; Sorbonne Universite	Lahav, M (corresponding author), Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel.	leslie.leiserowitz@weizmann.ac.il; isabelle.weissbuch@welzmann.ac.il; meir.lahav@weizmann.ac.il		Jensen, Torben Rene/0000-0002-4278-3221				ADDADI L, 1977, ISRAEL J CHEM, V15, P116; Avetisov V, 1996, P NATL ACAD SCI USA, V93, P11435, DOI 10.1073/pnas.93.21.11435; BANIEL A, 1948, J ORG CHEM, V13, P791, DOI 10.1021/jo01164a001; Blocher M, 2001, HELV CHIM ACTA, V84, P842, DOI 10.1002/1522-2675(20010418)84:4<842::AID-HLCA842>3.0.CO;2-1; BLOUT ER, 1957, J AM CHEM SOC, V79, P749, DOI 10.1021/ja01560a068; Bolli M, 1997, CHEM BIOL, V4, P309, DOI 10.1016/S1074-5521(97)90074-0; Bonner WA, 1999, ORIGINS LIFE EVOL B, V29, P329, DOI 10.1023/A:1006511115735; BRACK A, 1981, ORIGINS LIFE EVOL B, V11, P135, DOI 10.1007/BF00928004; Cronin JR, 1997, SCIENCE, V275, P951, DOI 10.1126/science.275.5302.951; DALY WH, 1988, TETRAHEDRON LETT, V29, P5859, DOI 10.1016/S0040-4039(00)82209-1; Deamer DW, 1997, MICROBIOL MOL BIOL R, V61, P239, DOI 10.1128/.61.2.239-261.1997; FRANCK P, 2000, CHEM 21 CENTURY, P175, DOI DOI 10.1002/9783527612949.CH11; FRANK FC, 1953, BIOCHIM BIOPHYS ACTA, V11, P459, DOI 10.1016/0006-3002(53)90082-1; Fukuda K, 2000, ADV COLLOID INTERFAC, V87, P113, DOI 10.1016/S0001-8686(99)00041-X; Girard C, 1998, ANGEW CHEM INT EDIT, V37, P2923, DOI 10.1002/(SICI)1521-3773(19981116)37:21<2922::AID-ANIE2922>3.0.CO;2-1; JOYCE GF, 1984, NATURE, V310, P602, DOI 10.1038/310602a0; Kuzmenko I, 2001, CHEM REV, V101, P1659, DOI 10.1021/cr990038y; LAHAV M, 1976, J AM CHEM SOC, V98, P1620, DOI 10.1021/ja00422a078; MASON S, 1984, NATURE, V310, P546, DOI 10.1038/310546b0; Saghatelian A, 2001, NATURE, V409, P797, DOI 10.1038/35057238; Segre D, 2001, ORIGINS LIFE EVOL B, V31, P119, DOI 10.1023/A:1006746807104; SHEEHAN JC, 1952, J AM CHEM SOC, V74, P4726, DOI 10.1021/ja01138a528; SHIBATA A, 1991, LANGMUIR, V7, P2261, DOI 10.1021/la00058a047; Siegel JS, 1998, CHIRALITY, V10, P24, DOI 10.1002/chir.5; Weissbuch I, 1997, J AM CHEM SOC, V119, P933, DOI 10.1021/ja9613926; Weissbuch I, 2000, CHEM-EUR J, V6, P725, DOI 10.1002/(SICI)1521-3765(20000218)6:4<725::AID-CHEM725>3.3.CO;2-5; WEISSBUCH I, 1994, PER SUPRAMOL CHEM, V1, P173; Zhang LS, 1999, J AM CHEM SOC, V121, P3311, DOI 10.1021/ja983859d	28	161	163	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2002	295	5558					1266	1269		10.1126/science.1065625	http://dx.doi.org/10.1126/science.1065625			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11786606				2022-12-24	WOS:000173926000035
J	Van Damme, R; Wilson, RS; Vanhooydonck, B; Aerts, P				Van Damme, R; Wilson, RS; Vanhooydonck, B; Aerts, P			Evolutionary biology - Performance constraints in decathletes	NATURE			English	Article							ENDURANCE		Univ Instelling Antwerp, Dept Biol, B-2610 Wilrijk, Belgium	University of Antwerp	Van Damme, R (corresponding author), Univ Instelling Antwerp, Dept Biol, Univ Pl 1, B-2610 Wilrijk, Belgium.		Wilson, Robbie S/F-1463-2011	Aerts, Peter/0000-0002-6867-5421; Wilson, Robbie/0000-0002-0116-5427; Van Damme, Raoul/0000-0002-4585-6940				Dohm MR, 1996, EVOLUTION, V50, P1688, DOI 10.1111/j.1558-5646.1996.tb03940.x; ESBJORNSSON M, 1993, INT J SPORTS MED, V14, P257, DOI 10.1055/s-2007-1021174; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Garland Theodore Jr., 1994, P251; Gilchrist GW, 1996, EVOLUTION, V50, P1560, DOI [10.2307/2410892, 10.1111/j.1558-5646.1996.tb03928.x]; LEVINS RICHARD, 1968; MCPEEK MA, 1996, AM NAT             S, V148, P124; RIVERO JLL, 1993, J APPL PHYSIOL, V75, P1758, DOI 10.1152/jappl.1993.75.4.1758; Vanhooydonck B, 2001, EVOLUTION, V55, P1040, DOI 10.1554/0014-3820(2001)055[1040:SASTOI]2.0.CO;2; [No title captured]	10	127	127	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					755	756		10.1038/415755b	http://dx.doi.org/10.1038/415755b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845199				2022-12-24	WOS:000173833900036
J	van Dam, RM; Rimm, EB; Willett, WC; Stampfer, MJ; Hu, FB				van Dam, RM; Rimm, EB; Willett, WC; Stampfer, MJ; Hu, FB			Dietary patterns and risk for type 2 diabetes mellitus in US men	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; GLYCEMIC LOAD; PIMA-INDIANS; WOMEN; HEALTH; FIBER; FAT; REPRODUCIBILITY; QUESTIONNAIRE; CARBOHYDRATE	Background: The role of diet in the development of type 2 diabetes mellitus remains unsettled. Objective: To examine the association between major dietary patterns and risk for type 2 diabetes mellitus. Design: Prospective cohort study. Setting: United States. Participants: 42 504 male health professionals, 40 to 75 years of age, without diagnosed diabetes, cardiovascular disease, or cancer at baseline. Measurements: Using factor analysis based on data from food-frequency questionnaires, we identified and validated two major dietary patterns that we labeled "prudent" (characterized by higher consumption of vegetables, fruit, fish, poultry and whole grains) and "western" (characterized by higher consumption of red meat, processed meat, French fries, high-fat dairy products, refined grains, and sweets and desserts). Relative risks and 95% CIs were adjusted for potential confounders, including body mass index (BMI), physical activity, and cigarette smoking. Results: During 12 years of follow-up (466508 person-years), we documented 1321 cases of type 2 diabetes. The prudent dietary pattern score was associated with a modestly lower risk for type 2 diabetes (relative risk for extreme quintiles, 0.84 [CI, 0.70 to 1.00]). In contrast, the western dietary pattern score was associated with an increased risk for type 2 diabetes (relative risk, 1.59 [CI, 1.32 to 1.93]; P < 0.001 for trend). A high score for the western dietary pattern combined with low physical activity (relative risk comparing extreme quintiles of dietary pattern score and physical activity, 1.96 [CI, 1.35 to 2.84]) or obesity (relative risk for BMI greater than or equal to 30 kg/m(2) vs. <25 kg/m(2), 11.2 [CI, 8.07 to 15.6]) was associated with a particularly high risk for type 2 diabetes. Conclusion: Our findings suggest that a western dietary pattern is associated with a substantially increased risk for type 2 diabetes in men.	Harvard Univ, Sch Publ Hlth, Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Netherlands National Institute for Public Health & the Environment	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	frank.hu@channing.harvard.edu	van Dam, Rob M/F-9674-2010; Robles-Sardin, Alma E/M-7714-2015; Hu, Frank/C-1919-2013	van Dam, Rob M/0000-0002-7354-8734; Robles-Sardin, Alma E/0000-0003-2044-7793; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464] Funding Source: NIH RePORTER; NCI NIH HHS [CA 55075] Funding Source: Medline; NHLBI NIH HHS [HL 35464] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Burke JP, 1999, ARCH INTERN MED, V159, P1450, DOI 10.1001/archinte.159.13.1450; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; Fung TT, 2001, ARCH INTERN MED, V161, P1857, DOI 10.1001/archinte.161.15.1857; Fung TT, 2001, AM J CLIN NUTR, V73, P61; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gittelsohn J, 1998, J NUTR, V128, P541, DOI 10.1093/jn/128.3.541; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Himsworth HP, 1935, CLIN SCI, V2, P117; Hu FB, 2000, AM J CLIN NUTR, V72, P912; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547; Jacobs DR, 1998, AM J CLIN NUTR, V68, P248, DOI 10.1093/ajcn/68.2.248; Kawate R, 1979, Diabetes Care, V2, P161, DOI 10.2337/diacare.2.2.161; Kim J.-O., 1978, FACTOR ANAL STAT MET; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Martinez ME, 1998, AM J EPIDEMIOL, V148, P17, DOI 10.1093/oxfordjournals.aje.a009552; Meyer KA, 2000, AM J CLIN NUTR, V71, P921; Pratley RE, 1998, P NUTR SOC, V57, P175, DOI 10.1079/PNS19980029; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P115; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; Salmeron J, 1997, DIABETES CARE, V20, P545, DOI 10.2337/diacare.20.4.545; *SAS I, 1989, SAS STAT US GUID VER; Slattery ML, 1998, AM J EPIDEMIOL, V148, P4, DOI 10.1093/aje/148.1.4-a; SWINBURN BA, 1991, J CLIN ENDOCR METAB, V73, P156, DOI 10.1210/jcem-73-1-156; *WHO STUD GROUP DI, 1995, DIAB MELL REP WHO ST; Willett W.C., 1998, SAUPTIKAPARVAN MAHAB, DOI DOI 10.1093/ACPROF:OSO/9780195122978.003.11; Williams DEM, 2000, BRIT J NUTR, V83, P257, DOI 10.1017/S0007114500000337	33	584	591	0	62	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2002	136	3					201	209		10.7326/0003-4819-136-3-200202050-00008	http://dx.doi.org/10.7326/0003-4819-136-3-200202050-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517YD	11827496				2022-12-24	WOS:000173637400003
J	Chen, X; Schauder, S; Potier, N; Van Dorsselaer, A; Pelczer, I; Bassler, BL; Hughson, FM				Chen, X; Schauder, S; Potier, N; Van Dorsselaer, A; Pelczer, I; Bassler, BL; Hughson, FM			Structural identification of a bacterial quorum-sensing signal containing boron	NATURE			English	Article							ESCHERICHIA-COLI; VIBRIO-HARVEYI; EXPRESSION; BIOSYNTHESIS; SEQUENCE; SYSTEMS; FAMILY	Cell-cell communication in bacteria is accomplished through the exchange of extracellular signalling molecules called autoinducers. This process, termed quorum sensing, allows bacterial populations to coordinate gene expression. Community cooperation probably enhances the effectiveness of processes such as bioluminescence, virulence factor expression, antibiotic production and biofilm development(1-4). Unlike other autoinducers, which are specific to a particular species of bacteria, a recently discovered autoinducer (AI-2)(5) is produced by a large number of bacterial species. AI-2 has been proposed to serve as a 'universal' signal for inter-species communication(1,2,6,7). The chemical identity of AI-2 has, however, proved elusive. Here we present the crystal structure of an AI-2 sensor protein, LuxP, in a complex with autoinducer. The bound ligand is a furanosyl borate diester that bears no resemblance to previously characterized autoinducers. Our findings suggest that addition of naturally occurring borate to an AI-2 precursor generates active AI-2. Furthermore, they indicate a potential biological role for boron, an element required by a number of organisms but for unknown reasons.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; Ecol Chim Polymeres & Mat, Lab Spectrometrie Masse Bioorgan, F-67087 Strasbourg, France	Princeton University; Princeton University	Hughson, FM (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	hughson@princeton.edu	Noelle, POTIER/AAX-7633-2021	Bassler, Bonnie/0000-0002-0043-746X; POTIER, Noelle/0000-0002-6381-4365				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; BOESEKEN J, 1949, ADV CARBOHYD CHEM, V4, P189; Bowen H.J.M., 1966, TRACE ELEMENTS BIOCH; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cornell KA, 1996, BIOCHEM BIOPH RES CO, V228, P724, DOI 10.1006/bbrc.1996.1723; de Kievit TR, 2000, INFECT IMMUN, V68, P4839, DOI 10.1128/IAI.68.9.4839-4849.2000; DUERRE JA, 1977, BIOCH ADENOSYLMETHIO, P43; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleerebezem M, 1997, MOL MICROBIOL, V24, P895, DOI 10.1046/j.1365-2958.1997.4251782.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lewis HA, 2001, STRUCTURE, V9, P527, DOI 10.1016/S0969-2126(01)00613-X; LOOMIS WD, 1992, BIOFACTORS, V3, P229; MAZUREK M, 1963, CAN J CHEM, V41, P2403, DOI 10.1139/v63-354; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MILLER CH, 1968, J BIOL CHEM, V243, P92; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; RAGIONE ED, 1985, BIOCHEM J, V232, P335, DOI 10.1042/bj2320335; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Schauder S, 2001, GENE DEV, V15, P1468, DOI 10.1101/gad.899601; Schummer D, 1996, LIEBIGS ANN, P965; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Surette MG, 1998, P NATL ACAD SCI USA, V95, P7046, DOI 10.1073/pnas.95.12.7046; Taga ME, 2001, MOL MICROBIOL, V42, P777, DOI 10.1046/j.1365-2958.2001.02669.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; VANDENBERG R, 1994, CARBOHYD RES, V253, P1, DOI 10.1016/0008-6215(94)80050-2	31	1102	1203	13	361	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2002	415	6871					545	549		10.1038/415545a	http://dx.doi.org/10.1038/415545a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823863				2022-12-24	WOS:000173564300051
J	Barral, JM; Hutagalung, AH; Brinker, A; Hartl, FU; Epstein, HF				Barral, JM; Hutagalung, AH; Brinker, A; Hartl, FU; Epstein, HF			Role of the myosin assembly protein UNC-45 as a molecular chaperone for myosin	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; TETRATRICOPEPTIDE REPEAT; HEAVY-CHAIN; DOMAIN; GENE; RECONSTITUTION; EXPRESSION; COMPLEXES; MACHINES; RECEPTOR	The organization of myosin into motile cellular structures requires precise temporal and spatial regulation. Proteins containing a UCS (UNC-45/CRO1/She4p) domain are necessary for the incorporation of myosin into the contractite ring during cytokinesis and into thick filaments during muscle development. We report that the carboxyl-terminal regions of UNC-45 bound and exerted chaperone activity on the myosin head. The amino-terminal tetratricopeptide repeat domain of UNC-45 bound the molecular chaperone Hsp90. Thus, UNC-45 functions both as a molecular chaperone and as an Hsp90 co-chaperone for myosin, which can explain previous findings of altered assembly and decreased accumulation of myosin in UNC-45 mutants of Caenorhabditis elegans.	Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Max Planck Inst Biochem, D-82152 Martinsried, Germany	Baylor College of Medicine; Baylor College of Medicine; Max Planck Society	Epstein, HF (corresponding author), Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	hepstein@bcm.tmc.edu	Hutagalung, Alex/AAH-5795-2021; Hartl, F. Ulrich/Y-8206-2019					Ao WY, 2000, J CELL BIOL, V148, P375, DOI 10.1083/jcb.148.2.375; Barral JM, 1998, J CELL BIOL, V143, P1215, DOI 10.1083/jcb.143.5.1215; Barral JM, 1999, BIOESSAYS, V21, P813, DOI 10.1002/(SICI)1521-1878(199910)21:10<813::AID-BIES3>3.0.CO;2-0; Berteaux-Lecellier V, 1998, EMBO J, V17, P1248, DOI 10.1093/emboj/17.5.1248; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.3.CO;2-E; Bose S, 1996, SCIENCE, V274, P1715, DOI 10.1126/science.274.5293.1715; Buchner J, 1998, METHOD ENZYMOL, V290, P323, DOI 10.1016/S0076-6879(98)90029-5; DELOZANNE A, 1987, J CELL BIOL, V105, P2999, DOI 10.1083/jcb.105.6.2999; Dittmar KD, 1996, J BIOL CHEM, V271, P12833, DOI 10.1074/jbc.271.22.12833; EPSTEIN HF, 1974, NATURE, V250, P579, DOI 10.1038/250579a0; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Jansen RP, 1996, CELL, V84, P687, DOI 10.1016/S0092-8674(00)81047-8; Kimura Y, 1997, GENE DEV, V11, P1775, DOI 10.1101/gad.11.14.1775; Kosano H, 1998, J BIOL CHEM, V273, P32973, DOI 10.1074/jbc.273.49.32973; MCNALLY EM, 1988, P NATL ACAD SCI USA, V85, P7270, DOI 10.1073/pnas.85.19.7270; PRICE MG, UNPUB; Russell LC, 1999, J BIOL CHEM, V274, P20060, DOI 10.1074/jbc.274.29.20060; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; SMITH DF, 1990, MOL ENDOCRINOL, V4, P1704, DOI 10.1210/mend-4-11-1704; Srikakulam R, 1999, J BIOL CHEM, V274, P27265, DOI 10.1074/jbc.274.38.27265; Venolia L, 1999, CELL MOTIL CYTOSKEL, V42, P163, DOI 10.1002/(SICI)1097-0169(1999)42:3&lt;163::AID-CM1&gt;3.0.CO;2-E; VENOLIA L, 1990, GENETICS, V126, P345; Wendland B, 1996, J CELL BIOL, V135, P1485, DOI 10.1083/jcb.135.6.1485; WOLFFLONG VL, 1993, J BIOL CHEM, V268, P23162; Wong KCY, 2000, J CELL SCI, V113, P2421	26	196	198	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2002	295	5555					669	671		10.1126/science.1066648	http://dx.doi.org/10.1126/science.1066648			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809970				2022-12-24	WOS:000173560900042
J	Schoch, S; Castillo, PE; Jo, T; Mukherjee, K; Geppert, M; Wang, Y; Schmitz, F; Malenka, RC; Sudhof, TC				Schoch, S; Castillo, PE; Jo, T; Mukherjee, K; Geppert, M; Wang, Y; Schmitz, F; Malenka, RC; Sudhof, TC			RIM1 alpha forms a protein scaffold for regulating neurotransmitter release at the active zone	NATURE			English	Article							SYNAPTIC-VESICLE FUSION; C-ELEGANS; RAB3; UNC-13; FAMILY; PROBABILITY; EXOCYTOSIS; EFFECTOR	Neurotransmitters are released by synaptic vesicle fusion at the active zone(1,2). The active zone of a synapse mediates Ca2+-triggered neurotransmitter release, and integrates presynaptic signals in regulating this release. Much is known about the structure of active zones and synaptic vesicles, but the functional relation between their components is poorly understood(3). Here we show that RIM1alpha, an active zone protein that was identified as a putative effector for the synaptic vesicle protein Rab3A(4,5), interacts with several active zone molecules, including Munc13-1 (ref. 6) and alpha-liprins(7,8), to form a protein scaffold in the presynaptic nerve terminal. Abolishing the expression of RIM1alpha in mice shows that RIM1alpha is essential for maintaining normal probability of neurotransmitter release, and for regulating release during short-term synaptic plasticity. These data indicate that RIM1alpha has a central function in integrating active zone proteins and synaptic vesicles into a molecular scaffold that controls neurotransmitter release.	Univ Texas, SW Med Ctr, Ctr Basci Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dept Mol Genet, Dallas, TX 75390 USA; Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Friend Pritzker Lab, Stanford, CA 94304 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Stanford University; Yeshiva University; Albert Einstein College of Medicine; Max Planck Society	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Ctr Basci Neurosci, Dallas, TX 75390 USA.		Schoch, Susanne/F-7741-2012	Castillo, Pablo/0000-0002-9834-1801				Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Coppola T, 2001, J BIOL CHEM, V276, P32756, DOI 10.1074/jbc.M100929200; Coppola T, 1999, EMBO J, V18, P5885, DOI 10.1093/emboj/18.21.5885; COWAN WM, 2001, SYNAPSES; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Garner CC, 2000, CURR OPIN NEUROBIOL, V10, P321, DOI 10.1016/S0959-4388(00)00093-3; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Harlow ML, 2001, NATURE, V409, P479, DOI 10.1038/35054000; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Katz B., 1969, RELEASE NEURAL TRANS; Kraushaar U, 2000, J NEUROSCI, V20, P5594, DOI 10.1523/JNEUROSCI.20-15-05594.2000; LI C, 1994, NEURON, V13, P885, DOI 10.1016/0896-6273(94)90254-2; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Schluter OM, 1999, J NEUROSCI, V19, P5834, DOI 10.1523/JNEUROSCI.19-14-05834.1999; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; Sun L, 2001, J BIOL CHEM, V276, P12911, DOI 10.1074/jbc.M011110200; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; Wang XL, 2001, J BIOL CHEM, V276, P32480, DOI 10.1074/jbc.M103337200; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43889	28	454	477	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2002	415	6869					321	326		10.1038/415321a	http://dx.doi.org/10.1038/415321a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797009				2022-12-24	WOS:000173293500044
J	Percec, I; Bartolomei, MS				Percec, I; Bartolomei, MS			Genetics - Do X chromosomes set boundaries?	SCIENCE			English	Editorial Material							ENHANCER-BLOCKING ACTIVITY; INACTIVATION CENTER; METHYLATION; REGION; MOUSE; CTCF		Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania	Percec, I (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.							Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Boumil RM, 2001, HUM MOL GENET, V10, P2225; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; CATTANACH BM, 1981, GENET RES, V38, P57, DOI 10.1017/S0016672300020401; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; COURTIER B, 1995, P NATL ACAD SCI USA, V92, P3531, DOI 10.1073/pnas.92.8.3531; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lyon MF, 1996, NATURE, V379, P116, DOI 10.1038/379116a0; RASTAN S, 1990, GENET RES, V56, P99, DOI 10.1017/S0016672300035163; Zhan HC, 2001, HUM GENET, V109, P471, DOI 10.1007/s004390100601	11	12	12	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					287	288		10.1126/science.1068663	http://dx.doi.org/10.1126/science.1068663			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786631				2022-12-24	WOS:000173278600035
J	Tanaka, H; Homma, K; Iwane, AH; Katayama, E; Ikebe, R; Saito, J; Yanagida, T; Ikebe, M				Tanaka, H; Homma, K; Iwane, AH; Katayama, E; Ikebe, R; Saito, J; Yanagida, T; Ikebe, M			The motor domain determines the large step of myosin-V	NATURE			English	Article							LIGHT-CHAIN; ACTIN FILAMENT; MOVEMENT; FORCE; MECHANICS; MOLECULE; BINDING; LEVER; HEAD	Class-V myosin proceeds along actin filaments with large (similar to 36 nm) steps(1-3). Myosin-V has two heads, each of which consists of a motor domain and a long (23 nm) neck domain. In accordance with the widely accepted lever-arm model(4), it was suggested that myosin-V steps to successive (36 nm) target zones along the actin helical repeat by tilting its long neck (lever-arm)(5). To test this hypothesis, we measured the mechanical properties of single molecules of myosin-V truncation mutants with neck domains only one-sixth of the native length. Our results show that the processivity and step distance along actin are both similar to those of full-length myosin-V. Thus, the long neck domain is not essential for either the large steps or processivity of myosin-V. These results challenge the lever-arm model. We propose that the motor domain and/or the actomyosin interface enable myosin-V to produce large processive steps during translocation along actin.	JST, ICORP, Single Mol Proc Project, Osaka 5620035, Japan; Univ Massachusetts, Sch Med, Dept Physiol, Worcester, MA 01655 USA; Osaka Univ, Grad Sch Med, Dept Physiol & Biosignaling, Suita, Osaka 5650871, Japan; Univ Tokyo, Inst Med Sci, Div Biomol Imaging, Minato Ku, Tokyo 1088639, Japan; Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama 3320012, Japan	Japan Science & Technology Agency (JST); University of Massachusetts System; University of Massachusetts Worcester; Osaka University; University of Tokyo; Japan Science & Technology Agency (JST)	Yanagida, T (corresponding author), JST, ICORP, Single Mol Proc Project, 2-4-14 Senba Higashi, Osaka 5620035, Japan.		Yanagida, Toshio/D-1919-2009					Cooke R, 1999, CURR BIOL, V9, pR773, DOI 10.1016/S0960-9822(00)80010-X; Corrie JET, 1999, NATURE, V400, P425, DOI 10.1038/22704; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Dupuis DE, 1997, J MUSCLE RES CELL M, V18, P17, DOI 10.1023/A:1018672631256; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Homma K, 2000, J BIOL CHEM, V275, P34766, DOI 10.1074/jbc.M003132200; Homma K, 2001, NATURE, V412, P831, DOI 10.1038/35090597; Ikebe M, 1998, J BIOL CHEM, V273, P17702, DOI 10.1074/jbc.273.28.17702; Ishijima A, 1998, CELL, V92, P161, DOI 10.1016/S0092-8674(00)80911-3; ITAKURA S, 1993, BIOCHEM BIOPH RES CO, V196, P1504, DOI 10.1006/bbrc.1993.2422; KATAYAMA E, 1989, J BIOCHEM-TOKYO, V106, P751, DOI 10.1093/oxfordjournals.jbchem.a122928; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; Perreault-Micale C, 2000, J BIOL CHEM, V275, P21618, DOI 10.1074/jbc.M000363200; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Ruff C, 2001, NAT STRUCT BIOL, V8, P226, DOI 10.1038/84962; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; STRYER L, 1995, BIOCHEMISTRY-US, P443; Tanaka H, 1998, BIOPHYS J, V75, P1886, DOI 10.1016/S0006-3495(98)77629-5; Trybus KM, 1999, J BIOL CHEM, V274, P27448, DOI 10.1074/jbc.274.39.27448; Tsuda Y, 1996, P NATL ACAD SCI USA, V93, P12937, DOI 10.1073/pnas.93.23.12937; Uyeda TQP, 1996, P NATL ACAD SCI USA, V93, P4459, DOI 10.1073/pnas.93.9.4459; WAKABAYASHI K, 1992, SCIENCE, V258, P443, DOI 10.1126/science.1411537; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Warshaw DM, 2000, J BIOL CHEM, V275, P37167, DOI 10.1074/jbc.M006438200	28	116	115	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					192	195		10.1038/415192a	http://dx.doi.org/10.1038/415192a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805840				2022-12-24	WOS:000173159300047
J	Bernal, W; Donaldson, N; Wyncoll, D; Wendon, J				Bernal, W; Donaldson, N; Wyncoll, D; Wendon, J			Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study	LANCET			English	Article							FULMINANT HEPATIC-FAILURE; EARLY INDICATORS; LACTIC-ACIDOSIS; ORGAN FAILURE; SEPTIC SHOCK; ACETAMINOPHEN; TRANSPLANTATION; METABOLISM; PROGNOSIS; OVERDOSE	Background Although the King's College Hospital (KCH) selection criteria for emergency liver transplantation in paracetamol-induced acute liver failure are widely used, strategies to improve sensitivity and facilitate earlier transplantation are required. We investigated the use of arterial blood lactate measurement for the identification of transplantation candidates. Methods In a single-centre study, we measured arterial blood lactate early (median 4 h) and after fluid resuscitation (median 12 h) in patients admitted to a tertiary-referral intensive-care unit. Threshold values that best identified individuals likely to die without transplantation were derived in a retrospective initial sample of 103 patients with paracetamol-induced acute liver failure and applied to a prospective validation sample of 107 patients. Predictive value and speed of identification were compared with those of KCH criteria. Findings In the initial sample, median lactate was significantly higher in non-surviving patients than in survivors both in the early samples (8.5 [range 1.7-21.0] vs 1.4 [0.53-7.9] mmol/L, p<0.0001) and after fluid resuscitation (5.5 [1.3-18.6] vs 1.3 [0.26-3.2], p<0.0001). Applied to the validation sample, a threshold value of 3.5 mmol/L early after admission had sensitivity 67%, specificity 95%, positive likelihood ratio 13, and negative likelihood ratio 0.35; the corresponding values for a threshold of 3.0 mmol/L after fluid resuscitation were 76%, 97%, 30, and 0.24. Combined early and postresuscitation lactate concentrations had similar predictive ability to KCH criteria but identified non-surviving patients earlier (4 [3.13] vs 10 [3.5-19.5] h, p=0.01). Addition of postresuscitation lactate concentration to KCH criteria increased sensitivity from 76% to 91% and lowered negative likelihood ratio from 0.25 to 0.10. Interpretation Arterial blood lactate measurement rapidly and accurately identifies patients who will die from paracetamol-induced acute liver failure. Its use could improve the speed and accuracy of selection of appropriate candidates for transplantation.	Kings Coll Hosp London, Inst Liver Studies, London SE5 9RS, England; Kings Coll Hosp London, Dept Res & Dev, London SE5 9RS, England; St Thomas Hosp, Dept Intens Care, London, England; Guys Kings & St Thomas Hosp, London, England	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Wendon, J (corresponding author), Kings Coll Hosp London, Inst Liver Studies, Denmark Hill, London SE5 9RS, England.	julia.wendon@kcl.ac.uk						ALMENOFF PL, 1989, CRIT CARE MED, V17, P870, DOI 10.1097/00003246-198909000-00004; Anand AC, 1997, J HEPATOL, V26, P62, DOI 10.1016/S0168-8278(97)80010-4; BAKKER J, 1991, CHEST, V99, P956, DOI 10.1378/chest.99.4.956; Bakker J, 1996, AM J SURG, V171, P221, DOI 10.1016/S0002-9610(97)89552-9; Bernal W, 1998, HEPATOLOGY, V27, P1050, DOI 10.1002/hep.510270421; BIHARI D, 1985, CRIT CARE MED, V13, P1034, DOI 10.1097/00003246-198512000-00010; BIHARI D, 1985, J HEPATOL, V1, P405, DOI 10.1016/S0168-8278(85)80778-9; BIHARI DJ, 1986, SEMIN LIVER DIS, V6, P119, DOI 10.1055/s-2008-1040595; Chiolero R, 1999, ANN SURG, V229, P505, DOI 10.1097/00000658-199904000-00009; Clemmesen JO, 2000, J HEPATOL, V33, P941, DOI 10.1016/S0168-8278(00)80126-9; De Jonghe B, 1999, J CRIT CARE, V14, P7, DOI 10.1016/S0883-9441(99)90002-3; ESTERLINE RL, 1989, BIOCHEM PHARMACOL, V38, P2387, DOI 10.1016/0006-2952(89)90481-4; GRAY TA, 1987, Q J MED, V65, P811; Levraut J, 1998, AM J RESP CRIT CARE, V157, P1021, DOI 10.1164/ajrccm.157.4.9705037; MAKIN AJ, 1995, GASTROENTEROLOGY, V109, P1907, DOI 10.1016/0016-5085(95)90758-0; MANIKIS P, 1995, AM J EMERG MED, V13, P619, DOI 10.1016/0735-6757(95)90043-8; Mitchell I, 1998, CRIT CARE MED, V26, P279, DOI 10.1097/00003246-199802000-00026; MIZOCK BA, 1992, CRIT CARE MED, V20, P80, DOI 10.1097/00003246-199201000-00020; OGRADY J, 2000, COMPREHENSIVE CLIN H; OGRADY JG, 1991, BRIT MED J, V303, P221, DOI 10.1136/bmj.303.6796.221; OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4; RECORD CO, 1981, METABOLISM, V30, P638, DOI 10.1016/0026-0495(81)90076-7; Riordan SM, 2000, LIVER TRANSPLANT, V6, P170, DOI 10.1016/S1527-6465(00)80006-4; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; Shakil AO, 2000, LIVER TRANSPLANT, V6, P163, DOI 10.1002/lt.500060218; SUBRAMANIAN S, 2000, YB INTENSIVE CARE EM, P743; WENDON J, 1995, PRACTICE LIVER TRANS, P93; Williams R, 1997, ACUTE LIVER FAILURE, P1	28	311	320	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 16	2002	359	9306					558	563		10.1016/S0140-6736(02)07743-7	http://dx.doi.org/10.1016/S0140-6736(02)07743-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523FP	11867109				2022-12-24	WOS:000173943600008
J	Vagero, D; Modin, B				Vagero, D; Modin, B			Prenatal growth, subsequent marital status, and mortality: longitudinal study	BRITISH MEDICAL JOURNAL			English	Article							FETAL		Stockholm Univ, Ctr Hlth Equity Studies, S-10691 Stockholm, Sweden; Stockholm Univ, Karolinska Inst CHESS, S-10691 Stockholm, Sweden	Stockholm University; Stockholm University	Vagero, D (corresponding author), Stockholm Univ, Ctr Hlth Equity Studies, S-10691 Stockholm, Sweden.			Modin, Bitte/0000-0001-6606-2157				Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; OLSEN J, 1995, SCAND J SOC MED, V23, P156, DOI 10.1177/140349489502300304; Phillips DIW, 2001, BRIT MED J, V322, P771, DOI 10.1136/bmj.322.7289.771; PHILLIPS DIW, 2001, 1 WORLD C FET OR AD; Vagero D, 1999, ACTA PAEDIATR, V88, P445, DOI 10.1080/08035259950169855	5	22	22	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2002	324	7334					398	398		10.1136/bmj.324.7334.398	http://dx.doi.org/10.1136/bmj.324.7334.398			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	524HC	11850371	Bronze, Green Published			2022-12-24	WOS:000174006300019
J	Sleutels, F; Zwart, R; Barlow, DP				Sleutels, F; Zwart, R; Barlow, DP			The non-coding Air RNA is required for silencing autosomal imprinted genes	NATURE			English	Article							X-INACTIVATION; ANTISENSE RNA; CPG ISLAND; TRANSCRIPT; LOCUS; METHYLATION; EXPRESSION; CHROMOSOME; OVERLAPS; IGF2	In genomic imprinting, one of the two parental alleles of an autosomal gene is silenced epigenetically by a cis-acting mechanism(1,2). A bidirectional silencer for a 400-kilobase region that contains three imprinted, maternally expressed protein-coding genes (Igf2r/Slc22a2/Slc22a3) has been shown by targeted deletion to be located in a sequence of 3.7 kilobases(3-5), which also contains the promoter for the imprinted, paternally expressed non-coding Air RNA(6). Expression of Air is correlated with repression of all three genes on the paternal allele(5); however, Air RNA overlaps just one of these genes in an antisense orientation(6). Here we show, by inserting a polyadenylation signal that truncates 96% of the RNA transcript, that Air RNA is required for silencing. The truncated Air allele maintains imprinted expression and methylation of the Air promoter, but shows complete loss of silencing of the Igf2r/Slc22a2/Slc22a3 gene cluster on the paternal chromosome. Our results indicate that non-coding RNAs have an active role in genomic imprinting.	Austrian Acad Sci, Inst Mol Biol, A-5020 Salzburg, Austria; Netherlands Canc Inst, Dept Mol Genet, NL-1066 CX Amsterdam, Netherlands	Austrian Academy of Sciences; Netherlands Cancer Institute	Barlow, DP (corresponding author), Austrian Acad Sci, Inst Mol Biol, Billrothstr 11, A-5020 Salzburg, Austria.							Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; BEECHEY CV, 2000, MRC MAMMALIAN GENETI; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Constancia M, 2000, NAT GENET, V26, P203, DOI 10.1038/79930; Graves JAM, 1996, ANNU REV GENET, V30, P233, DOI 10.1146/annurev.genet.30.1.233; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hogan B, 1994, MANIPULATING MOUSE E; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; Lee YJ, 2000, FEBS LETT, V472, P230, DOI 10.1016/S0014-5793(00)01461-7; Lyle R, 2000, NAT GENET, V25, P19, DOI 10.1038/75546; Lyon Mary F., 1999, Results and Problems in Cell Differentiation, V25, P73; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Reik W, 2000, NATURE, V405, P408, DOI 10.1038/35013178; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rougeulle C, 1998, NAT GENET, V19, P15, DOI 10.1038/ng0598-15; Schmidt JV, 1999, P NATL ACAD SCI USA, V96, P9733, DOI 10.1073/pnas.96.17.9733; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; Sleutels F, 2001, MOL CELL BIOL, V21, P5008, DOI 10.1128/MCB.21.15.5008-5017.2001; SLEUTELS F, IN PRESS HOMOLOGY EF; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; Wroe SF, 2000, P NATL ACAD SCI USA, V97, P3342, DOI 10.1073/pnas.050015397; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Wutz A, 2001, DEVELOPMENT, V128, P1881; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Zwart R, 2001, GENE DEV, V15, P2361, DOI 10.1101/gad.206201	27	827	876	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					810	813		10.1038/415810a	http://dx.doi.org/10.1038/415810a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845212				2022-12-24	WOS:000173833900051
J	Berson, DM; Dunn, FA; Takao, M				Berson, DM; Dunn, FA; Takao, M			Phototransduction by retinal ganglion cells that set the circadian clock	SCIENCE			English	Article							SUPRACHIASMATIC NUCLEUS; LIGHT; PHOTORECEPTORS; ENTRAINMENT; OPSIN; RAT; EYE; INTEGRATION; SENSITIVITY; PATHWAY	Light synchronizes mammalian circadian rhythms with environmental time by modulating retinal input to the circadian pacemaker-the suprachiasmatic nucleus (SCN) of the hypothalamus. Such photic entrainment requires neither rods nor cones, the only known retinal photoreceptors. Here, we show that retinal ganglion cells innervating the SCN are intrinsically photosensitive. Unlike other ganglion cells, they depolarized in response to tight even when all synaptic input from rods and cones was blocked. The sensitivity, spectral tuning, and slow kinetics of this tight response matched those of the photic entrainment mechanism, suggesting that these ganglion cells may be the primary photoreceptors for this system.	Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Berson, DM (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.		Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X	NEI NIH HHS [EY12793] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012793] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aggelopoulos NC, 2000, J PHYSIOL-LONDON, V523, P211, DOI 10.1111/j.1469-7793.2000.t01-1-00211.x; BARR L, 1963, J GEN PHYSIOL, V46, P1249, DOI 10.1085/jgp.46.6.1249; DANIOLOS A, 1990, PIGM CELL RES, V3, P38, DOI 10.1111/j.1600-0749.1990.tb00260.x; Dkhissi-Benyahya O, 2000, J NEUROSCI, V20, P7790; DODT E, 1961, J NEUROPHYSIOL, V24, P427, DOI 10.1152/jn.1961.24.4.427; DUNN FA, UNPUB; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Green DG, 1999, VISUAL NEUROSCI, V16, P727, DOI 10.1017/S0952523899164125; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hsu DS, 1996, BIOCHEMISTRY-US, V35, P13871, DOI 10.1021/bi962209o; HUGHES A, 1979, VISION RES, V19, P569, DOI 10.1016/0042-6989(79)90143-3; Kojima D, 2000, J NEUROSCI, V20, P2845; LAMB TD, 1995, VISION RES, V35, P3083, DOI 10.1016/0042-6989(95)00114-F; Meijer JH, 1998, J NEUROSCI, V18, P9078; MOORE MAS, 1995, CLIN CANCER RES, V1, P3; NELSON DE, 1991, J PHYSIOL-LONDON, V439, P115, DOI 10.1113/jphysiol.1991.sp018660; Nelson DE, 1999, AM J PHYSIOL-REG I, V277, pR1351, DOI 10.1152/ajpregu.1999.277.5.R1351; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; PROVENCIO I, 1995, BRAIN RES, V694, P183, DOI 10.1016/0006-8993(95)00694-L; Pu M, 2000, J BIOL RHYTHM, V15, P31, DOI 10.1177/074873040001500104; PU M, 1992, J NEUROSCI METH, V41, P45, DOI 10.1016/0165-0270(92)90122-T; Pu ML, 1999, J COMP NEUROL, V414, P267; Roenneberg T, 1997, PHOTOCHEM PHOTOBIOL, V66, P549, DOI 10.1111/j.1751-1097.1997.tb03188.x; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; TAKAHASHI JS, 1984, NATURE, V308, P186, DOI 10.1038/308186a0; von Schantz M, 2000, INVEST OPHTH VIS SCI, V41, P1605	29	2193	2286	27	463	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1070	1073		10.1126/science.1067262	http://dx.doi.org/10.1126/science.1067262			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834835				2022-12-24	WOS:000173793000065
J	Nagai, H; Kagan, JC; Zhu, XJ; Kahn, RA; Roy, CR				Nagai, H; Kagan, JC; Zhu, XJ; Kahn, RA; Roy, CR			A bacterial guanine nucleotide exchange factor activates ARF on Legionella phagosomes	SCIENCE			English	Article							INTRACELLULAR GROWTH; LEGIONNAIRES-DISEASE; HOST-CELLS; HELICOBACTER-PYLORI; HUMAN-MONOCYTES; PNEUMOPHILA; IDENTIFICATION; ESTABLISHMENT; ORGANELLE; GTPASES	The intracellular pathogen Legionella pneumophila subverts vesicle traffic in eukaryotic host cells to create a vacuole that supports replication. The dot/icm genes encode a protein secretion apparatus that L. pneumophila require for biogenesis of this vacuole. Here we show that L. pneumophila produce a protein called RalF that functions as an exchange factor for the ADP ribosylation factor (ARF) family of guanosine triphosphatases (GTPases). The RalF protein is required for the localization of ARF on phagosomes containing L. pneumophila. Translocation of RalF protein through the phagosomal membrane is a dot/km-dependent process. Thus, RalF is a substrate of the Dot/Icm secretion apparatus.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA; Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Yale University; Emory University	Roy, CR (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, 295 Congress Ave, New Haven, CT 06536 USA.		Nagai, Hiroki/GXZ-7815-2022; Nagai, Hiroki/G-4113-2015; Kahn, Richard/ABD-2666-2020	Nagai, Hiroki/0000-0003-1659-2197; Kahn, Richard/0000-0002-0259-0601; Roy, Craig/0000-0003-4490-440X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI041699, R01AI044371] Funding Source: NIH RePORTER; NIAID NIH HHS [R29 AI41699, R01 AI44371] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Breiman R F, 1998, Semin Respir Infect, V13, P84; Byrne B, 1998, INFECT IMMUN, V66, P3029, DOI 10.1128/IAI.66.7.3029-3034.1998; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; Coers J, 1999, NAT CELL BIOL, V1, P451, DOI 10.1038/15687; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Edelstein PH, 1999, P NATL ACAD SCI USA, V96, P8190, DOI 10.1073/pnas.96.14.8190; Fields BS, 1996, TRENDS MICROBIOL, V4, P286, DOI 10.1016/0966-842X(96)10041-X; Gao LY, 1997, INFECT IMMUN, V65, P4738, DOI 10.1128/IAI.65.11.4738-4746.1997; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Heiner CR, 1998, GENOME RES, V8, P557, DOI 10.1101/gr.8.5.557; HORWITZ MA, 1980, J CLIN INVEST, V66, P441, DOI 10.1172/JCI109874; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Jones S, 1999, GENETICS, V152, P1543; KAGAN J, UNPUB; Matthews M, 2000, INFECT IMMUN, V68, P3971, DOI 10.1128/IAI.68.7.3971-3982.2000; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; Nagai H, 2001, EMBO J, V20, P5962, DOI 10.1093/emboj/20.21.5962; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; RANDAZZO PA, 1995, METHOD ENZYMOL, V250, P394; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Tilney LG, 2001, J CELL SCI, V114, P4637; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Zuckman DM, 1999, MOL MICROBIOL, V32, P990, DOI 10.1046/j.1365-2958.1999.01410.x	32	440	455	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					679	682		10.1126/science.1067025	http://dx.doi.org/10.1126/science.1067025			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809974				2022-12-24	WOS:000173560900046
J	Altabet, MA; Higginson, MJ; Murray, DW				Altabet, MA; Higginson, MJ; Murray, DW			The effect of millennial-scale changes in Arabian Sea denitrification on atmospheric CO2	NATURE			English	Article							INDIAN-OCEAN; ICE CORE; CYCLE; MONSOON; OSCILLATIONS; VARIABILITY; ATLANTIC; METHANE; RATIOS	Most global biogeochemical processes are known to respond to climate change, some of which have the capacity to produce feedbacks through the regulation of atmospheric greenhouse gases(1). Marine denitrification-the reduction of nitrate to gaseous nitrogen-is an important process in this regard, affecting greenhouse gas concentrations directly through the incidental production of nitrous oxide, and indirectly through modification of the marine nitrogen inventory and hence the biological pump for CO2. Although denitrification has been shown to vary with glacial-interglacial cycles(2,3), its response to more rapid climate change has not yet been well characterized. Here we present nitrogen isotope ratio, nitrogen content and chlorin abundance data from sediment cores with high accumulation rates on the Oman continental margin that reveal substantial millennial-scale variability in Arabian Sea denitrification and productivity during the last glacial period. The detailed correspondence of these changes with Dansgaard-Oeschger events recorded in Greenland ice cores(4) indicates rapid, century-scale reorganization of the Arabian Sea ecosystem in response to climate excursions, mediated through the intensity of summer monsoonal upwelling. Considering the several-thousand-year residence time of fixed nitrogen in the ocean, the response of global marine productivity to changes in denitrification would have occurred at lower frequency and appears to be related to climatic and atmospheric CO2 oscillations observed in Antarctic ice cores between 20 and 60 kyr ago(5).	Univ Massachusetts, Sch Marine Sci & Technol, New Bedford, MA 02744 USA; Brown Univ, Ctr Environm Studies, Providence, RI 02912 USA	University of Massachusetts System; Brown University	Altabet, MA (corresponding author), Univ Massachusetts, Sch Marine Sci & Technol, 706 S Rodney French Blvd, New Bedford, MA 02744 USA.							ALTABET MA, 1995, NATURE, V373, P506, DOI 10.1038/373506a0; Altabet MA, 1999, DEEP-SEA RES PT I, V46, P655, DOI 10.1016/S0967-0637(98)00084-3; Altabet MA, 1999, PALEOCEANOGRAPHY, V14, P732, DOI 10.1029/1999PA900035; ANDERSON DM, 1991, FORAMINIFER EVIDENCE; Bond G, 1997, SCIENCE, V278, P1257, DOI 10.1126/science.278.5341.1257; Brandes JA, 1998, LIMNOL OCEANOGR, V43, P1680, DOI 10.4319/lo.1998.43.7.1680; BROECKER WS, 1982, PROG OCEANOGR, V11, P151, DOI 10.1016/0079-6611(82)90007-6; CLEMENS S, 1991, NATURE, V353, P720, DOI 10.1038/353720a0; CLINE J D, 1975, Marine Chemistry, V3, P271, DOI 10.1016/0304-4203(75)90009-2; DANSGAARD W, 1982, SCIENCE, V218, P1273, DOI 10.1126/science.218.4579.1273; Ganeshram RS, 2000, PALEOCEANOGRAPHY, V15, P361, DOI 10.1029/1999PA000422; Grootes PM, 1997, J GEOPHYS RES-OCEANS, V102, P26455, DOI 10.1029/97JC00880; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; HIGGINSON MJ, 2000, THESIS U BRISTOL; Honjo S, 1999, DEEP-SEA RES PT II, V46, P1859, DOI 10.1016/S0967-0645(99)00047-8; Howell EA, 1997, GEOPHYS RES LETT, V24, P2549, DOI 10.1029/97GL01538; Indermuhle A, 2000, GEOPHYS RES LETT, V27, P735, DOI 10.1029/1999GL010960; Kennett JP, 2000, SCIENCE, V288, P128, DOI 10.1126/science.288.5463.128; KROM MD, 1993, DEEP-SEA RES PT I, V40, P805, DOI 10.1016/0967-0637(93)90073-C; OLSON DB, 1993, DEEP-SEA RES PT II, V40, P673, DOI 10.1016/0967-0645(93)90051-N; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Schulz H, 1998, NATURE, V393, P54, DOI 10.1038/31750; Shackleton NJ, 2000, PALEOCEANOGRAPHY, V15, P565, DOI 10.1029/2000PA000513; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Stuiver M, 1998, RADIOCARBON, V40, P1127, DOI 10.1017/S0033822200019172; Stuiver M, 2000, QUATERNARY RES, V53, P277, DOI 10.1006/qres.2000.2127; Suthhof A, 2001, GLOBAL BIOGEOCHEM CY, V15, P637, DOI 10.1029/2000GB001337; Upstill-Goddard RC, 1999, J GEOPHYS RES-OCEANS, V104, P30067, DOI 10.1029/1999JC900232; von Rad U, 1999, PALAEOGEOGR PALAEOCL, V152, P129, DOI 10.1016/S0031-0182(99)00042-5; WARREN BA, 1994, BIOGEOCHEMISTRY ARAB, P301	30	332	351	1	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					159	162		10.1038/415159a	http://dx.doi.org/10.1038/415159a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805831				2022-12-24	WOS:000173159300038
J	Corder, R; Douthwaite, JA; Lees, DM; Khan, NQ; dos Santos, ACV; Wood, EG; Carrier, MJ				Corder, R; Douthwaite, JA; Lees, DM; Khan, NQ; dos Santos, ACV; Wood, EG; Carrier, MJ			Endothelin-1 synthesis reduced by red wine - Red wines confer extra benefit when it comes to preventing coronary heart disease.	NATURE			English	Article							MORTALITY; CONSUMPTION; ALCOHOL		Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England	University of London; Queen Mary University London	Corder, R (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.		Corder, Roger/H-2588-2012	Corder, Roger/0000-0003-1712-6841; Lees, Delphine M/0000-0002-2119-3978				Caligiuri G, 1999, P NATL ACAD SCI USA, V96, P6920, DOI 10.1073/pnas.96.12.6920; CORDER R, 2001, HANDB EXP PHARM, V152, P35; Diebolt M, 2001, HYPERTENSION, V38, P159, DOI 10.1161/01.HYP.38.2.159; DOLL R, 1994, BRIT MED J, V309, P911, DOI 10.1136/bmj.309.6959.911; FRANKEL EN, 1993, LANCET, V341, P454, DOI 10.1016/0140-6736(93)90206-V; Goldberg IJ, 2001, CIRCULATION, V103, P472; Kinlay S, 2001, CIRCULATION, V104, P1114, DOI 10.1161/hc3501.095707; Law M, 1999, BRIT MED J, V318, P1471, DOI 10.1136/bmj.318.7196.1471; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; STLEGER AS, 1979, LANCET, V1, P1017, DOI 10.1016/S0140-6736(79)92765-X; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	11	237	258	4	42	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					863	864		10.1038/414863a	http://dx.doi.org/10.1038/414863a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780050				2022-12-24	WOS:000172813300033
J	Kyle, RA; Therneau, TM; Rajkumar, SV; Offord, JR; Larson, DR; Plevak, MF; Melton, L				Kyle, RA; Therneau, TM; Rajkumar, SV; Offord, JR; Larson, DR; Plevak, MF; Melton, L			A long-term study of prognosis in monoclonal gammopathy of undetermined significance	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MALIGNANT TRANSFORMATION; NATURAL-HISTORY; MINNESOTA; COMMUNITY	Background: A monoclonal gammopathy of undetermined significance (MGUS) occurs in up to 2 percent of persons 50 years of age or older. Reliable predictors of progression have not been identified, and information on prognosis is limited. Methods: We identified 1384 patients residing in southeastern Minnesota in whom MGUS was diagnosed at the Mayo Clinic from 1960 through 1994. The primary end point was progression to multiple myeloma or another plasma-cell cancer. Results: During 11,009 person-years of follow-up, MGUS progressed in 115 of the 1384 patients to multiple myeloma, IgM lymphoma, primary amyloidosis, macroglobulinemia, chronic lymphocytic leukemia, or plasmacytoma (relative risk of progression, 25.0, 2.4, 8.4, 46.0, 0.9, and 8.5, respectively). The overall relative risk of progression was 7.3 in these patients as compared with the white population of the Iowa Surveillance, Epidemiology, and End Results program. In 32 additional patients, the monoclonal protein concentration increased to more than 3 g per deciliter or the percentage of plasma cells in the bone marrow increased to more than 10 percent (smoldering multiple myeloma) but without progression to overt myeloma or related disorders. The cumulative probability of progression was 12 percent at 10 years, 25 percent at 20 years, and 30 percent at 25 years. The initial concentration of serum monoclonal protein was a significant predictor of progression at 20 years. Conclusions: The risk of progression of MGUS to multiple myeloma or related disorders is about 1 percent per year. Copyright (C) 2002 Massachusetts Medical Society.	Mayo Clin & Mayo Fdn, Div Hematol & Internal Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Biostat Sect, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Clin Epidemiol Sect, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Kyle, RA (corresponding author), Mayo Clin & Mayo Fdn, Div Hematol & Internal Med, 200 1st St SW, Rochester, MN 55905 USA.		Rajkumar, S. Vincent/AAV-1834-2021	Rajkumar, S. Vincent/0000-0002-5862-1833	NATIONAL CANCER INSTITUTE [P01CA062242] Funding Source: NIH RePORTER; NCI NIH HHS [CA62242] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AXELSSON U, 1966, ACTA MED SCAND, V179, P235; Baldini L, 1996, BLOOD, V87, P912, DOI 10.1182/blood.V87.3.912.bloodjournal873912; BERRY G, 1983, BIOMETRICS, V39, P173, DOI 10.2307/2530817; BLADE J, 1992, BRIT J HAEMATOL, V81, P391, DOI 10.1111/j.1365-2141.1992.tb08245.x; COX DR, 1972, J R STAT SOC B, V34, P187; Fonseca R, 1999, BLOOD, V94, p663A; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; HALLEN J, 1963, ACTA MED SCAND, V173, P737; Hallen J, 1966, Acta Med Scand Suppl, V462, P1; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kyle R, 1997, MANUAL CLIN LAB IMMU, P156; KYLE RA, 1972, BLOOD-J HEMATOL, V40, P719, DOI 10.1182/blood.V40.5.719.719; KYLE RA, 1978, AM J MED, V64, P814, DOI 10.1016/0002-9343(78)90522-3; KYLE RA, 1993, MAYO CLIN PROC, V68, P26, DOI 10.1016/S0025-6196(12)60015-9; KYLE RA, 1992, BLOOD, V79, P1817; Kyle RA, 1999, BLOOD, V94, p537A; Melton LJ, 1997, NEW ENGL J MED, V337, P1466, DOI 10.1056/NEJM199711133372012; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; *NAT CANC I CAN ST, 2001, SURV EP END RES PROG; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; SALEUN JP, 1982, J CLIN PATHOL, V35, P63, DOI 10.1136/jcp.35.1.63; VANDEPOEL MHW, 1995, BRIT J HAEMATOL, V91, P121	22	978	1013	0	31	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2002	346	8					564	569		10.1056/NEJMoa01133202	http://dx.doi.org/10.1056/NEJMoa01133202			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	522ZK	11856795				2022-12-24	WOS:000173926700004
J	Shiba, T; Takatsu, H; Nogi, T; Matsugaki, N; Kawasaki, M; Igarashi, N; Suzuki, M; Kato, R; Earnest, T; Nakayama, K; Wakatsuki, S				Shiba, T; Takatsu, H; Nogi, T; Matsugaki, N; Kawasaki, M; Igarashi, N; Suzuki, M; Kato, R; Earnest, T; Nakayama, K; Wakatsuki, S			Structural basis for recognition of acidic-cluster dileucine sequence by GGA1	NATURE			English	Article							EAR HOMOLOGY DOMAIN; GAMMA-ADAPTIN; VHS DOMAIN; PROTEINS INTERACT; BINDING; TRANSPORT; FAMILY; TRAFFICKING; RECEPTORS; INSIGHTS	GGAs (Golgi-localizing, g-adaptin ear homology domain, ARF-interacting proteins) are critical for the transport of soluble proteins from the trans-Golgi network (TGN) to endosomes/lysosomes by means of interactions with TGN-sorting receptors, ADP-ribosylation factor (ARF), and clathrin(1,2). The amino-terminal VHS domains of GGAs form complexes with the cytoplasmic domains of sorting receptors by recognizing acidic-cluster dileucine (ACLL) sequences(1-6). Here we report the X-ray structure of the GGA1 VHS domain alone, and in complex with the carboxyterminal peptide of cation-independent mannose 6-phosphate receptor containing an ACLL sequence. The VHS domain forms a super helix with eight alpha-helices, similar to the VHS domains of TOM1 and Hrs. Unidirectional movements of helices alpha6 and alpha8, and some of their side chains, create a set of electrostatic and hydrophobic interactions for correct recognition of the ACLL peptide. This recognition mechanism provides the basis for regulation of protein transport from the TGN to endosomes/lysosomes, which is shared by sortilin and low-density lipoprotein receptor-related protein.	High Energy Accelerator Res Org, Inst Mat Struct Sci, Photon Factory, Tsukuba, Ibaraki 3050801, Japan; Fdn Advancement Int Sci, Tsukuba, Ibaraki 3050062, Japan; Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 3058572, Japan; Univ Tsukuba, Ctr Gene Res, Tsukuba, Ibaraki 3058572, Japan; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley Ctr Struct Biol,Adv Light Source, Berkeley, CA 94720 USA	High Energy Accelerator Research Organization (KEK); University of Tsukuba; University of Tsukuba; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Wakatsuki, S (corresponding author), High Energy Accelerator Res Org, Inst Mat Struct Sci, Photon Factory, Tsukuba, Ibaraki 3050801, Japan.	soichi.wakatsuki@kek.jp	Nakayama, Kazuhisa/ABF-2924-2020; Nogi, Terukazu/GPF-7203-2022; Suzuki, Mamoru/G-6576-2016	Nogi, Terukazu/0000-0001-8663-3519; Suzuki, Mamoru/0000-0001-7071-5093; Nakayama, Kazuhisa/0000-0001-7701-7183; Igarashi, Noriyuki/0000-0003-2617-3690; Kato, Ryuichi/0000-0003-2087-2896; Kawasaki, Masato/0000-0002-8319-2102; Matsugaki, Naohiro/0000-0001-9640-1949; Wakatsuki, Soichi/0000-0001-5896-7968				Black MW, 2001, CURR BIOL, V11, pR460, DOI 10.1016/S0960-9822(01)00281-0; Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen HJ, 1997, J BIOL CHEM, V272, P7003, DOI 10.1074/jbc.272.11.7003; Costaguta G, 2001, MOL BIOL CELL, V12, P1885, DOI 10.1091/mbc.12.6.1885; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LESLIE AGW, 1992, JOINT CCP4 ESF EACMB, V26; Lohi O, 1998, FEBS LETT, V440, P255, DOI 10.1016/S0014-5793(98)01401-X; Mao YX, 2000, CELL, V100, P447, DOI 10.1016/S0092-8674(00)80680-7; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Misra S, 2000, BIOCHEMISTRY-US, V39, P11282, DOI 10.1021/bi0013546; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; Poussu A, 2000, J BIOL CHEM, V275, P7176, DOI 10.1074/jbc.275.10.7176; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; ROUSSEL A, 1991, SILICON GRAPHICS GEO; Takatsu H, 2000, BIOCHEM BIOPH RES CO, V271, P719, DOI 10.1006/bbrc.2000.2700; Takatsu H, 2001, J BIOL CHEM, V276, P28541, DOI 10.1074/jbc.C100218200; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Zhdankina O, 2001, YEAST, V18, P1, DOI 10.1002/1097-0061(200101)18:1<1::AID-YEA644>3.0.CO;2-5; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896	29	122	126	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2002	415	6874					937	941		10.1038/415937a	http://dx.doi.org/10.1038/415937a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859376				2022-12-24	WOS:000173941000052
J	Shin, T; Kraemer, D; Pryor, J; Liu, L; Rugila, J; Howe, L; Buck, S; Murphy, K; Lyons, L; Westhusin, M				Shin, T; Kraemer, D; Pryor, J; Liu, L; Rugila, J; Howe, L; Buck, S; Murphy, K; Lyons, L; Westhusin, M			A cat cloned by nuclear transplantation	NATURE			English	Article							SOMATIC-CELLS; ADULT		Texas A&M Univ, Coll Vet Med, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; Texas A&M Univ, Coll Vet Med, Dept Small Anim Med & Surg, College Stn, TX 77843 USA; Texas A&M Univ, Coll Vet Med, Dept Pathobiol, College Stn, TX 77843 USA; Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of California System; University of California Davis	Shin, T (corresponding author), Texas A&M Univ, Coll Vet Med, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA.		Westhusin, Mark/AAX-2351-2020	Westhusin, Mark/0000-0002-6126-6211				Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0	5	377	451	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2002	415	6874					859	859		10.1038/nature723	http://dx.doi.org/10.1038/nature723			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859353				2022-12-24	WOS:000173941000029
J	Raxworthy, CJ; Forstner, MRJ; Nussbaum, RA				Raxworthy, CJ; Forstner, MRJ; Nussbaum, RA			Chameleon radiation by oceanic dispersal	NATURE			English	Article							HISTORICAL BIOGEOGRAPHY; INDIAN-OCEAN; MADAGASCAR; PHYLOGENY; VOLCANISM; REPTILIA; BREAKUP; SKULL	Historical biogeography is dominated by vicariance methods that search for a congruent pattern of fragmentation of ancestral distributions produced by shared Earth history(1-3). A focus of vicariant studies has been austral area relationships and the break-up of the supercontinent Gondwana(3-5). Chameleons are one of the few extant terrestrial vertebrates thought to have biogeographic patterns that are congruent with the Gondwanan break-up of Madagascar and Africa(6,7). Here we show, using molecular and morphological evidence for 52 chameleon taxa, support for a phylogeny and area cladogram that does not fit a simple vicariant history. Oceanic dispersal-not Gondwanan breakup-facilitated species radiation, and the most parsimonious biogeographic hypothesis supports a Madagascan origin for chameleons, with multiple 'out-of-Madagascar' dispersal events to Africa, the Seychelles, the Comoros archipelago, and possibly Reunion Island. Although dispersal is evident in other Indian Ocean terrestrial animal groups(8-16), our study finds substantial out-of-Madagascar species radiation, and further highlights the importance of oceanic dispersal as a potential precursor for speciation.	Amer Museum Nat Hist, New York, NY 10024 USA; SW Texas State Univ, Dept Biol, San Marcos, TX 78666 USA; Univ Michigan, Museum Zool, Ann Arbor, MI 48109 USA	American Museum of Natural History (AMNH); Texas State University System; Texas State University San Marcos; University of Michigan System; University of Michigan	Raxworthy, CJ (corresponding author), Amer Museum Nat Hist, Cent Pk W & 79th St, New York, NY 10024 USA.	rax@amnh.edu						ARNOLD EN, 1979, PHILOS T ROY SOC B, V286, P127, DOI 10.1098/rstb.1979.0022; BLANC C P, 1972, P501; Brown J.H., 1998, BIOGEOGRAPHY; Caccone A, 1999, MOL PHYLOGENET EVOL, V12, P1, DOI 10.1006/mpev.1998.0594; CRISCI JV, 1991, SYST ZOOL, V40, P152, DOI 10.2307/2992254; EMERICK CM, 1982, EARTH PLANET SC LETT, V60, P415, DOI 10.1016/0012-821X(82)90077-2; Fisher BL, 1996, COLLOQ SEMI, P457; FROST DR, 1989, MISC PUBL U KANSAS M, V81, P1; Griswold Charles E., 2000, P345; Hay WW, 1999, GEOL S AM S, P1; HILLENIUS D, 1978, Beaufortia, V28, P9; HOFMAN A, 1991, Amphibia-Reptilia, V12, P245, DOI 10.1163/156853891X00428; Humphries C.J., 1999, CLADISTIC BIOGEOGRAP; Jansa SA, 1999, CLADISTICS, V15, P253, DOI 10.1111/j.1096-0031.1999.tb00267.x; KLAVER C, 1986, BONN ZOOL MONOGR, V22, P1; Kluge A. G., 1995, MISC PUBL MUS ZOOL, V183, P1; Mausfeld P, 2000, MOL PHYLOGENET EVOL, V17, P11, DOI 10.1006/mpev.2000.0809; MOODY S, 1980, Vestnik Ustredniho Ustavu Geologickeho, V55, P85; MORRONE JJ, 1995, ANNU REV ECOL SYST, V26, P373, DOI 10.1146/annurev.es.26.110195.002105; Nelson G, 1981, SYSTEMATICS BIOGEORA; PAGE RDM, 1994, SYST BIOL, V43, P58, DOI 10.2307/2413581; RABINOWITZ PD, 1983, SCIENCE, V220, P67, DOI 10.1126/science.220.4592.67; RAND DM, 1994, TRENDS ECOL EVOL, V9, P125, DOI 10.1016/0169-5347(94)90176-7; RIEPPEL O, 1992, J HERPETOL, V26, P77, DOI 10.2307/1565027; RIEPPEL O, 1987, ZOOL J LINN SOC-LOND, V89, P41, DOI 10.1111/j.1096-3642.1987.tb01343.x; Rieppel O, 1997, J ZOOL, V243, P351, DOI 10.1111/j.1469-7998.1997.tb02788.x; STOREY BC, 1995, NATURE, V377, P301, DOI 10.1038/377301a0; STOREY M, 1995, SCIENCE, V267, P852, DOI 10.1126/science.267.5199.852; Trueman JWH, 1998, SYST BIOL, V47, P733, DOI 10.1080/106351598260725; Yoder AD, 1996, COLLOQ SEMI, P245	30	247	258	6	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2002	415	6873					784	787		10.1038/415784a	http://dx.doi.org/10.1038/415784a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845207	Green Published			2022-12-24	WOS:000173833900044
J	Chen, CL; Weiss, NS; Newcomb, P; Barlow, WN; White, E				Chen, CL; Weiss, NS; Newcomb, P; Barlow, WN; White, E			Hormone replacement therapy in relation to breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MENOPAUSAL ESTROGENS; RISK; CARCINOMA; PROLIFERATION; PROGESTERONE; WOMEN; STAGE	Context Studies of long-term hormone replacement therapy (HRT) suggest an associated increased risk of breast cancer, but whether this association differs according to histologic type of cancer has not been extensively studied. Objective To determine whether the association between HRT and risk of breast cancer varies by HRT formulation and differs across histologic cancer types. Design, Setting, and Participants Nested case-control study among 705 postmenopausal women enrolled in the Group Health Cooperative of Puget Sound (GHC) who were aged 50 to 74 years and had primary invasive breast cancer diagnosed between July 1, 1990, and December 31, 1995 (cases), and 692 randomly selected aged-matched female members of GHC (controls). Main Outcome Measure Incidence and type of breast cancer by duration of HRT use in the 5-year period ending 1 year before diagnosis, which was ascertained from computerized pharmacy records. Results The incidence of breast cancer, all histologic types combined, was increased by 60% to 85% in recent long-term users of HRT, whether estrogen alone or estrogen plus progestin. Longer use of HRT (odds ratio [OR], 3.07 for 57 months or more; 95% confidence interval [CI], 1.55-6.06) and current use of combination therapy (OR, 3.91; 95% CI, 2.05-7.44) were associated with increased risk of lobular breast cancer. Long-term HRT use was associated with a 50% increase in nonlobular cancer (OR, 1.52 for 57 months or more; 95% CI, 1.01-2.29). Conclusion Our data add to the growing body of evidence that recent long-term use of HRT is associated with an increased risk of breast cancer and that such use may be related particularly to lobular tumors.	Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Ctr Hlth Studies, Grp Hlth Cooperat, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	White, E (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1100 Fairview Ave N,MP702, Seattle, WA 98109 USA.	ewhite@fhcrc.org			NATIONAL CANCER INSTITUTE [U01CA063731] Funding Source: NIH RePORTER; NCI NIH HHS [UO1CA63731] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON TJ, 1989, HUM PATHOL, V20, P1139, DOI 10.1016/S0046-8177(89)80003-6; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; BERGKVIST L, 1989, NEW ENGL J MED, V321, P293, DOI 10.1056/NEJM198908033210505; BRINTON LA, 1986, BRIT J CANCER, V54, P825, DOI 10.1038/bjc.1986.246; CLARKE CL, 1990, ENDOCR REV, V11, P266, DOI 10.1210/edrv-11-2-266; COLDITZ GA, 1995, NEW ENGL J MED, V332, P1589, DOI 10.1056/NEJM199506153322401; DIXON JM, 1982, HISTOPATHOLOGY, V6, P149, DOI 10.1111/j.1365-2559.1982.tb02712.x; EWERTZ M, 1988, INT J CANCER, V42, P832, DOI 10.1002/ijc.2910420606; GAMBRELL RD, 1983, OBSTET GYNECOL, V62, P435; Graham JD, 1997, ENDOCR REV, V18, P502, DOI 10.1210/er.18.4.502; HARRIS RE, 1992, J NATL CANCER I, V84, P1575, DOI 10.1093/jnci/84.20.1575; HIATT RA, 1984, CANCER, V54, P139, DOI 10.1002/1097-0142(19840701)54:1<139::AID-CNCR2820540128>3.0.CO;2-X; Hofseth LJ, 1999, J CLIN ENDOCR METAB, V84, P4559, DOI 10.1210/jc.84.12.4559; HULKA BS, 1982, AM J OBSTET GYNECOL, V143, P638, DOI 10.1016/0002-9378(82)90108-9; JICK H, 1980, AM J EPIDEMIOL, V112, P586, DOI 10.1093/oxfordjournals.aje.a113031; KAUFMAN DW, 1991, AM J EPIDEMIOL, V134, P1375, DOI 10.1093/oxfordjournals.aje.a116041; KELSEY JL, 1993, EPIDEMIOL REV, V15, P36, DOI 10.1093/oxfordjournals.epirev.a036115; KEY TJA, 1988, EUR J CANCER CLIN ON, V24, P29, DOI 10.1016/0277-5379(88)90173-3; LAVECCHIA C, 1992, INT J CANCER, V50, P161, DOI 10.1002/ijc.2910500131; LAVECCHIA C, 1995, BRIT J CANCER, V72, P244, DOI 10.1038/bjc.1995.310; Li CI, 2000, CANCER, V88, P2561, DOI 10.1002/1097-0142(20000601)88:11<2561::AID-CNCR19>3.3.CO;2-O; Li CI, 2000, CANCER, V88, P2570, DOI 10.1002/1097-0142(20000601)88:11<2570::AID-CNCR20>3.0.CO;2-O; LIPWORTH L, 1995, INT J CANCER, V62, P548, DOI 10.1002/ijc.2910620510; LOBO RA, 1991, J CLIN ENDOCR METAB, V73, P925, DOI 10.1210/jcem-73-5-925; Magnusson C, 1999, INT J CANCER, V81, P339, DOI 10.1002/(SICI)1097-0215(19990505)81:3<339::AID-IJC5>3.3.CO;2-Y; MILLS PK, 1989, CANCER, V64, P591, DOI 10.1002/1097-0142(19890801)64:3<591::AID-CNCR2820640305>3.0.CO;2-U; NANDI S, 1995, P NATL ACAD SCI USA, V92, P3650, DOI 10.1073/pnas.92.9.3650; NEWCOMB PA, 1995, AM J EPIDEMIOL, V142, P788, DOI 10.1093/oxfordjournals.aje.a117717; Newcomer LM, 1999, AM J EPIDEMIOL, V149, pS79; NEWSTEAD GM, 1992, RADIOLOGY, V184, P623, DOI 10.1148/radiology.184.3.1324506; NOMURA AMY, 1986, INT J CANCER, V37, P49, DOI 10.1002/ijc.2910370109; PALMER JR, 1991, AM J EPIDEMIOL, V134, P1386, DOI 10.1093/oxfordjournals.aje.a116042; Persson I, 1997, INT J CANCER, V72, P758, DOI 10.1002/(SICI)1097-0215(19970904)72:5<758::AID-IJC9>3.3.CO;2-2; PIKE MC, 1993, EPIDEMIOL REV, V15, P17, DOI 10.1093/oxfordjournals.epirev.a036102; PRESTONMARTIN S, 1990, CANCER RES, V50, P7415; RISCH HA, 1994, AM J EPIDEMIOL, V139, P670, DOI 10.1093/oxfordjournals.aje.a117057; Ross RK, 2000, JNCI-J NATL CANCER I, V92, P328, DOI 10.1093/jnci/92.4.328; Schairer C, 2000, JAMA-J AM MED ASSOC, V283, P485, DOI 10.1001/jama.283.4.485; SCHUURMAN AG, 1995, CANCER CAUSE CONTROL, V6, P416, DOI 10.1007/BF00052181; STANFORD JL, 1995, JAMA-J AM MED ASSOC, V274, P137, DOI 10.1001/jama.274.2.137; STIERER M, 1993, ANN SURG, V218, P13, DOI 10.1097/00000658-199307000-00004; TALAMINI R, 1985, INT J EPIDEMIOL, V14, P70, DOI 10.1093/ije/14.1.70; Taplin SH, 1997, CANCER EPIDEM BIOMAR, V6, P625; THOMPSON RS, 1988, HMO PRACT, V2, P178; WEINSTEIN AL, 1993, INT J EPIDEMIOL, V22, P781, DOI 10.1093/ije/22.5.781; WINGO PA, 1987, JAMA-J AM MED ASSOC, V257, P209, DOI 10.1001/jama.257.2.209; YANG CP, 1992, CANCER CAUSE CONTROL, V3, P475, DOI 10.1007/BF00051360	47	247	255	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2002	287	6					734	741		10.1001/jama.287.6.734	http://dx.doi.org/10.1001/jama.287.6.734			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520XR	11851540	Bronze			2022-12-24	WOS:000173809500030
J	Stromberg, B; Dahlquist, G; Ericson, A; Finnstrom, O; Koster, M; Stjernqvist, K				Stromberg, B; Dahlquist, G; Ericson, A; Finnstrom, O; Koster, M; Stjernqvist, K			Neurological sequelae in children born after in-vitro fertilisation: a population-based study	LANCET			English	Article							INVITRO FERTILIZATION; CONGENITAL-MALFORMATIONS; CRYOPRESERVED EMBRYOS; PREGNANCIES; GROWTH; SWEDEN; HEALTH	Background There is an absence of population-based long-term studies on the risk of neurological sequelae in children born after in-vitro fertilisation (IVF). Our aim was to compare the frequency of such problems between IVF-born children and controls. Methods We did a population-based retrospective cohort study in which we compared development of neurological problems in 5680 children born after IVF, with 11 360 matched controls. For 2060 twins born after IVF, a second set of controls (n=4120), all twins, were selected. We obtained data on neurological problems from the records of the Swedish habilitation centres. Findings Children born after IVF are more likely to need habilitation services than controls (odds ratio 1.7, 95% Cl 1.3-2.2). For singletons, the risk was 1.4 (1.0-2.1). The most common neurological diagnosis was cerebral palsy, for which children born after IVF had an increased risk of 3.7 (2.0-6.6), and IVF singletons of 2.8 (1.3-5.8). Suspected developmental delay was increased four-fold (1.9-8.3) in children born after IVF. Twins born after IVF did not differ from control twins with respect to risk of neurological sequelae. Low-birthweight and premature infants were more likely to need habilitation than fullterm babies. Maternal age did not affect risk. Interpretation Our study suggests that children born after IVF have an increased risk of developing neurological problems, especially cerebral palsy. These risks are largely due to the high frequency of twin pregnancies, low birthweight, and prematurity among babies born after IVF. To limit these risks, we recommend that only one embryo should be transferred during IVF.	Univ Childrens Hosp, Dept Women & Child Hlth, S-75185 Uppsala, Sweden; Umea Univ, Dept Clin Sci, Umea, Sweden; Natl Board Hlth & Welf, Ctr Epidemiol, Stockholm, Sweden; Linkoping Univ Hosp, Dept Paediat, S-58185 Linkoping, Sweden; Lund Univ, Dept Psychol, Lund, Sweden	Umea University; National Board of Health & Welfare; Linkoping University; Lund University	Stromberg, B (corresponding author), Univ Childrens Hosp, Dept Women & Child Hlth, S-75185 Uppsala, Sweden.	bo.stromberg@kbh.uu.se						BERAL V, 1990, BMJ-BRIT MED J, V300, P1229; Bergh T, 1999, LANCET, V354, P1579, DOI 10.1016/S0140-6736(99)04345-7; Bonduelle M, 1996, HUM REPROD, V11, P131, DOI 10.1093/humrep/11.suppl_4.131; BRANDES JM, 1992, PEDIATRICS, V90, P424; Cornel M C, 1990, Ned Tijdschr Geneeskd, V134, P1357; DAHLQUIST G, 2000, CHILDREN BORN IN VIT; DEMOUZON J, 1997, J ASSIST REPROD GE S, V14, P251; Dhont M, 1997, J ASSIST REPROD GEN, V14, P575, DOI 10.1023/A:1022576500894; Ericson A, 2001, HUM REPROD, V16, P504, DOI 10.1093/humrep/16.3.504; GISSLER M, 1995, HUM REPROD, V10, P1856, DOI 10.1093/oxfordjournals.humrep.a136191; Hagberg B, 1996, ACTA PAEDIATR, V85, P48, DOI 10.1111/j.1651-2227.1996.tb14277.x; HAGBERG B, 1993, ACTA PAEDIATR, V82, P387, DOI 10.1111/j.1651-2227.1993.tb12704.x; Hagberg B, 2001, ACTA PAEDIATR, V90, P271, DOI 10.1080/080352501300067532; LANCASTER PAL, 1987, LANCET, V2, P1392; LOGEROTLEBRUN H, 1995, FERTIL STERIL, V64, P746; RIZK B, 1991, HUM REPROD, V6, P1259, DOI 10.1093/oxfordjournals.humrep.a137523; Saunders K, 1996, PEDIATRICS, V97, P688; TALLO CP, 1995, J PEDIATR-US, V127, P794, DOI 10.1016/S0022-3476(95)70175-3; von During V, 1995, Tidsskr Nor Laegeforen, V115, P2054; WANG JX, 1994, HUM REPROD, V9, P141, DOI 10.1093/oxfordjournals.humrep.a138304; Wennerholm UB, 1998, LANCET, V351, P1085, DOI 10.1016/S0140-6736(97)08247-0; Wennerholm UB, 1997, HUM REPROD, V12, P1819, DOI 10.1093/humrep/12.8.1819; 2000, STAT HLTH DIS	23	357	379	1	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2002	359	9305					461	465		10.1016/S0140-6736(02)07674-2	http://dx.doi.org/10.1016/S0140-6736(02)07674-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520ML	11853790				2022-12-24	WOS:000173785600007
J	von Bubnoff, N; Schneller, F; Peschel, C; Duyster, J				von Bubnoff, N; Schneller, F; Peschel, C; Duyster, J			BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study	LANCET			English	Article							CHRONIC MYELOID-LEUKEMIA; KINASE INHIBITOR STI571; TYROSINE KINASE; CELL-LINES; AMPLIFICATION; MECHANISMS; INDUCTION	Background BCR-ABL, a constitutively activated tyrosine kinase, is the oncogene that causes Philadelphia-chromosome-positive (Ph+) leukaemia. STI571, a competitive inhibitor at the ATP-binding site of BCR-ABL, has been shown to have high activity in this type of leukaemia. However, most patients with advanced disease relapse despite continued treatment with STI571. We aimed to find out whether point mutations in BCR-ABL cause resistance to STI571. Methods We analysed clinical samples from eight patients resistant to STI571-who had advanced-stage Ph+ leukaemia-for mutations within the ATP-binding site and activation loop of BCR-ABL. Analysis was done before treatment with STI571 and at time of relapse. Findings We identified five distinct point mutations in the BCR-ABL kinase domain in seven patients. All point mutations arose at positions that have proved to be important for drug binding and have conferred resistance to STI571 in vitro. All patients with mutations had lymphoid leukaemia. Interpretation Different mutations within the kinase domain of BCR-ABL can be responsible for refractoriness of Ph+ leukaemia to STI571. Mutation in the BCR-ABL kinase domain might be a frequent mechanism of STI571 resistance in lymphoid disease.	Tech Univ Munich, Dept Internal Med 3, Lab Leukemogenesis, D-81675 Munich, Germany	Technical University of Munich; University of Munich	Duyster, J (corresponding author), Tech Univ Munich, Dept Internal Med 3, Lab Leukemogenesis, Ismaningerstr 22, D-81675 Munich, Germany.	justus.duyster@lrz.tum.de	von Bubnoff, Nikolas/AAG-1845-2021; von Bubnoff, Nikolas/F-2351-2017	von Bubnoff, Nikolas/0000-0001-9593-8947				Bai RY, 2000, BLOOD, V96, P4319, DOI 10.1182/blood.V96.13.4319; Barthe C, 2001, SCIENCE, V293; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Faderl S, 1999, NEW ENGL J MED, V341, P164, DOI 10.1056/NEJM199907153410306; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hochhaus A, 2001, SCIENCE, V293, P2163; le Coutre P, 2000, BLOOD, V95, P1758, DOI 10.1182/blood.V95.5.1758.005a41_1758_1766; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; NAGAR B, 2000, IN PRESS CRYSTAL STR; NOWELL PC, 1960, SCIENCE, V132, P1497; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Weisberg E, 2000, BLOOD, V95, P3498, DOI 10.1182/blood.V95.11.3498.011k27_3498_3505	16	398	417	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2002	359	9305					487	491		10.1016/S0140-6736(02)07679-1	http://dx.doi.org/10.1016/S0140-6736(02)07679-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520ML	11853795				2022-12-24	WOS:000173785600012
J	Breinig, F; Tipper, DJ; Schmitt, MJ				Breinig, F; Tipper, DJ; Schmitt, MJ			Kre1p, the plasma membrane receptor for the yeast K1 viral toxin	CELL			English	Article							SACCHAROMYCES-CEREVISIAE STRAIN-28; CELL-WALL RECEPTOR; KILLER-TOXIN; PREPROTOXIN; PROTEINS; MUTANTS; VIRUSES; DSRNA; GLYCOPROTEIN; EXPRESSION	Saccharomyces cerevisiae K1 killer strains are infected by the M1 double-stranded RNA virus encoding a secreted protein toxin that kills sensitive cells by disrupting cytoplasmic membrane function. Toxin binding to spheroplasts is mediated by Kre1p, a cell wall protein initially attached to the plasma membrane by its C-terminal GPI anchor. Kre1p binds toxin directly. Both cells and spheroplasts of Deltakre1 mutants are completely toxin resistant; binding to cell walls and spheroplasts is reduced to 10% and <0.5%, respectively. Expression of K28-Kre1p, an inactive C-terminal fragment of Kre1p retaining its toxin affinity and membrane anchor, fully restored toxin binding and sensitivity to spheroplasts, while intact cells remained resistant. Kre1p is apparently the toxin membrane receptor required for subsequent lethal ion channel formation.	Univ Saarland, D-66041 Saarbrucken, Germany; Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA	Saarland University; University of Massachusetts System; University of Massachusetts Worcester	Schmitt, MJ (corresponding author), Univ Saarland, D-66041 Saarbrucken, Germany.		/AHE-2458-2022	Breinig, Frank/0000-0003-1557-4691				Ahmed A, 1999, CELL, V99, P283, DOI 10.1016/S0092-8674(00)81659-1; ALAIDROOS K, 1978, CAN J MICROBIOL, V24, P228, DOI 10.1139/m78-041; BOONE C, 1990, J CELL BIOL, V110, P1833, DOI 10.1083/jcb.110.5.1833; BOSTIAN KA, 1984, CELL, V36, P741, DOI 10.1016/0092-8674(84)90354-4; BROWN JL, 1993, GENETICS, V133, P837; DELAPENA P, 1981, J BIOL CHEM, V256, P420; Eisfeld K, 2000, MOL MICROBIOL, V37, P926, DOI 10.1046/j.1365-2958.2000.02063.x; Gordon VM, 1999, J BIOL CHEM, V274, P27274, DOI 10.1074/jbc.274.38.27274; Hamada K, 1999, J BACTERIOL, V181, P3886, DOI 10.1128/JB.181.13.3886-3889.1999; Hamada K, 1998, MOL GEN GENET, V258, P53, DOI 10.1007/s004380050706; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HUTCHINS K, 1983, J BACTERIOL, V154, P161, DOI 10.1128/JB.154.1.161-169.1983; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; MARTINAC B, 1990, P NATL ACAD SCI USA, V87, P6228, DOI 10.1073/pnas.87.16.6228; Mortimer R K, 1975, Methods Cell Biol, V11, P221, DOI 10.1016/S0091-679X(08)60325-8; Nelson KL, 1997, J BIOL CHEM, V272, P12170, DOI 10.1074/jbc.272.18.12170; PFEIFFER P, 1982, J GEN MICROBIOL, V128, P2699; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; ROEMER T, 1995, MOL GEN GENET, V249, P209, DOI 10.1007/BF00290368; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHMITT M, 1987, J GEN MICROBIOL, V133, P3347; SCHMITT M, 1988, J BACTERIOL, V170, P2192, DOI 10.1128/jb.170.5.2192-2196.1988; Schmitt MJ, 1995, ARCH MICROBIOL, V164, P435; SCHMITT MJ, 1990, MOL CELL BIOL, V10, P4807, DOI 10.1128/MCB.10.9.4807; SCHMITT MJ, 1990, ANTIMICROB AGENTS CH, V34, P1615, DOI 10.1128/AAC.34.8.1615; SCHMITT MJ, 1995, VIROLOGY, V213, P341, DOI 10.1006/viro.1995.0007; SCHMITT MJ, 1999, RRD VIROLOGY III, V1, P525; Sesti F, 2001, CELL, V105, P637, DOI 10.1016/S0092-8674(01)00376-2; Shahinian S, 2000, MOL MICROBIOL, V35, P477, DOI 10.1046/j.1365-2958.2000.01713.x; STURLEY SL, 1986, EMBO J, V5, P3381, DOI 10.1002/j.1460-2075.1986.tb04654.x; TIPPER DJ, 1991, MOL MICROBIOL, V5, P2331, DOI 10.1111/j.1365-2958.1991.tb02078.x; Wickner RB, 1996, MICROBIOL REV, V60, P250, DOI 10.1128/MMBR.60.1.250-265.1996; WICKNER RB, 1976, GENETICS, V82, P429; Wickner RB, 1995, MYCOTA, VII, P211; YOUNG TW, 1978, A VAN LEEUW J MICROB, V44, P59, DOI 10.1007/BF00400077; ZHU YS, 1993, YEAST, V9, P251, DOI 10.1002/yea.320090305	38	86	91	1	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 8	2002	108	3					395	405		10.1016/S0092-8674(02)00634-7	http://dx.doi.org/10.1016/S0092-8674(02)00634-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	520VB	11853673	Bronze			2022-12-24	WOS:000173801600011
J	Tijsterman, M; Ketting, RF; Okihara, KL; Sijen, T; Plasterk, RHA				Tijsterman, M; Ketting, RF; Okihara, KL; Sijen, T; Plasterk, RHA			RNA helicase MUT-14-dependent gene silencing triggered in C-elegans by short antisense RNAs	SCIENCE			English	Article							GERM-LINE DEVELOPMENT; MESSENGER-RNA; UNWINDING RNA; INTERFERENCE; REQUIREMENTS; POLYMERASE; TRANSGENE	Posttranscriptional gene silencing in Caenorhabditis elegans results from exposure to double-stranded RNA (dsRNA), a phenomenon designated as RNA interference (RNAi), or from co-suppression, in which transgenic DNA leads to silencing of both the transgene and the endogenous gene. Here we show that single-stranded RNA oligomers of antisense polarity can also be potent inducers of gene silencing. As is the case for co-suppression, antisense RNAs act independently of the RNAi genes rde-1 and rde-4 but require the mutator/RNAi gene mut-7 and a putative DEAD box RNA helicase, mut-14. Our data favor the hypothesis that gene silencing is accomplished by RNA primer extension using the mRNA as template, leading to dsRNA that is subsequently degraded.	Netherlands Inst Dev Biol, Hubrecht Lab, Ctr Biomed Genet, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Plasterk, RHA (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Ctr Biomed Genet, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	plasterk@niob.knaw.nl	Tijsterman, Marcel/H-5663-2018	Tijsterman, Marcel/0000-0001-8465-9002; Ketting, Rene/0000-0001-6161-5621				Baulcombe DC, 2000, SCIENCE, V290, P1108, DOI 10.1126/science.290.5494.1108; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; Domeier ME, 2000, SCIENCE, V289, P1928, DOI 10.1126/science.289.5486.1928; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; ELBASHIR SM, IN PRESS EMBO J; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Ketting RF, 2000, NATURE, V404, P296, DOI 10.1038/35005113; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	26	119	213	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2002	295	5555					694	697		10.1126/science.1067534	http://dx.doi.org/10.1126/science.1067534			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809977				2022-12-24	WOS:000173560900050
J	Tan, HL; Kupershmidt, S; Zhang, R; Stepanovic, S; Roden, DM; Wilde, AAM; Anderson, ME; Balser, JR				Tan, HL; Kupershmidt, S; Zhang, R; Stepanovic, S; Roden, DM; Wilde, AAM; Anderson, ME; Balser, JR			A calcium sensor in the sodium channel modulates cardiac excitability	NATURE			English	Article							ACTIVATED POTASSIUM CHANNELS; ST-SEGMENT ELEVATION; BRUGADA-SYNDROME; SLOW INACTIVATION; PROTEIN-KINASE; NA+ CHANNEL; CALMODULIN; ARRHYTHMIAS; DEATH; MECHANISM	Sodium channels are principal molecular determinants responsible for myocardial conduction and maintenance of the cardiac rhythm. Calcium ions (Ca2+) have a fundamental role in the coupling of cardiac myocyte excitation and contraction, yet mechanisms whereby intracellular Ca2+ may directly modulate Na channel function have yet to be identified. Here we show that calmodulin (CaM), a ubiquitous Ca2+-sensing protein, binds to the carboxy-terminal 'IQ' domain(1) of the human cardiac Na channel (hH1) in a Ca2+-dependent manner. This binding interaction significantly enhances slow inactivation-a channel-gating process linked to life-threatening idiopathic ventricular arrhythmias(2,3). Mutations targeted to the IQ domain disrupted CaM binding and eliminated Ca2+/CaM-dependent slow inactivation, whereas the gating effects of Ca2+/CaM were restored by intracellular application of a peptide modelled after the IQ domain. A naturally occurring mutation (A1924T) in the IQ domain altered hH1 function in a manner characteristic of the Brugada arrhythmia syndrome(4,5), but at the same time inhibited slow inactivation induced by Ca2+/CaM, yielding a clinically benign (arrhythmia free) phenotype.	Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; Univ Amsterdam, Acad Med Ctr, Expt & Mol Cardiol Grp, NL-1105 AZ Amsterdam, Netherlands	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Amsterdam; Academic Medical Center Amsterdam	Balser, JR (corresponding author), Vanderbilt Univ, Sch Med, Dept Anesthesiol, 221 Kirkland Hall, Nashville, TN 37232 USA.		Kupershmidt, Sabina/AAO-5464-2021; Roden, Dan/ABD-5412-2021	Kupershmidt, Sabina/0000-0002-8119-2723; 				Aimond F, 1999, CARDIOVASC RES, V42, P402, DOI 10.1016/S0008-6363(99)00070-X; BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; Balser JR, 1999, CIRC RES, V85, P872, DOI 10.1161/01.RES.85.9.872; BERS DM, 1994, METHOD CELL BIOL, V40, P3; BRAUN AP, 1995, J PHYSIOL-LONDON, V488, P37, DOI 10.1113/jphysiol.1995.sp020944; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; CLUSIN WT, 1983, LANCET, V1, P272, DOI 10.1016/S0140-6736(83)91688-4; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; DIDIEGO JM, 1994, CIRCULATION, V89, P1839, DOI 10.1161/01.CIR.89.4.1839; Dumaine R, 1999, CIRC RES, V85, P803, DOI 10.1161/01.RES.85.9.803; HANLEY RM, 1987, SCIENCE, V237, P293, DOI 10.1126/science.3037704; James P, 1996, GENETICS, V144, P1425; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; MAUNE JF, 1992, J BIOL CHEM, V267, P5286; Mori M, 2000, BIOCHEMISTRY-US, V39, P1316, DOI 10.1021/bi9912600; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Richmond JE, 1998, BIOPHYS J, V74, P2945, DOI 10.1016/S0006-3495(98)78001-4; Rook MB, 1999, CARDIOVASC RES, V44, P507, DOI 10.1016/S0008-6363(99)00350-8; RUDY B, 1978, J PHYSL, V238, P1; Tan HL, 2001, NATURE, V409, P1043, DOI 10.1038/35059090; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; Todt H, 1999, BIOPHYS J, V76, P1335, DOI 10.1016/S0006-3495(99)77296-6; Veldkamp MW, 2000, CIRC RES, V86, pE91, DOI 10.1161/01.RES.86.9.e91; Wang DW, 2000, CIRC RES, V87, pE37, DOI 10.1161/01.RES.87.8.e37; Wilde A, 1999, CIRCULATION, V99, P722; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Zuhlke RD, 1998, P NATL ACAD SCI USA, V95, P3287, DOI 10.1073/pnas.95.6.3287	30	175	186	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					442	447		10.1038/415442a	http://dx.doi.org/10.1038/415442a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807557				2022-12-24	WOS:000173433600053
J	Hobson, DE; Lang, AE; Martin, WRW; Razmy, A; Rivest, J; Fleming, J				Hobson, DE; Lang, AE; Martin, WRW; Razmy, A; Rivest, J; Fleming, J			Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease - A survey by the Canadian Movement Disorders Group	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FALLING ASLEEP; EPISODES; ATTACKS; DRIVERS; PRAMIPEXOLE; ROPINIROLE; ACCIDENTS	Context Somnolence is a recognized adverse effect of dopamine agonists. Two new dopamine agonists, pramipexole and ropinirole, have been reported to cause sudden-onset sleep spells in patients with Parkinson disease (PD) while they were driving. The frequency of these spells and whether driving should be restricted has yet to be established. Objective To determine the frequency of and predictors for sudden-onset sleep and, particularly, episodes of falling asleep while driving among patients with PD. Design, Setting, and Participants Prospective survey conducted between January and April 2000 in 18 clinics directed by members of the Canadian Movement Disorders Group; 638 consecutive highly functional PD patients without dementia were enrolled, of whom 420 were currently drivers. Main Outcome Measures Excessive daytime sleepiness and sudden-onset sleep as assessed by the Epworth Sleepiness Scale and the Inappropriate Sleep Composite Score. The latter score, designed for this study, addressed falling asleep in unusual circumstances. The 2 scales were combined in 3 separate formats dozing off, sudden unexpected sleep, and sudden blank spells. Results Excessive daytime sleepiness was present overall in 327 (51 %) of the 638 patients and in 213 (51%) of the 420 drivers. Patients taking a variety of different dopamine agonists had no differences in Epworth sleepiness scores, in the composite score, or in the risk of failing asleep while driving. Sixteen patients (3.8%) had experienced at least 1 episode of sudden onset of sleep while driving (after the diagnosis of PD); in 3 (0.7%), it occurred without warning. The 2 risk factors associated with failing asleep at the wheel were the Epworth Sleepiness Scale score (odds ratio [OR], 1.14; 95% confidence interval [CI], 1.06-1.24) and the Inappropriate Sleep Composite Score (OR, 2.54; 95% CI, 1.76-3.66). A standard Epworth Sleepiness Scale score of 7 or higher predicted 75% of episodes of sleep behind the wheel at a specificity of 50% (exclusion of the question related to driving provided 70% sensitivity and 52% specificity), whereas a score of 1 on the Inappropriate Sleep Composite Score generated a sensitivity of 52% and specificity of 82%. Conclusions Excessive daytime sleepiness is common even in patients with PD who are independent and do not have dementia. Sudden-onset sleep without warning is infrequent. The Epworth score has adequate sensitivity for predicting prior episodes of failing asleep while driving and its specificity can be increased by use of the Inappropriate Sleep Composite Score. It is unknown if routinely performing these assessments could be more effective in predicting future risk for these rare sleep attacks. Patients should be warned not to drive if they doze in unusual circumstances.	Univ Manitoba, Dept Med, Div Neurol, Winnipeg, MB, Canada; Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; Univ Alberta, Dept Med, Div Neurol, Edmonton, AB, Canada; Univ Sherbrooke, Dept Med, Sherbrooke, PQ J1K 2R1, Canada; Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada	University of Manitoba; University of Toronto; University of Toronto; University of Alberta; University of Sherbrooke; University of British Columbia	Hobson, DE (corresponding author), Winnipeg Clin, 425 St Mary Ave, Winnipeg, MB R3C ON2, Canada.	dhobson@cc.umanitoba.ca	Lang, Anthony/ABF-8114-2021	Martin, WR Wayne/0000-0002-3416-691X; Lang, Anthony/0000-0003-1229-3667				Arnulf I, 2000, NEUROLOGY, V55, P281, DOI 10.1212/WNL.55.2.281; DRACHMAN DA, 1988, ANN NEUROL, V24, P787, DOI 10.1002/ana.410240614; EBERSBACH G, 2000, MOV DISORD S3, V15, P89; FACTOR SA, 1990, MOVEMENT DISORD, V5, P280, DOI 10.1002/mds.870050404; Ferreira JJ, 2000, LANCET, V355, P1333, DOI 10.1016/S0140-6736(00)02119-X; Ferreira JJ, 2000, MOV DISORD S3, V15, P128; Ferreira JJ, 2000, MOV DISORD S3, V15, P187; FERREIRA JJ, 2000, MOVEMENT DISORD, V15, P129; Frucht S, 2000, NEUROLOGY, V54, P276; Frucht S, 1999, NEUROLOGY, V52, P1908, DOI 10.1212/WNL.52.9.1908; Gottwald MD, 1997, ANN PHARMACOTHER, V31, P1205, DOI 10.1177/106002809703101014; Hauser RA, 2000, MOVEMENT DISORD, V15, P658, DOI 10.1002/1531-8257(200007)15:4<658::AID-MDS1009>3.0.CO;2-N; Hobson DE, 1999, CAN J NEUROL SCI, V26, pS27, DOI 10.1017/S0317167100000068; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HOMANN CN, 2000, MOVEMENT DISORD, V15, P108; HORNE JA, 1995, BRIT MED J, V310, P565, DOI 10.1136/bmj.310.6979.565; Horne JA, 1995, J SLEEP RES, V4, P23, DOI 10.1111/j.1365-2869.1995.tb00222.x; ITOI A, 1993, CAND RIVERS AVOID FA; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; Karlsen K, 1999, MOVEMENT DISORD, V14, P237, DOI 10.1002/1531-8257(199903)14:2<237::AID-MDS1006>3.3.CO;2-O; Lyznicki JM, 1998, JAMA-J AM MED ASSOC, V279, P1908, DOI 10.1001/jama.279.23.1908; Maycock G, 1997, ACCIDENT ANAL PREV, V29, P453, DOI 10.1016/S0001-4575(97)00024-9; Montastruc JL, 2000, MOVEMENT DISORD, V15, P361, DOI 10.1002/1531-8257(200003)15:2<361::AID-MDS1034>3.0.CO;2-J; Natl Ctr Sleep Disorders Res Working Grp, 1999, AM FAM PHYSICIAN, V59, P937; NAUSIEDA PA, 1987, HDB PARKINSONS DISEA, P371; Olanow CW, 2000, MOVEMENT DISORD, V15, P212, DOI 10.1002/1531-8257(200003)15:2<212::AID-MDS1002>3.0.CO;2-6; PALADINI D, 2000, MOV DISORD S3, V15, P130; Parkinson Study Group, 2000, JAMA, V284, P1931; Partinen R, 1997, J NEUROL, V244, pS3, DOI 10.1007/BF03160564; Rascol O, 2000, NEW ENGL J MED, V342, P1484, DOI 10.1056/NEJM200005183422004; Reyner LA, 1998, INT J LEGAL MED, V111, P120, DOI 10.1007/s004140050131; Ryan M, 2000, PHARMACOTHERAPY, V20, P724, DOI 10.1592/phco.20.7.724.35181; Sagberg F, 1999, ACCIDENT ANAL PREV, V31, P639, DOI 10.1016/S0001-4575(99)00023-8; Schapira AHV, 2000, LANCET, V355, P1332, DOI 10.1016/S0140-6736(00)02118-8; Schwab R.S., 1969, 3 S PARK DIS, P152; STIASNY K, 2000, MOV DISORD S3, V15, P114; Stocchi F, 1998, J NEUROL, V245, pS15, DOI 10.1007/PL00007731; Tracik F, 2001, MOVEMENT DISORD, V16, P500, DOI 10.1002/mds.1083	38	411	433	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2002	287	4					455	463		10.1001/jama.287.4.455	http://dx.doi.org/10.1001/jama.287.4.455			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	513VX	11798367	Bronze			2022-12-24	WOS:000173401900022
J	Kemper, F; Jager, C; Waters, LBFM; Henning, T; Molster, FJ; Barlow, MJ; Lim, T; de Koter, A				Kemper, F; Jager, C; Waters, LBFM; Henning, T; Molster, FJ; Barlow, MJ; Lim, T; de Koter, A			Detection of carbonates in dust shells around evolved stars	NATURE			English	Article							INTERSTELLAR SILICATE MINERALOGY; PLANETARY-NEBULA; ISO SPECTRUM; NGC-6302; ICE; BODIES; STEPS; DISKS	Carbonates on large Solar System bodies like Earth and Mars 1,2 (the latter represented by the meteorite ALH84001) form through the weathering of silicates in a watery (CO3)(2-) solution. The presence of carbonates in interplanetary dust particles and asteroids (again, represented by meteorites) is not completely understood, but has been attributed to aqueous alteration on a large parent body, which was subsequently shattered into smaller pieces. Despite efforts(3-5), the presence of carbonates outside the Solar System has hitherto not been established(6,7). Here we report the discovery of the carbonates calcite and dolomite in the dust shells of evolved stars, where the conditions are too primitive for the formation of large parent bodies with liquid water. These carbonates, therefore, are not formed by aqueous alteration, but perhaps through processes on the surfaces of dust or ice grains or gas phase condensation. The presence of carbonates which did not form by aqueous alteration suggests that some of the carbonates found in Solar System bodies no longer provide direct evidence that liquid water was present on large parent bodies early in the history of the Solar System(8).	Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 SJ Amsterdam, Netherlands; Univ Jena, Inst Astrophys & Univ Observ, D-07745 Jena, Germany; Katholieke Univ Leuven, Inst Sterrenkunde, B-3001 Heverlee, Belgium; Georgia Tech, Sch Mat Sci & Engn, Atlanta, GA 30332 USA; ESA, ESTEC, Solar Syst Div, NL-2201 AZ Noordwijk, Netherlands; UCL, Dept Phys & Astron, London WC1E 6BT, England; Rutherford Appleton Lab, Dept Space Sci, Didcot OX11 0QX, Oxon, England	University of Amsterdam; Friedrich Schiller University of Jena; KU Leuven; University System of Georgia; Georgia Institute of Technology; European Space Agency; University of London; University College London; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Kemper, F (corresponding author), Univ Amsterdam, Astron Inst Anton Pannekoek, Kruislaan 403, NL-1098 SJ Amsterdam, Netherlands.	ciska@science.uva.nl	Henning, Thomas K/O-4372-2018; Barlow, Michael J/A-5638-2009; Kemper, Francisca/AAZ-8274-2020	Henning, Thomas K/0000-0002-1493-300X; Barlow, Michael J/0000-0002-3875-1171; Kemper, Francisca/0000-0003-2743-8240				BERTIE JE, 1969, J CHEM PHYS, V50, P4501, DOI 10.1063/1.1670922; COHEN M, 1986, ASTROPHYS J, V302, P737, DOI 10.1086/164035; CORRADI RLM, 1993, ASTRON ASTROPHYS, V269, P462; Endress M, 1996, NATURE, V379, P701, DOI 10.1038/379701a0; GILLETT FC, 1973, ASTROPHYS J, V183, P87, DOI 10.1086/152211; Gonzalez-Alfonso E, 1999, ASTROPHYS J, V525, P845, DOI 10.1086/307909; Henning T, 1996, ASTRON ASTROPHYS, V311, P291; JAGER C, 1994, ASTRON ASTROPHYS, V292, P641; Jager C, 1998, ASTRON ASTROPHYS, V339, P904; Keane JV, 2001, ASTRON ASTROPHYS, V376, P254, DOI 10.1051/0004-6361:20010936; Kessler M.F., 1996, ASTRON ASTROPHYS, V315, P27; Koike C, 2000, ASTRON ASTROPHYS, V363, P1115; KOIKE C, 1999, P 32 ISAS LUN PLAN S, V32, P175, DOI DOI 10.1051/0004-6361:20053256; LANCET MS, 1970, SCIENCE, V170, P980, DOI 10.1126/science.170.3961.980; LESTER DF, 1984, ASTROPHYS J, V281, pL67, DOI 10.1086/184287; METZLER K, 1992, GEOCHIM COSMOCHIM AC, V56, P2873, DOI 10.1016/0016-7037(92)90365-P; MITTLEFEHLDT DW, 1994, METEORITICS, V29, P214, DOI 10.1111/j.1945-5100.1994.tb00673.x; Molster FJ, 1999, NATURE, V401, P563, DOI 10.1038/44085; Molster FJ, 2001, ASTRON ASTROPHYS, V372, P165, DOI 10.1051/0004-6361:20010465; PAYNE HE, 1988, ASTROPHYS J, V326, P368, DOI 10.1086/166098; PENMAN JM, 1976, MON NOT R ASTRON SOC, V176, P539, DOI 10.1093/mnras/176.3.539; POPE KO, 1996, LUNAR PLANET SCI, V27, P1045; Pottasch SR, 1999, ASTRON ASTROPHYS, V347, P975; RIETMEIJER FJM, 1985, NATURE, V313, P293, DOI 10.1038/313293a0; SANDFORD SA, 1985, ASTROPHYS J, V291, P838, DOI 10.1086/163120; Scott ERD, 1998, METEORIT PLANET SCI, V33, P709, DOI 10.1111/j.1945-5100.1998.tb01677.x; WARREN SG, 1984, APPL OPTICS, V23, P1206, DOI 10.1364/AO.23.001206; Waters LBFM, 1996, ASTRON ASTROPHYS, V315, pL361	28	85	86	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2002	415	6869					295	297		10.1038/415295a	http://dx.doi.org/10.1038/415295a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797000				2022-12-24	WOS:000173293500035
J	Green, RC; Cupples, LA; Go, R; Benke, KS; Edeki, T; Griffith, PA; Williams, M; Hipps, Y; Graff-Radford, N; Bachman, D; Farrer, LA				Green, RC; Cupples, LA; Go, R; Benke, KS; Edeki, T; Griffith, PA; Williams, M; Hipps, Y; Graff-Radford, N; Bachman, D; Farrer, LA		MIRAGE Study Grp	Risk of dementia among white and African American relatives of patients with Alzheimer disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							APOLIPOPROTEIN-E GENOTYPE; FAMILIAL AGGREGATION; HEAD-INJURY; AGE; METAANALYSIS; ASSOCIATION; POPULATION; DIAGNOSIS; MIRAGE; STATEMENT	Context Evidence exists that the incidence of Alzheimer disease (AD), as well as risk attributable to specific genetic factors such as apolipoprotein E (APOE) genotype, may vary considerably among ethnic groups. Family studies of probands with AD offer an opportunity to evaluate lifetime risk of dementia among relatives of these probands. Objective To compare lifetime dementia risk estimates among relatives of white and African American probands with probable or definite AD. Design and Setting Risk analysis using data collected by questionnaire and supplemental records between May 1991 and March 2001 at 17 medical centers contributing to the Multi-Institutional Research in Alzheimer's Genetic Epidemiology Study. Participants A total of 17639 first-degree biological relatives and 2474 spouses of 2339 white AD probands, and 2281 first-degree biological relatives and 257 spouses of 255 African American AD probands. Main Outcome Measures Cumulative risk of dementia by age 85 years, stratified by ethnicity and sex of relatives and by APOE genotype of probands. Results Cumulative risk of dementia in first-degree biological relatives of African American AD probands by age 85 years was 43.7% (SE, 3.1%), and the corresponding risk in first-degree biological relatives of white AD probands was 26.9% (SE, 0.8%), yielding a relative risk (RR) of 1.6 (95% confidence interval [CI], 1.4-1.9; P<.001). The risk in spouses of African American AD probands of 18.5% (SE, 8.4%) was also higher than the risk in white spouses of 10.4% (SE, 1.7%) but did not reach statistical significance (RR, 1.8; 95% CI, 0.5-6.0; P=.34), likely due to the smaller sample size of African Americans. The proportional increase in risk of dementia among white first-degree biological relatives compared with white spouses of 2.6 (95% CI, 2.1-3.2) was similar to that of 2.4 (95% CI, 1.3-4.4) in African American first-degree biological relatives compared with African American spouses. Female first-degree biological relatives of probands had a higher risk of developing dementia than did their male counterparts, among whites (31.2% vs 20.4%; RR, 1.5; 95% CI, 1.3-1.7; P<.001) as well as among African Americans, although this was not significant among African Americans (46.7% vs 40.1%; RR, 1.2; 95% CI, 0.9-1.7, P=.30). The patterns of risk among first-degree biological relatives stratified by APOE genotype of the probands were similar in white families and African American families. Conclusion First-degree relatives of African Americans with AD have a higher cumulative risk of dementia than do those of whites with AD. However, in this study, the additional risk of dementia conferred by being a first-degree relative, by being female, or by the probability of having an APOE epsilon4 allele appeared similar in African American and white families. These data provide estimates of dementia risk that can be used to offer counseling to family members of patients with AD.	Boston Univ, Sch Med, Genet Program, Boston, MA 02118 USA; Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Boston, MA USA; Univ Alabama, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; Morehouse Sch Med, Dept Med, Atlanta, GA 30310 USA; Morehouse Sch Med, Dept Pharmacol, Atlanta, GA 30310 USA; Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; Med Univ S Carolina, Dept Psychiat, Charleston, SC 29425 USA	Boston University; Boston University; Boston University; Boston University; Boston University; University of Alabama System; University of Alabama Birmingham; Morehouse School of Medicine; Morehouse School of Medicine; Mayo Clinic; Medical University of South Carolina	Green, RC (corresponding author), Boston Univ, Sch Med, Genet Program, 715 Albany St,L-320, Boston, MA 02118 USA.		Farrer, Lindsay/AAS-1035-2020	Farrer, Lindsay/0000-0001-5533-4225; Cupples, L. Adrienne/0000-0003-0273-7965	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009029, P30AG013846] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG/AG02213] Funding Source: Medline; NIA NIH HHS [AG13846, AG09029] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BALLARD EL, 1993, GERONTOLOGIST, V33, P561, DOI 10.1093/geront/33.4.561; BELGRAVE LL, 1993, GERONTOLOGIST, V33, P379, DOI 10.1093/geront/33.3.379; Brodaty H, 1995, ALZ DIS ASSOC DIS, V9, P182; Connell CM, 1997, GERONTOLOGIST, V37, P355, DOI 10.1093/geront/37.3.355; CUPPLES LA, 1991, AM J HUM GENET, V49, P76; Demissie S, 2001, NEUROEPIDEMIOLOGY, V20, P105, DOI 10.1159/000054768; Devi G, 2000, ARCH NEUROL-CHICAGO, V57, P72, DOI 10.1001/archneur.57.1.72; Devi G, 1999, NEUROLOGY, V53, P789, DOI 10.1212/WNL.53.4.789; Devi G, 1998, GENET EPIDEMIOL, V15, P215, DOI 10.1002/(SICI)1098-2272(1998)15:3<215::AID-GEPI1>3.0.CO;2-3; FARRER LA, 1995, JAMA-J AM MED ASSOC, V274, P1627, DOI 10.1001/jama.1995.03530200063039; FARRER LA, 1995, ANN NEUROL, V38, P797, DOI 10.1002/ana.410380515; FARRER LA, 1994, NEUROLOGY, V44, P652, DOI 10.1212/WNL.44.4.652; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Farrer LA, 1997, NEUROLOGIST, V3, P13, DOI 10.1097/00127893-199701000-00003; Gao S, 1998, ARCH GEN PSYCHIAT, V55, P809, DOI 10.1001/archpsyc.55.9.809; GRAFFRADFORD N, IN PRESS ARCH NEUROL; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Gurland BJ, 1999, INT J GERIATR PSYCH, V14, P481, DOI 10.1002/(SICI)1099-1166(199906)14:6<481::AID-GPS959>3.0.CO;2-5; Hendrie HC, 2001, JAMA-J AM MED ASSOC, V285, P739, DOI 10.1001/jama.285.6.739; Jorm AF, 1998, NEUROLOGY, V51, P728, DOI 10.1212/WNL.51.3.728; Lautenschlager NT, 1996, NEUROLOGY, V46, P641, DOI 10.1212/WNL.46.3.641; Lopez Oscar L, 2010, Neuroepidemiology, V34, P63, DOI 10.1159/000264678; LOVESTONE S, 1995, INT J GERIATR PSYCH, V10, P1; MAESTRE G, 1995, ANN NEUROL, V37, P254, DOI 10.1002/ana.410370217; McConnell LM, 1998, NAT MED, V4, P757, DOI 10.1038/nm0798-757; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; OSUNTOKUN BO, 1995, ANN NEUROL, V38, P463, DOI 10.1002/ana.410380319; Post SG, 1997, JAMA-J AM MED ASSOC, V277, P832, DOI 10.1001/jama.277.10.832; RELKIN NR, 1996, NEUROL ALERT, V14, P58; Sahota A, 1997, ANN NEUROL, V42, P659, DOI 10.1002/ana.410420418; Sayi JG, 1997, E AFR MED J, V74, P668; SILVERMAN JM, 1986, AM J PSYCHIAT, V143, P1279; SILVERMAN JM, 1994, ARCH GEN PSYCHIAT, V51, P577; Tang MX, 1996, ANN NY ACAD SCI, V802, P6, DOI 10.1111/j.1749-6632.1996.tb32593.x; Tang MX, 1998, JAMA-J AM MED ASSOC, V279, P751, DOI 10.1001/jama.279.10.751; Tang MX, 2001, NEUROLOGY, V56, P49, DOI 10.1212/WNL.56.1.49; *US BUR CENS, 1991, CENS POP HOUS 1990 S; VANDUIJN CM, 1993, J MED GENET, V30, P640, DOI 10.1136/jmg.30.8.640; WELSH KA, 1993, NEUROPSY NEUROPSY BE, V6, P103; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K	40	250	254	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2002	287	3					329	336		10.1001/jama.287.3.329	http://dx.doi.org/10.1001/jama.287.3.329			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	511YQ	11790212	Bronze			2022-12-24	WOS:000173294700027
J	Preiser, PR; Khan, S; Costa, FTM; Jarra, W; Belnoue, E; Ogun, S; Holder, AA; Voza, T; Landau, I; Snounou, G; Renia, L				Preiser, PR; Khan, S; Costa, FTM; Jarra, W; Belnoue, E; Ogun, S; Holder, AA; Voza, T; Landau, I; Snounou, G; Renia, L			Stage-specific transcription of distinct repertoires of a multigene family during plasmodium life cycle	SCIENCE			English	Article							YOELII RHOPTRY PROTEIN; MALARIA PARASITE; RODENT MALARIA; FALCIPARUM; VIVAX; GENE; IDENTIFICATION; MEROZOITES; SELECTION; INVASION	Members of a multigene family in the rodent malaria parasite Plasmodium yoelii yoelli code for 235-kilodalton proteins (Py235) that are located in the merozoite apical complex, are implicated in virulence, and may determine red blood cell specificity. We show that distinct subsets of py235 genes are expressed in sporozoites and hepatic and erythrocytic stages, Antibodies to Py235 inhibited sporozoite invasion of hepatocytes, The switch in expression profile occurred immediately after transition from one stage to another, The results suggest that this differential expression is driven by strong biological requirements and provide evidence that hepatic and erythrocytic merozoites differ.	Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; Univ Paris 05, Hop Cochin, Inst Cochin Genet Mol, Dept Immunol,INSERM,U445, F-75014 Paris, France; Natl Museum Nat Hist, Lab Biol Parasitaire, F-75231 Paris, France; Inst Pasteur, Unite Parasitol Biomed, F-75724 Paris 15, France	MRC National Institute for Medical Research; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Museum National d'Histoire Naturelle (MNHN); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Preiser, PR (corresponding author), Natl Inst Med Res, Div Parasitol, Ridgeway, London NW7 1AA, England.		Holder, Anthony A/A-7554-2013; Snounou, Georges/F-3352-2011; Costa, Fabio/E-1181-2012; Preiser, Peter R/A-2201-2011; Renia, Laurent/E-2117-2011	Holder, Anthony A/0000-0002-8490-6058; Snounou, Georges/0000-0002-6133-6398; Costa, Fabio/0000-0001-9969-7300; Renia, Laurent/0000-0003-0349-1557; Khan, Shahid/0000-0002-0533-4670; , Peter/0000-0003-4331-7000	Medical Research Council [MC_U117532067] Funding Source: Medline; MRC [MC_U117532067] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barry JD, 2001, ADV PARASIT, V49, P1, DOI 10.1016/S0065-308X(01)49037-3; Borst P, 2001, MOL BIOCHEM PARASIT, V114, P17, DOI 10.1016/S0166-6851(01)00243-2; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; FREEMAN RR, 1980, NATURE, V284, P366, DOI 10.1038/284366a0; GALINSKI MR, 1992, CELL, V69, P1213, DOI 10.1016/0092-8674(92)90642-P; Galinski MR, 2000, MOL BIOCHEM PARASIT, V108, P257, DOI 10.1016/S0166-6851(00)00219-X; Galinski MR, 1996, PARASITOL TODAY, V12, P20, DOI 10.1016/0169-4758(96)80641-7; Hayward RE, 1999, P NATL ACAD SCI USA, V96, P4563, DOI 10.1073/pnas.96.8.4563; HOLDER AA, 1984, PHILOS T ROY SOC B, V307, P171, DOI 10.1098/rstb.1984.0117; Holder AA, 1981, NATURE, V294, P361, DOI 10.1038/294361a0; KEEN J, 1990, MOL BIOCHEM PARASIT, V42, P241, DOI 10.1016/0166-6851(90)90167-K; KEEN JK, 1994, MOL BIOCHEM PARASIT, V65, P171, DOI 10.1016/0166-6851(94)90125-2; Khan SM, 2001, MOL BIOCHEM PARASIT, V114, P197, DOI 10.1016/S0166-6851(01)00253-5; Landau Irene, 1998, P401; Marussig M, 1997, INT IMMUNOL, V9, P1817, DOI 10.1093/intimm/9.12.1817; Narum DL, 2001, MOL BIOCHEM PARASIT, V112, P193, DOI 10.1016/S0166-6851(00)00363-7; Ogun SA, 1996, MOL BIOCHEM PARASIT, V76, P321, DOI 10.1016/0166-6851(95)02540-5; OGUN SA, 1994, EXP PARASITOL, V79, P270, DOI 10.1006/expr.1994.1090; Owen CA, 1999, MOL BIOCHEM PARASIT, V99, P183, DOI 10.1016/S0166-6851(99)00015-8; Preiser PR, 1998, EXP PARASITOL, V89, P50, DOI 10.1006/expr.1998.4259; Preiser PR, 1999, NATURE, V398, P618, DOI 10.1038/19309; Preiser PR, 1996, EMBO J, V15, P684, DOI 10.1002/j.1460-2075.1996.tb00401.x; PREISER PR, UNPUB; Rayner JC, 2000, P NATL ACAD SCI USA, V97, P9648, DOI 10.1073/pnas.160469097; RENIA L, 1990, EUR J IMMUNOL, V20, P1445, DOI 10.1002/eji.1830200706; RENIA L, UNPUB; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Sinha KA, 1996, MOL BIOCHEM PARASIT, V76, P329, DOI 10.1016/0166-6851(95)02546-4; Snounou G, 2000, PARASITOL TODAY, V16, P28, DOI 10.1016/S0169-4758(99)01546-X; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Taylor HM, 2001, INFECT IMMUN, V69, P3635, DOI 10.1128/IAI.69.6.3635-3645.2001; Thompson J, 1999, MOL MICROBIOL, V31, P253, DOI 10.1046/j.1365-2958.1999.01167.x; Triglia T, 2001, INFECT IMMUN, V69, P1084, DOI 10.1128/IAI.69.2.1084-1092.2001	33	59	61	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					342	345		10.1126/science.1064938	http://dx.doi.org/10.1126/science.1064938			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786645				2022-12-24	WOS:000173278600054
J	Fehr, E; Gachter, S				Fehr, E; Gachter, S			Altruistic punishment in humans	NATURE			English	Article							INDIRECT RECIPROCITY; EVOLUTION; COOPERATION; HANDICAP	Human cooperation is an evolutionary puzzle. Unlike other creatures, people frequently cooperate with genetically unrelated strangers, often in large groups, with people they will never meet again, and when reputation gains are small or absent. These patterns of cooperation cannot be explained by the nepotistic motives associated with the evolutionary theory of kin selection and the selfish motives associated with signalling theory or the theory of reciprocal altruism. Here we show experimentally that the altruistic punishment of defectors is a key motive for the explanation of cooperation. Altruistic punishment means that individuals punish, although the punishment is costly for them and yields no material gain. We show that cooperation flourishes if altruistic punishment is possible, and breaks down if it is ruled out. The evidence indicates that negative emotions towards defectors are the proximate mechanism behind altruistic punishment. These results suggest that future study of the evolution of human cooperation should include a strong focus on explaining altruistic punishment.	Univ Zurich, Inst Empir Res Econ, CH-8006 Zurich, Switzerland; Univ St Gallen, FEW HSG, CH-9000 St Gallen, Switzerland	University of Zurich; University of St Gallen	Fehr, E (corresponding author), Univ Zurich, Inst Empir Res Econ, Blumlisalpstr 10, CH-8006 Zurich, Switzerland.		Gachter, Simon/C-9787-2009; Osuna, Luis E/A-5858-2010	Gachter, Simon/0000-0002-7182-8505; 				Alexander R., 2008, ESSAYS PEDAGOGY; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; AXELROD R, 1986, AM POLIT SCI REV, V80, P1095, DOI 10.2307/1960858; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; BOYD R, IN PRESS EVOLUTION C; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; FISCHBACHER U, 1999, 21 U ZUR I EMP RES E; Frank Robert H., 1988, PASSIONS REASON STRA; Gintis H, 2001, J THEOR BIOL, V213, P103, DOI 10.1006/jtbi.2001.2406; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Heckathorn DD., 1989, RATION SOC, V1, P78, DOI [10.1177/1043463189001001006, DOI 10.1177/1043463189001001006]; Henrich J, 2001, J THEOR BIOL, V208, P79, DOI 10.1006/jtbi.2000.2202; HIRSHLEIFER J, 1987, LATEST BEST ESSAYS E; Leimar O, 2001, P ROY SOC B-BIOL SCI, V268, P745, DOI 10.1098/rspb.2000.1573; Lotem A, 1999, NATURE, V400, P226, DOI 10.1038/22247; NOWAK MA, 1995, SCI AM, V272, P76, DOI 10.1038/scientificamerican0695-76; Nowak MA, 1998, J THEOR BIOL, V194, P561, DOI 10.1006/jtbi.1998.0775; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Richerson P.J., 1998, INDOCTRINABILITY IDE, P71; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Smuts B. B., 1987, PRIMATE SOC; Sober Elliott, 1998, OTHERS EVOLUTION PSY; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; ZAHAVI A, 1977, J THEOR BIOL, V67, P603, DOI 10.1016/0022-5193(77)90061-3; ZAHAVI A, 1995, J AVIAN BIOL, V26, P1, DOI 10.2307/3677205	28	3332	3410	30	1152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					137	140		10.1038/415137a	http://dx.doi.org/10.1038/415137a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509PR	11805825				2022-12-24	WOS:000173159300032
J	Wang, XB; Zuckerman, B; Pearson, C; Kaufman, G; Chen, CZ; Wang, GY; Niu, TH; Wise, PH; Bauchner, H; Xu, XP				Wang, XB; Zuckerman, B; Pearson, C; Kaufman, G; Chen, CZ; Wang, GY; Niu, TH; Wise, PH; Bauchner, H; Xu, XP			Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							S-TRANSFERASE-THETA; LUNG-CANCER; HOMOZYGOUS DELETION; GESTATIONAL-AGE; PRETERM BIRTH; SUSCEPTIBILITY; CYP1A1; OUTCOMES; SMOKERS; RISK	Context Little is known about genetic susceptibility to cigarette smoke in relation to adverse pregnancy outcomes. Objective To investigate whether the association between maternal cigarette smoking and infant birth weight differs by polymorphisms of 2 maternal metabolic genes: CYP1A1 and GSTT1. Design, Setting, and Participants Case-control study conducted in 1998-2000 among 741 mothers (174 ever smokers and 567 never smokers) who delivered singleton live births at Boston Medical Center. A total of 207 cases were preterm or low-birth-weight infants and 534 were non-low-birth-weight, full-term infants (control). Main Outcome Measure Birth weight, gestation, fetal growth by smoking status and CYP1A1 Mspl (AA vs Aa and aa, where Aa and as were combined because of small numbers of as and similar results), and GSTT1 (present vs absent) genotypes. Results Without consideration of genotype, continuous maternal smoking during pregnancy was associated with a mean reduction of 377 g (SE, 89 g) in birth weight (odds ratio [OR], 2.1; 95% confidence interval [CI], 1.2-3.7). When CYP1A1 genotype was considered, the estimated reduction in birth weight was 252 g (SE, 111 g) for the AA genotype group (n = 75; OR, 1.3; 95% CI, 0.6-2.6); but was 520 g (SE, 124 g) for the Aa/aa genotype group (n=43 for Aa, n=6 for aa; OR, 3.2; 95% CI, 1.6-6.4). When GSTT1 genotype was considered, the estimated reduction in birth weight was 285 g (SE, 99 g) (OR, 1.7; 95% CI, 0.9-3.2) and 642 g (SE, 154 g) (OR, 3.5; 95% Cl, 1.5-8.3) for the present and absent genotype groups, respectively. When both CYP1A1 and GSTT1 genotypes were considered, the,greatest reduction in birth weight was found among smoking mothers with the CYP1A1 Aa/aa and GSTT1 absent genotypes (-1285 g; SE, 234 g; P<.001). Among never smokers,, genotype did not independently confer an adverse effect. A similar pattern emerged in analyses stratified by maternal ethnicity and in analyses for gestation. Conclusions In our study, maternal CYP1A1 and GSTT1 genotypes modified the association between maternal cigarette smoking and infant birth weight, suggesting an interaction between metabolic genes and cigarette smoking.	Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Obstet & Gynecol, Boston, MA 02118 USA; Boston Med Ctr, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Program Populat Genet, Boston, MA 02115 USA; Beijing Med Univ, Ctr Ecogenet & Reprod Hlth, Beijing 100083, Peoples R China	Boston University; Boston University; Boston Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Peking University	Wang, XB (corresponding author), Boston Univ, Sch Med, Dept Pediat, 91 E Concord St,Matern 4, Boston, MA 02118 USA.		Wang, Guoying/F-8908-2011	Bauchner, Howard/0000-0002-8368-9805; Zuckerman, Barry/0000-0002-0044-2592				ALEXANDROV K, 1992, CANCER RES, V52, P6248; Bartsch H, 2000, CANCER EPIDEM BIOMAR, V9, P3; BARTSCH H, 1995, PHARMACOGENETICS, V5, pS84, DOI 10.1097/00008571-199512001-00007; BERKOWITZ GS, 1993, EPIDEMIOL REV, V15, P414, DOI 10.1093/oxfordjournals.epirev.a036128; BRUNNEMANN KD, 1991, CRIT REV TOXICOL, V21, P235, DOI 10.3109/10408449109017910; Cnattingius S, 1999, NEW ENGL J MED, V341, P943, DOI 10.1056/NEJM199909233411303; Collins FS, 2001, JAMA-J AM MED ASSOC, V285, P540, DOI 10.1001/jama.285.5.540; DOLANMULLEN P, 1994, AM J OBSTET GYNECOL, V171, P1328, DOI 10.1016/0002-9378(94)90156-2; EVERSON RB, 1988, J NATL CANCER I, V80, P567, DOI 10.1093/jnci/80.8.567; Fennell TR, 2000, CANCER EPIDEM BIOMAR, V9, P705; Guyer B, 1999, PEDIATRICS, V104, P1229, DOI 10.1542/peds.104.6.1229; HAYASHI S, 1992, JPN J CANCER RES, V83, P866, DOI 10.1111/j.1349-7006.1992.tb01992.x; Hellerstedt WL, 1997, AM J PUBLIC HEALTH, V87, P591, DOI 10.2105/AJPH.87.4.591; Ishibe N, 1997, CANCER EPIDEM BIOMAR, V6, P1075; KATOH T, 1995, CARCINOGENESIS, V16, P655, DOI 10.1093/carcin/16.3.655; KAWAJIRI K, 1990, FEBS LETT, V263, P131, DOI 10.1016/0014-5793(90)80721-T; Klebanoff MA, 2001, PAEDIATR PERINAT EP, V15, P140, DOI 10.1046/j.1365-3016.2001.00321.x; Kramer MS, 1999, PEDIATRICS, V103, P599, DOI 10.1542/peds.103.3.599; Kramer MS, 1998, EUR J CLIN NUTR, V52, pS29; Kramer MS, 1998, JAMA-J AM MED ASSOC, V280, P1849, DOI 10.1001/jama.280.21.1849; KRAMER MS, 1987, PEDIATRICS, V80, P502; LANDI MT, 1994, PHARMACOGENETICS, V4, P242, DOI 10.1097/00008571-199410000-00002; Meis PJ, 1997, PAEDIATR PERINAT EP, V11, P287, DOI 10.1111/j.1365-3016.1997.tb00006.x; NAKACHI K, 1993, CANCER RES, V53, P2994; National Research Council, 1983, POL AR HYDR EV SOURC, P197; NELSON HH, 1995, CARCINOGENESIS, V16, P1243, DOI 10.1093/carcin/16.5.1243; Peacock JL, 1998, INT J EPIDEMIOL, V27, P647, DOI 10.1093/ije/27.4.647; PEMBLE S, 1994, BIOCHEM J, V300, P271, DOI 10.1042/bj3000271; Perera FP, 1999, ENVIRON HEALTH PERSP, V107, P451, DOI 10.1289/ehp.99107s3451; Pollack H, 2000, AM J PUBLIC HEALTH, V90, P395, DOI 10.2105/AJPH.90.3.395; Prada JA, 1998, EUR J CLIN NUTR, V52, pS21; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; SCHRODER KR, 1995, ARCH TOXICOL, V69, P505, DOI 10.1007/s002040050205; TIMBRELL JA, 1991, PRINCIPLES BIOCH TOX; Umbach DM, 2000, AM J EPIDEMIOL, V152, P701, DOI 10.1093/aje/152.8.701; *US DEP HHS, 1990, HLTH BEN SMOK CESS R, P367; Wang XB, 2000, AM J EPIDEMIOL, V152, P693, DOI 10.1093/aje/152.8.693; Wang XB, 1997, INT J EPIDEMIOL, V26, P978, DOI 10.1093/ije/26.5.978; Wang XB, 1995, NEW ENGL J MED, V333, P1744, DOI 10.1056/NEJM199512283332606; WIENCKE JK, 1995, CANCER EPIDEM BIOMAR, V4, P253; Xu XP, 1998, AM J IND MED, V33, P157, DOI 10.1002/(SICI)1097-0274(199802)33:2<157::AID-AJIM7>3.0.CO;2-V; Xu XP, 1996, CANCER EPIDEM BIOMAR, V5, P687	42	436	455	1	16	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2002	287	2					195	202		10.1001/jama.287.2.195	http://dx.doi.org/10.1001/jama.287.2.195			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508XK	11779261	Bronze			2022-12-24	WOS:000173114900021
J	Boustany, AM; Davis, SF; Pyle, P; Anderson, SD; Le Boeuf, BJ; Block, BA				Boustany, AM; Davis, SF; Pyle, P; Anderson, SD; Le Boeuf, BJ; Block, BA			Satellite tagging - Expanded niche for white sharks	NATURE			English	Article							TRACKING; TAGS		Stanford Univ, Tuna Res & Conservat Ctr, Pacific Grove, CA 93950 USA; Monterey Bay Aquarium, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; Point Reyes Bird Observ, Stinson Beach, CA 94970 USA	Stanford University; Monterey Bay Aquarium Research Institute; University of California System; University of California Santa Cruz	Boustany, AM (corresponding author), Stanford Univ, Tuna Res & Conservat Ctr, Pacific Grove, CA 93950 USA.							Block BA, 1998, P NATL ACAD SCI USA, V95, P9384, DOI 10.1073/pnas.95.16.9384; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; CAREY FG, 1969, COMP BIOCHEM PHYSIOL, V28, P199, DOI 10.1016/0010-406X(69)91335-8; Compagno LJV., 1984, FAO FISH SYNOP, P20; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; Goldman KJ, 1996, GREAT WHITE SHARKS, P111, DOI 10.1016/B978-012415031-7/50012-4; Hill Roger D., 1994, P227; Klimley A.P., 1985, Memoirs of the Southern California Academy of Sciences, V9, P15; Klimley AP, 2001, MAR BIOL, V138, P617, DOI 10.1007/s002270000489; Metcalfe JD, 1997, NATURE, V387, P665, DOI 10.1038/42622; Taylor L., 1985, Memoirs of the Southern California Academy of Sciences, V9, P41; Welch DW, 1999, CAN J FISH AQUAT SCI, V56, P1317, DOI 10.1139/cjfas-56-7-1317	12	180	185	3	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					35	36		10.1038/415035b	http://dx.doi.org/10.1038/415035b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780105				2022-12-24	WOS:000173028800028
J	Taatjes, DJ; Naar, AM; Andel, F; Nogales, E; Tjian, R				Taatjes, DJ; Naar, AM; Andel, F; Nogales, E; Tjian, R			Structure, function, and activator-induced conformations of the CRSP coactivator	SCIENCE			English	Article							RNA-POLYMERASE-II; TRANSCRIPTIONAL ACTIVATION; NUCLEAR RECEPTORS; COFACTOR COMPLEX; CHROMATIN; MEDIATOR; PROTEIN; DOMAIN; SMCC; SP1	The human cofactor complexes ARC (activator-recruited cofactor) and CRSP (cofactor required for Sp1 activation) mediate activator-dependent transcription in vitro. Although these complexes share several common subunits, their structural and functional relationships remain unknown. Here, we report that affinity-purified ARC consists of two distinct multisubunit complexes: a larger complex, denoted ARC-L, and a smaller coactivator, CRSP. Reconstituted in vitro transcription with biochemically separated ARC-L and CRSP reveals differential cofactor functions. The ARC-L complex is transcriptionally inactive, whereas the CRSP complex is highly active. Structural determination by electron microscopy (EM) and three-dimensional reconstruction indicate substantial differences in size and shape between ARC-L and CRSP. Moreover, EM analysis of independently derived CRSP complexes reveals distinct conformations induced by different activators. These results suggest that CRSP may potentiate transcription via specific activator-induced conformational changes.	Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Tjian, R (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, 401 Barker Hall, Berkeley, CA 94720 USA.		Taatjes, Dylan J/G-2027-2011					Akoulitchev S, 2000, NATURE, V407, P102, DOI 10.1038/35024111; Booth V, 2000, J BIOL CHEM, V275, P31266, DOI 10.1074/jbc.M002595200; Boyer TG, 1999, NATURE, V399, P276, DOI 10.1038/20466; Dotson MR, 2000, P NATL ACAD SCI USA, V97, P14307, DOI 10.1073/pnas.260489497; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; KAMAKAKA RT, 1993, GENE DEV, V7, P1779, DOI 10.1101/gad.7.9.1779; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Malik S, 2000, MOL CELL, V5, P753, DOI 10.1016/S1097-2765(00)80254-3; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Naar AM, 1998, GENE DEV, V12, P3020, DOI 10.1101/gad.12.19.3020; NAAR AM, UNPUB; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Rachez C, 2001, CURR OPIN CELL BIOL, V13, P274, DOI 10.1016/S0955-0674(00)00209-X; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Sun XQ, 1998, MOL CELL, V2, P213, DOI 10.1016/S1097-2765(00)80131-8	19	209	217	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1058	1062		10.1126/science.1065249	http://dx.doi.org/10.1126/science.1065249			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834832				2022-12-24	WOS:000173793000062
J	MacArthur, C; Winter, HR; Bick, DE; Knowles, H; Lilford, R; Henderson, C; Lancashire, RJ; Braunholtz, DA; Gee, H				MacArthur, C; Winter, HR; Bick, DE; Knowles, H; Lilford, R; Henderson, C; Lancashire, RJ; Braunholtz, DA; Gee, H			Effects of redesigned community postnatal care on womens' health 4 months after birth: a cluster randomised controlled trial	LANCET			English	Article							MATERNAL HEALTH; DEPRESSION; CHILDBIRTH; PREVENTION; SUPPORT	Background Much postpartum physical and psychological morbidity is not addressed by present care, which tends to focus on routine examinations. We undertook a cluster randomised controlled trial to assess community postnatal care that has been redesigned to identify and manage individual needs. Methods We randomly allocated 36 general practice clusters from the West Midlands health region of the UK to intervention (n=17) or control (19) care. Midwives from the practices recruited women and provided care. 1087 (53%) of 2064 women were in practices randomly assigned to the intervention group, with 977 (47%) women in practices assigned to the control group. Care was led by midwives, with no routine contact with general practitioners, and was extended to 3 months. Midwives used symptom checklists and the Edinburgh postnatal depression scale (EPDS) to identify health needs and guidelines for the management of these needs. Primary outcomes at 4 months were obtained by postal questionnaire and included the women's short form 36 physical (PCS) and mental (MCS) component summary scores and the EPDS. Secondary outcomes were women's views about care. Multilevel analysis accounted for possible cluster effects. Findings 801 (77%) of 1087 women in the intervention group and 702 (76%) of 977 controls responded at 4 months. Women's mental health measures were significantly better in the intervention group (MCS, 3.03 [95% CI 1.53-4.52]; EPDS -1.92 [-2.55 to -1.29]; EPDS 13+ odds ratio 0.57 [0.43-0.76]) than in controls, but the physical health score did not differ. Interpretation Redesign of care so that it is midwife-led, flexible, and tailored to needs, could help to improve women's mental health and reduce probable depression at 4 months' postpartum.	Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham, W Midlands, England; Radcliffe Infirm, RCN Inst, Oxford OX2 6HE, England; Bournemouth Univ, Inst Hlth, Poole BH12 5BB, Dorset, England; Univ Birmingham, Sch Hlth Sci Nursing, Birmingham, W Midlands, England; Birmingham Womens Hosp NHS Trust, Birmingham, W Midlands, England	University of Birmingham; Radcliffe Infirmary; Bournemouth University; University of Birmingham; Birmingham Women's Hospital	MacArthur, C (corresponding author), Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham, W Midlands, England.		MacArthur, Christine/ABA-8601-2021; Bick, Debra/P-9575-2018	MacArthur, Christine/0000-0003-0434-2158; Bick, Debra/0000-0002-8557-7276				Altman D.G., 1991, PRACTICAL STATISTIC; [Anonymous], 1995, BR J MIDWIFE; Audit Commission, 1997, 1 CLASS DEL IMPR MAT; BICK DE, 2001, POSTNATAL CARE EVIDE; Brown S, 2000, BRIT J OBSTET GYNAEC, V107, P1194, DOI 10.1111/j.1471-0528.2000.tb11607.x; Brown S, 1998, BRIT J OBSTET GYNAEC, V105, P156, DOI 10.1111/j.1471-0528.1998.tb10045.x; Brugha TS, 2000, PSYCHOL MED, V30, P1273, DOI 10.1017/S0033291799002937; CLEMENT S, 1999, COMMUNITY BASED MAT, pCH18; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; *DEP HLTH, COMM MAT SERV SUMM I; Elliott SA, 2000, BRIT J CLIN PSYCHOL, V39, P223, DOI 10.1348/014466500163248; Expert Maternity Group Department of Health, 1993, CHANG CHILDB; GARCIA J, 1994, MIDWIFERY, V10, P40, DOI 10.1016/0266-6138(94)90007-8; GLAZENER CMA, 1995, BRIT J OBSTET GYNAEC, V102, P282, DOI 10.1111/j.1471-0528.1995.tb09132.x; Gunn J, 1998, BRIT J OBSTET GYNAEC, V105, P991, DOI 10.1111/j.1471-0528.1998.tb10263.x; *HOUS COMM SEL COM, 1992, WINT REP; MACARTHUR C, 1991, HLTH CHILDBIRTH; Marchant S, 1995, BRIT J MIDWIFERY, V3, P34; Marsh J, 1991, Midwifery, V7, P177, DOI 10.1016/S0266-6138(05)80196-2; Morrell CJ, 2000, BRIT MED J, V321, P593, DOI 10.1136/bmj.321.7261.593; OAKLEY A, 2000, EXPT KNOWING, P182; Oakley A., 1992, SOCIAL SUPPORT MOTHE; OAKLEY A, 1994, EUR J PUBLIC HEALTH, V4, P265; OKOUMUNNE OC, 1999, HEALTH TECHNOL ASSES, V3, P1; PREMARANTNE UN, THORAX, V52, pA18; Rasbash J., 2000, USERS GUIDE MLWIN MU; RAY KL, 2000, COCHRANE LIB, V4; REID M, 1999, 2 CTR PRAGMATIC RAND; *ROYAL COLL MIDW, 2000, LIF BIRTH REFL POSTN; Saurel-Cubizolles MJ, 2000, BRIT J OBSTET GYNAEC, V107, P1202, DOI 10.1111/j.1471-0528.2000.tb11608.x; SHARIF K, 1993, J OBSTET GYNAECOL, V13, P251; Shields N, 1997, J REPROD INFANT PSYC, V15, P91, DOI DOI 10.1080/02646839708404537; STAMP EE, 1995, BIRTH-ISS PERINAT C, V22, P138; Townsend PP., 1988, HLTH DEPRIVATION INE; Trevelyan J, 1994, Nurs Times, V90, P38; Turnbull D, 1996, LANCET, V348, P213; WARE JE, 1994, PHYSICAL MENTAL HLTH	37	164	165	2	17	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 2	2002	359	9304					378	385		10.1016/S0140-6736(02)07596-7	http://dx.doi.org/10.1016/S0140-6736(02)07596-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	518UP	11844507				2022-12-24	WOS:000173686500007
J	Walraven, G				Walraven, G			Rural Africa	LANCET			English	Editorial Material									MRC Labs, Farafenni Field Stn, Farafenni, Gambia	MRC Laboratory Molecular Biology	Walraven, G (corresponding author), MRC Labs, Farafenni Field Stn, Farafenni, Gambia.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 2	2002	359	9304					401	401		10.1016/S0140-6736(02)07601-8	http://dx.doi.org/10.1016/S0140-6736(02)07601-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UP	11844512				2022-12-24	WOS:000173686500012
J	Quayle, WC; Peck, LS; Peat, H; Ellis-Evans, JC; Harrigan, PR				Quayle, WC; Peck, LS; Peat, H; Ellis-Evans, JC; Harrigan, PR			Extreme responses to climate change in Antarctic lakes	SCIENCE			English	Article							AIR-TEMPERATURE; ICE		British Antarctic Survey, NERC, Cambridge CB3 0ET, England; BC Ctr Excellence, Vancouver, BC V6Z 1Y6, Canada	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; B.C. Centre for Excellence in HIV/AIDS	Peck, LS (corresponding author), British Antarctic Survey, NERC, High Cross,Madingley Rd, Cambridge CB3 0ET, England.		QUAYLE, WENDY/Q-3719-2016; Peat, Helen J/E-9666-2015; QUAYLE, Wendy/D-4634-2011	QUAYLE, WENDY/0000-0003-0622-1915; Peat, Helen/0000-0003-2017-8597				CHAPMAN WL, 1993, B AM METEOROL SOC, V74, P33, DOI 10.1175/1520-0477(1993)074<0033:RVOSIA>2.0.CO;2; HAWES I, 1985, HYDROBIOLOGIA, V123, P69, DOI 10.1007/BF00006616; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; Magnuson JJ, 2000, SCIENCE, V289, P1743, DOI 10.1126/science.289.5485.1743; Roberts EC, 1999, FRESHWATER BIOL, V41, P737, DOI 10.1046/j.1365-2427.1999.00401.x; Smith R.I.L., 1990, ANTARCTIC ECOSYSTEMS, P30; Vincent W.F., 1988, MICROBIAL ECOSYSTEMS	7	223	233	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					645	645		10.1126/science.1064074	http://dx.doi.org/10.1126/science.1064074			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809962				2022-12-24	WOS:000173560900034
J	Pichler, A; Gast, A; Seeler, JS; Dejean, A; Melchior, F				Pichler, A; Gast, A; Seeler, JS; Dejean, A; Melchior, F			The nucleoporin RanBP2 has SUMO1 E3 ligase activity	CELL			English	Article							GTPASE-ACTIVATING PROTEIN; NUCLEAR-PORE COMPLEX; UBIQUITIN; RANGAP1; YEAST; TRANSPORT; SUBSTRATE; HOMOLOG; IMPORT; NUP358	Posttranslational modification with SUMO1 regulates protein/protein interactions, localization, and stability. SUMOylation requires the E1 enzyme Aos1/Uba2 and the E2 enzyme Ubc9. A family of E3-like factors, PIAS proteins, was discovered recently. Here we show that the nucleoporin RanBP2/Nup358 also has SUMO1 E3-like activity. RanBP2 directly interacts with the E2 enzyme Ubc9 and strongly enhances SUMO1-transfer from Ubc9 to the SUMO1 target Sp100. The E3-like activity is contained within a 33 kDa domain of RanBP2 that lacks RING finger motifs and does not resemble PIAS family proteins. Our findings place SUMOylation at the cytoplasmic filaments of the NPC and suggest that, at least for some substrates, modification and nuclear import are linked events.	Max Planck Inst Biochem, D-82152 Martinsried, Germany; Inst Pasteur, INSERM, U163, Unite Recombinaison & Express Genet, F-75724 Paris 15, France	Max Planck Society; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Melchior, F (corresponding author), Max Planck Inst Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.		Dejean, Anne/L-5145-2018; Melchior, Frauke/E-2014-2014	Melchior, Frauke/0000-0001-9546-8797; Seeler, Jacob-Sebastian/0000-0001-8209-8555				Azuma Y, 2001, FASEB J, V15, P1825, DOI 10.1096/fj.00-0818fje; Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; FINLAY DR, 1987, J CELL BIOL, V104, P189, DOI 10.1083/jcb.104.2.189; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hay RT, 2001, TRENDS BIOCHEM SCI, V26, P332, DOI 10.1016/S0968-0004(01)01849-7; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Lee GW, 1998, J BIOL CHEM, V273, P6503, DOI 10.1074/jbc.273.11.6503; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mahajan R, 1998, J CELL BIOL, V140, P259, DOI 10.1083/jcb.140.2.259; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Melchior F, 1998, METH MOL B, V88, P265; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Nuber U, 1998, EUR J BIOCHEM, V254, P643, DOI 10.1046/j.1432-1327.1998.2540643.x; Okuma T, 1999, BIOCHEM BIOPH RES CO, V254, P693, DOI 10.1006/bbrc.1998.9995; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Saitoh H, 1998, CURR BIOL, V8, P121, DOI 10.1016/S0960-9822(98)70044-2; Saitoh H, 1997, P NATL ACAD SCI USA, V94, P3736, DOI 10.1073/pnas.94.8.3736; SAITOH H, 2001, IN PRESS J BIOL CHEM; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Seeler JS, 2001, MOL CELL BIOL, V21, P3314, DOI 10.1128/MCB.21.10.3314-3324.2001; STACHDEV S, 2001, GENE DEV, V15, P3088; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Stewart M, 2001, FEBS LETT, V498, P145, DOI 10.1016/S0014-5793(01)02489-9; Takahashi Y, 2001, GENE, V275, P223, DOI 10.1016/S0378-1119(01)00662-X; Tanaka K, 1999, MOL CELL BIOL, V19, P8660; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Yaseen NR, 1999, J BIOL CHEM, V274, P26493, DOI 10.1074/jbc.274.37.26493; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0	38	627	654	1	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 11	2002	108	1					109	120		10.1016/S0092-8674(01)00633-X	http://dx.doi.org/10.1016/S0092-8674(01)00633-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792325	Bronze			2022-12-24	WOS:000173280700012
J	Kirchner, JW				Kirchner, JW			Evolutionary speed limits inferred from the fossil record	NATURE			English	Article							TIME-SERIES ANALYSIS; SPECTRAL-ANALYSIS; EXTINCTION; RECOVERY; BIODIVERSITY; END	The dynamics of extinction and diversification determine the long-term effects of extinction episodes(1). If rapid bursts of extinction are offset by equally rapid bursts of diversification, their biodiversity consequences will be transient. But if diversification rates cannot accelerate rapidly enough, pulses of extinction will lead to long-lasting depletion of biodiversity(2,3). Here I use spectral analysis of the fossil record to test whether diversification rates can accelerate as much as extinction rates, over both short and long spans of geological time. I show that although the long-wavelength variability of diversification rates equals or exceeds that of extinctions, diversification rates are markedly less variable than extinction rates at wavelengths shorter than roughly 25 million years. This implies that there are intrinsic speed limits that constrain how rapidly diversification rates can accelerate in response to pulses of extinction.	Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Kirchner, JW (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.		Kirchner, James W/B-6126-2009; Kirchner, James/AAC-4707-2019	Kirchner, James W/0000-0001-6577-3619; Kirchner, James/0000-0001-6577-3619				Cartwright M, 1990, FOURIER METHODS MATH; EHRLICH PR, 1991, SCIENCE, V253, P758, DOI 10.1126/science.253.5021.758; Erwin DH, 2001, P NATL ACAD SCI USA, V98, P5399, DOI 10.1073/pnas.091092698; Erwin DH, 1998, TRENDS ECOL EVOL, V13, P344, DOI 10.1016/S0169-5347(98)01436-0; FOOTE M, 1994, PALEOBIOLOGY, V20, P424, DOI 10.1017/S0094837300012914; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Foote M, 2000, PALEOBIOLOGY, V26, P578, DOI 10.1666/0094-8373(2000)026<0578:OAECOT>2.0.CO;2; Foster G, 1996, ASTRON J, V111, P541, DOI 10.1086/117805; GILINSKY NL, 1991, ANAL PALEOBIOLOGY, P157; Jablonski D, 1998, SCIENCE, V279, P1327, DOI 10.1126/science.279.5355.1327; Jablonski D, 2001, P NATL ACAD SCI USA, V98, P5393, DOI 10.1073/pnas.101092598; Jablonski David, 1995, P25; Kirchner JW, 2000, NATURE, V404, P177, DOI 10.1038/35004564; Kirchner JW, 1998, NATURE, V395, P337, DOI 10.1038/26384; Miller AI, 1998, SCIENCE, V281, P1157, DOI 10.1126/science.281.5380.1157; Myers N, 2001, P NATL ACAD SCI USA, V98, P5389, DOI 10.1073/pnas.091092498; NEWELL ND, 1967, GEOL SOC AM SPEC PAP, V89, P63; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; RAUP DM, 1992, PALEOBIOLOGY, V18, P80, DOI 10.1017/S0094837300012227; SCARGLE JD, 1982, ASTROPHYS J, V263, P835, DOI 10.1086/160554; Schulz M, 1997, COMPUT GEOSCI, V23, P929, DOI 10.1016/S0098-3004(97)00087-3; Sepkoski J.J., 1996, GLOBAL EVENT STRATIG, P35, DOI [10.1007/978-3-642-79634-0_4, DOI 10.1007/978-3-642-79634-0_4]; SEPKOSKI JJ, 1993, PALEOBIOLOGY, V19, P43, DOI 10.1017/S0094837300012306; Smith AB, 2001, PHILOS T R SOC B, V356, P351, DOI 10.1098/rstb.2000.0768; STANLEY SM, 1990, PALEOBIOLOGY, V16, P401, DOI 10.1017/S0094837300010150; Wilson EO, 1999, DIVERSITY LIFE	26	27	27	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					65	68		10.1038/415065a	http://dx.doi.org/10.1038/415065a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780116				2022-12-24	WOS:000173028800039
J	Tyner, SD; Venkatachalam, S; Choi, J; Jones, S; Ghebranious, N; Igelmann, H; Lu, XB; Soron, G; Cooper, B; Brayton, C; Park, SH; Thompson, T; Karsenty, G; Bradley, A; Donehower, LA				Tyner, SD; Venkatachalam, S; Choi, J; Jones, S; Ghebranious, N; Igelmann, H; Lu, XB; Soron, G; Cooper, B; Brayton, C; Park, SH; Thompson, T; Karsenty, G; Bradley, A; Donehower, LA			p53 mutant mice that display early ageing-associated phenotypes	NATURE			English	Article							REPLICATIVE SENESCENCE; CELLULAR SENESCENCE; STRESS-RESPONSE; DEFICIENT MICE; DNA-BINDING; FIBROBLASTS; CANCER; TUMORS; BONE; SUPPRESSION	The p53 tumour suppressor is activated by numerous stressors to induce apoptosis, cell cycle arrest, or senescence. To study the biological effects of altered p53 function, we generated mice with a deletion mutation in the first six exons of the p53 gene that express a truncated RNA capable of encoding a carboxy-terminal p53 fragment. This mutation confers phenotypes consistent with activated p53 rather than inactivated p53. Mutant (p53(+/m)) mice exhibit enhanced resistance to spontaneous tumours compared with wild-type (p53(+/+)) littermates. As p53(+/)m mice age, they display an early onset of phenotypes associated with ageing. These include reduced longevity, osteoporosis, generalized organ atrophy and a diminished stress tolerance. A second line of transgenic mice containing a temperature-sensitive mutant allele of p53 also exhibits early ageing phenotypes. These data suggest that p53 has a role in regulating organismal ageing.	Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; Baylor Coll Med, Cell & Mol Biol Program, Houston, TX 77030 USA; Baylor Coll Med, Ctr Comparat Med, Houston, TX 77030 USA; Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA; Baylor Coll Med, Dept Human & Mol Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Univ Massachusetts, Med Ctr, Dept Cell Biol, Worcester, MA 01655 USA; Marshfield Med Res Fdn, Marshfield, WI 54449 USA; Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-20251 Hamburg, Germany; Sanger Ctr, Cambridge CB10 1SA, Cambs, England	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Massachusetts System; University of Massachusetts Worcester; Heinrich Pette Institute; University of Hamburg; Wellcome Trust Sanger Institute	Donehower, LA (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	larryd@bcm.tmc.edu		Bradley, Allan/0000-0002-2349-8839				ARKING R, 1998, BIOL AGING; ATADJA P, 1995, P NATL ACAD SCI USA, V92, P8348, DOI 10.1073/pnas.92.18.8348; Bond J, 1996, ONCOGENE, V13, P2097; BOND JA, 1994, ONCOGENE, V9, P1885; Campisi J, 1997, J AM GERIATR SOC, V45, P482, DOI 10.1111/j.1532-5415.1997.tb05175.x; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Chuttani Anjali, 1995, P309; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; GERSTEIN AD, 1993, DERMATOL CLIN, V11, P749, DOI 10.1016/S0733-8635(18)30227-4; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Gire V, 1998, MOL CELL BIOL, V18, P1611, DOI 10.1128/MCB.18.3.1611; HARRISON DE, 1988, EXP GERONTOL, V23, P309, DOI 10.1016/0531-5565(88)90034-4; HARRISON DE, 1992, CURR TOP MICROBIOL, V177, P13; Harvey RC, 1999, VET CLIN N AM-SMALL, V29, P683, DOI 10.1016/S0195-5616(99)50055-7; HASTY P, 1991, NATURE, V350, P243, DOI 10.1038/350243a0; Hogan B., 1994, MANIPULATING MOUSE E, P189; HUPP TR, 1995, CELL, V83, P237, DOI 10.1016/0092-8674(95)90165-5; Itahana K, 2001, EUR J BIOCHEM, V268, P2784, DOI 10.1046/j.1432-1327.2001.02228.x; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; JAYARAMAN L, 1995, CELL, V81, P1021, DOI 10.1016/S0092-8674(05)80007-8; Kalu Dike N., 1995, P395; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; LAVIGUEUR A, 1989, MOL CELL BIOL, V9, P3982, DOI 10.1128/MCB.9.9.3982; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lim DS, 2000, MOL CELL BIOL, V20, P3772, DOI 10.1128/MCB.20.11.3772-3780.2000; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Muller-Tiemann BF, 1998, P NATL ACAD SCI USA, V95, P6079, DOI 10.1073/pnas.95.11.6079; Muravchick Stanley, 1997, P1125; PURDIE CA, 1994, ONCOGENE, V9, P603; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; SAGER R, 1991, ENVIRON HEALTH PERSP, V93, P59, DOI 10.2307/3431170; Selivanova G, 1999, MOL CELL BIOL, V19, P3395; Selivanova G, 1997, NAT MED, V3, P632, DOI 10.1038/nm0697-632; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; SHOCK NW, 1983, J CHRON DIS, V36, P137, DOI 10.1016/0021-9681(83)90053-X; Takeda T, 1997, EXP GERONTOL, V32, P117, DOI 10.1016/S0531-5565(96)00068-X; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770; Webley K, 2000, MOL CELL BIOL, V20, P2803, DOI 10.1128/MCB.20.8.2803-2808.2000; WEISS A, 1991, BONE, V12, P165, DOI 10.1016/8756-3282(91)90039-L; Wojcik SM, 2000, MOL CELL BIOL, V20, P5248, DOI 10.1128/MCB.20.14.5248-5255.2000	44	1117	1177	3	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2002	415	6867					45	53		10.1038/415045a	http://dx.doi.org/10.1038/415045a			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780111				2022-12-24	WOS:000173028800034
J	Habas, R; Kato, Y; He, X				Habas, R; Kato, Y; He, X			Wnt/Frizzled activation of Rho regulates vertebrate gastrulation and requires a novel formin homology protein Daam1	CELL			English	Article							PLANAR CELL POLARITY; CONVERGENT EXTENSION MOVEMENTS; SIGNALING SPECIFICITY; TISSUE POLARITY; DORSAL CLOSURE; BETA-CATENIN; SMALL GTPASE; WNT; DROSOPHILA; KINASE	Wnt signaling via the Frizzled (Fz) receptor controls cell polarity and movement during development, but the molecular nature of Wnt/Fz polarity signal transduction remains poorly defined. Here we report that in human cells and during Xenopus embryogenesis, Wnt/Fz signaling activates the small GTPase Rho, a key regulator of cytoskeleton architecture. Wnt/Fz activation of Rho requires the cytoplasmic protein Dishevelled (Dvl) and a novel Formin homology protein Daam1. Daam1 binds to both DvI and Rho, and mediates Wnt-induced DvI-Rho complex formation. Inhibition or depletion of Daam1 prevents Wnt/Fz activation of Rho and of Xenopus gastrulation, but not of beta -catenin signaling. Our study illustrates a molecular pathway from Wnt/Fz signaling to Rho activation in cell polarity signal transduction.	Harvard Univ, Childrens Hosp, Sch Med, Dept Neurol,Div Neurosci, Boston, MA 02115 USA; NICHHD, Genet Mol Lab, Bethesda, MD 20892 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	He, X (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Dept Neurol,Div Neurosci, Boston, MA 02115 USA.	xi.he@tch.harvard.edu						ADLER PN, 1992, BIOESSAYS, V14, P735, DOI 10.1002/bies.950141103; Akasaki T, 1999, J BIOL CHEM, V274, P18055, DOI 10.1074/jbc.274.25.18055; Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Axelrod JD, 2001, GENE DEV, V15, P1182; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Boutros M, 1999, MECH DEVELOP, V83, P27, DOI 10.1016/S0925-4773(99)00046-5; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Boutros M, 2000, SCIENCE, V288, P1825, DOI 10.1126/science.288.5472.1825; Djiane A, 2000, DEVELOPMENT, V127, P3091; Eaton S, 1996, J CELL BIOL, V135, P1277, DOI 10.1083/jcb.135.5.1277; Eaton S, 1997, CURR OPIN CELL BIOL, V9, P860, DOI 10.1016/S0955-0674(97)80089-0; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fanto M, 2000, CURR BIOL, V10, P979, DOI 10.1016/S0960-9822(00)00645-X; GUBB D, 1993, DEVELOPMENT, P269; Gulli MP, 2001, GENE DEV, V15, P365, DOI 10.1101/gad.876901; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HART MJ, 1994, J BIOL CHEM, V269, P62; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kato Y, 1999, J NEUROSCI, V19, P9364; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Lu Y, 1999, GENE DEV, V13, P1168, DOI 10.1101/gad.13.9.1168; McEwen DG, 2000, DEVELOPMENT, V127, P3607; Medina A, 2000, MECH DEVELOP, V92, P227, DOI 10.1016/S0925-4773(00)00240-9; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Mlodzik M, 1999, EMBO J, V18, P6873, DOI 10.1093/emboj/18.24.6873; Nakano K, 1999, MOL BIOL CELL, V10, P2481, DOI 10.1091/mbc.10.8.2481; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Shimada Y, 2001, CURR BIOL, V11, P859, DOI 10.1016/S0960-9822(01)00233-0; Shulman JM, 1998, TRENDS GENET, V14, P452, DOI 10.1016/S0168-9525(98)01584-4; Sokol S, 2000, NAT CELL BIOL, V2, pE124, DOI 10.1038/35017136; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Sumanas S, 2000, DEVELOPMENT, V127, P1981; Tada M, 2000, DEVELOPMENT, V127, P2227; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tao WK, 2001, GENE DEV, V15, P1796, DOI 10.1101/gad.894301; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wasserman S, 1998, TRENDS CELL BIOL, V8, P111, DOI 10.1016/S0962-8924(97)01217-8; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Westendorf JJ, 1999, GENE, V232, P173, DOI 10.1016/S0378-1119(99)00127-4; Westendorf JJ, 2001, J BIOL CHEM, V276, P46453, DOI 10.1074/jbc.M105162200; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; WOYCHIK RP, 1990, NATURE, V346, P850, DOI 10.1038/346850a0; Wunnenberg-Stapleton K, 1999, DEVELOPMENT, V126, P5339; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1; Yayoshi-Yamamoto S, 2000, MOL CELL BIOL, V20, P6872, DOI 10.1128/MCB.20.18.6872-6881.2000; Young CS, 1998, MOL CELL BIOL, V18, P2474, DOI 10.1128/MCB.18.5.2474	61	636	644	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 28	2001	107	7					843	854		10.1016/S0092-8674(01)00614-6	http://dx.doi.org/10.1016/S0092-8674(01)00614-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779461	Bronze			2022-12-24	WOS:000173024200006
J	Zhang, QH; Piston, DW; Goodman, RH				Zhang, QH; Piston, DW; Goodman, RH			Regulation of corepressor function by nuclear NADH	SCIENCE			English	Article							CELLULAR PHOSPHOPROTEIN; NEGATIVE MODULATION; PROTEIN SIR2; TRANSFORMATION; TRANSCRIPTION; METASTASIS; CARCINOMA; CELLS; CTBP	The corepressor CtBP (carboxyl-terminal binding protein) is involved in transcriptional pathways important for development, cell cycle regulation, and transformation. We demonstrate that CtBP binding to cellular and viral transcriptional repressors is regulated by the nicotinamide adenine dinucleotides NAD(+) and NADH, with NADH being two to three orders of magnitude more effective. Levels of free nuclear nicotinamide adenine dinucleotides, determined using two-photon microscopy, correspond to the levels required for half-maximal CtBP binding and are considerably tower than those previously reported. Agents capable of increasing NADH levels stimulate CtBP binding to its partners in vivo and potentiate CtBP-mediated repression. We propose that this ability to detect changes in nuclear NAD(+)/NADH ratio allows CtBP to serve as a redox sensor for transcription.	Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University	Goodman, RH (corresponding author), Oregon Hlth Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.				NCI NIH HHS [R01 CA115468, R01 CA115468-05, K01 CA096561] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA115468, K01CA096561] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BOYD JM, 1993, EMBO J, V12, P469, DOI 10.1002/j.1460-2075.1993.tb05679.x; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; French T, 1998, METHOD CELL BIOL, V56, P277, DOI 10.1016/S0091-679X(08)60431-8; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Mannervik M, 1999, SCIENCE, V284, P606, DOI 10.1126/science.284.5414.606; Meiners S, 1998, ONCOGENE, V16, P9, DOI 10.1038/sj.onc.1201486; Patterson GH, 2000, P NATL ACAD SCI USA, V97, P5203, DOI 10.1073/pnas.090098797; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; PHILIPPIDIS H, 1969, BIOCHEM J, V113, P651, DOI 10.1042/bj1130651; PISTON DW, 1992, P SOC PHOTO-OPT INS, V1640, P379, DOI 10.1117/12.58230; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; RESCIGNO M, 1994, BIOCHEMISTRY-US, V33, P5721, DOI 10.1021/bi00185a008; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Shigemori K, 1996, AM J PHYSIOL-LUNG C, V270, pL803, DOI 10.1152/ajplung.1996.270.5.L803; STUBBS M, 1972, BIOCHEM J, V126, P59, DOI 10.1042/bj1260059; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Turner J, 2001, BIOESSAYS, V23, P683, DOI 10.1002/bies.1097; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Zhang Q., UNPUB	22	474	485	3	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1895	1897						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11847309				2022-12-24	WOS:000174299500040
J	Misra, S; Puertollano, R; Kato, Y; Bonifacino, JS; Hurley, JH				Misra, S; Puertollano, R; Kato, Y; Bonifacino, JS; Hurley, JH			Structural basis for acidic-cluster-dileucine sorting-signal recognition by VHS domains	NATURE			English	Article							FACTOR-II RECEPTOR; GAMMA-ADAPTIN; CYTOPLASMIC TAIL; PROTEINS; FAMILY; BINDING; TRAFFICKING; TRANSPORT; GGA2	Specific sorting signals direct transmembrane proteins to the compartments of the endosomal-lysosomal system(1). Acidic-cluster-dileucine signals present within the cytoplasmic tails of sorting receptors, such as the cation-independent and cation-dependent mannose-6-phosphate receptors, are recognized by the GGA (Golgi-localized, gamma-ear-containing, ADP-ribosylation-factor-binding) proteins(2-5). The VHS (Vps27p, Hrs and STAM) domains(6) of the GGA proteins are responsible for the highly specific recognition of these acidic-cluster-dileucine signals(7-10). Here we report the structures of the VHS domain of human GGA3 complexed with signals from both mannose-6-phosphate receptors. The signals bind in an extended conformation to helices 6 and 8 of the VHS domain. The structures highlight an Asp residue separated by two residues from a dileucine sequence as critical recognition elements. The side chains of the Asp-X-X-Leu-Leu sequence interact with subsites consisting of one electropositive and two shallow hydrophobic pockets, respectively. The rigid spatial alignment of the three binding subsites leads to high specificity.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	jh8e@nih.gov	KATO, Yukio/D-8396-2015	Bonifacino, Juan S./0000-0002-5673-6370; Misra, Saurav/0000-0002-1385-8554	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036118] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen HJ, 1997, J BIOL CHEM, V272, P7003, DOI 10.1074/jbc.272.11.7003; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; JOHNSON KF, 1992, J CELL BIOL, V119, P249, DOI 10.1083/jcb.119.2.249; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Lohi O, 1998, FEBS LETT, V440, P255, DOI 10.1016/S0014-5793(98)01401-X; Mao YX, 2000, CELL, V100, P447, DOI 10.1016/S0092-8674(00)80680-7; MERESSE S, 1993, J CELL BIOL, V120, P67, DOI 10.1083/jcb.120.1.67; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Misra S, 2000, BIOCHEMISTRY-US, V39, P11282, DOI 10.1021/bi0013546; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Poussu A, 2000, J BIOL CHEM, V275, P7176, DOI 10.1074/jbc.275.10.7176; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Takatsu H, 2001, J BIOL CHEM, V276, P28541, DOI 10.1074/jbc.C100218200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896	26	141	143	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 21	2002	415	6874					933	937		10.1038/415933a	http://dx.doi.org/10.1038/415933a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859375				2022-12-24	WOS:000173941000051
J	Drake, MJ; Jakosky, BM				Drake, MJ; Jakosky, BM			Narrow horizons in astrobiology	NATURE			English	Editorial Material									Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA	University of Arizona; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Drake, MJ (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.							Gee H, 2001, NATURE, V409, P1079; MAYOR M, 1995, NATURE, V378, P355, DOI 10.1038/378355a0; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924	3	2	2	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 14	2002	415	6873					733	734		10.1038/415733a	http://dx.doi.org/10.1038/415733a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521HE	11845181				2022-12-24	WOS:000173833900022
J	Yoo, JY; Huso, DL; Nathans, D; Desiderio, S				Yoo, JY; Huso, DL; Nathans, D; Desiderio, S			Specific ablation of Stat3 beta distorts the pattern of Stat3-responsive gene expression and impairs recovery from endotoxic shock	CELL			English	Article							ACUTE-PHASE RESPONSE; ACTIVATING POLYPEPTIDE-II; EPIDERMAL-GROWTH-FACTOR; SIGNALING PATHWAY; FACTOR RECEPTOR; C-JUN; TRANSCRIPTION; MICE; CELLS; MECHANISMS	Alternative splicing of the gene for Stat3, a transcription factor activated by the IL-6 family of cytokines, produces two isoforms: Stat3alpha and a dominant-negative variant, Stat3beta. Stat3beta-deficient mice were generated by gene targeting. Despite intact expression and phosphorylation of Stat3alpha, overall Stat3 activity was impaired in Stat3beta(-/-) cells. Global comparison of transcription in Stat3beta(+/+) and Stat3beta(-/-) cells revealed stable differences. Stat3beta-deficient mice exhibit diminished recovery from endotoxic shock and hyper-responsiveness of a subset of endotoxin-inducible genes in liver. The hepatic response to endotoxin in wild-type mice is accompanied by a transient increase in the ratio of Stat3beta to Stat3alpha. These findings indicate a critical role for Stat3beta in the control of systemic inflammation.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Div Comparat Med, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Desiderio, S (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	sdesider@jhmi.edu						AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Barasch J, 1999, CELL, V99, P377, DOI 10.1016/S0092-8674(00)81524-X; Besser D, 1999, MOL CELL BIOL, V19, P1401; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Brett D, 2000, FEBS LETT, V474, P83, DOI 10.1016/S0014-5793(00)01581-7; Caldenhoven E, 1996, J BIOL CHEM, V271, P13221, DOI 10.1074/jbc.271.22.13221; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; Cotran R. S., 1999, PATHOLOGIC BASIS DIS; Fernandez-Cobo M, 1998, SHOCK, V10, P97, DOI 10.1097/00024382-199808000-00003; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Hauser PJ, 1998, CELL GROWTH DIFFER, V9, P847; Hillis GS, 1997, J PATHOL, V182, P373; Hogan B, 1994, MANIPULATING MOUSE E; Hsiao EC, 2000, MOL CELL BIOL, V20, P3742, DOI 10.1128/MCB.20.10.3742-3751.2000; Ihle James, 1998, V865, P1; Ivanov VN, 2001, MOL CELL, V7, P517, DOI 10.1016/S1097-2765(01)00199-X; KAO J, 1992, J BIOL CHEM, V267, P20239; KAO J, 1994, J BIOL CHEM, V269, P9774; Karima R, 1999, MOL MED TODAY, V5, P123, DOI 10.1016/S1357-4310(98)01430-0; Kunisada K, 2000, P NATL ACAD SCI USA, V97, P315, DOI 10.1073/pnas.97.1.315; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; Mascareno E, 1998, P NATL ACAD SCI USA, V95, P5590, DOI 10.1073/pnas.95.10.5590; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Narimatsu M, 2001, MOL CELL BIOL, V21, P6615, DOI 10.1128/MCB.21.19.6615-6625.2001; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; OKEYAN A, 1997, AM J PHYSIOL, V273, pR293; Park OK, 1996, P NATL ACAD SCI USA, V93, P13704, DOI 10.1073/pnas.93.24.13704; Park OK, 2000, J BIOL CHEM, V275, P32244, DOI 10.1074/jbc.M005082200; Patel BKR, 1998, P NATL ACAD SCI USA, V95, P172, DOI 10.1073/pnas.95.1.172; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Ramadori G, 1999, SEMIN LIVER DIS, V19, P141, DOI 10.1055/s-2007-1007106; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Ridger VC, 2001, J IMMUNOL, V166, P3484, DOI 10.4049/jimmunol.166.5.3484; Sano S, 2001, IMMUNITY, V15, P261, DOI 10.1016/S1074-7613(01)00180-7; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Sasse J, 1997, MOL CELL BIOL, V17, P4677, DOI 10.1128/MCB.17.8.4677; Schaefer TS, 1997, MOL CELL BIOL, V17, P5307, DOI 10.1128/MCB.17.9.5307; SCHAEFER TS, 1995, P NATL ACAD SCI USA, V92, P9097, DOI 10.1073/pnas.92.20.9097; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Sharp PA, 1997, CELL, V91, P875, DOI 10.1016/S0092-8674(00)80479-1; Shi W, 1996, INT IMMUNOL, V8, P1205, DOI 10.1093/intimm/8.8.1205; Takeda K, 1998, J IMMUNOL, V161, P4652; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Takemoto S, 1997, P NATL ACAD SCI USA, V94, P13897, DOI 10.1073/pnas.94.25.13897; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang DM, 1996, MOL CELL BIOL, V16, P6141; Warren GW, 2001, J INTERF CYTOK RES, V21, P821, DOI 10.1089/107999001753238060; Yoo JY, 2001, J BIOL CHEM, V276, P26421, DOI 10.1074/jbc.M009935200; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zhu C, 1997, MOL CELL BIOL, V17, P4957, DOI 10.1128/MCB.17.9.4957	56	109	118	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2002	108	3					331	344		10.1016/S0092-8674(02)00636-0	http://dx.doi.org/10.1016/S0092-8674(02)00636-0			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	520VB	11853668	Bronze			2022-12-24	WOS:000173801600006
J	Sharon, D; Grinvald, A				Sharon, D; Grinvald, A			Dynamics and constancy in cortical spatiotemporal patterns of orientation processing	SCIENCE			English	Article							PRIMARY VISUAL-CORTEX; CAT STRIATE CORTEX; SIMPLE CELLS; POSTSYNAPTIC POTENTIALS; THALAMIC INPUT; SELECTIVITY; INHIBITION; NEURONS; ORGANIZATION; EXCITATION	How does the high selectivity to stimulus orientation emerge in the visual cortex? Thalamic feedforward-dominated models of orientation selectivity predict constant selectivity during the visual response, whereas intracortical recurrent models predict dynamic improvement in selectivity. We imaged the cat visual cortex with voltage-sensitive dyes to measure orientation-tuning dynamics of a large neuronal population. Tuning-curve width did not narrow after response onset, whereas the difference between preferred and orthogonal responses (modulation depth) first increased, then declined. We identified a suppression of the evoked responses, referred to as the evoked deceleration-acceleration (DA) notch, which was larger for the orthogonal response, Furthermore, peak selectivity of the tuning curves was contemporaneous with the evoked DA notch. These findings suggest that in the cat brain, sustained visual cortical processing does not narrow orientation tuning; rather, intracortical interactions may amplify modulation depth and suppress the orthogonal response relatively more than the preferred, Thus, feedforward models and recurrent models of orientation selectivity must be combined.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Ctr Studies Higher Brain Funct, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Sharon, D (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.							Anderson Jessie Annie, COMMUNICATION; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; BONHOEFFER T, 1993, J NEUROSCI, V13, P4157; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; CELEBRINI S, 1993, VISUAL NEUROSCI, V10, P811, DOI 10.1017/S0952523800006052; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Crook JM, 1997, VISUAL NEUROSCI, V14, P141, DOI 10.1017/S095252380000883X; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; FERSTER D, 1986, J NEUROSCI, V6, P1284; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; GRINVALD A, 1984, NATURE, V308, P848, DOI 10.1038/308848a0; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1961, J PHYSIOL-LONDON, V155, P385, DOI 10.1113/jphysiol.1961.sp006635; McLaughlin D, 2000, P NATL ACAD SCI USA, V97, P8087, DOI 10.1073/pnas.110135097; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; SHEVELEV IA, 1993, NEUROSCIENCE, V56, P865, DOI 10.1016/0306-4522(93)90133-Z; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; SOMERS DC, 1995, J NEUROSCI, V15, P5448; STERKIN, UNPUB; Sterkin A., 1999, Society for Neuroscience Abstracts, V25, P784; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; Troyer TW, 1998, J NEUROSCI, V18, P5908; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; Volgushev M, 2000, EUR J NEUROSCI, V12, P257, DOI 10.1046/j.1460-9568.2000.00909.x; VOLGUSHEV M, 1995, VISUAL NEUROSCI, V12, P621, DOI 10.1017/S0952523800008919	31	73	75	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					512	515		10.1126/science.1065916	http://dx.doi.org/10.1126/science.1065916			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799249				2022-12-24	WOS:000173350700055
J	Nakashima, K; Zhou, X; Kunkel, G; Zhang, ZP; Deng, JM; Behringer, RR; de Crombrugghe, B				Nakashima, K; Zhou, X; Kunkel, G; Zhang, ZP; Deng, JM; Behringer, RR; de Crombrugghe, B			The novel zinc finger-containing transcription factor Osterix is required for osteoblast differentiation and bone formation	CELL			English	Article							VERTEBRATE LIMB DEVELOPMENT; PROMOTER REGION; BINDING-SITES; GENE PROMOTER; CHONDROCYTES; CBFA1; PROTEINS; SEQUENCE; LINEAGE; TISSUES	We have identified a novel zinc finger-containing transcription factor, called Osterix (Osx), that is specifically expressed in all developing bones. In Osx null mice, no bone formation occurs. In endochondral skeletal elements of Osx null mice, mesenchymal cells, together with osteoclasts and blood vessels, invade the mineralized cartilage matrix. However, the mesenchymal cells do not deposit bone matrix. Similarly, cells in the periosteum and in the condensed mesenchyme of membranous skeletal elements cannot differentiate into osteoblasts. These cells do, however, express Runx2/Cbfa1, another transcription factor required for bone formation. In contrast, Osx is not expressed in Runx2/Cbfa1 null mice. Thus, Osx acts downstream of Runx2/Cbfa1. Because Osx null preosteoblasts express typical chondrocyte marker genes, we propose that Runx2/Cbfa1-expressing preosteoblasts are still bipotential cells.	Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Program Genes & Dev, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	de Crombrugghe, B (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, 1515 Holcombe Blvd, Houston, TX 77030 USA.			Nakashima, Kazuhisa/0000-0003-0491-2149; Kunkel, Gary/0000-0002-4199-369X	NCI NIH HHS [CA 16672] Funding Source: Medline; NIAMS NIH HHS [P01 AR42919] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR042919] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Asano H, 2000, BLOOD, V95, P3578, DOI 10.1182/blood.V95.11.3578.011k48_3578_3584; Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; Benson MD, 1999, J BONE MINER RES, V14, P396, DOI 10.1359/jbmr.1999.14.3.396; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; BILEZIKIAN JP, 1996, PRINCIPLES BONE BIOL; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; CHEN JK, 1992, J BONE MINER RES, V7, P987; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Fang JM, 1997, ANAT EMBRYOL, V196, P349, DOI 10.1007/s004290050104; GASHLER AL, 1993, MOL CELL BIOL, V13, P4556, DOI 10.1128/MCB.13.8.4556; Gowen M, 1999, J BONE MINER RES, V14, P1654, DOI 10.1359/jbmr.1999.14.10.1654; Hafner M, 1995, MATRIX BIOL, V14, P733, DOI 10.1016/S0945-053X(05)80016-2; HOGAN B, 1994, MAIPULATING MOUSE EM; IMATAKA H, 1992, EMBO J, V11, P3663, DOI 10.1002/j.1460-2075.1992.tb05451.x; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; KARSENTY G, 1991, BIOCHEM BIOPH RES CO, V177, P538, DOI 10.1016/0006-291X(91)92017-E; Karsenty G, 1999, GENE DEV, V13, P3037, DOI 10.1101/gad.13.23.3037; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Ogata Y, 1997, J CELL BIOCHEM, V65, P501, DOI 10.1002/(SICI)1097-4644(19970615)65:4<501::AID-JCB6>3.0.CO;2-S; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Sato M, 1998, ONCOGENE, V17, P1517, DOI 10.1038/sj.onc.1202064; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; TICKLE C, 1995, CURR OPIN GENET DEV, V5, P478, DOI 10.1016/0959-437X(95)90052-I; Turner J, 1999, TRENDS BIOCHEM SCI, V24, P236, DOI 10.1016/S0968-0004(99)01406-1; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1	35	2618	2746	7	224	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 11	2002	108	1					17	29		10.1016/S0092-8674(01)00622-5	http://dx.doi.org/10.1016/S0092-8674(01)00622-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	511TB	11792318	Bronze			2022-12-24	WOS:000173280700005
J	Ho, Y; Gruhler, A; Heilbut, A; Bader, GD; Moore, L; Adams, SL; Millar, A; Taylor, P; Bennett, K; Boutilier, K; Yang, LY; Wolting, C; Donaldson, I; Schandorff, S; Shewnarane, J; Vo, M; Taggart, J; Goudreault, M; Muskat, B; Alfarano, C; Dewar, D; Lin, Z; Michalickova, K; Willems, AR; Sassi, H; Nielsen, PA; Rasmussen, KJ; Andersen, JR; Johansen, LE; Hansen, LH; Jespersen, H; Podtelejnikov, A; Nielsen, E; Crawford, J; Poulsen, V; Sorensen, BD; Matthiesen, J; Hendrickson, RC; Gleeson, F; Pawson, T; Moran, MF; Durocher, D; Mann, M; Hogue, CWV; Figeys, D; Tyers, M				Ho, Y; Gruhler, A; Heilbut, A; Bader, GD; Moore, L; Adams, SL; Millar, A; Taylor, P; Bennett, K; Boutilier, K; Yang, LY; Wolting, C; Donaldson, I; Schandorff, S; Shewnarane, J; Vo, M; Taggart, J; Goudreault, M; Muskat, B; Alfarano, C; Dewar, D; Lin, Z; Michalickova, K; Willems, AR; Sassi, H; Nielsen, PA; Rasmussen, KJ; Andersen, JR; Johansen, LE; Hansen, LH; Jespersen, H; Podtelejnikov, A; Nielsen, E; Crawford, J; Poulsen, V; Sorensen, BD; Matthiesen, J; Hendrickson, RC; Gleeson, F; Pawson, T; Moran, MF; Durocher, D; Mann, M; Hogue, CWV; Figeys, D; Tyers, M			Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry	NATURE			English	Article							YEAST; CHECKPOINT; DEGRADATION; PATHWAYS; LIGASE; DOMAIN; REPAIR	The recent abundance of genome sequence data has brought an urgent need for systematic proteomics to decipher the encoded protein networks that dictate cellular function(1). To date, generation of large-scale protein-protein interaction maps has relied on the yeast two-hybrid system, which detects binary interactions through activation of reporter gene expression(2-4). With the advent of ultrasensitive mass spectrometric protein identification methods, it is feasible to identify directly protein complexes on a proteome-wide scale(5,6). Here we report, using the budding yeast Saccharomyces cerevisiae as a test case, an example of this approach, which we term high-throughput mass spectrometric protein complex identification (HMS-PCI). Beginning with 10% of predicted yeast proteins as baits, we detected 3,617 associated proteins covering 25% of the yeast proteome. Numerous protein complexes were identified, including many new interactions in various signalling pathways and in the DNA damage response. Comparison of the HMS-PCI data set with interactions reported in the literature revealed an average threefold higher success rate in detection of known complexes compared with large-scale two-hybrid studies(3,4). Given the high degree of connectivity observed in this study, even partial HMS-PCI coverage of complex proteomes, including that of humans, should allow comprehensive identification of cellular networks.	MDS Proteom, Toronto, ON M9W 7H4, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Programme Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto	Figeys, D (corresponding author), MDS Proteom, 251 Attwell Dr, Toronto, ON M9W 7H4, Canada.		Hogue, Christopher W V/AAZ-3934-2020; Pawson, Tony J/E-4578-2013; Hogue, Christopher/B-6726-2008; Podtelejnikov, Alexandre/B-6120-2017; Heilbut, Adrian M/J-9427-2012; Tyers, Michael/ABE-3194-2021; Durocher, Daniel/A-7733-2010; Mann, Matthias/A-3454-2013; Moran, Michael/GYD-3631-2022; Bader, Gary/C-1176-2009; Donaldson, Ian/A-2867-2009	Hogue, Christopher W V/0000-0002-3107-5246; Podtelejnikov, Alexandre/0000-0002-8124-6584; Heilbut, Adrian M/0000-0002-8169-7967; Durocher, Daniel/0000-0003-3863-8635; Mann, Matthias/0000-0003-1292-4799; Bader, Gary/0000-0003-0185-8861; Donaldson, Ian/0000-0002-4203-8328; Figeys, Daniel/0000-0002-5373-7546; Bennett, Keiryn L./0000-0001-9356-7708				Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Bader GD, 2001, NUCLEIC ACIDS RES, V29, P242, DOI 10.1093/nar/29.1.242; Beaudenon SL, 1999, MOL CELL BIOL, V19, P6972; Chervitz SA, 1998, SCIENCE, V282, P2022, DOI 10.1126/science.282.5396.2022; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Emili A, 2001, MOL CELL, V7, P13, DOI 10.1016/S1097-2765(01)00150-2; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Hu FH, 2001, GENE DEV, V15, P1061, DOI 10.1101/gad.873201; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jorgensen P, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-3-reviews1022, DOI 10.1186/GB-2000-1-3-REVIEWS1022]; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Mann M, 2001, ANNU REV BIOCHEM, V70, P437, DOI 10.1146/annurev.biochem.70.1.437; Marsolier MC, 2000, GENETICS, V154, P1523; McMillan JN, 1999, MOL CELL BIOL, V19, P6929; Mewes HW, 2000, NUCLEIC ACIDS RES, V28, P37, DOI 10.1093/nar/28.1.37; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Neubauer G, 1997, P NATL ACAD SCI USA, V94, P385, DOI 10.1073/pnas.94.2.385; Ortolan TG, 2000, NAT CELL BIOL, V2, P601, DOI 10.1038/35023547; Pawson T, 2000, GENE DEV, V14, P1027; Philips J, 1998, J CELL BIOL, V143, P375, DOI 10.1083/jcb.143.2.375; Prakash S, 2000, MUTAT RES-FUND MOL M, V451, P13, DOI 10.1016/S0027-5107(00)00037-3; Thelen MP, 1999, CELL, V96, P769, DOI 10.1016/S0092-8674(00)80587-5; Tyers M, 1999, P NATL ACAD SCI USA, V96, P12230, DOI 10.1073/pnas.96.22.12230; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Zhao XL, 2001, EMBO J, V20, P3544, DOI 10.1093/emboj/20.13.3544; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	30	2822	2925	4	314	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					180	183		10.1038/415180a	http://dx.doi.org/10.1038/415180a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805837				2022-12-24	WOS:000173159300044
J	Merbach, MA; Merbach, DJ; Maschwitz, U; Booth, WE; Fiala, B; Zizka, G				Merbach, MA; Merbach, DJ; Maschwitz, U; Booth, WE; Fiala, B; Zizka, G			Carnivorous plants - Mass march of termites into the deadly trap	NATURE			English	Article							BORNEO		Univ Frankfurt, Inst Zool, Fachbereich Biol, D-60054 Frankfurt, Germany; Univ Wurzburg, Biozentrum, D-97074 Wurzburg, Germany; Univ Frankfurt, D-60325 Frankfurt, Germany; Forschungsinst Senckenberg, D-60325 Frankfurt, Germany	Goethe University Frankfurt; University of Wurzburg; Goethe University Frankfurt; Senckenberg Gesellschaft fur Naturforschung (SGN)	Merbach, MA (corresponding author), Univ Frankfurt, Inst Zool, Fachbereich Biol, Postfach 111932, D-60054 Frankfurt, Germany.		Fiala, Brigitte/I-3788-2016	Fiala, Brigitte/0000-0002-9625-1933				ADAMJUMAAT H, 1997, PERTANIKA J TROP AGR, V20, P121; Clarke C, 1997, NEPENTHES BORNEO; JONES DT, 1995, INSECT SOC, V42, P359, DOI 10.1007/BF01242164; KATO Y, 1993, J HOKKAIDO BRAIN RES, V6, P11; Miura T, 1997, INSECT SOC, V44, P267, DOI 10.1007/s000400050047; Moran JA, 1999, ANN BOT-LONDON, V83, P521, DOI 10.1006/anbo.1999.0857; Moran JA, 1996, J ECOL, V84, P515, DOI 10.2307/2261474	7	44	46	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					36	37		10.1038/415036a	http://dx.doi.org/10.1038/415036a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780106				2022-12-24	WOS:000173028800029
J	Andrus, CFT; Crowe, DE; Sandweiss, DH; Reitz, EJ; Romanek, CS				Andrus, CFT; Crowe, DE; Sandweiss, DH; Reitz, EJ; Romanek, CS			Otolith delta O-18 record of mid-Holocene sea surface temperatures in Peru	SCIENCE			English	Article							EL-NINO; EARLY HISTORY; HOLOCENE; BP; FRACTIONATION; VARIABILITY; PACIFIC; CLIMATE; COMPLEX; ONSET	Peruvian sea catfish (Galeichthys peruvianus) sagittal otoliths preserve a record of modern and mid-Holocene sea surface temperatures (SSTs). Oxygen isotope profiles in otoliths excavated from Ostra [6010 +/- 90 years before the present (yr B.P.); 8degrees55'S] indicate that summer SSTs were similar to3degreesC warmer than those of the present. Siches ototiths (6450 +/- 110 yr B.P.; 4degrees40'S) recorded mean annual temperatures similar to3degrees to 4degreesC warmer than were measured under modern conditions. Trophic level and population diversity and equitability data from these faunal assemblages and other Peruvian archaeological sites support the isotope interpretations and suggest that upwelling of the Peru-Chile current intensified after similar to5000 yr B.P.	Univ Georgia, Dept Geol, Athens, GA 30602 USA; Univ Maine, Dept Anthropol, Orono, ME 04469 USA; Univ Maine, Inst Quaternary Res, Orono, ME 04469 USA; Univ Georgia, Dept Anthropol, Athens, GA 30602 USA; Univ Georgia, Georgia Museum Nat Hist, Athens, GA 30602 USA; Savannah River Ecol Lab, Aiken, SC 29802 USA	University System of Georgia; University of Georgia; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; United States Department of Energy (DOE); Savannah River Ecology Laboratory	Andrus, CFT (corresponding author), Univ Georgia, Dept Geol, Athens, GA 30602 USA.	andrus@gly.uga.edu	Sandweiss, Daniel/K-5808-2019	Andrus, Fred/0000-0002-4075-8380				Andrus CFT, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000652; Andrus CFT, 2000, J ARCHAEOL SCI, V27, P33, DOI 10.1006/jasc.1999.0417; Bush ABG, 2001, QUATERNARY RES, V55, P25, DOI 10.1006/qres.2000.2198; Clement AC, 2000, PALEOCEANOGRAPHY, V15, P731, DOI 10.1029/1999PA000466; COOKE R, 1993, ARQUELOGIA CONT, V4, P57; DeVries TJ, 1997, SCIENCE, V276, P965, DOI 10.1126/science.276.5314.965; FROESE R, 2001, FISHBASE; Gagan MK, 1998, SCIENCE, V279, P1014, DOI 10.1126/science.279.5353.1014; GROSSMAN EL, 1986, CHEM GEOL, V59, P59, DOI 10.1016/0168-9622(86)90057-6; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Ivany LC, 2000, NATURE, V407, P887, DOI 10.1038/35038044; Liu ZY, 2000, GEOPHYS RES LETT, V27, P2265, DOI 10.1029/2000GL011452; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; PERRIER C, 1994, GEOGR PHYS QUATERN, V48, P23, DOI 10.7202/032970ar; POZORSKI S, 1986, J FIELD ARCHAEOL, V13, P381, DOI 10.1179/jfa.1986.13.4.381; Pozorski S., 1979, ANN CARNEGIE MUS, V48, P337; Reitz EJ, 2001, INT J OSTEOARCHAEOL, V11, P163, DOI 10.1002/oa.554; REITZ EJ, UNPUB; Rodbell DT, 1999, SCIENCE, V283, P516, DOI 10.1126/science.283.5401.516; Romanek CS, 1996, COMP BIOCHEM PHYS A, V114, P71, DOI 10.1016/0300-9629(95)02094-2; Sandweiss DH, 1996, SCIENCE, V273, P1531, DOI 10.1126/science.273.5281.1531; Sandweiss DH, 1997, SCIENCE, V276, P966; Sandweiss DH, 1998, J COASTAL RES, V14, P367; Shannon C. E., 1949, MATH THEORY INFORM; SHULMEISTER J, 1995, HOLOCENE, V5, P10, DOI 10.1177/095968369500500102; THOMPSON LG, 1995, SCIENCE, V269, P46, DOI 10.1126/science.269.5220.46; Thorrold SR, 1997, GEOCHIM COSMOCHIM AC, V61, P2909, DOI 10.1016/S0016-7037(97)00141-5; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; Wells L. E., 1999, GEOARCHAE686 OLOGY, V14, P755, DOI DOI 10.1002/(SICI)1520-6548(199912)14:8<LESSTHAN>755::AID-GEA5<GREATERTHAN>3.0.CO;2-7; Wells LE, 1997, SCIENCE, V276, P966	30	104	111	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2002	295	5559					1508	1511		10.1126/science.1062004	http://dx.doi.org/10.1126/science.1062004			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859190				2022-12-24	WOS:000173981300048
J	Hendy, EJ; Gagan, MK; Alibert, CA; McCulloch, MT; Lough, JM; Isdale, PJ				Hendy, EJ; Gagan, MK; Alibert, CA; McCulloch, MT; Lough, JM; Isdale, PJ			Abrupt decrease in tropical Pacific Sea surface salinity at end of Little Ice Age	SCIENCE			English	Article							GREAT-BARRIER-REEF; STABLE-ISOTOPE RECORD; TEMPERATURE VARIABILITY; SOUTHWEST PACIFIC; CLIMATE-CHANGE; CORAL; CIRCULATION; AUSTRALIA; OCEAN; RECONSTRUCTION	A 420-year history of strontium/calcium, uranium/calcium, and oxygen isotope ratios in eight coral cores from the Great Barrier Reef, Australia, indicates that sea surface temperature and salinity were higher in the 18th century than in the 20th century. An abrupt freshening after 1870 occurred simultaneously throughout the southwestern Pacific, coinciding with cooling tropical temperatures. Higher salinities between 1565 and 1870 are best explained by a combination of advection and wind-induced evaporation resulting from a strong latitudinal temperature gradient and intensified circulation. The global Little Ice Age glacial expansion may have been driven, in part, by greater poleward transport of water vapor from the tropical Pacific.	Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian National University; Australian Institute of Marine Science	Hendy, EJ (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia.		Gagan, Michael/L-5014-2018; Hendy, Erica J/H-4488-2016; Lough, Janice M/L-1682-2013; McCulloch, Malcolm T/C-3651-2009	Gagan, Michael/0000-0002-8279-323X; Hendy, Erica J/0000-0001-5949-4349; Lough, Janice M/0000-0002-3789-1009; McCulloch, Malcolm T/0000-0003-1538-1558				Alibert C, 1997, PALEOCEANOGRAPHY, V12, P345, DOI 10.1029/97PA00318; Bottomley M, 1990, GLOBAL OCEAN SURFACE; Bradley RS., 1993, HOLOCENE, V3, P367, DOI [10.1177/095968369300300409, DOI 10.1177/095968369300300409]; Briffa KR, 1998, NATURE, V393, P450, DOI 10.1038/30943; Crowley T. J., 1991, PALEOCLIMATOLOGY; Crowley TJ, 1999, PALEOCEANOGRAPHY, V14, P605, DOI 10.1029/1999PA900032; Crowley TJ, 2000, SCIENCE, V289, P270, DOI 10.1126/science.289.5477.270; Delcroix T, 1996, DEEP-SEA RES PT I, V43, P1123, DOI 10.1016/0967-0637(96)00048-9; Druffel ERM, 1999, J GEOPHYS RES-OCEANS, V104, P23607, DOI 10.1029/1999JC900212; DRUFFEL ERM, 1993, J GEOPHYS RES, V98, P20; Evans MN, 2000, PALEOCEANOGRAPHY, V15, P551, DOI 10.1029/2000PA000498; Gagan MK, 1998, SCIENCE, V279, P1014, DOI 10.1126/science.279.5353.1014; Grove JM, 1988, LITTLE ICE AGE; HENDY EJ, UNPUB; Isdale PJ, 1998, HOLOCENE, V8, P1, DOI 10.1191/095968398670905088; Jones PD, 2001, SCIENCE, V292, P662, DOI 10.1126/science.1059126; Jones PD, 1998, HOLOCENE, V8, P455, DOI 10.1191/095968398667194956; Kreutz KJ, 1997, SCIENCE, V277, P1294, DOI 10.1126/science.277.5330.1294; Lamb H.H., 1995, CLIMATE HIST MODERN, P211; Linsley BK, 2000, SCIENCE, V290, P1145, DOI 10.1126/science.290.5494.1145; LINSLEY BK, 1994, J GEOPHYS RES-OCEANS, V99, P9977, DOI 10.1029/94JC00360; Lough JM, 1997, INT J CLIMATOL, V17, P55, DOI 10.1002/(SICI)1097-0088(199701)17:1<55::AID-JOC109>3.0.CO;2-Z; Mann ME, 1998, NATURE, V392, P779, DOI 10.1038/33859; MCCULLOCH MT, 1994, GEOCHIM COSMOCHIM AC, V58, P2747, DOI 10.1016/0016-7037(94)90142-2; MIN GR, 1995, GEOCHIM COSMOCHIM AC, V59, P2025; Quinn TM, 1998, PALEOCEANOGRAPHY, V13, P412, DOI 10.1029/98PA00401; QUINN TM, 1993, QUATERNARY SCI REV, V12, P407, DOI 10.1016/S0277-3791(05)80005-8; Rayner N. A., 1996, VERSION 2 2 GLOBAL S; Rind D, 1998, J GEOPHYS RES-ATMOS, V103, P5943, DOI 10.1029/97JD03649; Rind D, 2000, QUATERNARY SCI REV, V19, P381, DOI 10.1016/S0277-3791(99)00070-0; Sokolov S, 2000, J MAR RES, V58, P223, DOI 10.1357/002224000321511151; STUIVER M, 1986, RADIOCARBON, V28, P980, DOI 10.1017/S0033822200060264; SWART PK, 1980, NATURE, V283, P557, DOI 10.1038/283557a0; THOMPSON LG, 1986, SCIENCE, V234, P361, DOI 10.1126/science.234.4774.361; Wolanski E., 1994, PHYSICAL OCEANOGRAPH	35	222	234	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2002	295	5559					1511	1514		10.1126/science.1067693	http://dx.doi.org/10.1126/science.1067693			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859191				2022-12-24	WOS:000173981300049
J	Rosenthal, MB; Berndt, ER; Donohue, JM; Frank, RG; Epstein, AM				Rosenthal, MB; Berndt, ER; Donohue, JM; Frank, RG; Epstein, AM			Promotion of prescription drugs to consumers.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background: Spending on prescription drugs is the fastest growing component of the health care budget. There is public concern about the possibility that direct-to-consumer advertising of prescription drugs will result in inappropriate prescribing and higher costs of care. Guidelines issued in 1997 by the Food and Drug Administration (FDA) regarding advertising to consumers through electronic media are considered by some to be responsible for unleashing a flood of direct-to-consumer advertising. Methods: Using data on spending for promotional purposes and sales of prescription drugs, we examined industrywide trends for various types of promotion. We also tracked the relation between promotional efforts and sales over time. Finally, we documented the variation in direct-to-consumer advertising among and within five therapeutic classes of drugs and compared the variation in the intensity of such advertising with variation in the intensity of promotion to health care professionals. Results: Annual spending on direct-to-consumer advertising for prescription drugs tripled between 1996 and 2000, when it reached nearly $2.5 billion. Despite this increase, such advertising accounts for only 15 percent of the money spent on drug promotion and is highly concentrated on a subgroup of products. Within a therapeutic class, there is marked variation in the intensity of direct-to-consumer advertising, and the amount of such advertising for specific products fluctuates over time. The initial surge in direct-to-consumer advertising preceded the 1997 FDA guidelines that clarified the rules for electronic direct-to-consumer advertising, and thus the 1997 guidelines may not have been the most important reason for the overall increase. Conclusions: Although the use of direct-to-consumer advertising has grown disproportionately to other forms of promotion, it continues to account for a small proportion of total promotional efforts. Nevertheless, physicians must assist patients in evaluating health-related information obtained through direct advertising. (N Engl J Med 2002;346:498-505.) Copyright (C) 2002 Massachusetts Medical Society.	Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; MIT, Alfred P Sloan Sch Management, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Rosenthal, MB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.			Rosenthal, Meredith/0000-0003-3410-0184; Donohue, Julie/0000-0003-2418-6017				[Anonymous], 2001, PREVENTION MAGAZINE, P46; BERNDT ER, 2001, LONG SHADOW PATIENT; Heffler S, 2001, HEALTH AFFAIR, V20, P193, DOI 10.1377/hlthaff.20.2.193; *J KAIS FAM FDN, 2001, PRESCR DRUG TRENDS C; Lipsky MS, 1997, J FAM PRACTICE, V45, P495; *NIH CAR MAN, 2001, PRESCR DRUG EXP 2000; PASTORE M, 2001, HEALTHCARE WEB ADVER; *PHARM RES MAN AM, 2000, IND PROF 2000; SCHWARTZ RK, 1989, SOC SCI MED, V28, P577, DOI 10.1016/0277-9536(89)90252-9; Wilkes MS, 2000, HEALTH AFFAIR, V19, P110, DOI 10.1377/hlthaff.19.2.110	10	282	287	0	18	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2002	346	7					498	505		10.1056/NEJMsa012075	http://dx.doi.org/10.1056/NEJMsa012075			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	521AE	11844852				2022-12-24	WOS:000173815300007
J	Akula, SM; Pramod, NP; Wang, FZ; Chandran, B				Akula, SM; Pramod, NP; Wang, FZ; Chandran, B			Integrin alpha 3 beta 1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells	CELL			English	Article							TYROSINE PHOSPHORYLATION; HUMAN-HERPESVIRUS-8; ADHESION; VIRUS; ALPHA-V-BETA-3; SURFACE; MEDIATE	Human herpesvirus-8 (HHV-8) is implicated in the pathogenesis of Kaposi's sarcoma. HHV-8 envelope glycoprotein B possesses the RGD motif known to interact with integrin molecules, and HHV-8 infectivity was inhibited by RGD peptides, antibodies against RGD-dependent alpha3 and beta1 integrins, and by soluble alpha3beta1 integrin. Expression of human alpha3 integrin increased the infectivity of virus for Chinese hamster ovary cells. Anti-gB antibodies immunoprecipitated the virus-alpha3 and -beta1 complexes, and virus binding studies suggest a role for alpha3beta1 in HHV-8 entry. Further, HHV-8 infection induced the integrin-mediated activation of focal adhesion kinase (FAK). These findings implicate a role for alpha3beta1 integrin and the associated signaling pathways in HHV-8 entry into the target cells.	Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Chandran, B (corresponding author), Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.				NATIONAL CANCER INSTITUTE [R01CA082056, R01CA075911] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016443] Funding Source: NIH RePORTER; NCI NIH HHS [CA 75911, CA 82056] Funding Source: Medline; NCRR NIH HHS [RR16443] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Akula SM, 2001, VIROLOGY, V282, P245, DOI 10.1006/viro.2000.0851; Akula SM, 2001, VIROLOGY, V284, P235, DOI 10.1006/viro.2001.0921; Anderson HA, 1996, MOL BIOL CELL, V7, P1825, DOI 10.1091/mbc.7.11.1825; Antman K, 2000, NEW ENGL J MED, V342, P1027, DOI 10.1056/NEJM200004063421407; Barillari G, 1999, BLOOD, V94, P663; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Cerimele F, 2001, J VIROL, V75, P2435, DOI 10.1128/JVI.75.5.2435-2443.2001; COMPTON T, 1992, VIROLOGY, V191, P387, DOI 10.1016/0042-6822(92)90200-9; Ganem D, 1998, CURR CLIN TOPICS INF, V18, P237; Gavrilovskaya IN, 1998, P NATL ACAD SCI USA, V95, P7074, DOI 10.1073/pnas.95.12.7074; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Guerrero CA, 2000, P NATL ACAD SCI USA, V97, P14644, DOI 10.1073/pnas.250299897; Hewish MJ, 2000, J VIROL, V74, P228, DOI 10.1128/JVI.74.1.228-236.2000; Li E, 2001, J VIROL, V75, P5405, DOI 10.1128/JVI.75.11.5405-5409.2001; McLean GW, 2000, J BIOL CHEM, V275, P23333, DOI 10.1074/jbc.M909322199; Meng YX, 1999, VIROLOGY, V261, P106, DOI 10.1006/viro.1999.9853; NEMEROW GR, 1984, VIROLOGY, V132, P186, DOI 10.1016/0042-6822(84)90102-8; Nemerow GR, 2000, VIROLOGY, V274, P1, DOI 10.1006/viro.2000.0468; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Renne R, 1998, J VIROL, V72, P5182, DOI 10.1128/JVI.72.6.5182-5188.1998; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043; SCHULZ TF, 1998, HUMAN TUMOR VIRUSES, V8, P87; Shaw AM, 2000, VIROLOGY, V268, P159, DOI 10.1006/viro.1999.0164; Spear PG, 2000, VIROLOGY, V275, P1, DOI 10.1006/viro.2000.0529; Triantafilou K, 2000, J VIROL, V74, P5856, DOI 10.1128/JVI.74.13.5856-5862.2000; Vieira J, 2001, J VIROL, V75, P1378, DOI 10.1128/JVI.75.3.1378-1386.2001; Wang FZ, 2001, J VIROL, V75, P7517, DOI 10.1128/JVI.75.16.7517-7527.2001; WEITZMAN JB, 1995, J CELL SCI, V108, P3635; WU CY, 1995, J CELL SCI, V108, P2511; Zhu LJ, 1999, VIROLOGY, V262, P237, DOI 10.1006/viro.1999.9900	31	302	315	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 8	2002	108	3					407	419		10.1016/S0092-8674(02)00628-1	http://dx.doi.org/10.1016/S0092-8674(02)00628-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	520VB	11853674	Bronze			2022-12-24	WOS:000173801600012
J	Bernier-Villamor, V; Sampson, DA; Matunis, MJ; Lima, CD				Bernier-Villamor, V; Sampson, DA; Matunis, MJ; Lima, CD			Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1	CELL			English	Article							CRYSTAL-STRUCTURE; ANOMALOUS DIFFRACTION; TUMOR-SUPPRESSOR; PROTEIN; INSIGHTS; IDENTIFICATION; DEGRADATION; HOMOLOG; DOMAIN; MAD	E2 enzymes catalyze attachment of ubiquitin and ubiquitin-like proteins to lysine residues directly or through E3-mediated reactions. The small ubiquitin-like modifier SUMO regulates nuclear transport, stress response, and signal transduction in eukaryotes and is essential for cell-cycle progression in yeast. In contrast to most ubiquitin conjugation, the SUMO E2 enzyme Ubc9 is sufficient for substrate recognition and lysine modification of known SUMO targets. Crystallographic analysis of a complex between mammalian Ubc9 and a C-terminal domain of RanGAP1 at 2.5 Angstrom reveals structural determinants for recognition of consensus SUMO modification sequences found within SUMO-conjugated proteins. Structure-based mutagenesis and biochemical analysis of Ubc9 and RanGAP1 reveal distinct motifs required for substrate binding and SUMO modification of p53, IkappaBalpha, and RanGAP1.	Cornell Univ, Weill Med Coll, Dept Biochem, Struct Biol Program, New York, NY 10021 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	Cornell University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lima, CD (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, Struct Biol Program, New York, NY 10021 USA.	lima@pinky.med.cornell.edu		Lima, Christopher/0000-0002-9163-6092; Matunis, Michael/0000-0002-9350-6611	NIGMS NIH HHS [GM60980] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060980] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Gonen H, 1999, J BIOL CHEM, V274, P14823, DOI 10.1074/jbc.274.21.14823; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hillig RC, 1999, MOL CELL, V3, P781, DOI 10.1016/S1097-2765(01)80010-1; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Johnson EW, 1997, J BACK MUSCULOSKELET, V9, P3, DOI 10.3233/BMR-1997-9102; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kamitani T, 1998, J BIOL CHEM, V273, P26675, DOI 10.1074/jbc.273.41.26675; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; MELUH PB, 1995, MOL BIOL CELL, V6, P793, DOI 10.1091/mbc.6.7.793; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Saitoh H, 1997, TRENDS BIOCHEM SCI, V22, P374, DOI 10.1016/S0968-0004(97)01102-X; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Sternsdorf T, 1997, J CELL BIOL, V139, P1621, DOI 10.1083/jcb.139.7.1621; Takahashi Y, 1999, BIOCHEM BIOPH RES CO, V259, P582, DOI 10.1006/bbrc.1999.0821; Takahashi Y, 2001, GENE, V275, P223, DOI 10.1016/S0378-1119(01)00662-X; Tanaka K, 1999, MOL CELL BIOL, V19, P8660; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tong H, 1997, J BIOL CHEM, V272, P21381, DOI 10.1074/jbc.272.34.21381; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	46	436	453	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2002	108	3					345	356		10.1016/S0092-8674(02)00630-X	http://dx.doi.org/10.1016/S0092-8674(02)00630-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	520VB	11853669	Bronze			2022-12-24	WOS:000173801600007
J	Myneni, SCB				Myneni, SCB			Formation of stable chlorinated hydrocarbons in weathering plant material	SCIENCE			English	Article							ABSORPTION	Though several chlorinated organic compounds produced by humans are carcinogenic and toxic, some are also produced by the biotic and abiotic processes in the environment. In situ x-ray spectroscopy data indicate that natural organic matter in soils, sediments, and natural waters contain stable, less volatile organic compounds with chlorinated phenolic and aliphatic groups as the principal Cl forms. These compounds are formed at rapid rates from the transformation of inorganic Cl during humification of plant material and, thus, play a critical role in the cycling of Cl and of several major and trace elements in the environment and may influence human health.	Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA	Princeton University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Myneni, SCB (corresponding author), Princeton Univ, Dept Geosci, 151 Guyot Hall, Princeton, NJ 08544 USA.							[Anonymous], 1992, PLANT PHYSIOL; ASPLUND G, 1991, ENVIRON SCI TECHNOL, V25, P1347; CARLSEN L, 1992, ORG GEOCHEM, V18, P477, DOI 10.1016/0146-6380(92)90110-J; DEJONG E, 1994, APPL ENVIRON MICROB, V60, P271, DOI 10.1128/AEM.60.1.271-277.1994; GRIBBLE GW, 1994, J CHEM EDUC, V71, P907, DOI 10.1021/ed071p907; HOEKSTRA EJ, 1995, CHEM BRIT, V31, P127; Hoekstra EJ, 1999, ENVIRON SCI TECHNOL, V33, P2543, DOI 10.1021/es9900104; Keppler F, 2000, NATURE, V403, P298, DOI 10.1038/35002055; Neidleman S.L., 1986, BIOHALOGENATION PRIN; PERERA RCC, 1987, J CHEM PHYS, V86, P4824, DOI 10.1063/1.452675; PERERA RCC, 1991, PHYS REV A, V43, P3609, DOI 10.1103/PhysRevA.43.3609; Porter G, 1996, PURE APPL CHEM, V68, P1683, DOI 10.1351/pac199668091683; Prospero JM, 1999, P NATL ACAD SCI USA, V96, P3396, DOI 10.1073/pnas.96.7.3396; Rompel A, 1997, J AM CHEM SOC, V119, P4465, DOI 10.1021/ja9610951; Schwarzenbach R., 1993, ENV ORGANIC CHEM; SHADLE SE, 1995, J AM CHEM SOC, V117, P2259, DOI 10.1021/ja00113a015; SMITH TA, 1994, J AM CHEM SOC, V116, P3836, DOI 10.1021/ja00088a020; Solomon S, 1999, REV GEOPHYS, V37, P275, DOI 10.1029/1999RG900008; Stohr J, 2013, SPRINGE SER SURF SCI	19	141	153	3	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					1039	1041		10.1126/science.1067153	http://dx.doi.org/10.1126/science.1067153			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11799203				2022-12-24	WOS:000173793000056
J	Rich, TH; Vickers-Rich, P; Gangloff, RA				Rich, TH; Vickers-Rich, P; Gangloff, RA			Polar dinosaurs	SCIENCE			English	Editorial Material							VICTORIA		Museum Victoria, Melbourne, Vic 3001, Australia; Monash Univ, Dept Earth Sci, Clayton, Vic 3800, Australia; Univ Alaska Museum, Fairbanks, AK 99775 USA	Museum Victoria; Monash University; University of Alaska System; University of Alaska Fairbanks	Rich, TH (corresponding author), Museum Victoria, POB 666E, Melbourne, Vic 3001, Australia.							Case Judd A., 1998, Journal of Vertebrate Paleontology, V18, p32A; Chinsamy A, 1998, J VERTEBR PALEONTOL, V18, P385, DOI 10.1080/02724634.1998.10011066; CLEMENS WA, 1993, GEOLOGY, V21, P503, DOI 10.1130/0091-7613(1993)021<0503:PIOATV>2.3.CO;2; DELAPPARENT AF, 1962, NORSK POLARINST ARBO, V14; DOUGLAS JG, 1982, PALAEOGEOGR PALAEOCL, V39, P171, DOI 10.1016/0031-0182(82)90021-9; GANGLOFF RA, 1998, DAKOTERRA, V5, P79; Gasparini Zulma, 1996, Memoirs of the Queensland Museum, V39, P583; GREGORY RT, 1989, EARTH PLANET SC LETT, V92, P27, DOI 10.1016/0012-821X(89)90018-6; Hammer William R., 1999, National Science Museum Monographs, V15, P211; Hotton N., 1980, COLD LOOK WARM BLOOD, P311; Laplace P. S., 1798, TRAITE MECANIQUE CEL, V2; PARRISH JT, 1988, GEOLOGY, V16, P22, DOI 10.1130/0091-7613(1988)016<0022:LCTVAN>2.3.CO;2; Pasch Anne D., 2001, P219; RICH TH, 2000, DINOSAURS DARKNESS; RICH TH, 1997, DINOSAUR ENCY, P562; Warren Anne, 1997, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V247, P1	16	75	79	0	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2002	295	5557					979	980		10.1126/science.1068920	http://dx.doi.org/10.1126/science.1068920			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834803				2022-12-24	WOS:000173793000030
J	Costa, RM; Federov, NB; Kogan, JH; Murphy, GG; Stern, J; Ohno, M; Kucherlapati, R; Jacks, T; Silva, AJ				Costa, RM; Federov, NB; Kogan, JH; Murphy, GG; Stern, J; Ohno, M; Kucherlapati, R; Jacks, T; Silva, AJ			Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1	NATURE			English	Article							LONG-TERM POTENTIATION; MORRIS WATER MAZE; FARNESYLTRANSFERASE INHIBITORS; N-RAS; NF1; GENE; CELLS; GAP; IMPAIRMENT; DROSOPHILA	Neurofibromatosis type I (NF1) is one of the most common single-gene disorders that causes learning deficits in humans(1). Mice carrying a heterozygous null mutation of the Nf1 gene (Nf1(+/-)) show important features of the learning deficits associated with NF1 (ref. 2). Although neurofibromin has several known properties and functions, including Ras GTPase-activating protein activity(3,4), adenylyl cyclase modulation(5,6) and microtubule binding(7), it is unclear which of these are essential for learning in mice and humans. Here we show that the learning deficits of Nf1(+/-) mice can be rescued by genetic and pharmacological manipulations that decrease Ras function. We also show that the Nf1(+/-) mice have increased GABA (gamma-amino butyric acid)-mediated inhibition and specific deficits in long-term potentiation, both of which can be reversed by decreasing Ras function. Our results indicate that the learning deficits associated with NF1 may be caused by excessive Ras activity, which leads to impairments in long-term potentiation caused by increased GABA-mediated inhibition. Our findings have implications for the development of treatments for learning deficits associated with NF1.	Univ Calif Los Angeles, BRI, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, BRI, Dept Psychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, BRI, Dept Psychol, Los Angeles, CA 90095 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Yeshiva University; Albert Einstein College of Medicine; Massachusetts Institute of Technology (MIT)	Silva, AJ (corresponding author), Univ Calif Los Angeles, BRI, Dept Neurobiol, Los Angeles, CA 90095 USA.		Silva, Alcino/ABD-7684-2021; Kucherlapati, Raju/ABC-8807-2021	Silva, Alcino/0000-0002-1587-4558; Stern, Joel N.H./0000-0002-1259-2256; Silva, Alcino/0000-0001-5525-0494; Costa, Rui M./0000-0003-0495-8374	NINDS NIH HHS [R01 NS38480] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038480] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; Chapman CA, 1998, HIPPOCAMPUS, V8, P289, DOI 10.1002/(SICI)1098-1063(1998)8:3<289::AID-HIPO10>3.0.CO;2-X; Chorvatova A, 2000, ENDOCRINOLOGY, V141, P684, DOI 10.1210/en.141.2.684; Costa RM, 2001, NAT GENET, V27, P399, DOI 10.1038/86898; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Gibbs JB, 1997, CURR OPIN CHEM BIOL, V1, P197, DOI 10.1016/S1367-5931(97)80010-5; Guo HF, 2000, NATURE, V403, P895, DOI 10.1038/35002593; Guo HF, 1997, SCIENCE, V276, P795, DOI 10.1126/science.276.5313.795; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Ingram DA, 2001, J EXP MED, V194, P57, DOI 10.1084/jem.194.1.57; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Kim HA, 1997, MOL CELL BIOL, V17, P862, DOI 10.1128/MCB.17.2.862; Klose A, 1998, HUM MOL GENET, V7, P1261, DOI 10.1093/hmg/7.8.1261; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Muthalif MM, 2000, HYPERTENSION, V35, P457, DOI 10.1161/01.HYP.35.1.457; North K, 2000, AM J MED GENET, V97, P119, DOI 10.1002/1096-8628(200022)97:2<119::AID-AJMG3>3.0.CO;2-3; Ozonoff S, 1999, AM J MED GENET, V89, P45, DOI 10.1002/(SICI)1096-8628(19990326)89:1<45::AID-AJMG9>3.0.CO;2-J; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; TONG J, 2000, SOC NEUR ABSTR; UMANOFF H, 1995, P NATL ACAD SCI USA, V92, P1709, DOI 10.1073/pnas.92.5.1709; Voikar V, 2001, PHYSIOL BEHAV, V72, P271, DOI 10.1016/S0031-9384(00)00405-4; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; Xu HM, 1997, BRAIN RES, V759, P149, DOI 10.1016/S0006-8993(97)00328-4; YAN N, 1995, CANCER RES, V55, P3569	30	418	430	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					526	530		10.1038/nature711	http://dx.doi.org/10.1038/nature711			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11793011				2022-12-24	WOS:000173564300047
J	Salanoubat, M; Genin, S; Artiguenave, F; Gouzy, J; Mangenot, S; Arlat, M; Billault, A; Brottier, P; Camus, JC; Cattolico, L; Chandler, M; Choisne, N; Claudel-Renard, C; Cunnac, S; Demange, N; Gaspin, C; Lavie, M; Moisan, A; Robert, C; Saurin, W; Schiex, T; Siguier, P; Thebault, P; Whalen, M; Wincker, P; Levy, M; Weissenbach, J; Boucher, CA				Salanoubat, M; Genin, S; Artiguenave, F; Gouzy, J; Mangenot, S; Arlat, M; Billault, A; Brottier, P; Camus, JC; Cattolico, L; Chandler, M; Choisne, N; Claudel-Renard, C; Cunnac, S; Demange, N; Gaspin, C; Lavie, M; Moisan, A; Robert, C; Saurin, W; Schiex, T; Siguier, P; Thebault, P; Whalen, M; Wincker, P; Levy, M; Weissenbach, J; Boucher, CA			Genome sequence of the plant pathogen Ralstonia solanacearum	NATURE			English	Article							SYMBIONT SINORHIZOBIUM-MELILOTI; PSEUDOMONAS-SOLANACEARUM; SECRETION APPARATUS; ESCHERICHIA-COLI; PROTEINS; VIRULENCE; GENES; BACTERIA; HRP; IDENTIFICATION	Ralstonia solanacearum is a devastating, soil-borne plant pathogen with a global distribution and an unusually wide host range. It is a model system for the dissection of molecular determinants governing pathogenicity. We present here the complete genome sequence and its analysis of strain GMI1000. The 5.8-megabase (Mb) genome is organized into two replicons: a 3.7-Mb chromosome and a 2.1-Mb megaplasmid. Both replicons have a mosaic structure providing evidence for the acquisition of genes through horizontal gene transfer. Regions containing genetically mobile elements associated with the percentage of G+C bias may have an important function in genome evolution. The genome encodes many proteins potentially associated with a role in pathogenicity. In particular, many putative attachment factors were identified. The complete repertoire of type III secreted effector proteins can be studied. Over 40 candidates were identified. Comparison with other genomes suggests that bacterial plant pathogens and animal pathogens harbour distinct arrays of specialized type III-dependent effectors.	INRA, CNRS, Lab Biol Mol Interact Plantes Microorganismes, F-31326 Castanet Tolosan, France; Genoscope, F-91057 Evry, France; CNRS, UMR 8030, F-91057 Evry, France; Fdn Jean Dausset, CEPH, F-75010 Paris, France; CNRS, LMGM, F-31062 Toulouse, France; INRA, URGV, F-91057 Evry, France; INRA, Lab Genet Cellulaire, F-31326 Castanet Tolosan, France; INRA, Unite Biometrie & Intelligence Artificielle, F-31326 Castanet Tolosan, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Foundation Jean Dausset-CEPH; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; INRAE	Boucher, CA (corresponding author), INRA, CNRS, Lab Biol Mol Interact Plantes Microorganismes, BP27, F-31326 Castanet Tolosan, France.	boucher@toulouse.inra.fr	Thébault, Patricia/AAD-1105-2020; Gouzy, Jerome/AAH-4977-2020; Arlat, Matthieu/CAH-3310-2022; Gaspin, Christine/B-6756-2015	Thébault, Patricia/0000-0003-2276-4573; Gouzy, Jerome/0000-0001-5695-4557; CHOISNE, Nathalie/0000-0001-6024-1664; Chandler, Michael/0000-0002-0292-6662; Arlat, Matthieu/0000-0001-6196-4856; Genin, Stephane/0000-0003-2498-2400; Lavie, Muriel/0000-0003-3308-811X; Cunnac, Sebastien/0000-0002-3695-491X				Alfano JR, 2000, P NATL ACAD SCI USA, V97, P4856, DOI 10.1073/pnas.97.9.4856; Alfano JR, 1996, PLANT CELL, V8, P1683, DOI 10.1105/tpc.8.10.1683; Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; Bertolla F, 1997, APPL ENVIRON MICROB, V63, P4965, DOI 10.1128/AEM.63.12.4965-4968.1997; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; BOUCHER C, 1986, MOL GEN GENET, V205, P270, DOI 10.1007/BF00430438; Boucher C. A., 1988, Molecular Plant-Microbe Interactions, V1, P282, DOI 10.1094/MPMI-1-282; BRUMBLEY SM, 1993, J BACTERIOL, V175, P5477, DOI 10.1128/JB.175.17.5477-5487.1993; Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x; Capela D, 2001, P NATL ACAD SCI USA, V98, P9877, DOI 10.1073/pnas.161294398; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Ezra D, 2000, MOL PLANT MICROBE IN, V13, P683, DOI 10.1094/MPMI.2000.13.6.683; Fenselau S, 1995, MOL PLANT MICROBE IN, V8, P845, DOI 10.1094/MPMI-8-0845; FISCHER RA, 1922, J R STAT SOC, V85, P87; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; GRANADA GA, 1983, CAN J MICROBIOL, V29, P433, DOI 10.1139/m83-070; Gueneron M, 2000, MOL MICROBIOL, V36, P261, DOI 10.1046/j.1365-2958.2000.01870.x; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; HAYWARD A. C., 2000, ENCY MICROBIOLOGY, V4, P32; Jacob-Dubuisson F, 2001, MOL MICROBIOL, V40, P306, DOI 10.1046/j.1365-2958.2001.02278.x; Kachlany SC, 2001, MOL MICROBIOL, V40, P542, DOI 10.1046/j.1365-2958.2001.02422.x; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Karp PD, 1999, NUCLEIC ACIDS RES, V27, P55, DOI 10.1093/nar/27.1.55; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kjemtrup S, 2000, CURR OPIN MICROBIOL, V3, P73, DOI 10.1016/S1369-5274(99)00054-5; Lally ET, 1999, TRENDS MICROBIOL, V7, P356, DOI 10.1016/S0966-842X(99)01530-9; Leach JE, 1996, ANNU REV PHYTOPATHOL, V34, P153, DOI 10.1146/annurev.phyto.34.1.153; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Matthysse AG, 2000, BBA-GENE STRUCT EXPR, V1490, P208, DOI 10.1016/S0167-4781(99)00250-X; Merlin C, 1997, MOL GEN GENET, V253, P499; Oggioni MR, 1999, MICROBIOL-SGM, V145, P2647, DOI 10.1099/00221287-145-10-2647; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; ROSENBERG C, 1982, J BACTERIOL, V150, P402, DOI 10.1128/JB.150.1.402-406.1982; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; Skerker JM, 2000, EMBO J, V19, P3223, DOI 10.1093/emboj/19.13.3223; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Smith E. F., 1896, US DEP AGR DIV VEG P, P1; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Thebaut P, 2000, JOBIM C P, P361; Wall D, 1999, MOL MICROBIOL, V32, P1, DOI 10.1046/j.1365-2958.1999.01339.x; Wang YD, 1998, J BACTERIOL, V180, P4102, DOI 10.1128/JB.180.16.4102-4110.1998; Wendler WMF, 1997, J BIOL CHEM, V272, P8482, DOI 10.1074/jbc.272.13.8482; Wilderman PJ, 2001, MOL MICROBIOL, V39, P291, DOI 10.1046/j.1365-2958.2001.02282.x; YABUUCHI E, 1995, MICROBIOL IMMUNOL, V39, P897, DOI 10.1111/j.1348-0421.1995.tb03275.x	47	699	1401	4	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					497	502		10.1038/415497a	http://dx.doi.org/10.1038/415497a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823852	Bronze			2022-12-24	WOS:000173564300038
J	Smith, AE; Slepchenko, BM; Schaff, JC; Loew, LM; Macara, IG				Smith, AE; Slepchenko, BM; Schaff, JC; Loew, LM; Macara, IG			Systems analysis of Ran transport	SCIENCE			English	Article							PORE COMPLEX PROTEIN; BINDING PROTEIN; NUCLEAR IMPORT; RCC1; GTPASE; NTF2; ACTIVATION; MECHANISM; BETA; P62	The separate components of nucleocytoplasmic transport have been well characterized, including the key regulatory rote of Ran, a guanine nucleotide triphosphatase. However, the overall system behavior in intact cells is difficult to analyze because the dynamics of these components are interdependent. We used a combined experimental and computational approach to study Ran transport in vivo. The resulting model provides the first quantitative picture of Ran flux between the nuclear and cytoplasmic compartments in eukaryotic cells. The model predicts that the Ran exchange factor RCC1, and not the flux capacity of the nuclear pore complex (NPC), is the crucial regulator of steady-state flux across the NPC. Moreover, it provides the first estimate of the total in vivo flux (520 molecules per NPC per second and predicts that the transport system is robust.	Univ Virginia, Dept Pharmacol, Ctr Cell Signaling, Charlottesville, VA 22908 USA; Univ Virginia, Dept Microbiol, Ctr Cell Signaling, Charlottesville, VA 22908 USA; Univ Connecticut, Ctr Hlth, Ctr Biomed Imaging Technol, Farmington, CT 06030 USA	University of Virginia; University of Virginia; University of Connecticut	Macara, IG (corresponding author), Univ Virginia, Dept Pharmacol, Ctr Cell Signaling, Charlottesville, VA 22908 USA.			Loew, Leslie/0000-0002-1851-4646	NCRR NIH HHS [NCRR-RR13186] Funding Source: Medline; NIGMS NIH HHS [GM-50526, NIH-GM-20438] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050526] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BISCHOFF FR, 1991, P NATL ACAD SCI USA, V88, P10830, DOI 10.1073/pnas.88.23.10830; Bischoff FR, 1997, FEBS LETT, V419, P249, DOI 10.1016/S0014-5793(97)01467-1; CLARKE PR, 1995, J CELL SCI, V108, P1217; Clarkson WD, 1996, J MOL BIOL, V263, P517, DOI 10.1006/jmbi.1996.0594; CORDES VC, 1995, EUR J CELL BIOL, V68, P240; Fink C, 1998, BIOPHYS J, V75, P1648, DOI 10.1016/S0006-3495(98)77607-6; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Lounsbury KM, 1996, J BIOL CHEM, V271, P32834, DOI 10.1074/jbc.271.51.32834; Lounsbury KM, 1997, J BIOL CHEM, V272, P551; NISHITANI H, 1991, EMBO J, V10, P1555, DOI 10.1002/j.1460-2075.1991.tb07675.x; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; PASCHAL BM, 1995, J CELL BIOL, V129, P925, DOI 10.1083/jcb.129.4.925; Pemberton LF, 1999, J CELL BIOL, V145, P1407, DOI 10.1083/jcb.145.7.1407; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Richards SA, 1997, SCIENCE, V276, P1842, DOI 10.1126/science.276.5320.1842; Schaff JC, 2000, METHOD ENZYMOL, V321, P1; Senger B, 1998, EMBO J, V17, P2196, DOI 10.1093/emboj/17.8.2196; Smith W, 1998, PIANO KEYBOARD, V1, P8	21	150	156	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					488	491		10.1126/science.1064732	http://dx.doi.org/10.1126/science.1064732			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799242				2022-12-24	WOS:000173350700048
J	Donaldson, GC; Keatinge, WR				Donaldson, GC; Keatinge, WR			Excess winter mortality: influenza or cold stress? Observational study	BRITISH MEDICAL JOURNAL			English	Article							DISEASE		Univ London Queen Mary & Westfield Coll, Div Biomed Sci, London E1 4NS, England	University of London; Queen Mary University London	Keatinge, WR (corresponding author), Univ London Queen Mary & Westfield Coll, Div Biomed Sci, Mile End Rd, London E1 4NS, England.		Donaldson, Gavin/M-7992-2017	Donaldson, Gavin/0000-0002-5538-4190				Donaldson GC, 1997, J EPIDEMIOL COMMUN H, V51, P643, DOI 10.1136/jech.51.6.643; Fleming D M, 2000, Commun Dis Public Health, V3, P32; Keatinge WR, 1997, LANCET, V349, P1341, DOI 10.1016/S0140-6736(96)12338-2; KEATINGE WR, 1986, BRIT MED J, V293, P732, DOI 10.1136/bmj.293.6549.732-a; KHAW KT, 1995, BRIT MED J, V310, P1559, DOI 10.1136/bmj.310.6994.1559	5	65	68	0	13	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 12	2002	324	7329					89	90		10.1136/bmj.324.7329.89	http://dx.doi.org/10.1136/bmj.324.7329.89			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512LG	11786453	Bronze, Green Published			2022-12-24	WOS:000173325400018
J	van Dam, MJ; de Groot, E; Clee, SM; Hovingh, GK; Roelants, R; Brooks-Wilson, A; Zwinderman, AH; Smit, AJ; Smelt, AHM; Groen, AK; Hayden, MR; Kastelein, JJP				van Dam, MJ; de Groot, E; Clee, SM; Hovingh, GK; Roelants, R; Brooks-Wilson, A; Zwinderman, AH; Smit, AJ; Smelt, AHM; Groen, AK; Hayden, MR; Kastelein, JJP			Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study	LANCET			English	Article							HIGH-DENSITY-LIPOPROTEIN; CORONARY HEART-DISEASE; INTIMA-MEDIA THICKNESS; BINDING CASSETTE TRANSPORTER-1; GROWTH EVALUATION STATIN; ATHEROSCLEROSIS RISK; TANGIER-DISEASE; HDL CHOLESTEROL; CAROTID-ARTERY; ABC1 GENE	Background Decreased concentrations of HDL cholesterol are associated with increased cardiovascular risk. These concentrations are directly related to cholesterol efflux from cells-the first step and a key process in reverse cholesterol transport. Cholesterol efflux is mediated by the ATP-binding cassette A1 transporter (ABCA1), the rate-limiting step in the production of HDL. We aimed to assess the relation between cholesterol efflux, HDL concentrations, and arterial-wall changes in individuals with impaired ABCA1 function. Methods We investigated 30 individuals from families with ABCA1 mutations, and 110 controls matched for age, sex, and ethnic origin. We measured concentrations of HDL cholesterol in plasma and intima-media thickness of the carotid arteries by B-mode ultrasonography in all participants, We also measured cholesterol efflux from skin fibroblasts in nine individuals with ABCA1 mutations and in ten controls. Findings Individuals with ABCA1 mutations had lower amounts of cholesterol efflux, lower HDL cholesterol concentrations, and-greater intima-media thicknesses than controls. An intima-media thickness at the upper limit of normal (0.80 mm) was reached by age 55 years in the ABCA1 heterozygotes, and at age 80 years in unaffected controls (p<0.0001). Additionally, strong positive correlations were seen between HDL cholesterol concentrations and cholesterol efflux (r=0.90, p=0.001), and negative correlations between apolipoprotein-Al-mediated (r=-0.61, p=0.030) and HDL-particle-mediated (r=-0.60, p=0.018) efflux and intima-media thickness in the ABCA1 mutation carriers. Interpretation These results show a direct relation between ABCA1-mediated cellular cholesterol efflux and arterial-wall thickness, and therefore suggest that increasing efflux could inhibit atherosclerosis progression before the manifestation of symptomatic cardiovascular disease.	Univ Amsterdam, Acad Med Ctr, Dept Vasc Med G1 146, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Expt Hematol, NL-1105 AZ Amsterdam, Netherlands; Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada; Xenon Genet, Vancouver, BC, Canada; Leiden Univ, Med Ctr, Dept Med Stat, NL-2300 RA Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Internal Med, NL-2300 RA Leiden, Netherlands; Univ Groningen Hosp, Dept Internal Med, NL-9713 EZ Groningen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of British Columbia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen	Kastelein, JJP (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med G1 146, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.		Brooks-Wilson, Angela/E-9399-2012; Clee, Susanne/AAC-4278-2020; Kastelein, John/AAF-7950-2020; van Dam, Marjel/AFT-3071-2022; Clee, Susanne/F-7312-2010; Hayden, Michael R/D-8581-2011	Brooks-Wilson, Angela/0000-0003-1009-6408; Clee, Susanne/0000-0001-7946-688X; Hayden, Michael R/0000-0001-5159-1419; van Dam, Marjel/0000-0001-9802-7516				Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; BOTS ML, 1992, HYPERTENSION, V19, P717, DOI 10.1161/01.HYP.19.6.717; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; BURKE GL, 1995, STROKE, V26, P386, DOI 10.1161/01.STR.26.3.386; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; Chambless LE, 1996, ULTRASOUND MED BIOL, V22, P545, DOI 10.1016/0301-5629(96)00039-7; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Clee SM, 2001, CIRCULATION, V103, P1198; Clee SM, 2000, J CLIN INVEST, V106, P1263, DOI 10.1172/JCI10727; de Groot E, 1998, J AM COLL CARDIOL, V31, P1561, DOI 10.1016/S0735-1097(98)00170-3; de Groot E, 1998, ULTRASOUND MED BIOL, V24, P825, DOI 10.1016/S0301-5629(98)00037-4; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Glomset J A, 1973, Adv Lipid Res, V11, P1; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; JUKEMA JW, 1995, CIRCULATION, V91, P2528, DOI 10.1161/01.CIR.91.10.2528; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Marcil M, 1999, LANCET, V354, P1341, DOI 10.1016/S0140-6736(99)07026-9; MILLER GJ, 1975, LANCET, V1, P16; MULLENBACH R, 1989, TRENDS GENET, V5, P391; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Owen JS, 1999, LANCET, V354, P1402, DOI 10.1016/S0140-6736(99)00297-4; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; SELZER RH, 1994, ATHEROSCLEROSIS, V111, P1, DOI 10.1016/0021-9150(94)90186-4; Singaraja RR, 2001, J BIOL CHEM, V276, P33969, DOI 10.1074/jbc.M102503200; Smilde TJ, 2000, EUR J CLIN INVEST, V30, P473; Smilde TJ, 2001, LANCET, V357, P577, DOI 10.1016/S0140-6736(00)04053-8; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P373, DOI 10.1056/NEJM199108083250601; STOK WJ, 2001, 3 C PULS WAV AN LOND; Vaisman BL, 2001, J CLIN INVEST, V108, P303; Wang J, 2000, ARTERIOSCL THROM VAS, V20, P1983, DOI 10.1161/01.ATV.20.8.1983	31	169	172	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 5	2002	359	9300					37	41		10.1016/S0140-6736(02)07277-X	http://dx.doi.org/10.1016/S0140-6736(02)07277-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809185				2022-12-24	WOS:000173143500014
J	Yan, H; Zhang, XP; Shen, ZY; Seeman, NC				Yan, H; Zhang, XP; Shen, ZY; Seeman, NC			A robust DNA mechanical device controlled by hybridization topology	NATURE			English	Article							DOUBLE-CROSSOVER MOLECULES; LIGATION; DESIGN	Controlled mechanical movement in molecular-scale devices has been realized in a variety of systems-catenanes and rotaxanes(1-3), chiroptical molecular switches(4), molecular ratchets(5) and DNA(6)- by exploiting conformational changes triggered by changes in redox potential or temperature, reversible binding of small molecules or ions, or irradiation. The incorporation of such devices into arrays(7,8) could in principle lead to complex structural states suitable for nanorobotic applications, provided that individual devices can be addressed separately. But because the triggers commonly used tend to act equally on all the devices that are present, they will need to be localized very tightly. This could be readily achieved with devices that are controlled individually by separate and device-specific reagents. A trigger mechanism that allows such specific control is the reversible binding of DNA strands, thereby 'fuelling' conformational changes in a DNA machine(9). Here we improve upon the initial prototype system that uses this mechanism but generates by-products(9), by demonstrating a robust sequence-dependent rotary DNA device operating in a four-step cycle. We show that DNA strands control and fuel our device cycle by inducing the interconversion between two robust topological motifs, paranemic crossover (PX) DNA(10,11) and its topoisomer JX(2) DNA, in which one strand end is rotated relative to the other by 180 degrees. We expect that a wide range of analogous yet distinct rotary devices can be created by changing the control strands and the device sequences to which they bind.	NYU, Dept Chem, New York, NY 10003 USA	New York University	Seeman, NC (corresponding author), NYU, Dept Chem, New York, NY 10003 USA.							Brouwer AM, 2001, SCIENCE, V291, P2124, DOI 10.1126/science.1057886; CARUTHERS MH, 1985, SCIENCE, V230, P281, DOI 10.1126/science.3863253; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Jimenez MC, 2000, ANGEW CHEM INT EDIT, V39, P3284, DOI 10.1002/1521-3773(20000915)39:18<3284::AID-ANIE3284>3.0.CO;2-7; Kelly TR, 1999, NATURE, V401, P150, DOI 10.1038/43639; Koumura N, 1999, NATURE, V401, P152, DOI 10.1038/43646; LaBean TH, 2000, J AM CHEM SOC, V122, P1848, DOI 10.1021/ja993393e; Mao CD, 1999, NATURE, V397, P144, DOI 10.1038/16437; Pease AR, 2001, ACCOUNTS CHEM RES, V34, P433, DOI 10.1021/ar000178q; SEEMAN NC, 1990, J BIOMOL STRUCT DYN, V8, P573, DOI 10.1080/07391102.1990.10507829; Seeman NC, 2001, NANO LETT, V1, P22, DOI 10.1021/nl000182v; Shen Z, 1999, THESIS NEW YORK U; Sun WQ, 1999, J MOL BIOL, V294, P683, DOI 10.1006/jmbi.1999.3155; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yang XP, 1998, J AM CHEM SOC, V120, P9779, DOI 10.1021/ja9817601; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524	16	624	645	7	240	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					62	65		10.1038/415062a	http://dx.doi.org/10.1038/415062a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780115				2022-12-24	WOS:000173028800038
J	Silver, DL; Montell, DJ				Silver, DL; Montell, DJ			Paracrine signaling through the JAK/STAT pathway activates invasive behavior of ovarian epithelial cells in Drosophila	CELL			English	Article							FOCAL ADHESION KINASE; JAK-STAT PATHWAY; CONSTITUTIVE ACTIVATION; IN-VIVO; PROTEIN; GENE; MIGRATION; OOGENESIS; ENCODES; C/EBP	The JAK/STAT signaling pathway, renowned for its effects on cell proliferation and survival, is constitutively active in various human cancers, including ovarian. We have found that JAK and STAT are required to convert the border cells in the Drosophila ovary from stationary, epithelial cells to migratory, invasive cells. The ligand for this pathway, Unpaired (UPD), is expressed by two central cells within the migratory cell cluster. Mutations in upd or jak cause defects in migration and a reduction in the number of cells recruited to the cluster. Ectopic expression of either UPD or JAK is sufficient to induce extra epithelial cells to migrate. Thus, a localized signal activates the JAK/ STAT pathway in neighboring epithelial cells, causing them to become invasive.	Johns Hopkins Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Montell, DJ (corresponding author), Johns Hopkins Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.			Silver, Debra/0000-0001-9189-844X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM046425, R01GM046425] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 46425] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akira S, 1999, STEM CELLS, V17, P138, DOI 10.1002/stem.170138; Bai JW, 2000, CELL, V103, P1047, DOI 10.1016/S0092-8674(00)00208-7; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1996, P NATL ACAD SCI USA, V93, P7673, DOI 10.1073/pnas.93.15.7673; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Bromberg JF, 2001, BIOESSAYS, V23, P161, DOI 10.1002/1521-1878(200102)23:2<161::AID-BIES1023>3.0.CO;2-0; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; Campbell CL, 2001, AM J PATHOL, V158, P25, DOI 10.1016/S0002-9440(10)63940-5; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Catlett-Falcone Robyn, 1999, Current Opinion in Oncology, V11, P490, DOI 10.1097/00001622-199911000-00010; DAMELL JE, 1997, SCIENCE, V277, P1630; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Duffy JB, 1998, DEVELOPMENT, V125, P2263; Fox GL, 1999, P NATL ACAD SCI USA, V96, P14978, DOI 10.1073/pnas.96.26.14978; Gao B, 2001, FEBS LETT, V488, P179, DOI 10.1016/S0014-5793(00)02430-3; Han DD, 2000, DEVELOPMENT, V127, P573; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; Horvath CM, 2000, TRENDS BIOCHEM SCI, V25, P496, DOI 10.1016/S0968-0004(00)01624-8; Hou XS, 1997, TRENDS GENET, V13, P105, DOI 10.1016/S0168-9525(97)01006-8; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Huang M, 2000, GYNECOL ONCOL, V79, P67, DOI 10.1006/gyno.2000.5931; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Jinks TM, 2000, MOL CELL, V5, P581, DOI 10.1016/S1097-2765(00)80451-7; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liu YR, 1999, DEVELOPMENT, V126, P1869; Liu YR, 2001, DEVELOPMENT, V128, P321; Luo H, 1997, MOL CELL BIOL, V17, P1562, DOI 10.1128/MCB.17.3.1562; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.3.CO;2-O; MCGREGOR JR, 2002, IN PRESS DEVELOPMENT; MERMALL V, 1995, J CELL BIOL, V129, P1575, DOI 10.1083/jcb.129.6.1575; MONTELL DJ, 1992, CELL, V71, P51, DOI 10.1016/0092-8674(92)90265-E; Montell DJ, 2001, MECH DEVELOP, V105, P19, DOI 10.1016/S0925-4773(01)00393-8; Montell DJ, 1999, DEVELOPMENT, V126, P3035; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; Palmer RH, 1999, J BIOL CHEM, V274, P35621, DOI 10.1074/jbc.274.50.35621; Rorth P, 2000, MOL CELL, V6, P23; RORTH P, 1992, GENE DEV, V6, P2299, DOI 10.1101/gad.6.12a.2299; Rorth P, 1998, DEVELOPMENT, V125, P1049; RUOHOLA H, 1991, CELL, V66, P433, DOI 10.1016/0092-8674(81)90008-8; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Sefton L, 2000, NATURE, V405, P970, DOI 10.1038/35016119; Shen YH, 2001, P NATL ACAD SCI USA, V98, P1543, DOI 10.1073/pnas.041588198; Spradling Allan C., 1993, P1; Sundfeldt K, 1999, BRIT J CANCER, V79, P1240, DOI 10.1038/sj.bjc.6690199; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Yan RQ, 1996, P NATL ACAD SCI USA, V93, P5842, DOI 10.1073/pnas.93.12.5842; Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8; Zeidler MP, 1999, CURR BIOL, V9, P1363, DOI 10.1016/S0960-9822(00)80081-0; Zhang XF, 2001, BLOOD, V97, P3342, DOI 10.1182/blood.V97.11.3342	51	228	230	0	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 28	2001	107	7					831	841		10.1016/S0092-8674(01)00607-9	http://dx.doi.org/10.1016/S0092-8674(01)00607-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507JQ	11779460	Bronze			2022-12-24	WOS:000173024200005
J	Eagles, JM				Eagles, JM			SAD - help arrives with the dawn?	LANCET			English	Editorial Material							WINTER DEPRESSION; LIGHT; SIMULATION		Royal Cornhill Hosp, Dept Psychiat, Aberdeen AB25 2ZH, Scotland		Eagles, JM (corresponding author), Royal Cornhill Hosp, Dept Psychiat, Aberdeen AB25 2ZH, Scotland.							Ando K, 1996, BIOL PSYCHIAT, V39, P22, DOI 10.1016/0006-3223(95)00109-3; Avery DH, 2001, BIOL PSYCHIAT, V50, P205, DOI 10.1016/S0006-3223(01)01200-8; Brainard GC, 2001, J NEUROSCI, V21, P6405; Eagles JM, 1999, BRIT J PSYCHIAT, V175, P472, DOI 10.1192/bjp.175.5.472; Lewy AJ, 1998, ARCH GEN PSYCHIAT, V55, P890, DOI 10.1001/archpsyc.55.10.890; LEWY AJ, 1987, SCIENCE, V235, P352, DOI 10.1126/science.3798117; Lingjaerde O, 1998, ACTA PSYCHIAT SCAND, V98, P73, DOI 10.1111/j.1600-0447.1998.tb10045.x; Michalak EE, 2001, BRIT J PSYCHIAT, V179, P31, DOI 10.1192/bjp.179.1.31; TERMAN M, 1989, BIOL PSYCHIAT, V25, P966, DOI 10.1016/0006-3223(89)90276-X; Thompson C., 2001, SEASONAL AFFECTIVE D, P151	10	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 22	2001	358	9299					2100	2100		10.1016/S0140-6736(01)07232-4	http://dx.doi.org/10.1016/S0140-6736(01)07232-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505GV	11784620				2022-12-24	WOS:000172905800005
J	Pepperberg, DR; Crouch, RK				Pepperberg, DR; Crouch, RK			An illuminating new step in visual-pigment regeneration	LANCET			English	Editorial Material									Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60612 USA; Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Medical University of South Carolina	Pepperberg, DR (corresponding author), Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60612 USA.							Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; BERNSTEIN PS, 1987, P NATL ACAD SCI USA, V84, P1849, DOI 10.1073/pnas.84.7.1849; Chen P, 2001, NAT GENET, V28, P256, DOI 10.1038/90089; Cideciyan AV, 2000, VISUAL NEUROSCI, V17, P667, DOI 10.1017/S0952523800175029; JIANG M, 1993, INVEST OPHTH VIS SCI, V34, P3669; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Morimura H, 1999, NAT GENET, V23, P393, DOI 10.1038/70496; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Saari JC, 2001, NEURON, V29, P739, DOI 10.1016/S0896-6273(01)00248-3; Seeliger MW, 2001, NAT GENET, V29, P70, DOI 10.1038/ng712; Terakita A, 2000, P NATL ACAD SCI USA, V97, P14263, DOI 10.1073/pnas.260349597; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9	14	15	16	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 22	2001	358	9299					2098	2099		10.1016/S0140-6736(01)07231-2	http://dx.doi.org/10.1016/S0140-6736(01)07231-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505GV	11784619				2022-12-24	WOS:000172905800004
J	Trewavas, A				Trewavas, A			Mindless mastery	NATURE			English	Editorial Material									Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JH, Midlothian, Scotland	University of Edinburgh	Trewavas, A (corresponding author), Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JH, Midlothian, Scotland.							Bazzaz FA, 2000, PLANTS CHANGING ENV; SILVERTOWN J, 1989, ANNU REV ECOL SYST, V20, P349, DOI 10.1146/annurev.es.20.110189.002025; STENHOUSE D, 1974, EVOLUTION INTELLIGEN; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0	4	64	66	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 21	2002	415	6874					841	841		10.1038/415841a	http://dx.doi.org/10.1038/415841a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859344	Bronze			2022-12-24	WOS:000173941000021
J	Dahl, M; Tybjaerg-Hansen, A; Lange, P; Vestbo, J; Nordestgaard, BG				Dahl, M; Tybjaerg-Hansen, A; Lange, P; Vestbo, J; Nordestgaard, BG			Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha(1)-antitrypsin MZ heterozygotes: A longitudinal study of the general population	ANNALS OF INTERNAL MEDICINE			English	Article							ALPHA-1-ANTITRYPSIN GENE; PIMZ PHENOTYPE; TAQ-I; DEFICIENCY; RISK; INTERMEDIATE; POLYMORPHISM; INDIVIDUALS; MUTATION; REGION	Background: A deteriorating effect of severe alpha(1)-antitrypsin deficiency (ZZ genotype) on lung function is well known, whereas the role of intermediate deficiency (MZ genotype) remains uncertain. Objective: To test the hypothesis that MZ intermediate alpha(1)-antitrypsin deficiency affects pulmonary function and disease. Design: Population-based cohort study with 21-year follow-up. Setting: Copenhagen, Denmark. Participants: 9187 adults randomly selected from the Danish general population. Measurements: Plasma alpha(1)-antitrypsin levels, annual decrease in FEV1, airway obstruction, and hospitalization and mortality from chronic obstructive pulmonary disease (COPD). Results: 451 participants (4.9%) carried the MZ genotype. Plasma alpha(1)-antitrypsin levels were 31% lower in MZ heterozygotes than in persons with the MM genotype (Student t-test, P < 0.001). Annual decrease in FEV1 was 25 mL in MZ heterozygotes and 21 mL in persons with the MM genotype (t-test, P = 0.048). Airway obstruction was found in 19% of MZ heterozygotes compared with 15% of MM carriers (chi-square test, P = 0.023); in a logistic regression analysis adjusted for age, sex, and tobacco consumption, the corresponding odds ratio was 1.3 (Cl, 1.0 to 1.7). The incidence of hospitalization and mortality from COPD was 32 cases per 10 000 person-years in persons with the MZ genotype and 22 cases per 10 000 person-years in those with the MM genotype (log-rank test, P = 0.063). In a Cox regression model adjusted for age, sex, tobacco use, and FEV1 at study entry, relative risk for COPD outcomes in persons with the MZ genotype versus persons with the MM genotype was 1.5 (Cl, 1.0 to 2.3). All these results were independent of the S and E alleles in this gene and were not affected by cystic fibrosis DeltaF508 heterozygosity. Conclusions: MZ heterozygotes had a slightly greater rate of decrease in FEV1 and were modestly over-represented among persons with airway obstruction and COPD. In the population at large, MZ heterozygosity may account for a fraction of COPD cases-on the order of 2%, similar to the percentage of persons with COPD who have the severe but rare ZZ genotype.	Herlev Univ Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; Univ Copenhagen Hosp, DK-2100 Copenhagen, Denmark; Bispebjerg Hosp, DK-2400 Copenhagen NV, Denmark; Hvidovre Univ Hosp, DK-2650 Hvidovre, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen	Nordestgaard, BG (corresponding author), Herlev Univ Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark.	brno@herlevhosp.kbhamt.dk	Dahl, Morten/F-4219-2014; Vestbo, Jorgen/Y-2912-2019; Nordestgaard, Borge Gronne/ABF-1310-2020	Dahl, Morten/0000-0002-6686-312X; Vestbo, Jorgen/0000-0001-6355-6362				[Anonymous], 1984, Acta Med Scand Suppl, V682, P1; ARMITAGE P, 1987, STATISTICAL METHODS, P160; BARKER AF, 1996, LUNG BIOL HEALTH DIS, V88, P245; Benetazzo MG, 1999, RESP MED, V93, P648, DOI 10.1016/S0954-6111(99)90105-1; BRANTLY ML, 1991, CHEST, V100, P703, DOI 10.1378/chest.100.3.703; Buist AS, 1994, TXB RESP MED, P1259; COX DW, 1995, METABOLIC MOL BASES, P4125; Dahl M, 2001, CLIN CHEM, V47, P56; Dahl M, 2001, J ALLERGY CLIN IMMUN, V107, P818, DOI 10.1067/mai.2001.114117; DEHAMEL FA, 1981, NEW ZEAL MED J, V94, P407; ERIKSSON S, 1985, EUR J RESPIR DIS, V67, P279; Horton F O 3rd, 1980, Chest, V77, P261, DOI 10.1378/chest.77.2_Supplement.261-a; KHOURY MJ, 1993, FUNDAMENTALS GENETIC, P77; LANGE P, 1991, EUR RESPIR J, V4, P1080; LAURELL CB, 1963, SCAND J CLIN LAB INV, V15, P132, DOI 10.3109/00365516309051324; MADISON R, 1981, AM REV RESPIR DIS, V124, P149; Mahadeva R, 1999, J CLIN INVEST, V103, P999, DOI 10.1172/JCI4874; Mahadeva R, 1998, EUR RESPIR J, V11, P873, DOI 10.1183/09031936.98.11040873; MITTMAN C, 1978, AM REV RESPIR DIS, V118, P649, DOI 10.1164/arrd.1978.118.4.649; Morgan K, 1997, INT J BIOCHEM CELL B, V29, P1501, DOI 10.1016/S1357-2725(97)00118-0; MORGAN K, 1993, HUM MOL GENET, V2, P253, DOI 10.1093/hmg/2.3.253; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; POLLER W, 1990, EUR J CLIN INVEST, V20, P1; Sandford AJ, 1997, J MED GENET, V34, P874, DOI 10.1136/jmg.34.10.874; Seersholm N, 2000, AM J RESP CRIT CARE, V161, P81, DOI 10.1164/ajrccm.161.1.9812131; SING CF, 1985, AM J HUM GENET, V37, P268; SPSS, 1996, SPSS BAS 7 0 WIND US; TARJAN E, 1994, EUR RESPIR J, V7, P2199, DOI 10.1183/09031936.94.07122199; World Health Organization, 1965, MAN INT STAT CLASS D; World Health Organization, 1992, INT STAT CLASS DIS R; 1989, SCAND J SOC MED S, V41, P1; 1997, THORAX S2, V52, pS1	32	116	120	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2002	136	4					270	279		10.7326/0003-4819-136-4-200202190-00006	http://dx.doi.org/10.7326/0003-4819-136-4-200202190-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523FQ	11848724				2022-12-24	WOS:000173943700002
J	Arakawa, H; Hauschild, J; Buerstedde, JM				Arakawa, H; Hauschild, J; Buerstedde, JM			Requirement of the activation-induced deaminase (AID) gene for immunoglobulin gene conversion	SCIENCE			English	Article							GERMINAL-CENTERS; CELL-LINE; RECOMBINATION; HYPERMUTATION	Three phenotypically distinct processes-somatic hypermutation, gene conversion, and switch recombination-remodel the functionally rearranged immunoglobulin (Ig) loci in B cells. Somatic hypermutation and switch recombination have recently been shown to depend on the activation-induced deaminase (AID) gene product. Here, we show that the disruption of the AID gene in the chicken B cell line DT40 completely blocks Ig gene conversion and that this block can be complemented by reintroduction of the AID complementary DNA. This demonstrates that the AID master gene controls all B cell-specific modifications of vertebrate Ig genes.	Heinrich Pette Inst, Dept Cellular Immunol, D-20251 Hamburg, Germany	Heinrich Pette Institute	Buerstedde, JM (corresponding author), Heinrich Pette Inst, Dept Cellular Immunol, Martinistr 52, D-20251 Hamburg, Germany.							Arakawa H, 1996, EMBO J, V15, P2540, DOI 10.1002/j.1460-2075.1996.tb00611.x; Arakawa H, 2001, BMC Biotechnol, V1, P7, DOI 10.1186/1472-6750-1-7; ARAKAWA H, UNPUB; Bezzubova O, 1997, CELL, V89, P185, DOI 10.1016/S0092-8674(00)80198-1; Buerstedde JM, 2002, NUCLEIC ACIDS RES, V30, P230, DOI 10.1093/nar/30.1.230; BUERSTEDDE JM, 1990, EMBO J, V9, P921, DOI 10.1002/j.1460-2075.1990.tb08190.x; Diaz M, 1998, IMMUNOL REV, V162, P13, DOI 10.1111/j.1600-065X.1998.tb01425.x; HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; LISKAY RM, 1983, CELL, V35, P157, DOI 10.1016/0092-8674(83)90218-0; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100; TAKEDA S, 1992, P NATL ACAD SCI USA, V89, P4023, DOI 10.1073/pnas.89.9.4023; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543	17	360	373	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1301	1306		10.1126/science.1067308	http://dx.doi.org/10.1126/science.1067308			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847344				2022-12-24	WOS:000173926000046
J	Schep, G; Bender, MHM; van de Tempel, G; Wijn, PFF; de Vries, WR; Eikelboom, BC				Schep, G; Bender, MHM; van de Tempel, G; Wijn, PFF; de Vries, WR; Eikelboom, BC			Detection and treatment of claudication due to functional iliac obstruction in top endurance athletes: a prospective study	LANCET			English	Article							ARTERY ENDOFIBROSIS	Background Endurance athletes often have restrictions in flow in their iliac arteries during exercise. Such restrictions have previously been ascribed solely to intravascular lesions. We postulate that flow could also be restricted by functional kinking in the arteries, and that surgical release of these kinks might be an effective treatment. Methods We prospectively studied 80 endurance athletes Who had complaints suggestive of flow restriction in the iliac arteries of one (n=74) or both 6) legs (total 92 legs). Using vascular diagnostic tools, we examined athletes while they were doing activities that often provoke flow restrictions. Restrictions were determined by measurement of systolic pressure in the ankle after exercise: peak systolic velocities were measured with echo-doppler. Kinks were detected with echo-doppler and magnetic-resonance angiography. When functional kinking was diagnosed as the cause of the restriction, the athlete was offered surgery to release the iliac arteries, as part of our prospective study. Findings We recorded flow restrictions in the iliac arteries of 58 of 92 (63%) legs. In 40 of these legs (69%), kinks were the most important cause of the restriction, making these legs suitable for surgical release. We operated on 23 of 58 (40%) legs. All athletes who had an operation subjectively improved. Maximum workload in a cycling test and ankle pressure significantly improved after the operation. 20 (87%) athletes were able to successfully return to their desired high level of competition. Interpretation Our sports-specific protocol is effective in detecting kinking of the iliac arteries as a cause for flow restriction in athletes who have few intravascular abnormalities when investigated with conventional vascular diagnostic tools. Surgical treatment directed at the kinking was less invasive and therefore a better alternative to vascular reconstruction in these athletes.	St Joseph Hosp, Dept Sports Med, NL-5500 MB Veldhoven, Netherlands; St Joseph Hosp, Dept Surg, NL-5500 MB Veldhoven, Netherlands; Algemeen Stedelijk Ziekenhuis, Dept Vasc Surg, Aalst, Belgium; Eindhoven Univ Technol, Dept Appl Phys, NL-5600 MB Eindhoven, Netherlands; Univ Med Ctr, Dept Med Physiol & Sports Med, Utrecht, Netherlands; Univ Med Ctr, Dept Surg, Utrecht, Netherlands	Eindhoven University of Technology; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Schep, G (corresponding author), St Joseph Hosp, Dept Sports Med, POB 7777, NL-5500 MB Veldhoven, Netherlands.	gschep@sjz.nl						Abraham P, 1997, SPORTS MED, V24, P221, DOI 10.2165/00007256-199724040-00001; ABRAHAM P, 1993, AM J SPORT MED, V21, P861, DOI 10.1177/036354659302100618; Abraham P, 1997, AM J SPORT MED, V25, P581, DOI 10.1177/036354659702500424; Bosch JL, 1997, RADIOLOGY, V204, P87, DOI 10.1148/radiology.204.1.9205227; Bradshaw C, 2000, MED SCI SPORT EXER, V32, pS34, DOI 10.1097/00005768-200003001-00006; Chevalier J M, 1986, Ann Vasc Surg, V1, P297, DOI 10.1016/S0890-5096(06)60123-4; CHEVALIER JM, 1991, J TRAUMATOL SPORT, V8, P176; CHEVALIER JM, 1997, ENCY MEDICOCHIRURGIC; DESVAUX B, 1995, J SPORT MED PHYS FIT, V35, P127; FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9; JAGER KA, 1985, ULTRASOUND MED BIOL, V11, P515, DOI 10.1016/0301-5629(85)90164-4; LEGEMATE DA, 1991, ULTRASOUND MED BIOL, V17, P769, DOI 10.1016/0301-5629(91)90159-T; LOPEZ JF, 1989, SURG RADIOL ANAT, V11, P275, DOI 10.1007/BF02098696; ROUSSELET MC, 1990, HUM PATHOL, V21, P524, DOI 10.1016/0046-8177(90)90009-T; RUURDA JP, 2000, NED TIJDSCHR HEELKD, V9, P124; Schep G, 1999, INT J SPORTS MED, V20, P421; Schep G, 2000, MED SCI SPORT EXER, V32, P1970, DOI 10.1097/00005768-200011000-00023; SCHEP G, 2000, NED TIJDSCHR HEELKD, V9, P127; SCHEP G, 2001, THESIS U UTRECHT, P19; STRANDNESS DE, 1994, VASCULAR DIS SURG IN, P139; VONHAYEK H, 1935, Z ANAT ENTWICKL GESC, V105, P25	21	76	78	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2002	359	9305					466	473		10.1016/S0140-6736(02)07675-4	http://dx.doi.org/10.1016/S0140-6736(02)07675-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520ML	11853791				2022-12-24	WOS:000173785600008
J	Pollack, IF; Finkelstein, SD; Woods, J; Burnham, J; Holmes, EJ; Hamilton, RL; Yates, AJ; Boyett, JM; Finlay, JL; Sposto, R				Pollack, IF; Finkelstein, SD; Woods, J; Burnham, J; Holmes, EJ; Hamilton, RL; Yates, AJ; Boyett, JM; Finlay, JL; Sposto, R		Children's Canc Grp	Expression of p53 and prognosis in children with malignant gliomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-GRADE ASTROCYTOMAS; LONG-TERM SURVIVAL; GLIOBLASTOMA-MULTIFORME; CLINICAL-IMPLICATIONS; EGFR AMPLIFICATION; GENE AMPLIFICATION; CANCER-THERAPY; MUTATIONS; OVEREXPRESSION; DELETION	Background: The prognosis of children with high-grade gliomas is uncertain, even when clinical and histologic findings are considered. We investigated whether mutations in the TP53 gene or the degree of expression of p53 protein in high-grade gliomas is associated with progression-free survival in children with these tumors. Methods: Paraffin-embedded specimens of malignant gliomas from children treated in the Children's Cancer Group study CCG-945 were assessed by mutational analysis of TP53 (121 specimens) and immunohistochemical analysis of p53 (115 specimens). For mutational studies, areas of tissue that contained malignant glioma were isolated by microdissection, and the DNA was subjected to polymerase-chain-reaction-based amplification and sequencing of TP53 exons 5, 6, 7, and 8. Immunohistochemical analysis was performed with the use of a microwave-enhanced antigen retrieval and an antibody that bound both wild-type and mutant p53. Results: We found a significant association between overexpression of p53 and outcome; this association was independent of histologic features, age, sex, the extent of resection, and tumor location. The rate (+/-SE) of progression-free survival at five years was 44+/-6 percent in the group of 74 patients whose tumors had low levels of expression of p53 and 17+/-6 percent in the group of 41 patients whose tumors had overexpression of p53 (P<0.001). A nonsignificant association was observed between mutations in TP53 and outcome. Conclusions: Overexpression of p53 in malignant gliomas during childhood is strongly associated with an adverse outcome, independently of clinical prognostic factors and histologic findings.	Univ Pittsburgh, Med Ctr, Dept Neurosurg, Pittsburgh, PA USA; Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA USA; Childrens Oncol Grp, Arcadia, CA USA; Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; NYU, Med Ctr, Dept Pediat, New York, NY 10016 USA; Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90089 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Children's Oncology Group (COG); University System of Ohio; Ohio State University; St Jude Children's Research Hospital; New York University; University of Southern California	Pollack, IF (corresponding author), Childrens Hosp Pittsburgh, Dept Neurosurg, 3705 5th Ave, Pittsburgh, PA 15213 USA.	pollaci@chplink.chp.edu			NATIONAL CANCER INSTITUTE [U10CA013539, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037704] Funding Source: NIH RePORTER; NCI NIH HHS [CA21765, CA13539] Funding Source: Medline; NINDS NIH HHS [NS01810, NS37704] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Boyett J., 1998, P ASCO, V17, p526a; Bredel M, 1999, CLIN CANCER RES, V5, P1786; Brown JM, 1999, CANCER RES, V59, P1391; Campbell JW, 1996, NEUROSURGERY, V38, P258, DOI 10.1097/00006123-199602000-00006; CHANDLER KL, 1993, NEUROSURGERY, V32, P716, DOI 10.1227/00006123-199305000-00003; Collins VP, 1999, SEMIN CANCER BIOL, V9, P267, DOI 10.1006/scbi.1999.0132; Cunningham JM, 1997, J NEUROSURG, V86, P121, DOI 10.3171/jns.1997.86.1.0121; DANKS RA, 1995, NEUROSURGERY, V37, P246, DOI 10.1227/00006123-199508000-00009; DEVAUX BC, 1993, J NEUROSURG, V78, P767, DOI 10.3171/jns.1993.78.5.0767; Dixon W. J., 1969, INTRO STAT ANAL; ESRIG D, 1994, NEW ENGL J MED, V331, P1259, DOI 10.1056/NEJM199411103311903; FINKELSTEIN SD, 1993, CANCER, V71, P3827, DOI 10.1002/1097-0142(19930615)71:12<3827::AID-CNCR2820711207>3.0.CO;2-N; FINLAY JL, 1995, J CLIN ONCOL, V13, P112, DOI 10.1200/JCO.1995.13.1.112; FULTS D, 1992, CANCER RES, V52, P674; FULTS D, 1993, GENE CHROMOSOME CANC, V7, P173, DOI 10.1002/gcc.2870070311; Galanis E, 1998, INT J ONCOL, V13, P717; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; GOH HS, 1995, CANCER RES, V55, P5217; HARRIS CC, 1993, NEW ENGL J MED, V329, P1318, DOI 10.1056/NEJM199310283291807; HE J, 1995, CANCER RES, V55, P4833; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Ichimura K, 2000, CANCER RES, V60, P417; Ichimura K, 1998, GENE CHROMOSOME CANC, V22, P9, DOI 10.1002/(SICI)1098-2264(199805)22:1<9::AID-GCC2>3.0.CO;2-1; JAMES CD, 1988, CANCER RES, V48, P5546; Kalbfleisch JD, 1980, STAT ANAL FAILURE TI; Kim SH, 1999, J UROLOGY, V162, P1512, DOI 10.1016/S0022-5347(05)68350-4; KINZLER KW, 1994, NEW ENGL J MED, V331, P49, DOI 10.1056/NEJM199407073310113; KLEIHUES P, 1993, INT HISTOLOGICAL CLA, V21, P11; LANG FF, 1994, J NEUROSURG, V81, P427, DOI 10.3171/jns.1994.81.3.0427; LANG FF, 1994, ONCOGENE, V9, P949; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; LITOFSKY NS, 1994, NEUROSURGERY, V34, P967, DOI 10.1227/00006123-199406000-00003; Liu WG, 1997, CANCER RES, V57, P5254; Louis DN, 1997, BRAIN PATHOL, V7, P755, DOI 10.1111/j.1750-3639.1997.tb01062.x; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; NAZZARO JM, 1990, J NEUROSURG, V73, P331, DOI 10.3171/jns.1990.73.3.0331; Newcomb EW, 2000, HUM PATHOL, V31, P115, DOI 10.1016/S0046-8177(00)80207-5; POLLACK IF, 1994, NEW ENGL J MED, V331, P1500, DOI 10.1056/NEJM199412013312207; Pollack IF, 1997, CANCER RES, V57, P304; Pollack IF, 2001, CANCER RES, V61, P7404; Quinn DI, 2000, CANCER RES, V60, P1585; Raffel C, 1999, CLIN CANCER RES, V5, P4085; RASHEED BKA, 1994, CANCER RES, V54, P1324; RASHEED BKA, 1995, ONCOGENE, V10, P2243; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; RUSCH V, 1995, CANCER RES, V55, P5038; SALCMAN M, 1994, NEUROSURGERY, V34, P213, DOI 10.1227/00006123-199402000-00002; SALFORD LG, 1988, J NEUROSURG, V69, P506, DOI 10.3171/jns.1988.69.4.0506; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; SPOSTO R, 1989, J NEURO-ONCOL, V7, P165, DOI 10.1007/BF00165101; Sung T, 2000, BRAIN PATHOL, V10, P249, DOI 10.1111/j.1750-3639.2000.tb00258.x; Sure U, 1997, J NEUROPATH EXP NEUR, V56, P782; VOJTESEK B, 1992, J IMMUNOL METHODS, V151, P237, DOI 10.1016/0022-1759(92)90122-A; VONDEIMLING A, 1993, BRAIN PATHOL, V3, P19; Watanabe K, 1996, BRAIN PATHOL, V6, P217, DOI 10.1111/j.1750-3639.1996.tb00848.x; Wu TT, 1996, MODERN PATHOL, V9, P199; YOUNG JL, 1975, J PEDIATR-US, V86, P254, DOI 10.1016/S0022-3476(75)80484-7	58	207	212	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2002	346	6					420	427		10.1056/NEJMoa012224	http://dx.doi.org/10.1056/NEJMoa012224			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518UN	11832530				2022-12-24	WOS:000173686400005
J	Lando, D; Peet, DJ; Whelan, DA; Gorman, JJ; Whitelaw, ML				Lando, D; Peet, DJ; Whelan, DA; Gorman, JJ; Whitelaw, ML			Asparagine hydroxylation of the HIF transactivation domain: A hypoxic switch	SCIENCE			English	Article							INDUCIBLE FACTOR 1-ALPHA; TRANSCRIPTION FACTOR; EXPRESSION; FACTOR-1-ALPHA; HOMEOSTASIS; HIF-1-ALPHA; PROTEIN-1; SUBUNIT; EPAS1	The hypoxia-inducible factors (HIFs) 1alpha and 2alpha are key mammalian transcription factors that exhibit dramatic increases in both protein stability and intrinsic transcriptional potency during low-oxygen stress. This increased stability is due to the absence of proline hydroxylation, which in normoxia promotes binding of HIF to the von Hippel-Lindau (VHL tumor suppressor) ubiquitin ligase. We now show that hypoxic induction of the COOH-terminal transactivation domain (CAD) of HIF occurs through abrogation of hydroxylation of a conserved asparagine in the CAD. Inhibitors of Fe(II)- and 2-oxoglutarate-dependent dioxygenases prevented hydroxylation of the Asn, thus allowing the CAD to interact with the p300 transcription coactivator. Replacement of the conserved Asn by Ala resulted in constitutive p300 interaction and strong transcriptional activity. Full induction of HIF-1alpha and -2alpha, therefore, relies on the abrogation of both Pro and Asn hydroxylation, which during normoxia occur at the degradation and COOH-terminal transactivation domains, respectively.	Univ Adelaide, Dept Mol Biosci Biochem, Adelaide, SA 5005, Australia; CSIRO Hlth Sci & Nutr, Parkville, Vic 3052, Australia	University of Adelaide; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Whitelaw, ML (corresponding author), Univ Adelaide, Dept Mol Biosci Biochem, Adelaide, SA 5005, Australia.		Lando, David/A-2546-2010; Lando, David/AAH-3052-2019; Peet, Daniel/AAE-6698-2020	Lando, David/0000-0001-5783-8769; Peet, Daniel/0000-0002-6085-8936				Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Carrero P, 2000, MOL CELL BIOL, V20, P402, DOI 10.1128/MCB.20.1.402-415.2000; Dinchuk JE, 2000, J BIOL CHEM, V275, P39543, DOI 10.1074/jbc.M006753200; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Flamme I, 1997, MECH DEVELOP, V63, P51, DOI 10.1016/S0925-4773(97)00674-6; Goldman LA, 1996, BIOTECHNIQUES, V21, P1013; Gu J, 2001, J BIOL CHEM, V276, P3550, DOI 10.1074/jbc.M009522200; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; Lopaticki S, 1998, J MASS SPECTROM, V33, P950, DOI 10.1002/(SICI)1096-9888(199810)33:10<950::AID-JMS704>3.3.CO;2-1; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; O'Rourke JF, 1999, J BIOL CHEM, V274, P2060, DOI 10.1074/jbc.274.4.2060; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Semenza GL, 2000, GENE DEV, V14, P1893; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Wallis TP, 2001, PROTEIN SCI, V10, P2251, DOI 10.1110/ps.15401; WANG QP, 1991, J BIOL CHEM, V266, P14004; Wood SM, 1998, J BIOL CHEM, V273, P8360, DOI 10.1074/jbc.273.14.8360; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	28	1193	1279	4	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					858	861		10.1126/science.1068592	http://dx.doi.org/10.1126/science.1068592			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823643				2022-12-24	WOS:000173733000046
J	Demarest, SJ; Martinez-Yamout, M; Chung, J; Chen, HW; Xu, W; Dyson, HJ; Evans, RM; Wright, PE				Demarest, SJ; Martinez-Yamout, M; Chung, J; Chen, HW; Xu, W; Dyson, HJ; Evans, RM; Wright, PE			Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators	NATURE			English	Article							J-COUPLINGS; PROTEINS; BINDING; NMR; CBP; SPECIFICITY; ACTIVATION; DYNAMICS; PROGRAMS; COMPLEX	Nuclear hormone receptors are ligand-activated transcription factors that regulate the expression of genes that are essential for development, reproduction and homeostasis(1). The hormone response is mediated through recruitment of p160 receptor coactivators and the general transcriptional coactivator CBP/p300, which function synergistically to activate transcription(2). These coactivators exhibit intrinsic histone acetyltransferase activity, function in the remodelling of chromatin, and facilitate the recruitment of RNA polymerase II and the basal transcription machinery(3). The activities of the p160 coactivators are dependent on CBP. Both coactivators are essential for proper cell-cycle control, differentiation and apoptosis, and are implicated in cancer and other diseases(4-7). To elucidate the molecular basis of assembling the multiprotein activation complex, we undertook a structural and thermodynamic analysis of the interaction domains of CBP and the activator for thyroid hormone and retinoid receptors(8). Here we show that although the isolated domains are intrinsically disordered, they combine with high affinity to form a cooperatively folded helical heterodimer. Our study uncovers a unique mechanism, called 'synergistic folding', through which p160 coactivators recruit CBP/p300 to allow transmission of the hormonal signal to the transcriptional machinery.	Scripps Res Inst, Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA; Howard Hughes Med Inst, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Salk Institute; Howard Hughes Medical Institute	Wright, PE (corresponding author), Scripps Res Inst, Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Evans, Ronald/AAF-4001-2019; Dyson, Jane/D-4160-2011	Evans, Ronald/0000-0002-9986-5965; Dyson, Jane/0000-0001-6855-3398; Wright, Peter/0000-0002-1368-0223				Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; BAX A, 1994, METHOD ENZYMOL, V239, P79; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; CLORE GM, 1994, METHOD ENZYMOL, V239, P349; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; Duggan BM, 2001, J BIOMOL NMR, V19, P321, DOI 10.1023/A:1011227824104; Goodman RH, 2000, GENE DEV, V14, P1553; GRZESIEK S, 1995, J AM CHEM SOC, V117, P5312, DOI 10.1021/ja00124a014; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li C, 1997, P NATL ACAD SCI USA, V94, P2278, DOI 10.1073/pnas.94.6.2278; Lin CH, 2001, MOL CELL, V8, P581, DOI 10.1016/S1097-2765(01)00333-1; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Sheppard HM, 2001, MOL CELL BIOL, V21, P39, DOI 10.1128/MCB.21.1.39-50.2001; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	30	336	347	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					549	553		10.1038/415549a	http://dx.doi.org/10.1038/415549a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823864				2022-12-24	WOS:000173564300052
J	Williams, JH; Friedman, WE				Williams, JH; Friedman, WE			Identification of diploid endosperm in an early angiosperm lineage	NATURE			English	Article							3 GENOMIC COMPARTMENTS; EXTANT GYMNOSPERMS; PHYLOGENY; EMBRYOLOGY; GNETALES; ORIGIN; PLANTS; GENES; ROOT	In flowering plants, the developmental and genetic basis for the establishment of an embryo-nourishing tissue differs from all other lineages of seed plants. Among extant nonflowering seed plants (conifers, cycads, Ginkgo, Gnetales), a maternally derived haploid tissue (female gametophyte) is responsible for the acquisition of nutrients from the maternal diploid plant, and the ultimate provisioning of the embryo. In flowering plants, a second fertilization event, contemporaneous with the fusion of sperm and egg to yield a zygote, initiates a genetically biparental and typically triploid embryo-nourishing tissue called endosperm. For over a century, triploid biparental endosperm has been viewed as the ancestral condition in extant flowering plants(1-3). Here we report diploid biparental endosperm in Nuphar polysepalum, a basal angiosperm. We show that diploid endosperms are common among early angiosperm lineages and may represent the ancestral condition among flowering plants. If diploid endosperm is plesiomorphic, the triploid endosperms of the vast majority of flowering plants must have evolved from a diploid condition through the developmental modification of the unique fertilization process that initiates endosperm.	Univ Colorado, Dept Environm Populat & Organism Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Friedman, WE (corresponding author), Univ Colorado, Dept Environm Populat & Organism Biol, Boulder, CO 80309 USA.	ned@colorado.edu	Williams, Joseph Hill/E-2227-2011	Friedman, William Edward/0000-0003-0374-3427; Williams, Joseph/0000-0002-1206-5667				Barkman TJ, 2000, P NATL ACAD SCI USA, V97, P13166, DOI 10.1073/pnas.220427497; Battaglia E, 1989, ANN BOT, V47, P7; BATYGINA T B, 1982, Botanicheskii Zhurnal (St. Petersburg), V67, P1179; Bowe LM, 2000, P NATL ACAD SCI USA, V97, P4092, DOI 10.1073/pnas.97.8.4092; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Chaw SM, 2000, P NATL ACAD SCI USA, V97, P4086, DOI 10.1073/pnas.97.8.4086; Endress PK, 2001, INT J PLANT SCI, V162, P1111, DOI 10.1086/321919; Feild TS, 2000, INT J PLANT SCI, V161, P705, DOI 10.1086/314293; FRIEDMAN WE, 1995, P NATL ACAD SCI USA, V92, P3913, DOI 10.1073/pnas.92.9.3913; Friedman WE, 2001, CURR OPIN PLANT BIOL, V4, P14, DOI 10.1016/S1369-5266(00)00129-1; Friedman WE, 2001, EVOLUTION, V55, P217; Galati BG, 1985, B SOC ARGENT BOT, V24, P9; Graham SW, 2000, AM J BOT, V87, P1712, DOI 10.2307/2656749; Johri B.M., 1992, COMP EMBRYOLOGY ANGI; Maheshwari P., 1950, INTRO EMBRYOLOGY ANG; Mathews S, 1999, SCIENCE, V286, P947, DOI 10.1126/science.286.5441.947; Orban I, 1998, BOT J LINN SOC, V126, P339, DOI 10.1006/bojl.1997.0157; PALSER BF, 1975, ANN MO BOT GARD, V62, P621, DOI 10.2307/2395269; Queller D. C., 1989, Oxford Surveys in Evolutionary Biology, V6, P73; Solntseva MP, 1981, COMP EMBRYOLOGY FLOW, P51; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; Swamy BGL., 1964, J INDIAN BOT SOC, V43, P391; Tobe H, 2000, J PLANT RES, V113, P271, DOI 10.1007/PL00013935; VANMIEGROET F, 1992, CAN J BOT, V70, P1991; Wilson M. F., 1983, MATE CHOICE PLANTS T; Winter A. N., 1991, BOT ZH, V76, P1716; Winter AN, 1991, BOT ZH, V76; YOSHIDA OSAMU, 1962, J COLL ARTS SCI CHIBA UNIV NAT SCI SER, V3, P459; [No title captured]	30	116	123	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2002	415	6871					522	526		10.1038/415522a	http://dx.doi.org/10.1038/415522a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823859				2022-12-24	WOS:000173564300046
J	Ernst, MO; Banks, MS				Ernst, MO; Banks, MS			Humans integrate visual and haptic information in a statistically optimal fashion	NATURE			English	Article							TEXTURE-PERCEPTION; IDEAL OBSERVERS; TOUCH; PSYCHOPHYSICS; DISCREPANCY; DOMINANCE; VISION; SLANT	When a person looks at an object while exploring it with their hand, vision and touch both provide information for estimating the properties of the object. Vision frequently dominates the integrated visual-haptic percept, for example when judging size, shape or position(1-3), but in some circumstances the percept is clearly affected by haptics(4-7). Here we propose that a general principle, which minimizes variance in the final estimate, determines the degree to which vision or haptics dominates. This principle is realized by using maximum-likelihood estimation(8-15) to combine the inputs. To investigate cue combination quantitatively, we first measured the variances associated with visual and haptic estimation of height. We then used these measurements to construct a maximum-likelihood integrator. This model behaved very similarly to humans in a visual-haptic task. Thus, the nervous system seems to combine visual and haptic information in a fashion that is similar to a maximum-likelihood integrator. Visual dominance occurs when the variance associated with visual estimation is lower than that associated with haptic estimation.	Univ Calif Berkeley, Sch Optometry, Vis Sci Program, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Ernst, MO (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	marc.ernst@tuebingen.mpg.de		Ernst, Marc/0000-0003-4197-8569				Backus BT, 1999, PERCEPTION, V28, P217, DOI 10.1068/p2753; Banks MS, 1998, VISION RES, V38, P187, DOI 10.1016/S0042-6989(97)00179-X; BLAKE A, 1993, VISION RES, V33, P1723, DOI 10.1016/0042-6989(93)90037-W; Clark J.J., 1990, DATA FUSION SENSORY; Ernst MO, 2000, NAT NEUROSCI, V3, P69, DOI 10.1038/71140; FESTINGE.L, 1967, J EXP PSYCHOL, V74, P1, DOI 10.1037/h0024766; GHARAMANI Z, 1997, SELF ORG COMPUTATION, P117; Gibson JJ, 1933, J EXP PSYCHOL, V16, P1, DOI 10.1037/h0074626; HAY JC, 1965, PSYCHON SCI, V2, P215, DOI 10.3758/BF03343413; HELLER MA, 1983, PERCEPTION, V12, P607, DOI 10.1068/p120607; HELLER MA, 1982, PERCEPT PSYCHOPHYS, V31, P339, DOI 10.3758/BF03202657; Knill DC, 1998, VISION RES, V38, P1683, DOI 10.1016/S0042-6989(97)00325-8; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; LEDERMAN SJ, 1981, J EXP PSYCHOL HUMAN, V7, P902, DOI 10.1037/0096-1523.7.4.902; MonWilliams M, 1997, P ROY SOC B-BIOL SCI, V264, P1007, DOI 10.1098/rspb.1997.0139; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Pena JL, 2001, SCIENCE, V292, P249, DOI 10.1126/science.1059201; POWER RP, 1980, PERCEPTION, V9, P457, DOI 10.1068/p090457; ROCK I, 1964, SCIENCE, V143, P594, DOI 10.1126/science.143.3606.594; Schrater PR, 2000, INT J COMPUT VISION, V40, P73, DOI 10.1023/A:1026557704054; SINGER G, 1969, PERCEPT PSYCHOPHYS, V5, P315, DOI 10.3758/BF03209572; Tastevin J, 1937, ENCEPHALE, V32, P57; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; Warren D. H., 1991, PSYCHOL TOUCH, P119; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638	25	2773	2805	22	375	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2002	415	6870					429	433		10.1038/415429a	http://dx.doi.org/10.1038/415429a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	514HR	11807554				2022-12-24	WOS:000173433600050
J	Keenan, SP				Keenan, SP			Weaning protocols: here to stay	LANCET			English	Editorial Material							MECHANICAL VENTILATION; DURATION; TRIAL; TIME		Royal Columbian Hosp, Intens Care Unit, New Westminster, BC V3L 5E7, Canada		Keenan, SP (corresponding author), Royal Columbian Hosp, Intens Care Unit, New Westminster, BC V3L 5E7, Canada.							BROCHARD L, 1994, AM J RESP CRIT CARE, V150, P896, DOI 10.1164/ajrccm.150.4.7921460; COHEN IL, 1991, CRIT CARE MED, V19, P1278, DOI 10.1097/00003246-199110000-00010; Ely EW, 1996, NEW ENGL J MED, V335, P1864, DOI 10.1056/NEJM199612193352502; ESTEBAN A, 1995, NEW ENGL J MED, V332, P345, DOI 10.1056/NEJM199502093320601; Henneman E, 2001, CRIT CARE MED, V29, P297, DOI 10.1097/00003246-200102000-00013; Horst HM, 1998, ARCH SURG-CHICAGO, V133, P483, DOI 10.1001/archsurg.133.5.483; Kollef MH, 1997, CRIT CARE MED, V25, P567, DOI 10.1097/00003246-199704000-00004; Marelich GP, 2000, CHEST, V118, P459, DOI 10.1378/chest.118.2.459; MORRIS AH, 1994, AM J RESP CRIT CARE, V149, P295, DOI 10.1164/ajrccm.149.2.8306022; Vitacca M, 2001, AM J RESP CRIT CARE, V164, P225, DOI 10.1164/ajrccm.164.2.2008160; Wood G, 1995, Respir Care, V40, P219; ZAPOL WM, 1979, JAMA-J AM MED ASSOC, V242, P2193, DOI 10.1001/jama.242.20.2193	12	8	9	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 19	2002	359	9302					186	187		10.1016/S0140-6736(02)07465-2	http://dx.doi.org/10.1016/S0140-6736(02)07465-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512YH	11812550				2022-12-24	WOS:000173350800006
J	Bond, DR; Holmes, DE; Tender, LM; Lovley, DR				Bond, DR; Holmes, DE; Tender, LM; Lovley, DR			Electrode-reducing microorganisms that harvest energy from marine sediments	SCIENCE			English	Article							MICROBIAL FUEL-CELLS; 16S RIBOSOMAL-RNA; DESULFUROMONAS-ACETOXIDANS; FE(III) REDUCTION; GEN-NOV; OXIDATION; BACTERIUM; AQUIFER	Energy in the form of electricity can be harvested from marine sediments by placing a graphite electrode (the anode) in the anoxic zone and connecting it to a graphite cathode in the overlying aerobic water. We report a specific enrichment of microorganisms of the family Geobacteraceae on energy-harvesting anodes, and we show that these microorganisms can conserve energy to support their growth by oxidizing organic compounds with an electrode serving as the sole electron acceptor. This finding not only provides a method for extracting energy from organic matter, but also suggests a strategy for promoting the bioremediation of organic contaminants in subsurface environments.	Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; USN, Res Lab, Ctr Biomol Sci & Engn, Washington, DC 20375 USA	University of Massachusetts System; University of Massachusetts Amherst; United States Department of Defense; United States Navy; Naval Research Laboratory	Lovley, DR (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA.			Bond, Daniel/0000-0001-8083-7107; saravanan, s/0000-0003-1269-1243				EMDE R, 1989, APPL MICROBIOL BIOT, V32, P170, DOI 10.1007/BF00165883; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lonergan DJ, 1996, J BACTERIOL, V178, P2402, DOI 10.1128/jb.178.8.2402-2408.1996; Lovley D.R., 2000, PROKARYOTES; LOVLEY DR, 1994, NATURE, V370, P128, DOI 10.1038/370128a0; LOVLEY DR, 1995, REV GEOPHYS, V33, P365, DOI 10.1029/95RG01305; Lovley DR, 1996, NATURE, V382, P445, DOI 10.1038/382445a0; LOVLEY DR, 1993, ARCH MICROBIOL, V159, P336, DOI 10.1007/BF00290916; Lovley DR, 2000, ENVIRONMENTAL MICROBE-METAL INTERACTIONS, P3; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Park DH, 2000, APPL ENVIRON MICROB, V66, P1292, DOI 10.1128/AEM.66.4.1292-1297.2000; PFENNIG N, 1976, ARCH MICROBIOL, V110, P3, DOI 10.1007/BF00416962; Reimers CE, 2001, ENVIRON SCI TECHNOL, V35, P192, DOI 10.1021/es001223s; RODEN EE, 1993, APPL ENVIRON MICROB, V59, P734, DOI 10.1128/AEM.59.3.734-742.1993; ROLLER SD, 1984, J CHEM TECH BIOT B, V34, P3; Rooney-Varga JN, 1999, APPL ENVIRON MICROB, V65, P3056; Snoeyenbos-West OL, 2000, MICROBIAL ECOL, V39, P153, DOI 10.1007/s002480000018	17	1040	1169	29	732	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					483	485		10.1126/science.1066771	http://dx.doi.org/10.1126/science.1066771			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799240				2022-12-24	WOS:000173350700046
J	Walker, GJ; Hayward, NK				Walker, GJ; Hayward, NK			p16INK4A and p14ARF tumour suppressors in melanoma: lessons from the mouse	LANCET			English	Editorial Material							GERMLINE MUTATIONS; INK4A LOCUS; CDK4; RAS		Royal Brisbane Hosp, Queensland Inst Med Res, Human Genet Lab, Brisbane, Qld 4029, Australia	QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital	Hayward, NK (corresponding author), Royal Brisbane Hosp, Queensland Inst Med Res, Human Genet Lab, Brisbane, Qld 4029, Australia.		hayward, nicholas k/C-1367-2015; Walker, Graeme J/C-2548-2012; hayward, nick/AAV-8802-2020	hayward, nicholas k/0000-0003-4760-1033; Walker, Graeme J/0000-0002-9392-8769; 				Bardeesy N, 2001, MOL CELL BIOL, V21, P2144, DOI 10.1128/MCB.21.6.2144-2153.2001; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Chin L, 1997, GENE DEV, V11, P2822, DOI 10.1101/gad.11.21.2822; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; Noonan FP, 2001, NATURE, V413, P271, DOI 10.1038/35095108; Pollock PM, 2000, CLIN LAB MED, V20, P667; Rizos H, 2001, ONCOGENE, V20, P5543, DOI 10.1038/sj.onc.1204728; SCHMIDT EE, 1994, CANCER RES, V54, P6321; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sotillo R, 2001, P NATL ACAD SCI USA, V98, P13312, DOI 10.1073/pnas.241338598; Soufir N, 1998, HUM MOL GENET, V7, P209, DOI 10.1093/hmg/7.2.209; Whiteman DC, 2001, CANCER CAUSE CONTROL, V12, P69, DOI 10.1023/A:1008980919928; Zuo L, 1996, NAT GENET, V12, P97, DOI 10.1038/ng0196-97	15	9	12	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 5	2002	359	9300					7	8		10.1016/S0140-6736(02)07271-9	http://dx.doi.org/10.1016/S0140-6736(02)07271-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	509HZ	11809177				2022-12-24	WOS:000173143500006
J	Zimmerman, C; Klein, KC; Kiser, PK; Singh, AR; Firestein, BL; Riba, SC; Lingappa, JR				Zimmerman, C; Klein, KC; Kiser, PK; Singh, AR; Firestein, BL; Riba, SC; Lingappa, JR			Identification of a host protein essential for assembly of immature HIV-1 capsids	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RNASE-L INHIBITOR; RETROVIRAL MORPHOGENESIS; VIF PROTEIN; TYPE-1; CELLS; PATHWAY; NEF; INFECTIVITY; EXPRESSION	To form an immature HIV-1 capsid, 1,500 HIV-1 Gag (p55) polypeptides must assemble properly along the host cell plasma membrane. Insect cells and many higher eukaryotic cell types support efficient capsid assembly 1, but yeast(2) and murine cells(3,4) do not, indicating that host machinery is required for immature HIV-1 capsid formation. Additionally, in a cell-free system that reconstitutes HIV-1 capsid formation, post-translational assembly events require ATP and a subcellular fraction(5), suggesting a requirement for a cellular ATP-binding protein. Here we identify such a protein (HP68), described previously as an RNase L inhibitor(6), and demonstrate that it associates post-translationally with HIV-1 Gag in a cell-free system and human T cells infected with HIV-1. Using a dominant negative mutant of HP68 in mammalian cells and depletion-reconstitution experiments in the cell-free system, we demonstrate that HP68 is essential for post-translational events in immature HIV-1 capsid assembly. Furthermore, in cells the HP68-Gag complex is associated with HIV-1 Vif, which is involved in virion morphogenesis and infectivity. These findings support a critical role for HP68 in posttranslational events of HIV-1 assembly and reveal a previously unappreciated dimension of host-viral interaction.	Univ Washington, Sch Publ Hlth, Dept Pathobiol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; Rutgers State University New Brunswick	Lingappa, JR (corresponding author), Univ Washington, Sch Publ Hlth, Dept Pathobiol, Seattle, WA 98195 USA.		Lingappa, Jairam/N-7760-2017	Firestein, Bonnie/0000-0002-1679-3565				BISBAL C, 1995, J BIOL CHEM, V270, P13308, DOI 10.1074/jbc.270.22.13308; Boulanger P, 1996, CURR TOP MICROBIOL, V214, P237; Bukovsky AA, 1997, J VIROL, V71, P1013, DOI 10.1128/JVI.71.2.1013-1018.1997; Cohen EA, 1996, CURR TOP MICROBIOL, V214, P219; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; HOCKLEY DJ, 1994, J GEN VIROL, V75, P2985, DOI 10.1099/0022-1317-75-11-2985; Hynes G, 1996, ELECTROPHORESIS, V17, P1720, DOI 10.1002/elps.1150171109; JACOBS E, 1989, GENE, V79, P71, DOI 10.1016/0378-1119(89)90093-0; JOWETT JBM, 1992, J GEN VIROL, V73, P3079, DOI 10.1099/0022-1317-73-12-3079; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; LINGAPPA JR, 1994, J CELL BIOL, V125, P99, DOI 10.1083/jcb.125.1.99; Lingappa JR, 1997, J CELL BIOL, V136, P567, DOI 10.1083/jcb.136.3.567; Madani N, 1998, J VIROL, V72, P10251, DOI 10.1128/JVI.72.12.10251-10255.1998; Mariani R, 2000, J VIROL, V74, P3859, DOI 10.1128/JVI.74.8.3859-3870.2000; Mariani R, 2001, J VIROL, V75, P3141, DOI 10.1128/JVI.75.7.3141-3151.2001; Martinand C, 1999, J VIROL, V73, P290, DOI 10.1128/JVI.73.1.290-296.1999; MORGAN PJ, 1989, J NEUROENDOCRINOL, V1, P1, DOI 10.1111/j.1365-2826.1989.tb00068.x; Pandori MW, 1996, J VIROL, V70, P4283, DOI 10.1128/JVI.70.7.4283-4290.1996; Player MR, 1998, PHARMACOL THERAPEUT, V78, P55, DOI 10.1016/S0163-7258(97)00167-8; ROYER M, 1991, VIROLOGY, V184, P417, DOI 10.1016/0042-6822(91)90861-5; SALEHZADA T, 1991, J BIOL CHEM, V266, P5808; Simon JHM, 1996, J VIROL, V70, P5297, DOI 10.1128/JVI.70.8.5297-5305.1996; Simon JHM, 1998, EMBO J, V17, P1259, DOI 10.1093/emboj/17.5.1259; Singh AR, 2001, VIROLOGY, V279, P257, DOI 10.1006/viro.2000.0706; SMITH AJ, 1993, J VIROL, V67, P2266, DOI 10.1128/JVI.67.4.2266-2275.1993; TRAUT TW, 1994, EUR J BIOCHEM, V222, P9, DOI 10.1111/j.1432-1033.1994.tb18835.x; Welker R, 1998, J VIROL, V72, P8833, DOI 10.1128/JVI.72.11.8833-8840.1998; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D	30	189	214	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2002	415	6867					88	92		10.1038/415088a	http://dx.doi.org/10.1038/415088a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780123				2022-12-24	WOS:000173028800046
J	Payne, MY				Payne, MY			Too young to be having a heart attack	LANCET			English	Article											Payne, MY (corresponding author), 75 Keel Court, Heathsville, VA 22473 USA.	mpayne@crosslink.net							0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2001				S			S64	S64		10.1016/S0140-6736(01)07076-3	http://dx.doi.org/10.1016/S0140-6736(01)07076-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505HK	11784613	Bronze			2022-12-24	WOS:000172907200064
J	Wilton, L; Williamson, R; McBain, J; Edgar, D; Voullaire, L				Wilton, L; Williamson, R; McBain, J; Edgar, D; Voullaire, L			Brief report: Birth of a healthy infant after preimplantation confirmation of euploidy by comparative genomic hybridization	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IN-VITRO FERTILIZATION; HUMAN EMBRYOS; SINGLE CELLS; ANEUPLOIDY; DIAGNOSIS; AMPLIFICATION		Melbourne IVF, Melbourne, Vic 3002, Australia; Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Wilton, L (corresponding author), Melbourne IVF, 320 Victoria Parade, Melbourne, Vic 3002, Australia.							COONEN E, 1994, HUM REPROD, V9, P533, DOI 10.1093/oxfordjournals.humrep.a138540; Delhanty JDA, 1997, HUM GENET, V99, P755, DOI 10.1007/s004390050443; Edgar DH, 2000, HUM REPROD, V15, P175, DOI 10.1093/humrep/15.1.175; Fung J, 2000, HUM GENET, V107, P615, DOI 10.1007/s004390000416; Gardner D.K, 2000, HDB VITRO FERTILIZAT, P205; Gianaroli L, 1999, FERTIL STERIL, V72, P837, DOI 10.1016/S0015-0282(99)00377-5; Iwarsson E, 1999, HUM GENET, V104, P376, DOI 10.1007/s004390050971; Kahraman S, 2000, HUM REPROD, V15, P2003, DOI 10.1093/humrep/15.9.2003; Munne S, 1999, HUM REPROD, V14, P2191, DOI 10.1093/humrep/14.9.2191; Munne S, 1998, FERTIL STERIL, V69, P904, DOI 10.1016/S0015-0282(98)00039-9; Voullaire L, 2000, HUM GENET, V106, P210, DOI 10.1007/s004390051030; Voullaire L, 1999, PRENATAL DIAG, V19, P846, DOI 10.1002/(SICI)1097-0223(199909)19:9<846::AID-PD657>3.0.CO;2-#; Wells D, 2000, MOL HUM REPROD, V6, P1055, DOI 10.1093/molehr/6.11.1055; Wells D, 1999, NUCLEIC ACIDS RES, V27, P1214, DOI 10.1093/nar/27.4.1214	14	123	154	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 22	2001	345	21					1537	1541		10.1056/NEJMoa011052	http://dx.doi.org/10.1056/NEJMoa011052			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494DC	11794220				2022-12-24	WOS:000172265200004
J	Austin, MJ; Muskett, P; Kahn, K; Feys, BJ; Jones, JDG; Parker, JE				Austin, MJ; Muskett, P; Kahn, K; Feys, BJ; Jones, JDG; Parker, JE			Regulatory role of SGT1 in early R gene-mediated plant defenses	SCIENCE			English	Article							DISEASE RESISTANCE; ESSENTIAL COMPONENT; ARABIDOPSIS; EDS1; DEGRADATION; EXPRESSION; PROTEINS	Animal SGT1 is a component of Skp1-Cullin-F-box protein (SCF) ubiquitin ligases that target regulatory proteins for degradation. Mutations in one (SGT1b) of two highly homologous Arabidopsis SGT1 genes disable early plant defenses conferred by multiple resistance (R) genes. Loss of SGT1b function in resistance is not compensated for by SGT1a. R genes differ in their requirements for SGT1b and a second resistance signaling gene, RAR1, that was previously implicated as an SGT1 interactor. Moreover, SGT1b and RAR1 contribute additively to RPP5-mediated pathogen recognition. These data imply both operationally distinct and cooperative functions of SGT1 and RAR1 in plant disease resistance.	John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Max Planck Society	Parker, JE (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England.	parker@mpiz-koeln.mpg.de	Jones, Jonathan DG/J-5129-2012	Jones, Jonathan DG/0000-0002-4953-261X; Austin, Mark/0000-0003-4943-7265				Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Andrade MA, 2001, PLANT MOL BIOL, V46, P603, DOI 10.1023/A:1010650809272; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; Callis J, 2000, CURR OPIN PLANT BIOL, V3, P381, DOI 10.1016/S1369-5266(00)00100-X; Clarke JD, 1998, PLANT CELL, V10, P557, DOI 10.1105/tpc.10.4.557; Cohn J, 2001, CURR OPIN IMMUNOL, V13, P55, DOI 10.1016/S0952-7915(00)00182-5; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Falk A, 1999, P NATL ACAD SCI USA, V96, P3292, DOI 10.1073/pnas.96.6.3292; Farras R, 2001, EMBO J, V20, P2742, DOI 10.1093/emboj/20.11.2742; Feys BJ, 2001, EMBO J, V20, P5400, DOI 10.1093/emboj/20.19.5400; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Inohara N, 2000, J BIOL CHEM, V275, P27823; Jirage D, 1999, P NATL ACAD SCI USA, V96, P13583, DOI 10.1073/pnas.96.23.13583; Jorgensen JH, 1996, GENOME, V39, P492, DOI 10.1139/g96-063; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Kliebenstein DJ, 1999, MOL PLANT MICROBE IN, V12, P1022, DOI 10.1094/MPMI.1999.12.11.1022; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; MUSKETT P, IN PRESS PLANT CELL; Parker JE, 1997, PLANT CELL, V9, P879, DOI 10.1105/tpc.9.6.879; Shirasu K, 1999, CELL, V99, P355, DOI 10.1016/S0092-8674(00)81522-6	23	332	370	3	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2002	295	5562					2077	2080		10.1126/science.1067747	http://dx.doi.org/10.1126/science.1067747			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532AY	11847308				2022-12-24	WOS:000174450500050
J	Chapman, MR; Robinson, LS; Pinkner, JS; Roth, R; Heuser, J; Hammar, M; Normark, S; Hultgren, SJ				Chapman, MR; Robinson, LS; Pinkner, JS; Roth, R; Heuser, J; Hammar, M; Normark, S; Hultgren, SJ			Role of Escherichia coli curli operons in directing amyloid fiber formation	SCIENCE			English	Article							THIN AGGREGATIVE FIMBRIAE; FIBRONECTIN-BINDING CURLI; SALMONELLA-ENTERITIDIS; ALZHEIMERS-DISEASE; SURFACE ORGANELLES; PEPTIDES; CSGB	Amyloid is associated with debilitating human ailments including Alzheimer's and prion diseases. Biochemical, biophysical, and imaging analyses revealed that fibers produced by Escherichia coli called curli were amyloid. The CsgA curlin subunit, purified in the absence of the CsgB nucleator, adopted a soluble, unstructured form that upon prolonged incubation assembled into fibers that were indistinguishable from curli. In vivo, curli biogenesis was dependent on the nucleation-precipitation machinery requiring the CsgE and CsgF chaperone-like and nucleator proteins, respectively. Unlike eukaryotic amyloid formation, curli biogenesis is a productive pathway, requiring a specific assembly machinery.	Washington Univ, Sch Med, Dept Mol Microbiol & Microbial Pathogenesis, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Karolinska Inst, Dept Microbiol, S-171777 Stockholm, Sweden; Karolinska Inst, Tumorbiol Ctr, S-171777 Stockholm, Sweden	Washington University (WUSTL); Washington University (WUSTL); Karolinska Institutet; Karolinska Institutet	Hultgren, SJ (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol & Microbial Pathogenesis, Box 8230, St Louis, MO 63110 USA.		Hammar, Mats/R-7908-2019	Hammar, Mats/0000-0002-4593-7273; Chapman, Matthew/0000-0002-2645-1294	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029549, R37AI029549, R01AI048689, F32AI010502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005681] Funding Source: NIH RePORTER; NIAID NIH HHS [1 F32 AI10502-01A1, AI48689, R01 AI029549, F32 AI010502-03, AI29549, R01 AI048689, R37 AI029549, F32 AI010502] Funding Source: Medline; NIA NIH HHS [NIA P50 AG05681-17, P50 AG005681] Funding Source: Medline; NIDDK NIH HHS [DK51406, R01 DK051406] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Austin JW, 1998, FEMS MICROBIOL LETT, V162, P295, DOI 10.1016/S0378-1097(98)00137-2; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; BenNasr A, 1996, MOL MICROBIOL, V20, P927; Bian Z, 1997, EMBO J, V16, P5827, DOI 10.1093/emboj/16.19.5827; CHAPMAN M, UNPUB; COLLINSON SK, 1991, J BACTERIOL, V173, P4773, DOI 10.1128/jb.173.15.4773-4781.1991; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Hammar M, 1996, P NATL ACAD SCI USA, V93, P6562, DOI 10.1073/pnas.93.13.6562; HUESER JE, 1987, J MUSCLE RES CELL M, V8, P303; Klunk WE, 1999, METHOD ENZYMOL, V309, P285; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Loferer H, 1997, MOL MICROBIOL, V26, P11, DOI 10.1046/j.1365-2958.1997.5231883.x; OLSEN A, 1989, NATURE, V338, P652, DOI 10.1038/338652a0; OLSEN A, 1993, INFECT AGENT DIS, V2, P272; OLSEN A, 1993, MOL MICROBIOL, V7, P523, DOI 10.1111/j.1365-2958.1993.tb01143.x; SJOBRING U, 1994, MOL MICROBIOL, V14, P443, DOI 10.1111/j.1365-2958.1994.tb02179.x; Vidal O, 1998, J BACTERIOL, V180, P2442, DOI 10.1128/JB.180.9.2442-2449.1998	17	901	938	5	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 1	2002	295	5556					851	855		10.1126/science.1067484	http://dx.doi.org/10.1126/science.1067484			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519NU	11823641	Green Accepted			2022-12-24	WOS:000173733000044
J	Drum, CL; Yan, SZ; Bard, J; Shen, YQ; Lu, D; Soelaiman, S; Grabarek, Z; Bohm, A; Tang, WJ				Drum, CL; Yan, SZ; Bard, J; Shen, YQ; Lu, D; Soelaiman, S; Grabarek, Z; Bohm, A; Tang, WJ			Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin	NATURE			English	Article							ELECTRON-DENSITY MAPS; BORDETELLA-PERTUSSIS; BACILLUS-ANTHRACIS; X-RAY; PHOSPHORYLASE-KINASE; CATALYTIC MECHANISM; PEPTIDE COMPLEX; EDEMA FACTOR; BINDING; DOMAIN	Oedema factor, a calmodulin-activated adenylyl cyclase, is important in the pathogenesis of anthrax. Here we report the X-ray structures of oedema factor with and without bound calmodulin. Oedema factor shares no significant structural homology with mammalian adenylyl cyclases or other proteins. In the active site, 39-deoxy-ATP and a single metal ion are well positioned for catalysis with histidine 351 as the catalytic base. This mechanism differs from the mechanism of two-metal-ion catalysis proposed for mammalian adenylyl cyclases. Four discrete regions of oedema factor form a surface that recognizes an extended conformation of calmodulin, which is very different from the collapsed conformation observed in other structures of calmodulin bound to effector peptides. On calmodulin binding, an oedema factor helical domain of relative molecular mass 15,000 undergoes a 15 Angstrom translation and a 30degrees rotation away from the oedema factor catalytic core, which stabilizes a disordered loop and leads to enzyme activation. These allosteric changes provide the first molecular details of how calmodulin modulates one of its targets.	Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA; Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA; Boston Biomed Res Inst, Watertown, MA 02472 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA	University of Chicago; University of Chicago; Boston Biomedical Research Institute; Tufts University	Tang, WJ (corresponding author), Univ Chicago, Ben May Inst Canc Res, 924 E 57th St, Chicago, IL 60637 USA.	bohm@bbri.org; wtang@midway.uchicago.edu	Drum, Chester/A-6089-2015	Drum, Chester/0000-0001-6327-4584; Tang, Wei-Jen/0000-0002-8267-8995; Grabarek, Zenon/0000-0002-3636-5701				BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; Bieger B, 2001, EMBO J, V20, P433, DOI 10.1093/emboj/20.3.433; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Drum CL, 2001, ACTA CRYSTALLOGR D, V57, P1881, DOI 10.1107/S0907444901014937; Drum CL, 2000, J BIOL CHEM, V275, P36334, DOI 10.1074/jbc.M004778200; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Eldik LV, 1998, CALMODULIN SIGNAL TR; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; FARRAR YJK, 1993, J BIOL CHEM, V268, P4120; FINN BE, 1995, NAT STRUCT BIOL, V2, P777, DOI 10.1038/nsb0995-777; Galburt EA, 1999, NAT STRUCT BIOL, V6, P1096, DOI 10.1038/70027; GLASER P, 1989, EMBO J, V8, P967, DOI 10.1002/j.1460-2075.1989.tb03459.x; GLASER P, 1991, EMBO J, V10, P1683, DOI 10.1002/j.1460-2075.1991.tb07692.x; Hayashi N, 2000, PROTEIN SCI, V9, P1905, DOI 10.1110/ps.9.10.1905; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kissinger CR, 2001, ACTA CRYSTALLOGR D, V57, P1474, DOI 10.1107/S0907444901012458; Krueger JK, 2001, J BIOL CHEM, V276, P4535, DOI 10.1074/jbc.C000857200; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; LABRUYERE E, 1990, BIOCHEMISTRY-US, V29, P4922, DOI 10.1021/bi00472a024; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Lo Conte L, 1999, J MOL BIOL, V285, P2177; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; Miller MD, 1999, J MOL BIOL, V288, P975, DOI 10.1006/jmbi.1999.2729; Montgomery HJ, 2000, J BIOL CHEM, V275, P5052, DOI 10.1074/jbc.275.7.5052; MUNIER H, 1995, ARCH BIOCHEM BIOPHYS, V320, P224, DOI 10.1016/0003-9861(95)90004-7; MUNIER H, 1992, J BIOL CHEM, V267, P9816; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Tang WJ, 1998, MOL PHARMACOL, V54, P231, DOI 10.1124/mol.54.2.231; TANG WJ, 1991, J BIOL CHEM, V266, P8595; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; TREWHELLA J, 1990, BIOCHEMISTRY-US, V29, P9316, DOI 10.1021/bi00492a003; Wang EZ, 1997, BIOCHEMISTRY-US, V36, P15026, DOI 10.1021/bi963075h; Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899; Yan SZ, 1997, J BIOL CHEM, V272, P12342, DOI 10.1074/jbc.272.19.12342; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758	51	332	348	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					396	402		10.1038/415396a	http://dx.doi.org/10.1038/415396a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807546				2022-12-24	WOS:000173433600041
J	Jackson, BE; McInerney, MJ				Jackson, BE; McInerney, MJ			Anaerobic microbial metabolism can proceed close to thermodynamic limits	NATURE			English	Article							SYNTROPHIC ASSOCIATION; BENZOATE DEGRADATION; ENERGETICS; BACTERIUM; OXIDATION; GROWTH	Many fermentative bacteria obtain energy for growth by reactions in which the change in free energy (DeltaG') is less than that needed to synthesize ATP(1-4). These bacteria couple substrate metabolism directly to ATP synthesis, however, by classical phosphoryl transfer reactions(4,5). An explanation for the energy economy of these organisms is that biological systems conserve energy in discrete amounts(3,)4, with a minimum, biochemically convertible energy value of about -20 kJ mol(-1) (refs(1-3)). This concept predicts that anaerobic substrate decay ceases before the minimum free energy value is reached, and several studies support this prediction(1,6-9). Here we show that metabolism by syntrophic associations, in which the degradation of a substrate by one species is thermodynamically possible only through removal of the end product by another species(1), can occur at values close to thermodynamic equilibrium (DeltaG' approximate to0 kJ mol(-1)). The free energy remaining when substrate metabolism halts is not constant; it depends on the terminal electron-accepting reaction and the amount of energy required for substrate activation. Syntrophic associations metabolize near thermodynamic equilibrium, indicating that bacteria operate extremely efficient catabolic systems.	Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	McInerney, MJ (corresponding author), Univ Oklahoma, Dept Bot & Microbiol, 770 Van Vleet Oval, Norman, OK 73019 USA.	mcinerney@ou.edu	McInerney, Michael J/E-6215-2012					AUBURGER G, 1992, APPL MICROBIOL BIOT, V37, P789, DOI 10.1007/BF00174847; BALCH WE, 1976, APPL ENVIRON MICROB, V32, P781, DOI 10.1128/AEM.32.6.781-791.1976; Christensen TH, 2000, J CONTAM HYDROL, V45, P165, DOI 10.1016/S0169-7722(00)00109-1; COUTTS DAP, 1987, J APPL BACTERIOL, V62, P251, DOI 10.1111/j.1365-2672.1987.tb02406.x; Cramer W.A., 1990, ENERGY TRANSDUCTION; Dojka MA, 1998, APPL ENVIRON MICROB, V64, P3869; DWYER DF, 1988, APPL ENVIRON MICROB, V54, P1354, DOI 10.1128/AEM.54.6.1354-1359.1988; Elshahed MS, 2001, APPL ENVIRON MICROB, V67, P1728, DOI 10.1128/AEM.67.4.1728-1738.2001; Harwood CS, 1997, J BACTERIOL, V179, P301, DOI 10.1128/jb.179.2.301-309.1997; Harwood CS, 1998, FEMS MICROBIOL REV, V22, P439, DOI 10.1016/S0168-6445(98)00026-6; JACKSON BE, 1999, THESIS U OKLAHOMA; JETTEN MSM, 1991, FEMS MICROBIOL LETT, V84, P313, DOI 10.1111/j.1574-6968.1991.tb04616.x; KAISER JL, 1982, ARCH MICROBIOL, V133, P384; Kleerebezem R, 2000, BIOTECHNOL BIOENG, V67, P529, DOI 10.1002/(SICI)1097-0290(20000305)67:5<529::AID-BIT4>3.0.CO;2-Q; MALONEY PC, 1983, J BACTERIOL, V153, P1461, DOI 10.1128/JB.153.3.1461-1470.1983; McInerney M.J., 1981, BIOMASS CONVERS PROC, P277, DOI DOI 10.1007/978-1-4757-0301-6_15; MCINERNEY MJ, 1979, ARCH MICROBIOL, V122, P129, DOI 10.1007/BF00411351; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; Schink B., 1988, NAT REV MICROBIOL, P5; Schocke L, 1997, MICROBIOL-UK, V143, P2345, DOI 10.1099/00221287-143-7-2345; Scholten JCM, 2000, APPL ENVIRON MICROB, V66, P2934, DOI 10.1128/AEM.66.7.2934-2942.2000; Seiler W., 1980, ATMOS TECHNOL, V12, P40; SEITZ HJ, 1990, ARCH MICROBIOL, V155, P82, DOI 10.1007/BF00291279; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Thauer R. K., 1984, S SOC GEN MICROBIOL, P123; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; Tran QH, 1998, EUR J BIOCHEM, V251, P538, DOI 10.1046/j.1432-1327.1998.2510538.x; Warikoo V, 1996, APPL ENVIRON MICROB, V62, P26, DOI 10.1128/AEM.62.1.26-32.1996; WOFFORD NQ, 1986, J BACTERIOL, V167, P179, DOI 10.1128/jb.167.1.179-185.1986; [No title captured]	30	188	198	2	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2002	415	6870					454	456		10.1038/415454a	http://dx.doi.org/10.1038/415454a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807560				2022-12-24	WOS:000173433600056
J	Raji, A				Raji, A			The body politic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2002	287	3					286	286		10.1001/jama.287.3.286	http://dx.doi.org/10.1001/jama.287.3.286			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	511YQ	11790190				2022-12-24	WOS:000173294700001
J	Fong, YW; Zhou, Q				Fong, YW; Zhou, Q			Stimulatory effect of splicing factors on transcriptional elongation	NATURE			English	Article							RNA-POLYMERASE-II; SMALL NUCLEAR RIBONUCLEOPROTEIN; C-TERMINAL DOMAIN; HIV-1 TAT; P-TEFB; TAT-SF1; PURIFICATION; AFFINITY; PROTEIN; U2	Transcription and pre-mRNA splicing are tightly coupled gene expression events in eukaryotic cells(1,2). An interaction between the carboxy-terminal domain of the largest subunit of RNA polymerase (Pol) II and components of the splicing machinery is postulated to mediate this coupling(3-5). Here, we show that splicing factors function directly to promote transcriptional elongation, demonstrating that transcription is more intimately coupled to splicing than previously thought. The spliceosomal U small nuclear ribonucleoproteins (snRNPs) interact with human transcription elongation factor TAT-SF1 (refs 6-9) and strongly stimulate polymerase elongation when directed to an intron-free human immunodeficiency virus-1 (HIV-1) template. This effect is likely to be mediated through the binding of TAT-SF1 to elongation factor P-TEFb(10), a proposed component of the transcription elongation complex(11,12). Inclusion of splicing signals in the nascent transcript further stimulates transcription, supporting the notion that the recruitment of U snRNPs near the elongating polymerase is important for transcription. Because the TAT-SF1-UsnRNP complex also stimulates splicing in vitro, it may serve as a dual-function factor to couple transcription and splicing and to facilitate their reciprocal activation.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Zhou, Q (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.							Ares M, 1999, RNA, V5, P1138, DOI 10.1017/S1355838299991379; BACH M, 1990, METHOD ENZYMOL, V181, P232; Bentley D, 1999, CURR OPIN CELL BIOL, V11, P347, DOI 10.1016/S0955-0674(99)80048-9; Blencowe BJ, 1999, METH MOL B, V118, P275; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; Fong N, 2001, GENE DEV, V15, P1783, DOI 10.1101/gad.889101; Fong YW, 2000, MOL CELL BIOL, V20, P5897, DOI 10.1128/MCB.20.16.5897-5907.2000; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Hirose Y, 1999, GENE DEV, V13, P1234, DOI 10.1101/gad.13.10.1234; Hirose Y, 2000, GENE DEV, V14, P1415; Jones KA, 1997, GENE DEV, V11, P2593, DOI 10.1101/gad.11.20.2593; Kim JB, 1999, MOL CELL BIOL, V19, P5960; KRAINER AR, 1988, NUCLEIC ACIDS RES, V16, P9415, DOI 10.1093/nar/16.20.9415; KRAINER AR, 1985, CELL, V42, P725, DOI 10.1016/0092-8674(85)90269-7; Li XY, 1998, GENE DEV, V12, P2992, DOI 10.1101/gad.12.19.2992; MARCINIAK RA, 1991, EMBO J, V10, P4189, DOI 10.1002/j.1460-2075.1991.tb04997.x; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; PADGETT RA, 1983, CELL, V35, P101, DOI 10.1016/0092-8674(83)90212-X; Parada CA, 1999, EMBO J, V18, P3688, DOI 10.1093/emboj/18.13.3688; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Perriman R, 2000, GENE DEV, V14, P97; Ping YH, 1999, J BIOL CHEM, V274, P7399, DOI 10.1074/jbc.274.11.7399; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Schnapp G, 1998, NUCLEIC ACIDS RES, V26, P3311, DOI 10.1093/nar/26.13.3311; SOLNICK D, 1985, CELL, V43, P667, DOI 10.1016/0092-8674(85)90239-9; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Yan D, 1998, MOL CELL BIOL, V18, P5000, DOI 10.1128/MCB.18.9.5000; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000; ZHOU QA, 1995, EMBO J, V14, P321, DOI 10.1002/j.1460-2075.1995.tb07006.x; Zhou QA, 1996, SCIENCE, V274, P605, DOI 10.1126/science.274.5287.605	30	271	276	1	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					929	933		10.1038/414929a	http://dx.doi.org/10.1038/414929a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780068				2022-12-24	WOS:000172813300051
J	Reichler, MR; Reves, R; Bur, S; Thompson, V; Mangura, BT; Ford, J; Valway, SE; Onorato, IM				Reichler, MR; Reves, R; Bur, S; Thompson, V; Mangura, BT; Ford, J; Valway, SE; Onorato, IM		Contact Invest Study Grp	Evaluation of investigations conducted to detect and prevent transmission of tuberculosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OUTBREAK	Context Contact investigations are routinely conducted by health departments throughout the United States for all cases of active pulmonary tuberculosis (TB) to identify secondary cases of active TB and latent TB infection and to initiate therapy as needed in these contacts. Little is known about the actual procedures followed, or the results. Objectives To evaluate contact investigations conducted by US health departments and the outcomes of these investigations. Design, Setting, and Subjects Review of health department records for all contacts of 349 patients with culture-positive pulmonary TB aged 15 years or older reported from 5 study areas in the United States during 1996. Main Outcome Measures Number of contacts identified, fully screened, and infected per TB patient; rates of TB infection and disease among contacts of TB patients; and type and completeness of data collected during contact investigations. Results A total of 3824 contacts were identified for 349 patients with active pulmonary TB. Of the TB patients, 45 (13%) had no contacts identified. Of the contacts, 55% completed screening, 27% had an initial but no postexposure tuberculin skin test, 12% were not screened, and 6% had a history of prior TB or prior positive tuberculin skin test. Of 2095 contacts who completed screening, 68% had negative skin test results, 24% had initial positive results with no prior test result available, 7% had documented skin test conversions, and 1% had active TB at the time of investigation. Close contacts younger than 15 years (76% screened vs 65% for older age groups; P<.001) or exposed to a TB patient with a positive smear (74% screened vs 59% for those with a negative smear; P<.001) were more likely to be fully screened. Close contacts exposed to TB patients with both a positive smear and a cavitary chest radiograph were more likely to have TB infection or disease (62% vs 33% for positive smear only vs 44% for cavitary radiograph only vs 37% for neither characteristic; P<.001). A number of factors associated with TB patient infectiousness, contact susceptibility to infection, contact risk of progression to active TB, and amount of contact exposure to the TB patient were not routinely recorded in health department records. Conclusions Improvement is needed in the complex, multistep process of contact investigations to ensure that contacts of patients with active pulmonary TB are identified and appropriately screened.	Ctr Dis Control & Prevent, DTBE, Div TB Eliminat, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA; Denver Publ Hlth, Denver, CO USA; Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA; Massachusetts Dept Publ Hlth, Jamaica Plain, MA USA; Mississippi Dept Hlth, Jackson, MS USA; New Jersey Dept Hlth & Senior Serv, Trenton, NJ USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Natl TB Ctr, Newark, NJ 07103 USA	Centers for Disease Control & Prevention - USA; Maryland Department of Health & Mental Hygiene; Massachusetts Department of Public Health; New Jersey Department of Health & Senior Services; Rutgers State University New Brunswick; Rutgers State University Medical Center	Reichler, MR (corresponding author), Ctr Dis Control & Prevent, DTBE, Div TB Eliminat, Natl Ctr HIV STD & TB Prevent, Mailstop E-10,1600 Clifton Rd, Atlanta, GA 30333 USA.	mrr3@cdc.gov						[Anonymous], 1994, Morbidity and Mortality Weekly Report, V43, P1; Barnes PF, 1997, JAMA-J AM MED ASSOC, V278, P1159, DOI 10.1001/jama.278.14.1159; BASS J, 1992, AM REV RESPIR DIS, V146, P1623; Bock NN, 1998, CLIN INFECT DIS, V27, P1221, DOI 10.1086/514986; *CDCP, 1990, MMWR-MORBID MORTAL W, V39, P9; *CDCP, 1999, CONT INV TUB, P7; *CDCP, 1990, MMWR-MORBID MORTAL W, V39, P1; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P317; ETKIND S, 1993, LUNG BIOL HLTH DIS, V144, P275; Fitzpatrick LK, 2001, CLIN INFECT DIS, V33, P1801, DOI 10.1086/323671; Mangura BT, 1998, CHEST, V113, P234, DOI 10.1378/chest.113.1.234; Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022; REICHLER MR, IN PRESS SO MED J; Sterling TR, 2000, INT J TUBERC LUNG D, V4, P1066	14	185	190	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2002	287	8					991	995		10.1001/jama.287.8.991	http://dx.doi.org/10.1001/jama.287.8.991			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525CX	11866646	Bronze			2022-12-24	WOS:000174052100026
J	Olff, H; Ritchie, ME; Prins, HHT				Olff, H; Ritchie, ME; Prins, HHT			Global environmental controls of diversity in large herbivores	NATURE			English	Article							PRODUCTIVITY; PATTERNS	Large mammalian herbivores occupy half of the earth's land surface and are important both ecologically and economically(1), but their diversity is threatened by human activities(2). We investigated how the diversity of large herbivores changes across gradients of global precipitation and soil fertility. Here we show that more plant-available moisture reduces the nutrient content of plants but increases productivity, whereas more plant-available nutrients increase both of these factors. Because larger herbivore species tolerate lower plant nutrient content but require greater plant abundance, the highest potential herbivore diversity should occur in locations with intermediate moisture and high nutrients. These areas are dry enough to yield high quality plants and support smaller herbivores, but productive enough to support larger herbivores. These predictions fit with observed patterns of body size and diversity for large mammalian herbivores in North America, Africa and Australia, and yield a global map of regions with potentially high herbivore diversity. Thus, gradients of precipitation, temperature and soil fertility might explain the global distribution of large herbivore diversity and help to identify crucial areas for conservation and restoration.	Univ Wageningen & Res Ctr, Trop Nat Conservat & Vertebrate Ecol Grp, NL-6708 PD Wageningen, Netherlands; Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Wageningen University & Research; Syracuse University	Olff, H (corresponding author), Univ Wageningen & Res Ctr, Trop Nat Conservat & Vertebrate Ecol Grp, Bornsesteeg 69, NL-6708 PD Wageningen, Netherlands.	han.olff@staf.ton.wau.nl	Olff, Han/A-8516-2008	Olff, Han/0000-0003-2154-3576; Prins, Herbert/0000-0003-1131-5107				ALCAMO J, 1994, WATER AIR SOIL POLL, V76, P37, DOI 10.1007/BF00478336; BELL RHV, 1982, ECOL STUD, V42, P193; BELOVSKY GE, 1986, AM ZOOL, V26, P51; Belovsky GE, 1997, EVOL ECOL, V11, P641, DOI 10.1023/A:1018430201230; BREMAN H, 1983, SCIENCE, V221, P1341, DOI 10.1126/science.221.4618.1341; BREMAN H, 1991, PRODUCTIVITE PATURAG, P322; COE M, 1983, NITROGEN ECOLOGICAL, P345; Danell K, 1996, ECOGRAPHY, V19, P404, DOI 10.1111/j.1600-0587.1996.tb00251.x; DUTOIT JT, 1989, AM NAT, V133, P736, DOI 10.1086/284949; EAST R, 1984, AFR J ECOL, V22, P245, DOI 10.1111/j.1365-2028.1984.tb00700.x; Eisenberg J.F., 1981, P1; Huston, 1994, BIOL DIVERSITY COEXI; HUSTON M, 1993, SCIENCE, V262, P1676, DOI 10.1126/science.262.5140.1676; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; KINYAMARIO JI, 1992, AFR J ECOL, V30, P33, DOI 10.1111/j.1365-2028.1992.tb00476.x; MCNAUGHTON SJ, 1989, NATURE, V341, P142, DOI 10.1038/341142a0; MILCHUNAS DG, 1995, OECOLOGIA, V101, P366, DOI 10.1007/BF00328824; Murray Martyn G., 1995, P231; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; OWENSMITH N, 1987, PALEOBIOLOGY, V13, P351; OWENSMITH N, 1988, INFLUENCE VERY LARGE; Prins H.H.T., 1998, P449; PRINS HHT, 1992, ENVIRON CONSERV, V19, P117, DOI 10.1017/S0376892900030587; Prins HHT, 1996, ECOLOGY BEHAV AFRICA; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Van Soest PJ, 1982, NUTR ECOLOGY RUMINAN; Van Wijngaarden W, 1985, ITC PUBLICATION, V4; VOETEN MM, 1999, TROPICAL RESOURCE MA, V29; Walker BH, 1997, J BIOGEOGR, V24, P813, DOI 10.1046/j.1365-2699.1997.00123.x; WESTERN D, 1981, AFR J ECOL, V19, P7, DOI 10.1111/j.1365-2028.1981.tb00648.x	30	250	263	5	104	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 21	2002	415	6874					901	904		10.1038/415901a	http://dx.doi.org/10.1038/415901a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523EL	11859367	Green Published			2022-12-24	WOS:000173941000043
J	Roberts, CM; McClean, CJ; Veron, JEN; Hawkins, JP; Allen, GR; McAllister, DE; Mittermeier, CG; Schueler, FW; Spalding, M; Wells, F; Vynne, C; Werner, TB				Roberts, CM; McClean, CJ; Veron, JEN; Hawkins, JP; Allen, GR; McAllister, DE; Mittermeier, CG; Schueler, FW; Spalding, M; Wells, F; Vynne, C; Werner, TB			Marine biodiversity hotspots and conservation priorities for tropical reefs	SCIENCE			English	Article							RECRUITMENT; POPULATION; EXTINCTION	Coral reefs are the most biologically diverse of shallow water marine ecosystems but are being degraded worldwide by human activities and climate warming. Analyses of the geographic ranges of 3235 species of reef fish, corals, snails, and lobsters revealed that between 7.2% and 53.6% of each taxon have highly restricted ranges, rendering them vulnerable to extinction. Restricted-range species are clustered into centers of endemism, like those described for terrestrial taxa. The 10 richest centers of endemism cover 15.8% of the world's coral reefs (0.012% of the oceans) but include between 44.8 and 54.2% of the restricted-range species, Many occur in regions where reefs are being severely affected by people, potentially leading to numerous extinctions. Threatened centers of endemism are major biodiversity hotspots, and conservation efforts targeted toward them could help avert the loss of tropical reef biodiversity.	Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Australian Inst Marine Sci, Townsville MC, Qld 4810, Australia; Conservat Int, Ctr Appl Biodivers Sci, Washington, DC 20036 USA; Ocean Voice Int, Perth, ON K7H 3M6, Canada; Eastern Ontario Biodivers Museum, Kemptville, ON, Canada; UNEP, WCMC, Cambridge CB3 0DL, England; Western Australian Museum, Perth, WA 6000, Australia; Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England	Harvard University; Australian Institute of Marine Science; Conservation International; Western Australian Museum; University of York - UK	Roberts, CM (corresponding author), Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England.	cr10@york.ac.uk	Spalding, Mark/GVU-0739-2022	Spalding, Mark/0000-0001-9456-4533				Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; Birkeland C., 1997, LIFE DEATH CORAL REE; Bryant D., 1998, REEFS RISK MAP BASED; Floeter SR, 2001, GLOBAL ECOL BIOGEOGR, V10, P423, DOI 10.1046/j.1466-822X.2001.00245.x; Ginsburg RN, 1994, P C GLOB ASP COR REE; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; MCALLISTER DE, 1991, SEA WIND, V5, P14; McAllister Don E., 1994, P155; Miya M, 1997, NATURE, V389, P803, DOI 10.1038/39774; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nott M. Philip, 1997, P125; PIMENTEL D, 1995, SCIENCE, V267, P1117, DOI 10.1126/science.267.5201.1117; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Pimm SL, 2001, SCIENCE, V293, P2207, DOI 10.1126/science.1061626; Polunin NVC, 1996, REEF FISHERIES; Reaka-Kudla M. L., 1997, BIODIVERSITY, P83; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Robertson DR, 2001, P NATL ACAD SCI USA, V98, P5667, DOI 10.1073/pnas.091367798; Spalding M. D., 2001, WORLD ATLAS CORAL RE; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Veron J., 2000, CORALS WORLD, V1-3; WERNER TB, 1998, RAPID BODIVERSITY AS	24	1056	1095	22	677	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2002	295	5558					1280	1284		10.1126/science.1067728	http://dx.doi.org/10.1126/science.1067728			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847338				2022-12-24	WOS:000173926000040
J	Monney, L; Sabatos, CA; Gaglia, JL; Ryu, A; Waldner, H; Chernova, T; Manning, S; Greenfield, EA; Coyle, AJ; Sobel, RA; Freeman, GJ; Kuchroo, VK				Monney, L; Sabatos, CA; Gaglia, JL; Ryu, A; Waldner, H; Chernova, T; Manning, S; Greenfield, EA; Coyle, AJ; Sobel, RA; Freeman, GJ; Kuchroo, VK			Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease	NATURE			English	Article							CHEMOKINE RECEPTOR EXPRESSION; CENTRAL-NERVOUS-SYSTEM; CD4(+) T-CELLS; CUTTING EDGE; LYMPHOCYTES; TH1; ENCEPHALOMYELITIS; THERAPY; ANTIGEN; SUBSETS	Activation of naive CD4(+) T-helper cells results in the development of at least two distinct effector populations, Th1 and Th2 cells(1-3). Th1 cells produce cytokines (interferon (IFN)-gamma, interleukin (IL)-2, tumour-necrosis factor (TNF)-alpha and lymphotoxin) that are commonly associated with cell-mediated immune responses against intracellular pathogens, delayed-type hypersensitivity reactions 4, and induction of organ-specific autoimmune diseases(5). Th2 cells produce cytokines (IL-4, IL-10 and IL-13) that are crucial for control of extracellular helminthic infections and promote atopic and allergic diseases(4). Although much is known about the functions of these two subsets of T-helper cells, there are few known surface molecules that distinguish between them(6). We report here the identification and characterization of a transmembrane protein, Tim-3, which contains an immunoglobulin and a mucin-like domain and is expressed on differentiated Th1 cells. In vivo administration of antibody to Tim-3 enhances the clinical and pathological severity of experimental autoimmune encephalomyelitis (EAE), a Th1-dependent autoimmune disease, and increases the number and activation level of macrophages. Tim-3 may have an important role in the induction of autoimmune diseases by regulating macrophage activation and/or function.	Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Millennium Pharmaceut, Cambridge, MA 02139 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 95305 USA; VA Hlth Care Syst, Palo Alto, CA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Stanford University	Kuchroo, VK (corresponding author), Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, 75 Francis St, Boston, MA 02115 USA.		Freeman, Gordon/AAC-5380-2019	Freeman, Gordon/0000-0002-7210-5616; Sobel, Raymond/0000-0002-0477-9002				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; GORDON EJ, 1995, J NEUROIMMUNOL, V62, P153, DOI 10.1016/0165-5728(95)00120-2; Hofstra CL, 1998, J IMMUNOL, V161, P5054; Jourdan P, 1998, J IMMUNOL, V160, P4153; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; LACK G, 1994, J IMMUNOL, V152, P2546; LIBLAU RS, 1995, IMMUNOL TODAY, V16, P34, DOI 10.1016/0167-5699(95)80068-9; Loetscher P, 1998, NATURE, V391, P344, DOI 10.1038/34814; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; MCINTIRE JJ, 2001, NATURE IMMUNOL, V2, P1019; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; NICHOLSON LB, 1995, IMMUNITY, V3, P397, DOI 10.1016/1074-7613(95)90169-8; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; SHER A, 1992, ANNU REV IMMUNOL, V10, P385, DOI 10.1146/annurev.iy.10.040192.002125; Syrbe U, 1999, SPRINGER SEMIN IMMUN, V21, P263, DOI 10.1007/BF00812257; Tran EH, 1998, J IMMUNOL, V161, P3767; Venkataraman C, 2000, J IMMUNOL, V165, P632, DOI 10.4049/jimmunol.165.2.632; Waldner H, 2000, P NATL ACAD SCI USA, V97, P3412, DOI 10.1073/pnas.97.7.3412; Zingoni A, 1998, J IMMUNOL, V161, P547	24	1125	1310	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					536	541		10.1038/415536a	http://dx.doi.org/10.1038/415536a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823861				2022-12-24	WOS:000173564300049
J	Schwartz, MK; Mills, LS; McKelvey, KS; Ruggiero, LF; Allendorf, FW				Schwartz, MK; Mills, LS; McKelvey, KS; Ruggiero, LF; Allendorf, FW			DNA reveals high dispersal synchronizing the population dynamics of Canada lynx	NATURE			English	Article							GENE FLOW; MICROSATELLITE LOCI; DIFFERENTIATION; MIGRATION; PATTERNS	Population dynamics of Canada lynx (Lynx canadensis) have been of interest to ecologists for nearly sixty years(1-4). Two competing hypotheses concerning lynx population dynamics and large-scale spatial synchrony are currently debated. The first suggests that dispersal is substantial among lynx populations(5), and the second proposes that lynx at the periphery of their range exist in small, isolated patches that maintain cycle synchrony via correlation with extrinsic environmental factors(2). Resolving the nature of lynx population dynamics and dispersal is important both to ecological theory and to the conservation of threatened lynx populations: the lack of knowledge about connectivity between populations at the southern periphery of the lynx's geographic range delayed their legal listing in the United States(6). We test these competing hypotheses using microsatellite DNA markers and lynx samples from 17 collection sites in the core and periphery of the lynx's geographic range. Here we show high gene flow despite separation by distances greater than 3,100 km, supporting the dispersal hypothesis. We therefore suggest that management actions in the contiguous United States should focus on maintaining connectivity with the core of the lynx's geographic range.	Univ Montana, Sch Forestry, Wildlife Biol Program, Missoula, MT 59812 USA; USDA, USFS, Rocky Mt Res Stn, Missoula, MT 59801 USA; Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	University of Montana System; University of Montana; United States Department of Agriculture (USDA); United States Forest Service; University of Montana System; University of Montana	Schwartz, MK (corresponding author), Univ Montana, Sch Forestry, Wildlife Biol Program, Missoula, MT 59812 USA.		Mills, L. Scott/K-2458-2012; Schwartz, Michael K/C-3184-2014	Mills, L. Scott/0000-0001-8771-509X; Schwartz, Michael K/0000-0003-3521-3367				BERTHIER P, IN PRESS GENETICS; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; Cattadori IM, 2000, J ANIM ECOL, V69, P620, DOI 10.1046/j.1365-2656.2000.00421.x; Cornuet JM, 1999, GENETICS, V153, P1989; Ehrich D, 2001, MOL ECOL, V10, P481, DOI 10.1046/j.1365-294x.2001.01229.x; Elton C, 1942, J ANIM ECOL, V11, P215, DOI 10.2307/1358; Forbes SH, 1997, CONSERV BIOL, V11, P1226, DOI 10.1046/j.1523-1739.1997.96296.x; Greenman JV, 2001, OIKOS, V93, P343, DOI 10.1034/j.1600-0706.2001.930217.x; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; Hudson PJ, 1999, TRENDS ECOL EVOL, V14, P1, DOI 10.1016/S0169-5347(98)01498-0; MANUEL S, IN PRESS CONS BIOL; McKelvey Kevin S., 2000, P207; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; MENOTTIRAYMOND MA, 1995, J HERED, V86, P319, DOI 10.1093/oxfordjournals.jhered.a111594; MORAN PAP, 1953, AUST J ZOOL, V1, P291, DOI 10.1071/ZO9530291; Mowat Garth, 2000, P265; Paetkau D, 1998, MOL ECOL, V7, P1283, DOI 10.1046/j.1365-294x.1998.00440.x; Predavec M, 2001, OECOLOGIA, V126, P216, DOI 10.1007/s004420000516; Ranta E, 1997, SCIENCE, V278, P1621, DOI 10.1126/science.278.5343.1621; ROY MS, 1994, MOL BIOL EVOL, V11, P553; Ruggiero Leonard F., 2000, P443; SCHWARTZ MK, UNPUB MOL ECOL; Slough BG, 1996, J WILDLIFE MANAGE, V60, P946, DOI 10.2307/3802397; Stenseth NC, 1999, SCIENCE, V285, P1071, DOI 10.1126/science.285.5430.1071; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Wright S., 1969, THEORY GENE FREQUENC, V2, P520; 2000, FED REG, V65, P15051	28	124	128	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					520	522		10.1038/415520a	http://dx.doi.org/10.1038/415520a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823858	Green Published			2022-12-24	WOS:000173564300045
J	Inoue, K; Kohda, T; Lee, J; Ogonuki, N; Mochida, K; Noguchi, Y; Tanemura, K; Kaneko-Ishino, T; Ishino, F; Ogura, A				Inoue, K; Kohda, T; Lee, J; Ogonuki, N; Mochida, K; Noguchi, Y; Tanemura, K; Kaneko-Ishino, T; Ishino, F; Ogura, A			Faithful expression of imprinted genes in cloned mice	SCIENCE			English	Article									Natl Inst Infect Dis, Dept Vet Sci, Shinjuku Ku, Tokyo 1628640, Japan; Tokyo Inst Technol, Ctr Gene Res, Kanagawa 2268501, Japan; CREST, JST, Saitama 3320012, Japan; Tokai Univ, Sch Hlth Sci, Kanagawa 2591100, Japan	National Institute of Infectious Diseases (NIID); Tokyo Institute of Technology; Japan Science & Technology Agency (JST); Tokai University	Ishino, F (corresponding author), Natl Inst Infect Dis, Dept Vet Sci, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	fishino@bio.titech.ac.jp; aogura@nih.go.jp	Ishino（Kaneko-Ishino）, Tomoko/AGY-0742-2022; Ogura, Atsuo/J-3916-2014; Kohda, Takashi/C-2879-2014	Ogura, Atsuo/0000-0003-0447-1988; Kohda, Takashi/0000-0002-6856-5601				Dean W, 1998, DEVELOPMENT, V125, P2273; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Ogura A, 2000, MOL REPROD DEV, V57, P55, DOI 10.1002/1098-2795(200009)57:1&lt;55::AID-MRD8&gt;3.0.CO;2-W; Ogura A, 2000, BIOL REPROD, V62, P1579, DOI 10.1095/biolreprod62.6.1579; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206	6	157	173	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2002	295	5553					297	297		10.1126/science.295.5553.297	http://dx.doi.org/10.1126/science.295.5553.297			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786635				2022-12-24	WOS:000173278600039
J	McKane, RB; Johnson, LC; Shaver, GR; Nadelhoffer, KJ; Rastetter, EB; Fry, B; Giblin, AE; Kielland, K; Kwiatkowski, BL; Laundre, JA; Murray, G				McKane, RB; Johnson, LC; Shaver, GR; Nadelhoffer, KJ; Rastetter, EB; Fry, B; Giblin, AE; Kielland, K; Kwiatkowski, BL; Laundre, JA; Murray, G			Resource-based niches provide a basis for plant species diversity and dominance in arctic tundra	NATURE			English	Article							ALASKAN TUNDRA; AMINO-ACIDS; COMPETITION; NITROGEN; GROWTH; TREES	Ecologists have long been intrigued by the ways co-occurring species divide limiting resources. Such resource partitioning, or niche differentiation, may promote species diversity by reducing competition(1,2). Although resource partitioning is an important determinant of species diversity and composition in animal communities(3), its importance in structuring plant communities has been difficult to resolve(4). This is due mainly to difficulties in studying how plants compete for belowground resources(5). Here we provide evidence from a N-15-tracer field experiment showing that plant species in a nitrogen-limited, arctic tundra community were differentiated in timing, depth and chemical form of nitrogen uptake, and that species dominance was strongly correlated with uptake of the most available soil nitrogen forms. That is, the most productive species used the most abundant nitrogen forms, and less productive species used less abundant forms. To our knowledge, this is the first documentation that the composition of a plant community is related to partitioning of differentially available forms of a single limiting resource.	US EPA, Corvallis, OR 97333 USA; Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; US Forest Serv, Inst Pacific Isl Forestry, USDA, Honolulu, HI 96813 USA; Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA; Appalachian Mt Club, Gorham, NH 03581 USA	United States Environmental Protection Agency; Kansas State University; United States Department of Agriculture (USDA); United States Forest Service; Marine Biological Laboratory - Woods Hole; University of Alaska System; University of Alaska Fairbanks	McKane, RB (corresponding author), US EPA, Corvallis, OR 97333 USA.	mckane.bob@epa.gov	Nadelhoffer, Knute/AAE-7744-2020; Laundre, James/P-1968-2016; Giblin, Anne/AAV-6838-2020	Nadelhoffer, Knute/0000-0001-9775-894X; Laundre, James/0000-0002-2061-8655; Giblin, Anne/0000-0003-3851-2178; Rastetter, Edward/0000-0002-8620-5431; Kwiatkowski, Bonnie/0000-0003-0158-9753				[Anonymous], 1975, COMMUNITIES ECOSYSTE; ARMSTRONG RA, 1980, AM NAT, V115, P151, DOI 10.1086/283553; Bliss L.C., 1992, ARCTIC ECOSYSTEMS CH, V59, P89; Casper BB, 1997, ANNU REV ECOL SYST, V28, P545, DOI 10.1146/annurev.ecolsys.28.1.545; CHAPIN FS, 1993, NATURE, V361, P150, DOI 10.1038/361150a0; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; FLANAGAN LB, 1992, PLANT CELL ENVIRON, V15, P831, DOI 10.1111/j.1365-3040.1992.tb02150.x; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Kielland K, 1995, BIOGEOCHEMISTRY, V31, P85, DOI 10.1007/BF00000940; KIELLAND K, 1994, ECOLOGY, V75, P2373, DOI 10.2307/1940891; MCKANE RB, 1990, ECOLOGY, V71, P1126, DOI 10.2307/1937380; MCNAUGHTON SJ, 1970, SCIENCE, V167, P131, DOI 10.1126/science.167.3915.131; Owen AG, 2001, SOIL BIOL BIOCHEM, V33, P651, DOI 10.1016/S0038-0717(00)00209-1; PARRISH JAD, 1976, ECOLOGY, V57, P1281, DOI 10.2307/1935052; Raab TK, 1999, ECOLOGY, V80, P2408, DOI 10.1890/0012-9658(1999)080[2408:SAAUAS]2.0.CO;2; RIEGER S, 1979, EXPLORATORY SOIL SUR; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; SHAVER GR, 1980, ECOLOGY, V61, P662, DOI 10.2307/1937432; SHAVER GR, 1991, ECOL MONOGR, V61, P1, DOI 10.2307/1942997; SHAVER GR, 1986, ECOLOGY, V67, P660, DOI 10.2307/1937690; SHAVER GR, 1975, ECOLOGY, V56, P401, DOI 10.2307/1934970; Silvertown J, 1999, NATURE, V400, P61, DOI 10.1038/21877; STEWART FM, 1973, AM NAT, V107, P171, DOI 10.1086/282825; Tilman D., 1982, Monographs in Population Biology, pi	26	641	689	12	372	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2002	415	6867					68	71		10.1038/415068a	http://dx.doi.org/10.1038/415068a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507KZ	11780117				2022-12-24	WOS:000173028800040
J	Cartron, JP				Cartron, JP			Rh-deficiency syndrome	LANCET			English	Article									Inst Natl Transfus Sanguine, INSERM, U76, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Cartron, JP (corresponding author), Inst Natl Transfus Sanguine, INSERM, U76, 6 Rue Alexandre Cabanel, F-75015 Paris, France.								0	7	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2001				S			S57	S57		10.1016/S0140-6736(01)07069-6	http://dx.doi.org/10.1016/S0140-6736(01)07069-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505HK	11784606	Bronze			2022-12-24	WOS:000172907200057
J	Fugmann, SD; Schatz, DG				Fugmann, SD; Schatz, DG			Immunology - One AID to unite them all	SCIENCE			English	Editorial Material							CYTIDINE DEAMINASE AID; CLASS-SWITCH RECOMBINATION; DOUBLE-STRAND BREAKS; SOMATIC HYPERMUTATION; IMMUNOGLOBULIN GENES; DEFICIENCY		Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Yale University	Fugmann, SD (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06510 USA.		Schatz, David/A-6748-2013	Schatz, David/0000-0002-5669-1176				Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484; HARRIS RS, IN PRESS CURR BIOL; Kong QZ, 2001, GENETICS, V158, P369; MAIZELS N, 1995, CELL, V83, P9, DOI 10.1016/0092-8674(95)90227-9; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; PAPAVASILIOU FN, IN PRESS J EXP MED; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Sale JE, 2001, NATURE, V412, P921, DOI 10.1038/35091100	14	15	19	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1244	1245		10.1126/science.1070023	http://dx.doi.org/10.1126/science.1070023			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847327				2022-12-24	WOS:000173926000027
J	He, L; Fong, J; von Zastrow, M; Whistler, JL				He, L; Fong, J; von Zastrow, M; Whistler, JL			Regulation of opioid receptor trafficking and morphine tolerance by receptor oligornerization	CELL			English	Article							RAT-BRAIN; G-PROTEINS; DOWN-REGULATION; UP-REGULATION; GABA RELEASE; MICE LACKING; NEURONS; DEPENDENCE; DESENSITIZATION; ENDOCYTOSIS	The utility of morphine for the treatment of chronic pain is hindered by the development of tolerance to the analgesic effects of the drug. Morphine is unique among opiates in its ability to activate the mu opioid receptor (MOR) without promoting its desensitization and endocytosis. Here we demonstrate that [D-Ala(2)-MePhe(4)-Gly(5)-ol] enkephalin (DAMGO) can facilitate the ability of morphine to stimulate MOR endocytosis. As a consequence, rats treated chronically with both drugs show reduced analgesic tolerance compared to rats treated with morphine alone. These results demonstrate that endocytosis of the MOR can reduce the development of tolerance, and hence suggest an approach for the development of opiate analogs with enhanced efficacy for the treatment of chronic pain.	Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA; Univ Calif San Francisco, Dept Neurol, Emeryville, CA 94608 USA; Univ Calif San Francisco, Dept Psychiat & Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Whistler, JL (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA.	shooz2@itsa.ucsf.edu						Abbadie C, 2000, J COMP NEUROL, V419, P244, DOI 10.1002/(SICI)1096-9861(20000403)419:2<244::AID-CNE8>3.0.CO;2-R; ABDELHAMID EE, 1991, EUR J PHARMACOL, V198, P157, DOI 10.1016/0014-2999(91)90615-W; ADVOKAT C, 1993, PHARMACOL BIOCHEM BE, V45, P871, DOI 10.1016/0091-3057(93)90134-F; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; ARDEN JR, 1995, J NEUROCHEM, V65, P1636; AvidorReiss T, 1996, J BIOL CHEM, V271, P21309, DOI 10.1074/jbc.271.35.21309; Bernstein MA, 1998, MOL BRAIN RES, V55, P237, DOI 10.1016/S0169-328X(98)00005-9; Blake AD, 1997, J BIOL CHEM, V272, P782, DOI 10.1074/jbc.272.2.782; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Bonci A, 1997, J NEUROSCI, V17, P796; BRADY LS, 1989, BRAIN RES, V477, P382, DOI 10.1016/0006-8993(89)91432-7; Chieng B, 1998, J NEUROSCI, V18, P7033; CHRISTIE MJ, 1987, MOL PHARMACOL, V32, P633; Connor M, 1999, BRIT J PHARMACOL, V126, P1553, DOI 10.1038/sj.bjp.0702457; DEVRIES TJ, 1993, LIFE SCI, V52, P1685, DOI 10.1016/0024-3205(93)90476-J; DUTTAROY A, 1995, ANESTHESIOLOGY, V82, P1226, DOI 10.1097/00000542-199505000-00018; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Finn AK, 2001, NEURON, V32, P829, DOI 10.1016/S0896-6273(01)00517-7; GOUARDERES C, 1990, PROG CLIN BIOL RES, V328, P175; HUGHES J, 1983, BRIT MED BULL, V39, P1; Jolas T, 2000, NEUROSCIENCE, V95, P433; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Jordan BA, 2001, P NATL ACAD SCI USA, V98, P343, DOI 10.1073/pnas.011384898; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Lee SP, 2000, NEUROPSYCHOPHARMACOL, V23, pS32, DOI 10.1016/S0893-133X(00)00155-X; Lefkowitz R J, 1998, Adv Pharmacol, V42, P416; MALMBERG AB, 1992, J PHARMACOL EXP THER, V263, P264; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Mitchell JM, 2000, NAT NEUROSCI, V3, P47, DOI 10.1038/71120; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nestler EJ, 1996, NEURON, V16, P897, DOI 10.1016/S0896-6273(00)80110-5; RAYNOR K, 1994, MOL PHARMACOL, V45, P330; REZVANI A, 1983, J PHARMACOL EXP THER, V225, P251; ROTHMAN RB, 1991, PEPTIDES, V12, P151, DOI 10.1016/0196-9781(91)90182-O; Selley DE, 1997, BRAIN RES, V746, P10, DOI 10.1016/S0006-8993(96)01125-0; SHARMA SK, 1975, P NATL ACAD SCI USA, V72, P3092, DOI 10.1073/pnas.72.8.3092; Sim LJ, 1996, J NEUROSCI, V16, P2684; Sim-Selley LJ, 2000, J NEUROSCI, V20, P4555, DOI 10.1523/JNEUROSCI.20-12-04555.2000; SIMANTOV R, 1984, NEUROPEPTIDES, V5, P197, DOI 10.1016/0143-4179(84)90061-1; Stafford K, 2001, PHARMACOL BIOCHEM BE, V69, P233, DOI 10.1016/S0091-3057(01)00525-1; Sternini C, 1996, P NATL ACAD SCI USA, V93, P9241, DOI 10.1073/pnas.93.17.9241; STEVENS CW, 1989, J PHARMACOL EXP THER, V250, P1; Tao PL, 1998, EUR J PHARMACOL, V344, P137, DOI 10.1016/S0014-2999(97)01596-3; Tejwani GA, 1998, BRAIN RES, V797, P305, DOI 10.1016/S0006-8993(98)00416-8; TERWILLIGER RZ, 1991, BRAIN RES, V548, P100, DOI 10.1016/0006-8993(91)91111-D; Trafton JA, 2000, J NEUROSCI, V20, P8578; Trapaidze N, 2000, MOL BRAIN RES, V76, P220, DOI 10.1016/S0169-328X(00)00002-4; WERLING LL, 1989, P NATL ACAD SCI USA, V86, P6393, DOI 10.1073/pnas.86.16.6393; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Yaksh TL, 1999, TRENDS PHARMACOL SCI, V20, P329, DOI 10.1016/S0165-6147(99)01370-X; YAKSH TL, 1986, PHARMACOL BIOCHEM BE, V25, P483, DOI 10.1016/0091-3057(86)90028-6; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157	57	264	276	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2002	108	2					271	282		10.1016/S0092-8674(02)00613-X	http://dx.doi.org/10.1016/S0092-8674(02)00613-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	515XE	11832216	Bronze			2022-12-24	WOS:000173521300013
J	del Castillo, I; Villamar, M; Moreno-Pelayo, MA; del Castillo, FJ; Alvarez, A; Telleria, D; Menendez, I; Moreno, F				del Castillo, I; Villamar, M; Moreno-Pelayo, MA; del Castillo, FJ; Alvarez, A; Telleria, D; Menendez, I; Moreno, F			A deletion involving the connexin 30 gene in nonsyndromic hearing impairment.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIDROTIC ECTODERMAL DYSPLASIA; SENSORINEURAL DEAFNESS; CHILDHOOD DEAFNESS; RAT COCHLEA; MUTATIONS; EXPRESSION; GJB2; POPULATION; FREQUENCY; DFNB1	Background: Inherited hearing impairment affects about 1 in 2000 newborns. Up to 50 percent of all patients with autosomal recessive nonsyndromic prelingual deafness in different populations have mutations in the gene encoding the gap-junction protein connexin 26 (GJB2) at locus DFNB1 on chromosome 13q12. However, a large fraction (10 to 42 percent) of patients with GJB2 mutations have only one mutant allele; the accompanying mutation has not been identified. DFNB1-linked familial cases with no mutation in GJB2 have also been reported. Methods: We evaluated 33 unrelated probands with nonsyndromic prelingual deafness who had only one GJB2 mutant allele. Nine subjects had evidence of linkage to DFNB1. We used haplotype analysis for markers on 13q12 to search for mutations other than the one involving GJB2. Results: We identified a 342-kb deletion in the gene encoding connexin 30 (GJB6), a protein that is reported to be expressed with connexin 26 in the inner ear. The deletion extended distally to GJB2, which remained intact. The break-point junction of the deletion was isolated and sequenced, and a specific diagnostic test was developed for this common mutation. Twenty-two of the 33 subjects were heterozygous for both the GJB6 and GJB2 mutations, including all 9 with evidence of linkage to DFNB1. Two subjects were homozygous for the GJB6 mutation. Conclusions: A 342-kb deletion in GJB6 is the second most frequent mutation causing prelingual deafness in the Spanish population. Our data suggest that mutations in the complex locus DFNB1, which contains two genes (GJB2 and GJB6), can result in a monogenic or a digenic pattern of inheritance of prelingual deafness. (N Engl J Med 2002;346:243-9.) Copyright (C) 2002 Massachusetts Medical Society.	Hosp Ramon y Cajal, Unite Genet Mol, E-28034 Madrid, Spain; Hosp Pediat William Soler, Dept Genet, Havana, Cuba	Hospital Universitario Ramon y Cajal	Moreno, F (corresponding author), Hosp Ramon y Cajal, Unite Genet Mol, Carretera Colmenar Km 9, E-28034 Madrid, Spain.		del Castillo, Ignacio/B-4314-2013; del Castillo, Francisco J./A-6467-2013; Villamar, Manuela/AAD-3842-2020	del Castillo, Ignacio/0000-0003-1188-3665; del Castillo, Francisco J./0000-0003-0467-4320; Villamar, Manuela/0000-0002-5115-4937; MORENO-PELAYO, MIGUEL ANGEL/0000-0003-3839-5098				Abe S, 2000, J MED GENET, V37, P41, DOI 10.1136/jmg.37.1.41; COHEN MM, 1995, OXFORD MONOGRAPHS ME, V28, P9; Dahl E, 1996, J BIOL CHEM, V271, P26444; Denoyelle F, 1999, LANCET, V353, P1298, DOI 10.1016/S0140-6736(98)11071-1; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; Gabriel H, 2001, Hum Mutat, V17, P521, DOI 10.1002/humu.1138; Gasparini P, 2000, EUR J HUM GENET, V8, P19, DOI 10.1038/sj.ejhg.5200406; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Grifa A, 1999, NAT GENET, V23, P16, DOI 10.1038/12612; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; KAJIWARA K, 1994, SCIENCE, V264, P1064; KEEN J, 1991, TRENDS GENET, V7, P5; Kelley PM, 1998, AM J HUM GENET, V62, P792, DOI 10.1086/301807; Kelley PM, 1999, GENOMICS, V62, P172, DOI 10.1006/geno.1999.6002; Kibar Z, 2000, EUR J HUM GENET, V8, P372, DOI 10.1038/sj.ejhg.5200471; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Lamartine J, 2000, NAT GENET, V26, P142, DOI 10.1038/79851; Lautermann J, 1999, DEV GENET, V25, P306, DOI 10.1002/(SICI)1520-6408(1999)25:4<306::AID-DVG4>3.0.CO;2-R; Lautermann J, 1998, CELL TISSUE RES, V294, P415, DOI 10.1007/s004410051192; Lench N, 1998, LANCET, V351, P415, DOI 10.1016/S0140-6736(98)24006-2; Lerer I, 2001, Hum Mutat, V18, P460, DOI 10.1002/humu.1222; Loffler J, 2001, EUR J HUM GENET, V9, P226, DOI 10.1038/sj.ejhg.5200607; MAW MA, 1995, AM J HUM GENET, V57, P629; Murgia A, 1999, J MED GENET, V36, P829; Rabionet R, 2000, HUM GENET, V106, P40, DOI 10.1007/s004390051007; Scott DA, 1998, HUM MUTAT, V11, P387, DOI 10.1002/(SICI)1098-1004(1998)11:5<387::AID-HUMU6>3.3.CO;2-#; Sobe T, 2000, HUM GENET, V106, P50, DOI 10.1007/s004390051009; Spicer SS, 1996, HEARING RES, V100, P80, DOI 10.1016/0378-5955(96)00106-2; Spicer SS, 1998, HEARING RES, V118, P1, DOI 10.1016/S0378-5955(98)00006-9; WHITE MB, 1992, GENOMICS, V12, P301, DOI 10.1016/0888-7543(92)90377-5; Wilcox SA, 2000, HUM GENET, V106, P399, DOI 10.1007/s004390000273; Wilcox SA, 1999, J MED GENET, V36, P383	33	426	445	0	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2002	346	4					243	U1		10.1056/NEJMoa012052	http://dx.doi.org/10.1056/NEJMoa012052			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	513UR	11807148	Bronze			2022-12-24	WOS:000173398900004
J	Shiver, JW; Fu, TM; Chen, L; Casimiro, DR; Davies, ME; Evans, RK; Zhang, ZQ; Simon, AJ; Trigona, WL; Dubey, SA; Huang, LY; Harris, VA; Long, RS; Liang, XP; Handt, L; Schleif, WA; Zhu, L; Freed, DC; Persaud, NV; Guan, L; Punt, KS; Tang, A; Chen, MC; Wilson, KA; Collins, KB; Heidecker, GJ; Fernandez, VR; Perry, HC; Joyce, JG; Grimm, KM; Cook, JC; Keller, PM; Kresock, DS; Mach, H; Troutman, RD; Isopi, LA; Williams, DM; Xu, Z; Bohannon, KE; Volkin, DB; Montefiori, DC; Miura, A; Krivulka, GR; Lifton, MA; Kuroda, MJ; Schmitz, JE; Letvin, NL; Caulfield, MJ; Bett, AJ; Youil, R; Kaslow, DC; Emini, EA				Shiver, JW; Fu, TM; Chen, L; Casimiro, DR; Davies, ME; Evans, RK; Zhang, ZQ; Simon, AJ; Trigona, WL; Dubey, SA; Huang, LY; Harris, VA; Long, RS; Liang, XP; Handt, L; Schleif, WA; Zhu, L; Freed, DC; Persaud, NV; Guan, L; Punt, KS; Tang, A; Chen, MC; Wilson, KA; Collins, KB; Heidecker, GJ; Fernandez, VR; Perry, HC; Joyce, JG; Grimm, KM; Cook, JC; Keller, PM; Kresock, DS; Mach, H; Troutman, RD; Isopi, LA; Williams, DM; Xu, Z; Bohannon, KE; Volkin, DB; Montefiori, DC; Miura, A; Krivulka, GR; Lifton, MA; Kuroda, MJ; Schmitz, JE; Letvin, NL; Caulfield, MJ; Bett, AJ; Youil, R; Kaslow, DC; Emini, EA			Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity	NATURE			English	Article							CYTOTOXIC T-LYMPHOCYTES; INFECTED RHESUS-MONKEYS; TYPE-1 INFECTION; DISEASE PROGRESSION; DNA VACCINATION; RESPONSES; VIREMIA; MAMU-A-ASTERISK-01; DOMINANT; EPITOPES	Recent studies of human immunodeficiency virus type 1 (HIV-1) infection in humans and of simian immunodeficiency virus (SIV) in rhesus monkeys have shown that resolution of the acute viral infection and control of the subsequent persistent infection are mediated by the antiviral cellular immune response(1-11). We comparatively assessed several vaccine vector delivery systems-three formulations of a plasmid DNA vector, the modified vaccinia Ankara (MVA) virus, and a replication incompetent adenovirus type 5 (Ad5) vector-expressing the SIV gag protein for their ability to elicit such immune responses in monkeys. The vaccines were tested either as a single modality or in combined modality regimens. Here we show that the most effective responses were elicited by a replication-incompetent Ad5 vector, used either alone or as a booster inoculation after priming with a DNA vector. After challenge with a pathogenic HIV-SIV hybrid virus (SHIV), the animals immunized with Ad5 vector exhibited the most pronounced attenuation of the virus infection. The replication-defective adenovirus is a promising vaccine vector for development of an HIV-1 vaccine.	Merck Res Labs, W Point, PA 19486 USA; Duke Univ, Med Ctr, Ctr AIDS Res, Durham, NC 27710 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Viral Pathogenesis, Boston, MA 02215 USA	Merck & Company; Duke University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Emini, EA (corresponding author), Merck Res Labs, W Point, PA 19486 USA.		Schmitz, Joern/A-4929-2018	Schmitz, Joern/0000-0001-8803-0922				Allen TM, 1998, J IMMUNOL, V160, P6062; Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Egan MA, 1999, J VIROL, V73, P5466, DOI 10.1128/JVI.73.7.5466-5472.1999; Fu TM, 1997, J VIROL, V71, P2715, DOI 10.1128/JVI.71.4.2715-2721.1997; GALLIMORE A, 1995, NAT MED, V1, P1167, DOI 10.1038/nm1195-1167; KLEIN MR, 1994, J INFECT DIS, V169, P1244, DOI 10.1093/infdis/169.6.1244; Knapp LA, 1997, TISSUE ANTIGENS, V50, P657, DOI 10.1111/j.1399-0039.1997.tb02927.x; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kuroda MJ, 1999, J IMMUNOL, V162, P5127; MILLER MD, 1991, J IMMUNOL, V147, P320; MONTGOMERY DL, 1993, DNA CELL BIOL, V12, P777, DOI 10.1089/dna.1993.12.777; Musey L, 1997, NEW ENGL J MED, V337, P1267, DOI 10.1056/NEJM199710303371803; Newman MJ, 1998, CRIT REV THER DRUG, V15, P89, DOI 10.1615/CritRevTherDrugCarrierSyst.v15.i2.10; Ogg GS, 1999, J VIROL, V73, P9153, DOI 10.1128/JVI.73.11.9153-9160.1999; Pontesilli O, 1998, J INFECT DIS, V178, P1008, DOI 10.1086/515659; Reimann KA, 1996, J VIROL, V70, P3198, DOI 10.1128/JVI.70.5.3198-3206.1996; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Wyatt LS, 1996, VACCINE, V14, P1451, DOI 10.1016/S0264-410X(96)00072-2	20	1037	1092	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2002	415	6869					331	335		10.1038/415331a	http://dx.doi.org/10.1038/415331a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797011				2022-12-24	WOS:000173293500046
J	Yanagisawa, H; Davis, EC; Starcher, BC; Ouchi, T; Yanagisawa, M; Richardson, JA; Olson, EN				Yanagisawa, H; Davis, EC; Starcher, BC; Ouchi, T; Yanagisawa, M; Richardson, JA; Olson, EN			Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo	NATURE			English	Article							DEVELOPING MOUSE AORTA; FIBRILLIN-1; FIBER; ORGANIZATION; TROPOELASTIN; MATRIX	Extracellular elastic fibres provide mechanical elasticity to tissues and contribute towards the processes of organ remodelling by affecting cell-cell signalling(1,2). The formation of elastic fibres requires the assembly and crosslinking of tropoelastin monomers, and organization of the resulting insoluble elastin matrix into functional fibres. The molecules and mechanisms involved in this process are unknown. Fibulin-5 (also known as EVEC/DANCE) is an extracellular matrix protein abundantly expressed in great vessels and cardiac valves during embryogenesis, and in many adult tissues including the aorta, lung, uterus and skin, all of which contain abundant elastic fibres(3,4). Here we show that fibulin-5 is a calcium-dependent, elastin-binding protein that localizes to the surface of elastic fibres in vivo. fibulin-5(-/-) mice develop marked elastinopathy owing to the disorganization of elastic fibres, with resulting loose skin, vascular abnormalities and emphysematous lung. This phenotype, which resembles the cutis laxa syndrome in humans(5), reveals a critical function for fibulin-5 as a scaffold protein that organizes and links elastic fibres to cells. This function may be mediated by the RGD motif in fibulin-5, which binds to cell surface integrins, and the Ca2+-binding epidermal growth factor (EGF) repeats, which bind elastin.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas Hlth Ctr, Dept Biochem, Tyler, TX 75708 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA.		Yanagisawa, Hiromi/Y-2843-2019; Davis, Elaine/F-3449-2012	Yanagisawa, Hiromi/0000-0002-7576-9186; 				Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Chaudhry SS, 2001, HUM MOL GENET, V10, P835, DOI 10.1093/hmg/10.8.835; DAVIS EC, 1994, J CELL SCI, V107, P727; DAVIS EC, 1993, LAB INVEST, V68, P89; Doliana R, 1999, J BIOL CHEM, V274, P16773, DOI 10.1074/jbc.274.24.16773; Kowal RC, 1999, CIRC RES, V84, P1166, DOI 10.1161/01.RES.84.10.1166; Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522; Mecham R. P., 1994, EXTRACELLULAR MATRIX, P281; Milewicz DM, 2000, MATRIX BIOL, V19, P471, DOI 10.1016/S0945-053X(00)00099-8; Nakamura T, 1999, J BIOL CHEM, V274, P22476, DOI 10.1074/jbc.274.32.22476; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; Sasaki T, 1999, FEBS LETT, V460, P280, DOI 10.1016/S0014-5793(99)01362-9; STARCHER B, 1995, CONNECT TISSUE RES, V31, P133, DOI 10.3109/03008209509028401; Trask BC, 2001, BIOCHEMISTRY-US, V40, P4372, DOI 10.1021/bi002738z; Trask TM, 2000, J BIOL CHEM, V275, P24400, DOI 10.1074/jbc.M003665200	18	466	493	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2002	415	6868					168	171		10.1038/415168a	http://dx.doi.org/10.1038/415168a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805834				2022-12-24	WOS:000173159300041
J	Pack, CC; Berezovskii, VK; Born, RT				Pack, CC; Berezovskii, VK; Born, RT			Dynamic properties of neurons in cortical area MT in alert and anaesthetized macaque monkeys	NATURE			English	Article							PRIMARY VISUAL-CORTEX; MOTION PERCEPTION; SEGREGATION; SELECTIVITY; COHERENCE; MODEL	In order to see the world with high spatial acuity, an animal must sample the visual image with many detectors that restrict their analyses to extremely small regions of space. The visual cortex must then integrate the information from these localized receptive fields to obtain a more global picture of the surrounding environment. We studied this process in single neurons within the middle temporal visual area (MT) of macaques using stimuli that produced conflicting local and global information about stimulus motion. Neuronal responses in alert animals initially reflected predominantly the ambiguous local motion features, but gradually converged to an unambiguous global representation. When the same animals were anaesthetized, the integration of local motion signals was markedly impaired even though neuronal responses remained vigorous and directional tuning characteristics were intact. Our results suggest that anaesthesia preferentially affects the visual processing responsible for integrating local signals into a global visual representation.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Pack, CC (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.		Berezovskii, Vladimir/AAB-5253-2022; Born, Richard/M-6454-2019; Berezovskii, Vladimir/B-9866-2013	Born, Richard/0000-0003-4360-427X; Berezovskii, Vladimir/0000-0003-4077-3940				ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; Alais D, 1997, VISION RES, V37, P143, DOI 10.1016/0042-6989(95)00320-7; ALBRIGHT TD, 1992, SCIENCE, V255, P1141, DOI 10.1126/science.1546317; Born RT, 2000, NEURON, V26, P725, DOI 10.1016/S0896-6273(00)81208-8; BORN RT, 1991, P NATL ACAD SCI USA, V88, P7066, DOI 10.1073/pnas.88.16.7066; Castelo-Branco M, 2000, NATURE, V405, P685, DOI 10.1038/35015079; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Hildreth E., 1984, MEASUREMENT VISUAL M; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Lamme VAF, 1998, P NATL ACAD SCI USA, V95, P3263, DOI 10.1073/pnas.95.6.3263; Liden L, 1999, VISION RES, V39, P3301, DOI 10.1016/S0042-6989(99)00055-3; MARR D, 1981, PROC R SOC SER B-BIO, V211, P151, DOI 10.1098/rspb.1981.0001; MIKAMI A, 1986, J NEUROPHYSIOL, V55, P1328, DOI 10.1152/jn.1986.55.6.1328; Movshon J. A., 1985, EXPT BRAIN RES S, V11, P117, DOI DOI 10.1007/978-3-662-09224-8_7.; Movshon JA, 1996, J NEUROSCI, V16, P7733; MUKHERJEE P, 1995, J NEUROPHYSIOL, V74, P1222, DOI 10.1152/jn.1995.74.3.1222; O'Keefe LP, 1998, VISUAL NEUROSCI, V15, P305, DOI 10.1017/S0952523898152094; Pack CC, 2001, NATURE, V409, P1040, DOI 10.1038/35059085; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; RODMAN HR, 1989, EXP BRAIN RES, V75, P53; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; SNODDERLY DM, 1995, J NEUROPHYSIOL, V74, P2100, DOI 10.1152/jn.1995.74.5.2100; STONER GR, 1992, NATURE, V358, P412, DOI 10.1038/358412a0; STONER GR, 1990, NATURE, V344, P153, DOI 10.1038/344153a0; Wallach H, 1935, PSYCHOL FORSCH, V20, P325, DOI 10.1007/BF02409790; WILSON HR, 1992, VISUAL NEUROSCI, V9, P79, DOI 10.1017/S0952523800006386	27	108	108	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					905	908		10.1038/414905a	http://dx.doi.org/10.1038/414905a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780062				2022-12-24	WOS:000172813300045
J	Wilson, AM; McGuigan, MP; Su, A; van den Bogert, AJ				Wilson, AM; McGuigan, MP; Su, A; van den Bogert, AJ			Horses damp the spring in their step	NATURE			English	Article							MUSCLE; LOCOMOTION; SIMULATION; ENERGY; STRAIN; GASTROCNEMIUS; BEHAVIOR; STORAGE; MODEL	The muscular work of galloping in horses is halved by storing and returning elastic strain energy in spring-like muscle-tendon units(1,2). These make the legs act like a child's pogo stick that is tuned to stretch and recoil at 2.5 strides per second. This mechanism is optimized by unique musculoskeletal adaptations: the digital flexor muscles have extremely short fibres and significant passive properties, whereas the tendons are very long and span several joints(3,4). Length change occurs by a stretching of the spring-like digital flexor tendons rather than through energetically expensive length changes in the muscle(5). Despite being apparently redundant for such a mechanism(5), the muscle fibres in the digital flexors are well developed. Here we show that the mechanical arrangement of the elastic leg permits it to vibrate at a higher frequency of 30-40 Hz that could cause fatigue damage to tendon and bone. Furthermore, we show that the digital flexor muscles have minimal ability to contribute to or regulate significantly the 2.5-Hz cycle of movement, but are ideally arranged to damp these high-frequency oscillations in the limb.	Univ London Royal Vet Coll, Dept Vet Basic Sci, Hatfield AL9 7TA, Herts, England; Cleveland Clin Fdn, Dept Biomed Engn, Cleveland, OH 44195 USA	University of London; University of London Royal Veterinary College; Cleveland Clinic Foundation	Wilson, AM (corresponding author), Univ London Royal Vet Coll, Dept Vet Basic Sci, Hatfield AL9 7TA, Herts, England.	awilson@rvc.ac.uk	van den Bogert, Antonie J/A-7809-2009; Su, Anne/M-3246-2013	van den Bogert, Antonie J/0000-0002-3791-3749; Su, Anne/0000-0002-6924-6899; Wilson, Alan/0000-0001-9914-3455				ALEXANDER RM, 1977, NATURE, V265, P114, DOI 10.1038/265114a0; Alexander RM., 1988, ELASTIC MECH ANIMAL; Biewener A A, 2000, Exerc Sport Sci Rev, V28, P99; Biewener AA, 1998, J EXP BIOL, V201, P1681; Biewener AA, 1998, COMP BIOCHEM PHYS B, V120, P73, DOI 10.1016/S0305-0491(98)00024-8; CARTER DR, 1984, CALCIFIED TISSUE INT, V36, pS19, DOI 10.1007/BF02406129; CHENEY JA, 1973, MED BIOL ENG, V11, P613, DOI 10.1007/BF02477408; DIMERY NJ, 1986, J ZOOL, V210, P415; DOW SM, 1991, EQUINE VET J, V23, P266, DOI 10.1111/j.2042-3306.1991.tb03715.x; ETTEMA GJC, 1994, J BIOMECH, V27, P1015, DOI 10.1016/0021-9290(94)90218-6; GERRITSEN KGM, 1995, J BIOMECH, V28, P661, DOI 10.1016/0021-9290(94)00127-P; GRANDAGE J, 1981, J ANAT, V132, P318; HERMANSON JW, 1992, J MORPHOL, V212, P269, DOI 10.1002/jmor.1052120306; HERRICK WC, 1978, J BIOMED MATER RES, V12, P877, DOI 10.1002/jbm.820120610; Hof AL, 1998, J BIOMECH, V31, P793, DOI 10.1016/S0021-9290(98)00062-1; Kawai M, 1980, J Muscle Res Cell Motil, V1, P279, DOI 10.1007/BF00711932; Kurokawa S, 2001, J APPL PHYSIOL, V90, P1349, DOI 10.1152/jappl.2001.90.4.1349; LAKE MJ, 2001, P 18 C INT SOC BIOM, P200; Minetti AE, 1999, J EXP BIOL, V202, P2329; NUNAMAKER DM, 1990, J ORTHOPAED RES, V8, P604, DOI 10.1002/jor.1100080417; PIAZZESI G, 1995, BIOPHYS J, V68, P1966, DOI 10.1016/S0006-3495(95)80374-7; Piazzesi G, 1996, J MUSCLE RES CELL M, V17, P45, DOI 10.1007/BF00140323; PRATT GA, 1995, P 4 INT S EXP ROB IS, P173; STEPHENS PR, 1989, AM J VET RES, V50, P1089; van den Bogert AJ, 1998, J ELECTROMYOGR KINES, V8, P119, DOI 10.1016/S1050-6411(97)00028-X; VANDENBOGERT AJ, 1993, ACTA ANAT, V146, P95; VANDENBOGERT AJ, 1989, THESIS U UTRECHT NET; VANSOEST AJ, 1993, BIOL CYBERN, V69, P195, DOI 10.1007/BF00198959; VANWEEREN PR, 1993, ACTA ANAT, V146, P154, DOI 10.1159/000147438; WANG XT, 1995, J EXP BIOL, V198, P847	30	174	174	4	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2001	414	6866					895	899		10.1038/414895a	http://dx.doi.org/10.1038/414895a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780059	Green Submitted			2022-12-24	WOS:000172813300042
J	Vasan, RS; Larson, MG; Leip, EP; Evans, JC; O'Donnell, CJ; Kannel, WB; Levy, D				Vasan, RS; Larson, MG; Leip, EP; Evans, JC; O'Donnell, CJ; Kannel, WB; Levy, D			Impact of high-normal blood pressure on the risk of cardiovascular disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY HEART-DISEASE; ISOLATED SYSTOLIC HYPERTENSION; REGRESSION DILUTION; MEN; MORTALITY; WOMEN; RECOMMENDATIONS; METAANALYSIS; POPULATION; PREVENTION	Background: Information is limited regarding the risk of cardiovascular disease in persons with high-normal blood pressure (systolic pressure of 130 to 139 mm Hg, diastolic pressure of 85 to 89 mm Hg, or both). Methods: We investigated the association between blood-pressure category at base line and the incidence of cardiovascular disease on follow-up among 6859 participants in the Framingham Heart Study who were initially free of hypertension and cardiovascular disease. Results: A stepwise increase in cardiovascular event rates was noted in persons with higher base-line blood-pressure categories. The 10-year cumulative incidence of cardiovascular disease in subjects 35 to 64 years of age who had high-normal blood pressure was 4 percent (95 percent confidence interval, 2 to 5 percent) for women and 8 percent (95 percent confidence interval, 6 to 10 percent) for men; in older subjects (those 65 to 90 years old), the incidence was 18 percent (95 percent confidence interval, 12 to 23 percent) for women and 25 percent (95 percent confidence interval, 17 to 34 percent) for men. As compared with optimal blood pressure, high-normal blood pressure was associated with a risk-factor-adjusted hazard ratio for cardiovascular disease of 2.5 (95 percent confidence interval, 1.6 to 4.1) in women and 1.6 (95 percent confidence interval, 1.1 to 2.2) in men. Conclusions: High-normal blood pressure is associated with an increased risk of cardiovascular disease. Our findings emphasize the need to determine whether lowering high-normal blood pressure can reduce the risk of cardiovascular disease. (N Engl J Med 2001;345:1291-7.) Copyright (C) 2001 Massachusetts Medical Society.	Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; Boston Univ, Sch Med, Cardiol Sect, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Epidemiol & Prevent Med, Boston, MA 02118 USA; Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; NHLBI, Bethesda, MD 20892 USA	Framingham Heart Study; Boston University; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Vasan, RS (corresponding author), Framingham Heart Dis Epidemiol Study, 5 Thurber St, Framingham, MA 01702 USA.		Levy, Daniel/ABF-6873-2021; Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABB-2752-2021	Levy, Daniel/0000-0003-1843-8724; Ramachandran, Vasan/0000-0001-7357-5970; Larson, Martin/0000-0002-9631-1254	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC038038] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-38038, K24 HL 04334-01A1] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Black HR, 1998, ARCH INTERN MED, V158, P573; Black HR, 1997, ARCH INTERN MED, V157, P2413; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Chalmers J, 1999, J HYPERTENS, V17, P151; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; COOK RJ, 1995, BRIT MED J, V310, P1056; Cox D. R., 1984, ANAL SURVIVAL DATA; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Escudero E, 1996, CAN J CARDIOL, V12, P959; Gueyffier F, 1997, ANN INTERN MED, V126, P761, DOI 10.7326/0003-4819-126-10-199705150-00002; JACKSON R, 1993, BRIT MED J, V307, P107, DOI 10.1136/bmj.307.6896.107; Kannel W., 1987, SOME RISK FACTORS RE; Kannel WB, 1996, JAMA-J AM MED ASSOC, V275, P1571, DOI 10.1001/jama.275.20.1571; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kimura Y, 1999, HYPERTENS RES-CLIN E, V22, P291, DOI 10.1291/hypres.22.291; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; LEITSCHUH M, 1991, HYPERTENSION, V17, P22, DOI 10.1161/01.HYP.17.1.22; Lloyd-Jones DM, 1999, ARCH INTERN MED, V159, P2206, DOI 10.1001/archinte.159.18.2206; LONATI L, 1993, CARDIOLOGY, V83, P298, DOI 10.1159/000175985; Lowe LP, 1998, ARCH INTERN MED, V158, P2007, DOI 10.1001/archinte.158.18.2007; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Neaton James D., 1995, P127; NEATON JD, 1992, ARCH INTERN MED, V152, P56, DOI 10.1001/archinte.152.1.56; Ogden LG, 2000, HYPERTENSION, V35, P539, DOI 10.1161/01.HYP.35.2.539; Psaty BM, 1997, JAMA-J AM MED ASSOC, V277, P739, DOI 10.1001/jama.277.9.739; Rodgers A, 1998, LANCET, V352, P1801; SAGIE A, 1993, NEW ENGL J MED, V329, P1912, DOI 10.1056/NEJM199312233292602; SAS Institute, 1996, SAS STAT SOFTW CHANG; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; STAMLER J, 1993, ARCH INTERN MED, V153, P598, DOI 10.1001/archinte.153.5.598; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101; Wood D, 1998, J HYPERTENS, V16, P1407, DOI 10.1097/00004872-199816100-00003	34	1347	1398	2	78	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 1	2001	345	18					1291	1297		10.1056/NEJMoa003417	http://dx.doi.org/10.1056/NEJMoa003417			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487UX	11794147				2022-12-24	WOS:000171896300001
J	Bailey, WC; Gerald, LB; Kimerling, ME; Redden, D; Brook, N; Bruce, F; Tang, SH; Duncan, S; Brooks, CM; Dunlap, NE				Bailey, WC; Gerald, LB; Kimerling, ME; Redden, D; Brook, N; Bruce, F; Tang, SH; Duncan, S; Brooks, CM; Dunlap, NE			Predictive model to identify positive tuberculosis skin test results during contact investigations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYCOBACTERIUM-TUBERCULOSIS; TRANSMISSION	Context Budgetary constraints in tuberculosis (TB) control programs require streamlining contact investigations without sacrificing disease control. Objective To develop more efficient methods of TB contact investigation by creating a model of TB transmission using variables that best predict a positive tuberculin skin test among contacts of an active TB case. Design, Setting, and Subjects After standardizing the interview and documentation process, data were collected on 292 consecutive TB cases and their 2941 contacts identified by the Alabama Department of Public Health between January and October 1998. Generalized estimating equations were used to create a model for predicting positive skin test results in contacts of active TB cases. The model was then validated using data from a prospective cohort of 366 new TB cases and their 3162 contacts identified between October 1998 and April 2000. Main Outcome Measure Tuberculin skin test result. Results Using generalized estimating equations to build a predictive model, 7 variables were found to significantly predict a positive tuberculin skin test result among contacts of an active TB case. Further testing showed this model to have a sensitivity, specificity, and positive predictive value of approximately 89%, 36%, and 26%, respectively. The false-negative rate was less than 10%, and about 40% of the contact workload could be eliminated using this model. Conclusions Certain characteristics can be used to predict contacts most likely to have a positive tuberculin skin test result. Use of such models can significantly reduce the number of contacts that public health officials need to investigate while still maintaining excellent disease control.	Univ Alabama Birmingham, Lung Hlth Ctr, Div Pulm & Crit Care Med, Birmingham, AL 35233 USA; Univ Alabama Birmingham, Div Gen Internal Med, Birmingham, AL USA; Univ Alabama Birmingham, Div Biostat, Birmingham, AL USA; Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; Univ Alabama Birmingham, Sch Hlth Related Profess, Birmingham, AL USA; Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA; Alabama Dept Publ Hlth, Div TB Control, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Bailey, WC (corresponding author), Univ Alabama Birmingham, Lung Hlth Ctr, Div Pulm & Crit Care Med, 620 S 20th St,NHB 104, Birmingham, AL 35233 USA.	wcbailey@uab.edu			NHLBI NIH HHS [5 R01 HL55752] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055752] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*ADV COUNC EL TUB, 1999, ADV COUNC ELIMINATE, V48, P1; *AM THOR SOC, 1990, AM REV RESPIR DIS, V142, P724; BAILEY W, 2000, WORLD C LUNG HLTH AU; BAMES PF, 1991, NEW ENGL J MED, V324, P1644; BASS J, 1992, AM REV RESPIR DIS, V146, P1623; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Brook N, 1999, AM J RESP CRIT CARE, V159, pA551; Cantwell MF, 1998, AM J RESP CRIT CARE, V157, P1016, DOI 10.1164/ajrccm.157.4.9704036; *CDCP, 1991, MMWR-MORBID MORTAL W, V40, P649; DIPERRI G, 1989, LANCET, V2, P1502; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; ETKIND SC, 1993, TUBERCULOSIS COMPREH, P275; ETKIND SC, 2000, LUNG BIOL HEALTH DIS, V144, P377; GERALD L, 2000, AM J RESP CRIT CARE, V161, pA305; Gerald LB, 1999, AM J RESP CRIT CARE, V159, pA301; GRZYBOWSKI S, 1975, Bulletin of the International Union Against Tuberculosis, V50, P90; Hennekens CH, 1987, EPIDEMIOLOGY MED, P327; HORWITZ O, 1971, AM REV RESPIR DIS, V104, P22; HOUK V, 1968, ARCH ENVIRON HEALTH, V16, P25; HOUK VN, 1968, ARCH ENVIRON HEALTH, V16, P4, DOI 10.1080/00039896.1968.10665007; *I MED, 2000, END NEGL EL TUB US; Kenyon TA, 1996, NEW ENGL J MED, V334, P933, DOI 10.1056/NEJM199604113341501; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; LIIPPO KK, 1993, AM REV RESPIR DIS, V148, P235, DOI 10.1164/ajrccm/148.1.235; MENZIES RI, 2000, LUNG BIOL HEALTH DIS, V144, P279; Moore M, 1999, CLIN INFECT DIS, V28, P52, DOI 10.1086/515089; Preisser JS, 1996, BIOMETRIKA, V83, P551, DOI 10.1093/biomet/83.3.551; ROSE CE, 1979, AM REV RESPIR DIS, V119, P603; SAS Institute Inc, 1999, SAS STAT US GUID VER; SHAW JB, 1954, AM REV TUBERC PULM, V69, P724; van Geuns H A, 1975, Bull Int Union Tuberc, V50, P107; VEEN J, 1992, TUBERCLE LUNG DIS, V73, P73, DOI 10.1016/0962-8479(92)90058-R	32	85	88	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2002	287	8					996	1002		10.1001/jama.287.8.996	http://dx.doi.org/10.1001/jama.287.8.996			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525CX	11866647	Bronze			2022-12-24	WOS:000174052100027
J	MacInnis, BL; Campenot, RB				MacInnis, BL; Campenot, RB			Retrograde support of neuronal survival without retrograde transport of nerve growth factor	SCIENCE			English	Article							RAT SYMPATHETIC NEURONS; AXONAL-TRANSPORT; TRKA; BINDING; KINASE; SIGNAL; PHOSPHORYLATION; INTERNALIZATION; ENDOCYTOSIS	Application of nerve growth factor (NGF) covalently cross-linked to beads increased the phosphorylation of TrkA and Akt, but not of mitogen-activated protein kinase, in cultured rat sympathetic neurons. NGF beads or iodine-125-labeled NGF beads supplied to distal axons resulted in the survival of over 80% of the neurons for 30 hours, with little or no retrograde transport of iodine-125-labeled NGF; whereas application of free iodine-125-labeled NGF (0.5 nanograms per milliliter) produced 20-fold more retrograde transport, but only 29% of the neurons survived. Thus, in contrast to widely accepted theory, a neuronal survival signal can reach the cell bodies unaccompanied by the NGF that initiated it.	Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada	University of Alberta	Campenot, RB (corresponding author), Univ Alberta, Dept Cell Biol, 6-14 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	bob.campenot@ualberta.ca						CAMPENOT RB, 1992, CELL CELL INTERACTIO, P275; CAMPENOT RB, 2001, PROTOCOLS NEURAL CEL, P49; CLAUDE P, 1982, J NEUROSCI, V2, P431; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; Grimes ML, 1997, P NATL ACAD SCI USA, V94, P9909, DOI 10.1073/pnas.94.18.9909; Grimes ML, 1996, J NEUROSCI, V16, P7950; HENDRY IA, 1991, NEUROSCI LETT, V133, P29, DOI 10.1016/0304-3940(91)90049-Y; HENDRY IA, 1974, BRAIN RES, V68, P103, DOI 10.1016/0006-8993(74)90536-8; KORSCHING S, 1983, NEUROSCI LETT, V39, P1, DOI 10.1016/0304-3940(83)90155-6; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; Neet KE, 2001, CELL MOL LIFE SCI, V58, P1021, DOI 10.1007/PL00000917; PALMATIER MA, 1984, J NEUROSCI, V4, P751; POPOV S, 1992, J NEUROSCI, V12, P77; Rakhit S, 2001, MOL PHARMACOL, V60, P63, DOI 10.1124/mol.60.1.63; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Senger DL, 1997, J CELL BIOL, V138, P411, DOI 10.1083/jcb.138.2.411; STOCKEL K, 1975, BRAIN RES, V99, P1, DOI 10.1016/0006-8993(75)90604-6; Tsui-Pierchala BA, 1999, J NEUROSCI, V19, P8207; Ure DR, 1997, J NEUROSCI, V17, P1282; URE DR, 1994, DEV BIOL, V162, P339, DOI 10.1006/dbio.1994.1091; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Viahos CJ, 1994, J BIOL CHEM, V269, P5241; Watson FL, 1999, J NEUROSCI, V19, P7889; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	26	211	214	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 22	2002	295	5559					1536	1539		10.1126/science.1064913	http://dx.doi.org/10.1126/science.1064913			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11799202				2022-12-24	WOS:000173981300057
J	Hofmann, WK; de Vos, S; Elashoff, D; Gschaidmeier, H; Hoelzer, D; Koeffler, HP; Ottmann, OG				Hofmann, WK; de Vos, S; Elashoff, D; Gschaidmeier, H; Hoelzer, D; Koeffler, HP; Ottmann, OG			Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor ST1571 and gene-expression profiles: a gene-expression study	LANCET			English	Article							CELL-LINES; MICROARRAY; STI571; SENSITIVITY; ACTIVATION; MECHANISM; LEUKEMIA; CANCER	Background The ABL tyrosine kinase inhibitor STI571 is a promising agent for treatment of advanced Philadelphia-chromosome-positive (Ph+) acute lymphoblastic leukaemia. However, resistance to this drug develops within a few months in most patients. We aimed to predict resistance to STI571. Methods Total RNA was extracted from 25 bone-marrow samples from 19 patients with Ph+ acute lymphoblastic leukaemia who were enrolled into a phase 11 study. 17 samples were obtained before STI571 treatment was started: ten from individuals who were classified as good responders to STI571 (sensitive), and seven from individuals who did not to respond to STI571 (primary resistance). Eight samples were obtained from patients during treatment with STI571. We analysed six matched samples, which were obtained before and during treatment with STI571. Oligonucleotide microarray analysis of samples was done with high-density microarrays. Findings We identified 95 genes whose expression could be used to predict sensitivity of leukaemic cells to STI571. On this basis, all the STI571-sensitive samples could clearly be distinguished from the resistant cases. 56 highly differentially expressed genes were identified in leukaemic cells that were secondarily resistant to STI571. Resistant leukaemic cells expressed high levels of Bruton's tyrosine kinase and two ATP synthetases (ATP5A1 and ATP5C1), and showed significantly reduced expression of the proapoptotic gene BAK1 and the cell-cycle control gene p15 INK4b, Interpretation We have shown the clinical relevance of gene expression data for the pretreatment assessment of acute lymphoblastic leukaemia. Our results have implications for future clinical studies of tyrosine kinase inhibitors.	Univ Hosp, Dept Haematol & Oncol, D-60596 Frankfurt, Germany; Univ Calif Los Angeles, Sch Med, Cedars Sinai Res Inst, Div Haematol & Oncol, Los Angeles, CA USA; Univ Calif Los Angeles, Sch Med, Dept Pathol, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA; Novartis Pharma AG, Nurnberg, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Novartis	Hofmann, WK (corresponding author), Univ Hosp, Dept Haematol & Oncol, Theodor Stern Kai 7, D-60596 Frankfurt, Germany.	W.K.Hofmann@em.uni-frankfurt.de	Ottmann, Oliver G/D-5007-2016	Ottmann, Oliver G/0000-0001-9559-1330				COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; DeRisi J, 2000, FEBS LETT, V470, P156, DOI 10.1016/S0014-5793(00)01294-1; Desiderio S, 1997, CURR OPIN IMMUNOL, V9, P534, DOI 10.1016/S0952-7915(97)80107-0; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Goldman JM, 2001, NEW ENGL J MED, V344, P1084, DOI 10.1056/NEJM200104053441409; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Hochhaus A, 2001, SCIENCE, V293, P2163; Hofmann WK, 2001, BLOOD, V98, P787, DOI 10.1182/blood.V98.3.787; Honda H, 1998, BLOOD, V91, P2067, DOI 10.1182/blood.V91.6.2067.2067_2067_2075; Huettner CS, 2000, NAT GENET, V24, P57, DOI 10.1038/71691; Kaminski N, 2000, P NATL ACAD SCI USA, V97, P1778, DOI 10.1073/pnas.97.4.1778; Knight ZA, 2000, BLOOD, V96, P4003, DOI 10.1182/blood.V96.12.4003.h8004000d_4003_4005; Komatani H, 2001, CANCER RES, V61, P2827; Kudoh K, 2000, CANCER RES, V60, P4161; le Coutre P, 2000, BLOOD, V95, P1758, DOI 10.1182/blood.V95.5.1758.005a41_1758_1766; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; Ottmann OG, 2000, BLOOD, V96, p828A; PUISSANT C, 1990, BIOTECHNIQUES, V8, P148; Satterthwaite AB, 2000, P NATL ACAD SCI USA, V97, P6687, DOI 10.1073/pnas.110146697; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; Voehringer DW, 2000, P NATL ACAD SCI USA, V97, P2680, DOI 10.1073/pnas.97.6.2680; Weisberg E, 2000, BLOOD, V95, P3498, DOI 10.1182/blood.V95.11.3498.011k27_3498_3505; Wilson W, 1999, P NATL ACAD SCI USA, V96, P12833, DOI 10.1073/pnas.96.22.12833	28	163	180	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2002	359	9305					481	486		10.1016/S0140-6736(02)07678-X	http://dx.doi.org/10.1016/S0140-6736(02)07678-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	520ML	11853794				2022-12-24	WOS:000173785600011
J	Krot, AN; McKeegan, KD; Leshin, LA; MacPherson, GJ; Scott, ERD				Krot, AN; McKeegan, KD; Leshin, LA; MacPherson, GJ; Scott, ERD			Existence of an O-16-rich gaseous reservoir in the solar nebula	SCIENCE			English	Article							REFRACTORY INCLUSION; ORDINARY CHONDRITES; CHONDRULE FORMATION; CONSTRAINTS; SYSTEM; AL-26; CONDENSATION; METEORITES; ALLENDE; MODELS	Carbonaceous chondrite condensate olivine grains from two distinct petrographic settings, calcium-aluminum-rich inclusion (CAI) accretionary rims and amoeboid olivine aggregates (AOAs), are oxygen-16 (O-16) enriched at the level, previously observed inside CAIs. This requires that the gas in the nebular region where these grains condensed was O-16-rich. This contrasts with an O-16-poor gas present during the formation of chondrules, suggesting that CAIs and AOAs formed in a spatially restricted region of the solar nebula containing O-16-rich gas. The O-16-rich gas composition may have resulted either from mass-independent isotopic chemistry or from evaporation of regions with enhanced dust/gas ratios, possibly in an X-wind environment near the young Sun.	Univ Hawaii, Sch Ocean & Earth Sci & Technol, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Smithsonian Inst, US Natl Museum Nat Hist, Dept Mineral Sci, Washington, DC 20560 USA	University of Hawaii System; University of California System; University of California Los Angeles; Arizona State University; Arizona State University-Tempe; Smithsonian Institution; Smithsonian National Museum of Natural History	Krot, AN (corresponding author), Univ Hawaii, Sch Ocean & Earth Sci & Technol, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA.	sasha@higp.hawaii.edu	McKeegan, Kevin D/A-4107-2008	McKeegan, Kevin D/0000-0002-1827-729X; Scott, Edward/0000-0002-5137-3830				BREARLEY AJ, 1989, GEOCHIM COSMOCHIM AC, V53, P2081, DOI 10.1016/0016-7037(89)90326-8; Cassen P, 2001, METEORIT PLANET SCI, V36, P671, DOI 10.1111/j.1945-5100.2001.tb01908.x; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.earth.21.1.115; CLAYTON RN, 1973, SCIENCE, V182, P485, DOI 10.1126/science.182.4111.485; DAVIS AM, 1994, METEORITICS, V29, P458; Ebel DS, 2000, GEOCHIM COSMOCHIM AC, V64, P339, DOI 10.1016/S0016-7037(99)00284-7; Fagan TJ, 2001, METEORIT PLANET SCI, V36, P223, DOI 10.1111/j.1945-5100.2001.tb01866.x; Guan Y, 2000, EARTH PLANET SC LETT, V181, P271, DOI 10.1016/S0012-821X(00)00218-1; Hewins R., 1996, CHONDRULES PROTOPLAN, P55; Hiyagon H, 1999, SCIENCE, V283, P828, DOI 10.1126/science.283.5403.828; IMAI H, 2001, LUNAR PLANET SCI, V32, P1580; Kita NT, 2000, GEOCHIM COSMOCHIM AC, V64, P3913, DOI 10.1016/S0016-7037(00)00488-9; Komatsu M, 2001, METEORIT PLANET SCI, V36, P629, DOI 10.1111/j.1945-5100.2001.tb01905.x; Krot AN, 1999, METEORIT PLANET SCI, V34, pA68; Krot AN, 2001, METEORIT PLANET SCI, V36, P611, DOI 10.1111/j.1945-5100.2001.tb01904.x; LESHIN LA, 2000, LUNAR PLANET SCI, V31, P1918; MacPherson G.J., 1988, METEORITES EARLY SOL, P746; MACPHERSON GJ, 1985, GEOCHIM COSMOCHIM AC, V49, P2267, DOI 10.1016/0016-7037(85)90227-3; MACPHERSON GJ, 1993, GEOCHIM COSMOCHIM AC, V57, P231, DOI 10.1016/0016-7037(93)90481-B; MACPHERSON GJ, 1995, METEORITICS, V30, P365, DOI 10.1111/j.1945-5100.1995.tb01141.x; McKeegan KD, 1998, SCIENCE, V280, P414, DOI 10.1126/science.280.5362.414; Petaev MI, 1998, METEORIT PLANET SCI, V33, P1123, DOI 10.1111/j.1945-5100.1998.tb01717.x; Rubin AE, 2000, EARTH-SCI REV, V50, P3, DOI 10.1016/S0012-8252(99)00067-7; Russell SS, 1996, SCIENCE, V273, P757, DOI 10.1126/science.273.5276.757; RUZICKA A, 1995, METEORITICS, V30, P570; Scott ERD, 2001, METEORIT PLANET SCI, V36, P1307, DOI 10.1111/j.1945-5100.2001.tb01826.x; Shu FH, 1996, SCIENCE, V271, P1545, DOI 10.1126/science.271.5255.1545; Thiemens MH, 1999, SCIENCE, V283, P341, DOI 10.1126/science.283.5400.341; Wark D. A., 1977, P 8 LUN SCI C, V8, P95; WOOD JA, 1981, EARTH PLANET SC LETT, V56, P32, DOI 10.1016/0012-821X(81)90115-1; Wood JA, 1998, ASTROPHYS J, V503, pL101, DOI 10.1086/311517; Yurimoto H, 1998, SCIENCE, V282, P1874, DOI 10.1126/science.282.5395.1874; YURIMOTO H, 2001, METEORIT PLANET SCI, V36, pA230	33	96	97	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2002	295	5557					1051	1054		10.1126/science.1068200	http://dx.doi.org/10.1126/science.1068200			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	520QR	11834830				2022-12-24	WOS:000173793000060
J	Seewald, MJ; Korner, C; Wittinghofer, A; Vetter, IR				Seewald, MJ; Korner, C; Wittinghofer, A; Vetter, IR			RanGAP mediates GTP hydrolysis without an arginine finger	NATURE			English	Article							ACTIVATING PROTEIN; CRYSTAL-STRUCTURE; TRANSITION-STATE; RAN/TC4 GTPASE; BINDING; TRANSPORT; COMPLEX; DOMAIN; GAP; RESIDUES	GTPase-activating proteins (GAPs) increase the rate of GTP hydrolysis on guanine nucleotide-binding proteins by many orders of magnitude. Studies with Ras and Rho have elucidated the mechanism of GAP action by showing that their catalytic machinery is both stabilized by GAP binding and complemented by the insertion of a so-called 'arginine finger' into the phosphate-binding pocket(1,2). This has been proposed as a universal mechanism for GAP-mediated GTP hydrolysis. Ran is a nuclear Ras-related protein that regulates both transport between the nucleus and cytoplasm during interphase, and formation of the mitotic spindle and/or nuclear envelope in dividing cells(3). RanGTP is hydrolysed by the combined action of Ran-binding proteins (RanBPs) and RanGAP(4). Here we present the three-dimensional structure of a Ran-RanBP1-RanGAP ternary complex in the ground state and in a transition-state mimic. The structure and biochemical experiments show that RanGAP does not act through an arginine finger, that the basic machinery for fast GTP hydrolysis is provided exclusively by Ran and that correct positioning of the catalytic glutamine is essential for catalysis.	Max Planck Inst Mol Physiol, Abt Strukturelle Biol, D-44026 Dortmund, Germany	Max Planck Society	Wittinghofer, A (corresponding author), Max Planck Inst Mol Physiol, Abt Strukturelle Biol, Postfach 102664, D-44026 Dortmund, Germany.	alfred.wittinghofer@mpi-dortmund.mpg.de	Ding, Cheng-Qiang/B-6287-2011	Seewald, Michael/0000-0001-6967-8993				Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; Allin C, 2001, P NATL ACAD SCI USA, V98, P7754, DOI 10.1073/pnas.131549798; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BECKER J, 1995, J BIOL CHEM, V270, P11860, DOI 10.1074/jbc.270.20.11860; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; Bischoff FR, 1997, FEBS LETT, V419, P249, DOI 10.1016/S0014-5793(97)01467-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Graham DL, 1999, BIOCHEMISTRY-US, V38, P985, DOI 10.1021/bi9821770; Haberland J, 1999, BIOCHEM J, V343, P653, DOI 10.1042/0264-6021:3430653; Haberland J, 1997, J BIOL CHEM, V272, P24717, DOI 10.1074/jbc.272.39.24717; Hillig RC, 1999, MOL CELL, V3, P781, DOI 10.1016/S1097-2765(01)80010-1; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Lounsbury KM, 1996, J BIOL CHEM, V271, P32834, DOI 10.1074/jbc.271.51.32834; Maegley KA, 1996, P NATL ACAD SCI USA, V93, P8160, DOI 10.1073/pnas.93.16.8160; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prakash B, 2000, EMBO J, V19, P4555, DOI 10.1093/emboj/19.17.4555; RICHARDS SA, 1995, J BIOL CHEM, V270, P14405, DOI 10.1074/jbc.270.24.14405; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SCHEFFZEK K, 1995, NATURE, V374, P378, DOI 10.1038/374378a0; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969	30	150	153	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2002	415	6872					662	666		10.1038/415662a	http://dx.doi.org/10.1038/415662a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	519DC	11832950				2022-12-24	WOS:000173709100052
J	Nepstad, D; McGrath, D; Alencar, A; Barros, AC; Carvalho, G; Santilli, M; Diaz, MDV				Nepstad, D; McGrath, D; Alencar, A; Barros, AC; Carvalho, G; Santilli, M; Diaz, MDV			Environment - Frontier governance in Amazonia	SCIENCE			English	Article							FOREST		Woods Hole Res Ctr, Woods Hole, MA 02543 USA; Inst Pesquisa Ambiental Amazonia, BR-66035170 Belem, Para, Brazil; Fed Univ Para, BR-66059 Belem, Para, Brazil	Woods Hole Research Center; Universidade Federal do Para	Nepstad, D (corresponding author), Woods Hole Res Ctr, POB 296, Woods Hole, MA 02543 USA.		/AAX-3684-2020	/0000-0001-5605-7469				Barreto P, 1998, FOREST ECOL MANAG, V108, P9, DOI 10.1016/S0378-1127(97)00251-X; *BRAZ I NAT STAT G, 2000, PROD AGR MUN 1999; Carvalho G, 2001, NATURE, V409, P131, DOI 10.1038/35051794; Costa MH, 2000, J CLIMATE, V13, P18, DOI [10.1175/1520-0442(2000)013<0018:CEODAD>2.0.CO;2, 10.1175/1520-0442(2000)013&lt;0018:CEODAD&gt;2.0.CO;2]; *GOV EST M GROSS F, 2001, SIST CONTR AMB PROPR; Holdsworth AR, 1997, ECOL APPL, V7, P713, DOI 10.1890/1051-0761(1997)007[0713:FIASLR]2.0.CO;2; Nepstad D, 2001, FOREST ECOL MANAG, V154, P395, DOI 10.1016/S0378-1127(01)00511-4; Schmink M., 1992, CONTESTED FRONTIERS; SCHNEIDER RR, 2000, PARTNERSHIP SERIES, V1; Webb Steven, 1999, 2121 WORLD BANK; Zimmer Kevin J., 1997, Ornithological Monographs, V48, P887; Zimmerman B, 2001, ENVIRON CONSERV, V28, P10, DOI 10.1017/S0376892901000029	12	145	151	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2002	295	5555					629	+		10.1126/science.1067053	http://dx.doi.org/10.1126/science.1067053			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PD	11809955				2022-12-24	WOS:000173560900025
J	Santiago, ML; Rodenburg, CM; Kamenya, S; Bibollet-Ruche, F; Gao, F; Bailes, E; Meleth, S; Soong, SJ; Kilby, JM; Moldoveanu, Z; Fahey, B; Muller, MN; Ayouba, A; Nerrienet, E; McClure, HM; Heeney, JL; Pusey, AE; Collins, DA; Boesch, C; Wrangham, RW; Goodall, J; Sharp, PM; Shaw, GM; Hahn, BH				Santiago, ML; Rodenburg, CM; Kamenya, S; Bibollet-Ruche, F; Gao, F; Bailes, E; Meleth, S; Soong, SJ; Kilby, JM; Moldoveanu, Z; Fahey, B; Muller, MN; Ayouba, A; Nerrienet, E; McClure, HM; Heeney, JL; Pusey, AE; Collins, DA; Boesch, C; Wrangham, RW; Goodall, J; Sharp, PM; Shaw, GM; Hahn, BH			SIVcpz in wild chimpanzees	SCIENCE			English	Article							VIRUS		Univ Alabama, Birmingham, AL 35294 USA; Gombe Stream Res Ctr, Kigoma, Tanzania; Howard Hughes Med Inst, Birmingham, AL 35294 USA; Univ Nottingham, Nottingham NG7 2UH, England; Harvard Univ, Cambridge, MA 02138 USA; Ctr Pasteur Cameroun, Yaounde, Cameroon; Yerkes Reg Primate Res Ctr, Atlanta, GA 30329 USA; Rijswijk ZH, Primate Res Ctr, NL-2288 GJ Rijswijk, Netherlands; Univ Minnesota, St Paul, MN 55108 USA; Max Planck Inst, D-04301 Leipzig, Germany; Jane Goodall Inst, Silver Spring, MD 20911 USA	University of Alabama System; University of Alabama Birmingham; Howard Hughes Medical Institute; University of Nottingham; Harvard University; Centre Pasteur du Cameroun; University of Minnesota System; University of Minnesota Twin Cities; Max Planck Society	Hahn, BH (corresponding author), Univ Alabama, Birmingham, AL 35294 USA.		Sharp, Paul/Y-3787-2019; Sharp, Paul M/GPX-1497-2022; Ayouba, Ahidjo/G-8775-2017; Sharp, Paul M/F-5783-2010	Sharp, Paul M/0000-0001-9771-543X; Ayouba, Ahidjo/0000-0002-5081-1632; Sharp, Paul M/0000-0001-9771-543X; Kilby, J. Michael/0000-0003-3222-1003; Hahn, Beatrice/0000-0002-9400-9887; Santiago, Mario L./0000-0001-7792-2706; Heeney, Jonathan/0000-0003-2702-1621; Pusey, Anne/0000-0002-2280-8954				Butynski Thomas M., 2001, P3; Corbet S, 2000, J VIROL, V74, P529, DOI 10.1128/JVI.74.1.529-534.2000; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; PEETERS M, 1989, AIDS, V3, P625, DOI 10.1097/00002030-198910000-00001; Teleki G., 1989, P312; VandenHaesevelde MM, 1996, VIROLOGY, V221, P346, DOI 10.1006/viro.1996.0384	6	161	165	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2002	295	5554					465	465		10.1126/science.295.5554.465	http://dx.doi.org/10.1126/science.295.5554.465			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512YG	11799233				2022-12-24	WOS:000173350700039
J	Finotto, S; Neurath, MF; Glickman, JN; Qin, SX; Lehr, HA; Green, FHY; Ackerman, K; Haley, K; Gatte, PR; Szabo, SJ; Drazen, JM; De Sanctis, GT; Glimcher, LH				Finotto, S; Neurath, MF; Glickman, JN; Qin, SX; Lehr, HA; Green, FHY; Ackerman, K; Haley, K; Gatte, PR; Szabo, SJ; Drazen, JM; De Sanctis, GT; Glimcher, LH			Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet	SCIENCE			English	Article							HYPERRESPONSIVENESS; INFLAMMATION; CELLS; TH2	Human asthma is associated with airway infiltration by T helper 2 (T(H)2) lymphocytes. We observed reduced expression of the T(H)1 transcription factor, T-bet, in T cells from airways of patients with asthma compared with that in T cells from airways of nonasthmatic patients, suggesting that loss of T-bet might be associated with asthma. Mice with a targeted deletion of the T-bet gene and severe combined immunodeficient mice receiving CD4(+) cells from T-bet knockout mice spontaneously demonstrated multiple physiological and inflammatory features characteristic of asthma, Thus, T-bet deficiency, in the absence of allergen exposure, induces a murine phenotype reminiscent of both acute and chronic human asthma.	Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pulm & Crit Care, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Millenium Pharmaceut, Cambridge, MA 02138 USA; Univ Mainz, Dept Pathol, D-55131 Mainz, Germany; Univ Calgary, Dept Pathol & Lab Med, Calgary, AB T2N 4N1, Canada; Univ Mainz, Med Clin 1, D-55131 Mainz, Germany	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Johannes Gutenberg University of Mainz; University of Calgary; Johannes Gutenberg University of Mainz	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.		Drazen, Jeffrey M/E-5841-2012; Finotto, Susetta/H-2753-2019		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036110] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-36110] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Cohn L, 1998, J IMMUNOL, V161, P3813; De Sanctis GT, 1999, J EXP MED, V189, P1621, DOI 10.1084/jem.189.10.1621; Drazen JM, 1999, ANNU REV PHYSIOL, V61, P593, DOI 10.1146/annurev.physiol.61.1.593; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; Finotto S, 1999, DEVELOPMENT, V126, P2935; FINOTTO S, UNPUB; GAVETT SH, 1995, J EXP MED, V182, P1527, DOI 10.1084/jem.182.5.1527; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; LI XM, 1996, J IMMUNOL, V157, P2316; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Papaioannou VE, 1997, TRENDS GENET, V13, P212, DOI 10.1016/S0168-9525(97)01144-X; Robinson DS, 2000, BRIT MED BULL, V56, P956, DOI 10.1258/0007142001903625; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543	16	491	566	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2002	295	5553					336	338		10.1126/science.1065544	http://dx.doi.org/10.1126/science.1065544			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511RD	11786643				2022-12-24	WOS:000173278600052
J	Thery, M; Casas, J				Thery, M; Casas, J			Predator and prey views of spider camouflage - Both hunter and hunted fail to notice crab-spiders blending with coloured petals	NATURE			English	Article							PERCEPTION; EVOLUTION; ECOLOGY		Museum Natl Hist Nat, Lab Ecol Gen, CNRS, UMR 8571, F-91800 Brunoy, France; Univ Tours, Inst Rech Biol Insecte, CNRS, UMR 6035, F-37200 Tours, France	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); Universite de Tours	Thery, M (corresponding author), Museum Natl Hist Nat, Lab Ecol Gen, CNRS, UMR 8571, F-91800 Brunoy, France.	thery@mnhn.fr	Casas, Jérôme/D-9620-2011	Casas, Jérôme/0000-0003-1666-295X				Bradbury Jack W., 1998, pi; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; CHEN DM, 1986, J COMP PHYSIOL A, V159, P473, DOI 10.1007/BF00604167; Chittka L, 2001, ENTOMOL GEN, V25, P181; Osorio D, 1999, EVOL ECOL, V13, P673, DOI 10.1023/A:1011059715610; Oxford GS, 1998, ANNU REV ENTOMOL, V43, P619, DOI 10.1146/annurev.ento.43.1.619; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098	7	180	186	1	73	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 10	2002	415	6868					133	133		10.1038/415133a	http://dx.doi.org/10.1038/415133a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509PR	11805822				2022-12-24	WOS:000173159300028
J	Lemon, B; Inouye, C; King, DS; Tjian, R				Lemon, B; Inouye, C; King, DS; Tjian, R			Selectivity of chromatin-remodelling cofactors for ligand-activated transcription	NATURE			English	Article							IN-VITRO; GLUCOCORTICOID RECEPTOR; COMPLEX; COACTIVATOR; BINDING; ACETYLATION; ENHANCEMENT; REQUIRES; FAMILY; GENES	An array of regulatory protein and multi-subunit cofactors has been identified(1) that directs eukaryotic gene transcription. However, establishing the specific functions of various related cofactors has been difficult owing to the limitations inherent in assaying transcription in animals and cells indirectly. Here we describe, using an integrated chromatin-dependent reconstituted transcription reaction, the purification and identification of a multi-subunit cofactor (PBAF)(2) that is necessary for ligand-dependent transactivation by nuclear hormone receptors. A highly related cofactor, human SWI/SNF3, and the ISWI-containing chromatin-remodelling complex ACF(4) both fail to potentiate transcription. We also show that transcriptional activation mediated by nuclear hormone receptors requires TATA-binding protein (TBP)-associated factors (TAFs) as well as the multi-subunit cofactors ARC(5)/CRSP6. These studies demonstrate functional selectivity amongst highly related complexes involved in gene regulation and help define a more complete set of factors and cofactors required to activate transcription.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Tjian, R (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, 401 Barker Hall, Berkeley, CA 94720 USA.							Armstrong JA, 1998, CELL, V95, P93, DOI 10.1016/S0092-8674(00)81785-7; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Fondell JD, 1999, P NATL ACAD SCI USA, V96, P1959, DOI 10.1073/pnas.96.5.1959; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Kal AJ, 2000, GENE DEV, V14, P1058; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; LeRoy G, 1998, SCIENCE, V282, P1900, DOI 10.1126/science.282.5395.1900; MERINO A, 1993, NATURE, V365, P227, DOI 10.1038/365227a0; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Naar AM, 1998, GENE DEV, V12, P3020, DOI 10.1101/gad.12.19.3020; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Reyes JC, 1997, J CELL BIOL, V137, P263, DOI 10.1083/jcb.137.2.263; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; TSUKIYAMA T, 1995, CELL, V83, P1021, DOI 10.1016/0092-8674(95)90217-1; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Xue YT, 2000, P NATL ACAD SCI USA, V97, P13015, DOI 10.1073/pnas.240208597	30	207	213	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					924	928		10.1038/414924a	http://dx.doi.org/10.1038/414924a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780067				2022-12-24	WOS:000172813300050
J	Shaffer, LG; Heilstedt, HA				Shaffer, LG; Heilstedt, HA			Terminal deletion of 1p36	LANCET			English	Article									Baylor Coll Med, Dept Mol & Human Genet, Kleberg Cytogenet Lab, Houston, TX 77030 USA	Baylor College of Medicine	Shaffer, LG (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Kleberg Cytogenet Lab, 1 Baylor Plaza,Room S801, Houston, TX 77030 USA.	lshaffer@bcm.tmc.edu							0	27	27	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC	2001				S			S9	S9		10.1016/S0140-6736(01)07022-2	http://dx.doi.org/10.1016/S0140-6736(01)07022-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505HK	11784558	Bronze			2022-12-24	WOS:000172907200009
J	Yu, JL; Rak, JW; Coomber, BL; Hicklin, DJ; Kerbel, RS				Yu, JL; Rak, JW; Coomber, BL; Hicklin, DJ; Kerbel, RS			Effect of p53 status on tumor response to antiangiogenic therapy	SCIENCE			English	Article							CANCER; CELLS; ANGIOGENESIS; HYPOXIA; CHEMOTHERAPY; RESISTANCE; SELECTION; AGENTS; ARREST; P21	The p53 tumor suppressor gene is inactivated in the majority of human cancers. Tumor cells deficient in p53 display a diminished rate of apoptosis under hypoxic conditions, a circumstance that might reduce their reliance on vascular supply, and hence their responsiveness to antiangiogenic therapy. Here, we report that mice bearing tumors derived from p53(-/-) HCT116 human colorectal cancer cells were less responsive to antiangiogenic combination therapy than mice bearing isogenic p53(+/+) tumors. Thus, although antiangiogenic therapy targets genetically stable endothelial cells in the tumor vasculature, genetic alterations that decrease the vascular dependence of tumor cells can influence the therapeutic response of tumors to this therapy.	Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada; McMaster Univ, Hamilton Civ Hosp, Res Ctr, Hamilton, ON L8V 1C3, Canada; Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada; ImClone Syst Inc, New York, NY 10014 USA	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; McMaster University; University of Guelph; Eli Lilly	Kerbel, RS (corresponding author), Sunnybrook & Womens Coll Hlth Sci Ctr, Room S-218,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.				NCI NIH HHS [CA-41233] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA041233] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akakura N, 2001, CANCER RES, V61, P6548; Blagosklonny MV, 2001, INT J ONCOL, V19, P257; Boehm T, 1997, NATURE, V390, P404, DOI 10.1038/37126; Browder T, 2000, CANCER RES, V60, P1878; Brown JM, 2000, DRUG RESIST UPDATE, V3, P7, DOI 10.1054/drup.2000.0120; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chaplin DJ, 1999, ANTICANCER RES, V19, P189; Dang LH, 2001, P NATL ACAD SCI USA, V98, P15155, DOI 10.1073/pnas.251543698; Denny WA, 2000, EXPERT OPIN INV DRUG, V9, P2889, DOI 10.1517/13543784.9.12.2889; EZEKOWITZ RAB, 1992, NEW ENGL J MED, V326, P1456, DOI 10.1056/NEJM199205283262203; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Folkman J, 2000, NAT REV MOL CELL BIO, V1, P76, DOI 10.1038/35036100; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Griggs J, 2001, LANCET ONCOL, V2, P82, DOI 10.1016/S1470-2045(00)00224-2; Kaban LB, 1999, PEDIATRICS, V103, P1145, DOI 10.1542/peds.103.6.1145; Kerbel RS, 2001, CANCER METAST REV, V20, P79, DOI 10.1023/A:1013172910858; KERBEL RS, 1991, BIOESSAYS, V13, P31, DOI 10.1002/bies.950130106; KERBEL RS, IN PRESS NATURE REV; Klement G, 2000, J CLIN INVEST, V105, pR15, DOI 10.1172/JCI8829; LORD EM, 1993, CANCER RES, V53, P5721; Masunaga S, 2000, INT J RADIAT ONCOL, V47, P799, DOI 10.1016/S0360-3016(00)00477-6; Rak J, 1996, EUR J CANCER, V32A, P2438, DOI 10.1016/S0959-8049(96)00396-6; Rak J, 1996, CANCER METAST REV, V15, P231, DOI 10.1007/BF00437476; Semenza GL, 2000, CRIT REV BIOCHEM MOL, V35, P71, DOI 10.1080/10409230091169186; WALDMAN T, 1995, CANCER RES, V55, P5187; Yu J., UNPUB; Yu JL, 2001, AM J PATHOL, V158, P1325, DOI 10.1016/S0002-9440(10)64083-7	28	363	390	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2002	295	5559					1526	1528		10.1126/science.1068327	http://dx.doi.org/10.1126/science.1068327			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	523WV	11859195				2022-12-24	WOS:000173981300054
J	Knox, AL; Brown, NH				Knox, AL; Brown, NH			Rap1 GTPase regulation of adherens junction positioning and cell adhesion	SCIENCE			English	Article							DIRECT BINDING; DROSOPHILA; MORPHOGENESIS; PROTEINS; ZO-1; LOCALIZATION; EXPRESSION; EPITHELIA; POLARITY; MEMBERS	Cell-cell junctions are distributed evenly around the lateral circumference of cells within an epithelium. We find that the even distribution of adherens junctions is an active process that requires the small guanosine triphosphatase Rap1. Cells mutant for Rap1 condensed their adherens junctions to one side of the cell. This disrupted normal epithelial. cell behavior, and mutant cell clones dispersed into the surrounding wild-type tissue. Rap1 is enriched at adherens junctions, particularly between newly divided sister cells where it may reseal the adherens junction ring. The regulation of adherens junction positioning could play a role in cell mobility and cell division.	Wellcome CRC Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Anat, Cambridge CB2 1QR, England	University of Cambridge	Brown, NH (corresponding author), Wellcome CRC Inst, Tennis Court Rd, Cambridge CB2 1QR, England.			Knox, Andrea/0000-0002-3367-6678; Brown, Nicholas/0000-0002-8958-7017				Asha H, 1999, EMBO J, V18, P605, DOI 10.1093/emboj/18.3.605; BOETTNER B, COMMUNICATION; BOKOCH GM, 1993, BIOCHEM J, V289, P17, DOI 10.1042/bj2890017; Chou TB, 1996, GENETICS, V144, P1673; DIAZBENJUMEA FJ, 1994, DEVELOPMENT, V120, P569; FRISTROM D, 1993, DEVELOPMENT, V117, P509; Fristrom D, 1993, DEV DROSOPHILA MELAN, P843; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; Godt D, 1998, NATURE, V395, P387, DOI 10.1038/26493; Gonzalez-Reyes A, 1998, DEVELOPMENT, V125, P3635; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; KNOX AL, UNPUB; Kusumi A, 1999, CURR OPIN CELL BIOL, V11, P582, DOI 10.1016/S0955-0674(99)00020-4; Linnemann T, 1999, J BIOL CHEM, V274, P13556, DOI 10.1074/jbc.274.19.13556; Luschnig S, 2000, MOL CELL, V5, P231, DOI 10.1016/S1097-2765(00)80419-0; Muller HAJ, 2000, DEV DYNAM, V218, P52; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Oda H, 1999, DEV GENES EVOL, V209, P218, DOI 10.1007/s004270050246; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Takahashi K, 1998, MECH DEVELOP, V78, P97, DOI 10.1016/S0925-4773(98)00151-8; Takahisa M, 1996, GENE DEV, V10, P1783, DOI 10.1101/gad.10.14.1783; Wei XR, 2001, MECH DEVELOP, V100, P217, DOI 10.1016/S0925-4773(00)00550-5; Woods DF, 1997, DEV GENET, V20, P111, DOI 10.1002/(SICI)1520-6408(1997)20:2<111::AID-DVG4>3.3.CO;2-O; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X	26	192	195	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1285	1288		10.1126/science.1067549	http://dx.doi.org/10.1126/science.1067549			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847339				2022-12-24	WOS:000173926000041
J	MacPhee, AG; Tate, MW; Powell, CF; Yue, Y; Renzi, MJ; Ercan, A; Narayanan, S; Fontes, E; Walther, J; Schaller, J; Gruner, SM; Wang, J				MacPhee, AG; Tate, MW; Powell, CF; Yue, Y; Renzi, MJ; Ercan, A; Narayanan, S; Fontes, E; Walther, J; Schaller, J; Gruner, SM; Wang, J			X-ray imaging of shock waves generated by high-pressure fuel sprays	SCIENCE			English	Article							PIXEL ARRAY DETECTOR; DIFFRACTION; INJECTION	Synchrotron x-radiography and a fast x-ray detector were used to record the time evolution of the transient fuel sprays from a high-pressure injector. A succession of 5.1-microsecond radiographs captured the propagation of the spray-induced shock waves in a gaseous medium and revealed the complex nature of the spray hydrodynamics. The monochromatic x-radiographs also allow quantitative analysis of the shock waves that has been difficult if not impossible with optical imaging. Under injection conditions similar to those found in operating engines, the fuel jets can exceed supersonic speeds and result in gaseous shock waves.	Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; Argonne Natl Lab, Div Energy Syst, Argonne, IL 60439 USA; Cornell Univ, Dept Phys, Ithaca, NY 14853 USA; Cornell Univ, Cornell High Energy Synchrotron Source, Ithaca, NY 14853 USA; Robert Bosch GmbH, Corp Res, D-70049 Stuttgart, Germany	United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; Cornell University; Cornell University; Bosch	Wang, J (corresponding author), Argonne Natl Lab, Adv Photon Source, 9700 S Cass Ave, Argonne, IL 60439 USA.		Gruner, Sol/G-2924-2010	Gruner, Sol/0000-0002-1171-4426	PHS HHS [DMR-9713424] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ADRIAN RJ, 1991, ANNU REV FLUID MECH, V23, P261, DOI 10.1146/annurev.fl.23.010191.001401; [Anonymous], 1971, COMPRESSIBLE FLUID D; Barna SL, 1997, IEEE T NUCL SCI, V44, P950, DOI 10.1109/23.603783; Cao ZM, 2000, JSME INT J B-FLUID T, V43, P582, DOI 10.1299/jsmeb.43.582; CHAR JM, 1990, J PROPUL POWER, V6, P544, DOI 10.2514/3.23254; CHIGIER N, 1991, PROG ENERG COMBUST, V17, P211, DOI 10.1016/0360-1285(91)90011-B; FIELD JE, 1977, PROC R SOC LON SER-A, V357, P143, DOI 10.1098/rspa.1977.0160; Hecht E, 1998, OPTICS; Hentschel W, 1996, OPT LASER ENG, V25, P401, DOI 10.1016/0143-8166(95)00091-7; Herman H, 1988, MRS BULL, V13, P60, DOI DOI 10.1557/S0883769400063715; Hurly JJ, 2000, INT J THERMOPHYS, V21, P739, DOI 10.1023/A:1006697620523; KUO K, 1996, RECENT ADV SPRAY COM, V1; KUO K, 1996, RECENT ADV SPRAY COM, V2; NAKAHIRA T, 1992, SHOCK WAVES, V2, P1271; OKEEFE JD, 1967, NATURE, V213, P23, DOI 10.1038/213023a0; Powell CF, 2000, J SYNCHROTRON RADIAT, V7, P356, DOI 10.1107/S0909049500013431; Rossi G, 1999, J SYNCHROTRON RADIAT, V6, P1096, DOI 10.1107/S0909049599009802; SHI HH, 1994, JSME INT J B-FLUID T, V37, P509, DOI 10.1299/jsmeb.37.509; Tikhomirov RA, 1992, HIGH PRESSURE JETCUT; Yule A. J., 1991, ATOMIZATION SPRAY, V1, P441; Zhang YY, 2000, APPL OPTICS, V39, P6221, DOI 10.1364/AO.39.006221	21	108	109	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1261	1263		10.1126/science.1068149	http://dx.doi.org/10.1126/science.1068149			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847333				2022-12-24	WOS:000173926000033
J	Vogelstein, B; Alberts, B; Shine, K				Vogelstein, B; Alberts, B; Shine, K			Genetics - Please don't call it cloning!	SCIENCE			English	Editorial Material									Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21231 USA; Johns Hopkins Univ, Kimmel Canc Ctr, Baltimore, MD 21231 USA; Natl Acad Sci, Washington, DC 20418 USA; CNR, Washington, DC 20418 USA; Natl Acad Sci, Inst Med, Washington, DC 20418 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; National Academies of Sciences, Engineering & Medicine; National Academies of Sciences, Engineering & Medicine	Vogelstein, B (corresponding author), Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21231 USA.							Kennedy D, 2001, SCIENCE, V294, P745, DOI 10.1126/science.294.5543.745; National Research Council, 2001, STEM CELLS FUT REG M; National Research Council, 2002, SCI MED ASP HUM REPR	3	71	72	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2002	295	5558					1237	1237		10.1126/science.1070247	http://dx.doi.org/10.1126/science.1070247			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	522ZC	11847324				2022-12-24	WOS:000173926000021
J	Lo, B; Ruston, D; Kates, LW; Arnold, RM; Cohen, CB; Faber-Langendoen, K; Pantilat, SZ; Puchalski, CM; Quill, TR; Rabow, MW; Schreiber, S; Sulmasy, DP; Tulsky, JA				Lo, B; Ruston, D; Kates, LW; Arnold, RM; Cohen, CB; Faber-Langendoen, K; Pantilat, SZ; Puchalski, CM; Quill, TR; Rabow, MW; Schreiber, S; Sulmasy, DP; Tulsky, JA		Working Grp Religious Spiritual Is	Discussing religious and spiritual issues at the end of life - A practical guide for physicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FAMILY MEDICINE; CARE; ATTITUDES; BELIEFS; ETHICS; INTERVIEW; CANCER; PRAYER; ILL; ME	As patients near the end of life, their spiritual and religious concerns may be awakened or intensified. Many physicians, however, feel unskilled and uncomfortable discussing these concerns. This article suggests how physicians might respond when patients or families raise such concerns. First, some patients may explicitly base decisions about life-sustaining interventions on their spiritual or religious beliefs. Physicians need to explore those beliefs to help patients think through their preferences regarding specific interventions. Second, other patients may not bring up spiritual or religious concerns but are troubled by them. Physicians should identify such concerns and listen to them empathetically, without trying to alleviate the patient's spiritual suffering or offering premature reassurance. Third, some patients or families may have religious reasons for insisting on life-sustaining interventions that physicians advise against. The physician should listen and try to understand the patient's viewpoint. Listening respectfully does not require the physician to agree with the patient or misrepresent his or her own views. Patients and families who feel that the physician understands them and cares about them may be more willing to consider the physician's views on prognosis and treatment. By responding to patients' spiritual and religious concerns and needs, physicians may help them find comfort and closure near the end of life.	Univ Calif San Francisco, Div Gen Internal Med, Program Med Eth, San Francisco, CA 94143 USA; Univ Pittsburgh, Sch Med, Ctr Bioeth & Hlth Law, Div Gen Internal Med, Pittsburgh, PA USA; Georgetown Univ, Kennedy Inst Eth, Washington, DC 20057 USA; SUNY Upstate Med Univ, Ctr Bioeth & Humanities, Syracuse, NY USA; George Washington Univ, Sch Med, Inst Spiritual & Hlth, Div Aging Studies, St Louis, MO USA; Univ Rochester, Sch Med, Dept Med, Program Biopsychol Studies, Rochester, NY USA; Hackensack Univ Med Ctr, Hackensack, NJ USA; New York Med Coll, Bioeth Inst, St Vincents Manhattan, John J Conley Dept Eth, New York, NY USA; Duke Univ, Dept Med, Program Med Encounter & Palliat Care, Durham, NC USA	University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Georgetown University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; George Washington University; University of Rochester; Hackensack University Medical Center; New York Medical College; Duke University	Lo, B (corresponding author), Room C 126,521 Parnassus Ave, San Francisco, CA 94143 USA.	bernie@medicine.ucsf.edu						*ASS CLIN PAST ED, 2001, OBJ CLIN PAST ED; Astrow AB, 2001, AM J MED, V110, P283; Baile WF, 1999, ONCOLOGY-NY, V13, P1021; BERNARDIN JC, 1998, GIFT PEACE PERSONAL; Byock I, 1997, DYING WELL PROSPECT; Clinebell H.J., 1984, BASIC TYPES PASTORAL; Cohen CB, 2000, HASTINGS CENT REP, V30, P40, DOI 10.2307/3528046; Cohen CB, 2001, HASTINGS CENT REP, V31, P29, DOI 10.2307/3527702; Coulehan JL, 2001, ANN INTERN MED, V135, P221, DOI 10.7326/0003-4819-135-3-200108070-00022; DAALEMAN TP, 1994, J FAM PRACTICE, V39, P564; Ehman JW, 1999, ARCH INTERN MED, V159, P1803, DOI 10.1001/archinte.159.15.1803; Ellis MR, 1999, J FAM PRACTICE, V48, P105; Emanuel EJ, 2000, ANN INTERN MED, V132, P451, DOI 10.7326/0003-4819-132-6-200003210-00005; Faber-Langendoen K, 2000, ANN INTERN MED, V132, P482, DOI 10.7326/0003-4819-132-6-200003210-00010; KING DE, 1994, J FAM PRACTICE, V39, P349; Levinson W, 2000, JAMA-J AM MED ASSOC, V284, P1021, DOI 10.1001/jama.284.8.1021; Lo B, 1999, ANN INTERN MED, V130, P744, DOI 10.7326/0003-4819-130-9-199905040-00015; LO B, 2000, RESOLVING ETHICAL DI, P128; Maguire P, 1996, EUR J CANCER, V32A, P78, DOI 10.1016/0959-8049(95)00527-7; Maguire P., 2000, COMMUNICATION SKILLS; Matthews DA, 1998, ARCH FAM MED, V7, P118, DOI 10.1001/archfami.7.2.118; *N CUMM FDN, 1997, SPIR BELI DYING PROC; Oyama O, 1998, ARCH FAM MED, V7, P431, DOI 10.1001/archfami.7.5.431; Platt FW, 2001, ANN INTERN MED, V134, P1079, DOI 10.7326/0003-4819-134-11-200106050-00020; Post SG, 2000, ANN INTERN MED, V132, P578, DOI 10.7326/0003-4819-132-7-200004040-00010; Prendergast TJ, 1997, AM J RESP CRIT CARE, V155, P15, DOI 10.1164/ajrccm.155.1.9001282; Puchalski C, 2000, J Palliat Med, V3, P129, DOI 10.1089/jpm.2000.3.129; Puchalski C., 1999, SUPPORT VOICE, V5, P12; Puchalski CM, 1999, SPIRITUAL LIFE, V45, P154; QUINN TE, 2001, ANN INTERN MED, V135, P51; Rabow MW, 1999, WESTERN J MED, V171, P260; Roter DL, 2000, ARCH INTERN MED, V160, P3477, DOI 10.1001/archinte.160.22.3477; Rushton C H, 1996, Pediatr Nurs, V22, P64; Savulescu J, 1998, J MED ETHICS, V24, P382, DOI 10.1136/jme.24.6.382; Singer PA, 1998, ARCH INTERN MED, V158, P879, DOI 10.1001/archinte.158.8.879; Sloan RP, 2000, NEW ENGL J MED, V342, P1913, DOI 10.1056/NEJM200006223422513; Sloan RP, 1999, LANCET, V353, P664, DOI 10.1016/S0140-6736(98)07376-0; Speck P., 1998, OXFORD TXB PALLIATIV, P805; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; STONE D, 1999, DIFFICULT CONSERVATI; Suchman AL, 1997, JAMA-J AM MED ASSOC, V277, P678, DOI 10.1001/jama.277.8.678; Sulmasy DP., 1997, HEALERS CALLING SPIR; Taylor EJ, 1999, PSYCHO-ONCOLOGY, V8, P386; TULSKY JA, 1995, J GEN INTERN MED, V10, P436, DOI 10.1007/BF02599915; Tulsky JA, 1998, ANN INTERN MED, V129, P441, DOI 10.7326/0003-4819-129-6-199809150-00003	45	198	201	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2002	287	6					749	754		10.1001/jama.287.6.749	http://dx.doi.org/10.1001/jama.287.6.749			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	520XR	11851542				2022-12-24	WOS:000173809500032
J	Verweij, M; van den Hoven, M				Verweij, M; van den Hoven, M			Influenza vaccination rates and informed consent in Dutch nursing homes: Survey of nursing home physicians	BRITISH MEDICAL JOURNAL			English	Article									Univ Utrecht, Ctr Bioeth & Hlth Law, NL-3584 CS Utrecht, Netherlands	Utrecht University	Verweij, M (corresponding author), Univ Utrecht, Ctr Bioeth & Hlth Law, Heidelberglaan 2, NL-3584 CS Utrecht, Netherlands.			Verweij, Marcel/0000-0001-9169-1852				BEAUCHAMP H, 1994, PRINCIPLES BIOMEDICA; Drinka PJ, 1997, J FAM PRACTICE, V45, P509; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; Nicholson KG, 2000, LANCET, V355, P83, DOI 10.1016/S0140-6736(99)00310-4; Verweij M, 2001, BIOETHICS, V15, P536, DOI 10.1111/1467-8519.00260	5	13	14	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 9	2002	324	7333					328	328		10.1136/bmj.324.7333.328	http://dx.doi.org/10.1136/bmj.324.7333.328			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521XH	11834559	Green Published, Bronze			2022-12-24	WOS:000173866300017
J	Provencio, I; Rollag, MD; Castrucci, AM				Provencio, I; Rollag, MD; Castrucci, AM			Anatomy: Photoreceptive net in the mammalian retina - This mesh of cells may explain how some blind mice can still tell day from night.	NATURE			English	Article									Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; Uniformed Serv Univ Hlth Sci, Circadian Res Ctr, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA	Provencio, I (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA.		Castrucci, Ana Maria L/C-3296-2014	Castrucci, Ana Maria/0000-0002-2065-8198; Provencio, Ignacio/0000-0003-1175-920X				Berson DM, 2001, INVEST OPHTH VIS SCI, V42, pS113; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; MOORE RY, 1995, J COMP NEUROL, V352, P351, DOI 10.1002/cne.903520304; Provencio I, 1998, J COMP NEUROL, V395, P417, DOI 10.1002/(SICI)1096-9861(19980615)395:4<417::AID-CNE1>3.0.CO;2-4; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Rollag MD, 2000, METHOD ENZYMOL, V316, P291	7	340	355	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					493	493		10.1038/415493a	http://dx.doi.org/10.1038/415493a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823848	Bronze			2022-12-24	WOS:000173564300033
J	Weeks, SJ; Currie, B; Bakun, A				Weeks, SJ; Currie, B; Bakun, A			Satellite imaging - Massive emissions of toxic gas in the Atlantic	NATURE			English	Article									Univ Cape Town, Ocean Space Ltd, ZA-7701 Rondebosch, South Africa; Univ Cape Town, IRD, IDYLE Project, Dept Oceanog, ZA-7701 Rondebosch, South Africa; Natl Marine Res & Informat Ctr, Swakopmund, Namibia	University of Cape Town; University of Cape Town	Weeks, SJ (corresponding author), Univ Cape Town, Ocean Space Ltd, ZA-7701 Rondebosch, South Africa.		Weeks, Scarla J/E-8632-2013	Weeks, Scarla J/0000-0002-0579-7069; Bakun, Andrew/0000-0002-4366-3846				BAILEY GW, 1985, S AFRICAN J MARINE S, V3, P197; Hamukuaya H, 1998, S AFR J MARINE SCI, V19, P57; MASRIERA J, 1990, MAR BIOL, V104, P175, DOI 10.1007/BF01313256; Tyrrell T, 1999, J GEOPHYS RES-OCEANS, V104, P3223, DOI 10.1029/1998JC900052; WOOSTER WS, 1963, SEA, V2, P253	5	92	95	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 31	2002	415	6871					493	494		10.1038/415493b	http://dx.doi.org/10.1038/415493b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	516PQ	11823847				2022-12-24	WOS:000173564300034
J	Cremona, G; Asnaghi, R; Baderna, P; Brunetto, A; Brutsaert, T; Cavallaro, C; Clark, TM; Cogo, A; Donis, R; Lanfranchi, P; Luks, A; Novello, N; Panzetta, S; Perini, L; Putnam, M; Spagnolatti, L; Wagner, H; Wagner, PD				Cremona, G; Asnaghi, R; Baderna, P; Brunetto, A; Brutsaert, T; Cavallaro, C; Clark, TM; Cogo, A; Donis, R; Lanfranchi, P; Luks, A; Novello, N; Panzetta, S; Perini, L; Putnam, M; Spagnolatti, L; Wagner, H; Wagner, PD			Pulmonary extravascular fluid accumulation in recreational climbers: a prospective study	LANCET			English	Article							ACUTE MOUNTAIN-SICKNESS; OPERATION EVEREST-II; LUNG LYMPH-FLOW; SIMULATED ALTITUDE; GAS-EXCHANGE; SEA-LEVEL; EXERCISE; EDEMA; HUMANS; SHEEP	Background High altitude pulmonary oedema (RAPE) that is severe enough to require urgent medical care is infrequent. We hypothesised that subclinical HAPE is far more frequent than suspected during even modest climbs of average effort. Methods We assessed 262 consecutive climbers of Monte Rosa (4559 m), before ascent and about 24 h later on the summit 1 h after arriving, by clinical examination, electrocardiography, oximetry, spirometry, carbon monoxide transfer, and closing volume. A chest radiograph was taken at altitude. Findings Only one climber was evacuated for HAPE, but 40 (15%) of 262 climbers had chest rales or interstitial oedema on radiograph after ascent. Of 37 of these climbers, 34 (92%) showed increased closing volume. Of the 197 climbers without oedema, 146 (74%) had an increase in closing volume at altitude. With no change in vital capacity, forced expiratory volume in 1 s and forced expiratory flow at 25-75% of forced vital capacity increased slightly at altitude, without evidence of oedema. If we assume that an increased closing volume at altitude indicates increased pulmonary extravascular fluid, our data suggest that three of every four healthy, recreational climbers have mild subclinical HAPE shortly after a modest climb. Interpretation The risk of HAPE might not be confined to a small group of genetically susceptible people, but likely exists for most climbers if the rate of ascent and degree of physical effort are great enough, especially if lung size is normal or low.	San Raffaele Univ Sci Inst, Resp Med Unit, I-20132 Milan, Italy; Univ Calif San Diego, Dept Med, Div Physiol, La Jolla, CA 92093 USA; Univ Ferrara, Club Alpino Italiano & Pulm Div, I-44100 Ferrara, Italy	Vita-Salute San Raffaele University; University of California System; University of California San Diego; University of Ferrara	Cremona, G (corresponding author), San Raffaele Univ Sci Inst, Resp Med Unit, Via Olgettina 60, I-20132 Milan, Italy.		Cremona, George/ABI-2752-2020	Asnaghi, Roberto/0000-0001-9746-6955	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007212, P01HL017731] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 07212, HL 17731] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		COATES G, 1984, J CLIN INVEST, V74, P133, DOI 10.1172/JCI111393; DEAL EC, 1980, AM REV RESPIR DIS, V121, P621; DEMEDTS M, 1974, B PHYSIO-PATHOL RESP, V10, P11; Eldridge MW, 1996, J APPL PHYSIOL, V81, P911, DOI 10.1152/jappl.1996.81.2.911; FASULES JW, 1985, CIRCULATION, V72, P957, DOI 10.1161/01.CIR.72.5.957; GALE GE, 1985, J APPL PHYSIOL, V58, P978, DOI 10.1152/jappl.1985.58.3.978; GRAY GW, 1973, J APPL PHYSIOL, V35, P227, DOI 10.1152/jappl.1973.35.2.227; GUY HJ, 1976, AM REV RESPIR DIS, V113, P737; HACKETT PH, 1976, LANCET, V2, P1149; HARKEN AH, 1976, ANN SURG, V184, P183, DOI 10.1097/00000658-197608000-00009; HOUSTON CS, 1987, J APPL PHYSIOL, V63, P877, DOI 10.1152/jappl.1987.63.2.877; MAGGIORINI M, 1990, BRIT MED J, V301, P853, DOI 10.1136/bmj.301.6756.853; Maggiorini M, 1999, HYPOXIA NEXT MILLENN, P408; NEWMAN JH, 1988, J APPL PHYSIOL, V64, P2125, DOI 10.1152/jappl.1988.64.5.2125; OBRODOVICH H, 1986, AM REV RESPIR DIS, V134, P862, DOI 10.1164/arrd.1986.134.5.862; Podolsky A, 1996, J APPL PHYSIOL, V81, P922, DOI 10.1152/jappl.1996.81.2.922; Rahn H., 1955, GRAPHICAL ANAL RESP; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; SCHAFFARTZIK W, 1992, J APPL PHYSIOL, V72, P1657, DOI 10.1152/jappl.1992.72.5.1657; Scherrer U, 1999, ADV EXP MED BIOL, V474, P93; SINGH I, 1965, LANCET, V1, P229; Steinacker JM, 1998, EUR RESPIR J, V11, P643; VISWANATHAN R, 1969, AM REV RESPIR DIS, V100, P334, DOI 10.1164/arrd.1969.100.3.334; VISWANATHAN R, 1978, RESPIRATION, V36, P216, DOI 10.1159/000193953; WAGNER PD, 1986, J APPL PHYSIOL, V61, P260, DOI 10.1152/jappl.1986.61.1.260; WAGNER PD, 1987, J APPL PHYSIOL, V63, P2348, DOI 10.1152/jappl.1987.63.6.2348; WEST JB, 1995, EUR RESPIR J, V8, P523; WEST JB, 1992, INT J SPORTS MED, V13, P54; WEST JB, 1995, PULMONARY PATHOPHYSI	29	138	146	1	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 26	2002	359	9303					303	309		10.1016/S0140-6736(02)07496-2	http://dx.doi.org/10.1016/S0140-6736(02)07496-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517AC	11830197				2022-12-24	WOS:000173588100011
J	Hibberd, JM; Quick, WP				Hibberd, JM; Quick, WP			Characteristics of C-4 photosynthesis in stems and petioles of C-3 flowering plants	NATURE			English	Article							DISSOLVED INORGANIC CARBON; PHOTORESPIRATORY ENZYMES; BUNDLE-SHEATH; METABOLISM; GROWTH; LOCALIZATION; RHIZOSPHERE; TOBACCO; LEAVES; CELLS	Most plants are known as C-3 plants because the first product of photosynthetic CO2 fixation is a three-carbon compound(1). C-4 plants, which use an alternative pathway in which the first product is a four-carbon compound, have evolved independently many times and are found in at least 18 families(2,3). In addition to differences in their biochemistry, photosynthetic organs of C-4 plants show alterations in their anatomy and ultrastructure(4). Little is known about whether the biochemical or anatomical characteristics of C-4 photosynthesis evolved first. Here we report that tobacco, a typical C-3 plant, shows characteristics of C-4 photosynthesis in cells of stems and petioles that surround the xylem and phloem, and that these cells are supplied with carbon for photosynthesis from the vascular system and not from stomata. These photosynthetic cells possess high activities of enzymes characteristic of C-4 photosynthesis, which allow the decarboxylation of four-carbon organic acids from the xylem and phloem, thus releasing CO2 for photosynthesis. These biochemical characteristics of C-4 photosynthesis in cells around the vascular bundles of stems of C-3 plants might explain why C-4 photosynthesis has evolved independently many times.	Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; Univ Sheffield, Robert Hill Inst, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Cambridge; University of Sheffield	Hibberd, JM (corresponding author), Univ Cambridge, Dept Plant Sci, Downing St, Cambridge CB2 3EA, England.	julian.hibberd@plantsci.cam.ac.uk						Ashton AR., 1990, METH PLANT BIOCH, V3, P39, DOI DOI 10.1016/B978-0-12-461013-2.50010-1; BENZIONI A, 1971, PHYSIOL PLANTARUM, V24, P288, DOI 10.1111/j.1399-3054.1971.tb03493.x; CALVIN M, 1951, SYM SOC EXP BIOL, V5, P284; Cramer MD, 1999, NEW PHYTOL, V142, P441, DOI 10.1046/j.1469-8137.1999.00415.x; Cramer MD, 1999, J EXP BOT, V50, P79, DOI 10.1093/jexbot/50.330.79; Esau K, 1965, PLANT ANATOMY, V2, P429; Gao ZF, 1996, PLANT PHYSIOL BIOCH, V34, P807; Gerendas J, 1999, J EXP BOT, V50, P1101, DOI 10.1093/jexbot/50.336.1101; HATCH MD, 1987, BIOCHIM BIOPHYS ACTA, V895, P81, DOI 10.1016/S0304-4173(87)80009-5; Hibberd JM, 1998, PLANTA, V205, P506, DOI 10.1007/s004250050349; Hibberd JM, 1999, PLANT CELL ENVIRON, V22, P937, DOI 10.1046/j.1365-3040.1999.00462.x; KEELEY JE, 1984, NATURE, V310, P694, DOI 10.1038/310694a0; Keeley JE, 1998, BOT REV, V64, P121, DOI 10.1007/BF02856581; Kinsman EA, 1998, DEVELOPMENT, V125, P1815; Lea PJ., 1999, PLANT BIOCH MOL BIOL; Monson RK, 1999, C4 PLANT BIOL, P377, DOI [10.1016/B978-012614440-6/50012-4, DOI 10.1016/B978-012614440-6/50012-4]; MOORE PD, 1982, NATURE, V310, P696; Nilsen Erik T., 1995, P223, DOI 10.1016/B978-012276460-8/50012-6; Pate J.S., 1975, TRANSPORT PLANTS, P451, DOI 10.1007/978-3-642-66161-7_19; RAVEN JA, 1991, PLANT CELL ENVIRON, V14, P139, DOI 10.1111/j.1365-3040.1991.tb01330.x; RAVEN JA, 1976, NEW PHYTOL, V76, P415, DOI 10.1111/j.1469-8137.1976.tb01477.x; RAWSTHORNE S, 1988, PLANTA, V173, P298, DOI 10.1007/BF00401016; RAWSTHORNE S, 1988, PLANTA, V176, P527, DOI 10.1007/BF00397660; RAWSTHORNE S, 1992, PLANT J, V2, P267, DOI 10.1111/j.1365-313X.1992.00267.x; Reinfelder JR, 2000, NATURE, V407, P996, DOI 10.1038/35039612; Sage R., 1999, C4 PLANT BIOL, P551, DOI DOI 10.1016/B978-012614440-6/50017-3; SCHAAF J, 1995, PLANT PHYSIOL, V108, P949, DOI 10.1104/pp.108.3.949; THOMAS JC, 1992, PLANT PHYSIOL, V98, P626, DOI 10.1104/pp.98.2.626; Vuorinen AH, 1995, J PLANT PHYSIOL, V147, P236, DOI 10.1016/S0176-1617(11)81510-5; WALKER RP, 1995, PLANTA, V196, P58, DOI 10.1007/BF00193217	30	296	333	4	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2002	415	6870					451	454		10.1038/415451a	http://dx.doi.org/10.1038/415451a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807559	Green Accepted			2022-12-24	WOS:000173433600055
J	Perakis, SS; Hedin, LO				Perakis, SS; Hedin, LO			Nitrogen loss from unpolluted South American forests mainly via dissolved organic compounds	NATURE			English	Article							CARBON SEQUESTRATION; TEMPERATE FOREST; ECOSYSTEMS; SOIL; DEPOSITION; SATURATION; PATTERNS; STORAGE; FLUXES	Conceptual(1-4) and numerical(5-8) models of nitrogen cycling in temperate forests assume that nitrogen is lost from these ecosystems predominantly by way of inorganic forms, such as nitrate and ammonium ions. Of these, nitrate is thought to be particularly mobile, being responsible for nitrogen loss to deep soil and stream waters. But human activities-such as fossil fuel combustion, fertilizer production and land-use change-have substantially altered the nitrogen cycle over large regions(9), making it difficult to separate natural aspects of nitrogen cycling from those induced by human perturbations(10). Here we report stream chemistry data from 100 unpolluted primary forests in temperate South America. Although the sites exhibit a broad range of environmental factors that influence ecosystem nutrient cycles(11-13) (such as climate, parent material, time of ecosystem development, topography and biotic diversity), we observed a remarkably consistent pattern of nitrogen loss across all forests. In contrast to findings from forests in polluted regions, streamwater nitrate concentrations are exceedingly low, such that nitrate to ammonium ratios were less than unity, and dissolved organic nitrogen is responsible for the majority of nitrogen losses from these forests. We therefore suggest that organic nitrogen losses should be considered in models of forest nutrient cycling, which could help to explain observations of nutrient limitation in temperate forest ecosystems.	Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA	Cornell University	Perakis, SS (corresponding author), US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, 3200 SW Jefferson Way, Corvallis, OR 97331 USA.	sperakis@usgs.gov						Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; AGUILAR R, 1985, SOIL SCI SOC AM J, V49, P695, DOI 10.2136/sssaj1985.03615995004900030034x; ALABACK PB, 1991, REV CHIL HIST NAT, V64, P399; ALMEYDA AE, 1958, RECOPILACION DATOS C; Campbell JL, 2000, BIOGEOCHEMISTRY, V49, P123, DOI 10.1023/A:1006383731753; Cleveland CC, 1999, GLOBAL BIOGEOCHEM CY, V13, P623, DOI 10.1029/1999GB900014; Goodale CL, 2000, ECOSYSTEMS, V3, P433, DOI 10.1007/s100210000039; GORHAM E, 1961, GEOL SOC AM BULL, V72, P795, DOI 10.1130/0016-7606(1961)72[795:FISOMI]2.0.CO;2; HEDIN LO, 1995, ECOLOGY, V76, P493, DOI 10.2307/1941208; Holland EA, 1999, BIOGEOCHEMISTRY, V46, P7, DOI 10.1007/BF01007572; Jenny H., 1941, FACTORS SOIL FORMATI; Likens G. E., 1995, BIOGEOCHEMISTRY FORE; Mcdowell WH, 1998, WATER AIR SOIL POLL, V105, P175, DOI 10.1023/A:1005032904590; McGuire AD, 1997, GLOBAL BIOGEOCHEM CY, V11, P173, DOI 10.1029/97GB00059; McKane RB, 1997, ECOLOGY, V78, P1170, DOI 10.1890/0012-9658(1997)078[1170:CEOTCS]2.0.CO;2; Nadelhoffer KJ, 1999, NATURE, V398, P145, DOI 10.1038/18205; Nodvin SC, 1995, WATER AIR SOIL POLL, V85, P1647, DOI 10.1007/BF00477216; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Paruelo Jose M., 1998, Ecologia Austral, V8, P85; Perakis SS, 2001, ECOLOGY, V82, P2245, DOI 10.1890/0012-9658(2001)082[2245:FAFONI]2.0.CO;2; Rastetter EB, 2001, ECOSYSTEMS, V4, P369, DOI 10.1007/s10021-001-0018-z; Schimel DS, 1997, P NATL ACAD SCI USA, V94, P8280, DOI 10.1073/pnas.94.16.8280; SOLLINS P, 1980, ECOL MONOGR, V50, P261, DOI 10.2307/2937252; STODDARD JL, 1994, ADV CHEM SER, V237, P223; Tamm C., 1991, NITROGEN TERRESTRIAL, DOI DOI 10.2307/2260680; Veblen Thomas T., 1996, P293; VILLAGRAM C, 1993, QUATERNARY LAKE DIST; Vitousek PM, 1998, SUCCESSES, LIMITATIONS, AND FRONTIERS IN ECOSYSTEM SCIENCE, P432; VITOUSEK PM, 1975, BIOSCIENCE, V25, P376, DOI 10.2307/1297148; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Weathers KC, 2000, ECOSYSTEMS, V3, P590, DOI 10.1007/s100210000051	31	498	584	2	208	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 24	2002	415	6870					416	419		10.1038/415416a	http://dx.doi.org/10.1038/415416a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807551				2022-12-24	WOS:000173433600046
J	Zasloff, M				Zasloff, M			Antimicrobial peptides of multicellular organisms	NATURE			English	Review							HUMAN BETA-DEFENSIN-2; INNATE IMMUNITY; BETA-DEFENSIN; HOST-DEFENSE; IN-VITRO; ANTIBACTERIAL PEPTIDE; STAPHYLOCOCCUS-AUREUS; EPITHELIAL-CELLS; INSECT IMMUNITY; EXPRESSION	Multicellular organisms live, by and large, harmoniously with microbes. The cornea of the eye of an animal is almost always free of signs of infection. The insect flourishes without lymphocytes or antibodies. A plant seed germinates successfully in the midst of soil microbes. How is this accomplished? Both animals and plants possess potent, broad-spectrum antimicrobial peptides, which they use to fend off a wide range of microbes, including bacteria, fungi, viruses and protozoa. What sorts of molecules are they? How are they employed by animals in their defence? As our need for new antibiotics becomes more pressing, could we design anti-infective drugs based on the design principles these molecules teach us?	Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania	Zasloff, M (corresponding author), Georgetown Univ, Med Ctr, 4000 Reservoir Rd NW, Washington, DC 20007 USA.	maz5@georgetown.edu	akbari, mohammad/O-4200-2017; Abrams, William R/A-5782-2008					AGERBERTH B, 1991, EUR J BIOCHEM, V202, P849, DOI 10.1111/j.1432-1033.1991.tb16442.x; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Bals R, 1999, INFECT IMMUN, V67, P6084, DOI 10.1128/IAI.67.11.6084-6089.1999; BECHINGER B, 1993, PROTEIN SCI, V2, P2077, DOI 10.1002/pro.5560021208; BIERBAUM G, 1985, ARCH MICROBIOL, V141, P249, DOI 10.1007/BF00408067; Birchler T, 2001, EUR J IMMUNOL, V31, P3131, DOI 10.1002/1521-4141(200111)31:11<3131::AID-IMMU3131>3.0.CO;2-G; Boman HG, 2000, IMMUNOL REV, V173, P5, DOI 10.1034/j.1600-065X.2000.917301.x; BREY PT, 1993, P NATL ACAD SCI USA, V90, P6275, DOI 10.1073/pnas.90.13.6275; Brotz H, 1998, MOL MICROBIOL, V30, P317, DOI 10.1046/j.1365-2958.1998.01065.x; BULET P, 1993, J BIOL CHEM, V268, P14893; Chertov O, 2000, IMMUNOL REV, V177, P68, DOI 10.1034/j.1600-065X.2000.17702.x; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DARVEAU RP, 1991, ANTIMICROB AGENTS CH, V35, P1153, DOI 10.1128/AAC.35.6.1153; DeGray G, 2001, PLANT PHYSIOL, V127, P852, DOI 10.1104/pp.010233; DIAMOND G, 1991, P NATL ACAD SCI USA, V88, P3952, DOI 10.1073/pnas.88.9.3952; ENGSTROM Y, 1993, J MOL BIOL, V232, P327, DOI 10.1006/jmbi.1993.1392; Fehlbaum P, 2000, P NATL ACAD SCI USA, V97, P12723, DOI 10.1073/pnas.220424597; Fernandez-Lopez S, 2001, NATURE, V412, P452, DOI 10.1038/35086601; Ge YG, 1999, ANTIMICROB AGENTS CH, V43, P782, DOI 10.1128/AAC.43.4.782; Giacometti A, 2000, DIAGN MICR INFEC DIS, V38, P115, DOI 10.1016/S0732-8893(00)00175-9; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Groisman EA, 1998, BIOESSAYS, V20, P96, DOI 10.1002/(SICI)1521-1878(199801)20:1<96::AID-BIES13>3.0.CO;2-3; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; Hamuro Y, 1999, J AM CHEM SOC, V121, P12200, DOI 10.1021/ja992728p; Hancock R E, 1995, Adv Microb Physiol, V37, P135, DOI 10.1016/S0065-2911(08)60145-9; Harder J, 2000, AM J RESP CELL MOL, V22, P714, DOI 10.1165/ajrcmb.22.6.4023; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; HAYNIE SL, 1995, ANTIMICROB AGENTS CH, V39, P301, DOI 10.1128/AAC.39.2.301; Imler JL, 2001, TRENDS CELL BIOL, V11, P304, DOI 10.1016/S0962-8924(01)02004-9; Islam D, 2001, NAT MED, V7, P180, DOI 10.1038/84627; KAPPLER C, 1993, EMBO J, V12, P1561, DOI 10.1002/j.1460-2075.1993.tb05800.x; Kim HS, 2000, J IMMUNOL, V165, P3268, DOI 10.4049/jimmunol.165.6.3268; Kimbrell DA, 2001, NAT REV GENET, V2, P256, DOI 10.1038/35066006; Kisich KO, 2001, INFECT IMMUN, V69, P2692, DOI 10.1128/IAI.69.4.2692-2699.2001; Kragol G, 2001, BIOCHEMISTRY-US, V40, P3016, DOI 10.1021/bi002656a; Krisanaprakornkit S, 2000, INFECT IMMUN, V68, P2907, DOI 10.1128/IAI.68.5.2907-2915.2000; KYLSTEN P, 1990, EMBO J, V9, P217, DOI 10.1002/j.1460-2075.1990.tb08098.x; Liu L, 1998, GENE, V222, P237, DOI 10.1016/S0378-1119(98)00480-6; MALOY WL, 1995, BIOPOLYMERS, V37, P105, DOI 10.1002/bip.360370206; Mangoni ML, 2001, FASEB J, V15, P1431, DOI 10.1096/fj.00-0695fje; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Murphy JE, 2000, J INVEST DERMATOL, V114, P602, DOI 10.1046/j.1523-1747.2000.00917.x; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; O'Neil DA, 1999, J IMMUNOL, V163, P6718; Oren Z, 2000, BIOCHEMISTRY-US, V39, P6103, DOI 10.1021/bi992408i; Osusky M, 2000, NAT BIOTECHNOL, V18, P1162, DOI 10.1038/81145; Ouellette AJ, 2001, INFLAMM BOWEL DIS, V7, P43, DOI 10.1097/00054725-200102000-00007; Porter EA, 2000, NATURE, V404, P565, DOI 10.1038/35007145; ROMEO D, 1988, J BIOL CHEM, V263, P9573; Russell JP, 1996, INFECT IMMUN, V64, P1565, DOI 10.1128/IAI.64.5.1565-1568.1996; SCHONWETTER BS, 1995, SCIENCE, V267, P1645, DOI 10.1126/science.7886453; SELSTED ME, 1985, J CLIN INVEST, V76, P1436, DOI 10.1172/JCI112121; SELSTED ME, 1992, J BIOL CHEM, V267, P4292; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shinnar A.E., 1996, P 14 PEPT AM S COL O, P189; Simmaco M, 1998, BIOPOLYMERS, V47, P435, DOI 10.1002/(SICI)1097-0282(1998)47:6<435::AID-BIP3>3.3.CO;2-#; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Smith JJ, 1996, CELL, V85, P229, DOI 10.1016/S0092-8674(00)81099-5; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Stoven S, 2000, EMBO REP, V1, P347, DOI 10.1093/embo-reports/kvd072; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Tarver AP, 1998, INFECT IMMUN, V66, P1045, DOI 10.1128/IAI.66.3.1045-1056.1998; Thevissen K, 2000, P NATL ACAD SCI USA, V97, P9531, DOI 10.1073/pnas.160077797; Ulvatne H, 2001, SCAND J INFECT DIS, V33, P507, DOI 10.1080/00365540110026692; Welling MM, 2000, EUR J NUCL MED, V27, P292, DOI 10.1007/s002590050036; WESTERHOFF HV, 1989, P NATL ACAD SCI USA, V86, P6597, DOI 10.1073/pnas.86.17.6597; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yang L, 2000, BIOPHYS J, V79, P2002, DOI 10.1016/S0006-3495(00)76448-4; Yasin B, 2000, EUR J CLIN MICROBIOL, V19, P187, DOI 10.1007/s100960050457; Zanetti M, 2000, ADV EXP MED BIOL, V479, P203; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zasloff Michael, 2001, P261	74	6501	6881	102	2279	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2002	415	6870					389	395		10.1038/415389a	http://dx.doi.org/10.1038/415389a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807545				2022-12-24	WOS:000173433600040
J	Beldade, P; Brakefield, PM; Long, AD				Beldade, P; Brakefield, PM; Long, AD			Contribution of Distal-less to quantitative variation in butterfly eyespots	NATURE			English	Article							DROSOPHILA-MELANOGASTER; BRISTLE NUMBER; BICYCLUS-ANYNANA; EVOLUTION; PATTERNS; WINGS; GENETICS; POLYMORPHISMS; LOCUS	The colour patterns decorating butterfly wings provide ideal material to study the reciprocal interactions between evolution and development. They are visually compelling products of selection, often with a clear adaptive value, and are amenable to a detailed developmental characterization(1). Research on wing-pattern evolution and development has focused on the eyespots of the tropical butterfly Bicyclus anynana(2). There is quantitative variation for several features of eyespot morphology(3-5) but the actual genes contributing to such variation are unknown. On the other hand, studies of gene expression patterns in wing primordia have implicated different developmental pathways in eyespot formation(6-11). To link these two sets of information we need to identify which genes within the implicated pathways contribute to the quantitative variation accessible to natural selection. Here we begin to bridge this gap by demonstrating linkage between DNA polymorphisms in the candidate gene Distal-less (Dll) and eyespot size in B. anynana.	Leiden Univ, Inst Evolutionary & Ecol Sci, NL-2300 RA Leiden, Netherlands; Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92612 USA	Leiden University; Leiden University - Excl LUMC; University of California System; University of California Irvine	Beldade, P (corresponding author), Leiden Univ, Inst Evolutionary & Ecol Sci, POB 9516, NL-2300 RA Leiden, Netherlands.		Beldade, Patrícia/E-1970-2011	Beldade, Patrícia/0000-0001-7831-979X; Long, Tony/0000-0002-5007-8514				Brakefield PM, 1998, HEREDITY, V80, P265, DOI 10.1038/sj.hdy.6883660; Brakefield PM, 1999, BIOESSAYS, V21, P391, DOI 10.1002/(SICI)1521-1878(199905)21:5&lt;391::AID-BIES6&gt;3.0.CO;2-Q; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; Brunetti CR, 2001, CURR BIOL, V11, P1578, DOI 10.1016/S0960-9822(01)00502-4; CARROLL SB, 1994, SCIENCE, V265, P109, DOI 10.1126/science.7912449; CARROLL SB, 1994, DEVELOPMENT, P217; Doerge RW, 1996, GENETICS, V142, P285; EDWARDS MD, 1987, GENETICS, V116, P113; Falconer D. S., 1996, INTRO QUANTITATIVE G; FRENCH V, 1995, DEV BIOL, V168, P112, DOI 10.1006/dbio.1995.1065; Keys DN, 1999, SCIENCE, V283, P532, DOI 10.1126/science.283.5401.532; KREITMAN M, 1983, NATURE, V304, P412, DOI 10.1038/304412a0; LAI CG, 1994, SCIENCE, V266, P1697, DOI 10.1126/science.7992053; LANDER ES, 1989, GENETICS, V121, P185; Long AD, 2000, GENETICS, V154, P1255; LONG AD, 1995, GENETICS, V139, P1273; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; Marec F, 1996, INT J INSECT MORPHOL, V25, P205, DOI 10.1016/0020-7322(96)00009-8; Monteiro A, 1997, EVOLUTION, V51, P1207, DOI 10.1111/j.1558-5646.1997.tb03968.x; Monteiro A, 1997, GENETICS, V146, P287; MONTEIRO AF, 1994, EVOLUTION, V48, P1147, DOI [10.1111/j.1558-5646.1994.tb05301.x, 10.2307/2410374]; Nijhout H.F., 1991, DEV EVOLUTION BUTTER; NIJHOUT HF, 1980, DEV BIOL, V80, P267, DOI 10.1016/0012-1606(80)90403-0; Palopoli MF, 1996, CURR OPIN GENET DEV, V6, P502, DOI 10.1016/S0959-437X(96)80074-8; PANGANIBAN G, 1994, CURR BIOL, V4, P671, DOI 10.1016/S0960-9822(00)00151-2; Robinson R., 1971, LEPIDOPTERA GENETICS; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Taylor BA, 2001, MAMM GENOME, V12, P95, DOI 10.1007/s003350010254; Weatherbee SD, 1999, CURR BIOL, V9, P109, DOI 10.1016/S0960-9822(99)80064-5; Wijngaarden PJ, 2000, HEREDITY, V85, P471, DOI 10.1046/j.1365-2540.2000.00786.x	30	108	111	0	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2002	415	6869					315	318		10.1038/415315a	http://dx.doi.org/10.1038/415315a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511YC	11797007				2022-12-24	WOS:000173293500042
J	Zoccali, C; Bode-Boger, SM; Mallamaci, F; Benedetto, FA; Tripepi, G; Malatino, LS; Cataliotti, A; Bellanuova, I; Fermo, I; Frolich, JC; Boger, RH				Zoccali, C; Bode-Boger, SM; Mallamaci, F; Benedetto, FA; Tripepi, G; Malatino, LS; Cataliotti, A; Bellanuova, I; Fermo, I; Frolich, JC; Boger, RH			Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study	LANCET			English	Article							NITRIC-OXIDE SYNTHESIS; L-ARGININE; ENDOGENOUS INHIBITOR; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR RISK; HEMODIALYSIS; SYNTHASE; IMPROVES; SERUM	Background The plasma concentration of asymmetrical dimethylarginine (ADMA), an inhibitor of nitric-oxide synthase, which has been linked to endothelial dysfunction and atherosclerosis in the general population, is raised in patients with end-stage renal disease and could contribute to the high cardiovascular risk in patients with chronic renal failure. We investigated the relation between cardiovascular risk factors and plasma ADMA concentration in a cohort of haemodialysis patients (n=225), and tested the predictive power of ADMA for mortality and cardiovascular outcomes. Methods Patients had standard dialysis three times a week. We accurately recorded cardiovascular events over a mean follow-up of 33.4 months (SID 14.6); these events were reviewed by a panel of physicians. We identified correlates of plasma ADMA by univariate and multivariate analyses. Findings On univariate analysis, ADMA concentration in plasma was directly related to concentrations of fibrinogen and L-arginine in plasma, duration of dialysis treatment, and serum cholesterol concentration, and was inversely related to serum albumin concentration. On multivariate analysis, only plasma fibrinogen (p=0.0001) and serum albumin (p=0.04) concentrations were independently related to plasma ADMA concentration (multiple r=0.44, p=0.0001). 83 patients died, 53 (64%) by cardiovascular causes. In a Cox's proportional-hazards model, plasma ADMA ranked as the second factor predicting overall mortality (hazard ratio 1.26, 95% CI 1.11-1.41, p=0.0001) and cardiovascular events (1.17, 1.04-1.33, p=0.008). Interpretation In haemodialysis patients, plasma ADMA is a strong and independent predictor of overall mortality and cardiovascular outcome. These findings lend support to the hypothesis that accumulation of ADMA is an important risk factor for cardiovascular disease in chronic renal failure.	Hannover Med Sch, Inst Clin Pharmacol, D-3000 Hannover, Germany; Univ Hamburg, Hosp Eppendorf, Inst Expt & Clin Pahrmacol & Toxicol, Dept Pharmacol,Clin Pharmacol Unit, D-20246 Hamburg, Germany; Hosp San Raffaele, Lab Cromatog & Tecn Separaz, I-20132 Milan, Italy; Univ Catania, Dept Internal Med, I-95124 Catania, Italy; CNR, Ctr Clin Physiol, Reggio Di Calabria, Italy; CNR, Renal Unit, Reggio Di Calabria, Italy	Hannover Medical School; University of Hamburg; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Catania; Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR)	Boger, RH (corresponding author), Hannover Med Sch, Inst Clin Pharmacol, D-3000 Hannover, Germany.	boeger@uke.uni-hamburg.de	Malatino, Lorenzo/I-7319-2018; fermo, isabella/AAN-3999-2020; Zoccali, Carmine/B-9445-2009; Cataliotti, Alessandro/G-7607-2012	Malatino, Lorenzo/0000-0003-2944-2729; fermo, isabella/0000-0003-2947-1933; Cataliotti, Alessandro/0000-0001-5476-8523; Bode-Boger, Stefanie/0000-0002-5132-6591; Zoccali, Carmine/0000-0002-6616-1996				Anderstam B, 1997, J AM SOC NEPHROL, V8, P1437; Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; Boger RH, 1997, CIRCULATION, V95, P2068, DOI 10.1161/01.CIR.95.8.2068; Boger RH, 1997, CIRCULATION, V96, P1282, DOI 10.1161/01.CIR.96.4.1282; Boger RH, 2000, CIRC RES, V87, P99, DOI 10.1161/01.RES.87.2.99; Boger RH, 2001, ANNU REV PHARMACOL, V41, P79, DOI 10.1146/annurev.pharmtox.41.1.79; Boger RH, 1998, J AM COLL CARDIOL, V32, P1336, DOI 10.1016/S0735-1097(98)00375-1; Boger RH, 2000, ARTERIOSCL THROM VAS, V20, P1557, DOI 10.1161/01.ATV.20.6.1557; CAYATTE AJ, 1994, ARTERIOSCLER THROMB, V14, P753, DOI 10.1161/01.ATV.14.5.753; COOKE JP, 1992, J CLIN INVEST, V90, P1168, DOI 10.1172/JCI115937; DREXLER H, 1991, LANCET, V338, P1546, DOI 10.1016/0140-6736(91)92372-9; FARACI FM, 1995, AM J PHYSIOL-HEART C, V269, pH1522, DOI 10.1152/ajpheart.1995.269.5.H1522; Hand MF, 1998, KIDNEY INT, V53, P1068, DOI 10.1046/j.1523-1755.1998.00851.x; Ito A, 1999, CIRCULATION, V99, P3092, DOI 10.1161/01.CIR.99.24.3092; Kari JA, 1997, KIDNEY INT, V52, P468, DOI 10.1038/ki.1997.354; Kielstein JT, 1999, J AM SOC NEPHROL, V10, P594; Lerman A, 1998, CIRCULATION, V97, P2123, DOI 10.1161/01.CIR.97.21.2123; Levey AS, 1998, AM J KIDNEY DIS, V32, pS5, DOI 10.1053/ajkd.1998.v32.pm9820463; MacAllister RJ, 1996, BRIT J PHARMACOL, V119, P1533, DOI 10.1111/j.1476-5381.1996.tb16069.x; MacAllister RJ, 1996, NEPHROL DIAL TRANSPL, V11, P2449, DOI 10.1093/oxfordjournals.ndt.a027213; Miyazaki H, 1999, CIRCULATION, V99, P1141, DOI 10.1161/01.CIR.99.9.1141; Moustapha A, 1998, CIRCULATION, V97, P138, DOI 10.1161/01.CIR.97.2.138; *NIH, 1997, US REN DAT SYST 1997; OGAWA T, 1989, J BIOL CHEM, V264, P10205; Surdacki A, 1999, J CARDIOVASC PHARM, V33, P652, DOI 10.1097/00005344-199904000-00020; VALLANCE P, 1992, LANCET, V339, P572; YU XJ, 1994, LIFE SCI, V54, P753, DOI 10.1016/0024-3205(94)00443-9; Zoccali C, 2000, NEPHROL DIAL TRANSPL, V15, P454, DOI 10.1093/ndt/15.4.454; Zoccali C, 1999, J HYPERTENS, V17, P1751, DOI 10.1097/00004872-199917120-00013	29	899	926	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 22	2001	358	9299					2113	2117		10.1016/S0140-6736(01)07217-8	http://dx.doi.org/10.1016/S0140-6736(01)07217-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505GV	11784625				2022-12-24	WOS:000172905800009
J	Oh, K; Jeong, KS; Moore, JS				Oh, K; Jeong, KS; Moore, JS			Folding-driven synthesis of oligomers	NATURE			English	Article							VIRTUAL COMBINATORIAL LIBRARIES; MOLECULES; POLYMERS	The biological function of biomacromolecules such as DNA and enzymes depends on their ability to perform and control molecular association, catalysis, self-replication or other chemical processes. In the case of proteins in particular, the dependence of these functions on the three-dimensional protein conformation is long known(1) and has inspired the development of synthetic oligomers and polymers with the capacity to fold in a controlled manner(2-7), but it remains challenging to design these so-called 'foldamers' so that they are capable of inducing or controlling chemical processes and interactions(8,9). Here we show that the stability gained from folding can be used to control the synthesis of oligomers from short chain segments reversibly ligated through an imine metathesis reaction. That is, folding shifts the ligation equilibrium(10-13) in favour of conformationally ordered sequences, so that oligomers having the most stable solution structures form preferentially. Crystallization has previously been used to shift an equilibrium in order to indirectly influence the synthesis of small molecules(14), but the present approach to selectively prepare macromolecules with stable conformations directly connects folding and synthesis, emphasizing molecular function rather than structure in polymer synthesis.	Univ Illinois, Dept Chem, Roger Adams Lab, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Moore, JS (corresponding author), Univ Illinois, Dept Chem, Roger Adams Lab, Urbana, IL 61801 USA.			Jeong, Kyu-Sung/0000-0003-1023-1796				Berl V, 2000, NATURE, V407, P720, DOI 10.1038/35037545; Gellman SH, 1998, ACCOUNTS CHEM RES, V31, P173, DOI 10.1021/ar960298r; GOODMAN M, 1969, P NATL ACAD SCI USA, V64, P444, DOI 10.1073/pnas.64.2.444; Hirschberg JHKK, 2000, NATURE, V407, P167, DOI 10.1038/35025027; Huc I, 1997, P NATL ACAD SCI USA, V94, P2106, DOI 10.1073/pnas.94.6.2106; Katz TJ, 2000, ANGEW CHEM INT EDIT, V39, P1921, DOI 10.1002/1521-3773(20000602)39:11<1921::AID-ANIE1921>3.0.CO;2-F; Kirshenbaum K, 1999, CURR OPIN STRUC BIOL, V9, P530, DOI 10.1016/S0959-440X(99)80075-X; Lehn JM, 2001, SCIENCE, V291, P2331, DOI 10.1126/science.1060066; Lehn JM, 1999, CHEM-EUR J, V5, P2455; Mirsky AE, 1936, P NATL ACAD SCI USA, V22, P439, DOI 10.1073/pnas.22.7.439; Moore JS, 2000, ORG LETT, V2, P915, DOI 10.1021/ol0055723; Nelson JC, 1997, SCIENCE, V277, P1793, DOI 10.1126/science.277.5333.1793; Nowick JS, 1999, ACCOUNTS CHEM RES, V32, P287, DOI 10.1021/ar970204t; Pace CN, 1989, PROTEIN STRUCTURE PR, P311; Prince RB, 1999, J AM CHEM SOC, V121, P3114, DOI 10.1021/ja983995i; Stigers KD, 1999, CURR OPIN CHEM BIOL, V3, P714, DOI 10.1016/S1367-5931(99)00030-7; TOTH G, 1974, TETRAHEDRON LETT, V15, P735; TROST BM, 1991, SCIENCE, V254, P1471, DOI 10.1126/science.1962206; WOODWARD RB, 1952, J AM CHEM SOC, V74, P4223, DOI 10.1021/ja01137a001; ZHANG JS, 1994, J AM CHEM SOC, V116, P4227, DOI 10.1021/ja00089a012	20	160	161	0	50	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2001	414	6866					889	893		10.1038/414889a	http://dx.doi.org/10.1038/414889a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503RB	11780057				2022-12-24	WOS:000172813300040
J	Hendry, JH; Booth, C; Potten, CS				Hendry, JH; Booth, C; Potten, CS			Endothelial cells and radiation gastrointestinal syndrome	SCIENCE			English	Editorial Material							FIBROBLAST GROWTH-FACTOR; INTESTINAL CRYPTS; CLONOGEN CONTENT; IN-VIVO; DEDUCTION; SURVIVAL; DEATH; ASSAY; MICE		Christie Hosp, Paterson Inst Canc Res, Manchester, Lancs, England; EpiStem Ltd, Manchester, Lancs, England	Christie NHS Foundation Trust; Christie Hospital; Paterson Institute for Cancer Research	Hendry, JH (corresponding author), Christie Hosp, Paterson Inst Canc Res, Manchester, Lancs, England.							FUKS Z, 1994, CANCER RES, V54, P2582; Houchen CW, 1999, AM J PHYSIOL-GASTR L, V276, pG249, DOI 10.1152/ajpgi.1999.276.1.G249; Okunieff P, 1998, RADIAT RES, V150, P204, DOI 10.2307/3579856; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; POTTEN CS, 1977, NATURE, V269, P518, DOI 10.1038/269518a0; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; ROBERTS SA, 1995, RADIAT RES, V141, P303, DOI 10.2307/3579007; ROBERTS SA, 1994, INT J RADIAT BIOL, V65, P477, DOI 10.1080/09553009414550551; TEE PG, 1995, CANCER RES, V55, P298; WITHERS HR, 1970, INT J RADIAT BIOL RE, V17, P261, DOI 10.1080/09553007014550291; WITHERS HR, 1993, RADIOTHER ONCOL, V26, P238	11	12	14	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2001	294	5546					1411A	1411A						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11826850				2022-12-24	WOS:000172240500002
J	Cyranoski, D				Cyranoski, D			Satellite set to keep track of whales	NATURE			English	News Item																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					354	354		10.1038/415354a	http://dx.doi.org/10.1038/415354a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807511	Bronze			2022-12-24	WOS:000173433600010
J	Cyranoski, D				Cyranoski, D			Japanese forum urges rethink over patents	NATURE			English	News Item																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2002	415	6870					354	354		10.1038/415354a	http://dx.doi.org/10.1038/415354a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514HR	11807511	Bronze			2022-12-24	WOS:000173433600009
